Citrus Sinensis ID: 027809
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 218 | 2.2.26 [Sep-21-2011] | |||||||
| Q9STV4 | 445 | CBL-interacting serine/th | no | no | 1.0 | 0.489 | 0.903 | 1e-117 | |
| Q5JLD8 | 446 | CBL-interacting protein k | yes | no | 0.990 | 0.484 | 0.879 | 1e-113 | |
| Q9LDI3 | 446 | CBL-interacting serine/th | no | no | 0.986 | 0.482 | 0.753 | 2e-99 | |
| Q69Q47 | 453 | CBL-interacting protein k | no | no | 0.981 | 0.472 | 0.757 | 1e-96 | |
| Q2V452 | 441 | CBL-interacting serine/th | no | no | 0.990 | 0.489 | 0.733 | 9e-96 | |
| Q2QY53 | 438 | CBL-interacting protein k | no | no | 0.990 | 0.493 | 0.724 | 1e-94 | |
| Q2RAX3 | 454 | CBL-interacting protein k | no | no | 0.990 | 0.475 | 0.720 | 5e-94 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.990 | 0.492 | 0.724 | 4e-93 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.972 | 0.439 | 0.710 | 6e-93 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.977 | 0.473 | 0.697 | 6e-92 |
| >sp|Q9STV4|CIPK8_ARATH CBL-interacting serine/threonine-protein kinase 8 OS=Arabidopsis thaliana GN=CIPK8 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 419 bits (1077), Expect = e-117, Method: Compositional matrix adjust.
Identities = 197/218 (90%), Positives = 211/218 (96%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMK++DRS IIK KM DQIKREISI
Sbjct: 1 MVVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHPCVVRL+EVLASRTKIYIILE+ITGGELFDKIV +GRLSESEAR+YF QLIDGV
Sbjct: 61 MKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALPEQGV++L+TTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGYNGA AD+WSCGVILYVL+AGYLPFDE+DL TLYS
Sbjct: 181 HKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYS 218
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5JLD8|CIPK8_ORYSJ CBL-interacting protein kinase 8 OS=Oryza sativa subsp. japonica GN=CIPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1043), Expect = e-113, Method: Compositional matrix adjust.
Identities = 190/216 (87%), Positives = 207/216 (95%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+R+VGKYEVGRTIGEGTFAKVKFAQNTE+GESVAMKV+DRS+I+KHKMADQIKREISIM
Sbjct: 6 ALRRVGKYEVGRTIGEGTFAKVKFAQNTESGESVAMKVVDRSSILKHKMADQIKREISIM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KLVRHP VVRLHEVLASR KI+IILEFITGGELFDKI+ HGRL+E++ARRYFQQLIDGVD
Sbjct: 66 KLVRHPNVVRLHEVLASRKKIFIILEFITGGELFDKIIRHGRLNEADARRYFQQLIDGVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+CHSKGVYHRDLKPENLLLDSQG+LKISDFGLSA P QG +LLRTTCGTPNYVAPEVLSH
Sbjct: 126 FCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSAWPAQGGALLRTTCGTPNYVAPEVLSH 185
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
KGY+GA AD WSCGVILYVL+AGYLPFDE+DLTTLY
Sbjct: 186 KGYDGALADTWSCGVILYVLLAGYLPFDEVDLTTLY 221
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDI3|CIPKO_ARATH CBL-interacting serine/threonine-protein kinase 24 OS=Arabidopsis thaliana GN=CIPK24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 361 bits (926), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 162/215 (75%), Positives = 198/215 (92%)
Query: 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+R+VGKYEVGRTIGEGTFAKVKFA+NT+TG++VA+K++ +S I+K++M DQIKREISIMK
Sbjct: 5 MRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+VRHP +VRL+EVLAS +KIYI+LEF+TGGELFD+IVH GRL ESE+R+YFQQL+D V +
Sbjct: 65 IVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAH 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
CH KGVYHRDLKPENLLLD+ G+LK+SDFGLSALP++GV LLRTTCGTPNYVAPEVLS +
Sbjct: 125 CHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEVLSGQ 184
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
GY+G+AAD+WSCGVIL+V++AGYLPF E DL LY
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLY 219
|
Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Activates the vacuolar H(+)/Ca(2+) antiporter CAX1 and operates in synergy with CBL4/SOS3 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q69Q47|CIPKO_ORYSJ CBL-interacting protein kinase 24 OS=Oryza sativa subsp. japonica GN=CIPK24 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (903), Expect = 1e-96, Method: Compositional matrix adjust.
Identities = 162/214 (75%), Positives = 191/214 (89%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
++VG+YEVGRTIG+GTFAKVKFA + +TG +VAMKVLD+ I+ H+M QIKREISIMK+
Sbjct: 13 KRVGRYEVGRTIGQGTFAKVKFAVDADTGAAVAMKVLDKDTILNHRMLHQIKREISIMKI 72
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
VRHP +VRL+EVLA +TKIYIILE ITGGELFDKI G+L E+EAR+YFQQLID ++YC
Sbjct: 73 VRHPNIVRLNEVLAGKTKIYIILELITGGELFDKIARQGKLRENEARKYFQQLIDAINYC 132
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
HSKGVYHRDLKPENLLLDS+G+LK+SDFGLS L ++GV LL TTCGTPNYVAPEVLS+ G
Sbjct: 133 HSKGVYHRDLKPENLLLDSRGNLKVSDFGLSTLAQKGVGLLHTTCGTPNYVAPEVLSNNG 192
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
Y+G+AADVWSCGVILYVL+AGYLPF+E DL TLY
Sbjct: 193 YDGSAADVWSCGVILYVLMAGYLPFEEDDLPTLY 226
|
Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Operates in synergy with CBL4 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 349 bits (895), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 160/218 (73%), Positives = 194/218 (88%), Gaps = 2/218 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVGRTIGEGTFAKVKFA+N+ETGE VA+K+LD+ ++KHKMA+QI+REI+ M
Sbjct: 7 VKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATM 66
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VV+L+EV+AS+TKI+IILE++TGGELFDKIV+ GR+ E EARRYFQQLI VD
Sbjct: 67 KLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVD 126
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LKISDFGLSAL +Q LL T+CGTPNYVAPEVL
Sbjct: 127 YCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVL 186
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ +GY+GA AD+WSCGV+LYVL+AGYLPFD+ +L LY
Sbjct: 187 NDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLY 224
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 158/218 (72%), Positives = 193/218 (88%), Gaps = 2/218 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYE+GRTIGEGTFAKVKFA++TETG+ VA+K+LD+ ++KHKM +QIKREIS M
Sbjct: 6 VKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VVR++EV+ S+TKIYI+LE++TGGELFD IV+HGR+ E EARRYFQQLI+ VD
Sbjct: 66 KLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LK+SDFGLSAL +Q LL TTCGTPNYVAPEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY
Sbjct: 186 EDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLY 223
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (880), Expect = 5e-94, Method: Compositional matrix adjust.
Identities = 157/218 (72%), Positives = 192/218 (88%), Gaps = 2/218 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYE+GRTIGEGTFAKVKFA++TETG+ VA+K+LD+ ++KHKM +QIKREIS M
Sbjct: 6 VKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VVR++EV+ S+T IYI+LE++TGGELFD IV+HGR+ E EARRYFQQLI+ VD
Sbjct: 66 KLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LK+SDFGLSAL +Q LL TTCGTPNYVAPEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY
Sbjct: 186 EDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLY 223
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 340 bits (872), Expect = 4e-93, Method: Compositional matrix adjust.
Identities = 158/218 (72%), Positives = 189/218 (86%), Gaps = 2/218 (0%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVG+T+G+GTFAKV+ A NTETGE VA+K+LD+ ++KHKMA+QI+REI M
Sbjct: 6 VQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL+ HP VVRL+EVLAS+TKIYI+LEF TGGELFDKIVH GRL E AR+YFQQLI+ VD
Sbjct: 66 KLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLD+QG+LK+SDFGLSAL Q G LL T CGTPNY APEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ +GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY
Sbjct: 186 NDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLY 223
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 6e-93, Method: Compositional matrix adjust.
Identities = 152/214 (71%), Positives = 189/214 (88%), Gaps = 2/214 (0%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
VGKYE+GRT+GEGTFAKVKFA+N E G++VA+KV+D+ ++K+KM QIKREIS MKL++
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
HP V+R+ EV+AS+TKIY +LEF+TGGELFDKI +GRL E EAR+YFQQLI+ VDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHKG 183
+GVYHRDLKPENLLLD+ G LK+SDFGLSALP+Q LL TTCGTPNYVAPEV+++KG
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
Y+GA AD+WSCGVIL+VL+AGYLPF++ +LT+LY
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLY 241
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 336 bits (862), Expect = 6e-92, Method: Compositional matrix adjust.
Identities = 150/215 (69%), Positives = 189/215 (87%), Gaps = 2/215 (0%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+VG+YE+GRT+GEGTFAKVKFA+N ++GE+VA+K+LD+ ++KHKM QIKREIS MKL+
Sbjct: 9 RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP V+R+HEV+AS+TKIYI++E +TGGELFDKI GRL E +AR+YFQQLI+ VDYCH
Sbjct: 69 RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHK 182
S+GVYHRDLKPENLLLD+ G LK+SDFGLSAL +Q LL TTCGTPNYVAPEV+++K
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
GY+GA AD+WSCGVIL+VL+AGYLPF++ +L +LY
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLY 223
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 218 | ||||||
| 357490169 | 475 | CBL-interacting protein kinase [Medicago | 1.0 | 0.458 | 0.944 | 1e-119 | |
| 356500781 | 444 | PREDICTED: CBL-interacting serine/threon | 1.0 | 0.490 | 0.931 | 1e-118 | |
| 356507985 | 446 | PREDICTED: CBL-interacting serine/threon | 1.0 | 0.488 | 0.935 | 1e-118 | |
| 255572824 | 446 | CBL-interacting serine/threonine-protein | 1.0 | 0.488 | 0.944 | 1e-118 | |
| 397133613 | 449 | CIPK [Gossypium aridum] | 1.0 | 0.485 | 0.935 | 1e-117 | |
| 356515679 | 446 | PREDICTED: CBL-interacting serine/threon | 1.0 | 0.488 | 0.922 | 1e-117 | |
| 388492050 | 429 | unknown [Lotus japonicus] | 1.0 | 0.508 | 0.912 | 1e-116 | |
| 449461361 | 446 | PREDICTED: CBL-interacting serine/threon | 1.0 | 0.488 | 0.922 | 1e-115 | |
| 302142105 | 453 | unnamed protein product [Vitis vinifera] | 1.0 | 0.481 | 0.926 | 1e-115 | |
| 297803674 | 445 | cbl-interacting protein kinase 8 [Arabid | 1.0 | 0.489 | 0.908 | 1e-115 |
| >gi|357490169|ref|XP_003615372.1| CBL-interacting protein kinase [Medicago truncatula] gi|355516707|gb|AES98330.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 433 bits (1114), Expect = e-119, Method: Compositional matrix adjust.
Identities = 206/218 (94%), Positives = 214/218 (98%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MV+RKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMK+LDRS IIKHKMADQIKREISI
Sbjct: 1 MVLRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKILDRSTIIKHKMADQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE+EARRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSEAEARRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDS G++KISDFGLSALPEQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSLGNMKISDFGLSALPEQGVSMLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGYNGA ADVWSCGVILYVL+AGYLPFDELDLTTLYS
Sbjct: 181 HKGYNGAPADVWSCGVILYVLMAGYLPFDELDLTTLYS 218
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500781|ref|XP_003519209.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1105), Expect = e-118, Method: Compositional matrix adjust.
Identities = 203/218 (93%), Positives = 213/218 (97%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MV+RKVGKYE+GRT+GEGTFAKVKFAQNTE+GESVAMKVLDRSAIIKHKM DQIKREISI
Sbjct: 1 MVLRKVGKYEIGRTVGEGTFAKVKFAQNTESGESVAMKVLDRSAIIKHKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIV HGRLSE+E+RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVSHGRLSEAESRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
D+CHSKGVYHRDLKPENLLLDSQG++KISDFGLSA PEQGVSLLRTTCGTPNYVAPEVLS
Sbjct: 121 DFCHSKGVYHRDLKPENLLLDSQGNIKISDFGLSAFPEQGVSLLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGYNGA ADVWSCGVILYVL+AGYLPFDELDLTTLYS
Sbjct: 181 HKGYNGAPADVWSCGVILYVLLAGYLPFDELDLTTLYS 218
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507985|ref|XP_003522743.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1104), Expect = e-118, Method: Compositional matrix adjust.
Identities = 204/218 (93%), Positives = 213/218 (97%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKMADQIKREISI
Sbjct: 1 MVVRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMADQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKI+HHGRLSE+++RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIIHHGRLSETDSRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDS G++KISDFGLSA PEQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSLGNIKISDFGLSAFPEQGVSILRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGYNGA ADVWSCGVILYVL+AGYLPFDELDLTTLYS
Sbjct: 181 HKGYNGAVADVWSCGVILYVLLAGYLPFDELDLTTLYS 218
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572824|ref|XP_002527344.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223533263|gb|EEF35016.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1102), Expect = e-118, Method: Compositional matrix adjust.
Identities = 206/218 (94%), Positives = 212/218 (97%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR+ IIKHKM DQIKREISI
Sbjct: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRTTIIKHKMIDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE+EARRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSEAEARRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGV+HRDLKPENLLLDSQG+LKISDFGLSA PE GVSLLRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVFHRDLKPENLLLDSQGNLKISDFGLSASPEDGVSLLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLYS
Sbjct: 181 HKGYDGAVADVWSCGVILYVLMAGYLPFDELDLTTLYS 218
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|397133613|gb|AFO10125.1| CIPK [Gossypium aridum] | Back alignment and taxonomy information |
|---|
Score = 426 bits (1094), Expect = e-117, Method: Compositional matrix adjust.
Identities = 204/218 (93%), Positives = 212/218 (97%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM DQIKREISI
Sbjct: 1 MVVRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEV+ASRTKIYIILEFITGGELFDKIVH GRLSE+EARR+FQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVIASRTKIYIILEFITGGELFDKIVHKGRLSEAEARRFFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
+YCHSKGVYHRDLKPENLLLDS G+LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS
Sbjct: 121 EYCHSKGVYHRDLKPENLLLDSLGNLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLYS
Sbjct: 181 HKGYDGAVADVWSCGVILYVLMAGYLPFDELDLTTLYS 218
|
Source: Gossypium aridum Species: Gossypium aridum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515679|ref|XP_003526526.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 425 bits (1093), Expect = e-117, Method: Compositional matrix adjust.
Identities = 201/218 (92%), Positives = 212/218 (97%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM DQIKREISI
Sbjct: 1 MVVRKVGKYEIGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKI+HHGRLSE+++RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIIHHGRLSEADSRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLL+S G++KISDFGLSA PEQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLNSLGNIKISDFGLSAFPEQGVSILRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGYNGA ADVWSCGVIL+VL+AGYLPFDELDLTTLYS
Sbjct: 181 HKGYNGAVADVWSCGVILFVLLAGYLPFDELDLTTLYS 218
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388492050|gb|AFK34091.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1084), Expect = e-116, Method: Compositional matrix adjust.
Identities = 199/218 (91%), Positives = 211/218 (96%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MV+RKVG+YE+GRT+GEGTFAKVKFAQNTE+GESVAMK+LDRS IIKHKM DQIKREISI
Sbjct: 1 MVLRKVGRYEIGRTVGEGTFAKVKFAQNTESGESVAMKILDRSTIIKHKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE+E+RRYFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSEAESRRYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG++KISDFGLSAL EQGVS+LRTTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSQGNIKISDFGLSALTEQGVSMLRTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
KGYNGA ADVWSCGVILYVL+AGYLPFDELDLT LYS
Sbjct: 181 RKGYNGAPADVWSCGVILYVLMAGYLPFDELDLTALYS 218
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449461361|ref|XP_004148410.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Cucumis sativus] gi|449523217|ref|XP_004168620.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 421 bits (1082), Expect = e-115, Method: Compositional matrix adjust.
Identities = 201/218 (92%), Positives = 212/218 (97%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM +QIK+EISI
Sbjct: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMVEQIKKEISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILE+ITGGELFDKIV HGRLSE+E+R+YFQQLIDGV
Sbjct: 61 MKLVRHPYVVRLHEVLASRTKIYIILEYITGGELFDKIVRHGRLSEAESRKYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHS+GVYHRDLKPENLLLDS G+LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL+
Sbjct: 121 DYCHSRGVYHRDLKPENLLLDSLGNLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLN 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLYS
Sbjct: 181 HKGYDGAMADVWSCGVILYVLMAGYLPFDELDLTTLYS 218
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142105|emb|CBI19308.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1079), Expect = e-115, Method: Compositional matrix adjust.
Identities = 202/218 (92%), Positives = 210/218 (96%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
+ VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRS IIKHKM DQIKREISI
Sbjct: 2 VAVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSTIIKHKMTDQIKREISI 61
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHP VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE+E+R YFQQLIDGV
Sbjct: 62 MKLVRHPYVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSENESRSYFQQLIDGV 121
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALP GVSLL+TTCGTPNYVAPEVLS
Sbjct: 122 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPAPGVSLLKTTCGTPNYVAPEVLS 181
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGY+GA ADVWSCGVILYVL+AGYLPFDELDLTTLY+
Sbjct: 182 HKGYDGAVADVWSCGVILYVLMAGYLPFDELDLTTLYN 219
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803674|ref|XP_002869721.1| cbl-interacting protein kinase 8 [Arabidopsis lyrata subsp. lyrata] gi|297315557|gb|EFH45980.1| cbl-interacting protein kinase 8 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 419 bits (1078), Expect = e-115, Method: Compositional matrix adjust.
Identities = 198/218 (90%), Positives = 211/218 (96%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMK++DRS IIK KM DQIKREISI
Sbjct: 1 MVVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHPCVVRL+EVLASRTKIYIILE+ITGGELFDKIV +GRL ESEAR+YFQQLIDGV
Sbjct: 61 MKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLGESEARKYFQQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALPEQGV++L+TTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGYNGA ADVWSCGVILYVL+AGYLPFDE+DL TLYS
Sbjct: 181 HKGYNGAVADVWSCGVILYVLMAGYLPFDEMDLPTLYS 218
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 218 | ||||||
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 1.0 | 0.489 | 0.903 | 5.8e-105 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.986 | 0.482 | 0.753 | 1.7e-89 | |
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.990 | 0.478 | 0.733 | 3.3e-86 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.990 | 0.492 | 0.724 | 1.3e-84 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.977 | 0.441 | 0.706 | 5e-83 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.990 | 0.259 | 0.665 | 1.5e-76 | |
| TAIR|locus:2090537 | 444 | CIPK1 "CBL-interacting protein | 0.977 | 0.479 | 0.618 | 1.1e-73 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.958 | 0.476 | 0.674 | 1.1e-73 | |
| TAIR|locus:2007685 | 432 | CIPK17 "CBL-interacting protei | 0.990 | 0.5 | 0.618 | 4.6e-73 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.963 | 0.476 | 0.624 | 5.5e-70 |
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1039 (370.8 bits), Expect = 5.8e-105, P = 5.8e-105
Identities = 197/218 (90%), Positives = 211/218 (96%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
MVVRKVGKYE+GRTIGEGTFAKVKFAQNTETGESVAMK++DRS IIK KM DQIKREISI
Sbjct: 1 MVVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISI 60
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
MKLVRHPCVVRL+EVLASRTKIYIILE+ITGGELFDKIV +GRLSESEAR+YF QLIDGV
Sbjct: 61 MKLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGV 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
DYCHSKGVYHRDLKPENLLLDSQG+LKISDFGLSALPEQGV++L+TTCGTPNYVAPEVLS
Sbjct: 121 DYCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLS 180
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
HKGYNGA AD+WSCGVILYVL+AGYLPFDE+DL TLYS
Sbjct: 181 HKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYS 218
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
Identities = 162/215 (75%), Positives = 198/215 (92%)
Query: 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+R+VGKYEVGRTIGEGTFAKVKFA+NT+TG++VA+K++ +S I+K++M DQIKREISIMK
Sbjct: 5 MRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+VRHP +VRL+EVLAS +KIYI+LEF+TGGELFD+IVH GRL ESE+R+YFQQL+D V +
Sbjct: 65 IVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAH 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
CH KGVYHRDLKPENLLLD+ G+LK+SDFGLSALP++GV LLRTTCGTPNYVAPEVLS +
Sbjct: 125 CHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEVLSGQ 184
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
GY+G+AAD+WSCGVIL+V++AGYLPF E DL LY
Sbjct: 185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLY 219
|
|
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 3.3e-86, P = 3.3e-86
Identities = 160/218 (73%), Positives = 194/218 (88%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVGRTIGEGTFAKVKFA+N+ETGE VA+K+LD+ ++KHKMA+QI+REI+ M
Sbjct: 17 VKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATM 76
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL++HP VV+L+EV+AS+TKI+IILE++TGGELFDKIV+ GR+ E EARRYFQQLI VD
Sbjct: 77 KLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVD 136
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLDS G+LKISDFGLSAL +Q LL T+CGTPNYVAPEVL
Sbjct: 137 YCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVL 196
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ +GY+GA AD+WSCGV+LYVL+AGYLPFD+ +L LY
Sbjct: 197 NDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLY 234
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 847 (303.2 bits), Expect = 1.3e-84, P = 1.3e-84
Identities = 158/218 (72%), Positives = 189/218 (86%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R+VGKYEVG+T+G+GTFAKV+ A NTETGE VA+K+LD+ ++KHKMA+QI+REI M
Sbjct: 6 VQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL+ HP VVRL+EVLAS+TKIYI+LEF TGGELFDKIVH GRL E AR+YFQQLI+ VD
Sbjct: 66 KLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLD+QG+LK+SDFGLSAL Q G LL T CGTPNY APEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ +GY+GA AD+WSCGVIL+VL+AGYLPF++ +L TLY
Sbjct: 186 NDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLY 223
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
Identities = 152/215 (70%), Positives = 190/215 (88%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+VGKYE+GRT+GEGTFAKVKFA+N E G++VA+KV+D+ ++K+KM QIKREIS MKL+
Sbjct: 27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP V+R+ EV+AS+TKIY +LEF+TGGELFDKI +GRL E EAR+YFQQLI+ VDYCH
Sbjct: 87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHK 182
S+GVYHRDLKPENLLLD+ G LK+SDFGLSALP+Q LL TTCGTPNYVAPEV+++K
Sbjct: 147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
GY+GA AD+WSCGVIL+VL+AGYLPF++ +LT+LY
Sbjct: 207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLY 241
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
Identities = 145/218 (66%), Positives = 183/218 (83%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
V R VGKYEVGR IGE F K++ A +TETG+ VA+ +LD+ ++KHKMA+QIKREISIM
Sbjct: 6 VRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKREISIM 65
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
KL+ HP VV+L+EVLAS+ KIYI+LEFI+GG+LFDKI + GR++E EA+RYFQQLI+ VD
Sbjct: 66 KLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQLINAVD 125
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVL 179
YCHS+GVYHRDLKPENLLLD+Q +LK+++FGL AL +Q G L T CG P+Y APEVL
Sbjct: 126 YCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYAAPEVL 185
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ +GY+GA AD+WSCGVIL+VL+AGYLPF++ LTTLY
Sbjct: 186 NDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLY 223
|
|
| TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 1.1e-73, P = 1.1e-73
Identities = 133/215 (61%), Positives = 182/215 (84%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
++GKYE+GRT+GEG F KVKFA++T +G S A+K++D+S I + QIKREI +K++
Sbjct: 16 RLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKREIRTLKML 75
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP +VRLHEVLAS+TKI +++E +TGGELFD+IV +G+L+E++ R+ FQQLIDG+ YCH
Sbjct: 76 KHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLIDGISYCH 135
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHK 182
SKGV+HRDLK EN+LLD++GH+KI+DFGLSALP+ + LL TTCG+PNYVAPEVL+++
Sbjct: 136 SKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 195
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
GY+GAA+D+WSCGVILYV++ G LPFD+ +L LY
Sbjct: 196 GYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLY 230
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 1.1e-73, P = 1.1e-73
Identities = 143/212 (67%), Positives = 172/212 (81%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KYE+GR +G+GTFAKV A+N +TGESVA+KV+D+ + K + DQIKREIS+M+LVRHP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
VV LHEV+AS+TKIY +E++ GGELFDK V G+L E+ AR+YFQQLI +DYCHS+G
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHKGYN 185
VYHRDLKPENLLLD G LKISDFGLSAL E Q LL TTCGTP YVAPEV+ KGY+
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
GA ADVWSCGV+LYVL+AG+LPF E +L +Y
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMY 221
|
|
| TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 738 (264.8 bits), Expect = 4.6e-73, P = 4.6e-73
Identities = 136/220 (61%), Positives = 186/220 (84%)
Query: 1 MVVR--KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI 58
MV++ +VGKYE+GRT+GEG AKVKFA +T TGES A+K++++S I + ++ QIKREI
Sbjct: 1 MVIKGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREI 60
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
+K+++HP +VRLHEVLAS+TKIY++LE +TGG+LFD+IV G+LSE++ R+ FQQLID
Sbjct: 61 RTLKVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLID 120
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAP 176
GV YCH+KGV+HRDLK EN+LLD++GH+KI+DFGLSAL + + LL TTCG+PNYVAP
Sbjct: 121 GVSYCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAP 180
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
EVL+++GY+GAA+D+WSCGVILYV++ G LPFD+ +L +
Sbjct: 181 EVLANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVI 220
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
Identities = 133/213 (62%), Positives = 169/213 (79%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+YE+GR +G GTFAKV A+N +TG+SVAMKV+ + ++K M DQIKREIS+M++V+H
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P +V LHEV+AS++KIY +E + GGELF K+ GRL E AR YFQQLI VD+CHS+
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHKGY 184
GVYHRDLKPENLLLD +G+LK++DFGLSA E + LL TTCGTP YVAPEV+ KGY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+GA AD+WSCGVIL+VL+AGYLPF + +L +Y
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMY 233
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5JLD8 | CIPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8796 | 0.9908 | 0.4843 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 218 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-95 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-81 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-72 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-71 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-69 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-62 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-58 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-58 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-57 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-57 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-53 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-53 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-51 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-51 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-49 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-48 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-48 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-48 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-47 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-47 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-46 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-46 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-45 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-45 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-45 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-45 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-44 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-44 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-44 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-44 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-43 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-43 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-42 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-42 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-42 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-42 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-42 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-42 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-41 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-41 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-41 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-41 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-41 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-41 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-40 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-40 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-40 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-40 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-40 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-40 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-40 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-39 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-39 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-39 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-38 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-38 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-38 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-38 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-38 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-38 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-37 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-37 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-36 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-36 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-35 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-34 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-34 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-34 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-34 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-34 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-33 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-33 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-33 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-32 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-32 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-32 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-31 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-31 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-31 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-31 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-30 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-30 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-30 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-30 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-30 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-30 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-30 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-29 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-29 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-29 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-29 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-28 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-28 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-28 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-27 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-27 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-27 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-26 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-26 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-26 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-24 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-24 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-24 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-24 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-23 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-23 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-22 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-22 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-21 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-21 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-21 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-20 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-18 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 277 bits (712), Expect = 4e-95
Identities = 99/204 (48%), Positives = 139/204 (68%), Gaps = 4/204 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YE+ +GEG+F KV A++ +TG+ VA+KV+ + I K + ++I REI I+K ++HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+VRL++V K+Y+++E+ GG+LFD + GRLSE EAR Y +Q++ ++Y HSKG+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRDLKPEN+LLD GH+K++DFGL+ L T GTP Y+APEVL KGY G A
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFVGTPEYMAPEVLLGKGY-GKA 176
Query: 189 ADVWSCGVILYVLIAGYLPFDELD 212
D+WS GVILY L+ G PF D
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 1e-81
Identities = 88/209 (42%), Positives = 128/209 (61%), Gaps = 1/209 (0%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YE+ R +G G+F V A++ TG+ VA+K+L + + K K +REI I++ + HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+VRL + + +Y+++E+ GG+LFD + G LSE EA++ Q++ G++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRDLKPEN+LLD G +KI+DFGL+ + S L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLY 217
DVWS GVILY L+ G PF ++
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQL 208
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 218 bits (559), Expect = 5e-72
Identities = 87/195 (44%), Positives = 123/195 (63%), Gaps = 1/195 (0%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G+F KV + +TG+ AMKVL + IIK K + E +I+ + HP +V+LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+ K+Y++LE+ GGELF + GR SE AR Y +++ ++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PEN+LLD+ GH+K++DFGL+ S T CGTP Y+APEVL KGY G A D WS
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179
Query: 195 GVILYVLIAGYLPFD 209
GV+LY ++ G PF
Sbjct: 180 GVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 4e-71
Identities = 84/189 (44%), Positives = 124/189 (65%), Gaps = 4/189 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+GEG F V A++ +TG+ VA+K++ + + +++ REI I+K + HP +V+L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 75 VLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V +Y+++E+ GG L D + + G+LSE E R Q+++G++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 134 KPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
KPEN+LLDS G +K++DFGLS L SLL+T GTP Y+APEVL KGY +D+W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178
Query: 193 SCGVILYVL 201
S GVILY L
Sbjct: 179 SLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 213 bits (546), Expect = 1e-69
Identities = 78/200 (39%), Positives = 127/200 (63%), Gaps = 4/200 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E +T+G G+F +V ++ +G+ A+K+L ++ I+K K + + E I++ +RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L+ + +Y+++E++ GGELF + GR E AR Y Q++ ++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPENLLLDS G++KI+DFG + + T CGTP Y+APE++ KGY G A
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY---TLCGTPEYLAPEIILSKGY-GKA 178
Query: 189 ADVWSCGVILYVLIAGYLPF 208
D W+ G+++Y ++AGY PF
Sbjct: 179 VDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 5e-62
Identities = 76/222 (34%), Positives = 120/222 (54%), Gaps = 22/222 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKRE-ISIMKLVRHP 67
++ G+ IGEG+F+ V A+ ET + A+K+LD+ +IK K +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L+ +Y +LE+ GEL I +G L E R Y +++ ++Y HSKG
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 128 VYHRDLKPENLLLDSQGHLKISDFG--------LSALPEQGVSLLRTT------------ 167
+ HRDLKPEN+LLD H+KI+DFG S +G + +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
GT YV+PE+L+ K G ++D+W+ G I+Y ++ G PF
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 3e-60
Identities = 72/198 (36%), Positives = 114/198 (57%), Gaps = 2/198 (1%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G G F +V+ + + A+K + + I++ + I E I++ HP +V+L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+ IY+++E+ GGEL+ + G E AR Y ++ +Y H++G+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PENLLLDS G++K+ DFG A + T CGTP YVAPE++ +KGY+ + D WS
Sbjct: 121 PENLLLDSNGYVKLVDFG-FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSL 178
Query: 195 GVILYVLIAGYLPFDELD 212
G++LY L+ G PF E D
Sbjct: 179 GILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 2e-58
Identities = 69/209 (33%), Positives = 118/209 (56%), Gaps = 6/209 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ G +G G+F V A + +TGE +A+K + + + + ++REI I+ ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59
Query: 68 CVVRL--HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+VR E + + I LE+++GG L + G+L E R+Y +Q+++G+ Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKG 183
G+ HRD+K N+L+DS G +K++DFG + + + GTP ++APEV+ +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y G AAD+WS G + + G P+ EL
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELG 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 7e-58
Identities = 70/210 (33%), Positives = 117/210 (55%), Gaps = 14/210 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR----EISIMKL 63
KYE+ + IG+G+F KV + G+ +K +D S M+++ + E+ I+K
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS-----NMSEKEREDALNEVKILKK 55
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDG 119
+ HP +++ +E + K+ I++E+ GG+L KI + E + +F QL
Sbjct: 56 LNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+ Y HS+ + HRD+KP+N+ L S G +K+ DFG+S + V L +T GTP Y++PE+
Sbjct: 116 LKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+K YN +D+WS G +LY L PF+
Sbjct: 176 QNKPYN-YKSDIWSLGCVLYELCTLKHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-57
Identities = 86/205 (41%), Positives = 130/205 (63%), Gaps = 6/205 (2%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K+ +E+G T+G G+F +V+ A++ TGE A+K L + I+K K + +E SI+ +
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
HP +V + ++Y +LEF+ GGELF + GR A+ Y +L+ +Y H
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
SK + +RDLKPENLLLD++GH+K++DFG + +P++ +L CGTP Y+APEV+ KG
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL----CGTPEYLAPEVIQSKG 191
Query: 184 YNGAAADVWSCGVILYVLIAGYLPF 208
+ G A D W+ GV+LY IAGY PF
Sbjct: 192 H-GKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 4e-57
Identities = 71/202 (35%), Positives = 117/202 (57%), Gaps = 9/202 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
I +G + +V A+ TG+ A+KV+ ++ +I+ DQ+ E I+ + P VV+L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+ +Y+++E++ GG+L + + G L E AR Y +++ ++Y HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLL--------RTTCGTPNYVAPEVLSHKGYNG 186
P+N+L+DS GHLK++DFGLS + + + GTP+Y+APEV+ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 187 AAADVWSCGVILYVLIAGYLPF 208
D WS G ILY + G PF
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPF 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-53
Identities = 73/200 (36%), Positives = 121/200 (60%), Gaps = 4/200 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
E +T+G GTF +V ++ + A+KV+ +I+ K + E ++K V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++RL + +Y+++E++ GGELF + + GR S S Y +++ ++Y HSK +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD +GH+K++DFG + ++ T CGTP Y+APEV+ KG+N A
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVIQSKGHN-KA 178
Query: 189 ADVWSCGVILYVLIAGYLPF 208
D W+ G+++Y ++ GY PF
Sbjct: 179 VDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 7e-53
Identities = 67/201 (33%), Positives = 113/201 (56%), Gaps = 2/201 (0%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ R IG+G F KV Q +T + AMK +++ ++ + E I++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L +Y++++ + GG+L + + SE + + + +++ ++Y HSKG+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRD+KP+N+LLD QGH+ I+DF ++ +L +T GTP Y+APEVL +GY A
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGY-SVA 179
Query: 189 ADVWSCGVILYVLIAGYLPFD 209
D WS GV Y + G P+
Sbjct: 180 VDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-51
Identities = 80/206 (38%), Positives = 118/206 (57%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A++ G+ A+KVL + AI+K K I E +++ K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L+++ GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPEN+LLDSQGH+ ++DFGL + T CGTP Y+APEVL + Y+ D
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W G +LY ++ G PF D +Y
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-51
Identities = 80/208 (38%), Positives = 121/208 (58%), Gaps = 9/208 (4%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
G IG GTF KV A N +TGE +A+K + R K +I E+ +++L++HP +V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYH 130
+ V R K+YI +E+ +GG L + ++ HGR L E R Y QL++G+ Y HS G+ H
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122
Query: 131 RDLKPENLLLDSQGHLKISDFGLSA-LPEQG---VSLLRTTCGTPNYVAPEVLSHKGYNG 186
RD+KP N+ LD G +K+ DFG + L +++ GTP Y+APEV++ G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 187 --AAADVWSCGVILYVLIAGYLPFDELD 212
AAD+WS G ++ + G P+ ELD
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELD 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 169 bits (427), Expect = 6e-51
Identities = 82/215 (38%), Positives = 126/215 (58%), Gaps = 16/215 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + R +GEG+F +V A++ + VA+KVL + K K ++ REI I+ + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 68 -CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYC 123
+V+L++ +Y+++E++ GG L D + GR LSESEA Q++ ++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 124 HSKGVYHRDLKPENLLLDSQGH-LKISDFGLSAL------PEQGVSLLRTTCGTPNYVAP 176
HSKG+ HRD+KPEN+LLD G +K+ DFGL+ L +L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 177 EVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFD 209
EVL Y +++D+WS G+ LY L+ G PF+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-49
Identities = 76/206 (36%), Positives = 126/206 (61%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ T E A+KVL + I++ + E ++ L +HP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH ++ +++ ++E++ GG+L I GR E AR Y +++ G+ + H +G+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLDS+GH+KI+DFG+ G T CGTP+Y+APE+LS++ Y G A D
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W+ GV+LY ++AG PF+ D L+
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (406), Expect = 2e-48
Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 45/218 (20%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-IK----REISIMKL 63
YE +GEGT+ V A++ +TGE VA+K I+ ++ I REIS++K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKK------IRLDNEEEGIPSTALREISLLKE 54
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGE-----LFDKIVHHGRLSESEARRYFQQLID 118
++HP +V+L +V+ + K+Y++ E+ + DK G LS + + QL+
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMYQLLR 109
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN------ 172
G+ YCHS + HRDLKP+N+L++ G LK++DFGL+ G P
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-----------RAFGIPLRTYTHE 158
Query: 173 -----YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
Y APE+L K Y A D+WS G I +I G
Sbjct: 159 VVTLWYRAPEILLGSKHY-STAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-48
Identities = 70/195 (35%), Positives = 110/195 (56%), Gaps = 4/195 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G + +V A+ +TGE VA+K + +S + K + E I+ + +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
+Y+ +E++ GG+ + + G LSE AR Y ++ + VD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PEN L+D+ GH+K++DFGLS V+ + G+P+Y+APEVL KGY+ D WS
Sbjct: 129 PENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYD-FTVDYWSL 184
Query: 195 GVILYVLIAGYLPFD 209
G +LY + G+ PF
Sbjct: 185 GCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 4e-48
Identities = 81/209 (38%), Positives = 121/209 (57%), Gaps = 8/209 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A+ G A+KVL + I+K K + I E +++ K ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L+++ GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGL---SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
DLKPEN+LLDSQGH+ ++DFGL PE+ S T CGTP Y+APEVL + Y+
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS---TFCGTPEYLAPEVLRKEPYD-RT 176
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D W G +LY ++ G PF D++ +Y
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-47
Identities = 72/229 (31%), Positives = 116/229 (50%), Gaps = 30/229 (13%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+EV + IG G F +V ++ +TG+ AMKVL +S +IK ++ E I+ P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V+L+ +Y+++E++ GG+L + ++ E AR Y +L+ +D H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLL----------------------- 164
HRD+KP+N+L+D+ GH+K++DFGL + +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 165 -----RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+T GTP+Y+APEVL Y D WS GVILY ++ G+ PF
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-47
Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 4/206 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y++G IG G F V N ETG+ VA+K + I + + I +EI ++K ++HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+ + + +YIILE+ G L I G ES Y Q++ G+ Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC-GTPNYVAPEVLSHKGYNG 186
V HRD+K N+L G +K++DFG+ A VS + GTP ++APEV+ G +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV-ATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS- 177
Query: 187 AAADVWSCGVILYVLIAGYLPFDELD 212
A+D+WS G + L+ G P+ +L+
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLN 203
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-47
Identities = 75/199 (37%), Positives = 122/199 (61%), Gaps = 5/199 (2%)
Query: 13 RTIGEGTFAKVKFAQN---TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G+G+F KV + + G+ AMKVL + A +K + + K E I+ V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V+LH + K+Y+IL+F+ GG+LF ++ +E + + Y +L +D+ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+RDLKPEN+LLD +GH+K++DFGLS + CGT Y+APEV++ +G+ +A
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSA 179
Query: 190 DVWSCGVILYVLIAGYLPF 208
D WS GV+++ ++ G LPF
Sbjct: 180 DWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 4e-46
Identities = 77/238 (32%), Positives = 118/238 (49%), Gaps = 39/238 (16%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + IG G F +V+ Q +TG AMK L +S +++ + ++ E I+ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV+L+ +Y+I+E++ GG++ ++ +E E R Y + I +D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLS-----------------ALPEQGVSLLRT----- 166
HRD+KP+NLLLD++GH+K+SDFGL ALP + +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 167 ----------------TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
T GTP+Y+APEV GYN D WS GVI+Y ++ GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-46
Identities = 78/208 (37%), Positives = 113/208 (54%), Gaps = 7/208 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG+ AMK+L + II E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ ++ ++E+ GGELF + SE AR Y +++ + Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAAA 189
LK ENL+LD GH+KI+DFGL ++G+S T CGTP Y+APEVL Y G A
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 176
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLY 217
D W GV++Y ++ G LPF D L+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 7e-46
Identities = 77/221 (34%), Positives = 117/221 (52%), Gaps = 29/221 (13%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD----QIKREISIMKLV 64
YE IGEGT+ +V A+N +TGE VA+K I + REI +++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFI----TGGELFDKIVHHG--RLSESEARRYFQQL 116
RHP +VRL E++ S+ K IY++ E++ TG ++ + +ES+ + Y +QL
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQL 109
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG--TPNYV 174
++G+ Y HS G+ HRD+K N+L+++ G LK++DFGL A P + T T Y
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYR 168
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD 212
PE+L G D+WS G IL L G F EL+
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-45
Identities = 79/209 (37%), Positives = 121/209 (57%), Gaps = 8/209 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A+ G+ A+KVL + ++ K I E +++ K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L+F+ GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAA 188
DLKPEN+LLDSQGH+ ++DFGL ++G++ TT CGTP Y+APEV+ + Y+
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-T 176
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D W G +LY ++ G PF D+ +Y
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-45
Identities = 73/206 (35%), Positives = 121/206 (58%), Gaps = 6/206 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E+ IG+G F +V A++ TG+ VA+KV+ + + ++I EI I+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V+ + + +++I++EF +GG L D + + L+ES+ ++L+ G++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G+ HRD+K N+LL S G +K+ DFGLSA + T GTP ++APEV++ K Y+
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDY 176
Query: 187 AAADVWSCGVILYVLIAGYLPFDELD 212
AD+WS G+ L G P+ EL
Sbjct: 177 -KADIWSLGITAIELAEGKPPYSELP 201
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 3e-45
Identities = 76/203 (37%), Positives = 112/203 (55%), Gaps = 1/203 (0%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F KV + +T A+K + ++ I+ E +++ V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
S K+Y++L FI GGELF + GR S AR Y +L+ ++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
PEN+LLD QGH+ + DFGL L + T CGTP Y+APE+L GY A D W+
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTL 179
Query: 195 GVILYVLIAGYLPFDELDLTTLY 217
GV+LY ++ G PF + ++ +Y
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMY 202
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-45
Identities = 75/200 (37%), Positives = 121/200 (60%), Gaps = 5/200 (2%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKH-KMADQIKREISIMKLVRHPC 68
+ +G+G + KV + +TG+ AMKVL ++ I+++ K K E +I++ V+HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L + K+Y+ILE+++GGELF + G E A Y ++ +++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD+QGH+K++DFGL ++ T CGT Y+APE+L G+ G A
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKA 180
Query: 189 ADVWSCGVILYVLIAGYLPF 208
D WS G ++Y ++ G PF
Sbjct: 181 VDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 7e-45
Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 13/212 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
YEV TIG+G+F V+ + G+ + K +D + K Q+ E++I++ ++HP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHP 59
Query: 68 CVVRL--HEVLASRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVD 121
+VR + S +YI++E+ GG+L I + E R QL+ +
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 122 YCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
CH++ V HRDLKP N+ LD+ ++K+ DFGL+ + S +T GTP Y++P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
E L+H Y+ +D+WS G ++Y L A PF
Sbjct: 180 EQLNHMSYD-EKSDIWSLGCLIYELCALSPPF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 9e-45
Identities = 67/199 (33%), Positives = 109/199 (54%), Gaps = 4/199 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y++ IGEG V A++ ETGE+VA+K + ++ + +Q REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSK 126
VV+L +V + +++E++ L + + R L E++ + Y + L+ GV Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT-TCGTPNYVAPEVLSHKGYN 185
G+ HRDLKP NLL+ + G LKI+DFGL+ L + L + T Y APE+L
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 186 GAAADVWSCGVILYVLIAG 204
D+W+ G I L+ G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 1e-44
Identities = 76/208 (36%), Positives = 116/208 (55%), Gaps = 7/208 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + II E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ ++ ++E+ GGELF + +E AR Y +++ ++Y HS+ V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+K ENL+LD GH+KI+DFGL ++G+S ++T CGTP Y+APEVL Y G A
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 176
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLY 217
D W GV++Y ++ G LPF D L+
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHERLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-44
Identities = 75/205 (36%), Positives = 113/205 (55%), Gaps = 1/205 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + +G+ AMK+L + II E ++K RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++ ++ ++E++ GGELF + SE R Y +++ +DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
LK ENL+LD GH+KI+DFGL + ++T CGTP Y+APEVL Y G A D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 193 SCGVILYVLIAGYLPFDELDLTTLY 217
GV++Y ++ G LPF D L+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 3e-44
Identities = 79/206 (38%), Positives = 117/206 (56%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A++ + A+KVL + AI+K K I E +++ K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L++I GGELF + E AR Y ++ + Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPEN+LLDSQGH+ ++DFGL + T CGTP Y+APEVL + Y+ D
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W G +LY ++ G PF + +Y
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 4e-44
Identities = 70/196 (35%), Positives = 112/196 (57%), Gaps = 6/196 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLH 73
I +G F V A+ TG+ A+KVL +S +I +K E +IM + P V +L+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
S+ +Y+++E++ GG+ I G L E A++Y +++ GV+ H +G+ HRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
KPENLL+D GHLK++DFGLS + + GTP+Y+APE + G + +D WS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLS----RNGLENKKFVGTPDYLAPETILGVGDD-KMSDWWS 178
Query: 194 CGVILYVLIAGYLPFD 209
G +++ + GY PF
Sbjct: 179 LGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-43
Identities = 73/204 (35%), Positives = 123/204 (60%), Gaps = 2/204 (0%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLH 73
+G+G+F KV A+ T E A+K+L + II+ + E ++ L + P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
+ ++Y ++E++ GG+L I G+ E A Y ++ G+ + HSKG+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
K +N++LD++GH+KI+DFG+ G RT CGTP+Y+APE+++++ Y G + D W+
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186
Query: 194 CGVILYVLIAGYLPFDELDLTTLY 217
GV+LY ++AG PFD D L+
Sbjct: 187 FGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 7e-43
Identities = 77/209 (36%), Positives = 124/209 (59%), Gaps = 11/209 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV 64
+E+ R +G G + KV + + G+ AMKVL ++ I+ K K A+ + E +++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 65 RH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
R P +V LH + TK+++IL+++ GGELF + +ESE R Y +++ +D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSH 181
H G+ +RD+K EN+LLDS+GH+ ++DFGLS L E+ + CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRG 180
Query: 182 K--GYNGAAADVWSCGVILYVLIAGYLPF 208
G++ A D WS GV+ + L+ G PF
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-42
Identities = 66/207 (31%), Positives = 123/207 (59%), Gaps = 8/207 (3%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRHPCV 69
G+ +G+G F +V + +TG +A+K + D + K + ++ EI ++K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V+ + L + I +E++ GG + D++ +G L+E+ R+Y +Q+++GV+Y HS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 130 HRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
HRD+K N+L DS G++K+ DFG L + G + +++ GTP +++PEV+S +GY
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGEGY- 184
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELD 212
G ADVWS G + ++ P+ E +
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-42
Identities = 72/206 (34%), Positives = 125/206 (60%), Gaps = 6/206 (2%)
Query: 9 YEVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV 64
+E+ + +G G + KV + +TG+ AMKVL ++A++ K K + + E ++++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 65 RH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
R P +V LH + K+++IL++++GGE+F + SE E R Y ++I +++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHK 182
H G+ +RD+K EN+LLDS+GH+ ++DFGLS + + CGT Y+APE++ K
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPF 208
G +G A D WS G++++ L+ G PF
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 6e-42
Identities = 70/198 (35%), Positives = 115/198 (58%), Gaps = 2/198 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVR 71
R +G+G+F KV A+ E+G A+KVL + I++ + E I+ L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ + +++ ++EF+ GG+L I R E+ AR Y ++ + + H KG+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD +GH K++DFG+ T CGTP+Y+APE+L Y G + D
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179
Query: 192 WSCGVILYVLIAGYLPFD 209
W+ GV+LY ++ G+ PF+
Sbjct: 180 WAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 6e-42
Identities = 71/200 (35%), Positives = 106/200 (53%), Gaps = 11/200 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVR 71
+G G F KV A+ +TGE A+K L + II + + E I + RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L + + ++E+ GG+L I H SE A Y ++ G+ Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAA 188
DLK +NLLLD++G +KI+DFGL ++G+ T CGTP ++APEVL+ Y A
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRA 181
Query: 189 ADVWSCGVILYVLIAGYLPF 208
D W GV++Y ++ G PF
Sbjct: 182 VDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 7e-42
Identities = 77/206 (37%), Positives = 113/206 (54%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + I+ E +++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHR 131
+ ++ ++E+ GGELF + SE AR Y +++ +DY HS K V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK ENL+LD GH+KI+DFGL + + ++T CGTP Y+APEVL Y G A D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W GV++Y ++ G LPF D L+
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-42
Identities = 74/207 (35%), Positives = 112/207 (54%), Gaps = 5/207 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK---LVRHPCVVR 71
IG+GTF +V + +T AMKVL + I+ K E +I+ L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L + + +Y++ ++++GGELF + GR SE A+ Y +L+ +++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV-LSHKGYNGAAAD 190
DLKPEN+LLD+ GH+ + DFGLS T CGT Y+APEV L KGY D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVD 179
Query: 191 VWSCGVILYVLIAGYLPFDELDLTTLY 217
WS GV+++ + G+ PF D +Y
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMY 206
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 1e-41
Identities = 71/204 (34%), Positives = 123/204 (60%), Gaps = 2/204 (0%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLH 73
+G+G+F KV A+ T E A+K+L + +I+ + E ++ L + P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
+ ++Y ++E++ GG+L +I GR E A Y ++ G+ + HSKG+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
K +N++LDS+GH+KI+DFG+ +T CGTP+Y+APE+++++ Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186
Query: 194 CGVILYVLIAGYLPFDELDLTTLY 217
GV+LY ++AG PF+ D L+
Sbjct: 187 FGVLLYEMLAGQAPFEGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-41
Identities = 73/197 (37%), Positives = 111/197 (56%), Gaps = 5/197 (2%)
Query: 13 RTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
RT+G G+F +V A E VA+K ++S IIK K D + E I+ + HP V
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ + +Y++LEF+ GGE F + + R Y Q++ +Y S + +R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPENLLLD G +K++DFG + + + + T CGTP Y+APE+L + G+ G AAD
Sbjct: 156 DLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYTLCGTPEYIAPEILLNVGH-GKAADW 211
Query: 192 WSCGVILYVLIAGYLPF 208
W+ G+ +Y ++ G PF
Sbjct: 212 WTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-41
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 10/203 (4%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMK---VLDRSAIIKHKMADQIKREISIMKLVRH 66
E + +G+G+ V ++ TG+ A+K V K Q+ RE+ ++
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P VV+ + +I I+LE++ GG L D + G++ E +Q++ G+DY H+K
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 127 -GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRD+KP NLL++S+G +KI+DFG+S + E + T GT Y++PE + + Y
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY- 177
Query: 186 GAAADVWSCGVILYVLIAGYLPF 208
AAD+WS G+ L G PF
Sbjct: 178 SYAADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 67/198 (33%), Positives = 113/198 (57%), Gaps = 2/198 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVR 71
+ +G+G+F KV A+ T E A+KVL + I++ D E I+ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH ++ +++ ++E++ GG+L +I + E +R Y ++ + + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD++GH K++DFG+ T CGTP+Y+APE+L Y G + D
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDW 179
Query: 192 WSCGVILYVLIAGYLPFD 209
W+ GV++Y ++AG PF+
Sbjct: 180 WALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-41
Identities = 71/234 (30%), Positives = 118/234 (50%), Gaps = 53/234 (22%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKV------------LDRSAIIKHKMADQIK 55
+YE G+ +GEGT+A V A++ ETG VA+K ++ +A+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL---------- 50
Query: 56 REISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG---GELFDKIVHHGRLSESEARRY 112
REI +++ ++HP ++ L +V ++ I ++ EF+ + DK + L+ ++ + Y
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSY 107
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172
+ G++Y HS + HRDLKP NLL+ S G LK++DFGL+ + G+PN
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-----------RSFGSPN 156
Query: 173 -----------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG--YLPFD-ELD 212
Y APE+L + G D+WS G I L+ +LP D ++D
Sbjct: 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-41
Identities = 70/204 (34%), Positives = 122/204 (59%), Gaps = 2/204 (0%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLH 73
+G+G+F KV A+ T E A+K+L + +I+ + E ++ L + P + +LH
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
+ ++Y ++E++ GG+L I G+ E +A Y ++ G+ + H +G+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
K +N++LDS+GH+KI+DFG+ RT CGTP+Y+APE+++++ Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186
Query: 194 CGVILYVLIAGYLPFDELDLTTLY 217
GV+LY ++AG PFD D L+
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELF 210
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-41
Identities = 66/198 (33%), Positives = 119/198 (60%), Gaps = 2/198 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AMKV+ + + + D ++ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++EF++GG+L + +L E AR Y ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD++GH+K++D+G+ + T CGTPNY+APE+L + Y G + D
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179
Query: 192 WSCGVILYVLIAGYLPFD 209
W+ GV+++ ++AG PFD
Sbjct: 180 WALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-40
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-REI-SIMKLVRH 66
Y+V + +G+GTF V A+N ETGE VA+K + + + + + RE+ S+ KL H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEH 57
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCH 124
P +V+L EV ++Y + E++ G L+ + SES R Q++ G+ + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYV------A 175
G +HRDLKPENLL+ +KI+DFGL+ R P +YV A
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA----------REIRSRPPYTDYVSTRWYRA 166
Query: 176 PEVLSHKGYNGAAADVWSCGVI---LYVL 201
PE+L + D+W+ G I LY L
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-40
Identities = 63/202 (31%), Positives = 113/202 (55%), Gaps = 6/202 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+ IGEG +V A + TG+ VA+K + ++ + + I EI IMK +HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
+V ++ ++++++E++ GG L D I + R++E + ++++ G++Y HS+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRD+K +N+LL G +K++DFG +A + S + GTP ++APEV+ K Y
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG- 194
Query: 187 AAADVWSCGVILYVLIAGYLPF 208
D+WS G++ + G P+
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-40
Identities = 68/209 (32%), Positives = 111/209 (53%), Gaps = 7/209 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++V +G G F +V+ + TG+ AMKV+ +S ++ + + E I+ + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ +L + +Y+++E+ GG+L + + + E A+ Y +L+ + H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVL-----SH 181
HRD+KPEN+L+D GH+K++DFG +A L + + GTP+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDE 210
KG G D WS GVI Y +I G PF E
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-40
Identities = 69/201 (34%), Positives = 122/201 (60%), Gaps = 8/201 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AMKV+ + + + D ++ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++E++ GG+L + +L E AR Y ++ ++Y H +G+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAA 188
DLK +N+LLDS+GH+K++D+G+ ++G+ TT CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFS 176
Query: 189 ADVWSCGVILYVLIAGYLPFD 209
D W+ GV+++ ++AG PFD
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-40
Identities = 78/218 (35%), Positives = 120/218 (55%), Gaps = 5/218 (2%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K YEV + IG G F +V+ ++ T + AMK+L + +IK + E IM
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P VV+L +Y+++E++ GG+L + + ++ + E AR Y +++ +D H
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIH 159
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHK- 182
S G HRD+KP+N+LLD GHLK++DFG + ++G+ T GTP+Y++PEVL +
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 183 --GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
GY G D WS GV LY ++ G PF L YS
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-40
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVA---MKVLDRSAIIKHKMADQIKREISIMKL 63
KYEV +GEG + V +N TGE VA K + +K RE+ +++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQ 56
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH------GRLSESEARRYFQQLI 117
+RH +V L E + ++Y++ E+ ++ + G L R Y QL+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEY------VERTLLELLEASPGGLPPDAVRSYIWQLL 110
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAP 176
+ YCHS + HRD+KPEN+L+ G LK+ DFG + AL + S L T Y AP
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAG 204
E+L G DVW+ G I+ L+ G
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-40
Identities = 75/235 (31%), Positives = 118/235 (50%), Gaps = 36/235 (15%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + IG G F +V+ Q +TG AMK+L ++ +++ + I+ E I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV++ + +Y+I+EF+ GG++ ++ LSE + Y + + +D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGL---------------------SALPEQGVS----- 162
HRD+KP+NLLLD++GH+K+SDFGL S Q ++
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 163 ---------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
L +T GTP+Y+APEV GYN D WS GVI+Y ++ GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-40
Identities = 73/200 (36%), Positives = 109/200 (54%), Gaps = 9/200 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLVR 65
Y+ IGEGT+ V A++ TGE VA+K + S I K A REI ++K +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP-KTA---LREIKLLKELN 56
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
HP +++L +V + +Y++ EF+ +L+ I R L ES + Y QL+ G+ +CH
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
S G+ HRDLKPENLL++++G LK++DFGL+ V T Y APE+L
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 185 NGAAADVWSCGVILYVLIAG 204
D+WS G I L++
Sbjct: 176 YSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-40
Identities = 77/235 (32%), Positives = 121/235 (51%), Gaps = 36/235 (15%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + IG G F +V+ Q +TG AMK+L ++ +++ + I+ E I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV++ + +Y+I+EF+ GG++ ++ L+E E + Y + + +D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLS-----------------ALPE----QGVSLLR-- 165
HRD+KP+NLLLDS+GH+K+SDFGL +LP Q ++ R
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 166 ------------TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+T GTP+Y+APEV GYN D WS GVI+Y ++ GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-39
Identities = 73/205 (35%), Positives = 116/205 (56%), Gaps = 7/205 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ T E A+K L + +++ + E ++ L HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L ++ ++ ++E++ GG+L I GR E+ AR Y ++I G+ + H KG+ +R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD GH+KI+DFG+ G T CGTP+Y+APE+L + YN + D
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN-ESVDW 179
Query: 192 WSCGVILYVLIAGYLPF-----DEL 211
WS GV+LY ++ G PF DEL
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 6e-39
Identities = 75/218 (34%), Positives = 120/218 (55%), Gaps = 5/218 (2%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K Y+V + IG G F +V+ ++ + + AMK+L + +IK + E IM
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P VV+L +Y+++E++ GG+L + + ++ + E A+ Y +++ +D H
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIH 159
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHK- 182
S G+ HRD+KP+N+LLD GHLK++DFG + E G+ T GTP+Y++PEVL +
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 183 --GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
GY G D WS GV L+ ++ G PF L YS
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS 257
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 8e-39
Identities = 68/196 (34%), Positives = 106/196 (54%), Gaps = 4/196 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+GEGT+A V +N TGE VA+K + A + REIS+MK ++H +VRLH+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 75 VLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
V+ + K+ ++ E++ + D G L + + + QL+ G+ +CH V HRD
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
LKP+NLL++ +G LK++DFGL+ V+ T Y AP+VL + D+W
Sbjct: 126 LKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIW 185
Query: 193 SCGVILYVLIAGYLPF 208
S G I+ +I G F
Sbjct: 186 SVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-38
Identities = 69/212 (32%), Positives = 114/212 (53%), Gaps = 12/212 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHK-----MADQIKREISIMKLV 64
G IG+GT+ +V A N TGE +A+K L + +H M ++ EI +K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
H +V+ + + I LE++ GG + + +GR E R + +Q+++G+ Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC--GTPNYVAPEV--LS 180
SKG+ HRDLK +NLL+D+ G KISDFG+S + + G+ ++APEV
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+GY+ A D+WS G ++ + AG P+ + +
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEE 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-38
Identities = 72/243 (29%), Positives = 111/243 (45%), Gaps = 44/243 (18%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +TIG G F +V + +T AMK L ++ ++ A +K E I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV+L+ + +Y ++++I GG++ ++ G E AR Y +L ++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGL----------------------SALPEQGVS---- 162
HRD+KP+N+L+D GH+K++DFGL S P + S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 163 -----------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
L + GTPNY+APEVL GY D WS GVILY ++ G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 241
Query: 206 LPF 208
PF
Sbjct: 242 PPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-38
Identities = 61/206 (29%), Positives = 112/206 (54%), Gaps = 3/206 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHKMADQIKREISIMKLVR 65
++ G +G G+F V N + G+ A+K L + Q+++EI+++ ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
HP +V+ +YI LE + GG L + +G E R Y +Q++ G++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRD+K N+L+D+ G +K++DFG++ + S ++ G+P ++APEV++ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 186 GAAADVWSCGVILYVLIAGYLPFDEL 211
G AAD+WS G + + G P+ +L
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQL 205
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 32/227 (14%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+G +V + TG+ A+KVLD+ +IK ++ E I+ + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 73 HEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ + T + +++++ GGELF + LSE AR Y +++ ++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 131 RDLKPENLLLDSQGHLKISDFGLS-------ALPEQGVSLLRTTC--------------- 168
RDLKPEN+LL GH+ +SDF LS + +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 169 -------GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
GT Y+APEV+S G+ G+A D W+ G++LY ++ G PF
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 74/218 (33%), Positives = 117/218 (53%), Gaps = 5/218 (2%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K ++V + IG G F +V+ ++ + + AMK+L + +IK + E IM
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+V+LH +Y+++E++ GG+L + + ++ + E AR Y +++ +D H
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVL---S 180
S G HRD+KP+N+LLD GHLK++DFG + G+ T GTP+Y++PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
GY G D WS GV LY ++ G PF L YS
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-38
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 10 EVGRTIGEGTFAKVK----FAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
E+G+ +GEG F +V T VA+K L A + + E SIMK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE--FLEEASIMKKLS 59
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
HP +VRL V +YI+ E++ GG+L D + HG L+ + + Q+ G++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTP-NYVAPEVLSHK 182
SK HRDL N L+ +KISDFGLS + E R P ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214
+ + +DVWS GV+L+ + G P+ +
Sbjct: 180 KFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
|
Length = 258 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 5e-38
Identities = 72/207 (34%), Positives = 121/207 (58%), Gaps = 7/207 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV 64
+E+ + +G G + KV + ++G+ AMKVL ++ I+ K K + + E +++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 65 RH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
R P +V LH + TK+++IL++I GGELF + R E E + Y +++ +++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLS-H 181
H G+ +RD+K EN+LLDS GH+ ++DFGLS E V + CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF 208
G + A D WS GV++Y L+ G PF
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-38
Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 22/218 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E + I G + V ++ ET + AMK +++ +I Q+ E I+ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV + ++ + +++E++ GG+ + + G L AR YF + + ++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT------------------TCGT 170
HRDLKP+NLL+ S GH+K++DFGLS + G+ L T CGT
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
P Y+APEV+ +GY G D W+ G+ILY + G +PF
Sbjct: 180 PEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 8e-38
Identities = 68/206 (33%), Positives = 115/206 (55%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ T + A+K L + ++ + E ++ L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ ++ ++ ++E++ GG+L I + A Y ++I G+ + HSKG+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD+ GH+KI+DFG+ G + T CGTP+Y+APE+L + YN + D
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYN-TSVDW 179
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
WS GV+LY ++ G PF D L+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-37
Identities = 65/201 (32%), Positives = 122/201 (60%), Gaps = 8/201 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVR 71
R IG G++AKV + + + AMKV+ + + + D ++ E + + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + +++++++E++ GG+L + +L E AR Y ++ +++ H +G+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGAA 188
DLK +N+LLD+ GH+K++D+G+ ++G+ TT CGTPNY+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC---KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFS 176
Query: 189 ADVWSCGVILYVLIAGYLPFD 209
D W+ GV+++ ++AG PFD
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-37
Identities = 62/189 (32%), Positives = 106/189 (56%), Gaps = 7/189 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+++ +GEG++ V A + ETG+ VA+KV+ ++ +I +EISI+K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+ + T ++I++E+ G + D + + L+E E Q + G++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
HRD+K N+LL+ +G K++DFG+S ++ T GTP ++APEV+ GYN
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-N 178
Query: 188 AADVWSCGV 196
AD+WS G+
Sbjct: 179 KADIWSLGI 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-37
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 10/213 (4%)
Query: 12 GRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
G+ +GEG F +V + + VA+K L A + + RE IM+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE--EFLREARIMRKLDHP 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSK 126
VV+L V +YI++E++ GG+L + + +LS S+ + Q+ G++Y SK
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL N L+ +KISDFGLS + P ++APE L +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181
Query: 186 GAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+ +DVWS GV+L+ + G P+ + +
Sbjct: 182 -SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 213
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-37
Identities = 75/200 (37%), Positives = 105/200 (52%), Gaps = 34/200 (17%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKV--LDR-------SAIIKHKMADQIKREISIMKLVR 65
IGEGT+ V A++ TGE VA+K L+ +AI REIS++K +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI----------REISLLKELN 56
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
HP +VRL +V+ S K+Y++ EF+ + D G L + Y QL+ G+ YC
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYC 115
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCG---TPNYVAPE 177
HS V HRDLKP+NLL+D +G LK++DFGL+ +P +RT T Y APE
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------VRTYTHEVVTLWYRAPE 169
Query: 178 VLSHKGYNGAAADVWSCGVI 197
+L D+WS G I
Sbjct: 170 ILLGSRQYSTPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-36
Identities = 69/186 (37%), Positives = 105/186 (56%), Gaps = 6/186 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEGT+ V A+N TGE VA+K + + + I REIS++K + HP +V+L +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66
Query: 75 VLASRTKIYIILEFITGG-ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V+ + K+Y++ EF+ + F + + Y QL+ G+ +CHS V HRDL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTPNYVAPEVLSHKGYNGAAADV 191
KP+NLL++++G +K++DFGL+ GV + T T Y APE+L Y A D+
Sbjct: 127 KPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184
Query: 192 WSCGVI 197
WS G I
Sbjct: 185 WSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-36
Identities = 66/197 (33%), Positives = 106/197 (53%), Gaps = 6/197 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V Q TG+ A K LD+ + K K E I++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++ + +++ + GG+L I + G E+ A Y Q+I G+++ H + + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
LKPEN+LLD G+++ISD GL+ L ++ GTP Y+APEVL + Y+ + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGEVYD-FSVDW 177
Query: 192 WSCGVILYVLIAGYLPF 208
++ G LY +IAG PF
Sbjct: 178 FALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-36
Identities = 61/213 (28%), Positives = 110/213 (51%), Gaps = 8/213 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++V + +G+G++ V + + A+K +D ++ + + D + EI I+ V HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYCH 124
++ E K+ I++E+ G+L I + + E E R F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ + HRDLK N+LL + +KI D G+S + ++ + +T GTP+Y+APEV + Y
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPY 178
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ +D+WS G +LY + PF+ + L
Sbjct: 179 S-YKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-36
Identities = 69/199 (34%), Positives = 110/199 (55%), Gaps = 20/199 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-----IKREISIMK 62
YE+ + IG GT+ V A++ TGE VA+KV+ K+ I++EIS++K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGV 120
RHP +V R K++I++E+ GG L D I R LSE + ++ + G+
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGL 114
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
Y H G HRD+K N+LL G +K++DFG+SA ++ ++ GTP ++APEV +
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 181 HK---GYNGAAADVWSCGV 196
+ GY+G D+W+ G+
Sbjct: 175 VERKGGYDG-KCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-36
Identities = 69/205 (33%), Positives = 113/205 (55%), Gaps = 7/205 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ GE A+K L + ++ + E ++ L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L+ ++ ++ ++EF+ GG+L I GR A Y +++ G+ + HSKG+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N++LD GH+KI+DFG+ G + T CGTP+Y+APE+L Y + D
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT-FSVDW 179
Query: 192 WSCGVILYVLIAGYLPF-----DEL 211
WS GV+LY ++ G PF DEL
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-35
Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLVR 65
YE+ IG G A V A E VA+K +D K D++++E+ M
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE-----KCQTSVDELRKEVQAMSQCN 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH---HGRLSESEARRYFQQLIDGVDY 122
HP VV+ + ++++++ +++GG L D + G L E+ ++++ G++Y
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR----TTCGTPNYVAPEV 178
HS G HRD+K N+LL G +KI+DFG+SA G R T GTP ++APEV
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 179 LS-HKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211
+ GY+ AD+WS G+ L G P+ +
Sbjct: 178 MEQVHGYD-FKADIWSFGITAIELATGAAPYSKY 210
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-35
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 11/214 (5%)
Query: 12 GRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
G+ +GEG F +V VA+K L A + RE IM+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHP 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGEL--FDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+V+L V + I++E++ GG+L + + LS S+ + Q+ G++Y S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGY 184
K HRDL N L+ +KISDFGLS P ++APE L +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+ +DVWS GV+L+ + G P+ + +
Sbjct: 182 T-SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL 214
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 3e-35
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 4/203 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ IG+G+F V AMK +D S + + ++ E ++ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSY 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGR-LSESEARRYFQQLIDGVDYCHSK 126
++R +E + K+ I++E+ G+L + + GR L E + R+F Q++ G+ + HSK
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+K NL LD+ ++KI D G++ L + T GTP Y++PE+ K YN
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN- 179
Query: 187 AAADVWSCGVILYVLIAGYLPFD 209
+DVW+ GV+LY G PFD
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-35
Identities = 64/194 (32%), Positives = 113/194 (58%), Gaps = 5/194 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A + TG VA+K +D + K + + + E+ IM+ +HP +V ++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV H R++E + ++ + + H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL S G +K+SDFG A + V ++ GTP ++APEV+S Y G D+WS
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 201
Query: 195 GVILYVLIAGYLPF 208
G+++ ++ G P+
Sbjct: 202 GIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-35
Identities = 66/206 (32%), Positives = 115/206 (55%), Gaps = 6/206 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLD-RSAIIKHKMADQIKREISIMKLVRH 66
+ + IG+G+F +V A + T + VA+KV+D A + ++ D I++EI + R
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIED-IQQEIQFLSQCRS 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P + + + +K++II+E+ GG D ++ G+L E+ ++++ G++Y H +
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G HRD+K N+LL +G +K++DFG+S +S T GTP ++APEV+ GY+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177
Query: 187 AAADVWSCGVILYVLIAGYLPFDELD 212
AD+WS G+ L G P +L
Sbjct: 178 -KADIWSLGITAIELAKGEPPLSDLH 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-34
Identities = 74/213 (34%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------R 56
R V +YE I EGT+ V A++ +TGE VA+K K KM + + R
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53
Query: 57 EISIMKLVRHPCVVRLHEVLASRT--KIYIILEFITGGELFDKI-VHHGRLSESEARRYF 113
EI+I+ ++HP +V + EV+ KIY+++E++ +L + +SE +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG--TP 171
QL+ GV + H + HRDLK NLLL+++G LKI DFGL+ E G L T T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTL 170
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG 204
Y APE+L A D+WS G I L+
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-34
Identities = 72/209 (34%), Positives = 112/209 (53%), Gaps = 18/209 (8%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R V K+++ IGEGT+ +V A++ +TGE VA+K + R K REI I++
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQ 62
Query: 64 VRHPCVVRLHEVLASRTK----------IYIILEFITG---GELFDKIVHHGRLSESEAR 110
+ H +V L E++ + Y++ E++ G L +VH SE +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIK 119
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CG 169
+ +QL++G++YCH K HRD+K N+LL+++G +K++DFGL+ L S T
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVIL 198
T Y PE+L + G A DVWSCG IL
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 2e-34
Identities = 64/213 (30%), Positives = 115/213 (53%), Gaps = 13/213 (6%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII------KHKMADQIKREISIMKLVR 65
G IG G+F V N +GE +A+K ++ ++ K M D + REI+++K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
H +V+ + I LE++ GG + + ++G E+ R + +Q++ G++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN------YVAPEVL 179
+G+ HRD+K N+L+D++G +KISDFG+S E +T P+ ++APEV+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y AD+WS G ++ ++ G PF +
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCT 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-34
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 36/223 (16%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVR- 65
Y++ IGEGTF++V AQ+ +TG+ A+K + + K +Q+ REI ++ +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 66 HPCVVRLHEVLASRT--KIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVD 121
HP ++RL EVL R ++ ++ E + EL L E + Y QL+ +D
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLLKSLD 114
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV------- 174
+ H G++HRD+KPEN+L+ LK++DFG S R P Y
Sbjct: 115 HMHRNGIFHRDIKPENILIK-DDILKLADFG-SC---------RGIYSKPPYTEYISTRW 163
Query: 175 --APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD 212
APE L GY G D+W+ G + + +++ + F +ELD
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD 206
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-34
Identities = 59/194 (30%), Positives = 111/194 (57%), Gaps = 4/194 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + IGEG+F K ++ E G+ +K ++ S + K ++ ++E++++ ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRL-SESEARRYFQQLIDGVDYCHS 125
+V+ E +YI++++ GG+L+ KI G L E + +F Q+ + + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ + HRD+K +N+ L G +K+ DFG++ + V L RT GTP Y++PE+ ++ YN
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179
Query: 186 GAAADVWSCGVILY 199
+D+W+ G +LY
Sbjct: 180 N-KSDIWALGCVLY 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-34
Identities = 72/206 (34%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA--DQIKREISIMKLVRHP 67
E IG G V + TG A+KV+ + H+ QI REI I++ V HP
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN----HEDTVRRQICREIEILRDVNHP 132
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
VV+ H++ +I ++LEF+ GG L I L++ AR Q++ G+ Y H +
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV-AR----QILSGIAYLHRR 187
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV----LSHK 182
+ HRD+KP NLL++S ++KI+DFG+S + Q + ++ GT Y++PE L+H
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPF 208
Y+G A D+WS GV + G PF
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-34
Identities = 71/243 (29%), Positives = 107/243 (44%), Gaps = 48/243 (19%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+T+G G F +V A+ +T AMK L + ++ +K E I+ + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ + +Y ++++I GG++ ++ G E AR Y +L V+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 133 LKPENLLLDSQGHLKISDFGL--------------------------------------- 153
+KP+N+L+D GH+K++DFGL
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 154 --------SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
A + L + GTPNY+APEVL GY D WS GVILY ++ G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 206 LPF 208
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-34
Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 6/217 (2%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+G +++ + IG+G F+ V A G VA+K + ++ K +EI ++K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH---HGRL-SESEARRYFQQLIDGVD 121
HP V++ ++ I+LE G+L I H RL E +YF QL ++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ HSK + HRD+KP N+ + + G +K+ D GL + + GTP Y++PE +
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
GYN +D+WS G +LY + A PF D LYS
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPF-YGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 9e-34
Identities = 66/213 (30%), Positives = 116/213 (54%), Gaps = 7/213 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKHKMADQIKREISIMKLVRH 66
+YE+ + IGEG+F K+ A+ E +K +D + + +K K A K+E+ ++ ++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAKMKH 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRL-SESEARRYFQQLIDGVDYCH 124
P +V +++I++E+ GG+L +I G L SE + +F Q+ G+ + H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 125 SKGVYHRDLKPENLLLDSQGHL-KISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
+ + HRD+K +N+ L G + K+ DFG++ + L T GTP Y++PE+ ++
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
YN D+WS G +LY L PF+ +L L
Sbjct: 179 YNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-33
Identities = 68/209 (32%), Positives = 121/209 (57%), Gaps = 10/209 (4%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRHPCV 69
G+ +G+G F +V + +TG +A K + D + K ++ EI ++K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 70 VRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
V+ + L R + + I +E++ GG + D++ +G L+ES R+Y +Q+++G+ Y HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
+ HRD+K N+L DS G++K+ DFG L + G +R+ GTP +++PEV+S +G
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG-IRSVTGTPYWMSPEVISGEG 185
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y G ADVWS G + ++ P+ E +
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-33
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 5/203 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y V R +GEG+F + Q+ + + AMK + R + D K + + K+ +HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKM-KHP 58
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRL-SESEARRYFQQLIDGVDYCHS 125
+V E + +YI++E+ GG+L KI + G+L E ++F Q+ GV + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
K V HRD+K +N+ L G +K+ DFG + L + T GTP YV PE+ + YN
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 186 GAAADVWSCGVILYVLIAGYLPF 208
+D+WS G ILY L PF
Sbjct: 179 N-KSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-33
Identities = 68/212 (32%), Positives = 121/212 (57%), Gaps = 10/212 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRH 66
+ +G+ +G G F +V + +TG +A+K + D + K + ++ EI ++K +RH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 67 PCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+V+ + L K+ I +E++ GG + D++ +G L+E+ RRY +Q++ GV Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS----ALPEQGVSLLRTTCGTPNYVAPEVLS 180
S + HRD+K N+L DS G++K+ DFG S + G +++ GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG-IKSVTGTPYWMSPEVIS 182
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+GY G ADVWS + ++ P+ E +
Sbjct: 183 GEGY-GRKADVWSVACTVVEMLTEKPPWAEYE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-33
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--- 65
YE IGEG + V A++ TG VA+K + R + + + REI+++K +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLSTLREIALLKQLESFE 59
Query: 66 HPCVVRLHEVLA-----SRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLID 118
HP +VRL +V K+ ++ E + K G L + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMRQLLR 118
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC-GTPNYVAPE 177
GVD+ HS + HRDLKP+N+L+ S G +KI+DFGL+ + ++L T+ T Y APE
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVVTLWYRAPE 176
Query: 178 VLSHKGYNGAAADVWSCGVILYVL 201
VL Y D+WS G I L
Sbjct: 177 VLLQSSYA-TPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 5e-33
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 44/216 (20%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
+YE+ + IG G + V A + TG VA+K + + + A +I REI +++ +RH
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDLIDAKRILREIKLLRHLRH 58
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFD----KIVHHGRLSESEARRYFQ-QL 116
++ L ++L + +YI+ E L + K++ + + +YF Q+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---- 172
+ G+ Y HS V HRDLKP N+L++S LKI DFGL+ R +
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA----------RGVDPDEDEKGF 162
Query: 173 ---YV------APEV-LSHKGYNGAAADVWSCGVIL 198
YV APE+ LS Y A D+WS G I
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYT-KAIDIWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 48/243 (19%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+T+G G F +V A +T AMK L + ++ +K E I+ + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ + +Y ++++I GG++ ++ E AR Y +L ++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 133 LKPENLLLDSQGHLKISDFGL--------------------------------------- 153
+KP+N+L+D GH+K++DFGL
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 154 --------SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
A + L + GTPNY+APEVL KGY D WS GVIL+ ++ G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 206 LPF 208
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 66/185 (35%), Positives = 104/185 (56%), Gaps = 3/185 (1%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEGT+ V +N +TG+ VAMK + R + + REIS++K ++HP +V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 75 VLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
VL +++Y+I EF++ + D + + + Y Q++ G+ +CHS+ V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
LKP+NLL+D++G +K++DFGL+ V + T Y APEVL D+W
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIW 186
Query: 193 SCGVI 197
S G I
Sbjct: 187 SIGTI 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-32
Identities = 69/202 (34%), Positives = 113/202 (55%), Gaps = 8/202 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F KV AQ+ ETG A K++ + + ++ D + EI I+ +HP +V L+E
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMV-EIDILSECKHPNIVGLYE 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
K++I++EF GG L ++ R L+E + R +Q+++ +++ HS V HRDL
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA----A 189
K N+LL G +K++DFG+SA + + T GTP ++APEV++ + + A
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 190 DVWSCGVILYVLIAGYLPFDEL 211
D+WS G+ L L P EL
Sbjct: 190 DIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-32
Identities = 71/196 (36%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIKHKMADQIKREISIMKLVR 65
KYE IGEGT+ V A+N ET E VA+K LD + REI ++K ++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELK 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
H +VRL++VL S K+ ++ E+ + FD +G + + + QL+ G+ +C
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFC 115
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL-SHK 182
HS V HRDLKP+NLL++ G LK++DFGL+ V T Y P+VL K
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 183 GYNGAAADVWSCGVIL 198
Y+ + D+WS G I
Sbjct: 176 LYS-TSIDMWSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-32
Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK----REISI 60
K+ YE+ +GEGTF +V A+ +TG VA+K I+ H D REI I
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKI 60
Query: 61 MKLVRHPCVVRLHEVLASRTK--------IYIILEFIT---GGELFDKIVHHGRLSESEA 109
+K ++HP VV L ++ R +Y++ ++ G L + V L+ES+
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI 117
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ Y QL++G++Y H + HRD+K N+L+D+QG LKI+DFGL A P G G
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL-ARPYDGPPPNPKGGG 176
Query: 170 TPN------------YVAPEVLSHKGYNGAAADVWSCGVIL 198
Y PE+L + A D+W G +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-32
Identities = 66/194 (34%), Positives = 111/194 (57%), Gaps = 5/194 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A TG+ VA+K +D + K + + + E+ IM+ H VV ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV H R++E + ++ + Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL S G +K+SDFG A + V ++ GTP ++APEV+S Y G D+WS
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 204
Query: 195 GVILYVLIAGYLPF 208
G+++ +I G P+
Sbjct: 205 GIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-32
Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 8/198 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVR 65
+Y + + +G+G+F V ++ + +KVL + + Q +E ++ +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKI---VHHGR-LSESEARRYFQQLIDGVD 121
HP +V+ H R II E+ G +L K+ H G+ LSE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
Y H + + HRDLK +N+ L LKI DFG+S L L T GTP Y++PE L H
Sbjct: 121 YMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 182 KGYNGAAADVWSCGVILY 199
+GY+ + +D+WS G ILY
Sbjct: 180 QGYD-SKSDIWSLGCILY 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-31
Identities = 67/190 (35%), Positives = 106/190 (55%), Gaps = 5/190 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG GT+ V A+N TGE A+KV+ + + +++EI +MK +H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V R K++I +EF GG L D G LSES+ ++ + G+ Y HSKG
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV--LSHKGYNG 186
HRD+K N+LL GH+K++DFG+SA ++ ++ GTP ++APEV + KG
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 187 AAADVWSCGV 196
D+W+ G+
Sbjct: 188 QLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-31
Identities = 64/194 (32%), Positives = 113/194 (58%), Gaps = 5/194 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A+ +G VA+K++D + K + + + E+ IM+ +H VV +++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV RL+E + + ++ + Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL G +K+SDFG A + V ++ GTP ++APEV+S Y G D+WS
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSL 203
Query: 195 GVILYVLIAGYLPF 208
G+++ ++ G P+
Sbjct: 204 GIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-31
Identities = 66/212 (31%), Positives = 120/212 (56%), Gaps = 10/212 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--DRSAIIKHKMADQIKREISIMKLVRH 66
+ +G+ +G+G F +V + +TG +A+K + D + K + ++ EI ++K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 67 PCVVRLHEVL--ASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+V+ + L + I +E + GG + D++ +G L+E+ R+Y +Q+++GV Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAPEVLS 180
S + HRD+K N+L DS G++K+ DFG L + G + T GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSPEVIS 182
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+GY G AD+WS G + ++ P+ E +
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAEFE 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-31
Identities = 71/201 (35%), Positives = 110/201 (54%), Gaps = 7/201 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH---PCVV 70
IG G F +V + +TG+ AMK LD+ I K K + + IM LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ + K+ IL+ + GG+L + HG SE+E R Y ++I G+++ H++ V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL ++AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 191 VWSCGVILYVLIAGYLPFDEL 211
+S G +L+ L+ G+ PF +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 6/215 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + + AMK+L++ ++K + E ++ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKG 127
+ LH +Y+++++ GG+L + RL E AR Y +++ +D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSH----K 182
HRD+KP+N+L+D GH++++DFG L E G GTP+Y++PE+L K
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
G G D WS GV +Y ++ G PF L Y
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 72/215 (33%), Positives = 107/215 (49%), Gaps = 23/215 (10%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK------ 55
R V ++E IGEGT+ V A++T +GE VA+K K +M D +
Sbjct: 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALK--------KVRM-DNERDGIPIS 52
Query: 56 --REISIMKLVRHPCVVRLHEVLASR--TKIYIILEFITG--GELFDKIVHHGRLSESEA 109
REI+++ +RHP +V L EV+ + I++++E+ L D + SES+
Sbjct: 53 SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQV 110
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ QL+ G+ Y H + HRDLK NLLL +G LKI+DFGL+ +
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG 204
T Y APE+L A D+W+ G IL L+A
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-31
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 13 RTIGEGTFAKVKFA---QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +GEG F +V VA+K L A + + +E +MK + HP V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYF--QQLID-------GV 120
VRL V +Y++LE++ GG+L D + + S + + L+ G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TPN-YVAPEV 178
+Y SK HRDL N L+ +KISDFGLS + T G P ++APE
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
L + + +DVWS GV+L+ + G P+ L +
Sbjct: 179 LKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL 217
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-31
Identities = 72/213 (33%), Positives = 113/213 (53%), Gaps = 6/213 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-REISIMKLVRH 66
KYE +GEG++ V ++ ETG+ VA+K S KM +I REI ++K +RH
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRH 59
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V L EV + ++Y++ EF+ L D + L ES R+Y Q++ G+++CHS
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+KPEN+L+ G +K+ DFG + + T Y APE+L G
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 187 AAADVWSCGVILYVLIAG--YLPFDELDLTTLY 217
A D+W+ G ++ ++ G P D D+ LY
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDS-DIDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-30
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 7/217 (3%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ + + + IG G F++V A G VA+K + ++ K +EI ++K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
HP V++ + ++ I+LE G+L I H + + E +YF QL ++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ HS+ V HRD+KP N+ + + G +K+ D GL + + GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF--DELDLTTL 216
GYN +D+WS G +LY + A PF D+++L +L
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-30
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REIS 59
+V KYE IG+GTF +V A++ +T + VA+K + + K I REI
Sbjct: 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIK 63
Query: 60 IMKLVRHPCVVRLHEVLAS--------RTKIYIILEFIT---GGELFDKIVHHGRLSESE 108
I++L++H VV L E+ + + Y++ EF G L +K V + + SE
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSE 120
Query: 109 ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLR 165
++ + L++G+ Y H + HRD+K N+L+ G LK++DFGL+ +L +
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 166 TT-CGTPNYVAPEVLSHKGYNGAAADVWSCGVIL 198
T T Y PE+L + G D+W G I+
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-30
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMK-VLDRSAIIKHKMADQIKREISIMKLVR 65
K +GEG V + TG A+K + K QI RE+ I K +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCK 57
Query: 66 HPCVVRLHE--VLASRTKIYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLID 118
P +V+ + + S + I I +E+ GG L D I GR+ E + + ++
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ Y HS+ + HRD+KP N+LL +G +K+ DFG+S E SL T GT Y+APE
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAPER 174
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ K Y+ +DVWS G+ L + PF
Sbjct: 175 IQGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-30
Identities = 67/198 (33%), Positives = 104/198 (52%), Gaps = 4/198 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I + G E A Y +++ G++ H + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD GH++ISD GL+ +G +R GT Y+APEVL+++ Y + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRY-TLSPD 183
Query: 191 VWSCGVILYVLIAGYLPF 208
W G ++Y +I G PF
Sbjct: 184 YWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-30
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 4/195 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y R +G+G F + + TE V K ++ + + + + D + EI I+ L++HP
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPN 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
++ + + I +E+ GG L+DKIV E Y Q++ V Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G+ HRD+K N+ L G +K+ DFG+S + S+ T GTP Y++PE+ YN
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYN- 179
Query: 187 AAADVWSCGVILYVL 201
+D+W+ G +LY L
Sbjct: 180 FKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 8e-30
Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 4/198 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I + G E A Y ++ G++ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD GH++ISD GL+ +G +R GT Y+APEV+ ++ Y + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERY-TFSPD 183
Query: 191 VWSCGVILYVLIAGYLPF 208
W G ++Y +I G PF
Sbjct: 184 WWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-30
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 7/217 (3%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +++ + IG G F++V A + VA+K + ++ K +EI ++K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
HP V++ + ++ I+LE G+L I + + + E +YF QL V+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ HS+ V HRD+KP N+ + + G +K+ D GL + + GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF--DELDLTTL 216
GYN +D+WS G +LY + A PF D+++L +L
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-30
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 6/212 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KYE R +G G F V + + V +K + + K + E ++KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHS 125
++ +E + I++E+ GG L + I L E +F Q++ + + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 126 KGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
K + HRDLK +N+LLD + +KI DFG+S + S T GTP Y++PE+ K Y
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTVVGTPCYISPELCEGKPY 178
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
N +D+W+ G +LY L + F+ +L L
Sbjct: 179 N-QKSDIWALGCVLYELASLKRAFEAANLPAL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-29
Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 7/200 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH---PCVV 70
IG G F +V + +TG+ AMK LD+ I K K + + IM LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ + K+ IL+ + GG+L + HG SE E R Y ++I G+++ H++ V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL ++AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 191 VWSCGVILYVLIAGYLPFDE 210
+S G +L+ L+ G+ PF +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 12/209 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + TG+ AMK+L++ ++K + E + LV
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV--LVNGDR 60
Query: 69 --VVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHS 125
+ LH +Y+++++ GG+L + RL E AR Y +++ +D H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFG--LSALPEQGVSLLRTTCGTPNYVAPEVLSH-- 181
G HRD+KP+N+LLD GH++++DFG L L + V GTP+Y++PE+L
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN-VAVGTPDYISPEILQAME 179
Query: 182 --KGYNGAAADVWSCGVILYVLIAGYLPF 208
KG G D WS GV +Y ++ G PF
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-29
Identities = 68/217 (31%), Positives = 118/217 (54%), Gaps = 13/217 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+K ++E IG+G V A + TG+ VA+K ++ K ++ I EI +M+
Sbjct: 19 KKYTRFE---KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---IINEILVMRE 72
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+HP +V + ++++++E++ GG L D +V + E + ++ + +++
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFL 131
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSH 181
HS V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR 189
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
K Y G D+WS G++ ++ G P+ +E L LY
Sbjct: 190 KAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-29
Identities = 68/200 (34%), Positives = 107/200 (53%), Gaps = 4/200 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYF--QQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I H G E R F ++ G++ H + + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD GH++ISD GL+ +G + ++ GT Y+APEV+ ++ Y + D
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKNERYT-FSPD 183
Query: 191 VWSCGVILYVLIAGYLPFDE 210
W+ G +LY +IAG PF +
Sbjct: 184 WWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-29
Identities = 61/194 (31%), Positives = 110/194 (56%), Gaps = 5/194 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IGEG+ V A +G+ VA+K +D + K + + + E+ IM+ +H VV ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++++EF+ GG L D IV H R++E + ++ + H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
+++LL G +K+SDFG A + V ++ GTP ++APE++S Y G D+WS
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSL 202
Query: 195 GVILYVLIAGYLPF 208
G+++ ++ G P+
Sbjct: 203 GIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-29
Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 4/197 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F +V + T E VA+K++D + I++EI+++ P + R +
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
TK++II+E++ GG D ++ G L E+ ++++ G+DY HS+ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
N+LL QG +K++DFG++ T GTP ++APEV+ Y+ AD+WS
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSL 187
Query: 195 GVILYVLIAGYLPFDEL 211
G+ L G P +L
Sbjct: 188 GITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-29
Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 48/243 (19%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ IG+G F +V+ Q +TG+ AMK L +S + K +K E ++ P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ +Y+I+EF+ GG+L ++ + SE R Y + + ++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 133 LKPENLLLDSQGHL------------KISDFGLSALPEQGVS------------------ 162
+KP+N+L+D GH+ K D QG S
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 163 -----------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
+ +T GTP+Y+APE+ +GY G D WS G I++ + G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 206 LPF 208
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-29
Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 13/199 (6%)
Query: 13 RTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +GEG F KV+ TGE VA+K L+ S +H +D +REI I++ + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH-RSD-FEREIEILRTLDHEN 67
Query: 69 VVRLHEVL--ASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHS 125
+V+ V + +I+E++ G L D + H +++ + Q+ G+DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTP-NYVAPEVLSHK 182
+ HRDL N+L++S+ +KISDFGL+ + + ++ +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187
Query: 183 GYNGAAADVWSCGVILYVL 201
++ +A+DVWS GV LY L
Sbjct: 188 KFS-SASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-29
Identities = 60/209 (28%), Positives = 115/209 (55%), Gaps = 9/209 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH- 66
+ E+ IG G + V ++ TG VA+K+++ ++D I+RE++++ +R
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSD-IQREVALLSQLRQS 59
Query: 67 --PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P + + + +++II+E+ GG + ++ G ++E ++++ + Y H
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
GV HRD+K N+L+ + G++K+ DFG++AL Q S T GTP ++APEV++ Y
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDL 213
AD+WS G+ +Y + G P+ ++D
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-29
Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLV 64
+Y+ +G G + +V A +T+TG VA+K L R SAI H A + RE+ ++K +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI--H--AKRTYRELRLLKHM 71
Query: 65 RHPCVVRLHEV------LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
H V+ L +V L +Y++ + G +L + IV +LS+ + Q++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILR 129
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ Y HS G+ HRDLKP N+ ++ LKI DFGL+ + + T Y APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEI 186
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAG 204
+ + + D+WS G I+ L+ G
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 1e-28
Identities = 68/217 (31%), Positives = 120/217 (55%), Gaps = 13/217 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+K +YE IG+G V A + TG+ VA+K ++ + K + I EI +MK
Sbjct: 19 KKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKE 72
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+++P +V + ++++++E++ GG L D +V + E++ ++ + +++
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFL 131
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSH 181
H+ V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTR 189
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
K Y G D+WS G++ ++ G P+ +E L LY
Sbjct: 190 KAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 46/140 (32%), Positives = 82/140 (58%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
I G F KV + + A+KV+ ++ +I M Q++ E + L + P +V L+
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
L S +Y+++E++ GG++ + +G E A +Y ++ +DY H G+ HRDLK
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 135 PENLLLDSQGHLKISDFGLS 154
P+N+L+ ++GH+K++DFGLS
Sbjct: 132 PDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-28
Identities = 68/213 (31%), Positives = 115/213 (53%), Gaps = 10/213 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IG+G V A + TG+ VA+K ++ K ++ I EI +M+ ++P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V + ++++++E++ GG L D +V + E + ++ + +D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++ K Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 186 GAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
G D+WS G++ ++ G P+ +E L LY
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-28
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G V + TG+ +A+K + I + QI RE+ I+ P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKI--VHHGRLSESEARRYFQQLIDGVDYCHSK-GVY 129
+ + I I +E++ GG L DKI GR+ E + ++ G+ Y H K +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRD+KP N+L++S+G +K+ DFG+S Q V SL +T GT +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDY-SVK 179
Query: 189 ADVWSCGVILYVLIAGYLPFD 209
+D+WS G+ L L G P+
Sbjct: 180 SDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-28
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 10/217 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + T AMK+L++ ++K + E ++ LV C
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV--LVNGDC 60
Query: 69 --VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHS 125
+ LH +Y+++++ GG+L + RL E AR Y +++ + H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSH--- 181
HRD+KP+N+LLD GH++++DFG + + G GTP+Y++PE+L
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 182 -KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
G G D WS GV +Y ++ G PF L Y
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-28
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 4/197 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F +V + T + VA+K++D + I++EI+++ P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
TK++II+E++ GG D ++ G L E++ ++++ G+DY HS+ HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
N+LL G +K++DFG++ T GTP ++APEV+ Y+ + AD+WS
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 187
Query: 195 GVILYVLIAGYLPFDEL 211
G+ L G P EL
Sbjct: 188 GITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-28
Identities = 59/206 (28%), Positives = 111/206 (53%), Gaps = 9/206 (4%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLD---RSAIIKHKMADQIKREISIMKLVRHPC 68
G+ +G G F+ A++ +TG +A+K + ++ + ++ + +++EI +M + HP
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++R+ + + +E++ GG + + +G E+ Y +QL+ G+ Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 129 YHRDLKPENLLLDSQGH-LKISDFGLSA-LPEQ--GVSLLR-TTCGTPNYVAPEVLSHKG 183
HRD+K NLL+DS G L+I+DFG +A L + G + GT ++APEVL +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFD 209
Y G + DVWS G ++ + P++
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 10/210 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ +G+G F KV AQN ETG A KV+D + + ++ D + EI I+ HP
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMV-EIDILASCDHPN 63
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+L + ++I++EF GG + ++ R L+E + R +Q ++ ++Y H
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL-----SHK 182
+ HRDLK N+L G +K++DFG+SA + + + GTP ++APEV+ +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y+ ADVWS G+ L + P EL+
Sbjct: 184 PYD-YKADVWSLGITLIEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLV 64
G +E+ IGEGT+ KV A++ +TG+ VA+K++D I ++IK E +I+ K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 65 RHPCVVRLHEV------LASRTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYF-Q 114
HP + + + ++++++E GG +L + G+ + E Y +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
+ + G+ Y H V HRD+K +N+LL +K+ DFG+SA + + T GTP ++
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 175 APEVLSHKGYNGAA----ADVWSCGV 196
APEV++ A+ +DVWS G+
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-28
Identities = 66/209 (31%), Positives = 113/209 (54%), Gaps = 8/209 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ +G+G F KV A+N ETG A KV++ + + ++ D + EI I+ HP
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMV-EIEILATCNHPY 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+L K++I++EF GG + ++ R L+E + + +Q+++ + Y HS
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRDLK N+LL G +K++DFG+SA + + + GTP ++APEV+ +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 188 ----AADVWSCGVILYVLIAGYLPFDELD 212
AD+WS G+ L + P EL+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-28
Identities = 69/196 (35%), Positives = 111/196 (56%), Gaps = 17/196 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ---IKREISIMKLVR 65
YE+ + +G GT+ V A+N TGE A+K IIK + D I++EI ++K +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVK------IIKLEPGDDFSLIQQEIFMVKECK 64
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYC 123
H +V SR K++I +E+ GG L D ++H G LSE + ++ + G+ Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVCRETLQGLAYL 122
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS--- 180
HSKG HRD+K N+LL G +K++DFG++A ++ ++ GTP ++APEV +
Sbjct: 123 HSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 181 HKGYNGAAADVWSCGV 196
+ GYN D+W+ G+
Sbjct: 183 NGGYN-QLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-28
Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH- 66
YE IGEGT+ KV A++ TG+ VA+K R + + + REIS+++++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGR-----LSESEARRYFQQL 116
+VRL +V K +Y++ E++ +L + +GR L + + QL
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTCGTPNYVA 175
+ GV +CH GV HRDLKP+NLL+D Q G LKI+D GL V T Y A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179
Query: 176 PEVLSHKGYNGAAADVWSCGVI 197
PEVL + D+WS G I
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-28
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ IG G + V A +T +G+ VA+K + A +A + RE+ I++ +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-AFDVPTLAKRTLRELKILRHFKHD 64
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGV 120
++ + ++L R +Y++++ + +L I+H + L+E R + QL+ G+
Sbjct: 65 NIIAIRDIL--RPPGADFKDVYVVMDLM-ESDL-HHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFG----LSALPEQGVSLLRTTCGTPNYVAP 176
Y HS V HRDLKP NLL++ L+I DFG LS+ P + + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 177 EVL-SHKGYNGAAADVWSCGVIL 198
E+L S Y A D+WS G I
Sbjct: 181 ELLLSLPEYT-TAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-27
Identities = 63/210 (30%), Positives = 112/210 (53%), Gaps = 11/210 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIK-HKMADQIKREISIMKLVRHPC 68
G +G+G + V + T G+ +A+K LD S ++ K ++++ E+ ++K ++H
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V+ I I +EF+ GG + + G L E +Y +Q++DGV Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLS------ALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
HRD+K N++L G +K+ DFG + L ++L++ GTP ++APEV++
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELD 212
GY G +D+WS G ++ + G P +D
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 64/198 (32%), Positives = 108/198 (54%), Gaps = 5/198 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V Q TG+ A K L++ + K K + E I+ V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
++T + +++ + GG+L I + + E A Y Q+I G+++ H + + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD+ G+++ISD GL+ + G S + GTP ++APE+L + Y+ + D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD-FSVD 179
Query: 191 VWSCGVILYVLIAGYLPF 208
++ GV LY +IA PF
Sbjct: 180 YFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 67/213 (31%), Positives = 115/213 (53%), Gaps = 10/213 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IG+G V A + TG+ VA++ ++ K ++ I EI +M+ ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V + ++++++E++ GG L D +V + E + ++ + +++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA--LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
V HRD+K +N+LL G +K++DFG A PEQ S T GTP ++APEV++ K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 186 GAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
G D+WS G++ +I G P+ +E L LY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 4/196 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V Q TG+ A K LD+ + K E I++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRD 132
S+T + +++ + GG+L I + G L Y Q+ G+ + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
+KPEN+LLD QG+ ++SD GL+ + G ++ + GT Y+APE+L + Y+ D +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA-GTNGYMAPEILKEEPYS-YPVDWF 178
Query: 193 SCGVILYVLIAGYLPF 208
+ G +Y ++AG PF
Sbjct: 179 AMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-27
Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 4/197 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG+G+F +V + T + VA+K++D + I++EI+++ P V + +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
TK++II+E++ GG D ++ G E + ++++ G+DY HS+ HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSC 194
N+LL QG +K++DFG++ T GTP ++APEV+ Y+ + AD+WS
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSL 187
Query: 195 GVILYVLIAGYLPFDEL 211
G+ L G P ++
Sbjct: 188 GITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-27
Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 4/198 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R +G+G F +V Q TG+ A K L++ I K K E I++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYH 130
++ + ++L + GG+L I + G E A Y +L G++ + + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAAD 190
RDLKPEN+LLD +GH++ISD GL+ +G + +R GT Y+APEV++++ Y + D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRVGTVGYMAPEVINNEKYT-FSPD 183
Query: 191 VWSCGVILYVLIAGYLPF 208
W G ++Y +I G PF
Sbjct: 184 WWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 6e-27
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA---IIKHKMADQIKREISIMKLV 64
KYE IGEG++ V +N ETG+ VA+K S +IK K+A REI ++K +
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP +V L EV + K++++ E+ L + + + E ++ Q + V++CH
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
HRD+KPEN+L+ QG +K+ DFG + + T Y APE+L
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ 177
Query: 185 NGAAADVWSCGVILYVLIAG 204
G DVW+ G + L+ G
Sbjct: 178 YGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-26
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 21/201 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-----IKREISIMK 62
+YE IGEGT+ V A++ T E++A+K I+ + D+ REIS++K
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESE-----ARRYFQQLI 117
++H +VRL +V+ S ++Y++ E++ D H + + Y Q++
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 118 DGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
G+ YCHS V HRDLKP+NLL+D LK++DFGL+ V T Y AP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
Query: 177 EVLSHKGYNGAAADVWSCGVI 197
E+L + D+WS G I
Sbjct: 173 EILLGSRHYSTPVDIWSVGCI 193
|
Length = 294 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 75/224 (33%), Positives = 116/224 (51%), Gaps = 24/224 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + R +G G V A+ GE A+KV+D + + AD+ + + + L+
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE---ADKNRAQAEVCCLLN-- 87
Query: 68 C----VVRLHEVLASRTK--------IYIILEFITGGELFDKIVHHGRLS----ESEARR 111
C +V+ HE A + I ++L++ G+L +I + + E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCG 169
F Q++ V + HSK + HRD+K N+LL S G +K+ DFG S + VS + RT CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213
TP YVAPE+ K Y+ AD++S GV+LY L+ PFD ++
Sbjct: 208 TPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENM 250
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 14/205 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y+ IGEG + V A + TG VA+K + S + REI I++ +H
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 69 VVRLHEVLASRT-----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
++ + +++ + +YI+ E + +L+ K++ LS + + Q++ G+ Y
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTT-CGTPNYVAPEV-L 179
HS V HRDLKP NLLL++ LKI DFGL A PE + T T Y APE+ L
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 180 SHKGYNGAAADVWSCGVILYVLIAG 204
+ KGY A D+WS G IL +++
Sbjct: 183 NSKGYT-KAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 70/224 (31%), Positives = 118/224 (52%), Gaps = 19/224 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-KMADQIKREISIMKLVRH 66
+Y++ IG+G++ V A +T TGE VA+K ++ + +H A +I REI +++L+RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRH 58
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
P +V + ++ ++ IY++ E + +L I + L+ + + QL+ +
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTT-CGTPNYVAPEV 178
Y H+ V+HRDLKP+N+L ++ LKI DFGL+ A + ++ T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 179 L-SHKGYNGAAADVWSCGVILYVLIAGYLPF------DELDLTT 215
S A D+WS G I ++ G F +LDL T
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLIT 221
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-25
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 16/222 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGES-VAMK-------VLDRSAIIKHKMADQIKREISI 60
Y V +G G F V + G++ +A+K + + K I E++I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 61 MK-LVRHPCVVRLHEVLASRTKIYIILEFITG---GELFDKIVH-HGRLSESEARRYFQQ 115
+K +RHP +VR ++ ++YI+++ I G GE F+ + R +E F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 116 LIDGVDYCH-SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
++ + Y H K + HRDL P N++L + I+DFGL A +Q S L + GT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYS 180
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
PE++ ++ Y G ADVW+ G ILY + PF ++ +L
Sbjct: 181 CPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSL 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 69/212 (32%), Positives = 101/212 (47%), Gaps = 39/212 (18%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + IG G + V A+N+ET E VA+K + +A A + REI +++ + H
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHE 64
Query: 68 CVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLI 117
V+ + +++ + +YI+ E L D +H LS+ + + QL+
Sbjct: 65 NVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----- 172
G+ Y HS V HRDLKP NLLL++ LKI DFGL+ RTT +
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----------RTTSEKGDFMTEY 168
Query: 173 -----YVAPEV-LSHKGYNGAAADVWSCGVIL 198
Y APE+ L+ Y A DVWS G I
Sbjct: 169 VVTRWYRAPELLLNCSEY-TTAIDVWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 6e-25
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 24/198 (12%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++G TIG+G F V G+ VA+K L + A E S+M +RHP +
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID-------GVDY 122
V+L V+ +YI+ E++ G L D + GR A Q + G++Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEY 117
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSH 181
K HRDL N+L+ K+SDFGL+ QG + P + APE L
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALRE 173
Query: 182 KGYNGAAADVWSCGVILY 199
K ++ +DVWS G++L+
Sbjct: 174 KKFS-TKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-25
Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G G F V A++ TG++VA+K + +A + RE+ ++K +RH
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 68 CVVRLHEVLAS-RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
++ L ++ S IY + E + G +++ L + + + Q++ G+ Y HS
Sbjct: 70 NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV-LSHKGYN 185
GV HRDLKP N+L++ LKI DFGL+ + + + T Y APE+ L+ + Y+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 186 GAAADVWSCGVILYVLIAG 204
D+WS G I ++ G
Sbjct: 185 -VEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-24
Identities = 62/194 (31%), Positives = 99/194 (51%), Gaps = 7/194 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
K+EV +GEG + V ++ ET E VA+K S ++ + RE+ +++ ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQE 60
Query: 68 CVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+V L E R K+Y++ E++ EL ++ + + R Y QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGY 184
+ HRD+KPENLL+ LK+ DFG + +G + T T Y +PE+L Y
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178
Query: 185 NGAAADVWSCGVIL 198
G A D+WS G IL
Sbjct: 179 -GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-24
Identities = 67/228 (29%), Positives = 113/228 (49%), Gaps = 33/228 (14%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--------SAIIKHKMADQIKR 56
K+ Y+ +GEG++A V ++ TG+ VA+K + +AI R
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI----------R 52
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQ 115
E S++K ++H +V LH+++ ++ + ++ E++ +L + G LS R + Q
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTPN 172
L+ G+ YCH + V HRDLKP+NLL+ +G LK++DFGL+ ++P + S T
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS---NEVVTLW 168
Query: 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-------DELDL 213
Y P+VL + D+W G I Y + G F D+L
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-24
Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRHP 67
+E+ TIG+GT+ KV N + G A+K+LD H + ++I+ E +I+K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHP 75
Query: 68 CVVRLHEVLASRT-----KIYIILEFITGGELFDKI---VHHG-RLSESEARRYFQQLID 118
VV+ + + + +++++LE GG + D + + G R+ E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ + H HRD+K N+LL ++G +K+ DFG+SA T+ GTP ++APEV
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195
Query: 179 LS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211
++ Y+ A DVWS G+ L G P +L
Sbjct: 196 IACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-24
Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 27/222 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIKHKMADQIKREISIMKLV 64
+Y R +G G+ V A +++ + VA+K VL +KH + REI I++ +
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59
Query: 65 RHPCVVRLHEVLASRTK--------------IYIILEFITGGELFDKIVHHGRLSESEAR 110
H +V+++EVL +YI+ E++ ++ G LSE AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-LKISDFGLSALPEQGVS---LLRT 166
+ QL+ G+ Y HS V HRDLKP N+ ++++ LKI DFGL+ + + S L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
T Y +P +L A D+W+ G I ++ G F
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-HKMADQIKREISIMKLVRHPCV 69
VGR F + G KV+ + ++ + A + E+ + H +
Sbjct: 75 VGRNPTTAAFVATR-------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGI 127
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHS 125
V+ + S K+ +I+E+ +GG+L +I H E E F Q++ +D HS
Sbjct: 128 VKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS 187
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKG 183
+ + HRDLK N+ L G +K+ DFG S VSL + CGTP Y+APE+ K
Sbjct: 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR 247
Query: 184 YNGAAADVWSCGVILYVLIAGYLPF 208
Y+ AD+WS GVILY L+ + PF
Sbjct: 248 YS-KKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-24
Identities = 60/208 (28%), Positives = 112/208 (53%), Gaps = 7/208 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLD-RSAIIKHKMADQIKREISIMKLVRHPCVVR 71
R +G+G++ +V ++ G+ +K L+ R+A + + A + +E ++ ++HP +V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIVA 63
Query: 72 LHEVLASRT-KIYIILEFITGGELFDKIVHH-GRL-SESEARRYFQQLIDGVDYCHSKGV 128
E +YI++ F GG+L+ K+ G+L E++ +F Q+ + Y H K +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRDLK +N+ L +K+ D G++ + E + T GTP Y++PE+ S+K YN
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN-YK 182
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTL 216
+DVW+ G +Y + F+ D+ +L
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-24
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 8/203 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ + R +G G F +V + + VA+K+L ++K + ++E+ +K +RH
Sbjct: 8 FTLERKLGSGYFGEV-WEGLWKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQ-QLIDGVDYCHSK 126
++ L V + +YII E + G L + G++ + Q+ +G+ Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
HRDL N+L+ K++DFGL+ L ++ V L + APE SH ++
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS- 182
Query: 187 AAADVWSCGVILY-VLIAGYLPF 208
+DVWS G++LY + G +P+
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-24
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 10/188 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG G+F V FA++ T E VA+K + S ++ I +E+ ++ +RHP +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 73 HEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
++++E+ G ++ + VH L E E + G+ Y HS H
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAA 188
RD+K N+LL G +K++DFG ++L VS + GTP ++APEV+ +G
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASL----VSPANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 189 ADVWSCGV 196
DVWS G+
Sbjct: 195 VDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-23
Identities = 71/226 (31%), Positives = 118/226 (52%), Gaps = 19/226 (8%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
+E+ TIG+GT+ KV N + G A+K+LD + + ++I+ E +I++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 66 HPCVVRLHEVLASRTK-----IYIILEFITGG---ELFDKIVHHG-RLSESEARRYFQQL 116
HP VV+ + + K ++++LE GG EL ++ G RL E+
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ G+ + H+ + HRD+K N+LL ++G +K+ DFG+SA T+ GTP ++AP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
Query: 177 EVLS-HKGYN---GAAADVWSCGVILYVLIAGYLP-FDELDLTTLY 217
EV++ + Y+ A DVWS G+ L G P FD + TL+
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-23
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G G + V A + TG VA+K L R A + RE+ ++K ++H
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHE 74
Query: 68 CVVRLHEVLASRTKI------YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
V+ L +V + Y+++ F+ G K++ H +LSE + Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
Y H+ G+ HRDLKP NL ++ LKI DFGL+ Q S + T Y APEV+ +
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPEVILN 189
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPF---DELD 212
+ D+WS G I+ ++ G F D LD
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-23
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 17/210 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-IKREISIMKLVRH 66
K +G IGEG F V Q TG+ VA+K IK + Q E ++M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVK------NIKCDVTAQAFLEETAVMTKLHH 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEAR--RYFQQLIDGVDYCH 124
+VRL V+ +YI++E ++ G L + + GR S + ++ + +G++Y
Sbjct: 59 KNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
SK + HRDL N+L+ G K+SDFGL+ + GV + + APE L HK +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEALKHKKF 174
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELDL 213
+ + +DVWS GV+L+ V G P+ ++ L
Sbjct: 175 S-SKSDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 3e-23
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 6/206 (2%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K YE +GEG++A V ++ G+ VA+KV+ + RE S++K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGL 60
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+H +V LH+++ ++ + ++ E++ + DK H G L + + QL+ G+ Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSY 118
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
H + + HRDLKP+NLL+ G LK++DFGL+ T Y P+VL
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPF 208
D+W G I +I G F
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-23
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTET--GESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
YE+ + +G+G + V A+N ET E+VA+K + K +A + RE+ +++ R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITN-VFSKKILAKRALRELKLLRHFRG 60
Query: 66 HPCVVRLHEV----LASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGV 120
H + L+++ + ++Y+ E + +I+ G L+++ + + Q++ G+
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL----SALPEQGVSLLRTTCGTPNYVAP 176
Y HS V HRDLKP NLL+++ LKI DFGL S P + + T Y AP
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 177 EV-LSHKGYNGAAADVWSCGVILYVLIAG 204
E+ LS + Y A DVWS G IL L+
Sbjct: 179 EIMLSFQSYT-KAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-23
Identities = 58/193 (30%), Positives = 101/193 (52%), Gaps = 8/193 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVRHPCVVRL 72
+GEGT+A V ++ T VA+K + ++H+ RE+S++K ++H +V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRL-SESEARRYFQQLIDGVDYCHSKGVYHR 131
H+++ + + ++ E++ +L + + G L S + + QL+ G+ YCH + + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKP+NLL++ +G LK++DFGL+ T Y P+VL D+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187
Query: 192 WSCGVILYVLIAG 204
W G ILY + G
Sbjct: 188 WGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-23
Identities = 59/193 (30%), Positives = 100/193 (51%), Gaps = 8/193 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+GEG++A V + G+ VA+KV+ + + RE S++K ++H +V LH+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++ ++ + + E++ I H G L R + QL+ G+ Y H + + HRDLK
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130
Query: 135 PENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
P+NLL+ G LK++DFGL+ ++P Q S + T Y P+VL +A D+
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSIPSQTYS---SEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 192 WSCGVILYVLIAG 204
W G I ++ G
Sbjct: 188 WGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-22
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 33/232 (14%)
Query: 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-----------REIS 59
G +GEGT+ KV+ A +T TG+ VA+K + I D+ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 60 IMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLI 117
IM ++H ++ L +V I ++++ + ++ D+ + RL+ES+ + Q++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQIL 129
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-----ALPEQGVSLLRTTCGTPN 172
+G++ H HRDL P N+ ++S+G KI+DFGL+ +S T
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 173 ---------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD 212
Y APE+L A D+WS G I L+ G F +E+D
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241
|
Length = 335 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 2e-22
Identities = 73/238 (30%), Positives = 119/238 (50%), Gaps = 39/238 (16%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
++ +YEV + IG G F +V ++ T E K + + K + Q+ E+++M+ +
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMREL 69
Query: 65 RHPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLID 118
+H +VR + ++ K+YI++EF G+L I G++ E +QL+
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 119 GVDYCHS-------KGVYHRDLKPENLLLDSQG--HL----------------KISDFGL 153
+ YCH+ + V HRDLKP+N+ L S G H+ KI DFGL
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFL-STGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 154 SALPEQGVSLLRTTC-GTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPF 208
S G+ + +C GTP Y +PE+L H K Y+ +D+W+ G I+Y L +G PF
Sbjct: 189 SK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-22
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 6/184 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG G+F V FA N+ T E VA+K + S ++ I +E+ ++ ++HP +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134
++++E+ G VH L E E + G+ Y HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 135 PENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAAADVW 192
N+LL G +K++DFG ++ S + GTP ++APEV+ +G DVW
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPANSFV----GTPYWMAPEVILAMDEGQYDGKVDVW 204
Query: 193 SCGV 196
S G+
Sbjct: 205 SLGI 208
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 2e-22
Identities = 55/186 (29%), Positives = 91/186 (48%), Gaps = 6/186 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG G+F V FA++ T E VA+K + S ++ I +E+ ++ ++HP +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++++E+ G VH L E E + G+ Y HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAAAD 190
+K N+LL G +K++DFG +++ S + GTP ++APEV+ +G D
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASI----ASPANSFVGTPYWMAPEVILAMDEGQYDGKVD 206
Query: 191 VWSCGV 196
VWS G+
Sbjct: 207 VWSLGI 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-22
Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 15/200 (7%)
Query: 13 RTIGEGTFAKVKF----AQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R +GEG F KV N TGE VA+K L R ++ K+EI+I+K + H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 69 VVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V+ + + + +I+E++ G L D + H +L+ ++ + QQ+ +G+ Y HS+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
HRDL N+LLD+ +KI DFGL+ A+PE G R + V A E L
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAVECLKEN 185
Query: 183 GYNGAAADVWSCGVILYVLI 202
++ A+DVWS GV LY L+
Sbjct: 186 KFS-YASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 6e-22
Identities = 75/217 (34%), Positives = 107/217 (49%), Gaps = 35/217 (16%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK-VLDRSAIIKHKMADQIKREISIMK-LVR 65
KYE+ + +G+G + V A + T E VA+K + D A A + REI ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD--AFRNATDAQRTFREIMFLQELGD 65
Query: 66 HPCVVRLHEVL-ASRTK-IYIILEF--------ITGGELFDKIVHHGRLSESEARRY-FQ 114
HP +V+L V+ A K IY++ E+ I L + VH +RY
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL--EDVH---------KRYIMY 114
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL----SALPE-QGVSLLRTTCG 169
QL+ + Y HS V HRDLKP N+LL+S +K++DFGL S L E +L
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 170 TPNYVAPEVL--SHKGYNGAAADVWSCGVILYVLIAG 204
T Y APE+L S + Y D+WS G IL ++ G
Sbjct: 175 TRWYRAPEILLGSTR-YT-KGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 6e-22
Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMK----VLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R IG G F V + G+ VA+K V K ++ RE+ ++ +H
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK-----RVFRELKMLCFFKHDN 60
Query: 69 VVRLHEVLASR-----TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
V+ ++L +IY++ E + +L IV LS + + Q++ G+ Y
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHK 182
HS G+ HRD+KP NLL++S LKI DFGL+ + E S T T Y APE+L
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179
Query: 183 GYNGAAADVWSCGVILYVLIAGYL------PFDELDLTT 215
+ +A D+WS G I L+ + P +LDL T
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 7e-22
Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 25/219 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRS-AIIKHKMADQIKREISIMKLVRH 66
+Y+ + IG G V A +T TG++VA+K L R + H A + RE+ +MKLV H
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTH--AKRAYRELVLMKLVNH 74
Query: 67 PCVVRLHEVLASRTK------IYIILEFITGG--ELFDKIVHHGRLSESEARRYF-QQLI 117
++ L V + +Y+++E + ++ + H R+S Y Q++
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQML 128
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAP 176
G+ + HS G+ HRDLKP N+++ S LKI DFGL+ G S + T T Y AP
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 186
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD 212
EV+ GY D+WS G I+ +I G + F D +D
Sbjct: 187 EVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHID 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-22
Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 12/179 (6%)
Query: 30 ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL-HEVLASRTKIYIILEF 88
TG VA+K+L A + + +RE ++ + HP +V L A ++ + E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---H 145
+ G L + + G L E R Q++D + H++G+ HRDLKP+N+++ G H
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 146 LKISDFGLSAL-PEQG----VSLLRTT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVI 197
K+ DFG+ L P +L RTT GTP Y APE L + +D+++ G+I
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLI 178
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-22
Identities = 54/186 (29%), Positives = 90/186 (48%), Gaps = 6/186 (3%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG G+F V FA++ E VA+K + S ++ I +E+ ++ +RHP ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++++E+ G VH L E E + G+ Y HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYNGAAAD 190
+K N+LL G +K+ DFG +++ ++ GTP ++APEV+ +G D
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 191 VWSCGV 196
VWS G+
Sbjct: 197 VWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-22
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
E +G G V ++ TG +A KV+ A K + QI RE+ IM R P +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYI 65
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSK-G 127
V + + I + +EF+ G L D+I G + + +++G+ Y ++
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRD+KP N+L++S+G +K+ DFG+S E S+ T GT Y++PE + Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFVGTSTYMSPERIQGGKYT-V 181
Query: 188 AADVWSCGVILYVLIAGYLPFDE 210
+DVWS G+ + L G PF
Sbjct: 182 KSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-21
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG G F +V + VA+K + + + + +E I+K HP +VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V + IYI++E + GG+ + G RL E + + G++Y SK HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----YVAPEVLSHKGYNGAAA 189
N L+ + LKISDFG+S E GV +T G + APE L++ Y+ + +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEALNYGRYS-SES 177
Query: 190 DVWSCGVILYVLIA-GYLPFDEL 211
DVWS G++L+ + G +P+ L
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANL 200
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-21
Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 15 IGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+G+G F V+ + TGE VA+K L S + D +REI I+K ++H +V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-FEREIEILKSLQHDNIV 68
Query: 71 RLHEVL--ASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ V A R + +++E++ G L D + H RL + Y Q+ G++Y SK
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN-----YVAPEVLSHK 182
HRDL N+L++S+ +KI DFGL+ + Q + P + APE L+
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR--EPGESPIFWYAPESLTES 186
Query: 183 GYNGAAADVWSCGVILYVL 201
++ A+DVWS GV+LY L
Sbjct: 187 KFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-21
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR----EISIMKLVRHPC 68
IG+G F V + + VA+K + + +KR E I+K HP
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKT------CRSTLPPDLKRKFLQEAEILKQYDHPN 53
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID-------GVD 121
+V+L V + IYI++E + GG L L + + R ++L+ G++
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLT------FLRKKKNRLTVKKLLQMSLDAAAGME 107
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVL 179
Y SK HRDL N L+ LKISDFG+S E G+ + P + APE L
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 180 SHKGYNGAAADVWSCGVILY 199
++ Y + +DVWS G++L+
Sbjct: 168 NYGRYT-SESDVWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-21
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-- 65
+YE IG G + V A++ +G VA+K + R + + RE++++K +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 66 -HPCVVRLHEVLAS-----RTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLI 117
HP +VRL +V A+ TK+ ++ E + DK+ G L + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ + ++L T Y APE
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPE 177
Query: 178 VLSHKGYNGAAADVWSCGVIL 198
VL Y D+WS G I
Sbjct: 178 VLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-21
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 32/203 (15%)
Query: 15 IGEGTFAKVKFAQ-NTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+G+G+F V+ + +T G+ VA+K L +S + M D + +E +IM + H ++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFL-KEAAIMHSLDHENLIR 60
Query: 72 LHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
L+ V+ + + ++ E G L D + G S Y Q+ +G+ Y SK
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 130 HRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYV------------AP 176
HRDL N+LL S +KI DFGL ALP+ +YV AP
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQ----------NEDHYVMEEHLKVPFAWCAP 169
Query: 177 EVLSHKGYNGAAADVWSCGVILY 199
E L + ++ A+DVW GV L+
Sbjct: 170 ESLRTRTFS-HASDVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-21
Identities = 69/202 (34%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
+YE IGEG + KV A++ + G VA+K + R + M RE+++++ +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 66 --HPCVVRLHEVLA-SRT----KIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQL 116
HP VVRL +V SRT K+ ++ E + DK+ G +E+ + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQL 119
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ G+D+ HS V HRDLKP+N+L+ S G +K++DFGL+ + L + T Y AP
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRAP 178
Query: 177 EVLSHKGYNGAAADVWSCGVIL 198
EVL Y D+WS G I
Sbjct: 179 EVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-21
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--SAIIKHKMADQIKREISIMKLVR 65
+Y+ +G G + V A +T + VA+K L R ++I A + RE+ ++K ++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH---ARRTYRELRLLKHMK 72
Query: 66 HPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
H V+ L +V T ++Y++ + G + IV +LS+ + QL+ G
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+ Y HS G+ HRDLKP N+ ++ L+I DFGL+ Q + T Y APE++
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEIM 187
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ + D+WS G I+ L+ G F
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-21
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 14/208 (6%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVRHPCVVRL 72
+GEGT+A V ++ T VA+K + ++H+ RE+S++K ++H +V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHR 131
H+++ + + ++ E++ +L + G +S + + Q++ G+ YCH + V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKP+NLL++ +G LK++DFGL+ T Y P+VL D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 192 WSCGVILYVLIAGYLPF------DELDL 213
W G I + + +G F DEL L
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-21
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 12 GRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R +G G F +V + T+ VA+K L + +E IMK +RH
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK----VAVKTLKPGTMSPEAFL----QEAQIMKKLRHDK 62
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARR-YFQQLID-------GV 120
+V+L+ V + IYI+ E+++ G L D L E ++ QL+D G+
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVL 179
Y S+ HRDL N+L+ KI+DFGL+ L E R P + APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 180 SHKGYNGAAADVWSCGVILYVLIA-GYLPF 208
++ G +DVWS G++L ++ G +P+
Sbjct: 177 NY-GRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 6e-21
Identities = 72/221 (32%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLV 64
+Y + +G G + V A + TGE VA+K L R S I A + RE++++K +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FAKRAYRELTLLKHM 71
Query: 65 RHPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
+H V+ L +V S Y+++ ++ KI+ H LSE + + Q++
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLC 128
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
G+ Y HS G+ HRDLKP NL ++ LKI DFGL+ + + T Y APEV
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEV 185
Query: 179 -LSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDLTT 215
L+ YN D+WS G I+ ++ G F D LD T
Sbjct: 186 ILNWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 7e-21
Identities = 55/193 (28%), Positives = 99/193 (51%), Gaps = 8/193 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK--REISIMKLVRHPCVVRL 72
+GEGT+A V ++ T VA+K + ++H+ RE+S++K ++H +V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRL-SESEARRYFQQLIDGVDYCHSKGVYHR 131
H+++ + + ++ E++ +L + G + + + QL+ G++YCH + V HR
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKP+NLL++ +G LK++DFGL+ T Y P++L D+
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 192 WSCGVILYVLIAG 204
W G I Y + G
Sbjct: 189 WGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-21
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 16/213 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--SAIIKHKMADQIKREISIMKLVR 65
+Y+ +G G + V A +T+TG VA+K L R +II A + RE+ ++K ++
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMK 74
Query: 66 HPCVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
H V+ L +V +Y++ + G + IV +L++ + Q++ G
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+ Y HS + HRDLKP NL ++ LKI DFGL+ + ++ T Y APE++
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIM 189
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ + D+WS G I+ L+ G F D
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-20
Identities = 64/200 (32%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 13 RTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
R +GEG F KV+ + TGE VA+K L + H +AD +K+EI I++ + H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-IAD-LKKEIEILRNLYHEN 67
Query: 69 VVRLHEVLASR--TKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS 125
+V+ + I +I+EF+ G L + + + +++ + +Y Q+ G+DY S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPE--QGVSLLRTTCGTPNY-VAPEVLSHK 182
+ HRDL N+L++S+ +KI DFGL+ E + ++ +P + APE L
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 183 GYNGAAADVWSCGVILYVLI 202
+ A+DVWS GV LY L+
Sbjct: 188 KFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-20
Identities = 59/204 (28%), Positives = 108/204 (52%), Gaps = 11/204 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G G F VK+ + VA+K++ ++ + D+ E +M + H +V+L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHR 131
+ V + IYI+ E+++ G L + + HG R S+ + + +G+ Y SK HR
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124
Query: 132 DLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
DL N L+D QG +K+SDFGLS L ++ S + + + PEVL + ++ + +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLLYSKFS-SKS 182
Query: 190 DVWSCGVILY-VLIAGYLPFDELD 212
DVW+ GV+++ V G +P++ +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFN 206
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-20
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 49/228 (21%)
Query: 8 KYEVGRTIGEGTFAKV-----------------KFAQNTETGESVAMKVLDRSAIIKHKM 50
KYE+ IG GT+ +V KF + E ++ SA
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQ-----SAC----- 50
Query: 51 ADQIKREISIMKLVRHPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGR----- 103
REI++++ ++H VV L EV +Y++ ++ +L+ I H +
Sbjct: 51 -----REIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVS 104
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL--- 156
+ S + Q+++GV Y HS V HRDLKP N+L+ +G +KI D GL+ L
Sbjct: 105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
Query: 157 PEQGVSLLRTTCGTPNYVAPEV-LSHKGYNGAAADVWSCGVILYVLIA 203
P + ++ L T Y APE+ L + Y A D+W+ G I L+
Sbjct: 165 PLKPLADLDPVVVTIWYRAPELLLGARHYT-KAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-20
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 10/203 (4%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+GT+ V A++ T +A+K + + + EI++ ++H +V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 75 VLASRTKIYIILEFITGGELFDKIVHH-GRLSESEA--RRYFQQLIDGVDYCHSKGVYHR 131
+ I +E + GG L + G L ++E Y +Q+++G+ Y H + HR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 132 DLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAA 188
D+K +N+L+++ G +KISDFG S T GT Y+APEV+ +GY GA
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAP 191
Query: 189 ADVWSCGVILYVLIAGYLPFDEL 211
AD+WS G + + G PF EL
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-20
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ IG G F +V + G+ VA+K L + K E SIM HP +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNI 67
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+RL V+ + II E++ G L DK + + G+ + + + + G+ Y
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGYN 185
HRDL N+L++S K+SDFGLS E + T G P + APE ++++ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELD 212
+A+DVWS G++++ V+ G P+ ++
Sbjct: 187 -SASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-20
Identities = 60/224 (26%), Positives = 113/224 (50%), Gaps = 29/224 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G +E+ +G GT+ +V ++ +TG+ A+KV+D + ++IK+EI+++K H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 67 PCVVRLHEVLAS-------------RTKIYIILEFITGGELFDKIVH-HGRLSESEARRY 112
H +A+ ++++++EF G + D I + G + E Y
Sbjct: 62 ------HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115
Query: 113 F-QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
++++ G+ + H V HRD+K +N+LL +K+ DFG+SA ++ V T GTP
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 175
Query: 172 NYVAPEVLSHKGYNGAA----ADVWSCGVILYVLIAGYLPFDEL 211
++APEV++ A +D+WS G+ + G P ++
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-20
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 14 TIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+G G V A + T +A+KV LD I ++ QI E+ I+ P ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIG 63
Query: 72 LHEVLASRTKIYIILEFITGGEL--FDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKG 127
+ +I I EF+ GG L + KI H GR++ + ++ G+ Y S
Sbjct: 64 FYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLK 115
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+KP N+L++++G +K+ DFG+S Q V S+ +T GT Y+APE +S + Y G
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQY-G 171
Query: 187 AAADVWSCGVILYVLIAGYLPF 208
+DVWS G+ L G P+
Sbjct: 172 IHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-20
Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 17/215 (7%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G +E+ +G GT+ +V ++ +TG+ A+KV+D + ++IK EI+++K
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 66 HPCVVRLHEVLASRT------KIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLI 117
H + + ++ ++++++EF G + D K L E ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+ + H+ V HRD+K +N+LL +K+ DFG+SA ++ V T GTP ++APE
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 178 VLSHKGYNGAA----ADVWSCGVILYVLIAGYLPF 208
V++ A +D+WS G+ + G P
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 6e-20
Identities = 54/179 (30%), Positives = 97/179 (54%), Gaps = 14/179 (7%)
Query: 45 IIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR 103
IIK K + I E + +L++ +P ++L+ + + +I+++I G+LFD + G+
Sbjct: 48 IIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK 105
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVS 162
LSE+E ++ +QL++ ++ H + H D+K EN+L D ++ + + D+GL S
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPS 164
Query: 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD-----ELDLTTL 216
GT +Y +PE + Y+ + D W+ GV+ Y L+ G PF ELDL +L
Sbjct: 165 CYD---GTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL 219
|
Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-19
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 13 RTIGEGTFAKVKFA-QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F +V N T VA+K L + E ++MK ++H +VR
Sbjct: 12 KKLGAGQFGEVWMGYYNNST--KVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVR 65
Query: 72 LHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
L+ V+ IYII E++ G L D K G++ + + Q+ +G+ Y K
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAA 188
HRDL+ N+L+ KI+DFGL+ + E R P + APE ++ +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IK 184
Query: 189 ADVWSCGVILYVLIA-GYLPF 208
+DVWS G++LY ++ G +P+
Sbjct: 185 SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-19
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G G F V + VA+K ++ A+ + + E +M + HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
+ V + +YI+ EF+ G L + + G+LS+ Q + +G++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 132 DLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTP---NYVAPEVLSHKGYNG 186
DL N L+ S G +K+SDFG++ L ++ S + G + PEV + Y+
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS----SSGAKFPVKWSPPEVFNFSKYS- 179
Query: 187 AAADVWSCGVILY-VLIAGYLPFD 209
+ +DVWS GV+++ V G +PF+
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-19
Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 22/192 (11%)
Query: 18 GTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA 77
G KV +T T ++ +K L +S+ + + I I V P +V LH+ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTI-IPHCV--PNMVCLHKYIV 55
Query: 78 SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPEN 137
S ++++L+ GG+L+ I + E +R+ +++ +D H +G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 138 LLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYVAPEV--LSHKGYNGAAADVW 192
+LLD +GH++++ F + + + G Y APEV +S + A D W
Sbjct: 116 ILLDDRGHIQLTYFS------RWSEVEDSCDGEAVENMYCAPEVGGISEE---TEACDWW 166
Query: 193 SCGVILYVLIAG 204
S G IL+ L+ G
Sbjct: 167 SLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-19
Identities = 63/211 (29%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 13 RTIGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G G F V VA+K L + I K + RE S+M + HPC+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
VRL V + +++E G L + + S+ + Q+ G+ Y SK
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT--P-NYVAPEVL-----SH 181
HRDL N+LL ++ KISDFG+S G R T P + APE + S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 182 KGYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
K DVWS GV L+ G P+ E+
Sbjct: 178 KS------DVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-19
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 8 KYEVGRTIGEGTFAKV--KFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V A+ GE VA+K ++ +A ++ ++ + E S+MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQ- 114
VVRL V+++ +++E + G+L + ++ L +++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 115 --QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ-------GVSLLR 165
++ DG+ Y +K HRDL N ++ +KI DFG++ + G LL
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL- 183
Query: 166 TTCGTP-NYVAPEVLSHKGYNGAAADVWSCGVILY 199
P ++APE L G +DVWS GV+L+
Sbjct: 184 -----PVRWMAPESLK-DGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-19
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 12/217 (5%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISI 60
K + E + +G G F V GE VA+KVL K +I E +
Sbjct: 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYV 62
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDG 119
M V HP VVRL + S + +I + + G L D + +H + + Q+ G
Sbjct: 63 MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPE 177
+ Y K + HRDL N+L+ + H+KI+DFGL+ L + G P ++A E
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213
+ H+ Y +DVWS GV ++ L+ G P++ +
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPA 217
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-19
Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A +T G +VA+K L R A + RE+ ++K V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 80
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLI 117
++ L V + +Y+++E + +++H H R+S Q++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMS-----YLLYQML 133
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-------- 169
G+ + HS G+ HRDLKP N+++ S LKI DFGL+ RT C
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA----------RTACTNFMMTPYV 183
Query: 170 -TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
T Y APEV+ GY D+WS G I+ L+ G + F D
Sbjct: 184 VTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-19
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 21/222 (9%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMK----VLDRSAIIKHKMADQIKREISIMKLVR 65
EV +G+G + V + TG ++AMK LD S +QI E+ I+
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF------NQIIMELDILHKAV 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
P +V + +Y+ +E++ G +L+ V + E RR ++ G+ +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 123 CHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
+ + HRD+KP N+L++ G +K+ DFG+S SL +T G +Y+APE +
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--SLAKTNIGCQSYMAPERIKS 175
Query: 182 KGYNGAA-----ADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
G N +DVWS G+ + + G P+ +++
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-18
Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 9 YEVGRT-------IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+E+ RT +G G + +V + +VA+K L + ++ +E ++M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVM 56
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ---QLID 118
K ++HP +V+L V YII EF+T G L D + R E A Q+
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPE 177
++Y K HRDL N L+ +K++DFGLS L P + APE
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 178 VLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
L++ ++ +DVW+ GV+L+ + G P+ +DL+ +Y
Sbjct: 176 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-18
Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 6/187 (3%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V F + VA+K + ++ + E I+K HP +V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 75 VLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V R IYI++E + GG+ + L + ++ G+ Y SK HRDL
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADVW 192
N L+ LKISDFG+S + G+ P + APE L++ Y+ + +DVW
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS-SESDVW 178
Query: 193 SCGVILY 199
S G++L+
Sbjct: 179 SYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-18
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 4/172 (2%)
Query: 46 IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLS 105
IK + +QI RE+ ++ P +V + S +I I +E + GG L + GR+
Sbjct: 42 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 101
Query: 106 ESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164
E + +I G+ Y K + HRD+KP N+L++S+G +K+ DFG+S + S+
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMA 159
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+ GT +Y++PE L Y+ +D+WS G+ L + G P D L
Sbjct: 160 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-18
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 13 RTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F +V A N T VA+K + ++ E ++MK ++H +V+
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKLVK 65
Query: 72 LHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
LH V+ ++ IYII EF+ G L D K + + + Q+ +G+ + +
Sbjct: 66 LHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAA 188
HRDL+ N+L+ + KI+DFGL+ + E R P + APE ++ +
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IK 183
Query: 189 ADVWSCGVILYVLIA-GYLPF 208
+DVWS G++L ++ G +P+
Sbjct: 184 SDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-18
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 13 RTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ IG G F +V + G+ VA+K L A K E SIM HP +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ L V+ + I+ E++ G L D + H G+ + + + + G+ Y G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYVAPEVLSHKGY 184
HRDL N+L++S K+SDFGLS + E TT G + APE ++++ +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDEL 211
+A+DVWS G++++ V+ G P+ E+
Sbjct: 187 T-SASDVWSYGIVMWEVMSYGERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F V + VA+K++ A+ + D E +M + HP +V+
Sbjct: 9 LKELGSGQFGVVHLGK-WRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQ 63
Query: 72 LHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
L+ V + I+I+ E++ G L + + G+L + + ++Y S G H
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIH 123
Query: 131 RDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTP---NYVAPEVLSHKGYN 185
RDL N L+ +K+SDFGL+ L +Q S + GT + PEV + ++
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS----SQGTKFPVKWAPPEVFDYSRFS 179
Query: 186 GAAADVWSCGVILY-VLIAGYLPFD 209
+ +DVWS GV+++ V G +P++
Sbjct: 180 -SKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-18
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y V +T+ G+ +V A + V +K+ + + M +++ V HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
V+R+ + L S ++L + +L+ + L +A +Q+++G+ Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRD+K EN+ ++ + I D G + P + L GT APEVL+ YN +
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGTVETNAPEVLARDKYN-S 235
Query: 188 AADVWSCGVILYVLIA 203
AD+WS G++L+ ++A
Sbjct: 236 KADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-18
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 83
Query: 68 CVVRLHEVLASRTK------IYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDG 119
++ L V + +YI++E + ++ + H R+S Q++ G
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 138
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEV 178
+ + HS G+ HRDLKP N+++ S LKI DFGL+ G S + T T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 196
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ GY D+WS G I+ +I G + F D
Sbjct: 197 ILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-18
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 6/203 (2%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G G V Q+ +G +A K++ IK + +QI RE+ ++ P +V +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDL 133
S +I I +E + GG L + R+ E + ++ G+ Y K + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193
KP N+L++S+G +K+ DFG+S + S+ + GT +Y++PE L Y+ +D+WS
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWS 187
Query: 194 CGVILYVLIAGYLPFDELDLTTL 216
G+ L L G P D L
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-18
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 13 RTIGEGTFAKV--KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+ +G G F +V + VA+K L + ++ + E ++MK ++HP +V
Sbjct: 12 KKLGAGQFGEVWMGYYNGHT---KVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLV 64
Query: 71 RLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
RL+ V+ ++ IYII E++ G L D K +L+ ++ Q+ +G+ + K
Sbjct: 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGA 187
HRDL+ N+L+ KI+DFGL+ L E R P + APE +++ G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTI 182
Query: 188 AADVWSCGVILYVLIA-GYLPF 208
+DVWS G++L ++ G +P+
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-17
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 76
Query: 68 CVVRLHEVLASRTK------IYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLIDG 119
++ L V + +Y+++E + ++ + H R+S Q++ G
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 131
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEV 178
+ + HS G+ HRDLKP N+++ S LKI DFGL+ G S + T T Y APEV
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 179 LSHKGYNGAAADVWSCGVIL 198
+ GY D+WS G I+
Sbjct: 190 ILGMGYK-ENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 38/236 (16%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +Y++ R IG+G +V A + VA+K + + + RE I +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGEL--FDKIV---------HHGRLSESEARRYFQ 114
HP +V ++ + + +Y + +I G L K V + S F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-------------SALPEQGV 161
++ ++Y HSKGV HRDLKP+N+LL G + I D+G + E+ +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 162 SLLRTT-----CGTPNYVAPEVLSHKGYNGAAA----DVWSCGVILYVLIAGYLPF 208
T GTP+Y+APE L G A D+++ GVILY ++ P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLL-----GVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-17
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
IG G F V E + VA+K + A+ + + E +M + HP +V+L+
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 75 VLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL 133
V R+ I ++ EF+ G L D + G+ S+ + +G+ Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 134 KPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTP---NYVAPEVLSHKGYNGAA 188
N L+ +K+SDFG++ L +Q S + GT + +PEV S Y+ +
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTS----STGTKFPVKWSSPEVFSFSKYS-SK 181
Query: 189 ADVWSCGVILY-VLIAGYLPFD 209
+DVWS GV+++ V G P++
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-17
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+TIG+G F V G VA+K + A + +A E S+M +RH +V+L
Sbjct: 12 QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 64
Query: 73 HEVLAS-RTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVY 129
V+ + +YI+ E++ G L D + GR L ++ + + ++Y +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAA 188
HRDL N+L+ K+SDFGL+ + S + T P + APE L K ++
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFS-TK 179
Query: 189 ADVWSCGVILYVLIA-GYLPFDELDL 213
+DVWS G++L+ + + G +P+ + L
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPL 205
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-17
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 17/210 (8%)
Query: 13 RTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ IG G F +V K E +VA+K L K E SIM H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEV--AVAIKTL--KPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHS 125
++RL V+ II E++ G L DK + H G S + + + G+ Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP---NYVAPEVLSHK 182
HRDL N+L++S K+SDFGLS + E TT G + APE ++++
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
+ +A+DVWS G++++ V+ G P+ ++
Sbjct: 186 KFT-SASDVWSFGIVMWEVMSFGERPYWDM 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-17
Identities = 65/230 (28%), Positives = 111/230 (48%), Gaps = 24/230 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +GR +G+G F V+ AQ + + VA+K+L ++ I ++ RE + MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 66 HPCVVRLHEV-LASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID- 118
HP V++L V L SR K +IL F+ G+L ++ R+ E Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM-SRIGEEPFTLPLQTLVRF 118
Query: 119 ------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP- 171
G++Y SK HRDL N +L+ + ++DFGLS G R C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKL 177
Query: 172 --NYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYS 218
++A E L+ Y +DVW+ GV ++ ++ G P+ ++ + +Y+
Sbjct: 178 PVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-17
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y++G IG G+F V A +T E VA+K + + K+ RE+ IMK + H
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-------RELLIMKNLNHIN 120
Query: 69 VVRLHE------VLASRTKIY--IILEFITGGELFDKIVHHGRLSESE----ARRYFQQL 116
++ L + + I+ +++EFI + + H+ R + + + Y QL
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGH-LKISDFGLSALPEQGVSLLRTTCGTPNYVA 175
+ Y HSK + HRDLKP+NLL+D H LK+ DFG + G + C + Y A
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-SRFYRA 238
Query: 176 PEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
PE++ D+WS G I+ +I GY F
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-16
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 15 IGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+GEG F KV + + SVA+K L +A K + + ++E +M ++HP +
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ--------------- 114
V L V ++ E++ G+L + +V + S+ A +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 115 -QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-------PEQGVSLLRT 166
Q+ G++Y S HRDL N L+ +KISDFGLS Q SLL
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
++ PE + + G +D+WS GV+L+
Sbjct: 191 -----RWMPPEAILY-GKFTTESDIWSFGVVLW 217
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-16
Identities = 51/164 (31%), Positives = 89/164 (54%), Gaps = 6/164 (3%)
Query: 46 IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRL 104
IK + +QI RE+ ++ P +V + S +I I +E + GG L D+++ GR+
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 96
Query: 105 SESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
E+ + ++ G+ Y K + HRD+KP N+L++S+G +K+ DFG+S + S+
Sbjct: 97 PENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSM 154
Query: 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP 207
+ GT +Y++PE L Y +D+WS G+ L + G P
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-16
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+ +G+ +GEG F +V A+ N +VA+K+L A + ++D + E+ +MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVS-EMEMMK 70
Query: 63 LV-RHPCVVRLHEVLASRTKIYIILEFITGGELFD----------------KIVHHGRLS 105
++ +H ++ L V +Y+++E+ G L D L+
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 106 ESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
+ + + Q+ G+++ SK HRDL N+L+ +KI+DFGL+ +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 166 TTCG-TP-NYVAPEVLSHKGYNGAAADVWSCGVILY 199
TT G P ++APE L + Y +DVWS GV+L+
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 7e-16
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 13 RTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
R +G G F +V + N T VA+K L + E IMK +RHP +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQ 65
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARR-YFQQLID-------GVDYC 123
L+ V IYI+ E + G L + L R QLID G+ Y
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHK 182
++ HRDL N+L+ K++DFGL+ + ++ + R P + APE +
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPF 208
++ +DVWS G++L ++ G +P+
Sbjct: 180 RFS-IKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 9e-16
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 15/205 (7%)
Query: 15 IGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
IG G F +V + G+ VA+K L +S + + D + E SIM HP ++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLS-EASIMGQFDHPNIIH 69
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
L V+ + II EF+ G L D + + G+ + + + + G+ Y
Sbjct: 70 LEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT----CGTP-NYVAPEVLSHKGY 184
HRDL N+L++S K+SDFGLS E S T P + APE ++++ +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 185 NGAAADVWSCGVILY-VLIAGYLPF 208
+A+DVWS G++++ V+ G P+
Sbjct: 189 T-SASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-15
Identities = 66/239 (27%), Positives = 112/239 (46%), Gaps = 38/239 (15%)
Query: 11 VGRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+G+ +GEG F +V A + +VA+K+L +A K +AD I E+ +MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLIS-EMELMKL 73
Query: 64 V-RHPCVVRLHEVLASRTKIYIILEFITGGEL---------------FDKI-VHHGRLSE 106
+ +H ++ L V +Y+I+E+ G L FD V +LS
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 107 SEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166
+ Q+ G++Y S+ HRDL N+L+ +KI+DFGL+ +GV +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA----RGVHDIDY 189
Query: 167 TCGTPN------YVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLYS 218
T N ++APE L + Y +DVWS G++++ + G P+ + + L+
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-15
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+YE G +G GT+ V A+ + + A+K ++ + I + REI++++ ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELK 56
Query: 66 HPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHG---------RLSESEARRYFQ 114
HP V+ L +V S + K++++ ++ +L+ I H +L S +
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL---PEQGVSLLRTT 167
Q++DG+ Y H+ V HRDLKP N+L+ +G +KI+D G + L P + ++ L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202
T Y APE+L + A D+W+ G I L+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 1e-15
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 6/203 (2%)
Query: 10 EVGRTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+GR IGEG F V + + E +A+ V + ++ +E IM+ HP
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L V+ + ++I++E GEL + V+ L + Y QL + Y SK
Sbjct: 69 IVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRD+ N+L+ S +K+ DFGLS E + P ++APE ++ + +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT- 186
Query: 187 AAADVWSCGVILY-VLIAGYLPF 208
+A+DVW GV ++ +L+ G PF
Sbjct: 187 SASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-15
Identities = 63/198 (31%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V T + VA+K L + M + +E IMK +RH +V L+
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 75 VLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
V+ S IYI+ EF+ G L D K L + Q+ DG+ Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADV 191
L+ N+L+ KI+DFGL+ L E R P + APE + G +DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 186
Query: 192 WSCGVILYVLIA-GYLPF 208
WS G++L L+ G +P+
Sbjct: 187 WSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-15
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 13 RTIGEGTFAKVKFAQNTETGES-VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+ +G G F +V T G + VA+K L + + E IMK +RH +V+
Sbjct: 12 KKLGNGQFGEV--WMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQ 65
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY-FQQLID-------GVDYC 123
L+ V+ S IYI+ E+++ G L D L + E R L+D G+ Y
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHK 182
HRDL+ N+L+ KI+DFGL+ L E R P + APE +
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPF 208
G +DVWS G++L L+ G +P+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-15
Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 8 KYEVGRTIGEGTFAKV---------------KFAQNTETGESVAMKVLDRSAIIKHKMAD 52
+ V + G F K+ + +T G+ +++ + + A
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208
Query: 53 QIKREISIMKLVRHPCVVRLHEVLASRTKIYII---LEFITGGELFDKIVH-HGRLSESE 108
Q++ EI + + H ++++ E+L S Y+I +F ++D+ R +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 109 ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT- 167
R +QL+ V+Y H K + HRD+K EN+ L+ G + + DFG +A+P +
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKEREAFDYG 327
Query: 168 -CGTPNYVAPEVLSHKGYNGAAADVWSCGVIL 198
GT +PE+L+ GY D+WSCG+IL
Sbjct: 328 WVGTVATNSPEILAGDGY-CEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-15
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ--NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+YE G +G GT+ V A+ + + A+K ++ + I + REI++++ ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELK 56
Query: 66 HPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHG---------RLSESEARRYFQ 114
HP V+ L +V S K++++ ++ +L+ I H +L +
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL---PEQGVSLLRTT 167
Q++DG+ Y H+ V HRDLKP N+L+ +G +KI+D G + L P + ++ L
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202
T Y APE+L + A D+W+ G I L+
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-14
Identities = 53/193 (27%), Positives = 101/193 (52%), Gaps = 14/193 (7%)
Query: 15 IGEGTFAKVK--FAQNTETGESVAMKVL---DRSAIIKHKMADQIKREISIMKLVRHPCV 69
+G G F VK + ++ ++VA+K+L + +K D++ RE ++M+ + +P +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALK----DELLREANVMQQLDNPYI 58
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
VR+ + + + + +++E G L + + ++E Q+ G+ Y
Sbjct: 59 VRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 130 HRDLKPENLLLDSQGHLKISDFGLS-ALPE-QGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL N+LL +Q + KISDFGLS AL + +T P + APE +++ ++
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176
Query: 187 AAADVWSCGVILY 199
+ +DVWS GV+++
Sbjct: 177 SKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-14
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR---EISIMKLVRHPC--V 69
IG GT +V + +TG +A+K + R+ ++ KR ++ ++ L H C +
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-----NKEENKRILMDLDVV-LKSHDCPYI 76
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSK- 126
V+ + + + ++I +E + DK++ G + E + ++ + Y K
Sbjct: 77 VKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRT-TCGTPNYVAPEVLSHKGY 184
GV HRD+KP N+LLD+ G++K+ DFG+S L + S +T + G Y+APE +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDP 191
Query: 185 NGA---AADVWSCGVILYVLIAGYLPFDELD 212
N ADVWS G+ L L G P+
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-14
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI-SIMKLVRHPCVVRLH 73
IG G F V + +G +A+K + RS + + + ++ ++ +M+ P +V+ +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQK-RLLMDLDVVMRSSDCPYIVKFY 69
Query: 74 EVLASRTKIYIILEFI-TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG----- 127
L +I +E + + F K V+ E ++++ + K
Sbjct: 70 GALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 128 ----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL---S 180
+ HRD+KP N+LLD G++K+ DFG+S ++ R P Y+APE + +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPERIDPSA 183
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
GY+ +DVWS G+ LY + G P+ + +
Sbjct: 184 RDGYD-VRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-14
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 34/226 (15%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETG-----ESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+G+T+GEG F KV A +VA+K+L +A + E +++K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLK 58
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGEL-----FDKIVHHGRLSESEARR------ 111
V HP V++L+ + + +I+E+ G L + V L R
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 112 -------------YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-LP 157
+ Q+ G+ Y + HRDL N+L+ +KISDFGLS +
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 158 EQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202
E+ + R+ P ++A E L Y +DVWS GV+L+ ++
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-14
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F V GE VA+K L R A K +I E +M V +P
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REAT-SPKANKEILDEAYVMASVDNPH 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
V RL + + T + +I + + G L D + H + + Q+ G++Y +
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGYN 185
+ HRDL N+L+ + H+KI+DFGL+ L G P ++A E + H+ Y
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 186 GAAADVWSCGVILYVLIA-GYLPFD 209
+DVWS GV ++ L+ G P+D
Sbjct: 190 -HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-13
Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 11/198 (5%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G+G F +V T VA+K L + + +E +MK +RH +V+L+
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYA 68
Query: 75 VLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
V+ S IYI+ E+++ G L D K L + Q+ G+ Y HRD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADV 191
L+ N+L+ K++DFGL+ L E R P + APE + G +DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDV 186
Query: 192 WSCGVILYVLIA-GYLPF 208
WS G++L L G +P+
Sbjct: 187 WSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 50/228 (21%), Positives = 99/228 (43%), Gaps = 31/228 (13%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G+ + V A++ T VA+K ++ + + +++EI + ++HP
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPN 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHS 125
++ +++Y++ + G D + H G L E + +++ +DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSA--------------LPEQGVSLLRTTCGTP 171
KG HR +K ++LL G + +S S P+ V L
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL------- 172
Query: 172 NYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+++PEVL +GYN +D++S G+ L G++PF ++ T +
Sbjct: 173 PWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-13
Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 26/224 (11%)
Query: 15 IGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
IGEG F +V A + G + A+K+L A E+ ++ KL HP ++
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 72 LHEVLASRTKIYIILEFITGGELFDKI-------------VHHGRLSESEARRYFQQLID 118
L +R +YI +E+ G L D + HG S +++ Q D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 119 ---GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYV 174
G+ Y K HRDL N+L+ KI+DFGLS E V + +T P ++
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEE--VYVKKTMGRLPVRWM 185
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
A E L++ Y +DVWS GV+L+ +++ G P+ + LY
Sbjct: 186 AIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-13
Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 30/234 (12%)
Query: 11 VGRTIGEGTFAKVKFAQNTETGES-------VAMKVLDRSAIIKHKMADQIKREISIMKL 63
+G+ +GEG F +V A+ + VA+K+L A K ++D I E+ +MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLIS-EMEMMKM 79
Query: 64 V-RHPCVVRLHEVLASRTKIYIILEFITGGELFDKI----------------VHHGRLSE 106
+ +H ++ L +Y+I+E+ + G L + + V +LS
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 107 SEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166
+ Q+ G++Y SK HRDL N+L+ +KI+DFGL+ +T
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 167 TCG--TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
T G ++APE L + Y +DVWS GV+L+ + G P+ + + L+
Sbjct: 200 TNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-13
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 43/215 (20%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIM-KL 63
G+T+G G F KV A +S VA+K+L +A + A + E+ IM L
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA--LMSELKIMSHL 95
Query: 64 VRHPCVVRLHEVLASRTK---IYIILEFITGGELFDKIVHHGR---LSESEARRYFQQLI 117
H +V L L + T I +I E+ G+L + + R L+ + + Q+
Sbjct: 96 GNHENIVNL---LGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVA 151
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHL-KISDFGLSALPEQGVSLLRTTCGTPNYV-- 174
G+ + SK HRDL N+LL + G + KI DFGL+ R NYV
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLA----------RDIMNDSNYVVK 200
Query: 175 ----------APEVLSHKGYNGAAADVWSCGVILY 199
APE + + Y +DVWS G++L+
Sbjct: 201 GNARLPVKWMAPESIFNCVYT-FESDVWSYGILLW 234
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-13
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHPC 68
EV +G G + V ++ TG +A+K + A + + ++ ++ I M+ V P
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 69 VVRLHEVLASRTKIYIILEFITGG--ELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHS 125
V + L ++I +E + + + K+ G + E + ++ ++Y HS
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 126 K-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRTT-CGTPNYVAPE----V 178
K V HRD+KP N+L++ G +K+ DFG+S V S+ +T G Y+APE
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
L+ KGY+ +DVWS G+ + L G P+D
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 5e-13
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS-----IMKLVRHPCV 69
IGEG F +V A+ + G +++ +K + R+ + + KL HP +
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIV-------------HHGRLSESEAR---RYF 113
+ L R +Y+ +E+ G L D + + S ++ +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-N 172
+ G+DY K HRDL N+L+ KI+DFGLS E V + +T P
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE--VYVKKTMGRLPVR 176
Query: 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
++A E L++ Y +DVWS GV+L+ +++ G P+ + LY
Sbjct: 177 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 221
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-13
Identities = 59/237 (24%), Positives = 111/237 (46%), Gaps = 30/237 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-------NTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
K +G+ +GEG F +V A+ + +VA+K+L A K ++D + E+ +
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVS-EMEM 73
Query: 61 MKLV-RHPCVVRLHEVLASRTKIYIILEFITGGELFDKI----------------VHHGR 103
MK++ +H ++ L +Y+I+E+ + G L + + V +
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
++ + Q+ G++Y S+ HRDL N+L+ +KI+DFGL+
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193
Query: 164 LRTTCG--TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
+TT G ++APE L + Y +DVWS GV+++ + G P+ + + L+
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-12
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGESV----AMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F V GE+V A+K+L+ + K + + E IM + HP
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRL V S T I ++ + + G L D + H + + Q+ G+ Y +
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP--NYVAPEVLSHKGYN 185
+ HRDL N+L+ S H+KI+DFGL+ L E G ++A E + ++ +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 186 GAAADVWSCGVILYVLIA-GYLPFD 209
+DVWS GV ++ L+ G P+D
Sbjct: 190 -HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-12
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 21/225 (9%)
Query: 11 VGRTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G+T+GEG F V Q + VA+K + + + +M D + E MK HP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPN 61
Query: 69 VVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI----- 117
V+RL V + +IL F+ G+L +++ RL + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY-SRLGDCPQYLPTQMLVKFMTD 120
Query: 118 --DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VSLLRTTCGTPNY 173
G++Y SK HRDL N +L+ ++ ++DFGLS G R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
+A E L+ + Y +DVWS GV ++ + G P+ ++ + +Y
Sbjct: 181 IAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-12
Identities = 60/237 (25%), Positives = 110/237 (46%), Gaps = 30/237 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-------NTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
+ +G+ +GEG F +V A+ +VA+K+L A K ++D + E+ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVS-EMEM 70
Query: 61 MKLV-RHPCVVRLHEVLASRTKIYIILEFITGGEL---------------FDKI-VHHGR 103
MK++ +H ++ L +Y+++E+ + G L FD + +
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
L+ + Q+ G++Y S+ HRDL N+L+ +KI+DFGL+
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY 190
Query: 164 LRTTCG--TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
+TT G ++APE L + Y +DVWS GV+L+ + G P+ + + L+
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-12
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 12/205 (5%)
Query: 13 RTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F V GE+ VA+KVL + K +I E +M V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPY 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
V RL + + T + ++ + + G L D + + R+ + + Q+ G+ Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGYN 185
+ HRDL N+L+ S H+KI+DFGL+ L + + G P ++A E + H+ +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 186 GAAADVWSCGVILYVLIA-GYLPFD 209
+DVWS GV ++ L+ G P+D
Sbjct: 190 -HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-12
Identities = 52/170 (30%), Positives = 90/170 (52%), Gaps = 10/170 (5%)
Query: 35 VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94
VA+KVL + + D++ RE IM + +P +VR+ V + + +++E +GG L
Sbjct: 25 VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPL 81
Query: 95 FDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152
+K + + ++ S Q+ G+ Y K HRDL N+LL +Q + KISDFG
Sbjct: 82 -NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140
Query: 153 LS-AL-PEQGVSLLRTTCGTP-NYVAPEVLSHKGYNGAAADVWSCGVILY 199
LS AL + R+ P + APE ++ + ++ + +DVWS G+ ++
Sbjct: 141 LSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-12
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 24/218 (11%)
Query: 11 VGRTIGEGTFAKVKFAQ-NTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+G+ +GEG F V Q + + G VA+K + + I + ++ E + MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 68 CVVRLHEV---LASRTKI---YIILEFITGGELFDKIVHHGRLSESEARRYFQQLID--- 118
V++L V +S KI +IL F+ G+L +++ RL + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLY-SRLGGLPEKLPLQTLLKFMV 120
Query: 119 ----GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP--- 171
G++Y ++ HRDL N +L + ++DFGLS G R
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 179
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
++A E L+ + Y + +DVW+ GV ++ + G P+
Sbjct: 180 KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 13 RTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +G G F ++ K E VA+ L K + E + H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRRG--FLAEALTLGQFDHS 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHS 125
+VRL V+ + I+ E+++ G L D + H G+L + L G+ Y
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
G H+ L +L++S KIS F L E + TT + V APE + +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY- 182
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPF 208
+ +A+DVWS G++++ V+ G P+
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-11
Identities = 58/225 (25%), Positives = 88/225 (39%), Gaps = 37/225 (16%)
Query: 10 EVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIK--REISIMK 62
+ R +G G F +V VA+K L S D+ E IM
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMS 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--------LSESEARRYFQ 114
H +VRL V R +I+LE + GG+L + R L+ + +
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGL-------SALPEQGVSLL 164
+ G Y HRD+ N LL +G KI+DFG+ S + G ++L
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
++ PE G + DVWS GV+L+ + GY+P+
Sbjct: 184 PI-----KWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-11
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 17 EGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR---EISIMKLVRHPCVVR-L 72
EGTF ++ + + +V + + H Q+ E ++ + H ++ L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK-TVKDHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 73 HEVLASRTKIYIILEFITGGEL--FDKIVHHGRLSESEARRYFQ------QLIDGVDYCH 124
H + +++ ++ G L F + G + +A Q Q+ G+ Y H
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
+GV H+D+ N ++D + +KI+D LS P L ++A E L +K
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194
Query: 183 GYNGAAADVWSCGVILYVLIA-GYLPFDELD 212
Y+ +A+DVWS GV+L+ L+ G P+ E+D
Sbjct: 195 EYS-SASDVWSFGVLLWELMTLGQTPYVEID 224
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 28/225 (12%)
Query: 15 IGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVV 70
IGEG F +V A+ + G ++ ++ + ++ H+ E+ ++ KL HP ++
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 71
Query: 71 RLHEVLASRTKIYIILEFITGGELFD--------------KIVHH--GRLSESEARRYFQ 114
L R +Y+ +E+ G L D I + LS + +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NY 173
+ G+DY K HRDL N+L+ KI+DFGLS Q V + +T P +
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 189
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+A E L++ Y +DVWS GV+L+ +++ G P+ + LY
Sbjct: 190 MAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-11
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 15 IGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
IG G V A+ TGE V ++ ++ A ++M ++ E+ + KL HP +V
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYH 130
+ +++++ F+ G D I H +SE Q ++ +DY H G H
Sbjct: 65 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124
Query: 131 RDLKPENLLLDSQGHLKISDF-GLSALPEQGVSLLRTTCGTPNY-------VAPEVLSH- 181
R +K ++L+ G + +S ++ G LR P Y ++PEVL
Sbjct: 125 RSVKASHILISVDGKVYLSGLRSNLSMINHG-QRLRVVHDFPKYSVKVLPWLSPEVLQQN 183
Query: 182 -KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+GY+ A +D++S G+ L G++PF ++ T +
Sbjct: 184 LQGYD-AKSDIYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-11
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 30/214 (14%)
Query: 8 KYEVGRTIGEGTFAKV--KFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V A++ GE+ VA+K ++ SA ++ ++ + E S+MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELF--------DKIVHHGRLSES--EARRY 112
VVRL V++ +++E + G+L + + GR + E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-------LPEQGVSLLR 165
++ DG+ Y ++K HRDL N ++ +KI DFG++ + G LL
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
++APE L G ++D+WS GV+L+
Sbjct: 185 V-----RWMAPESLK-DGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-10
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 13 RTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV A+ + VA+K L ++ K RE ++ ++H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK---DFHREAELLTNLQHE 67
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-------------RLSESEARRYFQ 114
+V+ + V + ++ E++ G+L + HG L++S+ Q
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPN 172
Q+ G+ Y S+ HRDL N L+ +KI DFG+S + T
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 173 YVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
++ PE + ++ + +DVWS GV+L+ + G P+ +L
Sbjct: 188 WMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-10
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 13 RTIGEGTFAKVKFAQNTE-----TGES-VAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+G G F +V T+ +G VA+K L + A + K + +E +M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID-------G 119
P +V+L V YII+E + GG+L + ++L+D G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSA-------LPEQGVSLLRTT 167
Y HRDL N L+ +G+ +KI DFGL+ ++G LL
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV- 177
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
++APE L + +DVWS GV+++ +L G P+
Sbjct: 178 ----RWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-10
Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 14 TIGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
T+G G F +V A+ E V +K L ++ + + +RE+ + + + H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKN 69
Query: 69 VVRLHEVLASRTKIYIILEFITGGEL---------FDKIVHHGRLSESEARRYFQQLIDG 119
VVRL + Y+ILE+ G+L D+ + LS + Q+ G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP-EQGVSLLRTTCGTPNYVAPEV 178
+D+ + HRDL N L+ SQ +K+S LS LR ++APE
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 179 LSHKGYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
+ ++ +DVWS GV+++ V G LPF L
Sbjct: 190 VQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGL 222
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 8/157 (5%)
Query: 56 REISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQ 115
REI I+K + H ++ L ++ + +++ +LF + G L +A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC----GTP 171
L++ + Y H +G+ HRD+K EN+ LD + + DFG A + C GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTL 251
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+PE+L+ Y A D+WS G++L+ + +
Sbjct: 252 ETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 43/187 (22%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 28 NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL- 86
+ +T E V +K R E I++ + HP +++L +IL
Sbjct: 113 DNKTCEHVVIKAGQRGGTAT---------EAHILRAINHPSIIQLKGTFTYNKFTCLILP 163
Query: 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL 146
+ T +L+ + ++ + + ++ + Y H + HRD+K EN+ ++ G +
Sbjct: 164 RYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221
Query: 147 KISDFGLSALP-EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY 205
+ DFG + P + + GT APE+L+ Y G A D+WS G++L+ + +
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
Query: 206 LPFDELD 212
E D
Sbjct: 281 DSLFEKD 287
|
Length = 391 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-10
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 44/218 (20%)
Query: 13 RTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV + E VA+K L +A + +RE ++ +H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHE 68
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG--------------RLSESEARRYF 113
+V+ + V ++ E++ G+L + HG L+ S+ +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
Q+ G+ Y S+ HRDL N L+ +KI DFG+S R T Y
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS----------RDVYTTDYY 178
Query: 174 ------------VAPEVLSHKGYNGAAADVWSCGVILY 199
+ PE + ++ + +DVWS GV+L+
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-10
Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 15 IGEGTFAKVK----FAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+GE F K+ + + + VA+K L + + ++E S+M + HP +V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIV-------------HHGRLSESEARRYFQ--- 114
L V+ + ++ E++ G+L + ++ G + S F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 115 -QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA-------LPEQGVSLLRT 166
Q+ G++Y S H+DL N+L+ Q H+KISD GLS Q SLL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPF 208
++ PE + + ++ + +D+WS GV+L+ + + G P+
Sbjct: 191 -----RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-10
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 8 KYEVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V K E VA+K ++ +A ++ ++ + E S+MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQ- 114
VVRL V++ +I+E +T G+L ++ ++ + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 115 --QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-------ALPEQGVSLLR 165
++ DG+ Y ++ HRDL N ++ +KI DFG++ + G LL
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
+++PE L G +DVWS GV+L+
Sbjct: 185 V-----RWMSPESLK-DGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-10
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 40/226 (17%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
E R IG+G F +V A+ E VA+K+L A M +RE ++M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALM 62
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQ 114
HP +V+L V A + ++ E++ G+L + + S S AR+
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 115 ---------------QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159
Q+ G+ Y + HRDL N L+ +KI+DFGLS +
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS----R 178
Query: 160 GVSLLRTTCGTPN------YVAPEVLSHKGYNGAAADVWSCGVILY 199
+ + N ++ PE + + Y +DVW+ GV+L+
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-10
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 35/231 (15%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
++++ +GEGTF KV A + + E A+K++ K K EI M+ VR
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQ 184
Query: 67 P------CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI--- 117
++++ + T I+ G L D I+ HG S R+ Q+I
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH----RHLAQIIFQT 240
Query: 118 -DGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL----LRTTC--- 168
+DY H++ + H DLKPEN+L+++ + ALP + L C
Sbjct: 241 GVALDYFHTELHLMHTDLKPENILMET-SDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299
Query: 169 -------GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
T +Y +PEV+ G+ + D+WS G I+Y L G L +D D
Sbjct: 300 HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHD 349
|
Length = 467 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-10
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 28/223 (12%)
Query: 13 RTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV A+ T+ VA+K L + K +RE ++ ++H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHE 67
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARR 111
+V+ + V + ++ E++ G+L + HG L S+
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCG 169
Q+ G+ Y S+ HRDL N L+ + +KI DFG+S + T
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
++ PE + ++ + +DVWS GVIL+ + G P+ +L
Sbjct: 188 PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQL 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-09
Identities = 47/172 (27%), Positives = 75/172 (43%), Gaps = 40/172 (23%)
Query: 15 IGEGTFAKVKFAQ------------NTETGES--VAMKVLDRSAIIKHKMADQIKREISI 60
+GEG F +V + G+ VA+K+L R+ + K D +K EI I
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLK-EIKI 70
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ------ 114
M +++P ++RL V S + +I E++ G+L + LS+ E F
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL------NQFLSQREIESTFTHANNIP 124
Query: 115 ------------QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
Q+ G+ Y S HRDL N L+ + +KI+DFG+S
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 3/88 (3%)
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTP 171
+QL+ +DY H +G+ HRD+K EN+L++ + + DFG + S GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILY 199
+ APEVL+ Y + D+WS G++++
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 41/175 (23%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGES----------------VAMKVLDRSAIIKHKM 50
+GEG F +V + + VA+KVL R +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 51 ADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL---------FDKIVHH 101
D +K E+ I+ + P + RL V + +I+E++ G+L +
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 102 GRLSESEARRYFQ--QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
S S + + Q+ G+ Y S HRDL N L+ +KI+DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
E+GR G V A++T TG V +++ D + + ++ E+ + RHP +
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 70 VRLHEVLASRTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+ V + + +++I F+ G L G +SE+ + G++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------------TTCGTPN 172
G HR++K ++L+ G + +S GLS L SL+R +T P
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHL----YSLVRNGQKAKVVYDFPQFSTSVLP- 173
Query: 173 YVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+++PE+L GYN +D++S G+ L G +PF ++ T +
Sbjct: 174 WLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-09
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 54/242 (22%)
Query: 15 IGEGTFAKV--------------KFAQNTETGES--VAMKVLDRSAIIKHKMADQIKREI 58
+GEG F +V +F N G VA+K+L R K+ D +K E+
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEAR-------- 110
I+ ++ P ++RL V + +I E++ G+L + H L + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGNDAVPPA 129
Query: 111 ------------RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA--- 155
Q+ G+ Y S HRDL N L+ +KI+DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 156 ----LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY--VLIAGYLPFD 209
QG ++L ++A E + G A+DVW+ GV L+ +++ P+
Sbjct: 190 AGDYYRIQGRAVLPI-----RWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 210 EL 211
EL
Sbjct: 244 EL 245
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-08
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS----IMKLVRHP 67
+ +G G F V G+S+ + V + I+ + Q +EI+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIK--TIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
+VRL + + ++ + G L D + H L + Q+ G+ Y
Sbjct: 70 YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTP-NYVAPEVLSHKGY 184
+ HR+L N+LL S ++I+DFG++ L + TP ++A E + G
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI-LFGR 187
Query: 185 NGAAADVWSCGVILYVLIA 203
+DVWS GV ++ +++
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-08
Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 15 IGEGTFAKV---------KFAQNTETGES-------VAMKVLDRSAIIKHKMADQIKREI 58
+GEG F +V KF + + VA+K+L R K+ D +K EI
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLK-EI 70
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-----------GRLSES 107
IM ++ P ++RL V + + +I E++ G+L + H +S S
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 108 EARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
Q+ G+ Y S HRDL N L+ +KI+DFG+S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-08
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
R IG+G F V + A+K L+R I + +Q +E IMK HP V
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 70 VRLHEV-LASRTKIYIILEFITGGELFDKIVHHGRLSESEARR--------YFQQLIDGV 120
+ L + L S ++L ++ G+L + I SE + Q+ G+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFI-------RSETHNPTVKDLIGFGLQVAKGM 111
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGT-P-NYVAP 176
+Y SK HRDL N +LD +K++DFGL+ ++ S+ T P ++A
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELD 212
E L + + +DVWS GV+L+ L+ G P+ ++D
Sbjct: 172 ESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y Q+ G+++ S+ HRDL N+LL +KI DFGL+ R P
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDP 227
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
+YV APE + K Y +DVWS GV+L+
Sbjct: 228 DYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 15 IGEGTFAKVKFAQ--NTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+GE F KV T GE +VA+K L A + + ++ K E + ++HP +
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNI 70
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH---HGRLSESEARRYFQ------------ 114
V L V+ + +I + + +L + +V H + ++ + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 115 -QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTP 171
Q+ G+++ S V H+DL N+L+ + ++KISD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
+++PE + + G +D+WS GV+L+ V G P+
Sbjct: 191 RWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-07
Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 22/215 (10%)
Query: 15 IGEGTFAKVKFAQNTETGESVA---MKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
IG G F KV G S A +K L SA ++ +E+ + + HP V++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQ 59
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEA------RRYFQQLIDGVDYCHS 125
++LEF G+L + R ++ +R ++ G+ + H
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDL-KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H DL N L + +KI D+GL PE ++APE++ +G
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 184 YNGAAAD------VWSCGVILYVLI-AGYLPFDEL 211
+ D +WS GV ++ L A P+ +L
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-07
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y Q+ G+++ S+ HRDL N+LL +KI DFGL+ R P
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDP 228
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
+YV APE + K Y +DVWS GV+L+
Sbjct: 229 DYVRKGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-07
Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 47/233 (20%)
Query: 15 IGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+GEG F KV A+ VA+K L ++ +RE ++ +++H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHG---------------RLSESEARRYFQ 114
VR + V + ++ E++ G+L + HG +L+ +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY- 173
Q+ G+ Y S HRDL N L+ +KI DFG+S R T Y
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS----------RDIYSTDYYR 179
Query: 174 -----------VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLT 214
+ PE + ++ + +D+WS GV+L+ + G P+ +L T
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNT 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-07
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 14/111 (12%)
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-------SALPEQGVSLLRTT 167
Q+ +G+++ SK HRDL N+L+ +KI DFGL S +G + L
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL- 305
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
++APE + + Y +DVWS G++L+ + G P+ EL + +
Sbjct: 306 ----KWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 19/39 (48%), Positives = 27/39 (69%)
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152
+Q++ G+ H G+ HRD+KPENLL+ G +KI DFG
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 23/100 (23%)
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y Q+ G+++ S+ HRDL N+LL +KI DFGL+ R P
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDP 233
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
+YV APE + + Y +DVWS GV+L+
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 25/75 (33%), Positives = 38/75 (50%), Gaps = 12/75 (16%)
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVS------ 162
+ +Q++ +D HS G+ HRD+KP+N++ G KI D G +A G++
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317
Query: 163 LLRTTCGTPNYVAPE 177
LL P Y APE
Sbjct: 318 LL-----DPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-05
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 33/212 (15%)
Query: 13 RTIGEGTFAKVKFAQ-NTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+ IG G F KV + N+ T V +K L SA ++ +M + E + ++H ++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLL 58
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEA------RRYFQQLIDGVDYCH 124
+ T +++EF G+L + R +E +R ++ G+ + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSAL---------PEQGVSLLRTTCGTPNYVA 175
H DL N LL + +KI D+GLS P+Q LR ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR-------WIA 170
Query: 176 PEVLSHKGYNGAAAD------VWSCGVILYVL 201
PE++ N D VWS GV ++ L
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 32/101 (31%), Positives = 44/101 (43%), Gaps = 23/101 (22%)
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170
R+ Q+ G+D+ SK HRD+ N+LL KI DFGL+ R
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA----------RDIMND 265
Query: 171 PNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
NYV APE + Y +DVWS G++L+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 305
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 2/43 (4%)
Query: 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-DE 210
GTP+Y+APE+L K + G A D W+ GV L+ + G PF DE
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDE 583
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 49/168 (29%), Positives = 76/168 (45%), Gaps = 36/168 (21%)
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSE-----SEARR 111
EI+ M ++HP +V+L + S Y+I E+I G LSE S RR
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG----------KNLSEVLRNLSWERR 782
Query: 112 YFQQLIDGVD------YCH-SKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVS 162
+++ G+ +C S V +L PE +++D + HL++S LP G+
Sbjct: 783 --RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLS------LP--GLL 832
Query: 163 LLRTTCGTPN-YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
T C + YVAPE K +D++ G+IL L+ G P D
Sbjct: 833 CTDTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 34/108 (31%), Positives = 50/108 (46%), Gaps = 26/108 (24%)
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL-KISDFGLSALPEQGVSLLRTTCGTPNY 173
Q+ G+ + SK HRDL N+LL + G + KI DFGL+ R NY
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILL-THGRITKICDFGLA----------RDIRNDSNY 270
Query: 174 V------------APEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPF 208
V APE + + Y +DVWS G++L+ + + G P+
Sbjct: 271 VVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 14/102 (13%)
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-------SALPEQGVSLLRTT 167
Q+ G+++ SK HRDL N+LL +KI DFGL S +G + L
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV- 303
Query: 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPF 208
++APE + Y +DVWS G++L+ + + G P+
Sbjct: 304 ----KWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 14 TIGEGTFAKVKFAQNTETGE-------SVAMKVLDRSAIIKHK-MADQIKREISIMKLVR 65
++G+GTF K+ E G+ V +KVLD+S H+ ++ S+M +
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLS 57
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYC 123
H +V + V + ++ E++ G L D + + ++ S +QL + +
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFL 116
Query: 124 HSKGVYHRDLKPENLLLDSQGH--------LKISDFGLS--ALPEQGVSLLRTTCGTPNY 173
KG+ H ++ +N+LL + +K+SD G+S LP++ + L R +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-ILLERIP-----W 170
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
V PE + + AAD WS G L+ + G P LD
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 16/124 (12%)
Query: 92 GELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150
L D + GR L+E E Q + + H + K N+LL G LK+
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKLDG 54
Query: 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP-FD 209
PEQ P ++APEV+ + Y AD++S G+ LY + LP +
Sbjct: 55 SVAFKTPEQSR-------PDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNE 106
Query: 210 ELDL 213
E +L
Sbjct: 107 EREL 110
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 18/152 (11%)
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQL 116
S+M+ V H +V L+ V + ++ EF+ G L D +H L+ + +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQL 114
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQG-------HLKISDFGLSALPEQGVSLLRTTC- 168
+ Y K + H ++ +N+LL +G +K+SD G+ L R C
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI-----TVLSRQECV 169
Query: 169 -GTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
P ++APE + AAD WS G L+
Sbjct: 170 ERIP-WIAPECVEDSKNLSIAADKWSFGTTLW 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 35/198 (17%)
Query: 34 SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGE 93
SV +KVL H+ + S+M + H +V+L+ V I ++ E++ G
Sbjct: 32 SVVLKVLGS----DHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGP 86
Query: 94 LFDKIVHHGRLSESEARRYF--QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH------ 145
L D +H + + S + +QL + Y K + H ++ +N+L+ G
Sbjct: 87 L-DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVP 145
Query: 146 -LKISDFGLSALPEQGVSLLRTTCGTPNY-------VAPEVLSHKGYN-GAAADVWSCGV 196
+K+SD G + T + +APE + + + AAD WS G
Sbjct: 146 FIKLSDPG-----------IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGT 194
Query: 197 ILY-VLIAGYLPFDELDL 213
L + G P L
Sbjct: 195 TLLEICSNGEEPLSTLSS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 6e-04
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 23/176 (13%)
Query: 35 VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94
V +KVLD S +A S+M V H + +H V ++ ++ EF+ G L
Sbjct: 47 VVLKVLDPS---HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 95 FDKIVHHGRLSESEARRYF--QQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-------H 145
D + + A + QQL + Y K + H ++ +N+LL G
Sbjct: 104 -DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 146 LKISDFGLS--ALP-EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVIL 198
+K+SD G+S AL E+ V + ++APE + AAD WS G L
Sbjct: 163 IKLSDPGVSFTALSREERVERI-------PWIAPECVPGGNSLSTAADKWSFGTTL 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 47/202 (23%), Positives = 85/202 (42%), Gaps = 18/202 (8%)
Query: 15 IGEGTFAKVKFAQNTETGESVA---MKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
IG G F KV ++ T VA +K L +A K + ++ ++ ++++HP +++
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQ 59
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ E+ G+L + H +R ++ GV + H
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTPNYVAPEVLS--HKG 183
H DL N L S +K+ D+G+ S E + C ++APE++ H G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 184 YNGAA----ADVWSCGVILYVL 201
A ++VW+ GV L+ L
Sbjct: 180 LITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 41/205 (20%), Positives = 89/205 (43%), Gaps = 35/205 (17%)
Query: 32 GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLH----EVLASRTKIYIILE 87
+ V ++ + + D + EI ++ + +++++ +++ ++ +ILE
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY---------HRDLKPENL 138
+ T G L + + LS + +L +D C KG+Y +++L +
Sbjct: 103 YCTRGYLREVLDKEKDLS------FKTKLDMAIDCC--KGLYNLYKYTNKPYKNLTSVSF 154
Query: 139 LLDSQGHLKISDFGL----SALPEQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAAADVW 192
L+ LKI GL S+ P + V+ + Y + ++L+ Y D++
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMV-------YFSYKMLNDIFSEYT-IKDDIY 206
Query: 193 SCGVILYVLIAGYLPFDELDLTTLY 217
S GV+L+ + G +PF+ L +Y
Sbjct: 207 SLGVVLWEIFTGKIPFENLTTKEIY 231
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 218 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.39 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.36 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.14 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 99.01 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.95 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.8 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.46 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.44 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.38 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.23 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.17 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.16 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.03 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.01 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.93 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.68 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.68 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.63 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.6 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.34 | |
| PLN02236 | 344 | choline kinase | 97.31 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.27 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.27 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.12 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.08 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.04 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.77 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.75 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.36 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.15 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.84 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.81 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.81 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.79 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.53 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.51 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.85 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=313.21 Aligned_cols=213 Identities=40% Similarity=0.751 Sum_probs=196.1
Q ss_pred ccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..+.+++|.+.+.||+|+|++||+|+.+.++..||||.+..... +.+..+-+..|+.+|+.++||||+.+++.++..+.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 45788999999999999999999999999999999999976654 45567788999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC------CcEEEeeccccc
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ------GHLKISDFGLSA 155 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~------~~~~l~d~~~~~ 155 (218)
+|+|||||+||+|..++..++.+++..+..++.|++.|+++||+++|+|+||||.|||++.+ -.+||+|||++.
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999765 358999999999
Q ss_pred cCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
...++ ......+|+|.|||||++....|+ .|+|+||+|+++|++++|..||...++.+++
T Consensus 164 ~L~~~-~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 164 FLQPG-SMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred hCCch-hHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 88764 445677899999999999988998 9999999999999999999999988887764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-50 Score=314.13 Aligned_cols=211 Identities=37% Similarity=0.694 Sum_probs=198.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|+.++.||+|||..+|.+.+..+|+.||+|++...........+++.+|+++.++++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 55999999999999999999999999999999999887777777889999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|.|+.++|.++++.+++++|.++++++.||+.++.|||+.+|+|+|++..|+|++++.++||+|||+|+..........+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999877655455567
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccccC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 218 (218)
.+|+|.|.|||++....+. ..+||||+||+||.|+.|++||+..+..+.|+
T Consensus 178 lCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~ 228 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYN 228 (592)
T ss_pred ecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence 8899999999999977775 99999999999999999999999999988774
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=296.14 Aligned_cols=212 Identities=41% Similarity=0.765 Sum_probs=198.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++++.||.|+||.||.++.+.+++.+|+|++....+......+....|..++..++||.|++++-.|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 46789999999999999999999999999999999998888777778889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+||++||.|...+++.+.+++..+.-.+.+|+.||.|||++||+|+|+||+|||+|.+|.++|+|||++...-......
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998666655566
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
...+|++.|||||.+....++ .+.|.||||+++|+|++|.+||...+...++
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~ 234 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMY 234 (357)
T ss_pred ccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHH
Confidence 677999999999999998887 9999999999999999999999998876654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=288.53 Aligned_cols=209 Identities=40% Similarity=0.760 Sum_probs=185.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh----hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH----KMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
.+.|.+.+.||+|+||.|-.|..+++|+.||||++........ .-.....+|+++++.++||||+++.++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3458999999999999999999999999999999976554321 123446799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC---CcEEEeeccccccCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPE 158 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~---~~~~l~d~~~~~~~~ 158 (218)
.|+|+||++||.|.+.+..++.+.+..-..++.|++.|+.|||+.||+|+||||+|||+..+ ..+|++|||++...+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g 330 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG 330 (475)
T ss_pred eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc
Confidence 99999999999999999999999999999999999999999999999999999999999766 789999999998877
Q ss_pred CCCcccccccccCccccccccccCCCC--CcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
+ .......+|+|.|.|||++.+.... ..+.|+|||||++|-+++|.+||++...+.
T Consensus 331 ~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 331 E-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred c-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 4 4667788999999999999865444 347799999999999999999999866544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=292.58 Aligned_cols=214 Identities=59% Similarity=1.054 Sum_probs=192.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhh--hhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIMKLVR-HPCVVRLHEVLASRT 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~ 80 (218)
...++|.+++.||+|.||+|+.|....+|..||+|++....... ....+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 45789999999999999999999999999999999776643221 134566778999999999 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-CcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-~~~~l~d~~~~~~~~~ 159 (218)
.+++||||+.+|.|.+.+.+.+++++.++..++.|++.|++|+|++|++|+||||+|++++.+ +++||+|||++.....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 9999999999998753
Q ss_pred CCcccccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
........+|++.|+|||.+.+.. ++..++|+||+|+++|.|++|+.||.+.+...+|
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~ 232 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY 232 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence 345566788999999999999888 8889999999999999999999999997765543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=284.92 Aligned_cols=206 Identities=32% Similarity=0.579 Sum_probs=184.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEE-EE-EcCCeEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE-VL-ASRTKIY 83 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~-~~-~~~~~~~ 83 (218)
+.+|++.++||+|.||.||++....+|+.+|.|.++-... +.+..+++..|+.+|++++||||+++++ .| ++...++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 4569999999999999999999999999999999974443 4455677899999999999999999998 34 4445599
Q ss_pred EEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 84 IILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHS--KG--VYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~--~~--i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
+|||+|+.|+|.+.++.. ..+++..+|+++.|++.||+++|. .. +.|+||||.|||++.+|.+||+|||++.
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999988653 458999999999999999999998 44 9999999999999999999999999999
Q ss_pred cCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
+............|+|.||+||.+....++ .++||||+||++|||+.-+.||...+-
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~ 233 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNL 233 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccH
Confidence 888877777788999999999999999997 999999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=271.97 Aligned_cols=210 Identities=39% Similarity=0.768 Sum_probs=195.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+.+|+.++.||.|+||.|..++.+.+|..+|+|++....+-.-...+...+|..+|+.+.||.++++.+.+.+...+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 36789999999999999999999999999999999988777666667888999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||.+||.|..++.+.+++++..++-.+.||+.|++|||.++++++|++|+|||+|.+|.+|++|||++...... .
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---T 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---T 198 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---E
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999866554 3
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccccC
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 218 (218)
-+.||+|.|+|||.+....+. .+.|.|+||+++|||+.|.+||-+.++..+|+
T Consensus 199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~ 251 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE 251 (355)
T ss_pred EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHH
Confidence 367899999999999988887 99999999999999999999999999887763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=280.56 Aligned_cols=200 Identities=31% Similarity=0.548 Sum_probs=183.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-eEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-~~~lv 85 (218)
.+.+.++.||+|.-|+||++..+.+++.+|+|++.... +++..+++.+|+++++.+++||||++++.|.+++ ...++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 46778899999999999999999999999999995443 5666788999999999999999999999999888 59999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||++|+|...+...+.+++..+.+++.+++++|.|||+ .+|+|+||||+|+|++..|.+||||||.+....+. ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hc
Confidence 9999999999999998999999999999999999999995 89999999999999999999999999998766654 44
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
....|+..|||||.+.+..|. .++||||||+.++|+..|+.||...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCc
Confidence 566789999999999998887 9999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=286.04 Aligned_cols=212 Identities=35% Similarity=0.675 Sum_probs=190.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~ 82 (218)
+...+|..++.||+|+|++|+.|.++.+++.+|||++...-+..+...+.+..|-..+.++ .||.|++++-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4567899999999999999999999999999999999888777777777788888999999 799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
|+|+||++.|.|.+++...+.+++......+.||+.||+|||++||+|+||||+|||+|.||+++|.|||.+....+...
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999976554221
Q ss_pred c---------c----ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 163 L---------L----RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 163 ~---------~----~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
. . ...+|+..|.+||.+.+.... .++|+|+|||++|+|+.|.+||...+..-+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 1 1 234578899999999866554 999999999999999999999998776544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=281.81 Aligned_cols=212 Identities=36% Similarity=0.702 Sum_probs=191.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++++.||+|+||.||.|+.+.+|+.+|+|++..+.......++.++.|-.+|...++|++|+++-.|.+.+.+|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 46789999999999999999999999999999999988777777777888999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC-----
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ----- 159 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~----- 159 (218)
||||++||++..++.+.+.+++..+...+.+++.|++.+|+.|++|+||||+|+|+|..|++||+|||++.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999999852111
Q ss_pred ------------------CCc----c--------------------cccccccCccccccccccCCCCCcchhhhhHhHH
Q 027809 160 ------------------GVS----L--------------------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVI 197 (218)
Q Consensus 160 ------------------~~~----~--------------------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~ 197 (218)
... . .-..+|+|.|+|||++.+..+. ...|.|||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHHH
Confidence 000 0 0113489999999999999987 99999999999
Q ss_pred HHHHhhcCCCCCCCCccccc
Q 027809 198 LYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 198 l~~l~~g~~pf~~~~~~~~~ 217 (218)
|||||.|.+||...++.+.|
T Consensus 378 myEmLvGyPPF~s~tp~~T~ 397 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETY 397 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=289.50 Aligned_cols=207 Identities=34% Similarity=0.651 Sum_probs=191.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.... .+++..+.+.+++++++.++||||+.++++|+....+|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 478999999999999999999999999999999996654 3555678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
.||+.| +|..++...+.++++.+..++.+++.||.|||+++|.|+|++|.||+++.++.+|+||||++..+..+.....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 999987 9999999999999999999999999999999999999999999999999999999999999998888777766
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.-.|+|.|||||......++ ..+|+|||||++||++.|++||=..+..+
T Consensus 159 sikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~ 207 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQ 207 (808)
T ss_pred eccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence 67799999999999977776 99999999999999999999997655443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=280.59 Aligned_cols=209 Identities=35% Similarity=0.674 Sum_probs=183.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.+.+..+++.+++|++........+....+..|..++..++|++++++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997655444555667888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc----
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~---- 162 (218)
||+++++|.+.+...+.+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864321100
Q ss_pred -------------------------------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 163 -------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 163 -------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 01123578899999999877765 8999999999999999999999887
Q ss_pred Ccccc
Q 027809 212 DLTTL 216 (218)
Q Consensus 212 ~~~~~ 216 (218)
++.+.
T Consensus 240 ~~~~~ 244 (363)
T cd05628 240 TPQET 244 (363)
T ss_pred CHHHH
Confidence 76543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=277.18 Aligned_cols=208 Identities=44% Similarity=0.822 Sum_probs=198.2
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||.|.+|.|-.|.....|..||||.+..+++.++++.-.+++|++++..++||||+.++++|++.+...+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
|.++|.|.+++...+.+++.+..+++.||++|+.|+|+++++|+|++.+|||+|.|+++|+.|||++...... ......
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfLqTF 212 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFLQTF 212 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHHHHh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999877653 455677
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
+|+|.|.+||.+.+..|..+..|-||||+++|.++.|.+||...|...+
T Consensus 213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l 261 (668)
T KOG0611|consen 213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL 261 (668)
T ss_pred cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH
Confidence 8999999999999999999999999999999999999999999987654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=277.15 Aligned_cols=207 Identities=41% Similarity=0.754 Sum_probs=184.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.+.||+|++|.||.|.+..+++.+++|.+........+..+.+.+|+.++..++||||+++++.+...+..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 46889999999999999999999999999999999976554444556778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+||+++++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987543322
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....+++.|+|||.+....++ .++|+||||+++|+|++|..||...++.+
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~ 222 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222 (329)
T ss_pred ceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHH
Confidence 134577899999999877665 89999999999999999999998776544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=273.53 Aligned_cols=206 Identities=35% Similarity=0.683 Sum_probs=182.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.|.+..+++.+++|.+........+..+.+.+|+.+++.++||||+++++.+.+.+..++|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987654434444567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~---~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT---WT 157 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---cc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543322 12
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
..+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 158 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~ 206 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGI 206 (291)
T ss_pred ccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3577899999999876665 899999999999999999999988766543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=276.10 Aligned_cols=206 Identities=33% Similarity=0.639 Sum_probs=183.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.|.+..+++.+++|++.............+.+|...+..++||||+++++.+...+..++|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997654444444567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS 157 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875443 1223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
..+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...++.+.
T Consensus 158 ~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~ 206 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNET 206 (333)
T ss_pred cccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHH
Confidence 4578899999999877665 899999999999999999999988776543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=274.68 Aligned_cols=205 Identities=31% Similarity=0.558 Sum_probs=178.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcE-EEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-eEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGES-VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KIY 83 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~-~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-~~~ 83 (218)
....++.+.+|+|+||+||.+.+. |.. |++|.+......... .+.+.+|+.++..++||||+++++++.... .+.
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 344566777999999999999997 445 999999766544444 778999999999999999999999999887 799
Q ss_pred EEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCeEecCCC-cEEEeeccccccCCC
Q 027809 84 IILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKG-VYHRDLKPENLLLDSQG-HLKISDFGLSALPEQ 159 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~-i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~ 159 (218)
+|+||+++|+|.+++.. ...++...++.++.|||.++.|||+++ |+|+|+||.|+|++.+. .+||+|||++.....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999987 578999999999999999999999999 99999999999999997 999999999986655
Q ss_pred CCcccccccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.........|++.|||||.+.. ..++ .++|+||+|+++|||+||..||.+.++-
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~ 252 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPV 252 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHH
Confidence 3222233568899999999994 4554 9999999999999999999999998863
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=275.11 Aligned_cols=207 Identities=35% Similarity=0.637 Sum_probs=182.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCC-cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
.+++|++.+.||+|+||.||.|.+..++ ..+++|.+...........+.+.+|...+..++||||+++++++...+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4678999999999999999999876554 689999987655444455667889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-- 185 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-- 185 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...++..
T Consensus 186 -~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 235 (340)
T PTZ00426 186 -YTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLL 235 (340)
T ss_pred -ceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHH
Confidence 234577899999999876665 89999999999999999999999877654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=278.10 Aligned_cols=207 Identities=36% Similarity=0.692 Sum_probs=181.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.|.+..+++.+|+|++.............+.+|..++..++||||+++++.+...+..++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997655444455667888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc----
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~---- 162 (218)
||+++++|.+.+.....+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998754321100
Q ss_pred ----------------------------------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCC
Q 027809 163 ----------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208 (218)
Q Consensus 163 ----------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 208 (218)
......+++.|+|||.+....+. .++|+|||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 00112478899999999877665 8999999999999999999999
Q ss_pred CCCCcc
Q 027809 209 DELDLT 214 (218)
Q Consensus 209 ~~~~~~ 214 (218)
...++.
T Consensus 240 ~~~~~~ 245 (364)
T cd05599 240 CSDNPQ 245 (364)
T ss_pred CCCCHH
Confidence 877654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=273.35 Aligned_cols=202 Identities=37% Similarity=0.657 Sum_probs=177.7
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
+.||+|+||.||.+.+..+|+.+++|++.............+.+|...+..++||||+++.+.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997655444445566778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCc
Q 027809 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (218)
Q Consensus 93 ~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 172 (218)
+|.+.+.....+++.++..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++..............+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 99999988888999999999999999999999999999999999999999999999999998653332222334457889
Q ss_pred cccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 173 ~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
|+|||.+.+..+. .++|+||||+++|+|++|..||...+...
T Consensus 161 y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~ 202 (323)
T cd05571 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (323)
T ss_pred ccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHH
Confidence 9999999877665 89999999999999999999998776554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=278.29 Aligned_cols=208 Identities=33% Similarity=0.627 Sum_probs=180.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.+.+..+++.+++|++........+..+.+.+|..+++.++||||+++++++.+.+..|+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987655444555677888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-----
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~----- 161 (218)
||+++++|.+.+.....+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999885221100
Q ss_pred ---------c---------------------------------ccccccccCccccccccccCCCCCcchhhhhHhHHHH
Q 027809 162 ---------S---------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199 (218)
Q Consensus 162 ---------~---------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~ 199 (218)
. ......+++.|+|||.+....+. .++|+||||+++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 0 00013477889999999877665 8999999999999
Q ss_pred HHhhcCCCCCCCCccc
Q 027809 200 VLIAGYLPFDELDLTT 215 (218)
Q Consensus 200 ~l~~g~~pf~~~~~~~ 215 (218)
+|++|..||...+..+
T Consensus 240 elltG~~Pf~~~~~~~ 255 (377)
T cd05629 240 ECLIGWPPFCSENSHE 255 (377)
T ss_pred hhhcCCCCCCCCCHHH
Confidence 9999999998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=262.85 Aligned_cols=207 Identities=27% Similarity=0.457 Sum_probs=181.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|+.+.++|+|++|.||+++++.+|+.||||++-.+. .++...+-..+|++.|+++.|+|+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 367999999999999999999999999999999995443 3344455578999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+|||+..-|.++......++...+..++.|++.|+.++|+++++|+||+|+|||++.+|.+||||||+++..........
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 99999966666666677899999999999999999999999999999999999999999999999999986654444455
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+-.|.|||.+.+...-....|||++||++.||++|++.|...+.
T Consensus 160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 566777899999998754445899999999999999999999987653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=270.56 Aligned_cols=202 Identities=36% Similarity=0.666 Sum_probs=176.9
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
+.||+|+||.||.+.+..+|..+++|.+.............+.+|...++.++|||++++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997655444445567778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCc
Q 027809 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (218)
Q Consensus 93 ~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 172 (218)
+|...+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 99998888888999999999999999999999999999999999999999999999999987653332222233457889
Q ss_pred cccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 173 ~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 161 y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 202 (323)
T cd05595 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHER 202 (323)
T ss_pred cCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999876665 89999999999999999999998876554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=275.57 Aligned_cols=207 Identities=33% Similarity=0.591 Sum_probs=180.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
..|++++.||+|+||.||.|.+..++..+|+|++........+....+.+|..+++.++|+||+++++.+.+.+..++|+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999997665555555677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-----
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~----- 161 (218)
||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999864221000
Q ss_pred ------------------------------------------cccccccccCccccccccccCCCCCcchhhhhHhHHHH
Q 027809 162 ------------------------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199 (218)
Q Consensus 162 ------------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~ 199 (218)
.......+++.|+|||.+....+. .++|+|||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence 000123577899999999877665 8999999999999
Q ss_pred HHhhcCCCCCCCCcc
Q 027809 200 VLIAGYLPFDELDLT 214 (218)
Q Consensus 200 ~l~~g~~pf~~~~~~ 214 (218)
+|++|..||...++.
T Consensus 240 elltG~~Pf~~~~~~ 254 (381)
T cd05626 240 EMLVGQPPFLAPTPT 254 (381)
T ss_pred HHHhCCCCCcCCCHH
Confidence 999999999876654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=275.70 Aligned_cols=207 Identities=34% Similarity=0.609 Sum_probs=179.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|++++.||+|+||.||.|.+..+++.+++|.+.............+.+|..++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999987654444455677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC------
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG------ 160 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~------ 160 (218)
||+++++|.+.+...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999986421100
Q ss_pred -----------------------------------------CcccccccccCccccccccccCCCCCcchhhhhHhHHHH
Q 027809 161 -----------------------------------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199 (218)
Q Consensus 161 -----------------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~ 199 (218)
........+++.|+|||.+....+. .++|+|||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 0000112467899999999877776 8999999999999
Q ss_pred HHhhcCCCCCCCCcc
Q 027809 200 VLIAGYLPFDELDLT 214 (218)
Q Consensus 200 ~l~~g~~pf~~~~~~ 214 (218)
+|++|+.||...++.
T Consensus 240 elltG~~Pf~~~~~~ 254 (382)
T cd05625 240 EMLVGQPPFLAQTPL 254 (382)
T ss_pred HHHhCCCCCCCCCHH
Confidence 999999999877654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=268.51 Aligned_cols=208 Identities=35% Similarity=0.657 Sum_probs=179.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcCCeEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 86 (218)
+|++.+.||+|+||.||.|.+..+++.+++|++...........+.+..|...+..++| ++++++.+.+...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999876544344445667788888888876 56888999999889999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 99999999999988888999999999999999999999999999999999999999999999999987643332223334
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
..+++.|+|||.+.+..+. .++|+||||+++|+|++|+.||...+..++
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~ 209 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209 (324)
T ss_pred ecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 4578899999999876665 899999999999999999999987765543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=276.91 Aligned_cols=207 Identities=33% Similarity=0.610 Sum_probs=179.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++++.||+|+||.||.|.+..+++.+|+|.+.............+.+|+.++..++|+|++++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986554434444566788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC------
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG------ 160 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~------ 160 (218)
||+++++|.+.+...+.+++..+..++.||+.||++||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999986421100
Q ss_pred -------------------------------------CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh
Q 027809 161 -------------------------------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA 203 (218)
Q Consensus 161 -------------------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~ 203 (218)
........+++.|+|||.+....+. .++|+|||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0000123477899999999877765 89999999999999999
Q ss_pred cCCCCCCCCcc
Q 027809 204 GYLPFDELDLT 214 (218)
Q Consensus 204 g~~pf~~~~~~ 214 (218)
|..||...++.
T Consensus 240 G~~Pf~~~~~~ 250 (376)
T cd05598 240 GQPPFLADTPA 250 (376)
T ss_pred CCCCCCCCCHH
Confidence 99999887654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=268.28 Aligned_cols=201 Identities=37% Similarity=0.667 Sum_probs=176.4
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||+|+||.||.+.+..+++.+++|.+.............+..|..++..++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999999999999999999999998765444445566778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccc
Q 027809 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174 (218)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 174 (218)
.+.+...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..............+++.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888899999999999999999999999999999999999999999999999999875433222233345788999
Q ss_pred cccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 175 ~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 161 aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~ 201 (312)
T cd05585 161 APELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201 (312)
T ss_pred CHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHH
Confidence 99999877665 899999999999999999999987765543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=269.42 Aligned_cols=202 Identities=36% Similarity=0.679 Sum_probs=177.0
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
+.||+|+||.||.+.+..+++.+++|++.............+.+|...++.++|||++++.+.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997655444455667788999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCc
Q 027809 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (218)
Q Consensus 93 ~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 172 (218)
+|...+.....+++.+++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||++..............+++.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 99999888888999999999999999999999999999999999999999999999999998653332222233457889
Q ss_pred cccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 173 ~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 161 y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~ 202 (328)
T cd05593 161 YLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202 (328)
T ss_pred ccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHH
Confidence 9999999876665 89999999999999999999998776544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=274.76 Aligned_cols=208 Identities=35% Similarity=0.677 Sum_probs=183.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.|.+..+++.+++|++.............+.++...+..++|+|++++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999999999999999999997655444445667888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-----
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~----- 161 (218)
||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987544332
Q ss_pred ------------------------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 162 ------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 162 ------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 112234578899999999877665 89999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=274.56 Aligned_cols=209 Identities=35% Similarity=0.673 Sum_probs=182.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.+.+..+++.+++|++........+....+..|..++..++|++++++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654444555677888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-----
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----- 161 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~----- 161 (218)
||+++++|.+.+.....+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999875332110
Q ss_pred ------------------------------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 162 ------------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 162 ------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 001123578899999999877776 8999999999999999999999887
Q ss_pred Ccccc
Q 027809 212 DLTTL 216 (218)
Q Consensus 212 ~~~~~ 216 (218)
++.+.
T Consensus 240 ~~~~~ 244 (360)
T cd05627 240 TPQET 244 (360)
T ss_pred CHHHH
Confidence 76543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=268.28 Aligned_cols=208 Identities=34% Similarity=0.650 Sum_probs=178.1
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+|++.+.||+|+||.||.|.+..++..+++|.+...........+....+...+... .|++++++.+.+...+..++|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999998765443344445556666666666 5799999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||++++++.++|+|||++............
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999988643322222233
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
..+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 209 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209 (323)
T ss_pred CCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHH
Confidence 4578899999999877665 899999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=265.58 Aligned_cols=201 Identities=36% Similarity=0.653 Sum_probs=173.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC--eEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--KIYI 84 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--~~~l 84 (218)
.++..++.||+|+||.||.+.+.++|...|+|....... .+ .+.+.+|+.+++.++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 458889999999999999999999899999999876532 22 677899999999999999999999744333 6999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeeccccccCCC---
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQ--- 159 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~--- 159 (218)
.|||+++|+|.+++.+.+ ++++..+.+.+.|++++|.|||++|++|+||||+|||++. ++.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999999999877 7999999999999999999999999999999999999999 79999999998875542
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
.........+++.|||||.+........++|||||||++.||+||..||..
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 112223456889999999998632223599999999999999999999997
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=278.12 Aligned_cols=213 Identities=46% Similarity=0.927 Sum_probs=197.4
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+|-|++++-||.|+-|.|-.|++..+|...|||++....-.++.....+.+|+.+++.++|||+++++++++....+|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 46788999999999999999999999999999999997764444444566889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|.||+++|-|.+++...+++++.+..+++.||+.++.|+|..+|+|+|++|+|+|+|..+++||+|||.|....++ ..
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-kl 167 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-KL 167 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-cc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999887765 45
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
....||.|.|.|||++.+..|+..++||||-|+++|.|++|.+||.+.+-..++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL 221 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL 221 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH
Confidence 667899999999999999999999999999999999999999999988876654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=272.26 Aligned_cols=209 Identities=34% Similarity=0.627 Sum_probs=179.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+..+++.+|+|.+.............+.+|..+++.++|||++++++.+...+..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999999865443344445667889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-c
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 163 (218)
|+||+++++|.+.+... .+++.++..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 99999999999988654 689999999999999999999999999999999999999999999999999875433211 1
Q ss_pred cccccccCccccccccccCC---CCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||...+..
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~ 253 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence 22445788999999997543 2348999999999999999999999877653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=262.77 Aligned_cols=207 Identities=29% Similarity=0.506 Sum_probs=176.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
++++|++.+.||.|+||.||.|.+..++..+++|.+.... .......+.+|+.+++.++|||++++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 5788999999999999999999999999999999986433 12223456789999999999999999999999889999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+|++++ +|.+.+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9999986 8888776544 4789999999999999999999999999999999999999999999999998654433222
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 333456789999999876444458999999999999999999999876654
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=277.71 Aligned_cols=211 Identities=34% Similarity=0.658 Sum_probs=193.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~ 83 (218)
.+++|.+.+.||+|+||+|+.+..+.+++.+|||.++...+.....++....|.+++.... ||.++.++..|...+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4678999999999999999999999999999999999999988888999999999998885 999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+.||++. .+.....+++..+.-++.+++.||.|||++||+|+|+|-+|||+|.+|.+||+|||++.-.......
T Consensus 446 fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~ 524 (694)
T KOG0694|consen 446 FVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDR 524 (694)
T ss_pred EEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCc
Confidence 999999999953 3344468999999999999999999999999999999999999999999999999998765544556
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
..+.+|+|.|+|||.+....|. .+.|.||||++||||+.|+.||...|-++++
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred cccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 6788999999999999999997 9999999999999999999999998887765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=270.22 Aligned_cols=209 Identities=34% Similarity=0.573 Sum_probs=182.2
Q ss_pred ccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-- 79 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~-- 79 (218)
+++..+.|+.+++||+|.||.||+|++..+|+.||+|++..+.. .++...-..+|+.+|++++||||+++.+.+.+.
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 35667789999999999999999999999999999999966542 344456678999999999999999999988765
Q ss_pred CeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..+|+|+|||+. +|.-++.. .-.|++.++.-++.|++.+|+|+|.+|++|+|||.+|||+|.+|.+||+|||++.+..
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 689999999998 77777765 3479999999999999999999999999999999999999999999999999999766
Q ss_pred CCCc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 159 QGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 159 ~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.... .....+.+..|.|||.+.+...-+.+.|+||.||++.||+.|++.|+..+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 5432 34456678899999999876555699999999999999999999999765
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=260.20 Aligned_cols=208 Identities=33% Similarity=0.580 Sum_probs=183.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
--+.|++.+.||.|..++||.|.....++.|+||.+..+.-.+. .+.+++|+..++.++||||++++..|..+..+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 34679999999999999999999999999999999987764433 7889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
||.+|.+|++.+.+... ..+++..+..++.++++||.|||.+|.+|+|||+.|||++++|.++|+|||.+.....+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999999765 3589999999999999999999999999999999999999999999999998753333222
Q ss_pred cc----ccccccCccccccccc--cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 LL----RTTCGTPNYVAPEVLS--HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 ~~----~~~~~~~~~~~Pe~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.. ....++++|||||.++ ...|+ .|+||||||++..|+.+|+.||.++.|-.
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmk 239 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMK 239 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHH
Confidence 22 2336899999999965 34565 89999999999999999999999998754
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=265.59 Aligned_cols=203 Identities=35% Similarity=0.680 Sum_probs=172.1
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhh-cCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..+++.||+|.+...........+....+...+.. .+||||+++++.+...+..++|+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999876543333334444455555543 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++.++..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999998888999999999999999999999999999999999999999999999999999875433333333445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~ 204 (316)
T cd05592 161 DYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204 (316)
T ss_pred cccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999876665 899999999999999999999988766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=265.97 Aligned_cols=203 Identities=34% Similarity=0.642 Sum_probs=174.5
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..+++.+++|.+...........+.+..+...+... +|||++++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998765444444455666777777665 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|.+.+.....+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 99999998888999999999999999999999999999999999999999999999999998764332222233445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 204 (320)
T cd05590 161 DYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204 (320)
T ss_pred cccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 99999999876665 899999999999999999999988776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=266.40 Aligned_cols=203 Identities=39% Similarity=0.695 Sum_probs=172.8
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHH-HhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI-SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..+|+.+++|.+.............+..+. ..++.++||||+++++.+...+..++|+||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4689999999999999999999999998765443333334444444 456778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999998888899999999999999999999999999999999999999999999999998865433333333445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~ 204 (323)
T cd05575 161 EYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204 (323)
T ss_pred hhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHH
Confidence 99999999876665 899999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=264.66 Aligned_cols=207 Identities=33% Similarity=0.640 Sum_probs=177.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+|+..+.||+|+||.||.|.+..+|+.+|+|++...........+.+..|..++..+. |++++++.+.+...+..++|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999987654434444556667777777775 578888999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 99999999999988888999999999999999999999999999999999999999999999999988643322222233
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
..+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..+
T Consensus 161 ~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~ 208 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208 (323)
T ss_pred ccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 4578899999999876665 89999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=267.29 Aligned_cols=202 Identities=37% Similarity=0.671 Sum_probs=175.7
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
+.||+|+||.||.+.+..+|..+++|.+.............+..+...+..++||||+++.+.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997655444444566778889999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 93 ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 93 ~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
+|...+.....+++.+++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999988888889999999999999999999997 7999999999999999999999999998864332222223345788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~ 203 (325)
T cd05594 161 EYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK 203 (325)
T ss_pred ccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHH
Confidence 99999999877665 89999999999999999999998776544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=269.31 Aligned_cols=209 Identities=36% Similarity=0.627 Sum_probs=178.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+..+++.+++|.+.............+.++...++.++|||++++++.+...+..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999865443344445567788999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-c
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 163 (218)
|+||+++++|.+.+.. ..+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 121 v~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~ 199 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 199 (371)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccc
Confidence 9999999999988865 4689999999999999999999999999999999999999999999999999875433211 1
Q ss_pred cccccccCccccccccccCC---CCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||...+..
T Consensus 200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 253 (371)
T cd05622 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253 (371)
T ss_pred ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence 22345788999999987543 2348999999999999999999999877654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=264.50 Aligned_cols=205 Identities=34% Similarity=0.580 Sum_probs=173.6
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhh---hhcCCCCcceEEEEEEcCCeEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM---KLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
|++.+.||+|++|.||.+.+..+++.+++|.+...........+.+..+...+ ..++|||++++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999765433334445566665544 566899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|||+++++|...+.. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999877653 5799999999999999999999999999999999999999999999999998764332222233
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
...+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~ 208 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEE 208 (324)
T ss_pred ccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 44578899999999876665 89999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=261.86 Aligned_cols=204 Identities=29% Similarity=0.516 Sum_probs=171.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+..+++.+++|++..... ......+.+|+.+++.++|||++++.+++......++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 45789999999999999999999998999999999864331 1223456789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+||+++ +|.+.+... ..+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159 (303)
T ss_pred EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence 9999975 666666543 56899999999999999999999999999999999999999999999999988643332222
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 233456789999999875544458999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=269.36 Aligned_cols=210 Identities=34% Similarity=0.608 Sum_probs=179.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+..++..+|+|.+.............+.+|..+++.++|||++++++.+.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 45789999999999999999999999999999999876544444445567789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-c
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 163 (218)
|+||+++++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 9999999999988765 4689999999999999999999999999999999999999999999999999865433211 1
Q ss_pred cccccccCccccccccccCC---CCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||...+...
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 254 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH
Confidence 22345788999999986532 23589999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=266.60 Aligned_cols=211 Identities=40% Similarity=0.682 Sum_probs=178.6
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhh-----------HHHHHHHHHHhhhhcCCCCcceE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-----------MADQIKREISIMKLVRHPCVVRL 72 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~~i~~~ 72 (218)
+++++|++.+.||+|.+|.|-.|.+..+++.+|+|++......... -.++..+|+.+++++.|||+|++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4689999999999999999999999999999999999654432111 13578999999999999999999
Q ss_pred EEEEEc--CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEee
Q 027809 73 HEVLAS--RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 73 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d 150 (218)
+++..+ .+.+|+|+|||+.|.+...-.....+++.+++.++.+++.+|+|||..||+|+||||+|+|++++|.+||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 999864 457999999999988755444333389999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC-----CCcccccccccCcccccccccc---CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 151 FGLSALPEQ-----GVSLLRTTCGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~~~~~Pe~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
||.+..... .........|+|.|+|||.+.. ..+++.+.||||+|+++|.|+.|++||-+..--
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999875522 1222344679999999999976 455678999999999999999999999876443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=257.76 Aligned_cols=204 Identities=32% Similarity=0.519 Sum_probs=176.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|+..+.||+|+||.||.+.+..+|+.+++|.+.............+.+|+.++..++|++++++.+.+...+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999876554433444567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
++++++|...+... ..+++..++.++.|++.||++||+++++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-ec
Confidence 99999998777543 3689999999999999999999999999999999999999999999999999876433221 22
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred CCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 34578899999999877765 899999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=265.00 Aligned_cols=203 Identities=33% Similarity=0.637 Sum_probs=174.1
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..+++.+++|.+...........+.+..|..++..+ +||+++++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999998765443444455566777777655 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 99999998888899999999999999999999999999999999999999999999999998865333222233345788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+....+. .++|+||||+++|+|++|+.||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~ 204 (321)
T cd05591 161 DYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDL 204 (321)
T ss_pred cccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999876665 899999999999999999999988775543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=247.82 Aligned_cols=210 Identities=39% Similarity=0.722 Sum_probs=194.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++++.||.|.||.||.|..++++..|++|++..+-+.......++++|+++...++||||++.+++|-+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 36789999999999999999999999999999999988887777778889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++||...|++...+. ....+++...+....|+|.|+.|+|.++++|+||+|+|+|++.++..+++|||-+...+. .
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~--~ 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--N 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC--C
Confidence 999999999999998 566899999999999999999999999999999999999999999999999999887653 3
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
.....+++..|.+||...+..++ ...|+|++|++.||++.|.+||.+.+.++.|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etY 231 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETY 231 (281)
T ss_pred CceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHH
Confidence 33467899999999999998887 9999999999999999999999998877665
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=264.39 Aligned_cols=203 Identities=38% Similarity=0.689 Sum_probs=172.0
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHH-HhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI-SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..++..+++|.+.............+..+. ..++.++||||+++++.+...+..++|+||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998765443333334444444 467888999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++.++..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 99998888888899999999999999999999999999999999999999999999999998865333222223345778
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+....++ .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~ 204 (321)
T cd05603 161 EYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQM 204 (321)
T ss_pred ccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHH
Confidence 99999999876665 899999999999999999999988775543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=263.88 Aligned_cols=208 Identities=30% Similarity=0.601 Sum_probs=177.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.+....+++.+|+|++...........+.+.+|...+..++|+||+++++.+...+..++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999987544334444566788899999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-cc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 164 (218)
||+++++|.+++.. ...+++..+..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999876 45789999999999999999999999999999999999999999999999998864433221 12
Q ss_pred ccccccCcccccccccc----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+.. ....+.++|+||+|+++|+|++|..||...+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 22357889999999863 223347899999999999999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=263.35 Aligned_cols=197 Identities=33% Similarity=0.665 Sum_probs=172.8
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.+.+..+++.+++|++........+..+.+..|..++..+ +||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999766554555566678888888888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|.+.+....++++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 99999888888999999999999999999999999999999999999999999999999998864322222233445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
.|+|||.+.+..++ .++|+||||+++|+|++|..||..
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCccc
Confidence 99999999876665 899999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=265.01 Aligned_cols=203 Identities=37% Similarity=0.683 Sum_probs=172.6
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHH-HhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI-SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..+|+.+++|++.............+..+. ..++.++||||+++++.+...+..++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999999999999999998765433333334444444 456778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++.++..++.|++.||.+||++|++|+||+|+||++++++.++|+|||++..............+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 99999888888999999999999999999999999999999999999999999999999999864333222233445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~ 204 (325)
T cd05604 161 EYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204 (325)
T ss_pred hhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHH
Confidence 99999999877665 899999999999999999999998776544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=263.40 Aligned_cols=208 Identities=29% Similarity=0.555 Sum_probs=177.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.+.+..+++.+++|.+.............+.++...+..++|++|+++.+.+...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986544334444556788889999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-cc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 164 (218)
||+++++|.+.+.. ...+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999977 46789999999999999999999999999999999999999999999999999865433211 11
Q ss_pred ccccccCccccccccccC----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+... ...+.++|+||||+++|+|++|..||...+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 234578899999998642 22347899999999999999999999876654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=263.11 Aligned_cols=203 Identities=38% Similarity=0.670 Sum_probs=171.4
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHH-HHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKR-EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.+.+..+++.+++|++.............+.. +...++.++|+||+++++.+...+..++|+||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999987654333332333333 33456788999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999864333222233445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~ 204 (325)
T cd05602 161 EYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204 (325)
T ss_pred cccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999877665 899999999999999999999988765543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=261.58 Aligned_cols=203 Identities=33% Similarity=0.628 Sum_probs=172.3
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhh-cCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..+|+.+++|.+................+...+.. .+||+++++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999876543323334455566666654 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++.++..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998764332222233445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~ 204 (316)
T cd05620 161 DYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204 (316)
T ss_pred CccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999877665 899999999999999999999988766543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=260.87 Aligned_cols=203 Identities=33% Similarity=0.627 Sum_probs=171.8
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhh-cCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL-VRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.|.+..+++.+|+|.+................+...+.. .+|||++++++.+...+..++|+||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999876543323333445556666654 5899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|.+.+.....+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998864332222233445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~ 204 (316)
T cd05619 161 DYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204 (316)
T ss_pred cccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999876665 899999999999999999999988776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=265.53 Aligned_cols=208 Identities=32% Similarity=0.621 Sum_probs=179.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.+.+..+|+.+++|.+........+..+.+.++..++..++|+|++++.+.+...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999997665544555667888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-cc
Q 027809 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 164 (218)
||+++++|.+++... ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999776 6799999999999999999999999999999999999999999999999999875443222 22
Q ss_pred ccccccCcccccccccc-----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 215 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence 23457789999999863 222248999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=260.93 Aligned_cols=198 Identities=31% Similarity=0.649 Sum_probs=173.5
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.+.+..++..+++|.+........+..+.+.+|..++.++ +||+++++++.+...+..++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555555567788888888887 689999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++.+++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 99999888888899999999999999999999999999999999999999999999999998864332222223445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.|+|||.+.+..++ .++|+||||+++|+|++|..||...
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 161 NYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred ccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCcc
Confidence 99999999877665 8999999999999999999999643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=261.58 Aligned_cols=196 Identities=34% Similarity=0.672 Sum_probs=171.1
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.+.+..+++.+++|.+........+....+..|...+.++ +|||++++++.+...+..++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999766544445556677788777766 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 99998888888899999999999999999999999999999999999999999999999998864332222223345788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
.|+|||.+.+..+. .++|+||||+++|+|++|..||.
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 161 NYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCc
Confidence 99999999877665 89999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=260.68 Aligned_cols=203 Identities=37% Similarity=0.711 Sum_probs=174.5
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|+||.||.+.+..++..+++|.+.............+..+..++..+ +|||++++++++...+..++|+||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999765544444456666777777777 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|...+.....+++.++..++.|++.||.+||+++++|+||+|+||++++++.++|+|||++..............+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 99999988888899999999999999999999999999999999999999999999999998864322222223345778
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~ 204 (318)
T cd05570 161 DYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204 (318)
T ss_pred cccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHH
Confidence 99999999877765 899999999999999999999987765543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=267.09 Aligned_cols=205 Identities=32% Similarity=0.543 Sum_probs=187.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
..|+..++||+|.||.||+|.+..+++.||+|++..+.. ....+++.+|+..+.+++++||.++++.+-.+..+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 357788999999999999999999999999999987663 334688999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|||.+|++.+.+..+..+++.++.-++.+++.|+.|||..+.+|+||++.||++..+|.++|+|||.+............
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999998766554444456
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..|+|.|||||++....|+ .++||||||++.+||.+|.+||.+.+|-
T Consensus 171 fvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPm 217 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPM 217 (467)
T ss_pred ccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcc
Confidence 7899999999999987887 9999999999999999999999999873
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=260.83 Aligned_cols=202 Identities=37% Similarity=0.658 Sum_probs=172.5
Q ss_pred eeeecCccceEEEEEEec---CCCcEEEEEEEecchhh-hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
++.||+|+||.||.+.+. .+++.+++|.+...... .......+..|..+++.++||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 46789999998764432 22334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
|+++++|.+.+...+.+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999876433222222234
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..
T Consensus 161 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~ 206 (323)
T cd05584 161 CGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRK 206 (323)
T ss_pred CCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHH
Confidence 578899999999876665 8999999999999999999999877653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=260.60 Aligned_cols=209 Identities=28% Similarity=0.574 Sum_probs=177.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.+....+++.+++|.+.............+.++...+..++|++++++.+.+...+..++|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986544434444556788888999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC-Cccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG-VSLL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 164 (218)
||+++++|.+++.. ...+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 467899999999999999999999999999999999999999999999999988643222 1112
Q ss_pred ccccccCcccccccccc----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~ 215 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH
Confidence 23457889999999862 2223489999999999999999999998776543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=267.67 Aligned_cols=211 Identities=27% Similarity=0.529 Sum_probs=193.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe-EE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK-IY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~-~~ 83 (218)
..++|..++.+|.|+||.++.+..+.+++.+++|++........+. +...+|...++++.||||+.+.+.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 3678999999999999999999999999999999998777655543 467899999999999999999999988777 99
Q ss_pred EEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 84 IILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
|||+||+||+|.+.+...+ -+++..++.|+.|++.|+.|||+++|+|+|+++.|||+..++.++|+|||++....+..
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999997654 58999999999999999999999999999999999999999999999999999988877
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
.......|++.|++||.+.+..+. .++|||||||++|||++-+.+|...+-.++.
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li 215 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELI 215 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHH
Confidence 677788899999999999999997 9999999999999999999999998876653
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=257.64 Aligned_cols=204 Identities=28% Similarity=0.465 Sum_probs=179.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.+.+..++..+++|.+.... .....+.+.+|+..+++++|||++++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999886542 233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+||+++++|.+.+.....+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 159 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 159 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--c
Confidence 99999999999998888899999999999999999999986 69999999999999999999999999886543321 2
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 233577899999999876665 8999999999999999999999866543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=266.83 Aligned_cols=202 Identities=29% Similarity=0.575 Sum_probs=182.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
..|+..+++|+|..|.||.|....+++.||||.+....... .+-+.+|+.+++..+|+||+.+++.|-..+.+|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 46888999999999999999999999999999997766443 356889999999999999999999998889999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||++||+|.+.+.. ..+++.++..++.++++||+|||.+||+|+||+.+||+++.+|.+||+|||++............
T Consensus 350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 99999999887754 46999999999999999999999999999999999999999999999999999766665555566
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
-.|+|+|||||.+....|. .+.||||||++++||+.|++||=+-++
T Consensus 429 mVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~P 474 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENP 474 (550)
T ss_pred ccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCCh
Confidence 7899999999999988887 999999999999999999999986544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=255.66 Aligned_cols=205 Identities=30% Similarity=0.500 Sum_probs=175.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.+.+..++..+++|.+..... .....+.+.+|+..++.++|||++++++.+...+..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 579999999999999999999999999999999865432 2333566788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-ccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 165 (218)
||++++++.........+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9999877766555556799999999999999999999999999999999999999999999999999875433211 122
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred ccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 33567889999999876665 899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=258.35 Aligned_cols=204 Identities=35% Similarity=0.649 Sum_probs=173.6
Q ss_pred ceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhh-hhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~-~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~ 82 (218)
+|++.+.||+|+||.||.+.+. .++..+++|++...... .....+.+..|..++..+ +|++++++++.+...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 46789999998654432 223345677888999999 489999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~- 161 (218)
++|+||+++++|.+.+.....+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 11223457889999999976554458999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=265.80 Aligned_cols=198 Identities=33% Similarity=0.539 Sum_probs=176.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-C-----CCcceEEEEEEcCCe
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-H-----PCVVRLHEVLASRTK 81 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~-----~~i~~~~~~~~~~~~ 81 (218)
+|.+++.||+|.||.|-+|.+.++++.||||++++.+ ....+...|+.+|+.++ | -|+++++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 7999999999999999999999999999999997765 34566778889998886 3 599999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC--cEEEeeccccccC
Q 027809 82 IYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG--HLKISDFGLSALP 157 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~--~~~l~d~~~~~~~ 157 (218)
.++|+|.++. +|.++++.++ .++...+..++.||+.+|.+||+.||+||||||+|||+.+-+ .+|++|||+++..
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999976 9999998765 588999999999999999999999999999999999996543 6999999999987
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..... ..+-+..|.|||++.+..++ .+.|||||||++.||++|.+.|...+..
T Consensus 342 ~q~vy---tYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 342 SQRVY---TYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred CCcce---eeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHH
Confidence 66433 45556689999999999997 9999999999999999999999887643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=255.81 Aligned_cols=207 Identities=27% Similarity=0.479 Sum_probs=174.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
+.++|++.+.||+|+||.||.|.+..+++.+++|.+..... ......+.+|+..++.++|||++++++++...+..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 56789999999999999999999998999999999865432 2223456688999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+||+++ +|.+.+... ..+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9999986 777776554 45789999999999999999999999999999999999999999999999998654333222
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 211 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 233446778999999875544458999999999999999999999877654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=251.61 Aligned_cols=197 Identities=32% Similarity=0.532 Sum_probs=169.9
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||+|+||.||.+.+..+++.+++|.+...........+.+..|..+++.++|+|++++.+.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999999999999999998765544444456677889999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccccc
Q 027809 95 FDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (218)
Q Consensus 95 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 170 (218)
...+.. ...+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++..............++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 877642 3468999999999999999999999999999999999999999999999999986544433322334567
Q ss_pred CccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 171 ~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+
T Consensus 161 ~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 161 PGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 899999999877665 89999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=240.29 Aligned_cols=205 Identities=32% Similarity=0.530 Sum_probs=178.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|...+.+|+|.||.||+|.+.++|+.||||++...... +.......+|+..|+.++|+||+.++|.|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5788899999999999999999999999999999765432 112244678999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+++. +|...+.+.. .++..++..++.+++++++|||.+.|.|+|+||.|+|++++|.+|++|||+++...+......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99987 9988887654 589999999999999999999999999999999999999999999999999998776555444
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+-.|.|||.+.+...-....||||.||++.||+-|.+-|...+.
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD 207 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD 207 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch
Confidence 445667899999998655445889999999999999999998887653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=251.21 Aligned_cols=204 Identities=38% Similarity=0.741 Sum_probs=181.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.+.+..+++.+++|.+........+..+.+.+|+..++.++|||++++++.+.+.+..++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987655444455677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|++++++|.+.+.....+++..++.++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765443 223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..+++.|++||.+...... .++|+||||+++|+|++|..||...+..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~ 204 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPI 204 (290)
T ss_pred CCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 3467889999999766554 8999999999999999999999877643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=261.73 Aligned_cols=202 Identities=34% Similarity=0.598 Sum_probs=169.3
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc---CCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
||+|+||.||.|.+..+++.+++|++................+..++... +||+|+++++.+...+..++|+||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999999999999999999999998654433333334444455555444 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............+++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999865433333333445788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|+|||.+.+....+.++|+||||+++|+|++|..||...+..++
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~ 205 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH
Confidence 999999987554335899999999999999999999987765543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=275.95 Aligned_cols=207 Identities=27% Similarity=0.457 Sum_probs=176.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.++||+|++|.||.|.+..+++.|++|.+...........+++.+|+.++..++|||++++++++.+.+..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999998655433444556788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccc
Q 027809 86 LEFITGGELFDKIVHH-----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
|||+++++|.+.+... ...+...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999888542 23556788999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC------------------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 155 ALPEQGV------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 155 ~~~~~~~------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....... .......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 7541100 001123478899999999876664 899999999999999999999987554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=263.37 Aligned_cols=202 Identities=30% Similarity=0.502 Sum_probs=175.0
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
++..+.||+|-||.|+.|.+.. ...|++|.+...... .+++.+|+.++++++|++|++++++|+.++-++||+||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 4567899999999999999974 347999998665332 35677999999999999999999999998889999999
Q ss_pred cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-cc
Q 027809 89 ITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-LR 165 (218)
Q Consensus 89 ~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~ 165 (218)
+..|+|.+++.. +..++..+++.++.|||++++||++++++|+|+.++||||+++..+||+|||++....+.... ..
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999999987 456899999999999999999999999999999999999999999999999999955443332 22
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
...-+..|.|||.+.....+ .+||+||||++|+|++| |+.||..++..+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred CCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 33346689999999876665 99999999999999999 9999999887654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=251.74 Aligned_cols=211 Identities=30% Similarity=0.517 Sum_probs=185.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+..|++++.||.|.-|+||.+....++..+|+|++.+......+...++..|-++|..++||.++.++..|+.+...+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 35688899999999999999999999999999999988887777888999999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
||||+||+|....+.+ +-+++..+.-.+.+++-||+|||..||+++|+||+|||+.++|++.|+||.++.........
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999998888665 35999999999999999999999999999999999999999999999999886432110000
Q ss_pred -------------------------------c-------------------------ccccccCccccccccccCCCCCc
Q 027809 164 -------------------------------L-------------------------RTTCGTPNYVAPEVLSHKGYNGA 187 (218)
Q Consensus 164 -------------------------------~-------------------------~~~~~~~~~~~Pe~~~~~~~~~~ 187 (218)
. ...+|+-.|+|||++.+..+. .
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-s 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-S 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-c
Confidence 0 001256689999999998887 9
Q ss_pred chhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 188 AADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 188 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
+.|.|+||+++|||+.|..||...+.++.+
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl 344 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETL 344 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhH
Confidence 999999999999999999999998877643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=249.76 Aligned_cols=204 Identities=32% Similarity=0.520 Sum_probs=175.9
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|++.+.||+|++|.||.+.+..+++.+++|.+........+....+.+|+.+++.++|+|++++.+.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999998999999999876554444444567789999999999999999999998899999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+.+++|.+.+... ..+++..+..++.|++.++.+||+.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-cc
Confidence 99999998777543 3589999999999999999999999999999999999999999999999999875433221 12
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+....++ .++|+||+|+++|+|++|+.||...+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred cccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCch
Confidence 33567899999999866654 889999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=265.39 Aligned_cols=208 Identities=26% Similarity=0.452 Sum_probs=181.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++..++..||+|+||+||+|.+-+ .||||++..+.. +++.++.+++|+..+++-+|.||+-+.++|...+. .|
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 34667889999999999999999975 599999976654 44578999999999999999999999999998876 99
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC--CC
Q 027809 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GV 161 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~--~~ 161 (218)
|..+|+|.+|...+-. ..+|...+.+.|+.|+++++.|||.++|+|+|++..|||+.+++.++|+|||++....- ..
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 9999999999888844 35799999999999999999999999999999999999999999999999999874332 23
Q ss_pred cccccccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
.....+.+...|||||.++. ..+.+.++|+|++|+++|||++|..||....+++|+
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII 602 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence 33445667789999999984 344479999999999999999999999988888875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=256.06 Aligned_cols=203 Identities=31% Similarity=0.547 Sum_probs=170.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----CeE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----TKI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~-----~~~ 82 (218)
+|++.+.||+|++|.||.|.+..++..+++|.+..... .......+.+|+..++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999998864322 222345678899999999999999999987532 358
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|+||+. ++|.+.+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999996 58988888888899999999999999999999999999999999999999999999999999864332111
Q ss_pred ---ccccccccCccccccccccC-CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 163 ---LLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 163 ---~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
......+++.|+|||.+... ...+.++|+||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 11234577899999998652 223489999999999999999999997655
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=258.38 Aligned_cols=201 Identities=37% Similarity=0.689 Sum_probs=172.7
Q ss_pred eeecCccceEEEEEEec---CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 13 RTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
+.||+|+||.||.+.+. .+|+.+++|++...... ......+..|+.++.+++||||+++++.+...+..++|+||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999998763 56889999998764432 223345678889999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccc
Q 027809 90 TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169 (218)
Q Consensus 90 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 169 (218)
++++|.+.+.....+++.+++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..............+
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999988888999999999999999999999999999999999999999999999999998754443222333457
Q ss_pred cCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 170 ~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 161 ~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~ 205 (318)
T cd05582 161 TVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKE 205 (318)
T ss_pred ChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHH
Confidence 7899999999876664 89999999999999999999998876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=253.98 Aligned_cols=203 Identities=28% Similarity=0.472 Sum_probs=177.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.+.+..++..+++|.+.... .......+.+|+..++.++|+||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 478999999999999999999999999999999876543 233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+||+.+++|.+++...+.+++..+..++.|++.++.|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 159 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 159 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--c
Confidence 99999999999998888899999999999999999999975 79999999999999999999999999886443221 1
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....++..|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred ccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 223467799999999876654 899999999999999999999986554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=247.20 Aligned_cols=207 Identities=33% Similarity=0.446 Sum_probs=179.4
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CCe
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTK 81 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~~ 81 (218)
+.+++|+.+..|++|.||.||.|+++++++.||+|.+.-+.. ..-.----.+|+.+|.+++||||+.+..++.. -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 356789999999999999999999999999999999865541 11111123588999999999999999998764 457
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.|+|||||++ +|...+..-. ++...++.-+..|+++++.|||.+.|+|+|+||+|+|++..|.+|++|||+|+-.+..
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999998 8888886654 8999999999999999999999999999999999999999999999999999988877
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.........+..|.|||.+.+....+.+.||||+||++.||+++.+.|...+
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 6655566678899999999987666799999999999999999999998764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=251.52 Aligned_cols=206 Identities=27% Similarity=0.492 Sum_probs=174.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
++++|++.+.||+|++|.||.+.+..+++.+++|.+..... ......+.+|+..++.++|+||+++++++...+..++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 57889999999999999999999998999999998864432 2223456688999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+||+++ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 9999975 887777653 56899999999999999999999999999999999999999999999999998654433222
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22334577899999987654445899999999999999999999987664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=255.05 Aligned_cols=207 Identities=42% Similarity=0.758 Sum_probs=188.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 85 (218)
..|++.+.||+|.||.||.+....+|..+|+|.+........+....+.+|+.++++++ |||++.+.+.|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 46999999999999999999999999999999998887766666678999999999998 99999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC----CcEEEeeccccccCCCCC
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGV 161 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~----~~~~l~d~~~~~~~~~~~ 161 (218)
||++.||.|.+.+... .+++..+..++.|++.++.+||+.|++|+|++|+|+|+... +.++++|||++..... .
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-G 192 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-C
Confidence 9999999999999876 49999999999999999999999999999999999999533 4799999999988777 4
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
......+|++.|+|||.+....+. ...|+||+|+++|.|++|..||...+....
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~ 246 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEI 246 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence 456678899999999999877776 999999999999999999999998875543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=245.31 Aligned_cols=202 Identities=39% Similarity=0.704 Sum_probs=176.7
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|++++.||+|++|.||.+.+..+++.+++|.+......... ......|...++.++||||+++++++......++++|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999776543332 23345588999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccc
Q 027809 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 168 (218)
+.+++|.+++.....+++.+++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+..............
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999888999999999999999999999999999999999999999999999999999875333233334455
Q ss_pred ccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 169 ~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
++..|+|||.+......+.++|+||||+++++|++|..||...
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc
Confidence 6789999999873333459999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=255.92 Aligned_cols=204 Identities=27% Similarity=0.443 Sum_probs=166.7
Q ss_pred cceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC-
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR- 79 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~- 79 (218)
++|++.+.||+|+||.||.|.+. .++..||+|.+.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 58999999999999999999752 345679999886432 223346688899999999 899999999988654
Q ss_pred CeEEEEEEecCCCChHHHHHhc----------------------------------------------------------
Q 027809 80 TKIYIILEFITGGELFDKIVHH---------------------------------------------------------- 101 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 101 (218)
+..+++|||+++++|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999888642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc--cccccccCcccc
Q 027809 102 ----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVA 175 (218)
Q Consensus 102 ----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~ 175 (218)
.++++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......... .....+++.|+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 23778889999999999999999999999999999999999999999999998754322111 111223468999
Q ss_pred ccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 176 PEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 176 Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
||.+.+..++ .++|+||||+++|+|++ |..||...+.
T Consensus 245 PE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 245 PESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred cHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 9999876665 89999999999999997 9999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=260.66 Aligned_cols=205 Identities=32% Similarity=0.562 Sum_probs=178.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCC-e
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT-K 81 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~-~ 81 (218)
...+||.++++||.|.||.||.|+.+.+|+.||||.+...... .+....+ +|+..|++++ ||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nL-REvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNL-REVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHH-HHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 4568999999999999999999999999999999998665533 3333344 7788888888 999999999998877 9
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
+|+|||+|+. +|.++++.+. .|++..+..|+.||+++|.|+|++|+.|+|+||+|||+..+..+||+|||+++-....
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999976 9999997764 5899999999999999999999999999999999999998999999999999865553
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+.....+.+-.|.|||.+....+-+.+.|+|++||+++|+.+-++.|...+
T Consensus 164 -pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 164 -PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred -CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 333455667789999999876666799999999999999999999998764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=262.32 Aligned_cols=205 Identities=31% Similarity=0.489 Sum_probs=174.6
Q ss_pred cceEEeeeecCccceEEEEEEecCC-CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTET-GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
..|.+.+.||+|++|.||.|.+..+ +..+++|.+.... ......+..|+..+..++||||+++++.+...+..++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4499999999999999999998877 7788888764432 23345677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
|||+++++|.+.+.. ..++++.++..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999887643 3468999999999999999999999999999999999999999999999999987543321
Q ss_pred c--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 162 S--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 162 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
. ......+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~ 278 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQRE 278 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 12234578899999999876665 89999999999999999999998766543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=254.85 Aligned_cols=201 Identities=30% Similarity=0.436 Sum_probs=171.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-eEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KIYI 84 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-~~~l 84 (218)
.++|.-...||+|+||.||+|... +|..||||.+....... ...+.+|+..+..++|||+++++++|.+.+ ...+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 367888899999999999999976 45889999775544221 345999999999999999999999999888 5999
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 85 ILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKG---VYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~---i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
|+||++.|+|.+.+.... +++|..+++|+.++|.||+|||+.. ++|+||+|+|||+|++.+.||+|||++...+.
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999997765 8999999999999999999999743 99999999999999999999999999965554
Q ss_pred -CCcccccc-cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 -GVSLLRTT-CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 -~~~~~~~~-~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.... ... .++.+|++||....... +.++|+||+|+++.|+++|+.|.....
T Consensus 230 ~~~~~-~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 230 GDTSV-STTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred cccce-eeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCC
Confidence 2221 122 68889999999986444 489999999999999999998887643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=245.90 Aligned_cols=205 Identities=31% Similarity=0.514 Sum_probs=178.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-----CCe
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-----RTK 81 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~-----~~~ 81 (218)
.+|...+.||.|++|.|+.+.++.+|+.||||++.+.. .+...+++..+|+..++.++|+||+.+.+++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34666899999999999999999999999999996554 455567888999999999999999999998854 457
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC-
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG- 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~- 160 (218)
.|+|+|.|+. +|.+.+..+..+++..+..++.|++.+|.|+|+.+++|+|+||+|++++.++..|++|||+++...+.
T Consensus 101 vYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 9999999965 99999998888999999999999999999999999999999999999999999999999999866432
Q ss_pred -CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 -VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 -~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.........+-.|.|||.+.....-+.+.||||.||++.||++|++.|...+.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 22234455677899999997654445999999999999999999999998764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=243.82 Aligned_cols=206 Identities=29% Similarity=0.538 Sum_probs=176.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.+.||+|++|.||.|.+..++..+++|.+........+....+.+|+..++.++|||++++++.+...+..+++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999987654433445556788899999999999999999999988999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+|++++++|.+.+.. ...+++.+++.++.|++.|+.+||+++++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999887753 3458899999999999999999999999999999999999999999999999887654432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.......+.+.|+|||.+.+...+ .++|+||+|+++++|++|..||....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCcccc
Confidence 222233466789999999776664 89999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=255.95 Aligned_cols=201 Identities=33% Similarity=0.547 Sum_probs=169.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|+.++.||+|++|.||.+.+..+++.|++|++.... .......+.+|+.+++.++|+||+++++++...+..++
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3567899999999999999999999999999999985433 33345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+||+++++|.. ....++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 150 v~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 225 (353)
T PLN00034 150 LLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC 225 (353)
T ss_pred EEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence 999999998854 2345788899999999999999999999999999999999999999999999987544322222
Q ss_pred ccccccCcccccccccc----CCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 165 RTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
....++..|+|||.+.. ..+.+.++|+||||+++|+|++|+.||...
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 276 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 23457789999998753 233346899999999999999999999743
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=256.11 Aligned_cols=194 Identities=22% Similarity=0.383 Sum_probs=168.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.+.+..+++.+++|.... ..+.+|+.+++.++||||+++++++......+++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 4679999999999999999999999999999996421 3456889999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC-Cccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG-VSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 164 (218)
+|++. ++|...+.....+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 99996 488888888788999999999999999999999999999999999999999999999999998643321 1122
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
....+++.|+|||.+....+. .++|+||||+++|+|++|..||-.
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCC
Confidence 234578899999999876665 899999999999999999987643
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=241.95 Aligned_cols=206 Identities=31% Similarity=0.586 Sum_probs=177.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh--hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
++|++.+.||+|++|.+|.+.+..++..+++|.+...... .....+.+.+|+..++.++|||++++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999889999999988654322 22234568889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
++|++++++|.+.+.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999886443321111
Q ss_pred ---ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 ---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ---~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....++..|+|||.+.+.... .++|+||||+++|++++|..||...+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred ccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccch
Confidence 123456789999999876654 899999999999999999999987544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=240.80 Aligned_cols=205 Identities=30% Similarity=0.535 Sum_probs=178.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..+++.+++|.+...... ......+.+++..++.++|||++++++.+...+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999998654332 3345678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+++++|.+.+... ..+++.+++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999988764 5689999999999999999999999999999999999999999999999998875544333333
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...+.+.|+|||...+..++ .++|+||||+++++|++|..||...+..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~ 207 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQG 207 (256)
T ss_pred ccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 34567789999999877665 8999999999999999999999877643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=257.66 Aligned_cols=205 Identities=30% Similarity=0.495 Sum_probs=173.6
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-----eE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-----KI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-----~~ 82 (218)
+|++.+.||+|+||.||.+.+..+++.+++|.+..... .....+++.+|+.+++.++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 47899999999999999999998999999998854322 2233467788999999999999999999988766 78
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~- 161 (218)
++|+||+.+ +|.+.+.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 999999975 788888777889999999999999999999999999999999999999999999999999987543321
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...++.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 11222345778999999876554458999999999999999999999877654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=252.82 Aligned_cols=203 Identities=31% Similarity=0.500 Sum_probs=170.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++.+.||+|+||.||.+.+..+|..+++|.+..... .......+.+|+..++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 46899999999999999999999999999999999865432 233346677899999999999999999988643
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++|+||+++ +|.+.+. ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 357999999986 5555543 358899999999999999999999999999999999999999999999999986543
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... ......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 175 ~~~-~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 175 TNF-MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred cCc-cCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 221 12234567889999999877775 899999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=241.04 Aligned_cols=204 Identities=31% Similarity=0.578 Sum_probs=176.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||.|++|.+|.+.+..++..+++|.+.... .....+.+.+|...++.++|+|++++.+.++..+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986443 22335677888999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+++++|.+.+... ..+++..++.++.|++.|+.+||++|++|+||+|+||++++++.++++|||.+...........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 99999998887643 4578999999999999999999999999999999999999999999999999875544333233
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 206 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWK 206 (255)
T ss_pred cccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHH
Confidence 34567789999999776654 8999999999999999999999877644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=242.94 Aligned_cols=196 Identities=32% Similarity=0.531 Sum_probs=167.0
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||+|+||.||.+....+|+.+++|.+.............+..|..+++.++|||++++.+.++.....++|+||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 68999999999999999999999998654433333334456788999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCc
Q 027809 95 FDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (218)
Q Consensus 95 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 172 (218)
...+.... .+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||++........ .....+++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-eeccCCCCC
Confidence 88775443 588999999999999999999999999999999999999999999999999875544322 123456789
Q ss_pred cccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 173 ~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
|+|||.+.+..++ .++|+||||+++|+|++|..||....
T Consensus 160 y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 160 YMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999999877654 89999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=243.02 Aligned_cols=207 Identities=21% Similarity=0.355 Sum_probs=172.2
Q ss_pred ccceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++.+.||+|+||.||.|.+. ..+..+++|.+.... +......+.+|+..+.+++|||++++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467999999999999999999765 345689999886543 223345678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++||||+++++|.+++... ..+++.+++.++.|++.|+.+||++|++|+||+|+||+++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999988764 578999999999999999999999999999999999999999999999999876543221
Q ss_pred ccc-ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 162 SLL-RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~-~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... ....++..|+|||.+....++ .++|+||||+++|++++ |..||...+..+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~ 216 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQD 216 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 111 111234579999998776665 89999999999999775 999998776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=242.92 Aligned_cols=204 Identities=33% Similarity=0.533 Sum_probs=175.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|+..+.||+|+||.||.+.+..+++.+++|.+.............+.+|+.+++.++|++++++.+.+...+..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999866544444444567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+++++|.+.+... .++++..+..++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-cc
Confidence 99999998777543 3689999999999999999999999999999999999999999999999998865433211 12
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred CCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 33567899999999876665 899999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=243.04 Aligned_cols=203 Identities=33% Similarity=0.555 Sum_probs=175.1
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|+..+.||+|+||.||.+.+..+++.+++|.+........+....+.+|+.+++.++|++++++.+.+...+..++|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999876544444444567788999999999999999999999899999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+.+++|.+.+... ..+++.++..++.|++.||.+||+.+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-cc
Confidence 99999998887543 3589999999999999999999999999999999999999999999999998865443222 12
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
...++..|+|||.+....++ .++|+||+|+++|+|++|..||....
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCC
Confidence 34577899999999876654 89999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=242.50 Aligned_cols=205 Identities=32% Similarity=0.491 Sum_probs=175.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC-cceEEEEEEcCC-----
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRT----- 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~-i~~~~~~~~~~~----- 80 (218)
..|+.+++||+|.+|+||+|..+.+|+.||+|++...... +-.-....+|+..++.++|+| |+++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3477788999999999999999999999999999765421 112233568999999999999 999999987666
Q ss_pred -eEEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 81 -KIYIILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 81 -~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
.+++|+|+++. +|..++.... .++...+..++.||+.|+.|||+++|+|+|+||.|++++++|.+||+|||++.
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 89999999987 8988887655 47788999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...-..........+..|.|||.+.+...-+...||||+||++.||++++..|...+.
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 6554434344556778899999999875556999999999999999999999987654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=241.52 Aligned_cols=205 Identities=32% Similarity=0.489 Sum_probs=175.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.|.+..++..+++|+...... .....+.+|+..+..++|||++++++.+...+..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 4579999999999999999999998999999999864431 2235577889999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+||+++++|.+.+....++++.++..++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||++...........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999888788899999999999999999999999999999999999999999999999999875543322222
Q ss_pred cccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.. ....+.++|+||+|+++|+|++|..||...++
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 3446678999998852 22224789999999999999999999976544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=239.60 Aligned_cols=206 Identities=30% Similarity=0.551 Sum_probs=177.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.+|.|.+..+|+.+++|.+...........+.+.+|+..++.++|++++++++.+...+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 37899999999999999999999989999999988654433444456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+||+++++|...+.. ...+++.+++.++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999888754 3458999999999999999999999999999999999999999999999999886544433
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||....
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCC
Confidence 222334567789999999766665 89999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=243.18 Aligned_cols=206 Identities=30% Similarity=0.545 Sum_probs=178.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.+.||+|++|.||.+.+..+++.+++|.+.............+.+|+..++.++|+|++++++.+...+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999889999999988654444444556788999999999999999999999988999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+|++++++|.+.+.. ...+++.+++.++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999888763 3458999999999999999999999999999999999999999999999999887654433
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.......+...|+|||.+.....+ .++|+||||+++|+|++|..||....
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCccccc
Confidence 322334567789999999766654 89999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=242.26 Aligned_cols=204 Identities=32% Similarity=0.630 Sum_probs=181.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||.|++|.+|.+.+..+++.+++|.+...........+.+.+|+..+++++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998899999999976554444556788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
++.+++|.+.+....++++.++..++.|++++|.+||+++++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-TTST 159 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-cccc
Confidence 999999999998878899999999999999999999999999999999999999999999999999876544321 1233
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.+...|+|||.+...... .++|+||||+++|+|++|..||...+.
T Consensus 160 ~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 466789999999876654 899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=259.97 Aligned_cols=209 Identities=33% Similarity=0.536 Sum_probs=175.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~---- 80 (218)
..++|++.+.||+|+||.||.+.+..+|+.+|+|.+..... +......+.+|+..+..++|++++++.+.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 45789999999999999999999999999999999866543 2334566788899999999999999987764321
Q ss_pred ----eEEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecc
Q 027809 81 ----KIYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (218)
Q Consensus 81 ----~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~ 152 (218)
.+++|+||+++++|.+.+... ..+++..++.++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 478999999999999888653 468999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 153 LSALPEQG--VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 153 ~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
++...... ........+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~ 252 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEE 252 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 98654322 1112234578899999999877665 89999999999999999999998776543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=245.81 Aligned_cols=206 Identities=26% Similarity=0.415 Sum_probs=169.0
Q ss_pred cceEEeeeecCccceEEEEEEecC----------------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcc
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTE----------------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~----------------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~ 70 (218)
++|++.+.||+|+||.||.+.+.. ++..+++|.+.... .......+.+|+..+..++||||+
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence 589999999999999999997532 33479999886543 233356688999999999999999
Q ss_pred eEEEEEEcCCeEEEEEEecCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 027809 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHG-------------------RLSESEARRYFQQLIDGVDYCHSKGVYHR 131 (218)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~ 131 (218)
++++++...+..++++||+++++|.+++.... .+++.+++.++.|++.||.+||++|++|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999998889999999999999998885432 36778899999999999999999999999
Q ss_pred cCCCCCeEecCCCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh--cCCC
Q 027809 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLP 207 (218)
Q Consensus 132 di~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~--g~~p 207 (218)
||+|+||+++.++.++|+|||++........ ......++..|+|||.+....+. .++|+||||+++|+|++ +..|
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999865433211 11122335689999998766654 89999999999999986 6788
Q ss_pred CCCCCccc
Q 027809 208 FDELDLTT 215 (218)
Q Consensus 208 f~~~~~~~ 215 (218)
|...+..+
T Consensus 242 ~~~~~~~~ 249 (304)
T cd05096 242 YGELTDEQ 249 (304)
T ss_pred CCcCCHHH
Confidence 88765543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=243.03 Aligned_cols=206 Identities=30% Similarity=0.467 Sum_probs=175.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.+|.+.+..+++.+++|.+..... .....+.+.+|+.++++++|+|++++++.+......++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998999999998864432 2223355778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.........+++.+++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 99999888877777678999999999999999999999999999999999999999999999999998755443222223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..+...|+|||.+.+....+.++|+||||+++++|++|..||...+.
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 34567899999987644445899999999999999999999986653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=238.07 Aligned_cols=203 Identities=34% Similarity=0.557 Sum_probs=176.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.+|.|++|.+|.|.+..+++.+++|.+..... +..+.+.+++..++.++|||++++++.+......++++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999988889999999865432 24567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|++++++|.+.+... .++++.+++.++.|++.++.+||+++++|+||+|+||++++++.++++|||.+...........
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 999999999988776 7899999999999999999999999999999999999999999999999998875443222222
Q ss_pred cccccCccccccccccC---CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHK---GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+...|++||.+... .. +.++|+||||+++++|++|..||...++
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred cccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 33456789999998755 44 4899999999999999999999987653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=237.18 Aligned_cols=206 Identities=30% Similarity=0.552 Sum_probs=179.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||.|++|.+|.+....++..+++|.+....... ....++.+|+.++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999986554333 334667899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+++++|.+.+... ..+++.++..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999988765 4689999999999999999999999999999999999999999999999999876544332333
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
...+++.|+|||.+.+..++ .++|+||||+++++|++|..||...++.+
T Consensus 160 ~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLN 208 (256)
T ss_pred ccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 44567899999999876654 89999999999999999999998766544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=244.46 Aligned_cols=207 Identities=32% Similarity=0.571 Sum_probs=178.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.+.+..+++.+++|.+...........+.+..+...+..++|+|++++++.+......++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999889999999997765554455677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-
Q 027809 87 EFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (218)
Q Consensus 87 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~- 163 (218)
|++.+++|.+.+... ..+++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999988754 46899999999999999999999999999999999999999999999999987644321110
Q ss_pred ----------------------------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 ----------------------------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ----------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....++..|+|||.+.+..+. .++|+||||+++|+|++|..||...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112356679999999876654 8999999999999999999999876644
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=243.05 Aligned_cols=208 Identities=32% Similarity=0.644 Sum_probs=178.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.+|.+.+..+++.+++|.+.............+.+|+..++.++|||++++++.+...+..++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987654434444567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc----
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~---- 162 (218)
|++++++|.+.+.....+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998753211000
Q ss_pred -----------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 -----------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 -----------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......++..|+|||.+...... .++|+||||+++|++++|..||...++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~ 223 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEE 223 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112345689999998766654 89999999999999999999998776554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=256.47 Aligned_cols=199 Identities=30% Similarity=0.426 Sum_probs=163.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-------
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------- 78 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------- 78 (218)
.++|++++.||+|+||.||.|.+..++..+|+|.+.... ....+|+.+++.++|||++++.+++..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 357999999999999999999999899999999885432 223468899999999999999887632
Q ss_pred -CCeEEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeecc
Q 027809 79 -RTKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFG 152 (218)
Q Consensus 79 -~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~ 152 (218)
...+++||||+++ +|.+.+. ....+++..++.++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 2257799999986 6666554 345789999999999999999999999999999999999998665 69999999
Q ss_pred ccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
++......... ....+++.|+|||.+.+....+.++|+||||+++|+|++|.+||...+.
T Consensus 217 la~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 217 SAKNLLAGQRS-VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred cchhccCCCCc-ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99754432221 2345678899999987654335899999999999999999999987654
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=243.75 Aligned_cols=203 Identities=32% Similarity=0.487 Sum_probs=163.0
Q ss_pred cceEEeeeecCccceEEEEEEecC-CCcEEEEEEEecchhhhhhHHHHHHHHHHhhh---hcCCCCcceEEEEEE-----
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMK---LVRHPCVVRLHEVLA----- 77 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~---~l~~~~i~~~~~~~~----- 77 (218)
.+|++.+.||+|+||.||.|.+.. ++..+++|.+........ ......++...++ .++||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 467899998865432221 1223334555444 457999999999875
Q ss_pred cCCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 78 SRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
.....++|+|++++ +|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 34568999999975 888887653 358999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..... .......+++.|+|||.+....+. .++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred eccCC-cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 54433 222234567899999999766665 899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=250.84 Aligned_cols=204 Identities=29% Similarity=0.476 Sum_probs=171.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR---- 79 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~---- 79 (218)
..+++|++.+.||+|+||.||.+.+..+++.+++|.+..... .......+.+|+..++.++|||++++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 357899999999999999999999998999999998865432 233346677889999999999999999987543
Q ss_pred --CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 80 --TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 80 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
...++++|++++ +|.+.+. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999986 5655554 35889999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..... .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 170 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~ 223 (355)
T cd07874 170 GTSFM-MTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_pred CCccc-cCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 43221 2234567899999999877665 899999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=251.08 Aligned_cols=205 Identities=31% Similarity=0.486 Sum_probs=172.0
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR---- 79 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~---- 79 (218)
...++|++.+.||+|+||.||.+.+...++.+++|.+..... .......+.+|+..++.++|||++++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 356899999999999999999999999999999999865432 233345677889999999999999999987532
Q ss_pred --CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 80 --TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 80 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
...++||||+++ +|.+.+. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999976 6666654 35889999999999999999999999999999999999999999999999998755
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.... ......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..
T Consensus 177 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~ 231 (364)
T cd07875 177 GTSF-MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHI 231 (364)
T ss_pred CCCC-cccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 4322 12234567899999999877665 8999999999999999999999876643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=242.70 Aligned_cols=198 Identities=17% Similarity=0.240 Sum_probs=170.1
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc----CCeEEEEEEe
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RTKIYIILEF 88 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~ 88 (218)
..+++|++|.||.|.+ +|+.|++|.+...........+.+.+|+..+.+++||||+++++++.+ ....++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999988 578999999876554444456778899999999999999999999865 4578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
+++++|.+.+.....+++...+.++.|++.++.+||+ .+++|+||+|+||++++++.++++|||++....... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~ 180 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKN 180 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccc
Confidence 9999999999888889999999999999999999998 489999999999999999999999999986543321 123
Q ss_pred cccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 168 CGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.+++.|+|||.+.+ ..+ +.++|+||||+++|+|++|..||...+..++
T Consensus 181 ~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~ 230 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230 (283)
T ss_pred cCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 46678999999975 344 4899999999999999999999998876654
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=241.59 Aligned_cols=204 Identities=31% Similarity=0.567 Sum_probs=177.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||.|++|.+|.+.+..++..+++|.+.... .......+.+|+..++.++|+|++++.+.+......++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 57899999999999999999999999999999986543 2233456788999999999999999999999889999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|++++++|.+.+... ++++.+++.++.|++.++.+||+.+++|+||+|+||++++++.++++|||++............
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999999999888765 8899999999999999999999999999999999999999999999999998765543222333
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..+++.|++||.+.+..++ .++|+||||+++|+|++|..||...++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~ 204 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPM 204 (274)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchH
Confidence 4566789999999877654 9999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=242.39 Aligned_cols=202 Identities=27% Similarity=0.473 Sum_probs=175.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.+.+..++..+++|.+.... ......++.+|+.++++++|||++++++.+...+..++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999899999999876542 2334566888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||+++++|.+++.....+++..+..++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~ 156 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--AN 156 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--cc
Confidence 999999999999888889999999999999999999997 699999999999999999999999999876443321 12
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.+..+. .++|+||||+++++|++|..||...+.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred cCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 34567799999998765554 899999999999999999999975543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=241.77 Aligned_cols=204 Identities=34% Similarity=0.525 Sum_probs=175.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.+|.|.+..+++.+++|.+.... ......+.+++..++.++|||++++++.+...+..++++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 57899999999999999999999999999999986543 122355778899999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.+...+.+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS 165 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998654433332334
Q ss_pred ccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...++
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~ 214 (267)
T cd06645 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence 457789999999742 22234899999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=242.66 Aligned_cols=208 Identities=26% Similarity=0.437 Sum_probs=174.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC-----cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|++|.||.|.....+ ..+++|.+.... .......+.+|+..+..++|||++++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 568999999999999999999876554 678999875433 2334566889999999999999999999999888
Q ss_pred eEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~ 144 (218)
..++++|++++++|.+++... ..+++.+++.++.|++.||.+||+++++|+||+|+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999998764 4578899999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCC--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 145 HLKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 145 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.++|+|||++....... .......+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..++
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999986433221 111223346789999998766665 89999999999999998 9999987666543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=240.79 Aligned_cols=203 Identities=33% Similarity=0.536 Sum_probs=170.6
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.||.|.+..++..+++|.+..... .......+.+|+..++.++|||++++++.+..++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999998999999998854332 22234567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 88 FITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 88 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+++ +|.+.+... ..+++.+++.++.|++.||.+||+++++|+||+|+||++++++.++|+|||++..........
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 9985 777776442 468999999999999999999999999999999999999999999999999986543322222
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
....+++.|+|||.+.+....+.++|+||||+++++|++|+.||...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 233456789999998765444589999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=236.79 Aligned_cols=205 Identities=30% Similarity=0.583 Sum_probs=173.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh--hhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CCeE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~~~ 82 (218)
.+|++.+.||+|++|.||.+.+..++..+++|.+..... ...+..+.+.+|+..++.++|+|++++++.+.+ ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999998753321 122345678889999999999999999998865 3568
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++++|++++++|.+.+.....+++..++.++.|++.+|.+||+++++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999999999999998875432111
Q ss_pred ---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 163 ---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 163 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
......++..|+|||.+.+...+ .++|+||||+++|+|++|+.||...+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccc
Confidence 11123456789999999876554 89999999999999999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=252.13 Aligned_cols=205 Identities=26% Similarity=0.415 Sum_probs=168.8
Q ss_pred cceEEeeeecCccceEEEEEEecCC-----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
++|++++.||+|+||.||.|.+... +..|++|.+..... ....+.+.+|+.+++.+ +|+||+++++.+...+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4699999999999999999986443 35799998865432 22346688899999999 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhc-----------------------------------------------------------
Q 027809 81 KIYIILEFITGGELFDKIVHH----------------------------------------------------------- 101 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~----------------------------------------------------------- 101 (218)
..++||||+++++|.+++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999887532
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc--ccccc
Q 027809 102 -----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTC 168 (218)
Q Consensus 102 -----------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~ 168 (218)
.++++.++++++.|++.||.|||++|++|+||+|+||++++++.++|+|||++......... .....
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 24678899999999999999999999999999999999999999999999998654332111 11112
Q ss_pred ccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 169 ~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
+++.|+|||.+....++ .++|+||||+++|+|++ |..||......
T Consensus 276 ~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 276 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred CccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 34579999999766665 89999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=241.11 Aligned_cols=204 Identities=28% Similarity=0.511 Sum_probs=176.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.+.+..++..+++|.+...... ..+.+.+++..++.++|+|++++++.+......++
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 346899999999999999999999889999999988654422 23567788999999999999999999999899999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+||+++++|.+++.. ..+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 173 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence 9999999999988754 468999999999999999999999999999999999999999999999999887544332222
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+++.|+|||.+...... .++|+||||+++|+|++|..||...++
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred CcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 234567789999999866554 899999999999999999999977654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=240.39 Aligned_cols=205 Identities=28% Similarity=0.485 Sum_probs=169.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+..+|..+++|.+..... ......+.+|+..++.++|+|++++.+++......++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 35789999999999999999999998999999999865432 1222345678899999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+|++.+ ++.+.+.. ...+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 81 VFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred EEecccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC
Confidence 9999975 66555543 356788999999999999999999999999999999999999999999999988654332222
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 2233457789999998754433478999999999999999999997654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=243.00 Aligned_cols=205 Identities=32% Similarity=0.529 Sum_probs=175.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.|.+..+++.+++|.+...... ....+.+.+|+..++.++|||++++++++...+..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 5799999999999999999999888999999987544322 233456778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.......+++.+++.++.|++.++.+||+.+++|+|++|+||++++++.++|+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 99999888887766667999999999999999999999999999999999999999999999999998754433222223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..++..|+|||...+....+.++|+||||+++++|++|..||...+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 3456789999998765444588999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=241.22 Aligned_cols=204 Identities=32% Similarity=0.561 Sum_probs=169.5
Q ss_pred EEeeeecCccceEEEEEEec----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 10 EVGRTIGEGTFAKVKFAQNT----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
++.+.||.|.||.||.|.+. ..+..|+||.+... ...+..+.+.+++..+.+++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999988 34578999998442 2344467888999999999999999999999988889999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC--C
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--V 161 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~--~ 161 (218)
+||+++++|.+++... ..+++.+++.++.|++.||.|||+++++|++|+++||+++.++.+||+|||++...... .
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999887 67999999999999999999999999999999999999999999999999998765221 1
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
...........|+|||.+....++ .++||||||++++|+++ |..||.+.+..++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccc
Confidence 112233456689999999876654 99999999999999999 7899998876653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=235.40 Aligned_cols=205 Identities=27% Similarity=0.559 Sum_probs=174.6
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-CCeEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKIYIIL 86 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 86 (218)
+|++.+.||.|++|.+|.+.+..+++.+++|.+...... ....+.+.++...++.++|+|++++.+.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 589999999999999999999988999999998654322 2334567888999999999999999988764 45689999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 87 EFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|++++++|.+.+... ..+++.+++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 999999998888653 458999999999999999999999999999999999999999999999999987554433333
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+.+.|+|||.+.+..++ .++|+||||++++++++|..||...+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~ 208 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMN 208 (257)
T ss_pred ccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHH
Confidence 344567889999999877665 8999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=243.50 Aligned_cols=208 Identities=26% Similarity=0.409 Sum_probs=170.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcE--EEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~--~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
..+++|++.+.||+|+||.||.|.++.++.. +++|..... ........+.+|+..+..+ +|+|++++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3568999999999999999999998877764 466655322 2333456778899999999 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~ 144 (218)
..++++||+++++|.+++.... .+++.+++.++.|++.|+.+||++|++|+||+|+||+++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999886532 478999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 145 HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 145 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.++|+|||++........ ......+..|+|||.+....+. .++|+||||+++++|++ |..||...+..+
T Consensus 162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred cEEeCccccCcccchhhh-cccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 999999998853221111 1112234579999988766554 89999999999999998 999998766544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=242.62 Aligned_cols=205 Identities=32% Similarity=0.502 Sum_probs=174.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh--hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+|++.+.||+|++|.+|.|.+..++..+++|.+...... .......+..|+..++.++|+|++++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999988999999998655432 122335567889999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+|++ +++|.+.+.... .+++.+++.++.|+++||.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 779999987766 79999999999999999999999999999999999999999999999999987654433222
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......+.|+|||.+.+....+.++|+||||+++++|++|.+||...+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 2334566899999986554445899999999999999999888876553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=241.29 Aligned_cols=206 Identities=33% Similarity=0.518 Sum_probs=176.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||.|++|.||.+.+..++..+++|.+.... ....+.+..|+..++.++|+|++++++.+...+..++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 357999999999999999999998889999999986443 23346677889999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+||+++++|.+.+... ..+++.+++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999888664 568999999999999999999999999999999999999999999999999876554433323
Q ss_pred ccccccCccccccccccC----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|++||.+... ...+.++|+||||+++|+|++|..||...+..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~ 214 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH
Confidence 334567789999998522 22347899999999999999999999877643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=250.75 Aligned_cols=210 Identities=46% Similarity=0.874 Sum_probs=193.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...+.|.+.+.||+|.|+.|..+...-++..||+|.+......... .+.+.+|+.++..++||||++++++.+....+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 4578899999999999999999999999999999999776655444 455889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+.++.+.+++.+++...+.++...+.|++.|++|||+++++|+|+++.|++++.+.+++|+|||++.+... ...
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~ 210 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLM 210 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-ccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999987764 345
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....++.+.|.|||...+..++.++.|+||||+++|.|++|.+||+..+-.+
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 5678899999999999999999999999999999999999999999776544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=239.91 Aligned_cols=204 Identities=31% Similarity=0.511 Sum_probs=173.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.|++.+.||.|++|.||.+.+..++..+++|.+... +.+..+.+.+++..++.++|+|++++++.+...+..++|+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 5699999999999999999999999999999998643 2334567788999999999999999999999889999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||+++++|...+.. ...+++..++.++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||.+...........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 99999999877654 45689999999999999999999999999999999999999999999999998765433322223
Q ss_pred cccccCccccccccccC----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+... ...+.++|+||||+++|+|++|..||...++
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence 34467789999998522 2224789999999999999999999987654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=237.71 Aligned_cols=196 Identities=28% Similarity=0.477 Sum_probs=169.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.||.+.+..++..+++|.+.... ..+..+.+.+|..++.+++|||++++++.+...+..++|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999886542 2333466888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKT 152 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--ccC
Confidence 99999988543 357899999999999999999999999999999999999999999999999986543321 223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...
T Consensus 153 ~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 153 YVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhh
Confidence 4567799999999876664 8999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=249.88 Aligned_cols=204 Identities=25% Similarity=0.434 Sum_probs=168.3
Q ss_pred cceEEeeeecCccceEEEEEEe-----cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
++|++.+.||+|+||.||.|.+ ..++..+++|++.... .....+.+.+|+.++..+ +||||+++++++...+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 4799999999999999999874 3356689999886433 222346678899999999 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcC----------------------------------------------------------
Q 027809 81 KIYIILEFITGGELFDKIVHHG---------------------------------------------------------- 102 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~---------------------------------------------------------- 102 (218)
..++||||+++++|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999988885421
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc--
Q 027809 103 -----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-- 163 (218)
Q Consensus 103 -----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 163 (218)
.+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 4678889999999999999999999999999999999999999999999998654332211
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
......+..|+|||.+....++ .++|+||||+++|+|++ |..||.....
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~ 322 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPV 322 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence 1112234579999999876665 89999999999999998 9999987653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=238.58 Aligned_cols=202 Identities=28% Similarity=0.534 Sum_probs=174.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|++.+.||.|++|.+|.+.+..+++.+++|.+..... ...+.+.+++..++.++|+|++++++.+...+..++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 569999999999999999999999999999998865432 22456778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|++++++|.+.+.. ..+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 99999999887764 46899999999999999999999999999999999999999999999999987644332222223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..+.+.|+|||.+....+. .++|+||||+++|++++|..||...++
T Consensus 175 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred cCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3466789999999866654 899999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=239.69 Aligned_cols=205 Identities=30% Similarity=0.510 Sum_probs=171.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.+.||+|++|.||.+.+..+++.+++|.+...... .....+.+|+.+++.++|+|++++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 468999999999999999999999989999999998654321 112345678999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+||+++ +|.+.+... ..+++.+++.++.|+++||.+||+++++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9999986 888877654 46799999999999999999999999999999999999999999999999988643322221
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.....++..|+|||.+.+....+.++|+||+|+++|+|++|..||...+
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1222346789999998754434589999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=239.27 Aligned_cols=203 Identities=29% Similarity=0.515 Sum_probs=175.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.+|.+.+..++..+++|.+...... ..+.+.+++..++.++|+|++++++.+...+..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 47899999999999999999999889999999998654322 235577888999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+||+++++|.+++.. ..+++.++..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||++...........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 999999999988754 4688999999999999999999999999999999999999999999999998865443322222
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|++||.+.+..+. .++|+||||+++|++++|..||...++
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred cccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 33467789999999876664 899999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=241.83 Aligned_cols=200 Identities=34% Similarity=0.523 Sum_probs=168.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.||.|.+..+|+.+++|.+..... .......+.+|+..++.++|+|++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 68999999999999999999999999999999865432 22223456778999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 88 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|+++ +|.+.+.. ...+++..++.++.|+++||.+||+++++|+||+|+||+++.++.++|+|||++............
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9986 67666654 567899999999999999999999999999999999999999999999999988754332222223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
..+++.|+|||.+.+....+.++|+||||+++|+|++|..||-
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 3456789999998765544589999999999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=240.77 Aligned_cols=197 Identities=35% Similarity=0.537 Sum_probs=168.1
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-----eE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-----KI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-----~~ 82 (218)
.|...+++|+|+||.||.|...++++.+|||+.-.+.. .-..|+.+++.++||||+++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 58899999999999999999999999999998755542 2236788888999999999998875321 35
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-CcEEEeeccccccC
Q 027809 83 YIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALP 157 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-~~~~l~d~~~~~~~ 157 (218)
.+|+||++. +|.+.+.. +..++...+.....||++||.|||+.||+|+||||.|+|+|.+ |.+||||||.|...
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 579999976 89888874 5679999999999999999999999999999999999999976 89999999999876
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..+.+. .....+-.|.|||.+.+...-+.+.||||.||++.||+-|++.|...+.
T Consensus 177 ~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~ 231 (364)
T KOG0658|consen 177 VKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS 231 (364)
T ss_pred ccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence 665544 3455677899999998765556999999999999999999999998664
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=237.83 Aligned_cols=204 Identities=29% Similarity=0.540 Sum_probs=175.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.|+..+.||.|++|.+|.|.+..++..+++|.+.... .......+.++...++.++|+|++++++.+.+.+..++|+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46888999999999999999999889999999886443 2233567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|++++++|.+.+.. +++++.++..++.|++.++.+||+.+++|+||+|+||++++++.++++|||.+............
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 99999999988764 57899999999999999999999999999999999999999999999999998654433222223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..++..|+|||.+.+...+ .++|+||||+++|+|++|..||...++.
T Consensus 161 ~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPM 207 (277)
T ss_pred ccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChH
Confidence 3456789999998766554 8999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=235.78 Aligned_cols=204 Identities=31% Similarity=0.601 Sum_probs=174.8
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh------hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII------KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
+|.+.+.||.|++|.+|.|.+..++..+++|.+...... ..+..+.+.+|+.++++++|||++++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578899999999999999999888999999988654322 22334668889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.++++||+++++|.+.+...+.+++..+..++.|++.++.+||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999876544211
Q ss_pred c------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 162 S------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 162 ~------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
. ......+...|+|||.+....++ .++|+||||+++|+|++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 1 01112356789999999766654 88999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=235.28 Aligned_cols=207 Identities=26% Similarity=0.430 Sum_probs=173.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
-++|++.+.||+|+||.||.|.+..+ ...+++|...... .......+..|+..++.++|||++++.+.+...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 36799999999999999999988643 4578999875433 233345677899999999999999999999998999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++++|++++++|.+++... +.+++.+++.++.|++.++.+||+++++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999988664 468999999999999999999999999999999999999999999999999987654221
Q ss_pred ccc--ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 162 SLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~--~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... .....++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~ 216 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQD 216 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence 111 112234679999999876664 89999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=247.02 Aligned_cols=203 Identities=29% Similarity=0.484 Sum_probs=169.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++.+.||+|+||.||.|.+..++..+++|.+..... .....+.+.+|+..++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45789999999999999999999999999999999865432 222345577899999999999999999887532
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...+++++++ +++|.+.+. ...+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3578999988 558877664 4579999999999999999999999999999999999999999999999999987544
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... ....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 170 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 170 DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred CCc---CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 322 2345678999999997644445899999999999999999999987553
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=241.21 Aligned_cols=208 Identities=33% Similarity=0.449 Sum_probs=175.6
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--Ce
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TK 81 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~ 81 (218)
+.+++|++.+.||+|++|.||.|.+..+++.+++|.+...... ......+.+|+..+..++|||++++.+++... ..
T Consensus 2 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (293)
T cd07843 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80 (293)
T ss_pred cchhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCc
Confidence 4567899999999999999999999989999999998654322 22334566889999999999999999998776 88
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++++|++++ +|.+.+.... .+++.+++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 81 IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9999999985 8888876644 5899999999999999999999999999999999999999999999999988765543
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
........+++.|+|||.+.+....+.++|+||||+++++|++|..||...+.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~ 212 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 22222344567899999987655545899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=241.01 Aligned_cols=212 Identities=34% Similarity=0.647 Sum_probs=195.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|..++.||.|.||.|..++.+.+++.+|+|++....+.....+..-..|-+.|+..+||.+..+.=.|...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 57889999999999999999999999999999999988877777767777899999999999999998888888899999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||.+||.|.-.+.....+++........+|+.||.|||+++|+++|++.+|.++|.+|.+|+.|||++.-...-....
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 99999999998888888889999999999999999999999999999999999999999999999999987665555556
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
+..+|+|.|+|||++.+..+. .+.|.|++|++||||+||++||-+.+.+-+|
T Consensus 326 kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLF 377 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF 377 (516)
T ss_pred ccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHH
Confidence 778999999999999988887 9999999999999999999999999987665
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=233.89 Aligned_cols=203 Identities=31% Similarity=0.545 Sum_probs=179.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||.|++|.+|.|.+..+++.+++|.+..... ......+..++..+..++|+|++++.+.+...+..++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 479999999999999999999999999999998865442 144577889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|++++++|.+.+....++++..++.++.|++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999999999888889999999999999999999999 9999999999999999999999999998876554333322
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
...+...|+|||.+.....+ .++|+||||+++|+|++|..||...+
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYS-YAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ceeecccccCHhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccc
Confidence 34467789999998876554 89999999999999999999998775
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=233.11 Aligned_cols=205 Identities=32% Similarity=0.589 Sum_probs=174.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecch--hhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--CeE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA--IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~~ 82 (218)
.+|++.+.||+|++|.+|.+.+..+++.+++|.+.... ....+....+.+|+..++.++|+|++++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875322 12234456788999999999999999999998653 468
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~- 161 (218)
++++|++++++|.+.+...+.+++..++.++.|++.++.+||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 8999999999999999887789999999999999999999999999999999999999999999999999987543211
Q ss_pred --cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 162 --SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 162 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.......++..|+|||.+.+...+ .++|+||||++++++++|+.||...+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccC
Confidence 111123466789999999876654 89999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=238.10 Aligned_cols=204 Identities=32% Similarity=0.545 Sum_probs=175.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.+|.|.+..+++.+++|.+..... ..+..+.+.+|+..++.++|+|++++++.+...+..++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 579999999999999999999998999999998754332 2334567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-ccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 165 (218)
||++++.+.........+++.+++.++.|++.++.+||+.+++|+|++|+||++++++.++|+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9999877766666667799999999999999999999999999999999999999999999999999876554332 222
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
...+...|+|||.+......+.++|+||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3345678999999987634458999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=234.44 Aligned_cols=207 Identities=31% Similarity=0.574 Sum_probs=174.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh--hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CCeE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~~~ 82 (218)
.+|++.+.||+|++|.+|.+.+..++..+++|........ ..+....+.+|+..++.++|||++++++.+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3689999999999999999999989999999988644321 22345678889999999999999999998865 4678
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~- 161 (218)
++++|++++++|.+.+.....+++..++.++.|++.++.+||+++++|+|++|+||++++++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999999999999888889999999999999999999999999999999999999999999999999886543211
Q ss_pred --cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 162 --SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 162 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.......++..|+|||.+.+..++ .++|+||+|+++|++++|+.||...++.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~ 215 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAM 215 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchH
Confidence 111123356789999999776554 8999999999999999999999876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=233.40 Aligned_cols=206 Identities=28% Similarity=0.611 Sum_probs=176.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..+|+.+++|.+...... ....+.+.+++..++.++|+|++++.+.+...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 689999999999999999999999999999998654332 2334678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
++.+++|.+.+.... .+++.+++.++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+...........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 999999988886543 578999999999999999999999999999999999999999999999998875544322222
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
...+++.|+|||.+.+...+ .++|+||||+++++|++|..||...+..+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~ 208 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKN 208 (256)
T ss_pred hccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHH
Confidence 33466789999998766554 89999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=234.65 Aligned_cols=206 Identities=26% Similarity=0.435 Sum_probs=174.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
..+|++.+.||+|++|.||.|.+.+++..+++|.+.... .....+.+|+..++.++|+|++++++.+...+..+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 356999999999999999999999889999999875432 2245677899999999999999999999988999999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|++++++|.+.+... ..+++..++.++.|+++++.+||+++++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999988654 35889999999999999999999999999999999999999999999999998765443221
Q ss_pred cc-cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 164 LR-TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~-~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.. ....++.|+|||.+....++ .++|+||||+++|+|++ |..||...+.++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 214 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 214 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 11 11224579999998766664 89999999999999998 9999987766543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=233.69 Aligned_cols=199 Identities=31% Similarity=0.523 Sum_probs=166.9
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
+.||+|++|.||.|.+..+++.+++|.+.... ..+....+.+|+..++.++|||++++++++......++|+||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999899999999875432 3334567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc--ccccc
Q 027809 93 ELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL--RTTCG 169 (218)
Q Consensus 93 ~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~ 169 (218)
+|.+.+.... .+++.+++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+.......... .....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999886543 58999999999999999999999999999999999999999999999999986543321111 11112
Q ss_pred cCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 170 ~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
+..|+|||.+....+. .++|+||||+++|+|++ |..||...+..
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~ 203 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQ 203 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence 3469999998766654 89999999999999997 99999776543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=241.55 Aligned_cols=206 Identities=27% Similarity=0.445 Sum_probs=170.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCc----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..+|++.+.||+|+||.||.|.+..++. .+++|.+.... .....+.+.+|...++.++|||++++++.+... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 4579999999999999999998765555 38889875432 233456788899999999999999999998764 5
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.+++++++++++|.+.+... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 67999999999999988764 35889999999999999999999999999999999999999999999999999765432
Q ss_pred Cccc--ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 161 VSLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 161 ~~~~--~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.... .....+..|++||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 2211 112234579999999876665 89999999999999997 999998766544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=233.97 Aligned_cols=206 Identities=31% Similarity=0.538 Sum_probs=176.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||.|++|.+|.|....++..+++|.+....... ....+.+|+..++.++|+|++++++.+...+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 57999999999999999999998889999999886544222 4577889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 87 EFITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 87 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|++++++|.+.+... ..+++..++.++.|++.|+.+||+.|++|+|++|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999998764 45899999999999999999999999999999999999999999999999988654432221
Q ss_pred ----cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 ----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....++..|++||.+......+.++|+||||+++++|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 122245678999999876644458999999999999999999999876543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=256.40 Aligned_cols=207 Identities=30% Similarity=0.495 Sum_probs=173.8
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEE-E---cC---
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVL-A---SR--- 79 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~-~---~~--- 79 (218)
+.++.+.|.+|||+.||.|.+.+.|..+|+|.+-.. +++.++.+++|+.++++|+ |+|||.++|.. . ..
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 468999999999999999999988899999987543 5677899999999999997 99999999942 1 12
Q ss_pred CeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 80 TKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
-.++++||||.++.|.++++.+ ..|++.++++|+.|+++|+.+||..+ ++|+|||.+|+|++.+++.||||||.++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 2478999999999999999854 46999999999999999999999988 9999999999999999999999999997
Q ss_pred cCCCCCccc---------ccccccCccccccccc--cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 156 LPEQGVSLL---------RTTCGTPNYVAPEVLS--HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 156 ~~~~~~~~~---------~~~~~~~~~~~Pe~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
......... -....++.|.+||.+. .....+.|+|||+|||+||-|+....||+.-..-.|+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl 267 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL 267 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE
Confidence 544332111 1122578999999985 3344469999999999999999999999988655544
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=235.34 Aligned_cols=205 Identities=27% Similarity=0.519 Sum_probs=175.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh---hhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI---IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
+|+..+.||+|++|.+|.+.+..+++.+++|.+..... ...+..+.+..|+..++.++|+|++++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999999999999999864331 122345778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~ 163 (218)
|+|++++++|.+.+....++++..++.++.|++.|+.+||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 5999999998655432111
Q ss_pred ----cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 164 ----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 164 ----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....++..|+|||.+....++ .++|+||||++++++++|..||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~ 213 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKH 213 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 1122456789999998766554 899999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=243.86 Aligned_cols=200 Identities=29% Similarity=0.536 Sum_probs=179.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
-|.++++||+|++|.||+|..+++|..++||..+.+. +++.+.+|+.++++++.|++++|++.+.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 3778899999999999999999999999999876543 46778899999999999999999999988889999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 88 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||..|+..+.+.. ++++++.++..++.+-+++|+|||..+-+|+||++.|||+..+|..||.|||.+--..........
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT 188 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT 188 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence 9999999998854 568999999999999999999999999999999999999999999999999988644433233335
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
-.++|.|||||++..-.|+ .++||||||++..||..|++||.+.+|
T Consensus 189 VIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred cccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccc
Confidence 5689999999999988887 899999999999999999999998776
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=236.62 Aligned_cols=204 Identities=29% Similarity=0.571 Sum_probs=173.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC---CCCcceEEEEEEcCCeEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~---~~~i~~~~~~~~~~~~~~l 84 (218)
.|+..+.||+|++|.+|.|.+..+++.+++|.+.... .......+.+++..++.++ |||++++++.+......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999899999999885432 2233456777888888886 9999999999999899999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
++||+++++|.+.+.. ..+++..++.++.|++.++.+||+.|++|+||+|+||++++++.++++|||.+..........
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999988765 478999999999999999999999999999999999999999999999999887655433222
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....++..|+|||.+......+.++|+||||+++|+|++|..||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 33356778999999875444458999999999999999999999776543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=232.81 Aligned_cols=201 Identities=32% Similarity=0.563 Sum_probs=176.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.+|.+.+..++..+++|.+..... .+.+.+|+..++.++|+|++++.+.+......++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 689999999999999999999988889999998854431 567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|++++++|.+.+.. ...+++..++.++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||++...........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 99999999998865 45789999999999999999999999999999999999999999999999999876554332222
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+...|+|||.+.+...+ .++|+||||+++++|++|..||...++
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred cccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 33466789999998776654 899999999999999999999986554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=232.05 Aligned_cols=204 Identities=37% Similarity=0.664 Sum_probs=177.6
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..++..+++|.+...... .+..+.+..|+..++.++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999888999999998765433 3456788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc---
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL--- 164 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~--- 164 (218)
++++++|.+.+.....+++..++.++.|++.++.+||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999887778999999999999999999999999999999999999999999999999987654332211
Q ss_pred -ccccccCccccccccccCC--CCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 165 -RTTCGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 165 -~~~~~~~~~~~Pe~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
....+.+.|++||.+.... ..+.++|+||||++++++++|..||...+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 1234567899999997554 13489999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=236.97 Aligned_cols=207 Identities=23% Similarity=0.409 Sum_probs=171.2
Q ss_pred cccceEEeeeecCccceEEEEEEec----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNT----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.+.+|++.+.||+|+||.||.|.+. .++..+++|...... ..+....+.+|+..++.++|||++++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3578999999999999999999853 355789999886432 3344567888999999999999999999999989
Q ss_pred eEEEEEEecCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~ 143 (218)
..++++||+++++|.+++... ..+++.+++.++.|++.++.+||+++++|+||+|+||+++++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999888532 247889999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 144 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
+.++|+|||++........ ......++..|+|||.+....+. .++|+||||+++|+|++ |..||...++.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999875433211 11122234579999998766554 89999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=261.43 Aligned_cols=208 Identities=31% Similarity=0.577 Sum_probs=172.2
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CC
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RT 80 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~ 80 (218)
...+++|++++.||+|+||.||.|.+..++..+++|.+...... ......+..|+.++.+++||||++++++|.. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 34678999999999999999999999999999999998654432 3335678889999999999999999998753 45
Q ss_pred eEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCCeEecCC------
Q 027809 81 KIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSK-------GVYHRDLKPENLLLDSQ------ 143 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~-------~i~h~di~p~nil~~~~------ 143 (218)
.+|+||||+++++|.+.+.. ...+++..++.++.||+.||.|||+. +|+|+||+|+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 79999999999999988865 25799999999999999999999984 49999999999999642
Q ss_pred -----------CcEEEeeccccccCCCCCcccccccccCccccccccccC-CCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 144 -----------GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 144 -----------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..++|+|||++....... ......+++.|+|||.+... ...+.++|||||||++|+|++|..||...
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 348999999987543321 12234578899999998643 22348999999999999999999999764
Q ss_pred C
Q 027809 212 D 212 (218)
Q Consensus 212 ~ 212 (218)
+
T Consensus 247 ~ 247 (1021)
T PTZ00266 247 N 247 (1021)
T ss_pred C
Confidence 4
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=236.49 Aligned_cols=203 Identities=32% Similarity=0.530 Sum_probs=171.4
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|++.+.||+|++|.+|.+.+..++..+++|.+.... ....+.+.+|+..++.++|||++++++.+...+..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 688899999999999999999889999999875432 23356677889999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 89 ITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 89 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
+++++|...+.. ..++++..++.++.|++++|.+||+.|++|+||+|+||+++.++.++++|||++.............
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 999999887654 4578999999999999999999999999999999999999999999999999986544332222334
Q ss_pred cccCcccccccccc----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 168 CGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.+++.|+|||.+.. ....+.++|+||+|+++|+|++|..||...++.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 214 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence 46778999999842 122247899999999999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=232.44 Aligned_cols=205 Identities=29% Similarity=0.564 Sum_probs=177.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh--hhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+|+..+.||+|++|.+|.|.+..++..+++|.+..... ...+..+.+.+++..++.++|+|++++.+++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57889999999999999999988899999998864331 2234456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+||+++++|.+.+.....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK 159 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence 9999999999999888789999999999999999999999999999999999999999999999999887544332 122
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|++||.+......+.++|+||||++++++++|..||...+.
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 344677899999987655234899999999999999999999977653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=233.33 Aligned_cols=196 Identities=37% Similarity=0.702 Sum_probs=173.4
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||.|++|.+|.+.+..++..+++|.+........+..+.+.+|...++.++|||++++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999766554445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccc
Q 027809 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174 (218)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 174 (218)
.+.+.....+++..+..++.|++++|.+||+++++|+||+|+||+++.++.++|+|||++....... ......+.+.|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence 9999888889999999999999999999999999999999999999999999999999987654432 112234677899
Q ss_pred cccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 175 ~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+||.+....++ .++|+||+|+++|+|++|..||...+
T Consensus 160 ~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 160 APEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 99998766654 89999999999999999999998776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=233.76 Aligned_cols=201 Identities=31% Similarity=0.478 Sum_probs=173.2
Q ss_pred eeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 13 RTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
+.||+|++|.||.|.+... +..+++|.+....... ..+.+.+++..+..++|+|++++++++......++++|++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999866 8899999986654322 4577889999999999999999999999989999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 90 TGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 90 ~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
++++|.+.+... ..+++.+++.++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998765543
Q ss_pred C--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 161 V--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 161 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
. .......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 216 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 2 112233456789999998766554 89999999999999999 6999998766543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=250.96 Aligned_cols=199 Identities=29% Similarity=0.463 Sum_probs=162.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC------CCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR------HPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~------~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|+||.||.|.+..+++.||||++..... .......|+..++.++ +.+++++.+++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4689999999999999999999999999999999864321 1222334444444443 45688899988754
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCC-------------
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQG------------- 144 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~------------- 144 (218)
...++|++++ +++|.+.+...+.+++.++..++.|++.||.|||. .|++|+||||+||+++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5788999988 55888888888889999999999999999999997 6999999999999998665
Q ss_pred ---cEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 145 ---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 145 ---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.+||+|||.+...... .....+++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+.
T Consensus 283 ~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred CCceEEECCCCccccCccc---cccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 4999999987643322 1234578899999999887776 899999999999999999999987664
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=249.84 Aligned_cols=205 Identities=29% Similarity=0.481 Sum_probs=177.2
Q ss_pred eEEeeeecCccceEEEEEEecCCCc---E-EEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGE---S-VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~---~-~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
-.+.++||+|.||.||.|.....+. . ||+|....+.....+....+.+|++++++++||||++++|+.....-+++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3556899999999999999775422 3 89998876554566677889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|||.|++|+|.+++...+ .++..+.++++.+.|.+|+|||.++++|+||-++|+|++.++.+|++|||++..... ...
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-~~~ 317 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-YVM 317 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc-eee
Confidence 999999999999998877 499999999999999999999999999999999999999999999999999876542 222
Q ss_pred cc-cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 LR-TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 ~~-~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.. ....+.+|+|||.+....++ .++||||+|+++||+++ |..||......+
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~ 370 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYE 370 (474)
T ss_pred ccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence 22 22356799999999988665 99999999999999998 899999887654
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=237.57 Aligned_cols=205 Identities=27% Similarity=0.421 Sum_probs=168.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCc--EEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
++|++.+.||+|++|.||.|.++.++. .+++|.+.... .....+.+.+|+..+.++ +|||++++++.+...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999877664 46777664322 233456678899999888 7999999999999888999
Q ss_pred EEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEE
Q 027809 84 IILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~ 147 (218)
+++|++++++|.+.+.... .+++.+++.++.|++.|+.+||++|++|+||+|+||+++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999986532 478899999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 148 ISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 148 l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
|+|||++........ ......+..|+|||......+. .++|+||||+++|+|++ |..||...+..+
T Consensus 160 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 160 IADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred ECCcCCCccccceec-cCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999998764322111 1111224579999998766655 89999999999999997 999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=235.51 Aligned_cols=208 Identities=24% Similarity=0.344 Sum_probs=169.3
Q ss_pred cccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|++|.||.|.+.+ ++..+++|.+.... .......+.+|+..++.++|+|++++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34679999999999999999988642 34679999875432 122345577889999999999999999999988
Q ss_pred CeEEEEEEecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEe
Q 027809 80 TKIYIILEFITGGELFDKIVHHG----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKIS 149 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~ 149 (218)
...++|+||+++++|.+++.... .+++..++.++.|++.+|.+||+.+++|+||+|+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 89999999999999999886532 35678899999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCccc--ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 150 DFGLSALPEQGVSLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 150 d~~~~~~~~~~~~~~--~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
|||++.......... ....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~ 229 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999886443321111 112235679999999866654 89999999999999999 799998766543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=232.86 Aligned_cols=204 Identities=28% Similarity=0.560 Sum_probs=173.6
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh---hhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI---IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
+|++++.||.|+||.||.|.+. ++..+++|.+..... ...+....+.+|+..++.++|+|++++.+++...+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999864 778899998864432 123334668889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC----
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG---- 160 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~---- 160 (218)
++|++++++|.+.+....++++..++.++.|++.++.+||+.+++|+||+|+||++++++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999988643211
Q ss_pred --CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 --VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 --~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
........++..|+|||.+....+. .++|+||||+++++|++|..||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~ 213 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDR 213 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCCh
Confidence 1111223466789999999876665 899999999999999999999986553
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=235.25 Aligned_cols=203 Identities=33% Similarity=0.574 Sum_probs=174.2
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.|.+..+|..+++|.+..... .......+.+|+..++.++|||++++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 68999999999999999999998999999999865432 23334678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-ccc
Q 027809 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~ 165 (218)
++ +++|.+.+.. ..++++.+++.++.|++.+|.+||+.+++|+||+|+||++++++.++++|||.+........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 8899988754 35689999999999999999999999999999999999999999999999998875543321 122
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
...++..|+|||.+......+.++|+||+|+++++|++|..||...+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 34567789999998765544589999999999999999999887654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=235.58 Aligned_cols=209 Identities=24% Similarity=0.351 Sum_probs=172.6
Q ss_pred cccceEEeeeecCccceEEEEEEecCC-----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|++|.||.+.+... +..+++|...... .......+.+++..+..++|+|++++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 346899999999999999999987643 3789999875433 223345677889999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEe
Q 027809 80 TKIYIILEFITGGELFDKIVHH----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKIS 149 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~ 149 (218)
...++++|++++++|.+.+... ..+++..++.++.|++.+|.+||+++++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999988643 236788999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 150 DFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 150 d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
|||++........ ......++..|+|||.+....++ .++|+||||+++|++++ |..||...+..++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 230 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHH
Confidence 9998865433211 11122345689999998766654 89999999999999998 9999987765543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=235.95 Aligned_cols=206 Identities=31% Similarity=0.504 Sum_probs=170.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.+.||+|++|.+|++.+..+|+.+++|.+..... .....+.+.+|+..++.++|+|++++++++...+..++|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4789999999999999999999998999999998754332 222345677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~~~~ 162 (218)
+||+++ +|.+.+..... +++..++.++.|++.||.+||+++++|+||+|+||+++. ++.++++|||++........
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999975 77777655433 578889999999999999999999999999999999985 56799999999875443322
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~ 209 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 222334567899999987654445899999999999999999999986543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=235.24 Aligned_cols=204 Identities=34% Similarity=0.573 Sum_probs=171.7
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||.|++|.+|.|.+..+|..+++|.+..... ......+.+|+..+++++|+|++++++.+...+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999998865432 2223556678999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 88 FITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 88 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
++++ +|.+.+... ..+++.++..++.|++.++.+||+.|++|+||+|+||++++++.++|+|||.+..........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9986 787777654 358999999999999999999999999999999999999999999999999886543322222
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....++..|++||.+......+.++|+||||++++++++|..||...+..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 23345678999999865544458999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=236.06 Aligned_cols=206 Identities=26% Similarity=0.440 Sum_probs=174.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.-.+|++.+.||.|++|.||.|.+.. +..+++|.+.... ......+..++..++.++|+|++++++++......++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34579999999999999999999887 8889999886543 2234567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++||+++++|.+++... ..+++.+++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999998753 4689999999999999999999999999999999999999999999999999875443222
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......++..|++||......+. .++|+||||+++|+|++ |..||...+..+
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred cccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 22222345679999998766554 89999999999999998 899998776544
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=234.16 Aligned_cols=197 Identities=34% Similarity=0.549 Sum_probs=169.0
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||+|+||.||.+.+..+|+.+++|.+.............+..|..+++.++|||++++.+.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998765443333445567889999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCc
Q 027809 95 FDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (218)
Q Consensus 95 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 172 (218)
.+.+.... .+++.+++.++.|++.++.+||++|++|+||+|+||++++++.++|+|||.+....... ......+...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-ccccccCCCC
Confidence 99887765 68999999999999999999999999999999999999999999999999886543321 1123345678
Q ss_pred cccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 173 YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 173 ~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
|++||.+.+..+. .++|+||||+++++|++|..||...+.
T Consensus 160 y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 160 YMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 9999998766654 899999999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=233.76 Aligned_cols=209 Identities=29% Similarity=0.465 Sum_probs=174.0
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCc----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS 78 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~ 78 (218)
+-..++|++.+.||+|+||.+|.|.+..+|. .+++|...... .......+.+|+..+..++|+|++++++++..
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4456789999999999999999999876554 58888775543 23445678889999999999999999999887
Q ss_pred CCeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 79 RTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
...++++|++++++|.+.+... ..+++..++.++.|++.|+.+||+++++|+||+|+||++++++.++|+|||.+...
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7889999999999999988764 46899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccc--cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 158 EQGVSLLR--TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 158 ~~~~~~~~--~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
........ ....+..|++||.+....+. .++|+||||++++++++ |..||...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 219 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence 43322111 11124579999998765554 89999999999999998 999998876654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=233.60 Aligned_cols=207 Identities=30% Similarity=0.520 Sum_probs=173.8
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC--
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR-- 79 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~-- 79 (218)
+...++|++.+.||+|++|.+|.|.+..++..+++|.+..... ..+.+.+|+..++.+ +|+|++++++.+...
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 5667999999999999999999999988899999998865432 235678899999988 699999999998653
Q ss_pred ----CeEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeec
Q 027809 80 ----TKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 80 ----~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
...++++|++++++|.+.+.. ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 358999999999999888765 357899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccccccccCC----CCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG----YNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
|.+..............+++.|+|||.+.... ..+.++|+||||+++++|++|..||...++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 223 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch
Confidence 98875544333333445677899999875321 224789999999999999999999986543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=233.75 Aligned_cols=197 Identities=34% Similarity=0.536 Sum_probs=161.9
Q ss_pred eecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHH---HhhhhcCCCCcceEEEEEEcCCeEEEEEEecC
Q 027809 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI---SIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~---~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
.||+|+||.||.+.+..++..+++|.+...............++. ..+...+|++++.+.+.+...+..++|+||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999989999999988665433222222223333 23334478999999999998889999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccccc
Q 027809 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (218)
Q Consensus 91 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 170 (218)
+++|.+.+...+.+++..+..++.|++.|+.+||+.+++|+||+|+||++++++.++|+|||++....... .....++
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT 158 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCCC
Confidence 99999999888889999999999999999999999999999999999999999999999999886443321 1234577
Q ss_pred CccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 171 ~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+.|+|||.+......+.++|+||+|+++|+|++|..||...+
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 899999998643333489999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=236.53 Aligned_cols=202 Identities=30% Similarity=0.485 Sum_probs=162.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhh---hhcCCCCcceEEEEEEc-----C
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM---KLVRHPCVVRLHEVLAS-----R 79 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l---~~l~~~~i~~~~~~~~~-----~ 79 (218)
+|++.+.||+|++|.||.|.+..+++.+++|.+...... ........+|...+ ..++||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 689999999999999999999999999999988643211 11112233444444 45579999999998753 3
Q ss_pred CeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 80 TKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
...++++|++++ +|...+... ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999985 787777653 34899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..... .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 159 SCQMA-LTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred cCccc-CCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 43211 1223457789999999866654 899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=236.97 Aligned_cols=207 Identities=26% Similarity=0.399 Sum_probs=173.0
Q ss_pred ccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|.+.+.||+|++|.||.|.... ++..+++|.+.... ..+..+.+.+|+.+++.++|+|++++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998643 35789999886543 2334567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcE
Q 027809 81 KIYIILEFITGGELFDKIVHHG--------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL 146 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~ 146 (218)
..++++|++++++|.+++...+ .+++.+++.++.|++.++.+||++|++|+||+|+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999986542 47889999999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 147 KISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 147 ~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+|+|||++........ .......++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~ 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999998864322111 11122345689999999877665 89999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=244.74 Aligned_cols=205 Identities=27% Similarity=0.420 Sum_probs=167.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCC-----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~ 79 (218)
.++|+++++||+|+||.||.|.+... +..|++|.+.... .....+.+.+|+.++..+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 35678999999999999999986432 3469999885433 2233466888999999996 99999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhc----------------------------------------------------------
Q 027809 80 TKIYIILEFITGGELFDKIVHH---------------------------------------------------------- 101 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 101 (218)
+..++|+||+++++|.+++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999998877532
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC
Q 027809 102 --------------------------------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (218)
Q Consensus 102 --------------------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~ 143 (218)
..+++.+++.++.|++.||.+||+.+++|+||+|+||+++++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 236788899999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 144 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
+.++|+|||++........ ......+++.|+|||.+.+..+. .++|+||||+++|+|++ |..||.....
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999865432211 11122345689999999776665 89999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=231.07 Aligned_cols=204 Identities=26% Similarity=0.483 Sum_probs=170.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.+.++ ++..+++|.+...... ...+.+|+..++.++|||++++++++...+..+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 367999999999999999999875 4567999987543321 34677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+||+++++|.+.+... ..+++..++.++.|++.+|.+||+++++|+||+|+||++++++.++++|||.+..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999888653 468999999999999999999999999999999999999999999999999886543322111
Q ss_pred -ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 165 -RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 165 -~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....+..|+|||.+....+. .++|+||||+++|+|++ |+.||...+..+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 112234579999999866665 89999999999999999 999998776544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=238.87 Aligned_cols=204 Identities=31% Similarity=0.545 Sum_probs=174.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.|+..+.||+|++|.||.|.+..++..+++|.+.... .....+.+.+|+..++.++|||++++++.+...+..++|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 45778889999999999999998889999999875433 2233567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||+++++|.+.+.. ..+++..++.++.|++.++.+||+++++|+||+|+||++++++.++++|||++............
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 99999999887754 57899999999999999999999999999999999999999999999999988654432222222
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..++..|+|||.+.+..++ .++|+||||+++++|++|..||...++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~ 207 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPM 207 (277)
T ss_pred ccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchh
Confidence 3456789999999876665 8999999999999999999999866543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=235.55 Aligned_cols=207 Identities=27% Similarity=0.410 Sum_probs=171.7
Q ss_pred cccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..++|.+.+.||+|++|.+|.+.+.. ++..+++|.+.... ....+.+.+|+..++.++|+|++++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45679999999999999999997542 44568888775433 22235678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~ 143 (218)
+..++|+||+++++|.+++..+. .+++..++.++.|++.++.+||+++++|+||+|+||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999986543 37899999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 144 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+.++|+|||++........ ......++..|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999875433211 11122345689999999876665 89999999999999998 999997766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=237.41 Aligned_cols=207 Identities=27% Similarity=0.455 Sum_probs=170.1
Q ss_pred ccceEEeeeecCccceEEEEEEecC-------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~ 77 (218)
.++|.+++.||+|+||.||.+.+.. +...+++|.+.... .......+..|+..++.+ +|+|++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 3689999999999999999998643 22468999886432 233345677889999988 7999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
..+..++|+|++++++|.+++.... .+++.+++.++.|++.+|.+||++|++|+||+|+||+++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999987542 478899999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCccc--ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 142 SQGHLKISDFGLSALPEQGVSLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.++.++|+|||.+.......... .....++.|+|||.+.+..+. .++|+||||+++|+|++ |..||...+.++
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 99999999999986543321111 111233579999999876664 89999999999999998 999998776554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=234.48 Aligned_cols=205 Identities=26% Similarity=0.421 Sum_probs=170.6
Q ss_pred cceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
.+|.+.+.||+|++|.||.+... .++..+++|.+.... ......+.+|+..++.++|+|++++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 46999999999999999999752 345668888775432 2335668889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEE
Q 027809 82 IYIILEFITGGELFDKIVHHG-------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKI 148 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l 148 (218)
.++++||+++++|.+++...+ .+++.+++.++.|++.||.+||++|++|+||+|+||++++++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999886543 3899999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 149 SDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 149 ~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+|||++......... .....+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~ 230 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999998754332111 1112235679999999876665 89999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=244.63 Aligned_cols=198 Identities=23% Similarity=0.405 Sum_probs=168.7
Q ss_pred ccceEEeeeecCccceEEEEEEec--CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+|++++.||.|++|.||.+... ..+..+++|.+... ....+|+.+++.++||||+++++.+......+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 357999999999999999998754 34578899976432 22457889999999999999999999989999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+++|++.+ +|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 163 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 163 MVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred EEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 99999964 88888877788999999999999999999999999999999999999999999999999998754432221
Q ss_pred --cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 164 --LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 164 --~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....+++.|+|||.+....+. .++|+||||+++|+|++|..||.....
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 1234578899999999877665 899999999999999999999977654
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=232.51 Aligned_cols=207 Identities=27% Similarity=0.456 Sum_probs=172.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC---cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++.+.||+|+||.||.|.+..++ ..+++|.+.... .....+.+..|...++.++|||++++.+++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 468999999999999999999876444 368888875432 223346788899999999999999999999988999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++++|++++++|.+.+... ..+++.+++.++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999988764 468999999999999999999999999999999999999999999999999987654432
Q ss_pred ccccc---ccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 162 SLLRT---TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~~~---~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
..... ...+..|++||.+....++ .++|+||||+++|++++ |..||...+..+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~ 217 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQD 217 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHH
Confidence 21111 1123579999999876665 89999999999999886 999998776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=232.87 Aligned_cols=208 Identities=27% Similarity=0.448 Sum_probs=171.4
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCc----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS 78 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~ 78 (218)
+-...+|++.+.||+|++|.||.|.+..++. .|++|...... .....+.+.++...+..++|+|++++++++..
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 3456789999999999999999999876665 47889875433 23334667888899999999999999999865
Q ss_pred CCeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 79 RTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
...+++++++++++|.+.+... ..+++.+++.++.|++.||.+||+++++|+||+|+||++++++.++|+|||++...
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4578999999999999988764 46899999999999999999999999999999999999999999999999998755
Q ss_pred CCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 158 EQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 158 ~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
...... ......++.|++||......++ .++|+||||+++|+|++ |..||+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 432221 1112235679999999776665 89999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=231.40 Aligned_cols=199 Identities=35% Similarity=0.645 Sum_probs=166.7
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHH-HhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI-SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
+.||+|++|.||.|.+..+++.+++|.+.............+..+. ......+|+|++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999989999999998654433222233333333 344556899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccC
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 171 (218)
++|.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...... ....+.+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----KKFVGTP 157 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc----ccCCCCc
Confidence 999999988888999999999999999999999999999999999999999999999999987654331 1234567
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.|++||.+.+..+ +.++|+||||+++|+|++|..||...+..++
T Consensus 158 ~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 201 (260)
T cd05611 158 DYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201 (260)
T ss_pred CccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 8999999986664 4899999999999999999999987766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=249.24 Aligned_cols=194 Identities=26% Similarity=0.481 Sum_probs=170.3
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
..++-||+|+.|.||.|... ++.||||+... .-..++..|++++|+||+.+.++|.....++||||||
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 44667999999999999875 67999996532 1236688899999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccc
Q 027809 90 TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169 (218)
Q Consensus 90 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 169 (218)
..|.|...+..+.+++...+..|..+||.++.|||.++|+|+|+|.-||||+-+..+||+|||.+.-.... ...-..+|
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaG 273 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAG 273 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999987643332 22223568
Q ss_pred cCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 170 ~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
+..|||||++++... +.|.||||+|+++|||+||+.||.+-+...|+
T Consensus 274 TVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAII 320 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII 320 (904)
T ss_pred hHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeE
Confidence 899999999997655 49999999999999999999999998887764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=230.69 Aligned_cols=204 Identities=25% Similarity=0.405 Sum_probs=171.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.+.+. +++.+++|.+..... ..+.+.+|+..++.++|+|++++++++...+..+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 367999999999999999999875 456799998854332 235577899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|++++++|.+.+.... .+++.+++.++.|++.++.+||++|++|+||+|+||++++++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999987644 6899999999999999999999999999999999999999999999999998755432111
Q ss_pred -cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......+..|+|||...+..++ .++|+||||+++++|++ |+.||...+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 212 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212 (261)
T ss_pred ccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 1111123579999998766654 89999999999999999 999998766543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=236.13 Aligned_cols=206 Identities=35% Similarity=0.673 Sum_probs=179.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 85 (218)
++|++.+.||+|++|.+|.+.+..++..+++|++........+..+.+..+...+..++ |+|++++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999987655444444567788889999998 99999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc---
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--- 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~--- 162 (218)
||++++++|.+.+.....+++..++.++.|++.++.+||++|++|+|++|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999875443221
Q ss_pred -----------------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 -----------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 -----------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......++..|++||......+. .++|+||||++++++++|..||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG-KSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 11122346789999998765554 899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=237.80 Aligned_cols=208 Identities=32% Similarity=0.451 Sum_probs=172.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--CeE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKI 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~~ 82 (218)
..++|++.+.||+|++|.||.|.+..+|+.+++|.+....... .......+|+..+++++|+|++++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 4678999999999999999999999999999999986443211 2223455789999999999999999998654 568
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++|+|++.+ +|.+.+.. ...+++.+++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999976 77777765 3578999999999999999999999999999999999999999999999999987654432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.........+.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 22222334667999999876544458999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=234.87 Aligned_cols=203 Identities=33% Similarity=0.545 Sum_probs=171.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||.|++|.+|+|.+..++..+++|.+..... .......+.+|+..++.++|||++++++++.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58999999999999999999998999999998864432 22233567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+.+ +|...+.. ...+++..++.++.|++.|+.+||+.+++|+||+|+||++++++.++|+|||++...........
T Consensus 80 ~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred cccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 9964 78777754 35689999999999999999999999999999999999999999999999998865443322222
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
...+.+.|+|||.+.+....+.++|+||||+++|+|++|..||...+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 33356789999988765544588999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=231.68 Aligned_cols=206 Identities=33% Similarity=0.556 Sum_probs=174.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh-------hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-------KHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
+|.+.+.||+|++|.||.|.+..+|..+++|.+...... .....+.+.+|+..++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688999999999999999999888999999987543211 1112456788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++|+||+++++|.+.+...+.+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754432
Q ss_pred Ccc--cccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 VSL--LRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~~~--~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... .....++..|++||.+.... ..+.++|+||||++++++++|..||...+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 217 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence 111 11233567899999987554 234899999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=228.05 Aligned_cols=204 Identities=33% Similarity=0.591 Sum_probs=180.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..++..+++|.+...... ....+.+.+++..+..++|+|++++.+++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999988999999999765432 2445778899999999999999999999999899999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
++++++|.+.+.....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987665543322334
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.++..|++||....... +.++|+||+|+++++|++|..||...+.
T Consensus 160 ~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~ 204 (254)
T cd06627 160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNP 204 (254)
T ss_pred ccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence 56778999999876664 4899999999999999999999976543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=236.52 Aligned_cols=204 Identities=25% Similarity=0.452 Sum_probs=172.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|++|.+|.+.+..++..+++|.+.... +......+.++...+++++|+|++++++.+...+..++|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999899999999886432 2333466788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 87 EFITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 87 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
||+++++|..++... ..+++..+..++.|++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999998887663 378999999999999999999996 599999999999999999999999999886543321
Q ss_pred ccccccccCccccccccccCCC-----CCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGY-----NGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+.+.|+|||.+..... .+.++|+||||+++|+|++|..||...+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 122345678999999864332 247899999999999999999999765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=231.92 Aligned_cols=204 Identities=26% Similarity=0.483 Sum_probs=171.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.++||+|++|.||.|.+. ++..+++|.+..... ..+.+.+|..+++.++|+|++++++.+...+..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3568999999999999999999865 566799998754322 24677889999999999999999999998899999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|++++++|.+.+... ..+++.+++.++.|++.++++||+++++|+||+|+||++++++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999988653 4688999999999999999999999999999999999999999999999999875543221
Q ss_pred c-cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 163 L-LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 163 ~-~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
. .....++..|+|||.+....++ .++|+||||+++|+|++ |..||...+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred eccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 1 1112235579999998766554 89999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=235.87 Aligned_cols=206 Identities=28% Similarity=0.415 Sum_probs=169.0
Q ss_pred ceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+..+..++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57899999999999999998753 22468888775433 223346788899999999999999999999998999
Q ss_pred EEEEEecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 027809 83 YIILEFITGGELFDKIVHH------------------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENL 138 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~ni 138 (218)
++++||+.+++|.+++... ..+++.+++.++.|++.+|.+||+++++|+||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999887542 2478899999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 139 LLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 139 l~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
++++++.++|+|||++........ .......+..|+|||.+.+..++ .++|+||||+++++|++ |..||...++..
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999864332211 11122345689999998766654 89999999999999998 999998876654
Q ss_pred c
Q 027809 216 L 216 (218)
Q Consensus 216 ~ 216 (218)
+
T Consensus 238 ~ 238 (290)
T cd05045 238 L 238 (290)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=230.64 Aligned_cols=205 Identities=34% Similarity=0.622 Sum_probs=175.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE--cCCeEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SRTKIYII 85 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~--~~~~~~lv 85 (218)
+|++.+.||.|++|.+|++.+..++..+++|.+..... .....+++.+++..++.++|+|++++++.+. .....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999998865433 2333567888999999999999999999775 44578999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCCeEecCCCcEEEeecccccc
Q 027809 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCH-----SKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh-----~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~ 156 (218)
+||+++++|.+.+.. ..++++.+++.++.|++.++.+|| +.+++|+||+|+||++++++.++++|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999988865 357899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
............+.+.|++||.+.....+ .++|+||||+++++|++|..||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~ 216 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQL 216 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHH
Confidence 55443323334567889999999876654 8999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=231.67 Aligned_cols=206 Identities=27% Similarity=0.453 Sum_probs=171.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCc---EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.+.|++.+.||+|++|.+|.|....+++ .+++|...... .......+..|+..++.++|||++++.+.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999876654 59999875432 333456788999999999999999999999988899
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++++|++++++|.+++... +.+++.+++.++.|++.++.+||++|++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999888653 568999999999999999999999999999999999999999999999999886543322
Q ss_pred ccc--cccc---ccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 162 SLL--RTTC---GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 162 ~~~--~~~~---~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
... .... .+..|++||.+....++ .++|+||||+++|++++ |..||...+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 111 1111 13479999999876665 89999999999999886 99999876543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=230.88 Aligned_cols=203 Identities=27% Similarity=0.483 Sum_probs=169.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.+|.+.+.. +..+++|.+...... .+.+.+|+..++.++|||++++++++......+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998753 456999987543321 24578899999999999999999999988889999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~- 163 (218)
+|++.+++|.+.+... ..+++.+++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999988764 46899999999999999999999999999999999999999999999999987644332211
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
.....++..|++||......+. .++|+||||+++|+|++ |..||...+..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 1112234579999999766655 89999999999999998 99999876654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=232.67 Aligned_cols=200 Identities=36% Similarity=0.678 Sum_probs=173.5
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||.|++|.+|.+.+..+|+.+++|.+...........+.+.++...++.++|+|++++++.+......++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68899999999999988999999998765544445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--------cccc
Q 027809 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--------LLRT 166 (218)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~--------~~~~ 166 (218)
.+.+.....+++..++.++.|++++|.+||+++++|+||+|+||++++++.++|+|||++........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998877899999999999999999999999999999999999999999999999998875443211 1122
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
..++..|++||....... +.++|+||||++++++++|..||...++.+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 208 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEE 208 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 345678999999976665 489999999999999999999998776554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=233.09 Aligned_cols=205 Identities=21% Similarity=0.389 Sum_probs=167.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCc----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
.++|++.+.||.|++|.||.|.+..++. .+++|...... .......+..++..+..++|||++++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 4689999999999999999999876665 46777764322 22334567777888899999999999998754 45
Q ss_pred EEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++++|++++++|.+.+.. ...+++..++.++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7889999999999999875 456899999999999999999999999999999999999999999999999998754332
Q ss_pred Cc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 161 VS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 161 ~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
.. ......++..|++||.+....++ .++|+||||+++|++++ |..||...++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 11 11122345689999999766665 89999999999999998 99999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=238.39 Aligned_cols=202 Identities=23% Similarity=0.420 Sum_probs=166.3
Q ss_pred EeeeecCc--cceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 11 VGRTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 11 ~~~~l~~g--~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
++++||+| ++++||.+.++.+|+.+++|.+..... .....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 788999999999999999999865432 233456678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc----
Q 027809 89 ITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---- 162 (218)
Q Consensus 89 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~---- 162 (218)
+++++|.+++..+ ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++++||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999988653 4589999999999999999999999999999999999999999999999976433221110
Q ss_pred ---ccccccccCccccccccccC-CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 ---LLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 ---~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......+...|+|||.+... ...+.++|+||||+++++|++|..||.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 215 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 01112345579999999753 2234899999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=230.12 Aligned_cols=199 Identities=30% Similarity=0.481 Sum_probs=166.2
Q ss_pred eeecCccceEEEEEEecCCC---cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 13 RTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
+.||+|++|.||+|.+...+ ..+++|.+...... ...+.+..|+..++.++|+|++++++++.. +..++++|++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47899999999999876544 78999988655432 334678889999999999999999998764 4689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc--
Q 027809 90 TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-- 167 (218)
Q Consensus 90 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~-- 167 (218)
++++|.+++.....+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.............
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999888889999999999999999999999999999999999999999999999999987554432221111
Q ss_pred -cccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 168 -CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 168 -~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.++..|+|||.+....++ .++|+||||+++|++++ |..||...+..+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~ 206 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 123579999999766665 89999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=232.22 Aligned_cols=202 Identities=31% Similarity=0.562 Sum_probs=172.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
-|++.+.||+|++|.||.+.+..++..+++|....... ......+.+++..+..++|||++++++.+..++..++|+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47889999999999999999988899999998754332 2334678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
|+++++|.+.+.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||++.............
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 9999999887754 478999999999999999999999999999999999999999999999999876543322222223
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.+...|+|||.+.....+ .++|+||||+++++|++|..||...++
T Consensus 162 ~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~ 206 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHP 206 (277)
T ss_pred cCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccch
Confidence 456789999999766554 899999999999999999999986654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=233.88 Aligned_cols=211 Identities=37% Similarity=0.734 Sum_probs=186.8
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..-++|++.+.||.|.|+.|+.+....+|..+++|+++....... ..+.+.+|+++.+.++||||+++.+...+.+..|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345679999999999999999999999999999999977766554 5688999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---CCCcEEEeeccccccCCCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~---~~~~~~l~d~~~~~~~~~~ 160 (218)
+|+|.+.|+.|-.-+..+-..++..+-..+.||++||.|+|.+||+|+|++|.|+++- ...-+||+|||++.-.. .
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~ 165 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-D 165 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-C
Confidence 9999999999977777666788999999999999999999999999999999999994 34469999999997555 3
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
........|+|.|+|||.++...+. ...|||+-|+++|-++.|.+||-+-+...+|
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rly 221 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLY 221 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHH
Confidence 3455677899999999999987776 8999999999999999999999987766555
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=236.49 Aligned_cols=206 Identities=30% Similarity=0.479 Sum_probs=171.0
Q ss_pred ceEEeeeecCccceEEEEEEecC--CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--CeEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKIY 83 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~~~ 83 (218)
+|++.+.||+|++|.||.|.+.. ++..+++|.+...........+.+.+|+..+..++|||++++.+++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 7899999998764322333346677889999999999999999999877 7899
Q ss_pred EEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC----CCcEEEeecccc
Q 027809 84 IILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS----QGHLKISDFGLS 154 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~----~~~~~l~d~~~~ 154 (218)
+|+|++++ +|.+.+... ..+++..++.++.|++.++.+||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 666655432 26889999999999999999999999999999999999998 899999999998
Q ss_pred ccCCCCCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 155 ALPEQGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 155 ~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
......... .....+++.|+|||.+.+....+.++|+||||+++++|++|+.||...+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 765433221 112245678999998876544458999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=234.84 Aligned_cols=207 Identities=25% Similarity=0.368 Sum_probs=172.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC----------------cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG----------------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~----------------~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i 69 (218)
.++|++++.||+|+||.||.+.+...+ ..+++|.+.... .....+.+.+|+.++..++|+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999998876533 457889876443 22345678899999999999999
Q ss_pred ceEEEEEEcCCeEEEEEEecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 027809 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHG-----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENL 138 (218)
Q Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~ni 138 (218)
+++++++...+..++++|++.+++|.+++.... .+++..++.++.|++.||.+||+++++|+||+|+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999998899999999999999999987765 689999999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh--cCCCCCCCCcc
Q 027809 139 LLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLPFDELDLT 214 (218)
Q Consensus 139 l~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 214 (218)
+++.++.++|+|||.+........ ......+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999998865433211 11122345689999998765554 89999999999999987 78899876554
Q ss_pred c
Q 027809 215 T 215 (218)
Q Consensus 215 ~ 215 (218)
+
T Consensus 241 ~ 241 (296)
T cd05051 241 Q 241 (296)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=228.27 Aligned_cols=206 Identities=34% Similarity=0.644 Sum_probs=179.6
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..++..+++|.+..... ..+....+.+|++.++.++|+|++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 68999999999999999999998999999999866543 23345668889999999999999999999998899999999
Q ss_pred ecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 88 FITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 88 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
++++++|.+.+... ..+++.+++.++.++++++.+||++|++|+|++|+||++++++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999988764 67899999999999999999999999999999999999999999999999998765554333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.....+++.|+|||........ .++|+||+|+++++|++|..||...+..+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 210 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLE 210 (258)
T ss_pred ecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHH
Confidence 3344567789999998766654 89999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=232.58 Aligned_cols=204 Identities=27% Similarity=0.494 Sum_probs=169.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc------
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS------ 78 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~------ 78 (218)
-++|++.+.||+|++|.||.|.+..+++.+++|.+.... .....+.+++..+..+ +|+|++++.+.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 467999999999999999999999999999999986543 1234567888888888 69999999999864
Q ss_pred CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccccc
Q 027809 79 RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~ 156 (218)
....++++||+++++|.+.+... ..+++..+..++.|++.++.+||+++++|+|++|+||++++++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 24689999999999999988763 3689999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccccCccccccccccC----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
............+++.|+|||.+... ...+.++|+||+|+++|+|++|..||...++
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~ 221 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 43322222234567789999998632 1224789999999999999999999976543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=232.04 Aligned_cols=202 Identities=32% Similarity=0.480 Sum_probs=166.1
Q ss_pred cce-EEeeeecCccceEEEEEE----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--C
Q 027809 7 GKY-EVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--R 79 (218)
Q Consensus 7 ~~y-~~~~~l~~g~~g~vy~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~ 79 (218)
+|| ++.+.||+|+||.||.+. ...++..+++|.+.... .......+.+|+..++.++|||++++.+++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 566 999999999999998764 33567889999886543 22234567789999999999999999998764 3
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...++++|++++++|.+.+.. ..+++.+++.++.|++.++.+||+++++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 468999999999999988865 4699999999999999999999999999999999999999999999999999875543
Q ss_pred CCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 GVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.... .....++..|+|||.+.....+ .++|+||||+++++|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCc
Confidence 2211 1112234579999998766554 89999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=234.82 Aligned_cols=203 Identities=29% Similarity=0.483 Sum_probs=176.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.+.+..++..+++|+..... ..+..+.+.+|+.+++.++|||++++++.+...+..++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 467999999999999999999999889999999876543 233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+||+++++|.+.+...+.+++..+..++.+++.++.+||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~ 159 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--A 159 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--c
Confidence 9999999999998887889999999999999999999996 689999999999999999999999999875432221 1
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....++..|+|||.+....++ .++|+||||+++|++++|..||...+.
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred CccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccch
Confidence 123467799999998766554 899999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=232.33 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=170.5
Q ss_pred cccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|++|.||.|.+.. .+..+++|...... .......+..|+..++.++|+|++++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34679999999999999999999876 66788999875433 222335677889999999999999999999888
Q ss_pred CeEEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC---cEEEe
Q 027809 80 TKIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKIS 149 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---~~~l~ 149 (218)
+..++++|++++++|.+++.... .+++.+++.++.||+.++.+||+++++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 88999999999999999886643 478999999999999999999999999999999999998654 58999
Q ss_pred eccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 150 DFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 150 d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
|||++......... ......+..|+|||.+.+..++ .++|+||||+++|+|++ |..||...+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~ 229 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99998754321111 1111224579999999876665 99999999999999997 999998766543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=227.47 Aligned_cols=204 Identities=30% Similarity=0.533 Sum_probs=175.1
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..++..+++|.+...... .+....+.+|+..++.++|||++++++.+...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 689999999999999999999999999999998755433 3345778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCCCccc
Q 027809 88 FITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 88 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~ 164 (218)
++++++|.+.+... ..+++..++.++.+++.++.+||++|++|+||+|+||++++++ .++++|||.+........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-A 158 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-c
Confidence 99999999998764 3589999999999999999999999999999999999997554 579999999876544322 1
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....++..|+|||.+...... .++|+||+|+++++|++|..||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 207 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLP 207 (256)
T ss_pred cccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchH
Confidence 223466789999999866554 8999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=230.29 Aligned_cols=206 Identities=27% Similarity=0.426 Sum_probs=171.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCc---EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|+..+.||+|++|.||.|.+..++. .+++|.+.... .....+.+.+++..++.++|+|++++.+++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3579999999999999999999876554 68888875432 223346688899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++++|++++++|.+.+... ..+++.+++.++.|++.|+.+||+.+++|+|++|+||++++++.++++|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999988764 568999999999999999999999999999999999999999999999999986544322
Q ss_pred ccccc---ccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 162 SLLRT---TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 162 ~~~~~---~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
..... ...+..|+|||.+....++ .++|+||||+++|++++ |..||...+..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~ 217 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNH 217 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 11111 1123479999998776664 89999999999999997 99999766543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=230.19 Aligned_cols=203 Identities=26% Similarity=0.416 Sum_probs=168.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.|.+..+ ..+++|.+..... ..+.+..|+..++.++|+|++++++.+.. ...+++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 46799999999999999999988655 4699998864332 12457789999999999999999998754 557999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|++++++|.+.+... ..+++..++.++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999998753 35789999999999999999999999999999999999999999999999998654332211
Q ss_pred -cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....++..|+|||......++ .++|+||||+++|++++ |..||...+..+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~ 211 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNRE 211 (262)
T ss_pred cccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHH
Confidence 1122345679999998766664 89999999999999999 999998776544
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=235.88 Aligned_cols=207 Identities=27% Similarity=0.473 Sum_probs=169.7
Q ss_pred cceEEeeeecCccceEEEEEEec-------CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~ 78 (218)
++|++.+.||+|++|.||.+... ..+..+++|.+.... .......+.+|+..++.+ +|||++++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 58999999999999999999753 234568888875432 223356677889999988 69999999999998
Q ss_pred CCeEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC
Q 027809 79 RTKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~ 142 (218)
.+..++++||+++++|.+++... ..+++.++..++.|++.||.+||++|++|+||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 88999999999999999998653 24788999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 143 QGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 143 ~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
++.++|+|||.+......... ......+..|+|||.+.+..+. .++|+||||+++|+|++ |..||...+..++
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999998754332111 1111233579999999876554 89999999999999999 9999988766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=228.76 Aligned_cols=200 Identities=30% Similarity=0.561 Sum_probs=172.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.+... |+.+++|.+..... ..+++.+|...++.++|+|++++++++...+..++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 467999999999999999999874 68899999865442 346788899999999999999999999988899999
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|++++++|.+++.... .+++..++.++.|++.++.+||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999999987765 689999999999999999999999999999999999999999999999998876533222
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
....+..|+|||.+....+. .++|+||||++++++++ |..||...+..+
T Consensus 158 --~~~~~~~~~ape~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred --cCCCcccccCchhhcCCcCC-cHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 22234579999998766554 89999999999999997 999998776544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=233.77 Aligned_cols=202 Identities=28% Similarity=0.476 Sum_probs=171.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|+..+.||+|++|.+|.+.+..+++.+++|.+........+..+.+.+|+..++.++|||++++.+.+...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 56999999999999999999998889999999986544444445567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||+.+ ++.+.+.. ...+++.++..++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||++.......
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~---- 169 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---- 169 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCC----
Confidence 99975 66666543 4578999999999999999999999999999999999999999999999999886544322
Q ss_pred cccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 2345678999998852 22234899999999999999999999976553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=233.02 Aligned_cols=203 Identities=35% Similarity=0.540 Sum_probs=171.2
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|++.+.||.|++|.+|+|.+..+|..+++|.+..... .......+.+|+..++.++|+|++++++++...+..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999998999999999865432 222335577889999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 89 ITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 89 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
++ ++|.+.+.... .+++..++.++.|++.+|.+||+.+++|+||+|+||++++++.++|+|||++............
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 96 48988887665 6899999999999999999999999999999999999999999999999998654332222222
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 34467899999886654445899999999999999999999976553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=236.91 Aligned_cols=203 Identities=31% Similarity=0.542 Sum_probs=173.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
..|.....||+|++|.||.+.+..++..+++|.+.... ....+.+.+|+..++.++|+|++++++.+...+..++++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34566788999999999999998889999999875433 233466788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|++++++|.+.+. .+.+++.+++.++.|++.++.+||+++++|+||+|+||++++++.++|+|||++............
T Consensus 99 e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 9999999988764 457899999999999999999999999999999999999999999999999988654333222233
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..+++.|+|||.+.....+ .++|+||+|+++|+|++|..||...++.
T Consensus 178 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~ 224 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPL 224 (292)
T ss_pred eecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4567789999999766654 8999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=234.05 Aligned_cols=207 Identities=27% Similarity=0.473 Sum_probs=171.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCC-----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|++|.||.+..... ...+++|.+.... ..+....+.+|+..++.+ +|+|++++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 46899999999999999999987643 3678999876432 233345678889999999 799999999999998
Q ss_pred CeEEEEEEecCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC
Q 027809 80 TKIYIILEFITGGELFDKIVH----------------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~ 143 (218)
+..++++||+++++|..++.. ...+++..++.++.|++.|+.+||+++++|+||+|+||+++++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999998854 2358899999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCccc--ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 144 GHLKISDFGLSALPEQGVSLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 144 ~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+.++|+|||.+.......... .....+..|+|||.+.+..++ .++|+||||+++|++++ |..||...+..+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999987544322111 112234579999998766665 89999999999999997 999998776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=232.66 Aligned_cols=200 Identities=29% Similarity=0.508 Sum_probs=174.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|+..+.||+|++|.||.+.+..+++.+++|.+..... .+...++.+|+..++.++|||++++++.+...+..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478899999999999999999999999999998866542 234566788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|++++++|.+.+... .++++..++.++.|++.++.+||+ .+++|+||+|+||++++++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999989999999776 788999999999999999999999 99999999999999999999999999987654332111
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
...++..|+|||.+.+..+. .++|+||||+++++|++|..||...
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred -cccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcc
Confidence 14456789999999876655 8999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=232.81 Aligned_cols=205 Identities=28% Similarity=0.522 Sum_probs=174.6
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...++|++.+.||+|++|.+|++.+..++..+++|.+.... ....+.+.+|+..++.++|||++++++.+...+..+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 34578999999999999999999998889999999875432 222356778889999999999999999999989999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|+|++++++|.+++.. ..+++.++..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||++.........
T Consensus 93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999999988765 36789999999999999999999999999999999999999999999999987644332222
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....+++.|++||.+....++ .++|+||||+++|++++|..||...+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred cccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2233466789999998766554 899999999999999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=230.29 Aligned_cols=205 Identities=30% Similarity=0.486 Sum_probs=169.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR---- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~---- 79 (218)
-.++|++.+.||+|++|.+|.+.+..+++.+++|.+..... ....+.+++..+..+ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 35779999999999999999999999999999998854321 124456777888888 799999999988643
Q ss_pred -CeEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccc
Q 027809 80 -TKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
+..++|+||+++++|.+.+.. ...+++..++.++.|++.+|++||+.+++|+||+|+||++++++.++|+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 368999999999999887753 457899999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCcccccccccCccccccccccCCC----CCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGY----NGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..............++..|+|||.+..... .+.++|+||||+++|+|++|+.||...++
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 754432222223346678999999864321 24899999999999999999999987654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=232.33 Aligned_cols=204 Identities=33% Similarity=0.488 Sum_probs=166.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCe----
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTK---- 81 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~---- 81 (218)
++|++.+.||+|++|.||.|.+..+++.+++|....... .......+.+|+..+..++ |+|++++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 579999999999999999999999999999998755432 1222356778899999995 5999999999876554
Q ss_pred -EEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeecccc
Q 027809 82 -IYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLS 154 (218)
Q Consensus 82 -~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~ 154 (218)
.++++||+++ +|.+.+... ..+++..++.++.|++++|.+||+++++|+||+|+||+++. ++.++|+|||.+
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 787776542 35799999999999999999999999999999999999998 889999999988
Q ss_pred ccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..............+.+.|+|||.+.+....+.++|+||||+++|+|++|..||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 6443322222223456789999988654444589999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=233.57 Aligned_cols=206 Identities=25% Similarity=0.411 Sum_probs=168.1
Q ss_pred cceEEeeeecCccceEEEEEEec----------------CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcc
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT----------------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~----------------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~ 70 (218)
++|++.+.||+|+||.||.+.+. .++..+++|...... ......++.+|+..++.++|+|++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 57999999999999999998543 234568889876443 233456788999999999999999
Q ss_pred eEEEEEEcCCeEEEEEEecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 027809 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHG-----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (218)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil 139 (218)
++++++...+..++++|++++++|.+++.... .+++.+++.++.|++.|+.+||++|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999998899999999999999998886542 3667889999999999999999999999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh--cCCCCCCCCccc
Q 027809 140 LDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLPFDELDLTT 215 (218)
Q Consensus 140 ~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~ 215 (218)
+++++.++|+|||++......... ......++.|++||......+. .++|+||||+++|+|++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999998654332111 1112235679999988766554 89999999999999998 889998765543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=229.75 Aligned_cols=204 Identities=25% Similarity=0.464 Sum_probs=169.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
..+|++.+.||+|++|.||.+.+. ++..+++|.+...... ...+.+|+..++.++|+|++++++++...+..+++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 356899999999999999999875 4667999987543321 24566789999999999999999999988999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+|++++++|.+.+... ..+++..++.++.|++.++.+||+.+++|+||+|+||++++++.++++|||.+....+.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999988653 468999999999999999999999999999999999999999999999999886544322111
Q ss_pred -ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 165 -RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 165 -~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....+..|+|||.+....+. .++|+||||+++|++++ |..||...+..+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSE 209 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence 111223479999999876665 89999999999999998 899998766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=237.36 Aligned_cols=201 Identities=30% Similarity=0.543 Sum_probs=171.2
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|+....||+|+||.+|.+.+..++..+++|.+..... ...+.+.+|+..+..++|||++++++.+...+..++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 36667789999999999999988899999999854332 224567788999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
++++++|...+.. ..+++.+++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++.............
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 9999999886644 578999999999999999999999999999999999999999999999999886443322222234
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.++..|+|||.+....+. .++|+||||+++++|++|..||...++
T Consensus 178 ~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~ 222 (297)
T cd06659 178 VGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSP 222 (297)
T ss_pred ecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 467789999999866654 899999999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=228.66 Aligned_cols=198 Identities=28% Similarity=0.466 Sum_probs=162.4
Q ss_pred eecCccceEEEEEEec--CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 14 TIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
.||+|+||.||.|.+. +++..+++|...... .....+.+.+|+..++.++|+|+++++++++. +..++|+||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999765 345578999875543 33445678899999999999999999998864 568999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc---ccc
Q 027809 92 GELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL---RTT 167 (218)
Q Consensus 92 ~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~ 167 (218)
++|.+.+.. ...+++.++++++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++.......... ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999988865 4578999999999999999999999999999999999999999999999999986443322111 111
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
..++.|+|||.+....++ .++|+||||+++|++++ |..||...+..+
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 206 (257)
T cd05115 159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206 (257)
T ss_pred CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 224689999998765554 89999999999999996 999998776543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=238.81 Aligned_cols=204 Identities=26% Similarity=0.437 Sum_probs=166.0
Q ss_pred cceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc-C
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS-R 79 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~-~ 79 (218)
++|++.+.||+|+||.||.|.... +++.|++|.+.... .....+.+.+|+..+..+ +|+|++++++.+.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 489999999999999999997543 34789999886433 222345677889999998 79999999998764 4
Q ss_pred CeEEEEEEecCCCChHHHHHhc----------------------------------------------------------
Q 027809 80 TKIYIILEFITGGELFDKIVHH---------------------------------------------------------- 101 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 101 (218)
...++++||+++++|.+.+...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5688999999999998887532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc--cccccccCccccc
Q 027809 102 ---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAP 176 (218)
Q Consensus 102 ---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~P 176 (218)
.++++..+..++.|++.+|.+||+++++|+||+|+||++++++.++|+|||++......... .....++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25789999999999999999999999999999999999999999999999998754332111 1112235679999
Q ss_pred cccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 177 EVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 177 e~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
|.+.+..++ .++|+||||+++|+|++ |..||.....
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999877665 89999999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=225.78 Aligned_cols=203 Identities=33% Similarity=0.612 Sum_probs=178.8
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--CeEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKIYII 85 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 85 (218)
+|+..+.||+|++|.+|.|.+..++..+++|.+...... ....+.+.+++..++.++|+|++++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999998655432 34467788999999999999999999999887 889999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--c
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--L 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 163 (218)
+|++++++|.+.+.....+++.+++.++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||.+........ .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999876655432 1
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.....+...|++||........ .++|+||||+++++|++|..||...+
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234567789999999766654 89999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=228.81 Aligned_cols=198 Identities=25% Similarity=0.438 Sum_probs=164.5
Q ss_pred eecCccceEEEEEEe--cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 14 TIGEGTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
.||+|++|.||.|.+ ..++..+++|++.... ......+.+..|+..++.++|+|++++++++.. +..++++|++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 689999999999965 3567889999875443 233345678889999999999999999998864 467899999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc---cccc
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL---RTTC 168 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~ 168 (218)
++|.+++.....+++..++.++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++.......... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 9999999888889999999999999999999999999999999999999999999999999987654332211 1112
Q ss_pred ccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 169 ~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
++..|+|||.+....++ .++|+||||+++|+|++ |..||...+..
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~ 205 (257)
T cd05116 160 WPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205 (257)
T ss_pred CCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 34689999998755554 89999999999999998 99999876554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=227.54 Aligned_cols=204 Identities=42% Similarity=0.775 Sum_probs=179.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecch-----hhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA-----IIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~ 78 (218)
.++.|...+.+|.|..+.|-.+..+.+|..+++|++.... ....+..+.-.+|+.+|+++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3567888999999999999999999999999999984321 12344556678899999998 59999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+...++|+|.|+.|.|.+++.....+++.+..+++.|++++++|||.++|+|+|++|+|||++++.+++|+|||+++...
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999877
Q ss_pred CCCcccccccccCccccccccc------cCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLS------HKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
++.. ....+|+|+|+|||.+. ...| +...|+|++|++||.++.|.+||=+
T Consensus 175 ~Gek-LrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 175 PGEK-LRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred Cchh-HHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhH
Confidence 7643 45678999999999985 2233 4788999999999999999999954
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=238.20 Aligned_cols=212 Identities=29% Similarity=0.418 Sum_probs=175.9
Q ss_pred CccccccceEE-eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhh-----------HHHHHHHHHHhhhhcCCCC
Q 027809 1 MVVRKVGKYEV-GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-----------MADQIKREISIMKLVRHPC 68 (218)
Q Consensus 1 ~~~~~~~~y~~-~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~-----------~~~~~~~~~~~l~~l~~~~ 68 (218)
|.....++|.. .+.||+|++|.||.|.+..+++.+++|.+......... ....+.+|+..+..++|+|
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 56677788865 57799999999999999989999999998544322100 0124678899999999999
Q ss_pred cceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEE
Q 027809 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKI 148 (218)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l 148 (218)
++++++++...+..++++|++++ +|.+.+.....+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred eeeeeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 99999999999999999999975 89888888788999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCC--------------CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 149 SDFGLSALPEQG--------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 149 ~d~~~~~~~~~~--------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
+|||.+...... ........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999988654411 11111223466899999987655445899999999999999999999987654
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=233.09 Aligned_cols=205 Identities=26% Similarity=0.416 Sum_probs=169.8
Q ss_pred cceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
++|++.+.||+|++|.||.+.+. .++..+++|.+.... .....+.+.+|+..++.+ +|+|++++++.+...+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 47999999999999999999752 345578999875432 223346788999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 81 KIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..++++||+.+++|.+++.... .+++.+++.++.|++.++.+||+++++|+||+|+||+++.++.++++|||++....
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999999886543 38999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 159 QGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 159 ~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
..... .....++..|+|||.+....+. .++|+||+|+++|+|++ |..||...+..
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 32211 1112235679999999776665 89999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=228.61 Aligned_cols=204 Identities=27% Similarity=0.440 Sum_probs=171.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
-.++|++.+.||+|++|.||.|.+. ++..+++|.+..... ..+.+.+|+..++.++|+|++++++.+......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3468999999999999999999975 457799998864332 23567889999999999999999999998889999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|++++++|.+.+... ..+++.+++.++.|++.|+.+||+++++|+||+|+||++++++.++++|||.+........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999999988664 3689999999999999999999999999999999999999999999999998875443211
Q ss_pred c-cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 163 L-LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 163 ~-~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
. ......+..|+|||.+.+.... .++|+||||++++++++ |+.||...+..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 1 1122234579999999866554 89999999999999998 99999876654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=228.85 Aligned_cols=204 Identities=30% Similarity=0.492 Sum_probs=172.8
Q ss_pred eEEeeeecCccceEEEEEEecCCC----cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
+++.+.||.|++|.||.+.+...+ ..+++|...... ..+..+.+.+|+..+..++|+|++++++.+...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999998766 889999985543 22245678899999999999999999999998899999
Q ss_pred EEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|++++++|.+.+..... +++.+++.++.|++.++.+||+.+++|+||+|+||++++++.++|+|||.+........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999876544 89999999999999999999999999999999999999999999999999876554321
Q ss_pred ccc-cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLR-TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~-~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... ...+++.|++||.+....++ .++|+||||+++++|++ |..||...+..+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFT-SKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred cccccCCCcccccChHHhccCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 111 12245789999999665554 89999999999999998 899998766544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=224.82 Aligned_cols=200 Identities=37% Similarity=0.635 Sum_probs=176.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..++..+++|.+..... .....+.+++..++.++|++++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999998899999999865442 335678899999999999999999999999899999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 88 FITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 88 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
++++++|.+.+... ..+++..++.++.|++.++.+||+++++|+||+|+||++++++.++|+|||.+........ ...
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence 99999999988776 5789999999999999999999999999999999999999999999999998876555432 223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..+...|++||.+..... +.++|+||||+++++|++|..||...+
T Consensus 157 ~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 157 MVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred eecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 456778999999976654 489999999999999999999998764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=233.76 Aligned_cols=209 Identities=28% Similarity=0.428 Sum_probs=170.3
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC--
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-- 80 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-- 80 (218)
...+++|++.+.||+|++|.||.|.+..+++.+++|.+...... ........+|+..++.++|||++++++++...+
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 35678899999999999999999999999999999988644321 222234567889999999999999999876443
Q ss_pred ------eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 81 ------KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 81 ------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
..++|+||+.+ +|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 46999999976 777766554 3689999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcc----cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 154 SALPEQGVSL----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 154 ~~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
+......... .....++..|+|||.+.+....+.++|+||||+++|+|++|..||+..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 8754332211 12233566899999886554345899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=229.56 Aligned_cols=196 Identities=34% Similarity=0.546 Sum_probs=161.6
Q ss_pred eecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHH---HHhhhhcCCCCcceEEEEEEcCCeEEEEEEecC
Q 027809 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKRE---ISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
.||+|++|.||.+.+..+++.+++|.+................+ ...+....||+++++.+.+...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 47999999999999988899999999865433222211222222 334445679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccccc
Q 027809 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (218)
Q Consensus 91 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 170 (218)
+++|.+.+...+.+++.+++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+........ ....++
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGT 158 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--cCcCCC
Confidence 999999998888899999999999999999999999999999999999999999999999998864432211 233567
Q ss_pred CccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 171 ~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..|+|||.+......+.++|+||+|+++|+|++|..||...
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 89999999975433348999999999999999999999866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=238.46 Aligned_cols=192 Identities=27% Similarity=0.479 Sum_probs=162.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|++.+.||+|++|.||.|.+..++..+++|..... ....|+.+++.++|+||+++++++...+..++|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4699999999999999999999989999999974322 2235788899999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|++.+ +|.+.+.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 137 e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 214 (357)
T PHA03209 137 PHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-AFL 214 (357)
T ss_pred EccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-ccc
Confidence 99975 77776654 4578999999999999999999999999999999999999999999999999987543321 122
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcC-CCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY-LPFDE 210 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~ 210 (218)
...+++.|+|||.+....+. .++|+||||+++|+|+++. .+|..
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccC
Confidence 34577899999999877665 8999999999999999854 44443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=250.35 Aligned_cols=199 Identities=28% Similarity=0.493 Sum_probs=177.3
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|.-++.||.|+||.||.|.+..+.+.||||++..+...+.+...++.+|+..|.++.|||.+.|.+.|-.....|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55678899999999999999999999999999877666667778999999999999999999999999988899999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 89 ITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 89 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
|-| +..+++.-+ +++-+.+|..++.+.+.+|.|||+.+.+|+||++.|||+++.|.+||+|||.+....+.. ..
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn----sF 182 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN----SF 182 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchh----cc
Confidence 976 777777654 578899999999999999999999999999999999999999999999999998765543 46
Q ss_pred cccCcccccccccc---CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 168 CGTPNYVAPEVLSH---KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
+|+|+|||||++.. ..| +-+.||||||++-.++....+|+=+++.
T Consensus 183 vGTPywMAPEVILAMDEGqY-dgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred cCCccccchhHheecccccc-CCccceeeccchhhhhhhcCCCccCchH
Confidence 78999999999963 244 4899999999999999999999877654
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=233.26 Aligned_cols=206 Identities=25% Similarity=0.384 Sum_probs=168.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCC--------------CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcce
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTET--------------GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~--------------~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~ 71 (218)
.++|++.+.||+|+||.||.+.+.+. ...+++|.+.... .......+.+|+..+..++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 35899999999999999999886532 2358899876543 2333467889999999999999999
Q ss_pred EEEEEEcCCeEEEEEEecCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 027809 72 LHEVLASRTKIYIILEFITGGELFDKIVHHG------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (218)
Q Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil 139 (218)
+++++...+..++|+||+++++|.+.+.... .+++.+++.++.|++.|+.+||+.+++|+||+|+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999998885432 3678899999999999999999999999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh--cCCCCCCCCcc
Q 027809 140 LDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA--GYLPFDELDLT 214 (218)
Q Consensus 140 ~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 214 (218)
+++++.++|+|||++......... .....++..|+|||.+....+. .++|+||||+++++|++ |..||...+..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999998654332111 1112235689999998766654 89999999999999988 77888776543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=229.87 Aligned_cols=197 Identities=33% Similarity=0.625 Sum_probs=168.9
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEEEEecC
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
.+.||+|+++.|-.++...+|..+|||++.... . ....++.+|++++.+++ |+||++++++|+++..+|+|+|.+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--g-HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--G-HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--c-hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 467999999999999999999999999986653 2 23466778999999995 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC---cEEEeeccccccCC-------CC
Q 027809 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPE-------QG 160 (218)
Q Consensus 91 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---~~~l~d~~~~~~~~-------~~ 160 (218)
||+|...+..+.-+++.++.++..+|+.||.+||++||.|+|+||+|||-.+.. -+|||||.+..-.. ..
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 999999999999999999999999999999999999999999999999996554 48999998865322 12
Q ss_pred CcccccccccCccccccccc-----cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.+....++|+..|||||... ...|+ .+.|.||||+++|-|++|.+||....
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YD-KrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYD-KRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CccccCcccchhhcchhHHhhhcccccccc-ccccHHHHHHHHHHHHhCCCCccCcc
Confidence 23344566788999999974 23444 89999999999999999999998764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=230.76 Aligned_cols=203 Identities=31% Similarity=0.542 Sum_probs=176.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.+.|++.+.+++|++|.+|.+.+..++..+++|.+..... ..+.+.+|+..++.++|+|++++++.+...+..+++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4568899999999999999999998899999999865432 345677889999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+|++++++|.+.+.... .+++.+++.++.|++.+|.+||+.|++|+|++|+||+++.++.++|+|||.+..........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 99999999999998876 89999999999999999999999999999999999999999999999999876443322222
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+.+.|++||.+.+..++ .++|+||||+++|+|++|..||...++
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred ccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 223356789999998766654 899999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=230.56 Aligned_cols=207 Identities=25% Similarity=0.353 Sum_probs=167.8
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
-++|++.+.||+|++|.||.|..+ ..+..+++|.+..... ......+.++...++.++|+|++++++.+...+
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 468999999999999999998654 2345799998754432 222345778899999999999999999999888
Q ss_pred eEEEEEEecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEee
Q 027809 81 KIYIILEFITGGELFDKIVHHG----------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d 150 (218)
..++++||+++++|.+.+.... .++...++.++.|++.||.+||+++++|+||+|+||++++++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999999986532 245678899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCccc--ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 151 FGLSALPEQGVSLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 151 ~~~~~~~~~~~~~~--~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
||++.......... ....++..|+|||.+.....+ .++|+||||+++|+|++ |..||...+.++
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~ 229 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99876433221111 112235679999998766654 89999999999999998 899998766544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=233.56 Aligned_cols=208 Identities=26% Similarity=0.470 Sum_probs=171.2
Q ss_pred ccceEEeeeecCccceEEEEEEec-------CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~ 77 (218)
.++|++.+.||+|+||.||.+... .++..+++|...... ..+..+.+.+|+..++.+ +|||++++++.+.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 467999999999999999999743 234578999875432 233456788999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 78 SRTKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
.....++++||+++++|.+++... ..++..+++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999998653 2467888999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 142 SQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.++.++|+|||++......... .....+++.|+|||.+.+..++ .++|+||||+++|++++ |..||...+..++
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 9999999999998755432211 1112234679999999776665 89999999999999998 8999987766554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=231.10 Aligned_cols=203 Identities=35% Similarity=0.560 Sum_probs=172.3
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--CeEEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKIYIIL 86 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 86 (218)
|++.+.||+|++|.+|+|.+..+++.+++|.+.... ........+.+|+..++.++|+|++++.+++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 688999999999999999999889999999997653 2333446677899999999999999999999877 8899999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-cc
Q 027809 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-LL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~~ 164 (218)
||+++ +|.+.+... ..+++.+++.++.|+++|+.+||+.+++|+||+|+||++++++.++++|||.+........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 99975 888877665 5789999999999999999999999999999999999999999999999999875544321 11
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....+..|+|||.+.+....+.++|+||||+++++|++|..||...+.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2234466899999876544445899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=234.33 Aligned_cols=208 Identities=22% Similarity=0.382 Sum_probs=171.4
Q ss_pred ccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
+.+|++.+.||.|++|.||.|.+.. ++..+++|.+.... .....+.+.+|...+..++||||+++++.+...+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4568889999999999999998754 35789999986443 2233466888999999999999999999999888
Q ss_pred eEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~ 144 (218)
..++++|++.+++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||++++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999888532 2478889999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 145 HLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 145 ~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.++|+|||++......... .....+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999987654322111 1122345689999998766654 89999999999999998 9999988766543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=227.37 Aligned_cols=204 Identities=29% Similarity=0.541 Sum_probs=177.2
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..+++.+++|.+....... .....+.+++..++.++|+|++++.+.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999899999999986544322 334567788999999999999999999998899999999
Q ss_pred ecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 88 FITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 88 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
++++++|.+.+.. ...+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~ 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence 9999999988866 356899999999999999999999999999999999999999999999999998765554 2
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.....+.+.|++||.+.+..++ .++|+||||+++++|++|..||...+..+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred cccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2234567799999999876664 89999999999999999999998877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=237.31 Aligned_cols=205 Identities=33% Similarity=0.501 Sum_probs=172.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----C
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----T 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~-----~ 80 (218)
.++|++.+.||.|++|.||.+.+..++..+++|.+..... .......+.+|+..++.++|+|++++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4689999999999999999999999999999998864322 222345667889999999999999999987543 3
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++++||+. ++|.+.+.....+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999997 588888888888999999999999999999999999999999999999999999999999998765443
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
........++..|+|||.+......+.++|+||||+++|+|++|..||...+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 2222233456789999998754334589999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=229.50 Aligned_cols=201 Identities=30% Similarity=0.557 Sum_probs=172.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|...+.||+|++|.+|.+.+..++..+++|.+.... ....+.+.+++.+++.++|+|++++++.+...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 5667789999999999999998889999999875433 2224557788999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
++.+++|.+.+.. .++++.+++.++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+.............
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9999999988876 678999999999999999999999999999999999999999999999999876443322222234
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.+++.|+|||.+....+. .++|+||+|+++++|++|..||...++
T Consensus 176 ~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~ 220 (285)
T cd06648 176 VGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPP 220 (285)
T ss_pred cCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCH
Confidence 467789999999766554 899999999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=227.87 Aligned_cols=203 Identities=27% Similarity=0.463 Sum_probs=168.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
-++|++.++||+|++|.||.|... ++..+++|.+...... ..++.+|+..++.++|+|++++++++.. +..+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEE
Confidence 357999999999999999999865 5678999988654322 3567789999999999999999998754 568999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-c
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~ 162 (218)
+|++.+++|.+.+... ..+++.+++.++.|++.+|++||+.|++|+||+|+||++++++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999999887653 468899999999999999999999999999999999999999999999999986544221 1
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......++..|+|||.+....+. .++|+||||+++|++++ |+.||...+..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 211 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211 (260)
T ss_pred cccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 11122345689999998766654 89999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=227.57 Aligned_cols=204 Identities=30% Similarity=0.614 Sum_probs=174.8
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|++.+.||+|++|.+|.+.+..+|..+++|.+...... ....+.+.+|+..++.++|+|++++++.+...+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 689999999999999999999999999999998664322 2234567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCCCccc
Q 027809 88 FITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~ 164 (218)
++++++|.+.+.... .+++..+..++.|++.++.+||+++++|+|++|+||++++++ .++++|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999886643 478999999999999999999999999999999999998876 46999999887655433333
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+++.|+|||........ .++|+||||++++++++|..||...+.
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~ 207 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNL 207 (257)
T ss_pred cccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 334567789999998766554 899999999999999999999986654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=242.63 Aligned_cols=192 Identities=22% Similarity=0.378 Sum_probs=163.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
..+|.+.+.||+|++|.||.+.+...+..|++|.... ....+|+.+++.++|+||+++++++...+..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999995321 2345789999999999999999999988999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-- 162 (218)
+|++.+ +|...+... ..+++.+++.++.|++.+|.|||++|++|+||||+|||++.++.++|+|||++........
T Consensus 239 ~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 999964 777777553 4699999999999999999999999999999999999999999999999999875433211
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCC
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 208 (218)
......+++.|+|||.+.+..++ .++|+||||+++|+|++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCc
Confidence 11223478899999999877665 8999999999999999877654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=235.52 Aligned_cols=207 Identities=26% Similarity=0.467 Sum_probs=169.7
Q ss_pred cceEEeeeecCccceEEEEEEecCC-------CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTET-------GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~-------~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~ 78 (218)
.+|++++.||+|+||.||.|.+... +..+++|.+.... ..+..+.+.+|+..++++ +|+||+++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 4799999999999999999976432 2368899775432 333456788899999999 79999999999998
Q ss_pred CCeEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC
Q 027809 79 RTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~ 142 (218)
.+..++++||+++++|.+++.... .++..+++.++.|++.||.+||++|++|+||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 889999999999999999886532 3678899999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 143 QGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 143 ~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
++.++|+|||++......... .....++..|+|||.+....+. .++|+||||+++|+|++ |..||...+..++
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999998654332111 1112223579999999877665 89999999999999998 9999988765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=229.57 Aligned_cols=206 Identities=31% Similarity=0.500 Sum_probs=169.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE-----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA----- 77 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~----- 77 (218)
.-.++|++.+.||+|++|.||++.+..+++.+++|...... .....+..|...++.+ +|+|++++++.+.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34578999999999999999999999999999999874322 1124566788888888 6999999999873
Q ss_pred cCCeEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 78 SRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
..+..++++||+++++|.+.+.. ...+++..++.++.|++.++.+||+.+++|+|++|+||++++++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 44578999999999999887642 34688999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccccccccccC----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
+..............+++.|+|||.+... ...+.++|+||+|+++|+|++|..||...++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 86544322222233467889999998532 1124799999999999999999999987654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=236.16 Aligned_cols=202 Identities=33% Similarity=0.524 Sum_probs=170.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++.+.||+|++|.||.|.+..+++.+++|.+..... .......+.+|+..++.++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789999999999999999999999999999998854322 223345677899999999999999999987533
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++|+|++.+ +|.+.+... +++.++..++.|++.||++||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999976 777776543 8999999999999999999999999999999999999999999999999987554
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.... .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 TSFM-MTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCCC-CCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 3221 1223456789999999877665 89999999999999999999998765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=230.51 Aligned_cols=205 Identities=25% Similarity=0.409 Sum_probs=169.5
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..+|+..++||+|+||.||.+... .++..+++|.+.... ......+.+++..++.++|+|++++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457899999999999999998642 346678888765332 333567889999999999999999999999889
Q ss_pred eEEEEEEecCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc
Q 027809 81 KIYIILEFITGGELFDKIVHHG---------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~ 145 (218)
..++++|++++++|.+++.... .+++..++.++.|++.|+.+||++|++|+||+|+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999886643 4789999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 146 LKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 146 ~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
++|+|||++........ ......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~ 231 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNT 231 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence 99999998864432211 11112235689999998876665 89999999999999998 99999776543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=233.98 Aligned_cols=195 Identities=29% Similarity=0.515 Sum_probs=157.7
Q ss_pred eeeecCccceEEEEEEec--CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CCeEEEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKIYIILE 87 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 87 (218)
+++||+|+||.||.|.+. .++..+++|.+..... ...+.+|+.+++.++|||++++++.+.. ....++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 568999999999999865 4668899998854321 2346688999999999999999998853 456899999
Q ss_pred ecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----cCCCcEEEeecccc
Q 027809 88 FITGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLS 154 (218)
Q Consensus 88 ~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~----~~~~~~~l~d~~~~ 154 (218)
++.+ +|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9975 777766432 258899999999999999999999999999999999999 45678999999998
Q ss_pred ccCCCCCc---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 155 ALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 155 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
........ ......+++.|+|||.+.+....+.++|+||+|+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 75443211 11233567889999999765444589999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.84 Aligned_cols=203 Identities=31% Similarity=0.538 Sum_probs=172.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC------C
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------T 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~------~ 80 (218)
+-+...+.||.|+||.||.++++++|+.||||.+.... ...-.++.-.|++++++++|+|||++.++=+.. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 34677899999999999999999999999999987644 333467788999999999999999999885432 3
Q ss_pred eEEEEEEecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC--C--cEEEeeccc
Q 027809 81 KIYIILEFITGGELFDKIVHH---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ--G--HLKISDFGL 153 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~--~--~~~l~d~~~ 153 (218)
.-.++||||.+|+|+..+... ..+++.+++.++.++..|+.|||++||+|+||||.||++..+ | ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 467999999999999999654 469999999999999999999999999999999999999433 3 479999999
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+.-...+. ....-.|+..|++||......+.+...|.||+|+++|++.||..||...-
T Consensus 171 Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 98665544 33456689999999999864444589999999999999999999997543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=229.65 Aligned_cols=200 Identities=31% Similarity=0.542 Sum_probs=164.3
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcC--CeEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASR--TKIYII 85 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv 85 (218)
|++.+.||+|++|.+|.+.+..+++.+++|.+..... .... .....|...+..+. |+|++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6889999999999999999998999999998865432 1121 22345677777774 99999999999877 889999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+||+++ +|.+.+.. ...+++.+++.++.|++.+|.+||+.+++|+||+|+||+++. +.++|+|||.+.........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 999986 77777665 357899999999999999999999999999999999999999 99999999998755432221
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....++..|+|||.+......+.++|+||||+++|+|++|..||...+.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 1233567899999876555556899999999999999999999987654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=235.81 Aligned_cols=204 Identities=30% Similarity=0.520 Sum_probs=168.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++.+.||+|++|.||.|.+..+|..|++|.+.... .......+.+|+..++.++|+|++++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 3478999999999999999999999999999999885322 233456677899999999999999999886543
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...++++|++.+ +|.+.+. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 358999999976 7766664 45789999999999999999999999999999999999999999999999998865433
Q ss_pred CCc---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 GVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 ~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
... ......+++.|+|||.+.+....+.++|+||+|+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 11223457789999987654444589999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=228.45 Aligned_cols=205 Identities=25% Similarity=0.410 Sum_probs=167.0
Q ss_pred eEEeeeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-----
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----- 80 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~----- 80 (218)
|++++.||+|+||.||.|....+ +..+++|.+..... .......+.+|...++.++|+|++++++.+....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987653 47899998865432 2334567888999999999999999999875544
Q ss_pred -eEEEEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 81 -KIYIILEFITGGELFDKIVHH------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 81 -~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
..++++||+++++|...+... ..+++..++.++.|++.||.+||+.+++|+||+|+||++++++.++|+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 379999999999998887442 3589999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 154 SALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 154 ~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+......... ......+..|++||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHE 223 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 8754432111 1112234579999998766554 89999999999999999 999998766544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=225.67 Aligned_cols=199 Identities=44% Similarity=0.777 Sum_probs=174.1
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||.|++|.+|.+.+..+++.+++|.+.............+..++..++.++|+|++++++.++..+..++++|++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998766554444566788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccc
Q 027809 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174 (218)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 174 (218)
.+.+.....+++..++.++.|+++++.+||+++++|+||+|+||+++.++.++|+|||.+..............+...|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 99998888899999999999999999999999999999999999999999999999999876544322223344667899
Q ss_pred cccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 175 ~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+||........ .++|+||||+++|++++|..||...+..
T Consensus 161 ~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~ 199 (250)
T cd05123 161 APEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRK 199 (250)
T ss_pred ChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 99999766654 8999999999999999999999877643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=229.13 Aligned_cols=204 Identities=27% Similarity=0.489 Sum_probs=168.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE------c
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA------S 78 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~------~ 78 (218)
.++|++.+.||.|++|.+|.|.+..+++.+++|.+.... .....+..+...+..+ +|+|++++++.+. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 478999999999999999999999999999999885533 2234567778888887 6999999999874 3
Q ss_pred CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccccc
Q 027809 79 RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~ 156 (218)
....+++|||+++++|.+.+... ..+++..++.++.|++.++.+||+.+++|+|++|+||++++++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 45789999999999999888653 3578999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccCccccccccccC----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
............+++.|+|||.+... ...+.++|+||||+++|+|++|..||...++
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 43322222234567789999998631 2224789999999999999999999976554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=226.53 Aligned_cols=196 Identities=26% Similarity=0.489 Sum_probs=164.7
Q ss_pred cccceEEeeee--cCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhh-hcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTI--GEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l--~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~-~l~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+.+ |+|+||.||.+....++..+++|.+........ +..... ..+|+|++++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 45677787777 999999999999999999999999865432211 111111 1269999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~ 160 (218)
.++|+||+++++|.+.+.....+++.+++.++.|+++++.+||+.|++|+||+|+||+++.++ .++++|||++......
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999999998888999999999999999999999999999999999999999888 9999999988654332
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. ...++..|+|||.+....+. .++|+||+|+++|+|++|..||.....
T Consensus 164 ~----~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 164 S----CYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred c----cCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 1 23467789999999876665 899999999999999999999985543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=228.55 Aligned_cols=209 Identities=23% Similarity=0.337 Sum_probs=171.7
Q ss_pred ccccceEEeeeecCccceEEEEEEecC----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTE----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS- 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~- 78 (218)
...++|++.+.||+|+||.||.|.+.. .+..+++|.+.... .....+.+.+|...++.++|+|++++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999875 25778888875432 33345678889999999999999999998765
Q ss_pred CCeEEEEEEecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEee
Q 027809 79 RTKIYIILEFITGGELFDKIVHH--------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d 150 (218)
....+++++++++++|.+++... ..+++.+++.++.|++.||.+||+++++|+||+|+||++++++.++++|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999988653 4588999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 151 FGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 151 ~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
||++......... .....++..|+|||.+.+..+. .++|+||||+++|++++ |..||...++.+
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 9998643322111 1112234579999999776664 89999999999999999 999998776544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=228.26 Aligned_cols=199 Identities=28% Similarity=0.440 Sum_probs=162.0
Q ss_pred eeecCccceEEEEEEecCCCc--EEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEec
Q 027809 13 RTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
+.||+|++|.||.|.+..++. .+++|...... .....+.+.+|+..+..+ +|||++++++.+...+..++++|++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999887765 45777664322 233446678899999999 7999999999999989999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 90 TGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 90 ~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
++++|.+++.... .+++.+++.++.|++.|+.+||++|++|+||+|+||++++++.++++|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999886532 478999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+........ ......+..|+|||.+....++ .++|+||||+++++|++ |..||...+..+
T Consensus 159 ~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~ 219 (270)
T cd05047 159 SRGQEVYVK-KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219 (270)
T ss_pred ccccchhhh-ccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHH
Confidence 753221111 1112234579999998766554 89999999999999997 999998766543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=228.60 Aligned_cols=205 Identities=27% Similarity=0.433 Sum_probs=166.1
Q ss_pred eEEeeeecCccceEEEEEEecCCCc--EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc------CC
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------RT 80 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------~~ 80 (218)
+.+++.||+|++|.||.|.+..++. .+++|.+..... .....+.+..|...++.++|+|++++++.+.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3578899999999999999876664 588998765432 33345678889999999999999999997642 23
Q ss_pred eEEEEEEecCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccc
Q 027809 81 KIYIILEFITGGELFDKIVH------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
..++++||+.+++|.+.+.. ...+++..++.++.|++.+|.+||+++++|+||+|+||++++++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999887742 234789999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 155 ALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 155 ~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......... ......++.|++||......+. .++|+||||+++|+|++ |..||...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 765432211 1122345689999999876665 89999999999999999 899998766544
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=237.48 Aligned_cols=205 Identities=32% Similarity=0.505 Sum_probs=175.7
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-----eE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-----KI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-----~~ 82 (218)
+|++.+.||+|++|.+|.|.+..+++.+++|.+.... ......+.+.+|+..++.++|+|++++.+++...+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6899999999999999999998889999999886543 22334567888999999999999999999987664 78
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV- 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~- 161 (218)
++++|++.+ +|.+.+....++++..++.++.|++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 888888877789999999999999999999999999999999999999999999999999988655432
Q ss_pred --cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 162 --SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 162 --~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.......+++.|+|||.+.+....+.++|+||||+++++|++|..||...+..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 11223345678999999987634458999999999999999999999877653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=226.52 Aligned_cols=199 Identities=29% Similarity=0.469 Sum_probs=167.0
Q ss_pred eeecCccceEEEEEEecC-CC--cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 13 RTIGEGTFAKVKFAQNTE-TG--ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~-~~--~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
+.||+|++|.||+|.+.. ++ ..+++|.+...... +..+.+.+|...+++++|+|++++++.+.. ...++++|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998765 33 36899988665532 556788899999999999999999999888 8899999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc---c
Q 027809 90 TGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---L 164 (218)
Q Consensus 90 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---~ 164 (218)
++++|.+.+.... .+++..++.++.|++.||++||+++++|+||+|+||+++.++.++|+|||++......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999987654 6899999999999999999999999999999999999999999999999998755432111 1
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
....++..|+|||.+....+. .++|+||||+++++|++ |..||...+..+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 208 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 122345689999998766665 89999999999999998 999997665543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=237.81 Aligned_cols=208 Identities=36% Similarity=0.577 Sum_probs=187.3
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
+...+.|..-+.||.||||.||-+..+.+|+-+|.|.+....+.......-...|..+++.++.+.||.+-=.|+..+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45567799999999999999999999999999999998777766666666678899999999999999988888999999
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 83 YIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
++|+.-|+||+|.-.+.+.+ .+++..+.-.+.+|+-+|++||+.+|+++|++|+|||+|+.|+++|+|+|+++-...+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999987777766 6999999999999999999999999999999999999999999999999999977765
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.. ...+.|+.+|||||++.+..|+ ...|.|||||++|+|+.|+.||..+.
T Consensus 341 ~~-~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 341 KP-IRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred Cc-cccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhh
Confidence 44 3456899999999999998887 99999999999999999999998653
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=223.84 Aligned_cols=198 Identities=28% Similarity=0.485 Sum_probs=164.4
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
+.||+|++|.||.+... ++..+++|.+.... ..+....+.+|+..++.++|||++++++++...+..++|+||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999854 67889999876543 2333456788999999999999999999999989999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc-cccccc
Q 027809 93 ELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL-RTTCGT 170 (218)
Q Consensus 93 ~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~ 170 (218)
+|.+.+... ..+++.+++.++.|++.++.++|++|++|+||+|+||++++++.++|+|||++.......... .....+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999888653 457899999999999999999999999999999999999999999999999886433321111 111234
Q ss_pred CccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 171 ~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
+.|+|||.+....+. .++|+||||+++|++++ |..||...+..
T Consensus 158 ~~y~aPE~~~~~~~~-~~~Di~slG~ll~~~~~~g~~p~~~~~~~ 201 (250)
T cd05085 158 IKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQ 201 (250)
T ss_pred ccccCHHHhccCCCC-chhHHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 579999998766554 89999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=226.33 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=168.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
..+|++.+.||+|++|.||.|.+... ...+++|...... ..+..+.+.+|+..++.++|||++++++++.. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 46799999999999999999987543 3468889875543 23345678889999999999999999999876 457
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++++|++++++|.+++.... .+++.+++.++.|++.++.+||+++++|+||+|+||+++.++.++++|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 89999999999999987644 58999999999999999999999999999999999999999999999999886543321
Q ss_pred cc-cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 162 SL-LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 162 ~~-~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
.. ......+..|+|||.+....+. .++|+||||++++++++ |..||...+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~ 215 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNN 215 (270)
T ss_pred ceecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 11 1112234579999998766654 89999999999999986 99999877644
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=225.03 Aligned_cols=199 Identities=28% Similarity=0.528 Sum_probs=166.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEE-EcCCeEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL-ASRTKIYI 84 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~-~~~~~~~l 84 (218)
..+|++.+.||+|++|.+|.+... +..+++|...... ..+.+..|+..++.++|++++++++++ ...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 467999999999999999999764 6789999875432 235678899999999999999999875 45567899
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++||+++++|.+.+.... .+++..++.++.|++.+|.+||++|++|+||+|+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 157 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 157 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence 999999999999887654 378999999999999999999999999999999999999999999999998765433221
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
....+..|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 158 ---~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05082 158 ---TGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred ---CCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 12234579999998766654 89999999999999997 999998765543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=228.15 Aligned_cols=205 Identities=27% Similarity=0.409 Sum_probs=170.7
Q ss_pred cceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
++|++.+.||+|+||.||.|..+. +...+++|...... .....+.+.+|+..++.++|+|++++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999653 34578888775432 22245678899999999999999999999998889
Q ss_pred EEEEEEecCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecc
Q 027809 82 IYIILEFITGGELFDKIVHHG---------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~ 152 (218)
.++|+|++++++|.+++.... .+++.+++.++.|++.+|.+||+++++|+||+|+||+++.++.++++|++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999987655 68999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 153 LSALPEQGV-SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 153 ~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
.+....... .......+++.|++||.+...... .++|+||||+++|++++ |..||...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~ 225 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDE 225 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchH
Confidence 875432211 111223345679999998766654 89999999999999998 89999765543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=230.57 Aligned_cols=201 Identities=27% Similarity=0.491 Sum_probs=170.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|+..+.||+|++|.+|.+.+..++..+++|.+........+....+.+|+..++.++|+|++++++++......++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48889999999999999999988999999999865544444455678889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 88 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|+.+ +|.+.+.. ..++++.++..++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~ 180 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----NS 180 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----cc
Confidence 9986 66666643 557899999999999999999999999999999999999999999999999987643322 12
Q ss_pred ccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+.
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 346678999999852 22335899999999999999999999976554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=231.17 Aligned_cols=195 Identities=30% Similarity=0.519 Sum_probs=157.1
Q ss_pred eeeecCccceEEEEEEecC--CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE--cCCeEEEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SRTKIYIILE 87 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e 87 (218)
+.+||+|+||.||.|.... ++..+++|.+..... ...+.+|+.+++.++|||++++++++. .....++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 5689999999999999653 567899998754321 234668899999999999999999884 4567899999
Q ss_pred ecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----cCCCcEEEeecccc
Q 027809 88 FITGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLS 154 (218)
Q Consensus 88 ~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~----~~~~~~~l~d~~~~ 154 (218)
|+.+ +|.+.+... ..+++..++.++.|++.||.+||+.+++|+||+|+||++ +.++.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9976 676666421 247899999999999999999999999999999999999 45678999999998
Q ss_pred ccCCCCCc---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 155 ALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 155 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
........ ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 75443221 11223467789999998765444589999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=237.02 Aligned_cols=208 Identities=44% Similarity=0.798 Sum_probs=186.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
|=|.+.+-||+|.|..|-.|...-+|+.||||++..-+... -....+.+|++-++.++||||++++++......+|+|.
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34888999999999999999999999999999997766543 23466889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-CCCcEEEeeccccccCCCCCccc
Q 027809 87 EFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|.-++|+|.+++-++. .+.+....+.+.||+.|+.|+|+..++|+|++|+|+++. .-|.+||.|||++....++.. .
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-L 175 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-L 175 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-h
Confidence 9999999999997764 699999999999999999999999999999999998774 568999999999988777644 4
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
...+|...|.|||.+.+..|+-++.||||||+++|-++||++||+..+..+.
T Consensus 176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 4678999999999999999999999999999999999999999999887653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=255.60 Aligned_cols=207 Identities=27% Similarity=0.438 Sum_probs=177.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCc-----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGE-----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
+-+....||+|.||.||.|....... .|++|.+... .+.+...++.+|..++..++||||+++++++...+..
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 46788999999999999998764333 3777776554 3667788999999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 83 YIILEFITGGELFDKIVHH-------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
++++|||.+|+|..++.+. ..++...++.++.|+|+++.||++++.+|+||.++|+|++....+|++|||++.
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 9999999999999999876 348899999999999999999999999999999999999999999999999998
Q ss_pred -cCCCCCcccccc-cccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 156 -LPEQGVSLLRTT-CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 156 -~~~~~~~~~~~~-~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
............ ..+.+|||||.+.+.... .|+|+||||+++||++| |..||.+.+..+++
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt-skSDvWsFGVllWEifslG~~PY~~~~n~~v~ 914 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT-SKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL 914 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccc-cccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence 322222222222 345799999999986665 99999999999999999 99999999887653
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=226.65 Aligned_cols=201 Identities=25% Similarity=0.449 Sum_probs=162.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHH-hhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREIS-IMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~-~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
++|++.+.||+|+||.||.+.+..+|+.+++|.+....... . ...+..+.. .++..+|||++++++.+...+..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999886543222 2 223333444 46677899999999999988999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
+||+++ +|.+.+.. ...+++..++.++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999975 77766643 24689999999999999999999997 9999999999999999999999999998754332
Q ss_pred CcccccccccCccccccccccC---CCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHK---GYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.. .....++..|+|||.+.+. ...+.++|+||||+++|+|++|..||...
T Consensus 158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 158 VA-KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cc-cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 11 1123456789999988642 22247899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=226.06 Aligned_cols=203 Identities=27% Similarity=0.425 Sum_probs=167.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.|.+. ++..+++|.+...... .+.+.+|+..++.++|++++++++++.. ...+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence 467999999999999999999865 5667999988654321 2457889999999999999999998754 568899
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|++++++|.+.+... ..+++.+++.++.|++.++.+||+.+++|+||+|+||++++++.++|+|||.+.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999988653 35899999999999999999999999999999999999999999999999998754332211
Q ss_pred -cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....++..|+|||......++ .++|+||||+++|+|++ |..||...+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 211 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNRE 211 (260)
T ss_pred cccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 1122234579999998765554 89999999999999999 999998766543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=229.54 Aligned_cols=207 Identities=28% Similarity=0.427 Sum_probs=171.0
Q ss_pred ccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|+||.||.+.+.. ++..+++|.+.... .......+.+|+..+..++|||++++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4689999999999999999998743 56789999875433 2334466888999999999999999999999888
Q ss_pred eEEEEEEecCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 027809 81 KIYIILEFITGGELFDKIVHHG----------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENL 138 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~ni 138 (218)
..++++|++++++|.+.+.... .+++.+++.++.|++.+|.+||+++++|+||+|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999986432 367888999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 139 LLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 139 l~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+++.++.++|+|||.+........ .......+..|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999998764332211 11122234579999998766665 89999999999999997 889997665544
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=247.76 Aligned_cols=212 Identities=34% Similarity=0.638 Sum_probs=191.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+.+.+.+.-||.|+||.|-.+..+.....+|+|.++...+-.....+.+..|-.++.+++.|.|++++..|.++...|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 35667888999999999999888876666688888877666666666778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+||.|-||.|+..+.+++.+++.....++..+++|++|||.+||+++|++|+|.+++.+|-+||.|||++...+.+...
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT- 576 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT- 576 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCce-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999877765432
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccccC
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 218 (218)
-..+|+|.|.|||.+.+..++ .+.|.|+||+++||+++|.+||+.-||-..||
T Consensus 577 wTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn 629 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYN 629 (732)
T ss_pred eeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence 356799999999999999998 99999999999999999999999998866553
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=225.14 Aligned_cols=200 Identities=31% Similarity=0.503 Sum_probs=170.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CCeEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKIYI 84 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~~~~l 84 (218)
++|+..+.||.|++|.+|.+.+..+++.+++|.+.... .......+.+|++.++.++||||+++++++.. .+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 57999999999999999999999899999999886543 22345668889999999999999999998754 447899
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 85 ILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
|+||+++++|.+.+.. ...+++..+..++.|++.+|.+||+.+++|+|++|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999877643 345889999999999999999999999999999999999999999999999987644332
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.. ....++..|++||.+.+..++ .++|+||||+++|+|++|..||...
T Consensus 159 ~~--~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 LA--GTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc--ccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 123356689999999876665 8999999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=223.94 Aligned_cols=203 Identities=29% Similarity=0.460 Sum_probs=169.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.+.....||+|++|.||.+.+..++..+++|.+.... ....+.+.+|+..++.++|+|++++++++...+..++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 44555678999999999999998889999999875443 223467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeeccccccCCCCCc
Q 027809 87 EFITGGELFDKIVHH-GRL--SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~~~~ 162 (218)
|++++++|.+.+... ..+ ++..+..++.|++.++.+||+++++|+||+|+||+++. ++.++|+|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 999999999988764 445 88899999999999999999999999999999999976 67999999998865443222
Q ss_pred ccccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 163 LLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
......+++.|+|||.+.... ..+.++|+||+|+++++|++|..||...+
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 222334677999999986433 23489999999999999999999997643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=226.03 Aligned_cols=201 Identities=31% Similarity=0.502 Sum_probs=165.4
Q ss_pred cceEEeeeecCccceEEEEEE----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~ 80 (218)
.+|++.+.||+|+||.||.+. +..++..+++|.+.... ....+.+.+|+..+..++|||++++.+++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999987 34568899999876543 2334678899999999999999999998643 35
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|+||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999988654 4689999999999999999999999999999999999999999999999999876543
Q ss_pred CCccc---ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 160 GVSLL---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 160 ~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..... .....+..|+|||.+.+..+. .++|+||||+++++|++|..|+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 22111 111223468999999766654 8999999999999999987776443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=224.30 Aligned_cols=203 Identities=29% Similarity=0.440 Sum_probs=166.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|.+.+.||+|++|.||.+.+..+ ..+++|....... ..+.+.+|+..++.++|++++++++++.. +..+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence 46799999999999999999987654 4688998754331 23567789999999999999999998754 568899
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
||++.+++|.+.+.... .+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999999886543 4789999999999999999999999999999999999999999999999998754332211
Q ss_pred -cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....++..|+|||.......+ .++|+||||+++|+|++ |..||......+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 211 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNRE 211 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1122245679999988765554 89999999999999999 999998765543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=230.35 Aligned_cols=206 Identities=28% Similarity=0.444 Sum_probs=168.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCc----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..++|+..+.||+|++|.||.+.+..++. .+++|...... .......+.++...+..++|||++++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 35679999999999999999999876665 46888775433 222334577889999999999999999998654
Q ss_pred eEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++++|++++++|.+.+.... .+++..++.++.|++.+|.+||+++++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4678999999999999887654 589999999999999999999999999999999999999999999999999875443
Q ss_pred CCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 160 GVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 160 ~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
.... ......+..|++||.+.+..++ .++|+||||+++|++++ |..||......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~ 218 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTR 218 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 2211 1122235689999998766654 89999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=235.62 Aligned_cols=206 Identities=28% Similarity=0.486 Sum_probs=172.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE----cCCe
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA----SRTK 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~----~~~~ 81 (218)
-.+|++.+.||+|++|.||.+.+..+|..+++|.+.... ........+.+|+.+++.++|||++++.+++. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 368999999999999999999999999999999886533 22334566778999999999999999998875 3357
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.++|+||+.+ +|.+.+.....+++..++.++.|++.||.+||+++++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 8999999964 898888777789999999999999999999999999999999999999999999999999986543321
Q ss_pred c----ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 162 S----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 162 ~----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. ......++..|+|||.+......+.++|+||||+++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 1 112234667899999986544445899999999999999999999977653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=226.53 Aligned_cols=199 Identities=22% Similarity=0.311 Sum_probs=158.1
Q ss_pred eecCccceEEEEEEecC--CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 14 TIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
.||+|+||.||.|.... ....+++|.+.... ..+....+.+|+..++.++|+|++++++.+......++|+|++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 68999999999986432 34567888764332 233345677889999999999999999999988999999999999
Q ss_pred CChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--cc
Q 027809 92 GELFDKIVHHG-----RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LL 164 (218)
Q Consensus 92 ~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~ 164 (218)
++|.+++.... ..++..++.++.|++.++.+||+++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999986643 246778899999999999999999999999999999999999999999998764322111 11
Q ss_pred ccccccCccccccccccC------CCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHK------GYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
.....++.|+|||.+... ...+.++|+||||+++|+|++ |..||......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 216 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 122345679999987531 223579999999999999999 89999876543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=251.22 Aligned_cols=208 Identities=28% Similarity=0.447 Sum_probs=178.4
Q ss_pred cceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
.+-+..+.||+|.||+||.|.-.+ +...||||.++... +.+..++|++|++.+..++|||||+++++|..++-
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 445778999999999999987542 34679999987665 34456889999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEE
Q 027809 82 IYIILEFITGGELFDKIVHHG----------R----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~----------~----~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~ 147 (218)
+++|+|||..|+|.+++..+. + ++..+.+.+|.|||.+++||-++..+|+|+-.+|.||+++..+|
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 999999999999999996432 2 78999999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCC-Ccccc-cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 148 ISDFGLSALPEQG-VSLLR-TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 148 l~d~~~~~~~~~~-~~~~~-~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
|+|||++...... ..... ....+.+|||||.+.-..++ .++||||+|++|||+++ |..||-..+.+|.+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 9999999744332 22222 33457799999999987776 99999999999999998 99999998887754
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=222.62 Aligned_cols=198 Identities=29% Similarity=0.483 Sum_probs=166.5
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
++||.|++|.+|.+.+.. ++.+++|.+...... +....+.+++..+++++|+|++++++++......++++|+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 478999999999999877 899999988654422 34567889999999999999999999999999999999999999
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc--cccc
Q 027809 93 ELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--TTCG 169 (218)
Q Consensus 93 ~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~ 169 (218)
+|.+.+.. ...+++..++.++.+++.++.+||+++++|+||+|+||+++.++.++|+|||.+........... ....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99998865 35688999999999999999999999999999999999999999999999999875442211111 1122
Q ss_pred cCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 170 ~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
+..|+|||.+....+. .++|+||||+++|+|++ |..||...++.
T Consensus 158 ~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 158 PIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred eeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 4569999998766554 89999999999999999 89999877643
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=222.84 Aligned_cols=203 Identities=25% Similarity=0.471 Sum_probs=168.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.+.+. ++..+++|.+.... ...+.+.+|+..++.++|+|++++.+.+.. ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 3578999999999999999999865 45668999875432 224567789999999999999999999877 67899
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++||+++++|.+++... ..+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999988653 3578899999999999999999999999999999999999999999999998864432211
Q ss_pred -ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 163 -LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 163 -~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
......++..|+|||.+....++ .++|+||||+++|++++ |..||...+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred ccccCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 11122334579999999765554 89999999999999998 99999876654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=232.87 Aligned_cols=204 Identities=27% Similarity=0.445 Sum_probs=165.0
Q ss_pred cceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc-C
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS-R 79 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~-~ 79 (218)
++|++.+.||.|+||.||.|.+. .+++.+++|.+.... .......+.+|+..+..+ +|+|++++++.+.. .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 58999999999999999999843 456789999986543 223345677899999999 67999999998754 4
Q ss_pred CeEEEEEEecCCCChHHHHHhc----------------------------------------------------------
Q 027809 80 TKIYIILEFITGGELFDKIVHH---------------------------------------------------------- 101 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 101 (218)
...++++||+++++|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 5688999999999999887542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc--ccccccc
Q 027809 102 ---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGT 170 (218)
Q Consensus 102 ---------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~ 170 (218)
..+++.++..++.|++.||.+||+++++|+||+|.||+++.++.++++|||++......... .....++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 13677888999999999999999999999999999999999999999999998654322111 1112234
Q ss_pred CccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 171 ~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
..|+|||.+....+. .++|+||||+++++|++ |..||.....
T Consensus 245 ~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 245 LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred cceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 579999998776665 89999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=227.23 Aligned_cols=197 Identities=30% Similarity=0.493 Sum_probs=164.0
Q ss_pred eEEeeeecCccceEEEEEEe----cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--CeE
Q 027809 9 YEVGRTIGEGTFAKVKFAQN----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKI 82 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~~ 82 (218)
|++.+.||+|++|.||.+.. ..++..+++|.+.... .......+.+|+..++.++|||++++.+++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68999999999999999974 3467889999875443 233456788999999999999999999998764 568
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++++||+++++|.+++... ..+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999988654 358999999999999999999999999999999999999999999999999987544322
Q ss_pred cc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCC
Q 027809 162 SL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208 (218)
Q Consensus 162 ~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 208 (218)
.. .....++..|+|||.+.+..+. .++|+||||+++|+|+++..|+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCC
Confidence 11 1122345579999998766654 8999999999999999977654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=225.09 Aligned_cols=201 Identities=23% Similarity=0.298 Sum_probs=160.6
Q ss_pred eeecCccceEEEEEEecC--CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecC
Q 027809 13 RTIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
+.||+|+||.||.|.+.. ++..+++|.+.... .......+.+|+..++.++|||++++++.+.+....++|+||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998653 44678888875443 22234567889999999999999999999998888999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--c
Q 027809 91 GGELFDKIVHHG-----RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--L 163 (218)
Q Consensus 91 ~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 163 (218)
+++|.+.+.... ..++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999998886432 356778889999999999999999999999999999999999999999998864332211 1
Q ss_pred cccccccCccccccccccCC------CCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKG------YNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....++..|+|||.+.... ..+.++|+||||+++|+|++ |..||...+..+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 217 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 11223456799999986321 12479999999999999996 999998766543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=230.13 Aligned_cols=207 Identities=33% Similarity=0.578 Sum_probs=169.7
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC---
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--- 80 (218)
+..++|++.+.||+|++|.||.|.++.+|+.+++|.+..... .......+.+|+..++.++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456789999999999999999999998999999999865432 1222345678899999999999999999886544
Q ss_pred -------eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecc
Q 027809 81 -------KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (218)
Q Consensus 81 -------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~ 152 (218)
..++++|++++ ++...+... ..+++.+++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999987 666666543 468999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 153 LSALPEQGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 153 ~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
++........ .......+..|++||.+.+....+.++|+||||+++++|++|..||...+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8875443221 11122346689999988654444589999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=249.37 Aligned_cols=202 Identities=31% Similarity=0.515 Sum_probs=177.7
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
-|.+++.||.|+||.||+|.++.++...|.|++... +.+.++++.-++.+|..++||+|+++++.|...+.+|++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 367889999999999999999987777777877543 45668889999999999999999999999888899999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 88 FITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 88 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
+|.||-....+.. ...+++.++..++.|++.||.|||+++|+|+|+++.|||+.-+|.++|.|||.+............
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 9999988776654 457999999999999999999999999999999999999999999999999998776655555556
Q ss_pred ccccCccccccccc-----cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..|+|+|||||+.. +..|+ +++||||||+++.+|..+.+|....++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred ccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccch
Confidence 67999999999975 45565 999999999999999999999987765
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=231.12 Aligned_cols=207 Identities=30% Similarity=0.473 Sum_probs=167.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc------
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------ 78 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------ 78 (218)
.+++|++.+.||+|++|.||.|.+..++..+++|.+....... .......+|+..++.++|+|++++++.+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 4789999999999999999999999999999999886543221 122345688999999999999999987643
Q ss_pred --CCeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 79 --RTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 79 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
...+++++||+.+ ++...+.. ...+++.++..++.|++++|.+||+.|++|+|++|+||++++++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 2357999999976 56555543 4579999999999999999999999999999999999999999999999999887
Q ss_pred cCCCCCccc-----------ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVSLL-----------RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~~~-----------~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......... ....+++.|+|||.+......+.++|+||||+++|+|++|..||...+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 543321111 1112456799999886554445899999999999999999999986554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=224.95 Aligned_cols=203 Identities=33% Similarity=0.635 Sum_probs=170.0
Q ss_pred ceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhh-hhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~-~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~ 82 (218)
+|++.+.||.|++|.+|.+.+. .+|..+++|.+...... .....+.+..|+..+..+ +|++++++.+.++.+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999875 36889999998654322 222345677888999999 589999999999988999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|+|++++++|.+.+.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999998865433211
Q ss_pred -ccccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 163 -LLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 163 -~~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
......++..|++||.+.... ..+.++|+||||+++|+|++|..||..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 111234667899999987432 234789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=216.17 Aligned_cols=204 Identities=27% Similarity=0.443 Sum_probs=170.6
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-----c
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-----S 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~-----~ 78 (218)
.-.+||.+.+.||+|||+-||.+....+++.+|+|.+.-.. .+..+...+|+...++++|||+++.++..- .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 34678999999999999999999999999999999885443 344677889999999999999999987653 3
Q ss_pred CCeEEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecCCCcEEEeecc
Q 027809 79 RTKIYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFG 152 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~~~~~~l~d~~ 152 (218)
....|++++|...|+|.+.+... ..+++.+++.++.+++++|++||+.. +.|+||||.||++++.+.+++.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 34599999999999998888543 36899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCccc---------ccccccCccccccccccCCCC--CcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 153 LSALPEQGVSLL---------RTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 153 ~~~~~~~~~~~~---------~~~~~~~~~~~Pe~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
.++..+-..... .....+..|.|||.+.-.... +.+.|||||||++|+|+.|..||+.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 988655321111 011257789999998643333 6899999999999999999999974
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=222.40 Aligned_cols=203 Identities=27% Similarity=0.451 Sum_probs=170.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
..+|++.+.||+|++|.||.+.+. ++..+++|.+...... ...+.+|+..+++++||+++++++.+......+++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999875 4678999987544322 24577899999999999999999999988899999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~- 163 (218)
+|++.+++|.+.+... ..+++..++.++.|++.++.+||+++++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999888654 46899999999999999999999999999999999999999999999999988654332111
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
......+..|+|||.+....+. .++|+||||+++|+|++ |..||...+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNS 208 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 1112234579999999766655 89999999999999998 99999876544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=226.13 Aligned_cols=204 Identities=16% Similarity=0.193 Sum_probs=155.8
Q ss_pred cceEEeeeecCccceEEEEEEecCC---CcEEEEEEEecchhhh--hh------HHHHHHHHHHhhhhcCCCCcceEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIK--HK------MADQIKREISIMKLVRHPCVVRLHEV 75 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~--~~------~~~~~~~~~~~l~~l~~~~i~~~~~~ 75 (218)
++|++.+.||+|+||.||.|....+ +..+++|......... +. ...........+..++|++++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5899999999999999999998776 5667777543222110 00 00112233445567789999999987
Q ss_pred EEcCC----eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeec
Q 027809 76 LASRT----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 76 ~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
+.... ..+++++++.. ++.+.+......++..++.++.|++.++.+||+++++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 65332 45677887754 66666666556788999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCC-------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 152 GLSALPEQGV-------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 152 ~~~~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
|++....... .......+++.|+|||.+.+..++ .++|+||||+++++|++|..||...+
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 9986543211 111123478899999999877665 99999999999999999999998773
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=226.06 Aligned_cols=202 Identities=27% Similarity=0.471 Sum_probs=169.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.|...+.||+|++|.+|.|.+..++..+++|.+.............+.+|+..++.++|+|++++.+.+.+....++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34777889999999999999998899999999987654444444567888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||+.+ ++.+.+.. ..++++.+++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----~ 175 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----N 175 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----C
Confidence 99976 66666644 457899999999999999999999999999999999999999999999999987643321 1
Q ss_pred cccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...++..|+|||.+.. ....+.++|+||||+++++|++|..||...+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2346678999999853 23334899999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=235.46 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=167.2
Q ss_pred cceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~ 80 (218)
++|.+.+.||+|+||.||.|.+. ..+..|++|.+.... .....+.+.+|+.++..+. |||++++++.+...+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 56888999999999999999864 345689999996543 2223456788999999997 999999999999888
Q ss_pred eEEEEEEecCCCChHHHHHhcC----------------------------------------------------------
Q 027809 81 KIYIILEFITGGELFDKIVHHG---------------------------------------------------------- 102 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~---------------------------------------------------------- 102 (218)
..++|+||+++++|.+++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999998885421
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC
Q 027809 103 ----------------------------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (218)
Q Consensus 103 ----------------------------------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~ 142 (218)
.+++..++.++.|++.||.|||+.+++|+||+|+||++++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 2567778999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 143 QGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 143 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
++.++|+|||++........ ......+++.|++||.+....+. .++|+||||+++++|++ |..||.....
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999865332111 11122345689999999866654 89999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=227.30 Aligned_cols=202 Identities=34% Similarity=0.555 Sum_probs=172.9
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|+..+.||+|++|.+|.|....+++.+++|.+.... ......+.+..++..++.++|+|++++.+++.+.+..++|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677899999999999999999999999999986543 2233345677889999999999999999999988999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 89 ITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 89 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
+++ +|.+.+... ..+++.+++.++.|++.+|.+||+.|++|+||+|+||++++++.++|+|||.+.............
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 985 899988776 579999999999999999999999999999999999999999999999999887654433222233
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.....|+|||.+......+.++|+||||++++++++|..||...+
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 345679999998766344589999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=222.84 Aligned_cols=199 Identities=32% Similarity=0.583 Sum_probs=166.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.+.||+|++|.||.+.. +++.+++|.+.... ..+.+.+|+..++.++|||++++.+.+... ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999998864 67789999875432 134677889999999999999999998664 4799
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++||+.+++|.+.+.... .+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 999999999999987643 478999999999999999999999999999999999999999999999998865433211
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
....+..|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 156 ---~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 156 ---NSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ---CCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 12234679999998766554 89999999999999997 999998876543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=230.26 Aligned_cols=204 Identities=30% Similarity=0.498 Sum_probs=170.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC---
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--- 80 (218)
..-++|++.+.||+|++|.||.+.+..++..+++|.+.... ........+.+|+..++.++|||++++.+.+....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34578999999999999999999999999999999885432 22333456778999999999999999999886543
Q ss_pred ---eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 81 ---KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 81 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
..++|+|++ +++|.+.+. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 568877665 457899999999999999999999999999999999999999999999999988754
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.... ....+++.|++||.+.+....+.++|+||||+++|++++|..||...+.
T Consensus 169 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 169 DSEM---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred ccCc---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3321 1234567899999987644345899999999999999999999986653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=228.27 Aligned_cols=203 Identities=34% Similarity=0.563 Sum_probs=172.2
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|++.+.||+|++|.+|.+.+..+++.+++|.+..... .......+.+|+..++.++|+|++++++++......++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999998999999998865442 223446777899999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 89 ITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 89 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
+++ +|.+.+.. ..++++.+++.++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+.............
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 986 77777665 3578999999999999999999999999999999999999999999999999887655433222223
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.+...|+|||.+.+....+.++|+||||+++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4566899999987663445899999999999999999999977654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=233.28 Aligned_cols=207 Identities=31% Similarity=0.469 Sum_probs=170.6
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc--CC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS--RT 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~--~~ 80 (218)
...++|++.+.||+|++|.+|.|.+..++..+++|.+..... .......+..|+..+.++ +|+|++++++++.. ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 345789999999999999999999988899999998854322 222335566889999999 99999999998864 34
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++|+|++++ +|...+... .+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 68999999975 888877665 7889999999999999999999999999999999999999999999999988754432
Q ss_pred Cc-----ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 VS-----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.. ......++..|+|||.+......+.++|+||||+++|+|++|+.||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 21 111223567899999886555445899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.30 Aligned_cols=206 Identities=37% Similarity=0.620 Sum_probs=181.6
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+++.+..||.|.||.||.|.+..+|+-.|+|.+.-.... ....+.+.+|..+++-+.|||+++|+++=-+.+..++.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 577889999999999999999999999999998655544 5556778999999999999999999999889999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc----
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---- 163 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---- 163 (218)
||++|+|.+.+..+.-.++.-......|++.++.+||+.||+|+||||.||+++.+|.+|++|||.+....++.+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 9999999999888777888888888999999999999999999999999999999999999999999876665422
Q ss_pred cccccccCccccccccccCCCC--CcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....|++-|||||.+.+..-. ..++|||||||++.||+||+.||...|.+
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 3345689999999999754322 37899999999999999999999988754
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=221.50 Aligned_cols=203 Identities=26% Similarity=0.464 Sum_probs=167.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~l 84 (218)
+++.+.++.||+|..|.|+++..+.+|...|||.+.+.. +.+..+++...+.+.... +.|+|++.+++|..+...++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 455677889999999999999999999999999997654 555567776777655444 58999999999998888999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
.||.|.. -+..++.. .+++++.-+-++...+++||.||.+ ++++|+|++|+|||+|+.|++||||||++-+......
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 9999865 44444433 3578999999999999999999985 5899999999999999999999999999987665432
Q ss_pred ccccccccCccccccccccC---CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 LLRTTCGTPNYVAPEVLSHK---GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....|.+.|||||.+... .|+ .++|+||||++++|+.||+.||...+.
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred -cccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCc
Confidence 2234577899999999643 444 899999999999999999999998543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=258.39 Aligned_cols=206 Identities=33% Similarity=0.619 Sum_probs=178.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|.+++.||+|+||.|..++.+.+++.+|.|++..-.-.......-+.+|-.++.-.+.+=|+.+.=.|.+..++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 57999999999999999999999999999999885532222333456788888888888899999988899999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC-CCCcccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE-QGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~-~~~~~~~ 165 (218)
||++||+|..++.+..++|+..+...+.+|+.||..+|+.|+||+||+|+|+|+|..|+++|+|||.+-.+. ++.-...
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~ 234 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSS 234 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEec
Confidence 999999999999999899999999999999999999999999999999999999999999999999987666 4444445
Q ss_pred cccccCccccccccccC----CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHK----GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..+|+|.|.+||++... .......|.||+|+++|||+.|..||=..+
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 66899999999999632 223478999999999999999999996543
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=221.82 Aligned_cols=194 Identities=24% Similarity=0.323 Sum_probs=158.2
Q ss_pred eeecCccceEEEEEEecCC------------CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 13 RTIGEGTFAKVKFAQNTET------------GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~------------~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
+.||.|++|.||.|....+ ...+++|.+.... ......+.++...+..++|||++++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985422 2358888765432 233456788889999999999999999999888
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc-------EEEeecc
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-------LKISDFG 152 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~-------~~l~d~~ 152 (218)
..++++||+++++|..++... ..+++.+++.++.|++.|++|||+++++|+||+|+||+++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 899999999999998887653 56899999999999999999999999999999999999986664 8999999
Q ss_pred ccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHh-hcCCCCCCCCc
Q 027809 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI-AGYLPFDELDL 213 (218)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~ 213 (218)
++....... ...++..|+|||.+......+.++|+||||+++|+|+ .|..||.....
T Consensus 158 ~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 158 IPITVLSRQ----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CCccccCcc----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 876443221 2335668999998874444458999999999999997 59999987654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=228.99 Aligned_cols=202 Identities=29% Similarity=0.491 Sum_probs=166.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC------
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR------ 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~------ 79 (218)
-++|++.+.||+|++|.+|.+.+..+++.+++|.+..... .....+.+.+|+..+++++|+||+++.+++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3789999999999999999999988999999998865332 222345677899999999999999999987532
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...+++++++ +++|.+.+.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3477888887 5688776654 4689999999999999999999999999999999999999999999999998875433
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.. ....++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 173 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 173 EM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred cc---cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 2234567899999987644345899999999999999999999976553
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=224.66 Aligned_cols=202 Identities=30% Similarity=0.492 Sum_probs=169.4
Q ss_pred cceEEeeeecCccceEEEEEEec----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~ 80 (218)
..|++.+.||+|++|.||.+... .+++.+++|.+...... +..+.+.+++..++.++|+|++++.+++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888999999999999999864 34788999998655432 345678899999999999999999999876 55
Q ss_pred eEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++++||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7899999999999999987654 589999999999999999999999999999999999999999999999999876553
Q ss_pred CCccc---ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 160 GVSLL---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 160 ~~~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..... .....+..|++||......+. .++|+||||+++++|++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccc
Confidence 22211 112234569999998766554 8999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=221.79 Aligned_cols=192 Identities=23% Similarity=0.299 Sum_probs=160.4
Q ss_pred eeecCccceEEEEEEecCCC----------cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 13 RTIGEGTFAKVKFAQNTETG----------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~----------~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
+.||+|+||.||.|.+..++ ..+++|...... .....+.+++..++.++|||++++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999988665 346777654332 114667888999999999999999999877 778
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-------cEEEeecccc
Q 027809 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-------HLKISDFGLS 154 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-------~~~l~d~~~~ 154 (218)
++|+||+++++|.+++.... .+++..++.++.|++.+|.+||+++++|+||+|+||+++.++ .++++|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999987765 789999999999999999999999999999999999998887 7999999998
Q ss_pred ccCCCCCcccccccccCccccccccccC-CCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
...... ....+...|+|||.+... ...+.++|+||||++++++++ |..||...+.
T Consensus 156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 156 ITVLSR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred cccccc----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 754431 123345679999998765 233589999999999999999 6889987754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=226.74 Aligned_cols=199 Identities=29% Similarity=0.535 Sum_probs=168.5
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
+....||+|++|.||.+....++..+++|.+.... ......+.+|+..++.++|+|++++++.+...+..++++||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33467999999999999999999999999875432 233466888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccc
Q 027809 90 TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169 (218)
Q Consensus 90 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 169 (218)
++++|.+.+. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+..............+
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9999988664 457899999999999999999999999999999999999999999999999987644332222223346
Q ss_pred cCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 170 ~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
++.|++||.+....+ +.++|+||+|+++|+|++|..||...+.
T Consensus 179 ~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~ 221 (292)
T cd06657 179 TPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPP 221 (292)
T ss_pred CccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 678999999876555 4899999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=237.18 Aligned_cols=197 Identities=36% Similarity=0.701 Sum_probs=174.8
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCC
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
.+.||+|-||+||-|+.+++|+.||||++......+.+. .++++|+++|+.+.||.|+.+.-.|+..+..|+|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 478999999999999999999999999998877665543 7899999999999999999999999999999999999987
Q ss_pred CChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC---cEEEeeccccccCCCCCccccc
Q 027809 92 GELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 92 ~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
++.+.+.. .+.+++..-..++.||+.||+|||-++|+|||+||+|+|+.+.. ++||||||++++.+.. .....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrs 725 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRS 725 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhh
Confidence 55566643 45799999999999999999999999999999999999996553 6999999999987763 34445
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
-.|+|.|+|||.+++..+. ..-||||.|+++|.-++|.-||....
T Consensus 726 VVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc
Confidence 6799999999999999997 88999999999999999999998654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=227.96 Aligned_cols=202 Identities=27% Similarity=0.463 Sum_probs=169.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
..|+..+.||+|++|.+|.|.+..++..+++|.+............++.+++..++.++|+|++++.+++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45788899999999999999999899999999886543334444567778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||+.+ ++.+.+.. ..++++.+++.++.|++.++.+||+++++|+||+|+||+++.++.++++|||++.......
T Consensus 95 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~---- 169 (308)
T cd06634 95 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---- 169 (308)
T ss_pred EccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc----
Confidence 99975 77666643 4568999999999999999999999999999999999999999999999999886543321
Q ss_pred cccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.. ....+.++|+||||+++++|++|..||...+.
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 2345678999999853 22234799999999999999999999977654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=235.64 Aligned_cols=203 Identities=27% Similarity=0.467 Sum_probs=168.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~l 84 (218)
-..|++++.||+||.+.||++.... ...+++|..... ..+.+.+.-+.+|+..|.+++ |.+|++++|+-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 4459999999999999999998654 445666654322 234556778999999999995 7999999999888999999
Q ss_pred EEEecCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHHGRL-SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|||+-+. +|...+...... +...+..++.||+.|+.+.|++||+|+|+||.|+|+ ..|++||+|||++....+....
T Consensus 438 vmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 9999865 999999877654 446899999999999999999999999999999999 8899999999999866554322
Q ss_pred --cccccccCccccccccccCCCC----------CcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 164 --LRTTCGTPNYVAPEVLSHKGYN----------GAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 164 --~~~~~~~~~~~~Pe~~~~~~~~----------~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
....+|++.||+||.+...... +.++|||||||++|+|+-|..||.+.-
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 2345799999999999644332 578999999999999999999998653
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=223.01 Aligned_cols=194 Identities=26% Similarity=0.331 Sum_probs=156.9
Q ss_pred eecCccceEEEEEEecC------------------------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc
Q 027809 14 TIGEGTFAKVKFAQNTE------------------------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~~~------------------------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i 69 (218)
.||+|+||.||.|.... ....+++|.+.... ......+.++...++.++|||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 68999999999987432 12457888774332 2334567788889999999999
Q ss_pred ceEEEEEEcCCeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC----
Q 027809 70 VRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---- 144 (218)
Q Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---- 144 (218)
+++++++......++|+||+++++|...+.. .+.+++..+..++.|++.||.|||+++++|+||+|+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999998999999999999999888865 45689999999999999999999999999999999999997644
Q ss_pred ---cEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHh-hcCCCCCCCCcc
Q 027809 145 ---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI-AGYLPFDELDLT 214 (218)
Q Consensus 145 ---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~ 214 (218)
.++++|||.+....... ...++..|+|||.+......+.++|+||||+++|+++ +|..||...++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccceeeecCCcccccccccc----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 37999999875432221 2235667999998875443458999999999999985 699999876654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=226.08 Aligned_cols=203 Identities=29% Similarity=0.503 Sum_probs=169.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-CCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~-~~~~~ 83 (218)
..++|++.+.||.|++|.||.+.+..+++.+++|.+..... .....+.+..|+.++..++|||++++.+++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35789999999999999999999999999999998754322 22334667789999999999999999998865 56789
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+++|++. ++|.+.+. ..++++..+..++.|++++|.+||+.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 87 lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 87 FVTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred EEeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 9999995 48877665 3568889999999999999999999999999999999999999999999999887543321
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+++.|++||.+......+.++|+||||+++|+|++|..||...++
T Consensus 163 -~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 163 -TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred -CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1234567899999886534445899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=219.83 Aligned_cols=198 Identities=28% Similarity=0.397 Sum_probs=158.1
Q ss_pred eeecCccceEEEEEEecC---CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-cCCeEEEEEEe
Q 027809 13 RTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-SRTKIYIILEF 88 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~ 88 (218)
+.||+|+||.||.|.+.. ++..+++|.+.... ..+..+.+.++...++.++|||++++++++. .++..++++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 34578999874322 2334567788899999999999999999765 45568899999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc----c
Q 027809 89 ITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS----L 163 (218)
Q Consensus 89 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~----~ 163 (218)
+.+++|.+++... ..+++..++.++.|+++|+.+||+.+++|+||+|+||++++++.++|+|||++........ .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999998664 3467888899999999999999999999999999999999999999999999864332110 0
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
.....++..|+|||.+....+. .++|+||||+++|+|++ |.+||...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~ 208 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDS 208 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 1112235679999998766654 89999999999999999 6778876554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=220.80 Aligned_cols=204 Identities=29% Similarity=0.548 Sum_probs=168.9
Q ss_pred ceEEeeeecCccceEEEEEEecC-CCcEEEEEEEecchh-------hhhhHHHHHHHHHHhhh-hcCCCCcceEEEEEEc
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAI-------IKHKMADQIKREISIMK-LVRHPCVVRLHEVLAS 78 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~-------~~~~~~~~~~~~~~~l~-~l~~~~i~~~~~~~~~ 78 (218)
.|++.+.||+|++|.+|.+.+.. .++.+++|.+..... .......++.+|...+. .++|||++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999887 678899998753321 12233455666777665 4799999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 79 RTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
.+..++++||+++++|.+.+.. ...+++..++.++.|++.++.+||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
+....... ......++..|++||.+..... +.++|+||||+++|+|++|..||...+.
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~ 218 (269)
T cd08528 161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNM 218 (269)
T ss_pred eeeccccc-ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCH
Confidence 87654432 2234456778999999986555 4899999999999999999999976553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=240.38 Aligned_cols=203 Identities=26% Similarity=0.457 Sum_probs=156.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC-cEEEEEE--------------EecchhhhhhHHHHHHHHHHhhhhcCCCCcc
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKV--------------LDRSAIIKHKMADQIKREISIMKLVRHPCVV 70 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~-~~~~ik~--------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~ 70 (218)
.++|++++.||+|+||.||.+..+... ...+.|. +.............+.+|+.++..++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999998754322 1111111 1111111223345678899999999999999
Q ss_pred eEEEEEEcCCeEEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc
Q 027809 71 RLHEVLASRTKIYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (218)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~ 145 (218)
++++++...+..|++++++.+ +|..++... ......++..++.|++.||.|||++|++|+||+|+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999965 666665432 22346778899999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCC-CCCC
Q 027809 146 LKISDFGLSALPEQGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYL-PFDE 210 (218)
Q Consensus 146 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~-pf~~ 210 (218)
++|+|||++........ ......+++.|+|||.+.+..+. .++|+||||+++|+|++|.. ||..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccC
Confidence 99999999875443221 12234578899999999877765 89999999999999999775 4543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=223.05 Aligned_cols=201 Identities=32% Similarity=0.528 Sum_probs=167.6
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 87 (218)
|++.+.||+|++|.||.|.+..+++.+++|.+...... .+ .....+++..+..++ |+|++++++.+...+..++|+|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 68899999999999999999888999999987544321 11 223446788888888 9999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 88 FITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
++ +++|.+.+.... .+++.+++.++.|++.+|.+||+++++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YT 156 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cC
Confidence 99 668888887654 789999999999999999999999999999999999999999999999999875544222 12
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...++..|+|||.+......+.++|+||||+++++|++|..||...+.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 234566899999886544445899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=236.00 Aligned_cols=205 Identities=31% Similarity=0.591 Sum_probs=183.2
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHH-----HHHHHHhhhhcC---CCCcceEEE
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ-----IKREISIMKLVR---HPCVVRLHE 74 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-----~~~~~~~l~~l~---~~~i~~~~~ 74 (218)
+.++..|+..+++|+|+||.|+.|.++++...|+||.+...++.-+.+.++ +..|++++..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 567788999999999999999999999999999999998877766665544 667888888886 999999999
Q ss_pred EEEcCCeEEEEEEec-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 75 VLASRTKIYIILEFI-TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 75 ~~~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
+|++++.+|+++|.- ++.+|.+++.....+++.+...++.|++.++++||+.||+|+|||-+|+.++.+|-+||+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999975 4569999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
+....++ ..-...|+..|.|||.+++..|-....|||+||+++|.++..+-||=
T Consensus 717 aa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 8765543 22345688999999999999998889999999999999999888874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=226.73 Aligned_cols=204 Identities=30% Similarity=0.462 Sum_probs=166.7
Q ss_pred ceEEeeeecCccceEEEEEEecCC--CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc----CC
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTET--GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS----RT 80 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~----~~ 80 (218)
+|++.+.||+|+||.||.+.+..+ +..+++|.+.... ......+.+.+|+..++.+ +|||++++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999877 8899999875432 1222345667888888888 59999999987532 24
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..+++++++. ++|.+.+.....+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5788999986 489888888888999999999999999999999999999999999999999999999999998643322
Q ss_pred Ccc----cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 VSL----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... .....+++.|+|||.+......+.++|+||+|++++++++|..||...+.
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 111 11234677899999876543335899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=228.62 Aligned_cols=203 Identities=31% Similarity=0.477 Sum_probs=165.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
.-++|++.+.||.|++|.||.|.+..+|+.+++|.+..... +..+.+.+|+..++.++|||++++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 35789999999999999999999999999999998865442 3346677899999999999999998766433
Q ss_pred ---------CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-CCCcEEEe
Q 027809 80 ---------TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKIS 149 (218)
Q Consensus 80 ---------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-~~~~~~l~ 149 (218)
...++++||+++ +|.+.+.. ..+++..++.++.|+++|+.+||+.|++|+||+|+||+++ +++.++++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 357899999975 88777653 4789999999999999999999999999999999999997 45678999
Q ss_pred eccccccCCCCCc---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 150 DFGLSALPEQGVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 150 d~~~~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
|||.+........ ......++..|+|||.+......+.++|+||||+++|+|++|+.||...+
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998864322111 11122356689999987654444589999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=220.92 Aligned_cols=204 Identities=36% Similarity=0.635 Sum_probs=170.5
Q ss_pred ceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhh-hhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~-~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~ 82 (218)
+|++.+.||+|++|.+|.+.+. .++..+++|.+...... ..+..+.+.+|...+..+ +|++++++.+.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5889999999999999998864 45688999988654332 223445678899999999 589999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|+||+++++|.+.+.....+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999988777899999999999999999999999999999999999999999999999998765433221
Q ss_pred -ccccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 163 -LLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 163 -~~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
......++..|++||.+.... ..+.++|+||||+++++|++|..||...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 111234677899999986543 2348999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=227.83 Aligned_cols=202 Identities=31% Similarity=0.500 Sum_probs=166.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|.+.+.||+|++|.||.|.+..+|+.+++|.+..... .......+.+++..++.++|+|++++.+++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 35789999999999999999999988999999998865322 223345677899999999999999999988643
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++++|++.. +|.... ...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 346899999965 666544 3468999999999999999999999999999999999999999999999999886543
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... ....+++.|+|||.+......+.++|+||||+++|+|++|+.||...+.
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~ 220 (342)
T cd07879 169 AEM---TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220 (342)
T ss_pred CCC---CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 221 1234566899999987644345899999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=229.68 Aligned_cols=202 Identities=29% Similarity=0.494 Sum_probs=168.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe----
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK---- 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~---- 81 (218)
-++|++.+.||+|++|.+|.|.+..++..+++|.+..... ..+....+..|+.+++.++|+|++++.+.+...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4679999999999999999999999999999998754322 22334567788999999999999999887765443
Q ss_pred --EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 82 --IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 82 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.++|+|++. ++|.+.+.. ..+++..++.++.|+++++.+||+.|++|+||+|+||++++++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 899999995 588887764 5799999999999999999999999999999999999999999999999999875443
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. .....++..|+|||.+......+.++|+||||+++|++++|+.||...+.
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred c---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2 12234567899999986543445899999999999999999999986654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=237.35 Aligned_cols=202 Identities=27% Similarity=0.553 Sum_probs=175.8
Q ss_pred cce-EEeeeecCccceEEEEEEecCCCcEEEEEEEecchh-hhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC--eE
Q 027809 7 GKY-EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--KI 82 (218)
Q Consensus 7 ~~y-~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--~~ 82 (218)
+|| +....||+|.|-+||+|.|..+|..||...+..... .+++.++++..|+..|+.|+||||+++++++.+.. ..
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 444 667899999999999999999999998765543333 35556789999999999999999999999887654 47
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEec-CCCcEEEeeccccccCCC
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLD-SQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~-~~~~~~l~d~~~~~~~~~ 159 (218)
-+|.|.+..|+|+.+.++++.++...+..|+.||+++|.|||++. |+|+||+-+||||+ .-|.+||+|+|+|.....
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 889999999999999999999999999999999999999999875 99999999999995 568999999999987765
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
... ..-.|+|.|||||... ..|+ ...||||||++|+||.|+..||....
T Consensus 199 s~a--ksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 199 SHA--KSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred ccc--ceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhC
Confidence 432 2357999999999997 6776 99999999999999999999998764
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=220.27 Aligned_cols=201 Identities=32% Similarity=0.507 Sum_probs=163.8
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc---CCCCcceEEEEEEcCCe----
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLASRTK---- 81 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l---~~~~i~~~~~~~~~~~~---- 81 (218)
|++.+.||+|++|.+|.+.++.+++.+++|.+...... ......+.+++..++++ +|+|++++.+.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 68899999999999999999888999999998644321 12223344555555444 69999999999987665
Q ss_pred -EEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 82 -IYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 82 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
.++++|++++ +|.+.+.... .+++.+++.++.|++.||.+||+.+++|+|++|+||+++.++.++|+|||.+....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999976 7877776543 58999999999999999999999999999999999999999999999999886654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..... ....+...|+|||.+....+. .++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~-~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 159 FEMAL-TSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred CCccc-ccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 33221 122356789999999876654 899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=221.61 Aligned_cols=195 Identities=25% Similarity=0.353 Sum_probs=159.3
Q ss_pred eeecCccceEEEEEEecCCCc-------EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 13 RTIGEGTFAKVKFAQNTETGE-------SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~-------~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+.||+|+||.||.|.+...+. .+++|..... .....+.+.++...++.++|||++++++++...+..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 468999999999998865443 4777776432 233345677889999999999999999999988889999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc--------EEEeecccccc
Q 027809 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--------LKISDFGLSAL 156 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~--------~~l~d~~~~~~ 156 (218)
+||+++++|.+++...+ .+++..++.++.|++.++.+||+++++|+||+|+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999987644 5899999999999999999999999999999999999987664 69999998764
Q ss_pred CCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhc-CCCCCCCCcc
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLT 214 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~ 214 (218)
..... ...++..|+|||.+.+....+.++|+||||+++|+|++| ..||...++.
T Consensus 158 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 158 VLPKE----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred cCCch----hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 43321 233567899999997644445899999999999999998 5777765543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=221.73 Aligned_cols=198 Identities=27% Similarity=0.425 Sum_probs=161.5
Q ss_pred eeecCccceEEEEEEecCCC------cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 13 RTIGEGTFAKVKFAQNTETG------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~------~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.||+|++|.||.+.+...+ ..+++|.+.... .......+.+++..++.++||||+++++++...+..++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876433 678888774332 2233456778999999999999999999999888999999
Q ss_pred EecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-----cEEEeecccc
Q 027809 87 EFITGGELFDKIVHH-------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-----HLKISDFGLS 154 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-----~~~l~d~~~~ 154 (218)
|++++++|.+.+... ..+++.+++.++.|++.++.+||+.+++|+|++|+||++++++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999888642 3478899999999999999999999999999999999998877 8999999988
Q ss_pred ccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 155 ALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
........ .......+..|+|||.+...... .++|+||||+++|+|++ |..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~ 219 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNN 219 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCH
Confidence 64432211 11122335689999999876664 99999999999999998 9999976554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=220.57 Aligned_cols=205 Identities=27% Similarity=0.436 Sum_probs=164.9
Q ss_pred eEEeeeecCccceEEEEEEecC---CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-----
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----- 80 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~----- 80 (218)
|++.+.||+|++|.||.|.+.. ++..+++|.+..... .....+++.+|+..++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998653 468899998865432 2333566788999999999999999999875432
Q ss_pred -eEEEEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 81 -KIYIILEFITGGELFDKIVHH------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 81 -~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
..+++++++.+++|...+... ..++...++.++.|++.++.+||+++++|+||+|+||+++.++.++++|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347888999999998776432 2478899999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 154 SALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
+........ .......++.|++||.+.....+ .++|+||||+++|+|++ |..||...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 875433211 11122345679999998766665 89999999999999999 999998776544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=217.56 Aligned_cols=200 Identities=21% Similarity=0.327 Sum_probs=157.1
Q ss_pred eeecCccceEEEEEEecCC--CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecC
Q 027809 13 RTIGEGTFAKVKFAQNTET--GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~--~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
+.||+|+||.||.+....+ ...+++|...... .....+.+.++...++.++|||++++++.+......++|+||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3689999999999875432 2346667654432 22335678888889999999999999999998889999999999
Q ss_pred CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC--ccc
Q 027809 91 GGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--SLL 164 (218)
Q Consensus 91 ~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~ 164 (218)
+++|.+.+... ...+...++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999988654 245677889999999999999999999999999999999999999999999875322211 111
Q ss_pred ccccccCccccccccccCC------CCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKG------YNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
....++..|+|||.+.... ..+.++|+||||+++|+|++ |..||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 215 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 2334567899999985321 12478999999999999996 67899766554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=228.31 Aligned_cols=212 Identities=34% Similarity=0.640 Sum_probs=191.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~ 83 (218)
+..+|..+..||.|+||.|-.+..+++.+.+|||++..+.+.++.+.+--..|.++|.... -|.++++...|..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 4567899999999999999999999999999999998888777766666666777776664 588999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||++||+|-..++.-+++.+..+...+.+|+-+|-+||++||+++|++.+|++++.+|.+||.|||.+.-.......
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 99999999999988998899999999999999999999999999999999999999999999999999998766666666
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
....+++|.|+|||.+.-..|. ...|.||+|+++|||+.|++||+.-|-+++|
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred eeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 6778999999999999987776 8999999999999999999999999888775
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=221.45 Aligned_cols=202 Identities=23% Similarity=0.401 Sum_probs=164.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 85 (218)
.+|+..+.||+|++|.||.+.+..++..+++|.+...... .....+.+|+..+..+. |+|++++++++...+..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677788999999999999999999999999988643322 33456778888888886 99999999999888899999
Q ss_pred EEecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 86 LEFITGGELFDKIV-----HHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 86 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
+|++.. ++.+... ....+++..+..++.|++.++++||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 5544322 23578999999999999999999997 5999999999999999999999999998864332
Q ss_pred CCcccccccccCccccccccccC--CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.... ....++..|+|||.+... ...+.++|+||+|+++++|++|..||...+
T Consensus 161 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCcc-ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 2111 122456789999998765 233489999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=224.73 Aligned_cols=200 Identities=20% Similarity=0.366 Sum_probs=162.6
Q ss_pred eeecCc--cceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecC
Q 027809 13 RTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 13 ~~l~~g--~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
..||.| ++|+||.+.+..+|+.|++|........ .+..+.+.+|..+++.++||||+++++++...+..++++|++.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345665 9999999999999999999998654322 2345778889999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-----
Q 027809 91 GGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL----- 163 (218)
Q Consensus 91 ~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~----- 163 (218)
+++|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++++||+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999888764 35889999999999999999999999999999999999999999999998754322111000
Q ss_pred --cccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 164 --LRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 164 --~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....+...|++||.+.... ..+.++|+||||+++|+|++|..||...+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~ 215 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR 215 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh
Confidence 00112345699999997542 224899999999999999999999987654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=218.76 Aligned_cols=204 Identities=25% Similarity=0.452 Sum_probs=163.4
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~ 82 (218)
...++|++.+.||+|++|.+|.|.+..++..+++|.+...... .. ...+..+...+... .|+|++++++++......
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~-~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EE-NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HH-HHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3567899999999999999999999988999999998654321 12 23344455444444 599999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 83 YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
++++|++.+ ++.+.... ...+++..+..++.|++.++.+||+ .+++|+||+|+||++++++.++|+|||.+......
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999865 66666544 4578999999999999999999997 69999999999999999999999999988654332
Q ss_pred CcccccccccCccccccccccCC---CCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKG---YNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
... ....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||...
T Consensus 169 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 169 KAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred Ccc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1233567899999986543 2347999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=237.48 Aligned_cols=196 Identities=33% Similarity=0.548 Sum_probs=171.5
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG 92 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 92 (218)
-.||.|.+|+||-|++..+....+||.++... .+..+.+.+|+..-++++|+||++|++.+..++++-+.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 47999999999999999999999999886543 455678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-CCCcEEEeeccccccCCCCCccccccc
Q 027809 93 ELFDKIVHH-GRL--SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTTC 168 (218)
Q Consensus 93 ~L~~~~~~~-~~~--~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 168 (218)
+|..++... +++ ++.++-....||+++|.|||++.|+|+|||-+|+|+. -.|.+|++|||.+.....-.+......
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 999998765 456 7889999999999999999999999999999999995 568999999999865544445556667
Q ss_pred ccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 169 GTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 169 ~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
|+..|||||.+.. +.|. .++|||||||++.||.||++||-...
T Consensus 738 GTLQYMAPEvIDqG~RGYG-~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYG-KAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred cchhhhChHhhccCCcCCC-chhhhhhccceeEeeccCCCCeeecC
Confidence 8999999999963 4454 89999999999999999999997654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=217.75 Aligned_cols=204 Identities=32% Similarity=0.585 Sum_probs=166.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh--hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+|++.+.||+|++|.||.+.+...+...++|........ .......+..|...++.++|||++++++.+......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 689999999999999999998877666666665432221 122234566778899999999999999999888889999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 86 LEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+||+++++|.+.+.. ...+++.+++.++.|++.++.+||+.|++|+|++|+||++++ +.++++|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999887753 356899999999999999999999999999999999999965 569999999886554433
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.......+.+.|++||......++ .++|+||+|+++++|++|..||...+.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~ 210 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNF 210 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 322234466789999998766665 889999999999999999999975543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=202.69 Aligned_cols=198 Identities=24% Similarity=0.470 Sum_probs=162.1
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEEe
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
..+..||+|++|.+-+.+...+|...|+|.+... .+ .+..+++..+..+.... .+|.++.+++.....+..|+.||-
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 4567899999999999999999999999988543 33 33345566666655544 689999999998888999999999
Q ss_pred cCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 89 ITGGELFDK----IVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 89 ~~~~~L~~~----~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+. +|..+ +..++.+++.-+-+++.++..||.+||++ .++|+|++|+|||++.+|++|+||||++-...+....
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 986 77544 35567899999999999999999999965 8999999999999999999999999998765553211
Q ss_pred cccccccCcccccccccc----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
....|...|+|||.+.. ..| +.++|+||||+++.||.+++.||.++-
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccC
Confidence 12445668999999863 244 489999999999999999999999875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=212.94 Aligned_cols=197 Identities=39% Similarity=0.646 Sum_probs=164.7
Q ss_pred cceEE-eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhh-hhcCCCCcceEEEEEEc----CC
Q 027809 7 GKYEV-GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVRLHEVLAS----RT 80 (218)
Q Consensus 7 ~~y~~-~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~~i~~~~~~~~~----~~ 80 (218)
++|++ .+.||-|-.|.|-.+..+.+++.+|+|++... .+.++|++.- ..-.|||||.+++++++ ..
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 44543 36789999999999999999999999987322 3344555433 33369999999998863 45
Q ss_pred eEEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---CCCcEEEeeccccc
Q 027809 81 KIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSA 155 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~---~~~~~~l~d~~~~~ 155 (218)
.+.+|||.++||.|...+..++. +++.++..++.||..|+.|||+.+|.|+|+||+|+|.. +|..+||+|||++.
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 78899999999999999988765 99999999999999999999999999999999999995 45679999999997
Q ss_pred cCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+ .....++-+|+|.|||++....++ ...|+||||++||-|+||.+||=+..-
T Consensus 213 ~t~~~-~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 213 ETQEP-GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred ccCCC-ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCC
Confidence 66543 334567789999999999988887 899999999999999999999977654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=209.61 Aligned_cols=182 Identities=28% Similarity=0.450 Sum_probs=153.4
Q ss_pred ccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCChHHH
Q 027809 18 GTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDK 97 (218)
Q Consensus 18 g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (218)
|.+|.||.+.+..+++.+++|.+..... ..++...+....|||++++++.+...+..++++||+++++|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999999999999999865431 12233344455799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCcccccc
Q 027809 98 IVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177 (218)
Q Consensus 98 ~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe 177 (218)
+.....+++..+..++.|++++|.+||+.|++|+||+|+||+++.++.++++|||.+....... .....+..|+|||
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE 152 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPE 152 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCc
Confidence 9887789999999999999999999999999999999999999999999999999765443321 1223456799999
Q ss_pred ccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 178 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
......+. .++|+||+|+++|+|++|..||...
T Consensus 153 ~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 153 VGGISEET-EACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcC
Confidence 98766554 8999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=216.32 Aligned_cols=192 Identities=22% Similarity=0.420 Sum_probs=157.8
Q ss_pred cceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCChHHHH
Q 027809 19 TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKI 98 (218)
Q Consensus 19 ~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 98 (218)
+.|.+|.+....+++.+++|.+..... ..+..+.+.+|+..++.++|+|++++++.+...+..++++||+++++|.+.+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 345556666667899999999865432 3345677999999999999999999999999999999999999999999988
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-------cccccc
Q 027809 99 VHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-------LRTTCG 169 (218)
Q Consensus 99 ~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~ 169 (218)
... ..+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++++||+.+......... .....+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 764 45889999999999999999999999999999999999999999999999987643321110 111234
Q ss_pred cCccccccccccC--CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 170 TPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 170 ~~~~~~Pe~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+..|+|||.+... .+ +.++|+||+|+++++|++|..||...+
T Consensus 171 ~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 171 NLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5679999998653 34 478999999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=215.98 Aligned_cols=200 Identities=27% Similarity=0.475 Sum_probs=162.1
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.+-.+.||.|.||+|++...+.+|+..|||.+..... +....++..+.....+- +.|||+++++....++..|+.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3446789999999999999999999999999976653 34456666666555444 67999999999999999999999
Q ss_pred ecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 88 FITGGELFDKIV-----HHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 88 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.|+. +|..+-. ....++++-+-.+.-..+.||.||-+ .+++|+|++|+|||++..|.+||||||++--..+..
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si 222 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI 222 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence 9976 6644332 23468999999999999999999984 589999999999999999999999999985433321
Q ss_pred cccccccccCccccccccccC--CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. ..-..|...|+|||.+... .++ .++|+||||+++||+.||..||..|+.
T Consensus 223 A-kT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 223 A-KTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred H-hhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHH
Confidence 1 1123455689999999743 455 999999999999999999999998863
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=234.84 Aligned_cols=206 Identities=26% Similarity=0.449 Sum_probs=179.1
Q ss_pred eEEeeeecCccceEEEEEEecCCC---cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
-++.+.||.|.||.|+.|..+..| ..||||.++..- +++...+|..|+.++-|++||||+++.+++....-..+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 478899999999999999987555 579999986543 556667899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~- 163 (218)
.|||+.|+|..++..+ +.++..++.-|+..|+.++.||.+.+++|+|+.++|||++.+...|++|||+++...+....
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 9999999999999665 57999999999999999999999999999999999999999999999999999865443322
Q ss_pred --cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 164 --LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 164 --~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
......+.+|.|||.+..++.. .++|+||+|++|||.++ |+.||=+++..+.+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVI 844 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 844 (996)
T ss_pred ccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHH
Confidence 2222346799999999988776 99999999999999887 99999888876544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=212.53 Aligned_cols=204 Identities=31% Similarity=0.637 Sum_probs=187.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~l 84 (218)
+++|.+++.||+|++..|-.+..+++.+.+|+|+++..-.+.+++.++...|....++- +||.++.+...|.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 57899999999999999999999999999999999888888888889988888888777 57999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|.||++||+|--..+...++|++.+.....+|..||.+||++||+++|++..|+++|..|.+||.|+|.+.-........
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 99999999997777777899999999999999999999999999999999999999999999999999987655555666
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
+..+++|.|.|||.+++..+. ...|.|+||++|+||+.|+.||.-
T Consensus 409 stfcgtpnyiapeilrgeeyg-fsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred ccccCCCcccchhhhcccccC-ceehHHHHHHHHHHHHcCCCCcce
Confidence 788999999999999999987 999999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=203.09 Aligned_cols=199 Identities=47% Similarity=0.849 Sum_probs=171.7
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|++.+.|++|++|.+|.+....++..+++|.+...... +..+.+.+++..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888899999998765432 2457788899999999999999999999988899999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-ccccc
Q 027809 89 ITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLLRT 166 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 166 (218)
+++++|.+.+..... +++..++.++.+++.++.+||+++++|+|++|.|++++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999999987766 8999999999999999999999999999999999999999999999999887654432 11123
Q ss_pred ccccCccccccccc-cCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 167 TCGTPNYVAPEVLS-HKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
..+...|++||... ...+ +.++|+|+||+++++|++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccc
Confidence 34567899999984 3344 4799999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=223.30 Aligned_cols=204 Identities=27% Similarity=0.453 Sum_probs=172.8
Q ss_pred eEEeeeecCccceEEEEEEecCC----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTET----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
-++.+.||.|-||.||.|.+... +-.||||.++.+. +.+..+.+.+|..+++.++||||++++++|...+ .|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeE
Confidence 35567899999999999997632 3468999998766 3444688999999999999999999999998754 899
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC-CCc
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ-GVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~-~~~ 162 (218)
|||.++.|.|+.+++.++ .++...+...+.||..||.|||+++.+|+||.++|||+.+..-+||+|||+++.... ...
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999999997764 689999999999999999999999999999999999999999999999999985544 223
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
..+....+..|||||.+.-+... .++|+|-||++|||+++ |..||+.-..+..
T Consensus 548 kaS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDV 601 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDV 601 (974)
T ss_pred hccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccce
Confidence 33333456789999999866665 89999999999999876 9999998765543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=217.36 Aligned_cols=201 Identities=31% Similarity=0.472 Sum_probs=170.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC------CCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH------PCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~------~~i~~~~~~~~~~ 79 (218)
.++|+++..+|+|.||.|-.+.+.+.+..+|||++.+.. .+.+..+-|+..+.++.+ --++++.++|+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 578999999999999999999999999999999987654 234556677888888732 2467778889999
Q ss_pred CeEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---------------
Q 027809 80 TKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--------------- 142 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~--------------- 142 (218)
++.++|+|.+.. ++.+++.+++ +++..++..|+.|+++++.+||+.+++|.|++|+||++.+
T Consensus 164 ghiCivfellG~-S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELLGL-STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEeccCh-hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 999999999954 8899997754 6899999999999999999999999999999999999932
Q ss_pred -----CCcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 143 -----QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 143 -----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
+..++++|||.+++...... .-+.+-.|.|||++.+.+++ .++|+||+||++.|+.+|...|+..+..+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~hs---~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHHS---TIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCCCcceEEEecCCcceeccCcc---eeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHH
Confidence 23589999999988766542 23445689999999999997 99999999999999999999999988544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=237.93 Aligned_cols=201 Identities=33% Similarity=0.559 Sum_probs=164.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEE-------
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL------- 76 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~------- 76 (218)
|...+|+.++.||+||||.||+++++=+|..+|||++.... +.+....+.+|+..+..++|||+++|+..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 46778999999999999999999999999999999998776 555567889999999999999999998211
Q ss_pred --------------------------------------------------E---------------------c-------
Q 027809 77 --------------------------------------------------A---------------------S------- 78 (218)
Q Consensus 77 --------------------------------------------------~---------------------~------- 78 (218)
. +
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------C--------CeEEEEEEecCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 027809 79 --------------------------R--------TKIYIILEFITGGELFDKIVHHGRL-SESEARRYFQQLIDGVDYC 123 (218)
Q Consensus 79 --------------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~i~~~l~~L 123 (218)
. ..+||-||||+..++.+++..+... .....|+++.+|++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 2378899999987776666655444 4788999999999999999
Q ss_pred HhCCceeccCCCCCeEecCCCcEEEeeccccccCC--------------C----CCcccccccccCccccccccccCC--
Q 027809 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE--------------Q----GVSLLRTTCGTPNYVAPEVLSHKG-- 183 (218)
Q Consensus 124 h~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~--------------~----~~~~~~~~~~~~~~~~Pe~~~~~~-- 183 (218)
|+.|++|+||||.|||+++++.+||+|||+++... . .........|+.-|+|||.+.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998611 0 000122345777899999998765
Q ss_pred CCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 184 YNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 184 ~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
..+.|.||||||++++||+ .||.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~---yPF~ 816 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEML---YPFG 816 (1351)
T ss_pred cccchhhhHHHHHHHHHHh---ccCC
Confidence 3349999999999999998 5554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=219.16 Aligned_cols=209 Identities=30% Similarity=0.462 Sum_probs=177.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhh----HHHHHHHHHHhhhhcCCCCcceEEEEEE-c
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK----MADQIKREISIMKLVRHPCVVRLHEVLA-S 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~~i~~~~~~~~-~ 78 (218)
-..++|-.+++||+|||+.||+|.+......||+|+-...+.+.++ +.+...+|..+-+.++||.||+.+++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 3456788999999999999999999999999999998766655444 4455778899999999999999999997 5
Q ss_pred CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecC---CCcEEEeeccc
Q 027809 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDS---QGHLKISDFGL 153 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~---~~~~~l~d~~~ 153 (218)
.+.++-|.|||+|.+|.-+++.+..+++.++..|+.||+.||.||.+.+ |+|-|++|.|||+.+ .|.+||.|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 5677889999999999999999999999999999999999999999765 999999999999954 36799999999
Q ss_pred cccCCCC-------CcccccccccCccccccccccC---CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 154 SALPEQG-------VSLLRTTCGTPNYVAPEVLSHK---GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 154 ~~~~~~~-------~~~~~~~~~~~~~~~Pe~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+..+... ....+...|+..|++||.+.-. ...+.+.|+||.|+++|+++-|+.||.+.-
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 9876542 2223455677889999998632 333689999999999999999999998753
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=210.59 Aligned_cols=206 Identities=32% Similarity=0.471 Sum_probs=169.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCC----cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-C
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-R 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~-~ 79 (218)
.+..|+..+.||+|.+|.||+|...+++ +.+|||.+...+. ..-......+|+..++.++|||++.+..+|-. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 4567999999999999999999755443 3678888865532 11233556789999999999999999998865 7
Q ss_pred CeEEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC----CcEEEee
Q 027809 80 TKIYIILEFITGGELFDKIVHH-----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ----GHLKISD 150 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~----~~~~l~d 150 (218)
...|+++||.+. +|...+..+ ..++...+..+++||+.++.|||++.++|+|++|.||++.-+ |++||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 889999999988 888888544 358999999999999999999999999999999999999766 8999999
Q ss_pred ccccccCCCCCcccc---cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 151 FGLSALPEQGVSLLR---TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 151 ~~~~~~~~~~~~~~~---~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+|+++...+.-.... .-..+..|.|||.+.+...-+.+.|+|+.||++.||++-++.|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999987666433321 11245689999999877666799999999999999999999887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=223.06 Aligned_cols=198 Identities=37% Similarity=0.660 Sum_probs=167.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHh-hhhcCCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~-l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
....|.+...+|.|+|+.+-.+....++...++|++..... +..++..+ +..-+|||+++..+.+.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 45678999999999999999999999999999999876632 22244433 34447999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe-cCCCcEEEeeccccccCCCCCc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL-DSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~-~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+|||.+.++-+.+.+.....+. .++..|+.+|+.|+.+||.+|++|+|++|+|||+ ++.++++|+|||.+.-....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999987777776654444 7888899999999999999999999999999999 68999999999998755443
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...++-+..|.|||.+....++ .++|+||||+++|+|++|+.||......
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred -hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCch
Confidence 2234557789999999977776 9999999999999999999999988765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=218.70 Aligned_cols=206 Identities=33% Similarity=0.613 Sum_probs=181.7
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
|..++.||-|+||.|..+....+...+|.|.+..........+...+.|-.+|..-+++-+|+++=.|.+.+.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 78899999999999999998888888999999877777777777788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC---------C
Q 027809 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE---------Q 159 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~---------~ 159 (218)
.+||++-.++..-+-|.+..+...+.+++-|++..|+.|.+|+||||+|||||.+|.+||.|||+++-.. +
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 9999999999888899999999999999999999999999999999999999999999999999986322 0
Q ss_pred --C-Cc-c-----------------------------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCC
Q 027809 160 --G-VS-L-----------------------------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYL 206 (218)
Q Consensus 160 --~-~~-~-----------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 206 (218)
+ .. . .-...|++.|+|||++....+. ...|.||.|+++|+|+.|+.
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCCC
Confidence 0 00 0 0012378899999999988887 89999999999999999999
Q ss_pred CCCCCCccc
Q 027809 207 PFDELDLTT 215 (218)
Q Consensus 207 pf~~~~~~~ 215 (218)
||-..++.+
T Consensus 870 pf~~~tp~~ 878 (1034)
T KOG0608|consen 870 PFLADTPGE 878 (1034)
T ss_pred CccCCCCCc
Confidence 999887754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=192.02 Aligned_cols=207 Identities=35% Similarity=0.541 Sum_probs=178.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|+-.++||+|.+|+||++++..+++.|++|....+.. ++..-....+|+-.++.+.|+||+++++...++..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 356677899999999999999999999999998866542 2222345678899999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|+|+. .|..+... ++.++.+....++.|++.++.++|++++.|+|++|.|.++..+|..|+.|||++...+-.....+
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99987 77666644 46789999999999999999999999999999999999999999999999999987766555555
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
....+..|.+|..+.+....+...|+||-||++.|+.. |++.|...+++.
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd 210 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH
Confidence 66678899999999877666689999999999999987 999999888753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=219.07 Aligned_cols=205 Identities=26% Similarity=0.426 Sum_probs=174.7
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+..++++||+|-||.+..+... .+..||+|...... +.....++.+|++++.+++||||+.++++|..++-+.+++|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 3578999999999999999865 36899999987655 44446889999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC-Cccc
Q 027809 88 FITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG-VSLL 164 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 164 (218)
|++-|+|.+++..+.. .....-.+++.||+++++||.+.+++|+|+.++|+|++.++++|++|||.++-...+ ....
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999999999998843 356677889999999999999999999999999999999999999999998743322 1122
Q ss_pred c-cccccCccccccccccCCCCCcchhhhhHhHHHHHH--hhcCCCCCCCCcccc
Q 027809 165 R-TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVL--IAGYLPFDELDLTTL 216 (218)
Q Consensus 165 ~-~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l--~~g~~pf~~~~~~~~ 216 (218)
+ ....+.+|||+|.+...+.+ .++|+|++|+++||+ ++.+.||++.+.+++
T Consensus 696 qgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred ecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 2 22356799999999876665 999999999999997 569999999887764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=238.14 Aligned_cols=187 Identities=24% Similarity=0.375 Sum_probs=155.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
..++..+.||+|+||.||+|.+..++..|++|.+...... ...++..+++++||||+++++++...+..++||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466678899999999999999889999999987543211 123467788899999999999999989999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH---SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh---~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
||+++++|.+.+. .+++.++..++.|++.|++||| +.+++|+|++|+||+++.++..++. ++........
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999999885 4889999999999999999999 6699999999999999988887765 4433221111
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
....+++.|+|||.+....++ .++||||+|+++|||++|+.||.
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred -CCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCC
Confidence 122456799999999876665 89999999999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=220.50 Aligned_cols=206 Identities=28% Similarity=0.507 Sum_probs=176.3
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE-----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA----- 77 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~----- 77 (218)
..-+.|++.+.+|.|.+|.||++...++|...|+|+....... -+.+..|.++++.+ .|||++.+++++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3456799999999999999999999999999999998654422 24566788888877 5899999999884
Q ss_pred cCCeEEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 78 SRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
.++.+|+|||+|.+|+..++.++ +..+.|..+.+++..++.++.+||.+.++|+||+-.|||++.++.+||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 45689999999999999998865 3568899999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCcccccccccc-----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
-............++|.|||||++.- ..+ +.++|+||||++..||--|.+|+-++.|-
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchh
Confidence 54444444456779999999999962 233 47999999999999999999999998763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=223.68 Aligned_cols=209 Identities=29% Similarity=0.440 Sum_probs=178.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCC-C--cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTET-G--ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~-~--~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
-.++.++.++||+|+||.|+.|.|... | -.||||.+....... ...+|.+|+..+..++|+|++++++++.+ .-
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 345567789999999999999998743 3 368999987766543 56889999999999999999999999987 56
Q ss_pred EEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 82 IYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..+|+|.+..|+|.+.+.+ ...|.-..++.++.|||.|+.||..++.+|+|+.++|+++-....+||+|||+....+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 8899999999999999876 23477888999999999999999999999999999999999999999999999987665
Q ss_pred CCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 160 GVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 160 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
+.+. ......+..|+|||.++....+ .++|+|++|+++|||++ |+.||......+|+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL 325 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL 325 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHH
Confidence 4433 2233456689999999987776 99999999999999998 99999988776654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-31 Score=223.72 Aligned_cols=193 Identities=26% Similarity=0.495 Sum_probs=169.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.++||+|+||.||.|.+..+++.||+|++.............+..+...+..++|+||+++++.+...+..++
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 47899999999999999999999999999999999976554455556778889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||+.+++|.+++...+.+++..++.++.||+.||.|||.++++|+||+|+|||++.++.++|+|||++..........
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~ 161 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998665544334
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHH
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVI 197 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~ 197 (218)
....+++.|.+||...........+++|++|+-
T Consensus 162 ~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~ 194 (669)
T cd05610 162 MDILTTPSMAKPKNDYSRTPGQVLSLISSLGFN 194 (669)
T ss_pred cccccCccccCccccccCCCCceeeeeeecCcC
Confidence 445678889999988766665677888998853
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=217.11 Aligned_cols=204 Identities=26% Similarity=0.450 Sum_probs=177.9
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
....++||-|-+|.||.+.|++-.-.|+||.+..+. -.++.+..|+.+++.+.|||+++++++|....-+|||.||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 456789999999999999999988999999886543 2357788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc-c
Q 027809 89 ITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL-R 165 (218)
Q Consensus 89 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~ 165 (218)
|..|+|.+++.... .++..-+++|+.||.+|++||..++.+|+|+.++|.|++++..+|+.|||++.++....... .
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc
Confidence 99999999997654 47888899999999999999999999999999999999999999999999999877643322 1
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
...-+..|.|||.+.-... +.++|+|+||+++||+.| |-.||...+..+.|
T Consensus 425 GAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY 476 (1157)
T KOG4278|consen 425 GAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 476 (1157)
T ss_pred CccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH
Confidence 2223558999999985555 499999999999999998 99999999887766
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=198.11 Aligned_cols=188 Identities=51% Similarity=0.890 Sum_probs=164.2
Q ss_pred cceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCChHHHH
Q 027809 19 TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKI 98 (218)
Q Consensus 19 ~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 98 (218)
++|.+|.+.+..+++.+++|.+........ .+.+.+++..++.++|++++++.+.+......++++|++++++|.+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999865543221 577889999999999999999999999889999999999999999998
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccccccc
Q 027809 99 VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178 (218)
Q Consensus 99 ~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~ 178 (218)
.....++...++.++.+++.++.+||+.+++|+||+|+||++++++.++++|||.+....... ......+...|++||.
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV 157 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence 877668999999999999999999999999999999999999999999999999987655432 2223446678999999
Q ss_pred cccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 179 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
......+ .++|+||||++++++++|..||..
T Consensus 158 ~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 158 LLGKGYG-KAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HccCCCC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence 9866665 799999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=215.70 Aligned_cols=202 Identities=26% Similarity=0.453 Sum_probs=174.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC------CCCcceEEEEEEcCC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR------HPCVVRLHEVLASRT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~------~~~i~~~~~~~~~~~ 80 (218)
++|.+....|.|-||+|..|.++..|..||||++.+......+ =..|+++|+.|+ --|+++++..|.+.+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 6799999999999999999999999999999999876654433 347788888885 258999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeecccccc
Q 027809 81 KIYIILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSAL 156 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~ 156 (218)
++++|+|.+.- +|.+.+...+ .+....+...+.|++-||.+|-.+|++|+||+|.|||+..+. .+||||||.+.+
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 99999999965 9999998765 477889999999999999999999999999999999998765 589999999987
Q ss_pred CCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
...+.. .....+-.|.|||++.+..|+ +..|+||.||++||++||...|...+.+++
T Consensus 587 ~~enei--tPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 587 ASENEI--TPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred cccccc--cHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHH
Confidence 665432 123344579999999999998 999999999999999999999999887664
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=222.58 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=175.7
Q ss_pred ceEEeeeecCccceEEEEEEecCCCc----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
+.+-++.||+|+||+||+|.+.-.|+ +|++|++..... .+....+.+++-++..++|||++++++++..+. ..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 45667899999999999999886665 678888866553 333567889999999999999999999997755 78
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 84 IILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+|.+++++|+|.++...+ .++.....+.|..|||+++.|||+++++|+||-++|+||..-..+|+.|||++........
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 899999999999998765 5688999999999999999999999999999999999999999999999999987665444
Q ss_pred ccccc--cccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 LLRTT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~--~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
..... .-++.|+|-|.+....+. .++|+||+|+++||++| |..||.....++|
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 33232 235689999999888776 99999999999999998 9999999988775
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=204.75 Aligned_cols=210 Identities=28% Similarity=0.452 Sum_probs=175.9
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC---
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--- 79 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--- 79 (218)
|++--+-+..+.||-|.||.||.+.+-.+|+.+++|++.+....- ..-+++.+|...+..++|.|++..+++..-.
T Consensus 49 Pqqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L-~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 49 PQQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNL-ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred ccccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHH-HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 445556677899999999999999999999999999997765332 2346677889999999999999988876432
Q ss_pred --CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 80 --TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 80 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
+.+|++.|.+.. +|...+.....++...+.-++.||+.+|.|||+.+|.|+||||.|.++++|+..|+||||+++..
T Consensus 128 fFqEiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 128 FFQELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence 236778888854 88888888889999999999999999999999999999999999999999999999999999866
Q ss_pred CCCCc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 158 EQGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 158 ~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..... .......+-+|.|||.+++....+.+.||||.||++.|++..+..|+..++-
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 54322 2223345679999999997666669999999999999999999999987764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=213.84 Aligned_cols=198 Identities=20% Similarity=0.295 Sum_probs=140.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCC----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEE-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTET----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEV----- 75 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~----- 75 (218)
..++|++.+.||+|+||.||.|.+..+ +..+++|.+...... + ....+. +....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e--~~~~e~---l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--E--IWMNER---VRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--H--HHHHHH---HHhhchhhHHHHHHhhhccc
Confidence 467899999999999999999999888 899999987542211 1 011111 111111112111111
Q ss_pred -EEcCCeEEEEEEecCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 027809 76 -LASRTKIYIILEFITGGELFDKIVHHGR--------------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLK 134 (218)
Q Consensus 76 -~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~ 134 (218)
.......++|+||+++++|.+.+..... .....+..++.|++.+|.|||+++++|+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2455679999999999999888865321 1234467899999999999999999999999
Q ss_pred CCCeEecC-CCcEEEeeccccccCCCC-CcccccccccCccccccccccCCCC---------------------Ccchhh
Q 027809 135 PENLLLDS-QGHLKISDFGLSALPEQG-VSLLRTTCGTPNYVAPEVLSHKGYN---------------------GAAADV 191 (218)
Q Consensus 135 p~nil~~~-~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~---------------------~~~~Di 191 (218)
|+|||++. ++.++|+|||++...... ........+++.|+|||.+...... +.+.||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 579999999999643322 1122334567899999976432211 135699
Q ss_pred hhHhHHHHHHhhcCCCCC
Q 027809 192 WSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 192 ~slG~~l~~l~~g~~pf~ 209 (218)
||+||++|+|+++..|+.
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999877654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=191.57 Aligned_cols=197 Identities=27% Similarity=0.534 Sum_probs=166.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcC--Ce
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASR--TK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~--~~ 81 (218)
..++|++.+++|+|.++.||.|....+++.++||++...+ .+.+.+|+.+|+-+. +|||+++++++.+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3567999999999999999999999999999999987655 577999999999997 89999999998654 35
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-CcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-~~~~l~d~~~~~~~~~~ 160 (218)
..+++|+.+..+.. .-..+++...+...+.+++.||.|+|+.||.|+|++|.|+++|.. ...+|+|+|++.+..++
T Consensus 110 paLiFE~v~n~Dfk---~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFK---QLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHH---HHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67899999775443 333478899999999999999999999999999999999999865 46999999999987664
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.. ..-+..+-.|.-||.+.+...-++.-|+|||||++..|++...||=.-
T Consensus 187 ~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 187 KE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred ce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 32 223445667899999987666569999999999999999999998543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=202.72 Aligned_cols=194 Identities=26% Similarity=0.358 Sum_probs=156.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhh--cCCCCcceEEEEEEcCC----
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~--l~~~~i~~~~~~~~~~~---- 80 (218)
...++.+.+|+|+||.||+|... ++.||||+++.. ..+.+.+|.++.+. ++|+||+++++.-+...
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 34567889999999999999885 589999988532 34556666666554 47999999998865443
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeccCCCCCeEecCCCcEEEeec
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS---------KGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---------~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
.+++|+++.+.|+|.+++..+ .+++...++++..|+++|+|||+ ..|+|+||+.+|||+..|+...|+||
T Consensus 282 eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 799999999999999999865 78999999999999999999996 24999999999999999999999999
Q ss_pred cccccCCCCC--cccccccccCccccccccccCCCC-----CcchhhhhHhHHHHHHhhcCCCCC
Q 027809 152 GLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYN-----GAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~-----~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
|++....+.. ...-...|+.+|||||.+.+.--. =.+.||||+|.++|||+++..-+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 9997655432 223346789999999999753222 147899999999999998665543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=198.32 Aligned_cols=187 Identities=24% Similarity=0.447 Sum_probs=152.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhh--cCCCCcceEEEEEEcC----Ce
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLASR----TK 81 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~--l~~~~i~~~~~~~~~~----~~ 81 (218)
+-++.+.+|+|.||.||.|.++ |+.||||++.... .+...+|.++.+. ++|+||+.+++.-..+ .+
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3688999999999999999996 7899999985433 2344466666654 4999999999875322 36
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceeccCCCCCeEecCCCcEEEeeccc
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-----K---GVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-----~---~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
+|+|++|.+.|||.+++.. .+++....++++..+|.+|.+||. . .|.|+|||..||+|.+++..-|+|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 9999999999999999988 789999999999999999999995 2 299999999999999999999999999
Q ss_pred cccCCCCCc----ccccccccCccccccccccCC----CCC-cchhhhhHhHHHHHHhh
Q 027809 154 SALPEQGVS----LLRTTCGTPNYVAPEVLSHKG----YNG-AAADVWSCGVILYVLIA 203 (218)
Q Consensus 154 ~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~----~~~-~~~Di~slG~~l~~l~~ 203 (218)
+..-..... ....++|+.+|||||.+...- ..+ ..+||||||.++||+.-
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 975443311 133567899999999996321 112 47899999999999863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=212.94 Aligned_cols=201 Identities=26% Similarity=0.480 Sum_probs=167.7
Q ss_pred eEEeeeecCccceEEEEEEecC---C----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTE---T----GESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~---~----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
.++.+.||+|.||.|+.|.... . ...||||....... ....+.+..|+..++.+ .|+|++.+++.+...+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 3667799999999999987431 1 45789998765543 24467788999999988 5999999999999989
Q ss_pred eEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~ 144 (218)
..++|.||+..|+|..++.... .++...++.++.|||.+++||++.+.+|+|+.++|||+..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 9999999999999999997765 388999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCC-Cccccccc--ccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCC
Q 027809 145 HLKISDFGLSALPEQG-VSLLRTTC--GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELD 212 (218)
Q Consensus 145 ~~~l~d~~~~~~~~~~-~~~~~~~~--~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 212 (218)
.+|++|||++....+. ........ .+..|||||.+....++ .++|+||+|+++||+++ |..||....
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999853332 11111111 45689999999986665 99999999999999998 999998754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=202.05 Aligned_cols=205 Identities=20% Similarity=0.303 Sum_probs=147.1
Q ss_pred ccceEEeeeecCccceEEEEEEec----------------CCCcEEEEEEEecchhhhhh-----------HHHHHHHHH
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT----------------ETGESVAMKVLDRSAIIKHK-----------MADQIKREI 58 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~----------------~~~~~~~ik~~~~~~~~~~~-----------~~~~~~~~~ 58 (218)
.++|++.++||+|+||.||+|... ..+..|+||.+........+ ..+....|.
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999998642 24567999998543211110 011122344
Q ss_pred HhhhhcCCCC-----cceEEEEEEc--------CCeEEEEEEecCCCChHHHHHhc------------------------
Q 027809 59 SIMKLVRHPC-----VVRLHEVLAS--------RTKIYIILEFITGGELFDKIVHH------------------------ 101 (218)
Q Consensus 59 ~~l~~l~~~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~------------------------ 101 (218)
..+..++|++ +++++++|.. .+..++|+||+++++|.+.+...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 5555565544 3566666542 35689999999999998887532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc-ccccccCccccccccc
Q 027809 102 GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL-RTTCGTPNYVAPEVLS 180 (218)
Q Consensus 102 ~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~Pe~~~ 180 (218)
..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++.......... .....++.|++||.+.
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 123567788999999999999999999999999999999999999999999986543321111 1122367999999986
Q ss_pred cCCCC---------------------CcchhhhhHhHHHHHHhhcCC-CCCC
Q 027809 181 HKGYN---------------------GAAADVWSCGVILYVLIAGYL-PFDE 210 (218)
Q Consensus 181 ~~~~~---------------------~~~~Di~slG~~l~~l~~g~~-pf~~ 210 (218)
..... ..+.|+||+|+++++|++|.. ||..
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 43211 124699999999999999876 7754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-28 Score=177.63 Aligned_cols=185 Identities=45% Similarity=0.833 Sum_probs=158.1
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCCh
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGEL 94 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 94 (218)
||+|.+|.+|.+....+++.+++|.+....... ..+.+.+++..++.++|++++++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654321 346788999999999999999999999988999999999998899
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeeccccccCCCCCcccccccccCc
Q 027809 95 FDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPN 172 (218)
Q Consensus 95 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 172 (218)
.+.+... ..++...++.++.++++++.+||+.|++|+|++|.||+++. ++.++++||+.+..................
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9988776 57899999999999999999999999999999999999998 899999999998765543212223446678
Q ss_pred cccccccccCCCCCcchhhhhHhHHHHHH
Q 027809 173 YVAPEVLSHKGYNGAAADVWSCGVILYVL 201 (218)
Q Consensus 173 ~~~Pe~~~~~~~~~~~~Di~slG~~l~~l 201 (218)
|++||........+.+.|+|++|++++++
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 99999997652335899999999999876
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=190.89 Aligned_cols=200 Identities=32% Similarity=0.501 Sum_probs=172.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc------CC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------RT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------~~ 80 (218)
.||.-++.++.|.. .+..|.+.-.+.+|++|+...+... ...+++..+|...+..+.|+|+++++.+|.- -.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 57888999999999 6778888889999999999777443 5556788899999999999999999999853 23
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..|+|||+++. +|...+. -.++-..+.++..|++-++++||+.||+|+|++|+||++..++..|+.|||++......
T Consensus 95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 58999999976 8877776 35788999999999999999999999999999999999999999999999999876654
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
-.......+-.|.|||.+.+..+. ...||||+||++.||++|...|...+.
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~ 222 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDH 222 (369)
T ss_pred -cccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchH
Confidence 123344566789999999988876 999999999999999999999987654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-32 Score=194.74 Aligned_cols=207 Identities=30% Similarity=0.468 Sum_probs=167.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-------
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA------- 77 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~------- 77 (218)
..+.|.-..++|+|.||.||+|..+++|+.|++|+..-... .+-.-....+++.+++.+.|+|++.+++.|.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 34567778899999999999999999999998876532110 1112234568899999999999999887763
Q ss_pred -cCCeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 78 -SRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 78 -~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
....+|+|+++|.. +|.-.+.+. ..++..++.+++.++.++|.|+|..+|+|+|++|.|+|++.+|.++|.|||++.
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 23459999999987 787777766 579999999999999999999999999999999999999999999999999995
Q ss_pred cCCCCCcc----cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVSL----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
........ ...+..+..|.+||.+.+....+.+.|+|+-||++.+|++|.+.++..+-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 43322111 22234577899999998765556999999999999999999999987653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=186.71 Aligned_cols=201 Identities=25% Similarity=0.481 Sum_probs=160.7
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEE-EEcCCe
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEV-LASRTK 81 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~-~~~~~~ 81 (218)
+..+.|.+.+.+|+|.||.+-.+..+.++..+++|..+.+- ...+++.+|+-.--.+ .|.||+..++. |+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 44567999999999999999999999999999999876543 2356677777665555 47999988764 677788
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec--CCCcEEEeeccccccCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~--~~~~~~l~d~~~~~~~~~ 159 (218)
+++++|+++.|+|..-+.. ..+.+..-.+++.|+++|+.++|+++++|+||+.+|||+- +..++||||||.....+.
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999999776544 4577888999999999999999999999999999999993 335899999999876554
Q ss_pred CCcccccccccCccccccccccCC----CCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKG----YNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
-... ......|.+||.+.... ...+.+|+|.||++++.+++|..||+...
T Consensus 176 tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 176 TVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred eehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 3221 12234678888875321 11467899999999999999999999543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=189.39 Aligned_cols=209 Identities=22% Similarity=0.325 Sum_probs=168.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC-----cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEE-EcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL-ASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~-~~~ 79 (218)
..|++....+-+|.||.+|.|.++..+ +.+.+|...... ++-.+..+.+|.-.+.-..|||+.++.+++ ++.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 346788888999999999999877543 345666554333 222356678888888888999999999986 456
Q ss_pred CeEEEEEEecCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeec
Q 027809 80 TKIYIILEFITGGELFDKIVH--------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
...++++.+++.++|..++.. ...++..++..++.|++-|++|||++|++|.||.++|.++++..++||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 678899999999999999972 134788999999999999999999999999999999999999999999998
Q ss_pred cccccCCC-CCccc-ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 152 GLSALPEQ-GVSLL-RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 152 ~~~~~~~~-~~~~~-~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
.+++..-+ ..... .....+..||+||.+.+..++ .++|+||||+++|||+| |..||...||.+++
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 88763222 11111 112246689999999988886 99999999999999998 99999999998753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-27 Score=183.14 Aligned_cols=130 Identities=32% Similarity=0.543 Sum_probs=110.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC--------CCCcceEEEEEEc
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--------HPCVVRLHEVLAS 78 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~--------~~~i~~~~~~~~~ 78 (218)
+||.+.++||.|.|++||.+.+..+++.||+|+..+.... .+....|+.+|++++ ..+++++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 7899999999999999999999999999999998765533 455567788887773 3689999999964
Q ss_pred ----CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEec
Q 027809 79 ----RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCH-SKGVYHRDLKPENLLLD 141 (218)
Q Consensus 79 ----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh-~~~i~h~di~p~nil~~ 141 (218)
+.+.++|+|++.. +|..++... ..++...+..|+.|++.+|.||| ++||+|.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 4589999999955 777777543 46999999999999999999999 67999999999999993
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=171.54 Aligned_cols=204 Identities=23% Similarity=0.353 Sum_probs=168.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcCCeE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKI 82 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~~~~ 82 (218)
...++|+++++||+|+||.+|.|....+|+.||||.-.+... -.++.-|..+...+++ ..|+.+..++.....-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 357899999999999999999999999999999998754432 2456677788888876 7888888888888889
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC---CcEEEeeccccccCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPE 158 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~---~~~~l~d~~~~~~~~ 158 (218)
.+|||.+.+ +|.++.+-. ..++..+++-++.|++.-++++|.++.+|+||+|+|+|.+-+ ..+.++|||++....
T Consensus 87 vlVMdLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeeccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999999954 998887654 468999999999999999999999999999999999999765 469999999997654
Q ss_pred CCCcc-------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 159 QGVSL-------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 159 ~~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+.... .....++.+|.+.-.+.+...+ .+.|+-|+|++++++--|.+||+...+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchh
Confidence 32211 1223467788888877755554 8999999999999999999999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=201.66 Aligned_cols=203 Identities=33% Similarity=0.533 Sum_probs=176.5
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|..+..+|+|.+|.||+++++.+++..++|+++..... ...-+.+|+..++.++|+||+.|++.+-..+.+|++|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4699999999999999999999999999999988766533 3466789999999999999999999999889999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|||.+++|.+.-.--+++++.++.+...+.++++.|||+.|-+|+||+-.||++++.|.+++.|||.+--...--.....
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 99999999887766678999999999999999999999999999999999999999999999999987544433333445
Q ss_pred ccccCccccccccc---cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 167 TCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..|+++|||||+-. ...+. ..+|+|++|+...|+-.-++|--+..+
T Consensus 172 fiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhp 220 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHP 220 (829)
T ss_pred ccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccch
Confidence 67999999999974 34454 899999999999999888887665544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=180.45 Aligned_cols=201 Identities=26% Similarity=0.375 Sum_probs=161.3
Q ss_pred ceEEeeeecCccceEEEEEEecCCC-cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC----CCCcceEEEEE-EcCCe
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR----HPCVVRLHEVL-ASRTK 81 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~----~~~i~~~~~~~-~~~~~ 81 (218)
+|++.+.||+|+||.||.+.+..++ ..+|+|.......... ..+..|..++..+. .++++.+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988765 5788887755432111 14556666666665 37999999998 57778
Q ss_pred EEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-----CcEEEeecccc
Q 027809 82 IYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-----GHLKISDFGLS 154 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-----~~~~l~d~~~~ 154 (218)
.|+||+.+ |.+|.++.... +.++..+++.++.|++.+|+++|+.|++|+||+|.|+.++.. ..+.+.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 45998877544 479999999999999999999999999999999999999765 45999999999
Q ss_pred c--cCC-CCC----cc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 155 A--LPE-QGV----SL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 155 ~--~~~-~~~----~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. ... ... .. .....++.+|+++..+.+.... .+.|+||+++++.++..|.+||+....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccc
Confidence 8 311 110 11 1123378899999999887776 999999999999999999999987664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=199.95 Aligned_cols=194 Identities=32% Similarity=0.433 Sum_probs=157.5
Q ss_pred eEEeeeecCccceE-EEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEE
Q 027809 9 YEVGRTIGEGTFAK-VKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 9 y~~~~~l~~g~~g~-vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
|...+.+|.|+-|+ ||.|.. +|+.||||.+-... ...+.+|+..++.. +||||+++++.-.+.++.|+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34456778888875 788887 46799999764333 45677889888888 5999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---C--CcEEEeeccccccC
Q 027809 87 EFITGGELFDKIVHH-GR---LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---Q--GHLKISDFGLSALP 157 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-~~---~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~--~~~~l~d~~~~~~~ 157 (218)
|.|.. +|.+++... .. ......+....|+++++++||..+|+|+|++|-||||+. + .+++|+|||++...
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99976 999999774 11 122556888999999999999999999999999999975 2 47999999999876
Q ss_pred CCCCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCC
Q 027809 158 EQGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELD 212 (218)
Q Consensus 158 ~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 212 (218)
...... .....|+.+|+|||.+...... .+.|||||||++|+.++ |..||.+.-
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchH
Confidence 655443 3345578899999999876665 79999999999999988 599998753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=176.68 Aligned_cols=166 Identities=22% Similarity=0.251 Sum_probs=126.3
Q ss_pred ccccceEEeeeecCccceEEEEEEecC-CCcEEEEEEEecchh--hhhhHHHHHHHHHHhhhhcCCCCcce-EEEEEEcC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAI--IKHKMADQIKREISIMKLVRHPCVVR-LHEVLASR 79 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~~i~~-~~~~~~~~ 79 (218)
...++|++.+.||+|+||.||.|.+.. ++..++||....... ........+.+|+..++.++|+++++ +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 456789999999999999999998876 667789998643211 12233566899999999999999885 4432
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEecCCCcEEEeeccccccCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL-KPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di-~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+..++||||+++++|... . +.. ...++.+++++|.+||++|++|+|| +|+||+++.++.++|+|||++....
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 457999999999888632 1 111 2467889999999999999999999 9999999999999999999997554
Q ss_pred CCCccc--------ccccccCccccccccc
Q 027809 159 QGVSLL--------RTTCGTPNYVAPEVLS 180 (218)
Q Consensus 159 ~~~~~~--------~~~~~~~~~~~Pe~~~ 180 (218)
...... ....+.+.|.+||.+.
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 322111 1123456788888885
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=169.70 Aligned_cols=202 Identities=25% Similarity=0.397 Sum_probs=170.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 85 (218)
-.|+++++||+|+||..+.|.+.-++++||||.-+... .+.+++.|.+..+.+. .++|+..+=+...+.+=.+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 46999999999999999999999999999999764432 2577889999998885 59999888776666667789
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-----cEEEeeccccccCCC
Q 027809 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-----HLKISDFGLSALPEQ 159 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-----~~~l~d~~~~~~~~~ 159 (218)
+|.+. .+|.++....+ .|+..+++-+|.||+.-++++|++.++++||+|+|+||+..+ .+.++|||.+.-...
T Consensus 103 idLLG-PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 103 IDLLG-PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhC-cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 99995 49998887654 699999999999999999999999999999999999997443 589999999975554
Q ss_pred CCcc-------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 160 GVSL-------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 160 ~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.... .....|+.+||+--.+.+++.+ .+.|+.+||-++++++-|.+||+....++
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 3221 2334578899999999988876 99999999999999999999999887654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=179.68 Aligned_cols=202 Identities=29% Similarity=0.462 Sum_probs=168.4
Q ss_pred cccccceEEeeeecCccceEEEEEEecC---CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEc
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLAS 78 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~ 78 (218)
+...+.|..+++||+|.|++||++.+.. ..+.|++|.+..... ..++..|.+.+..+. +.|++++.+.+..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 4567789999999999999999999887 678999998855432 356889999999885 7999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeecccccc-
Q 027809 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSAL- 156 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~- 156 (218)
++...+|+||+++....++.. .++..++...+..++.||.++|.+||+|+||||+|++.+. .++-.|+|||++..
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999999988777765 4678999999999999999999999999999999999975 46789999999871
Q ss_pred CCCC-------------Cc------------------------------ccccccccCccccccccccCCCCCcchhhhh
Q 027809 157 PEQG-------------VS------------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWS 193 (218)
Q Consensus 157 ~~~~-------------~~------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~s 193 (218)
.... .+ ......|+++|.|||++......+.+.|+||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0000 00 0011237889999999988777778999999
Q ss_pred HhHHHHHHhhcCCCCCCCC
Q 027809 194 CGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 194 lG~~l~~l~~g~~pf~~~~ 212 (218)
-|+++..+++++.||=...
T Consensus 264 ~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred ccceeehhhccccccccCc
Confidence 9999999999999985543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=164.23 Aligned_cols=173 Identities=16% Similarity=0.197 Sum_probs=132.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHH------HHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ------IKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
-++|++.+.++.|+||.||.+.+ ++..+++|.+......++..... +.+|+..+.++.|+++..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999765 36689999997655444444344 57888899999999999999886532
Q ss_pred --------CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeec
Q 027809 80 --------TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 80 --------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
+..+++|||++|.+|.+... +++ ....+++.++..+|+.|++|+|++|+||++++++ ++++||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999977632 333 2456999999999999999999999999999888 999999
Q ss_pred cccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHh
Q 027809 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLI 202 (218)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~ 202 (218)
|.......... .........+. .++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a------------~d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA------------KDRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh------------HHHHHHHhHhc-ccccccceeEeehHHH
Confidence 97653322111 01133334455 7899999998876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=158.29 Aligned_cols=142 Identities=25% Similarity=0.299 Sum_probs=110.5
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhh-----------------------HHHHHHHHHHhhhhcCCCC
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-----------------------MADQIKREISIMKLVRHPC 68 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~l~~~~ 68 (218)
.+.||+|++|.||.|.+. +|++||+|++......... .......|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999754321111 0122345888888888777
Q ss_pred cceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCeEecCCCcEE
Q 027809 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC-HSKGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~i~h~di~p~nil~~~~~~~~ 147 (218)
+......... ..++||||++++++........+++..++..++.|++.+|.++ |+.|++|+|++|+||+++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6443333222 2389999999877765555567899999999999999999999 799999999999999997 57899
Q ss_pred EeeccccccC
Q 027809 148 ISDFGLSALP 157 (218)
Q Consensus 148 l~d~~~~~~~ 157 (218)
|+|||++...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-23 Score=158.60 Aligned_cols=202 Identities=41% Similarity=0.718 Sum_probs=171.1
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCC-CcceEEEEEEcCCeEEEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP-CVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 87 (218)
|.+.+.||.|+||.+|.+.+. ..+++|.+.............+.++...+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 67888988666544433467788888899999988 79999999987777899999
Q ss_pred ecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCCCc-
Q 027809 88 FITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~~~- 162 (218)
++.++++.+.+.... .++......++.|++.++.++|+.+++|+|++|+||+++..+ .++++|||.+........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776664 789999999999999999999999999999999999999888 799999999874443221
Q ss_pred -----ccccccccCccccccccccC--CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 -----LLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 -----~~~~~~~~~~~~~Pe~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......++..|++||.+... ...+...|+|++|++++++++|..||.....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 23455678899999999874 3445899999999999999999999877653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-23 Score=150.09 Aligned_cols=143 Identities=22% Similarity=0.271 Sum_probs=111.9
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhh-----------------------hhHHHHHHHHHHhhhhcCCCC
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-----------------------HKMADQIKREISIMKLVRHPC 68 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~l~~~~ 68 (218)
.+.||+|++|.||.|.+. +|+.|++|++....... .........|...+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999987542110 001223457788888888887
Q ss_pred cceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEE
Q 027809 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~ 147 (218)
+.....+.... .++||||++++++.........++..+...++.|++.++.++|. .|++|+||+|.||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75444433332 48999999987554443345678889999999999999999999 9999999999999998 89999
Q ss_pred EeeccccccCC
Q 027809 148 ISDFGLSALPE 158 (218)
Q Consensus 148 l~d~~~~~~~~ 158 (218)
|+|||++....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-23 Score=146.60 Aligned_cols=189 Identities=16% Similarity=0.195 Sum_probs=139.8
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHH-HHHHHHHHhhhhcCC-CCcceEEEEEEcCCeEEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA-DQIKREISIMKLVRH-PCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~-~~~~~~~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.+...|++|+||+|+.+.. .+.+++.+.+........... ..+.+|+++++++.| +++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999996654 567788777655543322222 247889999999964 889999886 3469999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEecCCCcEEEeeccccccCCCCCcc--
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDL-KPENLLLDSQGHLKISDFGLSALPEQGVSL-- 163 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di-~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 163 (218)
+|+.|.+|...... ....++.|++.++.++|++|++|+|| +|.||+++.++.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999888654321 12356789999999999999999999 799999999999999999999754433211
Q ss_pred --c---------ccccccCccccccccccCCCCC-cchhhhhHhHHHHHHhhcCCCCCC
Q 027809 164 --L---------RTTCGTPNYVAPEVLSHKGYNG-AAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 164 --~---------~~~~~~~~~~~Pe~~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
. ......+.+++|+........+ .+.+.++.|.-+|.++|+..|+=.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0111356777777765443333 678888999999999998887643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=186.79 Aligned_cols=142 Identities=22% Similarity=0.245 Sum_probs=105.8
Q ss_pred CCcceEEEEEE-------cCCeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 027809 67 PCVVRLHEVLA-------SRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENL 138 (218)
Q Consensus 67 ~~i~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~ni 138 (218)
+|+.++.++|. .....+.++|++++ +|.+.+... ..+++.+++.++.||++||.|||++||+|+||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 46666666662 22356777888854 999999653 4689999999999999999999999999999999999
Q ss_pred EecCCCcEE-------------------EeeccccccCCCCCc----------------ccccccccCccccccccccCC
Q 027809 139 LLDSQGHLK-------------------ISDFGLSALPEQGVS----------------LLRTTCGTPNYVAPEVLSHKG 183 (218)
Q Consensus 139 l~~~~~~~~-------------------l~d~~~~~~~~~~~~----------------~~~~~~~~~~~~~Pe~~~~~~ 183 (218)
|++..+.++ ++|||++........ ......+++.|+|||.+....
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 996655555 445554432110000 000123566799999998777
Q ss_pred CCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 184 YNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 184 ~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
+. .++|||||||++|||++|..|+..
T Consensus 192 ~~-~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 192 SN-CASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CC-chhhhhhHHHHHHHHhhCCCchhh
Confidence 75 999999999999999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=178.22 Aligned_cols=196 Identities=21% Similarity=0.304 Sum_probs=156.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
...|.|-+.+|+|++|.||.|.... |+.||+|+-.....+.-..-.++.+++ +..--+.|+.+...+...+.-++|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RL---k~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERL---KPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhh---chhhhcchHHHHHHHccCCcceee
Confidence 4569999999999999999999876 999999998766654333223332322 211235566666665666778899
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-------CCCcEEEeeccccccCC
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-------SQGHLKISDFGLSALPE 158 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-------~~~~~~l~d~~~~~~~~ 158 (218)
+||.+.|+|.++++..+.+++.-.+.+..||+..+++||..+|+||||||+|+++. +..-++|+|||.+..+.
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999999999888899999999999999999999999999999999999993 22348999999986433
Q ss_pred C--CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCC
Q 027809 159 Q--GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYL 206 (218)
Q Consensus 159 ~--~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 206 (218)
- ........+.+-.+-++|...++.|. ++.|.|+|+.+++.|++|+.
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence 2 11234455667789999999999997 99999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=156.39 Aligned_cols=203 Identities=28% Similarity=0.357 Sum_probs=138.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC----------CCcceEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH----------PCVVRLHEVLA 77 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~----------~~i~~~~~~~~ 77 (218)
....++.||.|+++.||.+.+.++|+.+++|+............+.++++......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 35788999999999999999999999999999977665555567777777766655432 12333333321
Q ss_pred ------------cCC-----eEEEEEEecCCCChHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 027809 78 ------------SRT-----KIYIILEFITGGELFDKIV---HHGR----LSESEARRYFQQLIDGVDYCHSKGVYHRDL 133 (218)
Q Consensus 78 ------------~~~-----~~~lv~e~~~~~~L~~~~~---~~~~----~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di 133 (218)
+.. ..+++|+.+.+ +|.+.+. .... +.....+.+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 24677887754 7766543 2222 234445667789999999999999999999
Q ss_pred CCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccccccccccC-------CCCCcchhhhhHhHHHHHHhhcCC
Q 027809 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK-------GYNGAAADVWSCGVILYVLIAGYL 206 (218)
Q Consensus 134 ~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~ 206 (218)
+|+|++++.+|.+.|+||+.....+..... ...+..|.+||..... ...+.+.|.|+||+++|.|+||..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 999999999999999999877765553322 2334678899877432 112578899999999999999999
Q ss_pred CCCCCCcc
Q 027809 207 PFDELDLT 214 (218)
Q Consensus 207 pf~~~~~~ 214 (218)
||....+.
T Consensus 249 Pf~~~~~~ 256 (288)
T PF14531_consen 249 PFGLSSPE 256 (288)
T ss_dssp STCCCGGG
T ss_pred CCCCCCcc
Confidence 99977654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=145.12 Aligned_cols=107 Identities=29% Similarity=0.403 Sum_probs=92.5
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccccc
Q 027809 92 GELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (218)
Q Consensus 92 ~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 170 (218)
|+|.+.+..+ ..+++.+++.++.|++.||.|||+.+ +|+||+++.++.+++ ||.+....... ..++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence 5888888764 46999999999999999999999998 999999999999999 99877554321 2467
Q ss_pred CccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 171 ~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
+.|+|||.+.+..+. .++||||||+++|+|++|..||....
T Consensus 68 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 68 PYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred ccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccc
Confidence 899999999877775 89999999999999999999997643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-23 Score=150.12 Aligned_cols=199 Identities=20% Similarity=0.353 Sum_probs=158.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++..+..+|.+...|..|.+++++ +.++.|++... ..+....+++.+|+-.++-+.||||+++++.|.+.....+++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr-~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVR-EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC--cchhhhhhhhh-hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 344567788999999999999974 46677776433 345555688999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecCCCcEEEe--eccccccCCCC
Q 027809 87 EFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKIS--DFGLSALPEQG 160 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~~~~~~l~--d~~~~~~~~~~ 160 (218)
.|++.++|...+-.... .+..++.+++.+++.++.|||+.. +.--.++...+++|++...+++ |.-++. .
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---q- 342 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---Q- 342 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---e-
Confidence 99999999999876654 688999999999999999999864 3344788999999998876665 322111 0
Q ss_pred CcccccccccCccccccccccCCCC--CcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
. ....-.|.|++||.+.....+ -.++|+|||+++++|+-|.+.||.++++-+
T Consensus 343 --e-~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 343 --E-VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred --c-cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 0 123346789999999755443 358999999999999999999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=143.14 Aligned_cols=147 Identities=19% Similarity=0.235 Sum_probs=114.4
Q ss_pred ceEEeeeecCccceEEEEEE-ecCCCcEEEEEEEecchhhh---------------------hhHHHHHHHHHHhhhhcC
Q 027809 8 KYEVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIK---------------------HKMADQIKREISIMKLVR 65 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~-~~~~~~~~~ik~~~~~~~~~---------------------~~~~~~~~~~~~~l~~l~ 65 (218)
-|++.+.||+|++|.||.|. +..+|..|++|++....... ......+..|+..+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47899999999999999998 66789999999986542100 011234567888888886
Q ss_pred C--CCcceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCeEecC
Q 027809 66 H--PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG-VYHRDLKPENLLLDS 142 (218)
Q Consensus 66 ~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~-i~h~di~p~nil~~~ 142 (218)
+ ..++++++. ...++|||++++.+|.........+...+...++.|++.++.+||+.| ++|+|++|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 5 334455543 234899999999887665544455667778899999999999999999 99999999999998
Q ss_pred CCcEEEeeccccccCCC
Q 027809 143 QGHLKISDFGLSALPEQ 159 (218)
Q Consensus 143 ~~~~~l~d~~~~~~~~~ 159 (218)
++.++++|||.+.....
T Consensus 184 ~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CCCEEEEEChhhhccCC
Confidence 88999999998875443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-23 Score=168.64 Aligned_cols=204 Identities=33% Similarity=0.555 Sum_probs=164.2
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEec---chhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR---SAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
.....+|.|.+|.++.+......+....|.... ...........+..|+-+-..+.|+|++..+..+.+.......|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 457788999999888877776666666655431 11122222233667777778889999987777666656566669
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC----c
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV----S 162 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~----~ 162 (218)
|||+. +|...+...+.++..++.-++.|++.++.|+|+.|+.|+|++++|+++..+|.++++|||.+....... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99999 999999887889999999999999999999999999999999999999999999999999986544322 2
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....++...|+|||.+....++....|+||.|++++.|.+|+.||.....+
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 2344567889999999999999988999999999999999999999876554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-20 Score=133.91 Aligned_cols=138 Identities=18% Similarity=0.253 Sum_probs=105.0
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-----CCCCcceEEEEEEcCC---e
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-----RHPCVVRLHEVLASRT---K 81 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-----~~~~i~~~~~~~~~~~---~ 81 (218)
.-.+.||+|++|.||. ...++.. +||++..... ...+.+.+|+..++.+ +||||++++++++.+. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3457899999999995 4455554 6888765432 2246688999999999 5799999999998763 4
Q ss_pred -EEEEEEe--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCCeEecC----CCcEEEee-cc
Q 027809 82 -IYIILEF--ITGGELFDKIVHHGRLSESEARRYFQQLIDGV-DYCHSKGVYHRDLKPENLLLDS----QGHLKISD-FG 152 (218)
Q Consensus 82 -~~lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l-~~Lh~~~i~h~di~p~nil~~~----~~~~~l~d-~~ 152 (218)
+.+|+|+ +.+++|.+++.+. .+++. ...+.+++.++ +|||+++|+|+||+|+||+++. +.+++|+| ||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 3378999 5578999999764 46555 35577777666 9999999999999999999974 33799999 55
Q ss_pred cccc
Q 027809 153 LSAL 156 (218)
Q Consensus 153 ~~~~ 156 (218)
....
T Consensus 156 ~~~~ 159 (210)
T PRK10345 156 ESTF 159 (210)
T ss_pred Ccce
Confidence 4433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-20 Score=134.41 Aligned_cols=139 Identities=24% Similarity=0.330 Sum_probs=113.6
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhh-----hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-----KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+.||+|++|.||.|.+ .|..+++|.......... ....++..|+..+..+.+++++....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 567799997654322111 123457788889999999888777777666677899999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+++|.+|.+.+..... +...++.+++.++.++|+.+++|+|++|.||+++ ++.++++|||.+....
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~~ 145 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFSK 145 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCCC
Confidence 9999999988865422 8889999999999999999999999999999998 8889999999887543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-22 Score=165.11 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=150.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecch--hhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA--IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
++...+.||++.|=++.+|++.+ |. +++|++-+.. +.-+...+++ +++. ....++||.+++.-+-......|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 78899999999999999998753 44 8889885433 1222222333 3333 5566899999998887777778889
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc--
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-- 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 163 (218)
-+|... +|.+.+..+.-+...+...++.|++.|+..+|+.|++|||||.+|||+.+=+.+.|+||..-....-..+.
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 899876 99999988877889999999999999999999999999999999999999999999999865321111111
Q ss_pred -----cccccccCccccccccccCC---------C-CCcchhhhhHhHHHHHHhh-cCCCCC
Q 027809 164 -----LRTTCGTPNYVAPEVLSHKG---------Y-NGAAADVWSCGVILYVLIA-GYLPFD 209 (218)
Q Consensus 164 -----~~~~~~~~~~~~Pe~~~~~~---------~-~~~~~Di~slG~~l~~l~~-g~~pf~ 209 (218)
.-......+|.|||.+.... + -+++.||||+||++.|+++ |++||.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 01111234899999986422 1 1478899999999999987 899986
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.2e-19 Score=129.42 Aligned_cols=135 Identities=20% Similarity=0.269 Sum_probs=105.9
Q ss_pred eecCccceEEEEEEecCCCcEEEEEEEecchhhh-----hhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-----HKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
.||+|++|.||.+.. ++..+++|......... .....++..|+..+..++++++....-++...+..+++||+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 479999999999985 46789999865432211 11235677889999999887655544444455667899999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+++++|.+.+..... .++.+++.++.+||+.|++|+|++|.||+++ ++.++++|||++....
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999887754321 7889999999999999999999999999998 8999999999887543
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.8e-19 Score=128.96 Aligned_cols=139 Identities=20% Similarity=0.304 Sum_probs=106.5
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh-------------------hHHHHHHHHHHhhhhcCCC--
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-------------------KMADQIKREISIMKLVRHP-- 67 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-------------------~~~~~~~~~~~~l~~l~~~-- 67 (218)
|.+.+.||+|++|.||.+... +|+.+++|++........ ........|+..+..+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999874 789999998764321100 0112356677778877666
Q ss_pred CcceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEE
Q 027809 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~ 147 (218)
.++..++. ...+++||++++++|..... ......++.+++.++.++|+.|++|+||+|.||+++.++.++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 44444442 34589999999988865432 134667889999999999999999999999999999999999
Q ss_pred EeeccccccCC
Q 027809 148 ISDFGLSALPE 158 (218)
Q Consensus 148 l~d~~~~~~~~ 158 (218)
|+|||.+....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999885433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=144.00 Aligned_cols=140 Identities=19% Similarity=0.258 Sum_probs=111.2
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecch-----hhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA-----IIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
|...+.||+|++|.||.+.+... .+++|...... .......+++.+|+..+..++|++++....++......+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 45678999999999999887543 34444332211 111223456889999999999999988777776666788
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
+||||+++++|.+.+. ....++.+++.++.+||+.+++|+|++|+||++ +++.++++|||++.....
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~~ 479 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSDL 479 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCCc
Confidence 9999999999988775 357789999999999999999999999999999 678999999999876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-20 Score=150.65 Aligned_cols=188 Identities=36% Similarity=0.655 Sum_probs=150.8
Q ss_pred ecCccceEEEEEEec---CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEEEEecC
Q 027809 15 IGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 15 l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
+|+|++|.++.+... ..|.-++.|+............ .-..+-.++...+ +|.+++..-.++.+...+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 688999998765422 2344556666544332222111 3345555666665 8999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccccc
Q 027809 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170 (218)
Q Consensus 91 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 170 (218)
++.|...+.....+++........+++-+++++|+.+++|+|+|++||+++.+|.+++.|||++........ .+++
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACGT 156 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----cccc
Confidence 999888888777888888999999999999999999999999999999999999999999999876554332 2778
Q ss_pred CccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 171 ~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
..|+|||.+. .. ..+.|.||+|+++++|++|..||..
T Consensus 157 ~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 157 YEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999997 33 3789999999999999999999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.8e-18 Score=121.29 Aligned_cols=137 Identities=24% Similarity=0.358 Sum_probs=95.6
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHH---------------------HHHHHHhhhhcCCC--C
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ---------------------IKREISIMKLVRHP--C 68 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~---------------------~~~~~~~l~~l~~~--~ 68 (218)
.+.||+|++|.||.|.+. ++..|++|++............. ...+...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999976 78999999986543221111111 12344444444333 2
Q ss_pred cceEEEEEEcCCeEEEEEEecCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcE
Q 027809 69 VVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHL 146 (218)
Q Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~ 146 (218)
+++.++. ...++++|+++++.+.. .+... .. ..+...++.+++.++.++|. .+++|+|++|+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 23589999999843321 11111 11 16788999999999999999 9999999999999999 8999
Q ss_pred EEeecccccc
Q 027809 147 KISDFGLSAL 156 (218)
Q Consensus 147 ~l~d~~~~~~ 156 (218)
+++|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999998853
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.3e-19 Score=135.30 Aligned_cols=144 Identities=27% Similarity=0.465 Sum_probs=109.4
Q ss_pred CCCCcceEEEEEEc---------------------------CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 027809 65 RHPCVVRLHEVLAS---------------------------RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117 (218)
Q Consensus 65 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~ 117 (218)
+||||+++..+|.+ +..+|+||...+. +|+.++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999876622 3468999999876 999888765 446677788899999
Q ss_pred HHHHHHHhCCceeccCCCCCeEe--cCCC--cEEEeeccccccCCCCCcccc------cccccCccccccccccCCCC--
Q 027809 118 DGVDYCHSKGVYHRDLKPENLLL--DSQG--HLKISDFGLSALPEQGVSLLR------TTCGTPNYVAPEVLSHKGYN-- 185 (218)
Q Consensus 118 ~~l~~Lh~~~i~h~di~p~nil~--~~~~--~~~l~d~~~~~~~~~~~~~~~------~~~~~~~~~~Pe~~~~~~~~-- 185 (218)
+++.|||++|+.|+|+|.+||++ |+|+ ...+.|||++-...+...... ..-+.-..||||......-.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999999 4444 478889998765544211111 11134567999998532111
Q ss_pred ---CcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 186 ---GAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 186 ---~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
-.++|.|+-|.+.||++...-||=.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccc
Confidence 2589999999999999999999865
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-17 Score=133.62 Aligned_cols=169 Identities=16% Similarity=0.285 Sum_probs=134.8
Q ss_pred EEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCC
Q 027809 25 FAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRL 104 (218)
Q Consensus 25 ~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 104 (218)
.|..+.++.++.|+.+..... +......+.+..++.++||||+++++.++..+..|+|.|.+. +|...+++-
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 456677889999998877653 455778899999999999999999999999999999999995 566666654
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccccccccccCC
Q 027809 105 SESEARRYFQQLIDGVDYCH-SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183 (218)
Q Consensus 105 ~~~~~~~~~~~i~~~l~~Lh-~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 183 (218)
+...+...+.||+.||.+|| +++++|++++-..++++..|.++|++|.+++.................|..|+.+....
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 47889999999999999998 67899999999999999999999999988764333221112222233566677654332
Q ss_pred CCCcchhhhhHhHHHHHHhhc
Q 027809 184 YNGAAADVWSCGVILYVLIAG 204 (218)
Q Consensus 184 ~~~~~~Di~slG~~l~~l~~g 204 (218)
...|.|.||+++++++.|
T Consensus 182 ---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 ---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cchhhhhHHHHHHHHhCc
Confidence 357999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-17 Score=120.83 Aligned_cols=140 Identities=24% Similarity=0.354 Sum_probs=104.4
Q ss_pred eeeec-CccceEEEEEEecCCCcEEEEEEEecchh----------hhhhHHHHHHHHHHhhhhcCCCCc--ceEEEEEEc
Q 027809 12 GRTIG-EGTFAKVKFAQNTETGESVAMKVLDRSAI----------IKHKMADQIKREISIMKLVRHPCV--VRLHEVLAS 78 (218)
Q Consensus 12 ~~~l~-~g~~g~vy~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~~~~~~~~l~~l~~~~i--~~~~~~~~~ 78 (218)
...|| .||.|++|.+... +..+++|.+..... .+.....++.+|+..+..++++++ ++.++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34576 7888888888764 67899998854221 011223567889999999988775 666666432
Q ss_pred C-C---eEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 79 R-T---KIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 79 ~-~---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
. . ..++|+|++++ .+|.+.+.. .++++.. +.+++.++.+||++|++|+|++|.||+++.++.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 2 23599999997 688877754 3455443 56899999999999999999999999999989999999998
Q ss_pred cccCC
Q 027809 154 SALPE 158 (218)
Q Consensus 154 ~~~~~ 158 (218)
+....
T Consensus 189 ~~~~~ 193 (239)
T PRK01723 189 GELRT 193 (239)
T ss_pred cccCC
Confidence 87543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=131.66 Aligned_cols=152 Identities=25% Similarity=0.410 Sum_probs=127.4
Q ss_pred hhhcCCCCcceEEEEEEcCCeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCCe
Q 027809 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGV-YHRDLKPENL 138 (218)
Q Consensus 61 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i-~h~di~p~ni 138 (218)
++++.|.|+.++++.+.+++..+.|.++|..|+|.+.+.. ..++++.....+..+++.++.|||.-.+ +||.++++|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678899999999999999999999999999999999987 4578899999999999999999997754 9999999999
Q ss_pred EecCCCcEEEeeccccccCCC--CCcccccccccCccccccccccCCC------CCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 139 LLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHKGY------NGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 139 l~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~Pe~~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
+++....+|++|||+..+... ............-|.|||.++.... -+.++|+||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876642 1111111223457999999986421 24679999999999999999999987
Q ss_pred CC
Q 027809 211 LD 212 (218)
Q Consensus 211 ~~ 212 (218)
..
T Consensus 161 ~~ 162 (484)
T KOG1023|consen 161 RN 162 (484)
T ss_pred cc
Confidence 43
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.8e-18 Score=141.80 Aligned_cols=171 Identities=36% Similarity=0.681 Sum_probs=128.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
-.+|..++.+..|++|.||.+.++.+..+++.| ++... .+.+. ++.....|.++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~--------lilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN--------LILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc--------hhhhc--cccccCCccee---------------
Confidence 357899999999999999999998888899984 33222 11111 22222333333
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc--
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL-- 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 163 (218)
++=...++..++++- +++.+++|||..||+|+|++|+|.+|..-|++|+.|||+..........
T Consensus 136 ------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 222333444444442 3389999999999999999999999999999999999997643321110
Q ss_pred -------------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 164 -------------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 164 -------------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
.++-+++|.|.|||++....|. ...|.|+||+++|+++-|..||-...+++++
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 1233689999999999988886 8899999999999999999999999999876
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-16 Score=110.77 Aligned_cols=134 Identities=23% Similarity=0.301 Sum_probs=109.9
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC--CCcceEEEEEEcCCeEEEEEEe
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
+++.+++|.++.+|.+...+ ..+++|....... ...+.+|...++.+++ .++++++.+....+..++++|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999998754 6789998754332 3456778888888866 5889999988877889999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK---GVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+++.++... +......++.++++++..+|.. +++|+|++|.|+++++++.++++||+.+....
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 998767543 5567778889999999999984 69999999999999998999999999876433
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-17 Score=138.32 Aligned_cols=208 Identities=38% Similarity=0.635 Sum_probs=167.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC-cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~ 83 (218)
...|.+.+.||.|.++.+-.+....+. ..++.|.+.... ........+..+...-..+. |+|++..++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 456888999999999999877765443 345555554332 23334556666777777776 999999999999999999
Q ss_pred EEEEecCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEecCCC-cEEEeeccccccCCC
Q 027809 84 IILEFITGGELFDKI-VHHG-RLSESEARRYFQQLIDGVDYCH-SKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQ 159 (218)
Q Consensus 84 lv~e~~~~~~L~~~~-~~~~-~~~~~~~~~~~~~i~~~l~~Lh-~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~ 159 (218)
+..++..++++...+ .... ..+....-..+.|+..++.|+| ..++.|+|++|+|.+++..+ ..++.||+++.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999998877 4444 5678888899999999999999 99999999999999999999 999999999975554
Q ss_pred --C-Ccccccccc-cCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 160 --G-VSLLRTTCG-TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 160 --~-~~~~~~~~~-~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+ .......++ ++.|.|||...+..+.....|+||.|+++..+++|..||...+..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 2 222344567 889999999988777778999999999999999999999876654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.2e-14 Score=101.03 Aligned_cols=141 Identities=17% Similarity=0.220 Sum_probs=101.4
Q ss_pred eeeecCccceEEEEEEecC------CCcEEEEEEEecchh----------------------hhh-hHHHHHHHHHHhhh
Q 027809 12 GRTIGEGTFAKVKFAQNTE------TGESVAMKVLDRSAI----------------------IKH-KMADQIKREISIMK 62 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~------~~~~~~ik~~~~~~~----------------------~~~-~~~~~~~~~~~~l~ 62 (218)
...||.|.-+.||.|.... ++..+|+|++..... ... ....+..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999998543 357899999943210 001 11123457888888
Q ss_pred hcCC--CCcceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCeE
Q 027809 63 LVRH--PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC-HSKGVYHRDLKPENLL 139 (218)
Q Consensus 63 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~i~h~di~p~nil 139 (218)
++.. -.++.++++ ..-++|||++.+..+.........+++.+...+..+++.++..+ |++|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8854 456677765 34579999998653422222233456667778889999999988 8999999999999999
Q ss_pred ecCCCcEEEeeccccccC
Q 027809 140 LDSQGHLKISDFGLSALP 157 (218)
Q Consensus 140 ~~~~~~~~l~d~~~~~~~ 157 (218)
++ ++.+.++||+.+...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 96 578999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.3e-14 Score=114.34 Aligned_cols=142 Identities=21% Similarity=0.330 Sum_probs=95.7
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh-------------------------------hHHH------HH
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-------------------------------KMAD------QI 54 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------~~~~------~~ 54 (218)
.++|++|++|.||.|... +|+.||||+........- +... ++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999875 789999999854321000 0000 12
Q ss_pred HHHHHhhhhc----CC-CCc--ceEEEEEEcCCeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHh
Q 027809 55 KREISIMKLV----RH-PCV--VRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLID-GVDYCHS 125 (218)
Q Consensus 55 ~~~~~~l~~l----~~-~~i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~-~l~~Lh~ 125 (218)
..|...+..+ ++ +++ ++++. +.....++||||++|.+|.+..... ... ....++.+++. .+..+|.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh
Confidence 2333333333 22 322 22222 2234578999999999998766432 122 23456666665 5788999
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.|++|+|++|.||++++++.++++|||++....+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999875543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.5e-16 Score=121.99 Aligned_cols=120 Identities=31% Similarity=0.514 Sum_probs=104.0
Q ss_pred CeEEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccccc
Q 027809 80 TKIYIILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~ 156 (218)
..+|+.|+.|...+|.+++..+. ..+......++.|++.++.| +|.+|.|++|.||+...+..++|.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46889999999999999997543 46788899999999999999 9999999999999999999999999999876
Q ss_pred CCCCC------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh
Q 027809 157 PEQGV------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA 203 (218)
Q Consensus 157 ~~~~~------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~ 203 (218)
..... .......++..||+||.+.+..+. .+.|||+||++++|++.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHH
Confidence 55433 223445688899999999998887 99999999999999986
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-14 Score=117.27 Aligned_cols=150 Identities=17% Similarity=0.292 Sum_probs=93.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh---------------------------hh----hHHHH-
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII---------------------------KH----KMADQ- 53 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~---------------------------~~----~~~~~- 53 (218)
+..|+. +++++|++|.||.|....+|+.||||+....... .. +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 8999999999999999877999999999643210 00 11111
Q ss_pred -----HHHHHHhhhhcC----CCCcceEEEEE-EcCCeEEEEEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHH-HHHH
Q 027809 54 -----IKREISIMKLVR----HPCVVRLHEVL-ASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLI-DGVD 121 (218)
Q Consensus 54 -----~~~~~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~-~~l~ 121 (218)
+..|.....++. +...+.+=.++ +.....++||||++|+++.+... .....+... ++...+ ..+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~ 274 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT 274 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence 233333333332 22222222222 22345789999999999976432 111222222 222222 2234
Q ss_pred HHHhCCceeccCCCCCeEecCCC----cEEEeeccccccCCC
Q 027809 122 YCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQ 159 (218)
Q Consensus 122 ~Lh~~~i~h~di~p~nil~~~~~----~~~l~d~~~~~~~~~ 159 (218)
.+...|++|+|++|.||+++.++ +++++|||.......
T Consensus 275 Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 275 QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45579999999999999999888 999999999865443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-13 Score=96.90 Aligned_cols=130 Identities=20% Similarity=0.242 Sum_probs=94.1
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC-cceEEEEEEcCCeEEEEEEecC
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
++.++.|..+.+|.+... +..+++|....... .......|+..++.+...+ .++++.... ...++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 578899999999998864 67899998754321 1123456777777775433 345555543 23579999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV-----YHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 91 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i-----~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+.++... . ......+.++++++..||..++ +|||++|.||+++ ++.++++||+.+....
T Consensus 75 G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~~ 138 (170)
T cd05151 75 GSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMND 138 (170)
T ss_pred CCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCCC
Confidence 9877542 1 1123456799999999999885 9999999999998 6789999999876543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-12 Score=89.59 Aligned_cols=137 Identities=21% Similarity=0.278 Sum_probs=100.9
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhh-----HHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-----MADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
..+.+|+-+.++.+.+. |.++++|.-.......++ ...+-.+|+.++..+..-.+.-..=+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35778999999988663 445777766444433333 23456778888888876555555545556667789999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
|.+|..|.+.+... ...++..+=..+.-||.+|++|||+.++||.+.. +++.++|||++.+...
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~-~~i~~IDfGLg~~s~~ 143 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG-GRIYFIDFGLGEFSDE 143 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC-CcEEEEECCccccccc
Confidence 99998888888765 2455666777788899999999999999999954 4599999999876544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.6e-14 Score=112.04 Aligned_cols=200 Identities=21% Similarity=0.232 Sum_probs=154.5
Q ss_pred ceEEeeeecC--ccceEEEEEEe--cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeE
Q 027809 8 KYEVGRTIGE--GTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 8 ~y~~~~~l~~--g~~g~vy~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~ 82 (218)
.+.+.+.+|. |.+|.+|.+.- ..++..+++|.-.............. +++...+.+ .|++.++-...++..+..
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~-~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKL-REFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccccccc-chhhcccccCccccccccCcccccCCcc
Confidence 4667888999 99999999887 78888999987544332222222223 334444444 588999988888999999
Q ss_pred EEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCCeEecCC-CcEEEeecccccc
Q 027809 83 YIILEFITGGELFDKIVHHGR-LSESEARRYFQQLID----GVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSAL 156 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~----~l~~Lh~~~i~h~di~p~nil~~~~-~~~~l~d~~~~~~ 156 (218)
++-.|.|+. +|..+...... +++..++....+..+ |+.++|...++|.|++|.||+...+ ...+++||++...
T Consensus 194 fiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 999999974 77666655554 889999999999999 9999999999999999999999999 8999999999876
Q ss_pred CCCCCcc-----cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 157 PEQGVSL-----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 157 ~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..+..-. .....+...|++||...+.. +..+|+|+||.+..+-.++..++...
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCC
Confidence 5544311 11224677899999997654 36999999999999988777666554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-11 Score=85.68 Aligned_cols=146 Identities=21% Similarity=0.248 Sum_probs=108.6
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh-----hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-----KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
...++.+|+-+.++.+.+. |+..+||.-.......+ -...+..+|++.+.++.--.|.-..=++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 6788999999999999874 67778876644443322 2345677888888888765665555555566666799
Q ss_pred EEecCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-c--EEEeeccccccCC
Q 027809 86 LEFITG-GELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-H--LKISDFGLSALPE 158 (218)
Q Consensus 86 ~e~~~~-~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~--~~l~d~~~~~~~~ 158 (218)
||+.++ .++.+++.... .....-...++..+=+.+.-||.++++|||+..+||++.+++ + +.++|||++....
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 999987 57777776543 223333478889999999999999999999999999996554 3 5899999987543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-11 Score=86.41 Aligned_cols=129 Identities=24% Similarity=0.327 Sum_probs=84.0
Q ss_pred EEEEEEecCCCcEEEEEEEecch-----------------------hhhhhHHHHHHHHHHhhhhcCCC--CcceEEEEE
Q 027809 22 KVKFAQNTETGESVAMKVLDRSA-----------------------IIKHKMADQIKREISIMKLVRHP--CVVRLHEVL 76 (218)
Q Consensus 22 ~vy~~~~~~~~~~~~ik~~~~~~-----------------------~~~~~~~~~~~~~~~~l~~l~~~--~i~~~~~~~ 76 (218)
.||.|.. .+|..+|+|+..... .+......+..+|++.|..+... ++++++++-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3788876 467899999984311 11222345678899999999765 567777653
Q ss_pred EcCCeEEEEEEecC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 77 ASRTKIYIILEFIT--GGELFDKIVHHGRLSESEARRYFQQLIDGVD-YCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 77 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~-~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
.-.+||||++ |.++..+... .++..+...++.+++..+. .+|..|++|||+++.||+++++ .+.++||+.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999999 6566443322 1224556777788888444 4689999999999999999777 999999998
Q ss_pred cccCC
Q 027809 154 SALPE 158 (218)
Q Consensus 154 ~~~~~ 158 (218)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 76443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.3e-11 Score=89.62 Aligned_cols=138 Identities=20% Similarity=0.284 Sum_probs=103.3
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecch-------------------hhhhhHHHHHHHHHHhhhhcCCC--
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA-------------------IIKHKMADQIKREISIMKLVRHP-- 67 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~-------------------~~~~~~~~~~~~~~~~l~~l~~~-- 67 (218)
..++..||.|.-|.||.|.+. +|.++++|.-.... .+-.-......+|+..|..+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457789999999999999986 68899999763211 01111223467888888888765
Q ss_pred CcceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEE
Q 027809 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~ 147 (218)
.+++.+++ +.-.+|||+.+|..|...-. +....-.++..|+..+..+-..|++|||+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 77888777 45579999999977754332 3445555666677666666699999999999999999999999
Q ss_pred Eeecccccc
Q 027809 148 ISDFGLSAL 156 (218)
Q Consensus 148 l~d~~~~~~ 156 (218)
++||..+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999976654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.3e-13 Score=105.54 Aligned_cols=202 Identities=22% Similarity=0.214 Sum_probs=145.1
Q ss_pred ccccceEEeeeecCccceEEEEEEec-CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCe
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNT-ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~ 81 (218)
...++|..+..|+.+.++.++....+ .++..+++|...+...........+ .+......+ .|.+.+.+...+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccccc
Confidence 35788999999999999999987766 5677888887755443333322223 333333333 57888887776666666
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-CcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-~~~~l~d~~~~~~~~~~ 160 (218)
.|+--|+|.++++.....-...+.+..++++..|++.++.++|+...+|.|++|+||++..+ +..+++|+++.......
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 77899999998887766555668899999999999999999999999999999999999775 78899999887642211
Q ss_pred CcccccccccCccc-cccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 161 VSLLRTTCGTPNYV-APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 161 ~~~~~~~~~~~~~~-~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
... ....-++. .+|.+........+.|++|||..+.+..++...-.
T Consensus 421 ~~~---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 421 SGV---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ccc---ccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 110 11112333 24555444444589999999999999888765443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-11 Score=89.42 Aligned_cols=144 Identities=19% Similarity=0.313 Sum_probs=100.8
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCC--CcceEEEEEEcC---CeEEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP--CVVRLHEVLASR---TKIYIIL 86 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~ 86 (218)
.+.++.|..+.+|.+... +|..+++|........ .....+..|...++.+.+. .+++++.+.... +..++++
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 467899999999998864 3678999986543311 1234577888888888653 456677776543 3568999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS----------------------------------------- 125 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~----------------------------------------- 125 (218)
|+++|.++...... ..++..+...++.++++++..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999877554321 234555555666666666666653
Q ss_pred ---------------CCceeccCCCCCeEecC--CCcEEEeeccccccCCC
Q 027809 126 ---------------KGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ---------------~~i~h~di~p~nil~~~--~~~~~l~d~~~~~~~~~ 159 (218)
..++|||++|.||+++. ++.+.++||+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~~ 209 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGDP 209 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCCh
Confidence 23699999999999988 56789999997765433
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-10 Score=86.15 Aligned_cols=132 Identities=17% Similarity=0.093 Sum_probs=90.8
Q ss_pred EEEEEecCCCcEEEEEEEecchhhh---h-----hHHHHHHHHHHhhhhcCCCCc--ceEEEEEEc-----CCeEEEEEE
Q 027809 23 VKFAQNTETGESVAMKVLDRSAIIK---H-----KMADQIKREISIMKLVRHPCV--VRLHEVLAS-----RTKIYIILE 87 (218)
Q Consensus 23 vy~~~~~~~~~~~~ik~~~~~~~~~---~-----~~~~~~~~~~~~l~~l~~~~i--~~~~~~~~~-----~~~~~lv~e 87 (218)
|..+.. +|+.+.||......... . .-.....+|+..+..+...+| ++++.+.+. ....++|+|
T Consensus 38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 444443 46788999763322100 0 000135677777777744333 333444432 235789999
Q ss_pred ecCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-------CCcEEEeecccccc
Q 027809 88 FITGG-ELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-------QGHLKISDFGLSAL 156 (218)
Q Consensus 88 ~~~~~-~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-------~~~~~l~d~~~~~~ 156 (218)
++++. +|.+++.. ..+.+......++.+++..+..||.+|++|+|++++||+++. +..+.++||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99885 78888754 345567778899999999999999999999999999999975 46799999997753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=6e-12 Score=94.55 Aligned_cols=154 Identities=16% Similarity=0.315 Sum_probs=114.5
Q ss_pred HHHHHHHhhhhcCCCCcceEEEEEEc-----CCeEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 027809 53 QIKREISIMKLVRHPCVVRLHEVLAS-----RTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYC 123 (218)
Q Consensus 53 ~~~~~~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~L 123 (218)
.....+..+-++.|-||++...++.+ .....++.||++.++|..++++ +..+......+|+.||.+||.||
T Consensus 113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yL 192 (458)
T KOG1266|consen 113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYL 192 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhh
Confidence 34455566677789899999888753 3457889999999999988865 34588889999999999999999
Q ss_pred HhCC--ceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc----cccccccCccccccccccCCCCCcchhhhhHhHH
Q 027809 124 HSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVI 197 (218)
Q Consensus 124 h~~~--i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~ 197 (218)
|.+. ++|+++..+.|++..+|.+|+.--.-...-...... .+...+.++|.+||.=...+.. -++|||++|++
T Consensus 193 hs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~-~a~dIy~fgmc 271 (458)
T KOG1266|consen 193 HSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTT-GASDIYKFGMC 271 (458)
T ss_pred hccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccc-cchhhhhhhHH
Confidence 9885 999999999999999999998632211111110000 0112246789999987655554 78999999999
Q ss_pred HHHHhhcCCC
Q 027809 198 LYVLIAGYLP 207 (218)
Q Consensus 198 l~~l~~g~~p 207 (218)
..+|.-++.-
T Consensus 272 AlemailEiq 281 (458)
T KOG1266|consen 272 ALEMAILEIQ 281 (458)
T ss_pred HHHHHHheec
Confidence 9999766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.5e-10 Score=88.92 Aligned_cols=192 Identities=15% Similarity=0.204 Sum_probs=128.5
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEE------EcC-CeE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL------ASR-TKI 82 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~------~~~-~~~ 82 (218)
..+..||+|+-+.+|..-... ..+.|++....... +..........-+||-+-.=+.|- -.. ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 456789999999998654332 34558886655211 111112222233455332212221 122 236
Q ss_pred EEEEEecCCC-ChHHHHHh---c---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 83 YIILEFITGG-ELFDKIVH---H---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 83 ~lv~e~~~~~-~L~~~~~~---~---~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
-++|..+++. ....+..- + .-.++..+++.+..++.+...||+.|.+-||++++|+++++++.+.|+|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 6788887764 22222211 1 126799999999999999999999999999999999999999999999855444
Q ss_pred cCCCCCcccccccccCccccccccc-----cCCCCCcchhhhhHhHHHHHHhhc-CCCCCCC
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAG-YLPFDEL 211 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~-----~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~ 211 (218)
...+. .....+.+.+.|.+||.-. +... +...|.|.||+++++++.| +.||+..
T Consensus 166 i~~ng-~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 INANG-TLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eccCC-ceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcc
Confidence 44333 3344667888999999875 2222 4789999999999999885 9999864
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.4e-10 Score=81.09 Aligned_cols=139 Identities=18% Similarity=0.261 Sum_probs=88.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHH------HHHHHHhhhhcCCC---CcceEEEE-
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ------IKREISIMKLVRHP---CVVRLHEV- 75 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~---~i~~~~~~- 75 (218)
-++|++.+.+.......|.... -+|..+++|.........+..... ..+.+.....++.. ....++-.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678888999887776555444 467889999875544333222221 12223333333222 22222222
Q ss_pred ----EEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeec
Q 027809 76 ----LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 76 ----~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
+.-....++++||++|..|.+... +++ .++..+.+++..+|+.|++|||.+|.|+++++++ ++++|+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 223345678999999988765432 222 2446778889999999999999999999997544 999999
Q ss_pred cccc
Q 027809 152 GLSA 155 (218)
Q Consensus 152 ~~~~ 155 (218)
+...
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 7543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.1e-10 Score=89.08 Aligned_cols=167 Identities=19% Similarity=0.260 Sum_probs=124.9
Q ss_pred ceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE----cCCeEEEEEEecCC-CCh
Q 027809 20 FAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA----SRTKIYIILEFITG-GEL 94 (218)
Q Consensus 20 ~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L 94 (218)
..+.|++....+|..+++|.++-...... ...-..++..+++.|.|++++-++|. +...+.+|++|.+. .+|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999998843332221 22335577888899999999988874 45679999999876 466
Q ss_pred HHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 95 FDKIVHH---------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 95 ~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+.-... .+.++..+|.++.|++.||.++|+.|...+-+.|++|+++.+.+++++.-|.-....+
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6655321 2367899999999999999999999999999999999998888999986665443322
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP 207 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 207 (218)
.. -+.+.. -.+.|.--||.++..|.||..-
T Consensus 446 d~--------------~~~le~----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP--------------TEPLES----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC--------------CcchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence 11 011111 1577999999999999998543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.5e-09 Score=79.11 Aligned_cols=107 Identities=24% Similarity=0.380 Sum_probs=82.9
Q ss_pred HHHHHHHHhhhhcCCCC--cceEEEEEEcC----CeEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027809 52 DQIKREISIMKLVRHPC--VVRLHEVLASR----TKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124 (218)
Q Consensus 52 ~~~~~~~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 124 (218)
.+..+|+..+..+...+ .++.+.+.+.. ...++|+|++++ .+|.+.+......+......++.+++..+..||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 44666777666664332 34455555432 245899999987 479888887556778888999999999999999
Q ss_pred hCCceeccCCCCCeEecCCC---cEEEeeccccccCC
Q 027809 125 SKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPE 158 (218)
Q Consensus 125 ~~~i~h~di~p~nil~~~~~---~~~l~d~~~~~~~~ 158 (218)
++|++|+|+++.|||++.++ .+.++||+-+....
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999999999998887 89999998766433
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.8e-11 Score=103.93 Aligned_cols=212 Identities=28% Similarity=0.452 Sum_probs=149.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..+.+.+.+.+.++.++.++.+.-...|....++.............+.+..+-...-...+|..+...-.+.-..-.++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 35678888899999999999988887776666655433221111111111111122111223333332222334456889
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC----
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG---- 160 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~---- 160 (218)
++++.+++.|...+.+.+..+.+-.......+..++++||...+.|+|++|.|.+...++..++.|+++....+-.
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 9999999999888877777777777788888999999999999999999999999999999999998733211100
Q ss_pred -------------------Cccc--------ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 -------------------VSLL--------RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 -------------------~~~~--------~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.... -...+++.|.+||...+.... ..+|.|+.|+++++.++|..||+.-.+
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0000 011357799999999988776 889999999999999999999999888
Q ss_pred cccc
Q 027809 214 TTLY 217 (218)
Q Consensus 214 ~~~~ 217 (218)
+.++
T Consensus 1041 q~~f 1044 (1205)
T KOG0606|consen 1041 QQIF 1044 (1205)
T ss_pred hhhh
Confidence 7765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.9e-09 Score=74.67 Aligned_cols=138 Identities=14% Similarity=0.156 Sum_probs=96.5
Q ss_pred cCccceEEEEEEecCCCcEEEEEEEecchhhh---hhHHHHHHHHHHhhhhcCCCC--cceEEEEEE---c--CCeEEEE
Q 027809 16 GEGTFAKVKFAQNTETGESVAMKVLDRSAIIK---HKMADQIKREISIMKLVRHPC--VVRLHEVLA---S--RTKIYII 85 (218)
Q Consensus 16 ~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~~--i~~~~~~~~---~--~~~~~lv 85 (218)
++||.|.|+..... |..+-+|...+.-..+ +-...-+.+|+..+..+...+ ++++. ++. . .-..++|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 45888888887654 3367778764211110 112345677787777775422 44444 332 1 1247789
Q ss_pred EEecCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc--EEEeecccccc
Q 027809 86 LEFITG-GELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSAL 156 (218)
Q Consensus 86 ~e~~~~-~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~--~~l~d~~~~~~ 156 (218)
+|-+++ .+|.+.+.+. .+.+..+...++.+++.++..||+.|+.|+|+.+.||+++.++. +.++||.-+..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 5888777553 35678888899999999999999999999999999999986677 99999986653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.2e-08 Score=73.28 Aligned_cols=142 Identities=20% Similarity=0.225 Sum_probs=96.8
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhh---------------------hhhHHHHHHHHHHhhhhcCC--C
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII---------------------KHKMADQIKREISIMKLVRH--P 67 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~---------------------~~~~~~~~~~~~~~l~~l~~--~ 67 (218)
+...|+.|.-..||.|.. .++..+++|++...... ......+..+|+..|..+.. -
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 445777888889999875 46789999999543321 11122345667777776643 4
Q ss_pred CcceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcE
Q 027809 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHL 146 (218)
Q Consensus 68 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~ 146 (218)
.+++.+.+.. -.+|||++.....-.......++...+...+..++++.+.-|-. ++++|||++.-|||+. ++.+
T Consensus 131 rvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 131 RVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 4556666643 35899998753111111111233333677788888888888876 9999999999999998 8999
Q ss_pred EEeeccccccCC
Q 027809 147 KISDFGLSALPE 158 (218)
Q Consensus 147 ~l~d~~~~~~~~ 158 (218)
.++|++.+....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999887554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.5e-10 Score=94.14 Aligned_cols=84 Identities=26% Similarity=0.427 Sum_probs=62.0
Q ss_pred ccCCCC-CeEecCCCcEEEeeccccccCCCCC--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCC
Q 027809 131 RDLKPE-NLLLDSQGHLKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP 207 (218)
Q Consensus 131 ~di~p~-nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 207 (218)
.+..|. |++++.+...++.||+.+....... .......+++.|+|||.+.+..+. .++|||||||++|+|++|..|
T Consensus 501 ~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~-~~~DiwSlG~il~ElltG~~p 579 (669)
T cd05610 501 QKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTGIPP 579 (669)
T ss_pred CCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCC-cHHHHHHHHHHHHHHHHCCCC
Confidence 344444 5677777777888888775433221 112234678999999999887765 899999999999999999999
Q ss_pred CCCCCccc
Q 027809 208 FDELDLTT 215 (218)
Q Consensus 208 f~~~~~~~ 215 (218)
|...+..+
T Consensus 580 f~~~~~~~ 587 (669)
T cd05610 580 FNDETPQQ 587 (669)
T ss_pred CCCCCHHH
Confidence 98766544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.8e-07 Score=69.16 Aligned_cols=137 Identities=16% Similarity=0.208 Sum_probs=84.0
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC--cceEEEEEEcCCeEEEEEEecC
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
.++++|..+.+|.. .+..+++|...... . ...+.+|.+.++.+..-. +++++.+.+..+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 67899999999973 24467888875422 1 234677888888776433 4777888887777889999999
Q ss_pred CCC-hHHHH--------------Hh-----cC----CCCHHHHH-HHHH----------HHHH-HHHHHH----hCCcee
Q 027809 91 GGE-LFDKI--------------VH-----HG----RLSESEAR-RYFQ----------QLID-GVDYCH----SKGVYH 130 (218)
Q Consensus 91 ~~~-L~~~~--------------~~-----~~----~~~~~~~~-~~~~----------~i~~-~l~~Lh----~~~i~h 130 (218)
|.+ +...+ .. +. ..+..... .+.. .+.+ ...+|. ....+|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11111 10 00 01111100 0100 0111 112222 124789
Q ss_pred ccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 131 RDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 131 ~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
||++|.|+++++++ +.++||+.+....+
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~Gdp 185 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGYGNP 185 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCcCCH
Confidence 99999999998888 99999998765543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=9.3e-08 Score=78.13 Aligned_cols=143 Identities=23% Similarity=0.308 Sum_probs=92.7
Q ss_pred eeecCccceEEEEEEecCCCcEEEEEEEecchh---------------------------hhhhH----------HHHHH
Q 027809 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI---------------------------IKHKM----------ADQIK 55 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~---------------------------~~~~~----------~~~~~ 55 (218)
++++.++-|.||.|... +|+.||||+....-. ...+. .-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 78899999999999987 499999999843210 00000 11233
Q ss_pred HHHHhhhhcC-----CCCcceEEEEEEcCCeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHH-HHHHHhCCc
Q 027809 56 REISIMKLVR-----HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDG-VDYCHSKGV 128 (218)
Q Consensus 56 ~~~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~-l~~Lh~~~i 128 (218)
.|...+.++. .+.+.-..=+.+..+...++|||++|..+.+.... ....+...+. ..++.+ +..+=..|.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHHhcCc
Confidence 3444444432 23322222223344567899999999888777532 2345533433 333332 445556899
Q ss_pred eeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 129 ~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
+|+|.+|.||+++.+|++.+.|||......+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999765544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.2e-09 Score=89.62 Aligned_cols=100 Identities=24% Similarity=0.407 Sum_probs=74.6
Q ss_pred HHHHHHHHHHHH-hCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc---------cccccccCccccccccccC
Q 027809 113 FQQLIDGVDYCH-SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---------LRTTCGTPNYVAPEVLSHK 182 (218)
Q Consensus 113 ~~~i~~~l~~Lh-~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~~Pe~~~~~ 182 (218)
+.+.+.++.++| +.+++|++|.|++|.++.++.+|++.|+.+.....+... .......+.|.+||.+...
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 345559999999 568999999999999999999999999887644331110 1111235589999999874
Q ss_pred CCCCcchhhhhHhHHHHHHh-hcCCCCCCCCc
Q 027809 183 GYNGAAADVWSCGVILYVLI-AGYLPFDELDL 213 (218)
Q Consensus 183 ~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~ 213 (218)
.- +.++|+||||+++|.+. .|...+.....
T Consensus 185 ~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~ 215 (700)
T KOG2137|consen 185 TN-TPASDVFSLGVLIYTIYNGGKSIIAANGG 215 (700)
T ss_pred cc-cccccceeeeeEEEEEecCCcchhhccCC
Confidence 44 58999999999999998 46555554443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.2e-06 Score=63.46 Aligned_cols=139 Identities=20% Similarity=0.322 Sum_probs=79.0
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCC--CcceEEEEE---EcCCeEEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP--CVVRLHEVL---ASRTKIYIIL 86 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~ 86 (218)
++.++.|..+.+|.+.... ..+++|..... .....+..+...++.+... -+++++... ......++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5788989999999998764 48999986543 2234566666676666433 245666543 2344579999
Q ss_pred EecCCCChHH----------------HHHh---c----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 027809 87 EFITGGELFD----------------KIVH---H----GRLSESE---------ARRY------------FQQLID-GVD 121 (218)
Q Consensus 87 e~~~~~~L~~----------------~~~~---~----~~~~~~~---------~~~~------------~~~i~~-~l~ 121 (218)
+++++.++.. .+.. . ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 1100 0 0000000 0000 111122 233
Q ss_pred HHH-------hCCceeccCCCCCeEec-CCCcEEEeeccccccC
Q 027809 122 YCH-------SKGVYHRDLKPENLLLD-SQGHLKISDFGLSALP 157 (218)
Q Consensus 122 ~Lh-------~~~i~h~di~p~nil~~-~~~~~~l~d~~~~~~~ 157 (218)
.++ ...++|||++|.||+++ .++.+-++||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 333 24599999999999998 5666689999877544
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.8e-06 Score=63.59 Aligned_cols=139 Identities=12% Similarity=0.119 Sum_probs=82.3
Q ss_pred eeecCccc-eEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEEEEEEecC
Q 027809 13 RTIGEGTF-AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 13 ~~l~~g~~-g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
..|..|.. ..||.+... +..+++|...... ...+..|+..++.+. +--+++++.+....+..++||++++
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 45555666 567887643 4678888775432 223456666666663 2346677887776667899999999
Q ss_pred CCChHHHHH----------------h-cC------CCCHH--HHHHHHH--------------------HHHHHHHHHH-
Q 027809 91 GGELFDKIV----------------H-HG------RLSES--EARRYFQ--------------------QLIDGVDYCH- 124 (218)
Q Consensus 91 ~~~L~~~~~----------------~-~~------~~~~~--~~~~~~~--------------------~i~~~l~~Lh- 124 (218)
|.++..... . +. ++... ....... ........|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 877654320 0 00 01100 0000000 0111222221
Q ss_pred ------hCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 125 ------SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 125 ------~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...++|||++|.|++++.++.+.|+||+.+....+
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~gdp 196 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVADR 196 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccccccH
Confidence 23489999999999999887788999998765443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.2e-06 Score=68.59 Aligned_cols=141 Identities=21% Similarity=0.298 Sum_probs=87.0
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhh----------------------------hhhHHHH------HHHH
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII----------------------------KHKMADQ------IKRE 57 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~----------------------------~~~~~~~------~~~~ 57 (218)
-+.|+..+.+.|+.|+.+. |+.|+||+.+..-.. -++..+. +.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4688999999999999875 999999998442100 0111111 2222
Q ss_pred HHhhhhc----CCCC------cceEEEEEEcCCeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHH-HHHHHh
Q 027809 58 ISIMKLV----RHPC------VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDG-VDYCHS 125 (218)
Q Consensus 58 ~~~l~~l----~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~-l~~Lh~ 125 (218)
++..+.+ .+-. +++++-. ......++|||++|..+.+...- ...++...+.. .+.++ ++.+=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~---~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILN---KLVEAYLEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHH---HHHHHHHHHHHh
Confidence 2222222 2323 3444333 23457899999999766554422 23455554443 44433 233446
Q ss_pred CCceeccCCCCCeEecC----CCcEEEeeccccccCC
Q 027809 126 KGVYHRDLKPENLLLDS----QGHLKISDFGLSALPE 158 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~----~~~~~l~d~~~~~~~~ 158 (218)
.|.+|+|=+|.||++.+ ++.+.+.|+|+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 78999999999999984 5689999999876443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-06 Score=62.70 Aligned_cols=98 Identities=16% Similarity=0.277 Sum_probs=78.2
Q ss_pred HHHHhhhhcCC-CCcceEEEEEEcCCeEEEEEEecCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 027809 56 REISIMKLVRH-PCVVRLHEVLASRTKIYIILEFITGGELFD---KIVHHGRLSESEARRYFQQLIDGVDYCHS---KGV 128 (218)
Q Consensus 56 ~~~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---~~i 128 (218)
.|...++.+++ +++++++|+|. .+++.|+...+++.. .+..-...++..+.+++.++++.++.|+. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 56777777766 69999999994 367889988665532 11222346899999999999999999997 458
Q ss_pred eeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 129 YHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 129 ~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
..+|++|+|+-++++++++++|+......
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.4e-05 Score=69.91 Aligned_cols=148 Identities=18% Similarity=0.370 Sum_probs=90.6
Q ss_pred EeeeecCccceEEEEEEecCCC--cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCc--ceEEEEEEcC---CeE
Q 027809 11 VGRTIGEGTFAKVKFAQNTETG--ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCV--VRLHEVLASR---TKI 82 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~--~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i--~~~~~~~~~~---~~~ 82 (218)
.++.++.|..+.+|.......+ ..+++|..+..... .....+.+|+..++.+. +.++ ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677888889999988765432 46788875443211 12346778888888885 5554 7777777653 467
Q ss_pred EEEEEecCCCChHH--------------------HHHh-cC------CC---------CHHHHHHHHH------------
Q 027809 83 YIILEFITGGELFD--------------------KIVH-HG------RL---------SESEARRYFQ------------ 114 (218)
Q Consensus 83 ~lv~e~~~~~~L~~--------------------~~~~-~~------~~---------~~~~~~~~~~------------ 114 (218)
|+|||+++|..+.+ .+.. +. .+ ...++-++..
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999854321 1110 00 00 0122322211
Q ss_pred ---HHHHHHHHHHh-----------CCceeccCCCCCeEecCC-C-cEEEeeccccccCCCC
Q 027809 115 ---QLIDGVDYCHS-----------KGVYHRDLKPENLLLDSQ-G-HLKISDFGLSALPEQG 160 (218)
Q Consensus 115 ---~i~~~l~~Lh~-----------~~i~h~di~p~nil~~~~-~-~~~l~d~~~~~~~~~~ 160 (218)
.+...+++|.. ..++|||+++.|++++.+ + ..-+.|+..+....+.
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdPl 261 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQM 261 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCChH
Confidence 12334556632 249999999999999753 3 3578999988765543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=59.95 Aligned_cols=34 Identities=29% Similarity=0.457 Sum_probs=27.5
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+++|||++|.|++++.++..-++||+.+.....
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gDp 197 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGDP 197 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCcCCh
Confidence 3489999999999998766567999998765544
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.9e-05 Score=55.23 Aligned_cols=132 Identities=20% Similarity=0.282 Sum_probs=93.2
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc-ceEEEEEEcCCeEEEEEEe
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~ 88 (218)
.+.+.|+.|..|.||.+.+. |..+++|+-..+.. ...+..|+.+++.+.-.++ ++++.+.+ .++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 45678899999999999986 45899998765442 3567888999998876554 44555543 3456999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCCeEecCCCcEEEeeccccccCCC
Q 027809 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLK-PENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~-p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+|.+|.+..... +. +-...+++...-|-..||-|+.++ |...++..++.+.|+||..++....
T Consensus 94 i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 94 IDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred hcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 9998886544321 22 233455666677778899999886 5555555666999999999885443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.23 E-value=9.8e-05 Score=53.30 Aligned_cols=134 Identities=20% Similarity=0.252 Sum_probs=88.4
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchh-------------hhhhHHHHHHHHHHhhhhcC------CCCcceE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-------------IKHKMADQIKREISIMKLVR------HPCVVRL 72 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-------------~~~~~~~~~~~~~~~l~~l~------~~~i~~~ 72 (218)
..+|++|+.-.+|.-- +.....||+...... ......++..+|+....++. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4578899998887432 335577888865540 00111234445554444444 7899999
Q ss_pred EEEEEcCCeEEEEEEecC------CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC--
Q 027809 73 HEVLASRTKIYIILEFIT------GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-- 144 (218)
Q Consensus 73 ~~~~~~~~~~~lv~e~~~------~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-- 144 (218)
+++.+.+...-+|+|..- ..+|.+++..+ .+++ + +...+-+...+|-+++|+.+|++|.||++..+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999998888888888643 24777777543 4555 3 333444566777899999999999999995332
Q ss_pred --cEEEee-ccc
Q 027809 145 --HLKISD-FGL 153 (218)
Q Consensus 145 --~~~l~d-~~~ 153 (218)
.+.++| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 577887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.17 E-value=4.2e-05 Score=59.70 Aligned_cols=142 Identities=25% Similarity=0.310 Sum_probs=98.1
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecch----------------------hhhhhH-HHHHHHHHHhhhhcCC
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSA----------------------IIKHKM-ADQIKREISIMKLVRH 66 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~----------------------~~~~~~-~~~~~~~~~~l~~l~~ 66 (218)
.+-..|.-|.-..||.|.. .+|..+|||++..+- .++... .-+...|.+.|..+..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3445666788889999885 478889999984311 112222 2345677777777765
Q ss_pred CCcceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCeEecCCCc
Q 027809 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC-HSKGVYHRDLKPENLLLDSQGH 145 (218)
Q Consensus 67 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~L-h~~~i~h~di~p~nil~~~~~~ 145 (218)
..|+-..-+.-. .-.+||+++....--........++...+..+-.+++..++-| +.++++|.|++--|+|+ .+|.
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 554322222111 2468999987543333334445678888999999999888877 47899999999999999 7788
Q ss_pred EEEeeccccc
Q 027809 146 LKISDFGLSA 155 (218)
Q Consensus 146 ~~l~d~~~~~ 155 (218)
+.++|.+.+.
T Consensus 303 lyiIDVSQSV 312 (520)
T KOG2270|consen 303 LYIIDVSQSV 312 (520)
T ss_pred EEEEEccccc
Confidence 9999988765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.16 E-value=0.00034 Score=55.90 Aligned_cols=80 Identities=20% Similarity=0.181 Sum_probs=52.0
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchh---hh-hhHHHHHHHHHHhhhhcC---CCCcceEEEEEEcCCeEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI---IK-HKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~---~~-~~~~~~~~~~~~~l~~l~---~~~i~~~~~~~~~~~~~~l 84 (218)
.+.+|.|....||.+.+...++.++||.-..... .. +-..++...|.+.|+.+. ..++++++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 5688999999999999864446899997531100 00 112345556666666652 35677777773 355789
Q ss_pred EEEecCCCC
Q 027809 85 ILEFITGGE 93 (218)
Q Consensus 85 v~e~~~~~~ 93 (218)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999988643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.1e-06 Score=64.11 Aligned_cols=135 Identities=16% Similarity=0.246 Sum_probs=91.9
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh-----------------hhhhHHHH--HHHHHHhhhhcCCCC-
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-----------------IKHKMADQ--IKREISIMKLVRHPC- 68 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-----------------~~~~~~~~--~~~~~~~l~~l~~~~- 68 (218)
+.++..||-|.-+.+|.+.+. +|++.++|.-..... .+.-++.+ ..+|+..++.+....
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 578899999999999999875 678888886522110 01111222 345666666664322
Q ss_pred -cceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEE
Q 027809 69 -VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 69 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~ 147 (218)
+++.++. +...+|||.+++-+|...-.- .+.. .+...+...+--|-.+|++|||++-=||++++++.++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 3444554 345789999988777543321 1223 3445666677788899999999999999999999999
Q ss_pred Eeecccc
Q 027809 148 ISDFGLS 154 (218)
Q Consensus 148 l~d~~~~ 154 (218)
++||-..
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.0002 Score=55.14 Aligned_cols=141 Identities=16% Similarity=0.195 Sum_probs=80.6
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC--cceEEE------EEEcCCeE
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHE------VLASRTKI 82 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~--i~~~~~------~~~~~~~~ 82 (218)
-.+.+..|....+|..... +..+++|..... + ...+..+...+..+...+ +++++. +....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEeC--CCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 3667777777888887643 347888987541 1 233445555555553222 344433 22334567
Q ss_pred EEEEEecCCCChHH-----------HHHh----cCCC----------CHHHHH----------HHHHHHHHHHHHHHh--
Q 027809 83 YIILEFITGGELFD-----------KIVH----HGRL----------SESEAR----------RYFQQLIDGVDYCHS-- 125 (218)
Q Consensus 83 ~lv~e~~~~~~L~~-----------~~~~----~~~~----------~~~~~~----------~~~~~i~~~l~~Lh~-- 125 (218)
++++++++|.++.. .+.. ...+ .+.... .....+..++..+.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999865421 0000 0000 000000 011112233444443
Q ss_pred -----CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 -----KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 -----~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+++|||++|.|+++++++.+.++||+.+.....
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g~~ 208 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACTDAF 208 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcCchH
Confidence 4699999999999999887788999998776543
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00017 Score=53.61 Aligned_cols=143 Identities=20% Similarity=0.272 Sum_probs=80.1
Q ss_pred eeeecCccceEEEEEEecC-CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcCCeEEEEEEec
Q 027809 12 GRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
++.|..|-...+|.+.... +++.+++|+...... . .-+..+|...+..+.. .-.++++..+. + .+++||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4667777788999887543 356788897643221 1 1123356666666643 23445554433 2 3799999
Q ss_pred CCCChHHH----------H----Hh----cCCC----------C-HHHHHHHHH----------------------HHHH
Q 027809 90 TGGELFDK----------I----VH----HGRL----------S-ESEARRYFQ----------------------QLID 118 (218)
Q Consensus 90 ~~~~L~~~----------~----~~----~~~~----------~-~~~~~~~~~----------------------~i~~ 118 (218)
+|.++... + .. .... + ...+..+.. .+.+
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665321 1 00 0001 1 112111111 1111
Q ss_pred HHHHH----H----hCCceeccCCCCCeEecC-CCcEEEeeccccccCCCCCc
Q 027809 119 GVDYC----H----SKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 119 ~l~~L----h----~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~~~~ 162 (218)
.+..| . ..+++|+|+++.||+++. ++.+.++||..+........
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~~~~D 207 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNYRAFD 207 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCchhee
Confidence 11222 1 135999999999999987 57899999998876554433
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00063 Score=49.01 Aligned_cols=128 Identities=23% Similarity=0.285 Sum_probs=85.6
Q ss_pred cceEEeeeecCccc-eEEEEEEecCCCcEEEEEEEec---ch-------hhh-h-------hHHHHHHHHH---Hhhhhc
Q 027809 7 GKYEVGRTIGEGTF-AKVKFAQNTETGESVAMKVLDR---SA-------IIK-H-------KMADQIKREI---SIMKLV 64 (218)
Q Consensus 7 ~~y~~~~~l~~g~~-g~vy~~~~~~~~~~~~ik~~~~---~~-------~~~-~-------~~~~~~~~~~---~~l~~l 64 (218)
.+++.++.||.|.- |.||++.. +|+.+|+|.+.. .. ... . .....+..|. .+++..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 99999876 467999999321 00 000 0 1223344444 445555
Q ss_pred CCCCc--ceEEEEEEcC------------------CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 027809 65 RHPCV--VRLHEVLASR------------------TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124 (218)
Q Consensus 65 ~~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh 124 (218)
.++++ ++.+++..-. ....||.|+.+... .++ .+-+.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 56677 8888886211 12456777766533 112 233457777888999
Q ss_pred hCCceeccCCCCCeEecCCCcEEEeecccc
Q 027809 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 125 ~~~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
..||+-.|+++.|..= -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~-----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG-----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC-----CEEEecccC
Confidence 9999999999999873 488998854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=2.3e-06 Score=70.50 Aligned_cols=185 Identities=22% Similarity=0.248 Sum_probs=122.9
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC-cceEEEEEEcCCeEEEEEEe
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~ 88 (218)
...+-.+.++.+..++.+...++..+ .+.+... ....-+++.|.+++||| .+.+++-++.+...++.+++
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 33444556777777777665443333 3333211 23446678899999999 67777777778889999999
Q ss_pred cCCC--ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 89 ITGG--ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 89 ~~~~--~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
++++ +........-.+-+.+.......-++.+.++|+.--+|.| ||+. ..+..+..+++......... ....
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~-~~~t 389 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTM-KPRT 389 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCccc-cccc
Confidence 9886 2211111112344556666667777888899887666666 6666 44778888888765433322 2234
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
..+++.+++||......+. ...|.|++|.-..++.-|..|-..
T Consensus 390 ~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCC
Confidence 4577899999988766665 889999999877777777777544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.6e-05 Score=56.30 Aligned_cols=137 Identities=18% Similarity=0.235 Sum_probs=75.8
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc-ceEEEEEEcCCeEEEEEEecCCCC
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILEFITGGE 93 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~ 93 (218)
+..|-.+.+|... .++..+++|...... ....-...+|...++.+....+ ++++.... -++|+|+++|.+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4556677888876 356678888753321 1100123566677776654323 44444432 268999999865
Q ss_pred hHHH----------H----Hh-c------CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeccCC
Q 027809 94 LFDK----------I----VH-H------GRLSE-SEARRYFQQL---------IDGVDYCHS--------KGVYHRDLK 134 (218)
Q Consensus 94 L~~~----------~----~~-~------~~~~~-~~~~~~~~~i---------~~~l~~Lh~--------~~i~h~di~ 134 (218)
+... + .. + .+++. ..+.....++ ...+..+.. ..++|+|++
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5321 1 10 0 11121 1111221111 122222222 248999999
Q ss_pred CCCeEecCCCcEEEeeccccccCCCCC
Q 027809 135 PENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 135 p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
|.||++++++ +.++||..+....+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~gdp~~ 180 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDGDIAL 180 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcCCHHH
Confidence 9999998877 7899999887665543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0031 Score=49.14 Aligned_cols=34 Identities=26% Similarity=0.398 Sum_probs=28.2
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+++|||++|.||+++.+...-++||+.++....
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~~~ 220 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACNDKL 220 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccCCch
Confidence 4799999999999998666668999998875543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0017 Score=50.34 Aligned_cols=143 Identities=18% Similarity=0.238 Sum_probs=78.0
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC--cceEEEE------EEcCCe
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEV------LASRTK 81 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~--i~~~~~~------~~~~~~ 81 (218)
...+.++.|....+|.+... +..+++|...... +. ..+..+.+.+..+.... +++++.. ....+.
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eeccccCCccccceEEEEeC--CCcEEEEEecCCC--CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 34566777777788987642 3367888764421 11 22333444444443211 3444332 123456
Q ss_pred EEEEEEecCCCChH-----------HHHHh-c---CCCC-------HHHHHH----------------HHHHHHHHHHHH
Q 027809 82 IYIILEFITGGELF-----------DKIVH-H---GRLS-------ESEARR----------------YFQQLIDGVDYC 123 (218)
Q Consensus 82 ~~lv~e~~~~~~L~-----------~~~~~-~---~~~~-------~~~~~~----------------~~~~i~~~l~~L 123 (218)
.++++++++|.++. ..+.. + ..++ ....|. ....+.+.++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885431 11100 0 0000 001110 011122344444
Q ss_pred H-------hCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 124 H-------SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 124 h-------~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
. ..+++|||+++.|++++.++...++||+.+.....
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~~~ 220 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTDAR 220 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCcch
Confidence 3 26799999999999999888778999998865543
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00076 Score=59.76 Aligned_cols=154 Identities=21% Similarity=0.207 Sum_probs=108.9
Q ss_pred HHHHHHhhhhcCCCCcceEEEEEEcCCeE----EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 027809 54 IKREISIMKLVRHPCVVRLHEVLASRTKI----YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129 (218)
Q Consensus 54 ~~~~~~~l~~l~~~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~ 129 (218)
...|...+....|+|+..++.+....... .+..++++.-++...+..-+..+....+.+..++..++.++|.....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 44566677778999999999987544332 24457888889988888888999999999999999999999999777
Q ss_pred eccCCCC---CeEecCCCcEEEe--eccccccCCCCCcccccccccCccccccccccCCCC-CcchhhhhHhHHHHHHhh
Q 027809 130 HRDLKPE---NLLLDSQGHLKIS--DFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIA 203 (218)
Q Consensus 130 h~di~p~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~~Di~slG~~l~~l~~ 203 (218)
|.-+..+ +-..+..+....+ |++.+.......... ....+..+.++|........ +...|+|++|.+...+..
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~-~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF-SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccch-hhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence 7766666 4444455555555 777665544432221 22234466777776543332 345799999999999988
Q ss_pred cCCCC
Q 027809 204 GYLPF 208 (218)
Q Consensus 204 g~~pf 208 (218)
|..+-
T Consensus 388 ~~~i~ 392 (1351)
T KOG1035|consen 388 GEDIS 392 (1351)
T ss_pred cCccc
Confidence 76553
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0014 Score=52.52 Aligned_cols=76 Identities=12% Similarity=0.058 Sum_probs=49.0
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchh-----hhhhHHHHHHHHHHhhhhcC---CCCcceEEEEEEcCCeE
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-----IKHKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKI 82 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~~~~~l~~l~---~~~i~~~~~~~~~~~~~ 82 (218)
..+.+|.|....+|.+.+. +..++||.-..... ++. ...+...|...|+.+. ...+++++.+++ +..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl-~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPM-TKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccC-CccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 4678898999999998863 45688887642111 111 2333344455555543 357888888877 345
Q ss_pred EEEEEecCC
Q 027809 83 YIILEFITG 91 (218)
Q Consensus 83 ~lv~e~~~~ 91 (218)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0016 Score=50.46 Aligned_cols=151 Identities=16% Similarity=0.185 Sum_probs=85.5
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC--cceEEEEEEcC--CeEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEVLASR--TKIYI 84 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~--i~~~~~~~~~~--~~~~l 84 (218)
..+++....|-...+|..... +++++++ .+. .........+..+++..+..+..-- .+..++.|... +..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 345555544444456655543 6788888 432 2223333456667777777764322 33345555443 36799
Q ss_pred EEEecCCCCh---------H-HHHH--------h-c-------------CCCCHHHHHHHHHHH--------------HH
Q 027809 85 ILEFITGGEL---------F-DKIV--------H-H-------------GRLSESEARRYFQQL--------------ID 118 (218)
Q Consensus 85 v~e~~~~~~L---------~-~~~~--------~-~-------------~~~~~~~~~~~~~~i--------------~~ 118 (218)
||+++.|... . .+.. . + ......++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999987211 1 1111 0 0 000111222222222 22
Q ss_pred HHHHHHh--------CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 119 GVDYCHS--------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 119 ~l~~Lh~--------~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
...+|+. ..++|||+++.|+++++++.+=+.||+.+....+....
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~Dl 235 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLEDL 235 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHHH
Confidence 3444443 23899999999999999999999999998877665443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0011 Score=51.17 Aligned_cols=36 Identities=28% Similarity=0.407 Sum_probs=30.5
Q ss_pred CceeccCCCCCeEecCC----CcEEEeeccccccCCCCCc
Q 027809 127 GVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 127 ~i~h~di~p~nil~~~~----~~~~l~d~~~~~~~~~~~~ 162 (218)
.++|+|+.|.||+++++ +.+.++||..+........
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p~~D 219 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYRGFD 219 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCcHHH
Confidence 48999999999999874 8899999999887665444
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0028 Score=49.92 Aligned_cols=76 Identities=16% Similarity=0.137 Sum_probs=46.2
Q ss_pred eecCccceEEEEEEecCCCcEEEEEEEecchh----hhhhHHHHHHHHHHhhhhcCC--C-CcceEEEEEEcCCeEEEEE
Q 027809 14 TIGEGTFAKVKFAQNTETGESVAMKVLDRSAI----IKHKMADQIKREISIMKLVRH--P-CVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 14 ~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~~~~~~~l~~l~~--~-~i~~~~~~~~~~~~~~lv~ 86 (218)
.+|.|....||.+.+...++.++||.-..-.. .-+-..++..-|...++.... | .+++++.+ +.+...++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57889999999999754446899987532111 001223455556666655432 3 55556555 445567899
Q ss_pred EecCC
Q 027809 87 EFITG 91 (218)
Q Consensus 87 e~~~~ 91 (218)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99864
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0053 Score=46.91 Aligned_cols=35 Identities=20% Similarity=0.393 Sum_probs=28.1
Q ss_pred CceeccCCCCCeEecCCCc-EEEeeccccccCCCCC
Q 027809 127 GVYHRDLKPENLLLDSQGH-LKISDFGLSALPEQGV 161 (218)
Q Consensus 127 ~i~h~di~p~nil~~~~~~-~~l~d~~~~~~~~~~~ 161 (218)
.++|||++|.|+++++++. .-++||+.+....+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDPa~ 221 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDPAR 221 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCHHH
Confidence 3899999999999987555 5699999887765543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0044 Score=48.95 Aligned_cols=145 Identities=17% Similarity=0.208 Sum_probs=82.6
Q ss_pred EEeeeecCccceEEEEEEecC----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc-ceEEEEEEcCCeEEE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTE----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYI 84 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i-~~~~~~~~~~~~~~l 84 (218)
.-++.+..|-...+|++.... .++.+++|+..... ....+ ..+|..+++.+...++ +++++.+.. + .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~ 110 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---R 110 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---e
Confidence 345566667778899886432 24678999875432 22222 2567777777754333 455566533 2 4
Q ss_pred EEEecCCCChHHH----------H----Hh-cC-C------CC-HHHHHHHHHHH-----------------HHHHHHH-
Q 027809 85 ILEFITGGELFDK----------I----VH-HG-R------LS-ESEARRYFQQL-----------------IDGVDYC- 123 (218)
Q Consensus 85 v~e~~~~~~L~~~----------~----~~-~~-~------~~-~~~~~~~~~~i-----------------~~~l~~L- 123 (218)
|.+|+++.++... + .. +. + ++ ..++..+..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7888877665321 0 00 00 0 11 22232332221 1112222
Q ss_pred ---H----hCCceeccCCCCCeEecC-CCcEEEeeccccccCCCCCc
Q 027809 124 ---H----SKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 124 ---h----~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~~~~ 162 (218)
. ...++|+|+++.||++++ ++.+.++||..+........
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~~~D 237 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNPVAYD 237 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccchHHH
Confidence 1 225899999999999976 46899999999887665433
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0038 Score=49.00 Aligned_cols=144 Identities=20% Similarity=0.276 Sum_probs=80.1
Q ss_pred eeeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc-ceEEEEEEcCCeEEEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILE 87 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e 87 (218)
++.+..|-...+|.+...+. +..+++|+..... ... -+..+|..+++.+...++ ++++.++. .+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---CeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 45555577777888765432 2478899875432 111 223466777777755444 45565553 22 4888
Q ss_pred ecCCCChHHH----------HHh-----c-CC------CC-HHHHHHHHHHH----------------------HHHHHH
Q 027809 88 FITGGELFDK----------IVH-----H-GR------LS-ESEARRYFQQL----------------------IDGVDY 122 (218)
Q Consensus 88 ~~~~~~L~~~----------~~~-----~-~~------~~-~~~~~~~~~~i----------------------~~~l~~ 122 (218)
|+++.++... +.. + .+ ++ ...+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 8877655211 100 0 01 11 22222222221 111222
Q ss_pred HH----hC----CceeccCCCCCeEecC-CCcEEEeeccccccCCCCCcc
Q 027809 123 CH----SK----GVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 123 Lh----~~----~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+. .. -..|+|+.+.||++++ ++.++++||..+.........
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~~fDI 220 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYRGYDI 220 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCccHHHH
Confidence 21 11 2799999999999974 578999999998877665444
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0065 Score=48.52 Aligned_cols=78 Identities=18% Similarity=0.205 Sum_probs=48.6
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhh---hhHHHHHHHHHHhhhhcC---CCCcceEEEEEEcCCeEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK---HKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~~~l~~l~---~~~i~~~~~~~~~~~~~~lv 85 (218)
.+.||.|...-||.+.+...++.++||.-..-.... +-..++..-|...|+... -.++++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999875345678888653111000 112455556666666553 2356666665 44556788
Q ss_pred EEecCC
Q 027809 86 LEFITG 91 (218)
Q Consensus 86 ~e~~~~ 91 (218)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0096 Score=45.73 Aligned_cols=75 Identities=19% Similarity=0.194 Sum_probs=45.6
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc---CCCCcceEEEEEEcCCeEEEEE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+-.+.++.|....+|... .+++.+.+|.-.... ...+..|..-|+.+ ..-.+++++.+....+..++++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 456778888899999876 567889999865222 23455666666666 3466888899887777779999
Q ss_pred EecCCC
Q 027809 87 EFITGG 92 (218)
Q Consensus 87 e~~~~~ 92 (218)
|+++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.017 Score=44.68 Aligned_cols=105 Identities=11% Similarity=0.097 Sum_probs=68.7
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC---CCcceEEEEEEc---CCeEE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH---PCVVRLHEVLAS---RTKIY 83 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~---~~i~~~~~~~~~---~~~~~ 83 (218)
.-.+.|+.|..+.+|...... + .+++|...... + ...+..|...++.+.. -.++++++.+.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~--~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS--T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEecccc--c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 446789999999999886532 3 46777743311 1 2456777888877743 357888887753 35689
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~ 126 (218)
+|||++++.++.+. ..+......++.++++++..||..
T Consensus 90 LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 90 LLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999776541 122333445556666777777763
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.037 Score=43.03 Aligned_cols=36 Identities=14% Similarity=0.134 Sum_probs=31.3
Q ss_pred CceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 127 ~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+++|||+.+.|++++.++.+-++||..++......+
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~~~~D 232 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFASPLTD 232 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccCCcHHH
Confidence 699999999999999999999999998887665443
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.014 Score=45.99 Aligned_cols=103 Identities=18% Similarity=0.232 Sum_probs=69.8
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...|+++++-. +++... ..-..+++..++.+.+..+.-+..+ ..-|+|+.-.||+++ +|++.|+||.+++...
T Consensus 299 ~y~yl~~kdhg-t~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 299 LYLYLHFKDHG-TPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred eEEEEEEecCC-ceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 35666777663 355322 2235788999999999999998865 699999999999998 9999999999998655
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHh
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCG 195 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG 195 (218)
.+...... +.-.|-.+.+.. +.+-+||-+-
T Consensus 373 ~q~~isy~-----rldhp~lF~G~d--d~QFeIYrlM 402 (488)
T COG5072 373 SQGIISYN-----RLDHPDLFNGVD--DYQFEIYRLM 402 (488)
T ss_pred CCceeecc-----ccCchhhhcCcc--ceeeeHHHHH
Confidence 54333222 223344443222 3566666543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.018 Score=46.17 Aligned_cols=36 Identities=22% Similarity=0.170 Sum_probs=28.4
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
....|+|+.+.||+.+ ++.+.++||..+........
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~n~~~fD 262 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGFNYVGWE 262 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEeccccCCchHhH
Confidence 3579999999999874 55699999998876665433
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.071 Score=39.47 Aligned_cols=77 Identities=18% Similarity=0.239 Sum_probs=53.8
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC---CCCcceEEEEEEcCCeEEEEEE
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e 87 (218)
..+.+.-|..-..|...+. ..++.+|.-. .+...-+..|+.-|+.+. .-.+++++.+..+.++.|+|+|
T Consensus 20 er~~v~gG~inea~~v~dg--~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 20 EREEVSGGDINEAWRLRDG--TDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred cccccCCccccceeEeecC--CcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 3445555666777777664 4578888532 223455666676666663 4568889999999999999999
Q ss_pred ecCCCChH
Q 027809 88 FITGGELF 95 (218)
Q Consensus 88 ~~~~~~L~ 95 (218)
|++.+++.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99986653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.015 Score=47.92 Aligned_cols=50 Identities=16% Similarity=0.232 Sum_probs=40.3
Q ss_pred HHHHHHHHhhhhcCCCCcceEEEEEEcC-CeEEEEEEecCCCChHHHHHhcC
Q 027809 52 DQIKREISIMKLVRHPCVVRLHEVLASR-TKIYIILEFITGGELFDKIVHHG 102 (218)
Q Consensus 52 ~~~~~~~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~ 102 (218)
.++.-.+..++.+.|+++..++++-... ....+|+|++.. +|.+.+..+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc
Confidence 4577888999999999999999987643 357788999965 9988887654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.18 Score=41.38 Aligned_cols=34 Identities=24% Similarity=0.330 Sum_probs=27.3
Q ss_pred CceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 127 ~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
..+|+|+.+.||+.+. +.++++||..+.......
T Consensus 285 VfCHNDl~~~NiL~~~-~~l~LIDfEYAg~ndpaf 318 (442)
T PTZ00296 285 VFCHNDLQENNIINTN-KCLRLIDFEYSGYNFLAT 318 (442)
T ss_pred eEEeCCCCccceeecC-CCEEEEeecccccccHHH
Confidence 4899999999998754 449999999887665543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.54 Score=42.85 Aligned_cols=32 Identities=28% Similarity=0.481 Sum_probs=26.6
Q ss_pred CCceeccCCCCCeEecCCC--cEE-EeeccccccC
Q 027809 126 KGVYHRDLKPENLLLDSQG--HLK-ISDFGLSALP 157 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~--~~~-l~d~~~~~~~ 157 (218)
.+++|+|+++.||+++.++ ++. |+|||-++..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 5699999999999998775 555 9999987654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.034 Score=43.16 Aligned_cols=33 Identities=24% Similarity=0.476 Sum_probs=27.4
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+++|||+++.|++++. +.+.++||+.+.....
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~~~~ 219 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTIDLP 219 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccccCCc
Confidence 47899999999999977 6789999997765443
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.00079 Score=61.61 Aligned_cols=149 Identities=17% Similarity=0.173 Sum_probs=102.2
Q ss_pred hhhhcCCCCcceEEEEEE--cCCeEEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CC--c
Q 027809 60 IMKLVRHPCVVRLHEVLA--SRTKIYIILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHS---KG--V 128 (218)
Q Consensus 60 ~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~Lh~---~~--i 128 (218)
-++...|+++.....-.. .+...+..++++.+|.+...+-++. ++...-......+.+.+..-.|. .| .
T Consensus 1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence 444556777766554432 2345678899999999988886653 23333333333333555444442 22 7
Q ss_pred eeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCC
Q 027809 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208 (218)
Q Consensus 129 ~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 208 (218)
+|.++++.|.++..+-++++.++|+.....+.........+++.|+.|+......+. .++|+|.+|+.+|....|..||
T Consensus 1362 v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHH
Confidence 888999999999999999999999988444443444444566778888887766665 6699999999999988887776
Q ss_pred C
Q 027809 209 D 209 (218)
Q Consensus 209 ~ 209 (218)
.
T Consensus 1441 i 1441 (2724)
T KOG1826|consen 1441 I 1441 (2724)
T ss_pred H
Confidence 4
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.014 Score=41.74 Aligned_cols=33 Identities=21% Similarity=0.387 Sum_probs=27.7
Q ss_pred CceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 127 ~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
-.+|+|+.|.|+++++++ ++++|++.+....+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gDp~ 110 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGDIA 110 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCCCHH
Confidence 379999999999998777 889999988765543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.032 Score=42.48 Aligned_cols=50 Identities=26% Similarity=0.422 Sum_probs=37.5
Q ss_pred HHHHHHHHHHHHHhC--CceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 112 YFQQLIDGVDYCHSK--GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 112 ~~~~i~~~l~~Lh~~--~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.+..+-.++...+.. -.+|+|+.|.|++.++.+.++|+||..+....+..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~D~~~ 188 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLNDPAF 188 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCccHHH
Confidence 444444444444433 58999999999999998999999999888766543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.074 Score=38.83 Aligned_cols=33 Identities=30% Similarity=0.650 Sum_probs=23.2
Q ss_pred CceeccCCCCCeEe-cCCCcEEEeeccccccCCC
Q 027809 127 GVYHRDLKPENLLL-DSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 127 ~i~h~di~p~nil~-~~~~~~~l~d~~~~~~~~~ 159 (218)
-..|+|+.|.||++ +.++.++++||..+.....
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n~~ 177 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYNDR 177 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EEEEH
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhhccc
Confidence 48999999999999 8899999999998875543
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 218 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-62 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-62 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-62 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-62 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-62 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-61 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-60 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-59 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-54 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-54 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-54 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-54 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-54 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-53 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-53 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-53 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-53 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-52 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-50 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-47 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-47 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-46 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-46 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-46 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-45 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-43 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-43 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-43 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-43 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-43 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-43 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-43 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-43 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-43 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-43 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-42 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-42 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-42 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-42 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-42 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-42 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-42 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-42 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-42 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-42 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-42 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-42 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-42 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-42 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-42 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-42 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-42 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-41 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-41 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-41 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-41 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-41 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-41 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-41 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-41 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-41 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-41 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-41 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-41 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-41 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-41 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-41 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-41 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-41 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-41 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-41 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-41 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-41 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-41 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-41 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-41 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-41 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-41 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-41 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-41 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-41 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-41 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-41 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-41 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-41 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-41 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-41 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-41 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-41 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-41 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-41 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-41 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-41 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-41 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-40 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-40 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-40 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-40 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-40 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-40 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-40 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-40 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-40 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-40 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-40 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-40 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-40 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-40 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-40 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-40 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-40 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-40 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-39 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-39 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-39 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-39 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-39 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-39 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-39 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-39 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-39 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-39 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-39 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-39 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-39 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-39 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-39 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-38 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-38 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-38 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-38 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-38 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-38 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-38 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-38 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-38 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-38 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-38 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-38 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-38 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-37 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-37 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-37 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-37 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-37 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-37 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-37 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-37 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-37 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-36 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-36 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-36 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-36 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-36 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-36 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-36 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-36 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-36 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-36 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-36 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-36 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-36 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-36 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-36 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-36 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-36 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-36 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-36 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-36 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-36 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-36 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-35 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-35 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-35 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-35 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-35 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-35 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-35 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-35 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-35 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-35 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-35 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-35 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-35 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-35 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-35 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-35 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-35 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-35 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-35 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-35 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-35 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-35 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-35 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-35 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-35 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-35 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-35 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-35 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-35 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-35 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-35 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-34 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-34 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-34 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-34 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-34 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-34 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-34 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-34 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-34 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-34 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-34 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-34 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-34 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-34 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-34 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-34 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-34 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-34 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-34 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-34 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-34 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-34 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-34 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-34 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-34 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-34 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-34 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-33 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-33 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-33 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-33 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-33 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-33 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-33 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-33 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-33 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-33 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-33 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-33 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-33 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-32 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-32 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-32 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-32 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-31 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-31 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-31 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-31 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-31 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-31 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-30 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-30 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-29 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-29 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-29 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-28 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-27 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-27 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-26 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-26 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-26 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-26 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-26 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-26 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-26 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-26 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-26 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-26 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-26 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-25 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-25 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-25 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-25 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-25 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-25 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-25 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-25 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-25 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-25 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-25 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-25 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-25 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-25 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-25 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-25 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-25 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-25 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-25 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-25 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-25 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-25 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-25 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-25 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-25 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-25 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-25 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-25 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-25 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-25 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-25 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-25 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-25 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-25 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-25 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-24 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-24 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-24 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-24 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-24 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-24 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-24 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-24 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-23 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-23 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-23 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-22 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-21 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-18 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-18 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-18 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-18 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-17 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-17 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-17 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 7e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-16 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-16 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-12 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-09 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-09 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 9e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-08 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-147
Identities = 90/220 (40%), Positives = 134/220 (60%), Gaps = 5/220 (2%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M V V +++ +T+GEG + +V+ A N T E+VA+K++D + + IK+EI I
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICI 58
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
K++ H VV+ + Y+ LE+ +GGELFD+I + E +A+R+F QL+ GV
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VSLLRTTCGTPNYVAPEV 178
Y H G+ HRD+KPENLLLD + +LKISDFGL+ + LL CGT YVAPE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLY 217
L + ++ DVWSCG++L ++AG LP+D+ D Y
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-146
Identities = 90/220 (40%), Positives = 134/220 (60%), Gaps = 5/220 (2%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M V V +++ +T+GEG + +V+ A N T E+VA+K++D + + IK+EI I
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICI 58
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
K++ H VV+ + Y+ LE+ +GGELFD+I + E +A+R+F QL+ GV
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VSLLRTTCGTPNYVAPEV 178
Y H G+ HRD+KPENLLLD + +LKISDFGL+ + LL CGT YVAPE+
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL-DLTTLY 217
L + ++ DVWSCG++L ++AG LP+D+ D Y
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-144
Identities = 109/214 (50%), Positives = 152/214 (71%), Gaps = 1/214 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
K+G Y +G T+G GTF KVK ++ TG VA+K+L+R I + +IKREI +KL
Sbjct: 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
RHP +++L++V+++ T ++++E+++GGELFD I HGR+ E EARR FQQ++ VDYC
Sbjct: 68 FRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYC 127
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLKPEN+LLD+ + KI+DFGLS + G LRT+CG+PNY APEV+S +
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRL 186
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
Y G D+WSCGVILY L+ G LPFD+ + TL+
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF 220
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 404 bits (1039), Expect = e-142
Identities = 107/214 (50%), Positives = 153/214 (71%), Gaps = 1/214 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
K+G Y +G T+G GTF KVK ++ TG VA+K+L+R I + +I+REI +KL
Sbjct: 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
RHP +++L++V+++ + I++++E+++GGELFD I +GRL E E+RR FQQ++ GVDYC
Sbjct: 73 FRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYC 132
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLKPEN+LLD+ + KI+DFGLS + G LRT+CG+PNY APEV+S +
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRL 191
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
Y G D+WS GVILY L+ G LPFD+ + TL+
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF 225
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-140
Identities = 102/214 (47%), Positives = 152/214 (71%), Gaps = 2/214 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R +G Y + T+GEG+F KVK A + +T + VA+K + R + K M +++REIS +KL
Sbjct: 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+RHP +++L++V+ + T I +++E+ GGELFD IV R++E E RR+FQQ+I ++YC
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H + HRDLKPENLLLD ++KI+DFGLS + G + L+T+CG+PNY APEV++ K
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKL 183
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
Y G DVWSCG++LYV++ G LPFD+ + L+
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 394 bits (1013), Expect = e-139
Identities = 94/218 (43%), Positives = 134/218 (61%), Gaps = 7/218 (3%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
++ +Y+ + IG G F + ++ T E VA+K ++R A I + ++REI
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINH 70
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
+ +RHP +VR EV+ + T + II+E+ +GGEL+++I + GR SE EAR +FQQL+ GV
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 122 YCHSKGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
YCHS + HRDLK EN LLD LKI DFG S S ++T GTP Y+APEVL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL 189
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ Y+G ADVWSCGV LYV++ G PF++ + Y
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY 227
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 387 bits (996), Expect = e-138
Identities = 79/214 (36%), Positives = 112/214 (52%), Gaps = 1/214 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R +Y GR +G+G FAK + +T E A K++ +S ++K +++ EISI +
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 71
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ H VV H ++++LE L + L+E EAR Y +Q++ G Y
Sbjct: 72 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLK NL L+ +KI DFGL+ E + CGTPNY+APEVLS KG
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ DVWS G I+Y L+ G PF+ L Y
Sbjct: 192 H-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-138
Identities = 79/214 (36%), Positives = 112/214 (52%), Gaps = 1/214 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R +Y GR +G+G FAK + +T E A K++ +S ++K +++ EISI +
Sbjct: 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ H VV H ++++LE L + L+E EAR Y +Q++ G Y
Sbjct: 98 LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H V HRDLK NL L+ +KI DFGL+ E + CGTPNY+APEVLS KG
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ DVWS G I+Y L+ G PF+ L Y
Sbjct: 218 H-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETY 250
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 383 bits (986), Expect = e-136
Identities = 75/222 (33%), Positives = 128/222 (57%), Gaps = 9/222 (4%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-MADQIKREISIMK 62
+ +GKY +G +GEG++ KVK ++ET A+K+L + + + +K+EI +++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 63 LVRHPCVVRLHEVL--ASRTKIYIILEFITGG--ELFDKIVHHGRLSESEARRYFQQLID 118
+RH V++L +VL + K+Y+++E+ G E+ D + R +A YF QLID
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLID 120
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--SLLRTTCGTPNYVAP 176
G++Y HS+G+ H+D+KP NLLL + G LKIS G++ RT+ G+P + P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 177 EVLS-HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
E+ + ++G D+WS GV LY + G PF+ ++ L+
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-135
Identities = 84/241 (34%), Positives = 130/241 (53%), Gaps = 28/241 (11%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-------------- 49
++ +Y + IG+G++ VK A N AMKVL + +I+
Sbjct: 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 50 ---------MADQIKREISIMKLVRHPCVVRLHEVL--ASRTKIYIILEFITGGELFDKI 98
+Q+ +EI+I+K + HP VV+L EVL + +Y++ E + G + + +
Sbjct: 70 PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-V 128
Query: 99 VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158
LSE +AR YFQ LI G++Y H + + HRD+KP NLL+ GH+KI+DFG+S +
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 159 QGVSLLRTTCGTPNYVAPEVLS--HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+LL T GTP ++APE LS K ++G A DVW+ GV LY + G PF + + L
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 217 Y 217
+
Sbjct: 249 H 249
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-135
Identities = 75/215 (34%), Positives = 122/215 (56%), Gaps = 2/215 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
K+ ++VG +G+G+FA V A++ TG VA+K++D+ A+ K M +++ E+ I
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDY 122
++HP ++ L+ +Y++LE GE+ + + SE+EAR + Q+I G+ Y
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
HS G+ HRDL NLLL ++KI+DFGL+ + T CGTPNY++PE+ +
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ G +DVWS G + Y L+ G PFD +
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-130
Identities = 77/213 (36%), Positives = 122/213 (57%), Gaps = 3/213 (1%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ +++GR +G+G F V A+ + +A+KVL +S + K + Q++REI I +
Sbjct: 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP ++R++ R +IY++LEF GEL+ ++ HGR E + + ++L D + YCH
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ V HRD+KPENLL+ +G LKI+DFG S RT CGT +Y+ PE++ K +
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKTH 189
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D+W GV+ Y + G PFD T +
Sbjct: 190 -DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-129
Identities = 98/214 (45%), Positives = 140/214 (65%), Gaps = 2/214 (0%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+G Y + +TIG+G FAKVK A++ TG VA+K++D++ + ++ RE+ IMK+
Sbjct: 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKI 70
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ HP +V+L EV+ + +Y+I+E+ +GGE+FD +V HGR+ E EAR F+Q++ V YC
Sbjct: 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
H K + HRDLK ENLLLD+ ++KI+DFG S G L CG P Y APE+ K
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKK 189
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
Y+G DVWS GVILY L++G LPFD +L L
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 360 bits (926), Expect = e-127
Identities = 73/213 (34%), Positives = 118/213 (55%), Gaps = 3/213 (1%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ +E+GR +G+G F V A+ ++ +A+KVL ++ + K + Q++RE+ I +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP ++RL+ T++Y+ILE+ G ++ ++ + E Y +L + + YCH
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
SK V HRD+KPENLLL S G LKI+DFG S S CGT +Y+ PE++ + +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRMH 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D+WS GV+ Y + G PF+ Y
Sbjct: 185 -DEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-126
Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 7/213 (3%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD-----QIKREISI 60
KY +G G F V A + E + V +K + + +++ + ++ EI+I
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEF-ITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
+ V H ++++ ++ ++ +++E +G +LF I H RL E A F+QL+
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
V Y K + HRD+K EN+++ +K+ DFG +A E+G L T CGT Y APEVL
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVL 201
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y G ++WS GV LY L+ PF EL+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-122
Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 11/216 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ---IKREISI 60
+Y +G +G+G F V VA+KV+ R+ ++ E+++
Sbjct: 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL 87
Query: 61 MKLVR----HPCVVRLHEVLASRTKIYIILEF-ITGGELFDKIVHHGRLSESEARRYFQQ 115
+ V HP V+RL + ++ ++LE + +LFD I G L E +R +F Q
Sbjct: 88 LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
++ + +CHS+GV HRD+K EN+L+D + G K+ DFG AL GT Y
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYS 205
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
PE +S Y+ A VWS G++LY ++ G +PF+
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-120
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 9/214 (4%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD---QIKREISI 60
+Y+VG +G G F V VA+K +++ I ++ E+ +
Sbjct: 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 99
Query: 61 MKLVRH--PCVVRLHEVLASRTKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLI 117
+K V V+RL + +ILE +LFD I G L E AR +F Q++
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ V +CH+ GV HRD+K EN+L+D +G LK+ DFG AL + + GT Y P
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPP 217
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
E + + Y+G +A VWS G++LY ++ G +PF+
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-119
Identities = 57/239 (23%), Positives = 112/239 (46%), Gaps = 29/239 (12%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK-------------- 49
+ + Y + RT+ +G F K+ + + + A+K ++S + K +
Sbjct: 28 KYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKS 85
Query: 50 MADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRL----- 104
D K E+ I+ +++ + ++ + ++YII E++ + + L
Sbjct: 86 KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 105 ---SESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160
+ + +++ Y H+ K + HRD+KP N+L+D G +K+SDFG S
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 161 VSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
++ + GT ++ PE S++ YNGA D+WS G+ LYV+ +PF ++ L L+
Sbjct: 206 --KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = e-100
Identities = 87/213 (40%), Positives = 128/213 (60%), Gaps = 12/213 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMK 62
+Y + +T+G G +VK A +T + VA+K++ + + A ++ EI I+K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ HPC++++ + YI+LE + GGELFDK+V + RL E+ + YF Q++ V Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 123 CHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
H G+ HRDLKPEN+LL SQ +KI+DFG S + + SL+RT CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 188
Query: 180 SHKGYN--GAAADVWSCGVILYVLIAGYLPFDE 210
G A D WS GVIL++ ++GY PF E
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 3e-97
Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 16/226 (7%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+ G +E+ +G G F V + +TGE VA+K + K++ ++ EI IMK
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMKK 68
Query: 64 VRHPCVVRLHEVLASRTKI------YIILEFITGGELFDKIVHHGR---LSESEARRYFQ 114
+ HP VV EV K+ + +E+ GG+L + L E R
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTP 171
+ + Y H + HRDLKPEN++L KI D G + +QG L GT
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTL 187
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
Y+APE+L K Y D WS G + + I G+ PF +
Sbjct: 188 QYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 7e-97
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 23/228 (10%)
Query: 1 MVVRKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI 58
M + + + +G+G A V ++ +TG+ A+KV + + ++ D RE
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 59 SIMKLVRHPCVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGR---LSESEARRYF 113
++K + H +V+L + T +I+EF G L+ + L ESE
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ ++ G+++ G+ HR++KP N++ D Q K++DFG + E + G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177
Query: 170 TPNYVAPEVLS--------HKGYNGAAADVWSCGVILYVLIAGYLPFD 209
T Y+ P++ K Y GA D+WS GV Y G LPF
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFR 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 9e-97
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 23/228 (10%)
Query: 1 MVVRKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI 58
M + + + +G+G A V ++ +TG+ A+KV + + ++ D RE
Sbjct: 1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58
Query: 59 SIMKLVRHPCVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGR---LSESEARRYF 113
++K + H +V+L + T +I+EF G L+ + L ESE
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ ++ G+++ G+ HR++KP N++ D Q K++DFG + E + G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177
Query: 170 TPNYVAPEVLS--------HKGYNGAAADVWSCGVILYVLIAGYLPFD 209
T Y+ P++ K Y GA D+WS GV Y G LPF
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFR 224
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-96
Identities = 87/214 (40%), Positives = 129/214 (60%), Gaps = 14/214 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMK 62
+Y + +T+G G +VK A +T + VA++++ + + A ++ EI I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ HPC++++ + YI+LE + GGELFDK+V + RL E+ + YF Q++ V Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 123 CHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
H G+ HRDLKPEN+LL SQ +KI+DFG S + + SL+RT CGTP Y+APEVL
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 313
Query: 180 S---HKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
GY A D WS GVIL++ ++GY PF E
Sbjct: 314 VSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSE 346
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 5e-95
Identities = 76/206 (36%), Positives = 122/206 (59%), Gaps = 6/206 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+V +G+G F+ V+ + TG A K+++ + + +++RE I + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHP 65
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+ + + Y++ + +TGGELF+ IV SE++A QQ+++ + YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HR+LKPENLLL S+ +K++DFGL+ GTP Y++PEVL Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDE 210
D+W+CGVILY+L+ GY PF +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWD 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-94
Identities = 76/214 (35%), Positives = 120/214 (56%), Gaps = 14/214 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-----IKHKMADQIKREISIMK 62
KY+ IG G + V+ + TG A+K+++ +A ++ + +RE I++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 63 -LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
+ HP ++ L + S + ++++ + + GELFD + LSE E R + L++ V
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL-- 179
+ H+ + HRDLKPEN+LLD +++SDFG S E G LR CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKC 273
Query: 180 ----SHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+H GY G D+W+CGVIL+ L+AG PF
Sbjct: 274 SMDETHPGY-GKEVDLWACGVILFTLLAGSPPFW 306
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-94
Identities = 70/216 (32%), Positives = 118/216 (54%), Gaps = 15/216 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK------HKMADQIKREISIM 61
YE +G G + V+ + T + A+K++D + ++ + +E+ I+
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 62 K-LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
+ + HP +++L + + T +++ + + GELFD + LSE E R+ + L++ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL- 179
H + HRDLKPEN+LLD ++K++DFG S + G LR CGTP+Y+APE++
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 196
Query: 180 -----SHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
+H GY G D+WS GVI+Y L+AG PF
Sbjct: 197 CSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 275 bits (706), Expect = 9e-94
Identities = 80/214 (37%), Positives = 125/214 (58%), Gaps = 9/214 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F++V + TG+ A+K + +S + ++ EI+++K ++H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHE 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V L ++ S T Y++++ ++GGELFD+I+ G +E +A QQ++ V Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLL + + I+DFGLS + + G+ + T CGTP YVAPEVL+ K Y
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEVLAQKPY 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
A D WS GVI Y+L+ GY PF E + L+
Sbjct: 185 -SKAVDCWSIGVITYILLCGYPPFYEETESKLFE 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 3e-93
Identities = 76/205 (37%), Positives = 119/205 (58%), Gaps = 6/205 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+V +G+G F+ V+ + TG A K+++ + ++RE I + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+ + + Y++ + +TGGELF+ IV SE++A QQ+++ + YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HR+LKPENLLL S+ +K++DFGL+ GTP Y++PEVL Y
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 207
Query: 185 NGAAADVWSCGVILYVLIAGYLPFD 209
D+W+CGVILY+L+ GY PF
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFW 231
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 4e-93
Identities = 85/205 (41%), Positives = 120/205 (58%), Gaps = 9/205 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + TIG G++ +VK A T A K + + + + D+ K+EI IMK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++RL+E T IY+++E TGGELF+++VH ES+A R + ++ V YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 128 VYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
V HRDLKPEN L + LK+ DFGL+A + G ++RT GTP YV+P+VL Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVL-EGLY 184
Query: 185 NGAAADVWSCGVILYVLIAGYLPFD 209
G D WS GV++YVL+ GY PF
Sbjct: 185 -GPECDEWSAGVMMYVLLCGYPPFS 208
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-91
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + + IG G +KV N E + A+K ++ + D + EI+ + ++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLNKLQQH 86
Query: 68 C--VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
++RL++ + IY+++E +L + + E + Y++ +++ V H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTT-CGTPNYVAPEVLSHKG 183
G+ H DLKP N L+ G LK+ DFG++ + S+++ + GT NY+ PE +
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 184 YN----------GAAADVWSCGVILYVLIAGYLPFDELD 212
+ +DVWS G ILY + G PF ++
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 5e-91
Identities = 77/205 (37%), Positives = 120/205 (58%), Gaps = 5/205 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y++ +G+G F+ V+ G+ A +++ + ++RE I +L++HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+ ++ Y+I + +TGGELF+ IV SE++A QQ+++ V +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
V HR+LKPENLLL S+ +K++DFGL+ E GTP Y++PEVL Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 185 NGAAADVWSCGVILYVLIAGYLPFD 209
G D+W+CGVILY+L+ GY PF
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFW 214
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 7e-91
Identities = 82/214 (38%), Positives = 123/214 (57%), Gaps = 11/214 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+EV +G G + V + T + A+KV + K ++ EI ++ + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLSHP 108
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L E+ + T+I ++LE +TGGELFD+IV G SE +A +Q+++ V Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLL + LKI+DFGLS + E L++T CGTP Y APE+L Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAY 227
Query: 185 NGAAADVWSCGVILYVLIAGYLPF-DELDLTTLY 217
G D+WS G+I Y+L+ G+ PF DE ++
Sbjct: 228 -GPEVDMWSVGIITYILLCGFEPFYDERGDQFMF 260
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 9e-91
Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E +G+G F +V A+N A+K + + + I E+ ++ + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQ 62
Query: 68 CVVRLHEV-------------LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYF 113
VVR + + ++ ++I +E+ G L+D I E R F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV------------ 161
+Q+++ + Y HS+G+ HRDLKP N+ +D ++KI DFGL+ + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 162 --SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
L + GT YVA EVL G+ D++S G+I + +I Y ++ +
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNIL 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 9e-91
Identities = 80/205 (39%), Positives = 124/205 (60%), Gaps = 7/205 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G+G+F +V ++ T + A+KV+++++ K I RE+ ++K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L E+L + YI+ E TGGELFD+I+ R SE +A R +Q+ G+ Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPEN+LL+S+ +KI DFGLS +Q + ++ GT Y+APEVL Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199
Query: 185 NGAAADVWSCGVILYVLIAGYLPFD 209
DVWS GVILY+L++G PF
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFY 223
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 5e-90
Identities = 77/208 (37%), Positives = 131/208 (62%), Gaps = 9/208 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLV 64
YE+G +G G FA V+ + TG+ A K + + + + ++I+RE++I++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
RHP ++ LH++ ++T + +ILE ++GGELFD + L+E EA ++ +Q++DGV Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 125 SKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
SK + H DLKPEN++L + +K+ DFG++ E G + + GTP +VAPE+++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVN 184
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPF 208
++ G AD+WS GVI Y+L++G PF
Sbjct: 185 YEPL-GLEADMWSIGVITYILLSGASPF 211
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 7e-90
Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + + IG G +KV N E + A+K ++ + D + EI+ + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLNKLQQH 67
Query: 68 C--VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
++RL++ + IY+++E +L + + E + Y++ +++ V H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTT-CGTPNYVAPEVLSHKG 183
G+ H DLKP N L+ G LK+ DFG++ + S+++ + GT NY+ PE +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 184 YN----------GAAADVWSCGVILYVLIAGYLPFDELD 212
+ +DVWS G ILY + G PF ++
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-89
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ R +G G F V + +G +K +++ +QI+ EI ++K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYC 123
++++ EV +YI++E GGEL ++IV LSE +Q+++ + Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 124 HSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
HS+ V H+DLKPEN+L +KI DFGL+ L + GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVF- 198
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+ D+WS GV++Y L+ G LPF
Sbjct: 199 KRDV-TFKCDIWSAGVVMYFLLTGCLPFT 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 2e-89
Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 18/225 (8%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+ K Y + + IG G +KV N E + A+K ++ + D + EI+ +
Sbjct: 51 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYL 108
Query: 62 KLVRHPC--VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
++ ++RL++ + IY+++E +L + + E + Y++ +++
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTT-CGTPNYVAPE 177
V H G+ H DLKP N L+ G LK+ DFG++ + S+++ + G NY+ PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 178 VLSHKGYN----------GAAADVWSCGVILYVLIAGYLPFDELD 212
+ + +DVWS G ILY + G PF ++
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 4e-89
Identities = 73/211 (34%), Positives = 120/211 (56%), Gaps = 10/211 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKLVR 65
YE+ IG+G F+ V+ N ETG+ A+K++D + +KRE SI +++
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
HP +V L E +S +Y++ EF+ G +L +IV SE+ A Y +Q+++ +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 122 YCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
YCH + HRD+KP +LL S+ + +K+ FG++ + + GTP+++APEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+ + Y G DVW CGVIL++L++G LPF
Sbjct: 205 VKREPY-GKPVDVWGCGVILFILLSGCLPFY 234
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 5e-88
Identities = 76/207 (36%), Positives = 110/207 (53%), Gaps = 13/207 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH 66
YEV IG G+++ K + T A+K++D+S EI I+ + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P ++ L +V +Y++ E + GGEL DKI+ SE EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 127 GVYHRDLKPENLLLDSQGH----LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
GV HRDLKP N+L + ++I DFG + LL T C T N+VAPEVL +
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFD 209
GY AA D+WS GV+LY ++ GY PF
Sbjct: 196 GY-DAACDIWSLGVLLYTMLTGYTPFA 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 6e-88
Identities = 82/208 (39%), Positives = 127/208 (61%), Gaps = 9/208 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLV 64
Y++G +G G FA VK + TG A K + + + ++I+RE+SI++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
H V+ LH+V +RT + +ILE ++GGELFD + LSE EA + +Q++DGV+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 125 SKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
+K + H DLKPEN++L + H+K+ DFGL+ E G + GTP +VAPE+++
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVN 191
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPF 208
++ G AD+WS GVI Y+L++G PF
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPF 218
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 7e-88
Identities = 80/208 (38%), Positives = 124/208 (59%), Gaps = 9/208 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQIKREISIMKLV 64
Y+ G +G G FA VK + TG A K + + + + I+RE+SI+K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP V+ LHEV ++T + +ILE + GGELFD + L+E EA + +Q+++GV Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 125 SKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
S + H DLKPEN++L + +KI DFGL+ + G + + GTP +VAPE+++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 190
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPF 208
++ G AD+WS GVI Y+L++G PF
Sbjct: 191 YEPL-GLEADMWSIGVITYILLSGASPF 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 2e-87
Identities = 84/219 (38%), Positives = 130/219 (59%), Gaps = 13/219 (5%)
Query: 1 MVVRKVG----KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA---DQ 53
M K Y++G +G G FA VK + TG A K + + + ++
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 54 IKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYF 113
I+RE+SI++ V HP ++ LH+V +RT + +ILE ++GGELFD + LSE EA +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVSLLRTTCG 169
+Q++DGV+Y H+K + H DLKPEN++L + H+K+ DFGL+ E G + G
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFG 180
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
TP +VAPE+++++ G AD+WS GVI Y+L++G PF
Sbjct: 181 TPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPF 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-86
Identities = 75/209 (35%), Positives = 122/209 (58%), Gaps = 14/209 (6%)
Query: 8 KYEVG---RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
Y++ + +GEG+F+ + + ++ ++ A+K+ I K A+ ++EI+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKI-----ISKRMEAN-TQKEITALKLC 62
Query: 65 R-HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
HP +V+LHEV + ++++E + GGELF++I SE+EA ++L+ V +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 124 HSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H GV HRDLKPENLL + +KI DFG + L L+T C T +Y APE+L+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFD 209
GY + D+WS GVILY +++G +PF
Sbjct: 183 QNGY-DESCDLWSLGVILYTMLSGQVPFQ 210
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 5e-86
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 9/204 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + +G G F V T + ++ K + + +K+EISI+ + RH
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
++ LHE S ++ +I EFI+G ++F++I L+E E Y Q+ + + + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 127 GVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ H D++PEN++ ++ +KI +FG + + G R P Y APEV H
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180
Query: 185 NGAAADVWSCGVILYVLIAGYLPF 208
A D+WS G ++YVL++G PF
Sbjct: 181 -STATDMWSLGTLVYVLLSGINPF 203
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 4e-85
Identities = 81/204 (39%), Positives = 126/204 (61%), Gaps = 7/204 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G+G+F +V ++ T + A+KV+++++ K+K I RE+ ++K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L E+L + YI+ E TGGELFD+I+ R SE +A R +Q+ G+ Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPEN+LL+S+ +KI DFGLS +Q + ++ GT Y+APEVL Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199
Query: 185 NGAAADVWSCGVILYVLIAGYLPF 208
DVWS GVILY+L++G PF
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPF 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 4e-85
Identities = 73/208 (35%), Positives = 116/208 (55%), Gaps = 10/208 (4%)
Query: 8 KYEV-GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y + + +G G FA V+ + TG+ A K L + + A+ I EI++++L +
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87
Query: 67 -PCVVRLHEVLASRTKIYIILEFITGGELFDKIV--HHGRLSESEARRYFQQLIDGVDYC 123
P V+ LHEV + ++I +ILE+ GGE+F + +SE++ R +Q+++GV Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 124 HSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H + H DLKP+N+LL S G +KI DFG+S LR GTP Y+APE+L+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILN 206
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ A D+W+ G+I Y+L+ PF
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPF 233
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 9e-85
Identities = 79/205 (38%), Positives = 126/205 (61%), Gaps = 6/205 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ R +G+G+F +V ++ TG+ A+KV+ + + + + + RE+ ++K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L+E + Y++ E TGGELFD+I+ R SE +A R +Q++ G+ Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLLL+S+ +++I DFGLS E ++ GT Y+APEVL H Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVL-HGTY 204
Query: 185 NGAAADVWSCGVILYVLIAGYLPFD 209
DVWS GVILY+L++G PF+
Sbjct: 205 -DEKCDVWSTGVILYILLSGCPPFN 228
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 2e-84
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 8/204 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y++ +G G F V TG K ++ + +K EISIM + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHP 108
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
++ LH+ + ++ +ILEF++GGELFD+I ++SE+E Y +Q +G+ + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 127 GVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ H D+KPEN++ +++ +KI DFGL+ +++ T T + APE++ +
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPV 227
Query: 185 NGAAADVWSCGVILYVLIAGYLPF 208
G D+W+ GV+ YVL++G PF
Sbjct: 228 -GFYTDMWAIGVLGYVLLSGLSPF 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 2e-83
Identities = 75/204 (36%), Positives = 124/204 (60%), Gaps = 7/204 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+ + +G G + +V ++ T A+K++ ++++ + + E++++KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+++L++ + Y+++E GGELFD+I+H + +E +A +Q++ GV Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 128 VYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLLL+S+ +KI DFGLSA+ E ++ GT Y+APEVL K Y
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL-RKKY 214
Query: 185 NGAAADVWSCGVILYVLIAGYLPF 208
DVWS GVIL++L+AGY PF
Sbjct: 215 -DEKCDVWSIGVILFILLAGYPPF 237
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-83
Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 49/251 (19%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKLVR 65
KY + IG+G++ V+ A +T A+K+++++ I + D IK E+ +MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR---------------------- 103
HP + RL+EV I +++E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 104 ------------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG- 144
E +Q+ + Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 145 -HLKISDFGLS----ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVIL 198
+K+ DFGLS L + T GTP +VAPEVL+ + G D WS GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 199 YVLIAGYLPFD 209
++L+ G +PF
Sbjct: 267 HLLLMGAVPFP 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-83
Identities = 70/208 (33%), Positives = 118/208 (56%), Gaps = 14/208 (6%)
Query: 8 KYEVGRT--IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKL 63
Y V +T +G G F +V + T TG +A K+ I M D+ +K EIS+M
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI-----IKTRGMKDKEEVKNEISVMNQ 142
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDY 122
+ H +++L++ S+ I +++E++ GGELFD+I+ L+E + + +Q+ +G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 123 CHSKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H + H DLKPEN+L ++ +KI DFGL+ + L+ GTP ++APEV++
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVN 261
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ D+WS GVI Y+L++G PF
Sbjct: 262 YDFV-SFPTDMWSVGVIAYMLLSGLSPF 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 4e-83
Identities = 76/214 (35%), Positives = 121/214 (56%), Gaps = 16/214 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA----------DQIKRE 57
Y R +G G + +V + A+KV+ +S K + + ++I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 58 ISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117
IS++K + HP +++L +V + Y++ EF GGELF++I++ + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
G+ Y H + HRD+KPEN+LL+++ ++KI DFGLS+ + LR GT Y+
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYI 215
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
APEVL K Y DVWSCGVI+Y+L+ GY PF
Sbjct: 216 APEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPF 247
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 1e-82
Identities = 70/206 (33%), Positives = 113/206 (54%), Gaps = 12/206 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQ--IKREISIMKLVR 65
Y++ +G G F V TG + A K ++ +D+ +++EI M ++R
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKF-----VMTPHESDKETVRKEIQTMSVLR 212
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCH 124
HP +V LH+ ++ +I EF++GGELF+K+ H ++SE EA Y +Q+ G+ + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 125 SKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
H DLKPEN++ ++ LK+ DFGL+A + ++ T GT + APEV K
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGK 331
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPF 208
G D+WS GV+ Y+L++G PF
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPF 356
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-82
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 8 KYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
Y++ +GEG A+V+ N T + A+K++++ + ++ RE+ ++ +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQG 69
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
H V+ L E + Y++ E + GG + I +E EA Q + +D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 126 KGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVS-------LLRTTCGTPNYVA 175
KG+ HRDLKPEN+L + +KI DF L + + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 176 PEVL-----SHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
PEV+ Y D+WS GVILY+L++GY PF
Sbjct: 190 PEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFV 227
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-80
Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 8 KYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVR 65
Y++ + +G G KV + TG+ A+K+L S + ++E+ +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 66 HPCVVRLHEV----LASRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDG 119
P +V + +V + + II+E + GGELF +I +E EA + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+ + HS + HRD+KPENLL S+ LK++DFG + Q L+T C TP YVAP
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAP 198
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
EVL + Y + D+WS GVI+Y+L+ G+ PF
Sbjct: 199 EVLGPEKY-DKSCDMWSLGVIMYILLCGFPPF 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-80
Identities = 74/210 (35%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRHP 67
+ +G G KV N T E A+K+L + +RE+ + + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 115
Query: 68 CVVRLHEV----LASRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVD 121
+VR+ +V A R + I++E + GGELF +I G +E EA + + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 122 YCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
Y HS + HRD+KPENLL S+ LK++DFG + S L T C TP YVAPEV
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEV 234
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
L + Y + D+WS GVI+Y+L+ GY PF
Sbjct: 235 LGPEKY-DKSCDMWSLGVIMYILLCGYPPF 263
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-77
Identities = 70/202 (34%), Positives = 111/202 (54%), Gaps = 3/202 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ G+ +GEG+F+ V A+ T A+K+L++ IIK + RE +M + HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
V+L+ K+Y L + GEL I G E+ R Y +++ ++Y H KG+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTPNYVAPEVLSHKGYNG 186
HRDLKPEN+LL+ H++I+DFG + + R GT YV+PE+L+ K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-C 210
Query: 187 AAADVWSCGVILYVLIAGYLPF 208
++D+W+ G I+Y L+AG PF
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-73
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 26/227 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD--QIKREISIMKLVR 65
Y + +GEG F+ V + G A+K I+ H+ D + +RE + +L
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR-----ILCHEQQDREEAQREADMHRLFN 84
Query: 66 HPCVVRLHEVLASRT----KIYIILEFITGGELFDKI----VHHGRLSESEARRYFQQLI 117
HP ++RL + +++L F G L+++I L+E + +
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR---------TTC 168
G++ H+KG HRDLKP N+LL +G + D G V R
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 169 GTPNYVAPEVLSHKGYN--GAAADVWSCGVILYVLIAGYLPFDELDL 213
T +Y APE+ S + + DVWS G +LY ++ G P+D +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-73
Identities = 68/225 (30%), Positives = 113/225 (50%), Gaps = 13/225 (5%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ YEV TIG G++ + + + G+ + K LD ++ + E+++++ +
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL 62
Query: 65 RHPCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLID 118
+HP +VR ++ + RT +YI++E+ GG+L I + L E R QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 119 GVDYCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
+ CH + V HRDLKP N+ LD + ++K+ DFGL+ + S +T GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
++PE ++ YN +D+WS G +LY L A PF L
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAG 226
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 8e-73
Identities = 61/212 (28%), Positives = 113/212 (53%), Gaps = 4/212 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + IGEG+F K ++TE G +K ++ S + K ++ +RE++++ ++HP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHP 83
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHS 125
+V+ E +YI++++ GG+LF +I E + +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ + HRD+K +N+ L G +++ DFG++ + V L R GTP Y++PE+ +K YN
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+D+W+ G +LY L F+ + L
Sbjct: 204 -NKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 9e-72
Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRH 66
+ V R + EG FA V AQ+ +G A+K L + + + I +E+ MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85
Query: 67 PCVVRLH-------EVLASRTKIYIILEFITGGELFDKIV---HHGRLSESEARRYFQQL 116
P +V+ E + +++L + G+L + + G LS + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 117 IDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------- 165
V + H + + HRDLK ENLLL +QG +K+ DFG +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 166 ---TTCGTPNYVAPEV--LSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
T TP Y PE+ L G D+W+ G ILY+L PF++
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-71
Identities = 75/209 (35%), Positives = 123/209 (58%), Gaps = 4/209 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ +T+G G+F +V ++ E+G AMK+LD+ ++K K + E I++ V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V+L + +Y+++E++ GGE+F + GR SE AR Y Q++ +Y HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPENLL+D QG+++++DFG + + T CGTP +APE++ KGY A
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---TLCGTPEALAPEIILSKGY-NKA 218
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D W+ GV++Y + AGY PF +Y
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIY 247
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 221 bits (563), Expect = 2e-71
Identities = 38/258 (14%), Positives = 79/258 (30%), Gaps = 47/258 (18%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+ G +G+ A + ETGES + V + Q+K E+ ++L
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 64 VR-------------------------HPCVVRLHEVLASRTKIYIILEF--------IT 90
+R ++R+ + +
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150
G L H L + Q+I + H G+ H L+P +++LD +G + ++
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLS----------HKGYNGAAADVWSCGVILYV 200
F + + + PE+ + + + D W+ G+++Y
Sbjct: 250 FEHLVRD----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 201 LIAGYLPFDELDLTTLYS 218
+ LP +
Sbjct: 306 IWCADLPITKDAALGGSE 323
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-71
Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 40/235 (17%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRH 66
+ +G G+ V F + G VA+K + D EI ++ + H
Sbjct: 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDH 68
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDG 119
P V+R + + +YI LE L D + E +Q+ G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH-------------LKISDFGLSALPEQGVS---- 162
V + HS + HRDLKP+N+L+ + + ISDFGL + G S
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 163 LLRTTCGTPNYVAPEVLSHKGYN------GAAADVWSCGVILYVLI-AGYLPFDE 210
L GT + APE+L + D++S G + Y ++ G PF +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 7e-71
Identities = 74/209 (35%), Positives = 124/209 (59%), Gaps = 4/209 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+++ RT+G G+F +V ++ G AMKVL + +++ K + E ++ +V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++R+ +I++I+++I GGELF + R A+ Y ++ ++Y HSK +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD GH+KI+DFG + + + T CGTP+Y+APEV+S K Y +
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPY-NKS 183
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D WS G+++Y ++AGY PF + + Y
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTY 212
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-69
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 5/212 (2%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M + + + + IG G F++V A G VA+K + ++ K +EI +
Sbjct: 26 MGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDL 85
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQL 116
+K + HP V++ + ++ I+LE G+L I H + + E +YF QL
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+++ HS+ V HRD+KP N+ + + G +K+ D GL + + GTP Y++P
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
E + GYN +D+WS G +LY + A PF
Sbjct: 206 ERIHENGYN-FKSDIWSLGCLLYEMAALQSPF 236
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 6e-68
Identities = 37/224 (16%), Positives = 82/224 (36%), Gaps = 27/224 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFA-----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
V +GEG FA+V A + + + +KV + + + + + +K
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI---GTQLMERLK 122
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-----LSESEARRYFQQLI 117
++ + + ++ E + G L + I + + + + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 118 DGVDYCHSKGVYHRDLKPENLLL-----------DSQGHLKISDFGLSALPE--QGVSLL 164
++ H + H D+KP+N +L D L + D G S + ++
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
C T + E+LS+K +N D + +Y ++ G
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMK 285
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 8e-68
Identities = 76/214 (35%), Positives = 118/214 (55%), Gaps = 5/214 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YEV + IG G F +V+ ++ T + AMK+L + +IK + E IM P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
VV+L +Y+++E++ GG+L ++ + + E AR Y +++ +D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-- 185
HRD+KP+N+LLD GHLK++DFG + ++G+ T GTP+Y++PEVL +G +
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 186 -GAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
G D WS GV LY ++ G PF L YS
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 283
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-67
Identities = 61/200 (30%), Positives = 110/200 (55%), Gaps = 5/200 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
R IG+G+F KV Q +T + AMK +++ ++ + +E+ IM+ + HP +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
++++++ + GG+L + + E + + +L+ +DY ++ + HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK---GYNGAAA 189
+KP+N+LLD GH+ I+DF ++A+ + + + T GT Y+APE+ S + GY A
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGY-SFAV 198
Query: 190 DVWSCGVILYVLIAGYLPFD 209
D WS GV Y L+ G P+
Sbjct: 199 DWWSLGVTAYELLRGRRPYH 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-67
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 41/210 (19%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHP 67
+ +G G KV N T E A+K+L + +RE+ + + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCP 71
Query: 68 CVVRLHEV----LASRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVD 121
+VR+ +V A R + I++E + GGELF +I +E EA + + + +
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 122 YCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
Y HS + HRD+KPENLL S+ LK++DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKET 170
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ Y + D+WS GVI+Y+L+ GY PF
Sbjct: 171 T-GEKY-DKSCDMWSLGVIMYILLCGYPPF 198
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-67
Identities = 56/224 (25%), Positives = 84/224 (37%), Gaps = 25/224 (11%)
Query: 3 VRKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
V VGK + +G G + + VA+K + RE+ +
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQL 70
Query: 61 MK-LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLID 118
++ HP V+R R YI +E L + + E QQ
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSALPEQGVS---LLRTTCGT 170
G+ + HS + HRDLKP N+L+ ISDFGL G GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 171 PNYVAPEVLS---HKGYNGAAADVWSCGVILY-VLIAGYLPFDE 210
++APE+LS + D++S G + Y V+ G PF +
Sbjct: 190 EGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGK 232
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-66
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 6/204 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ +G G++ +V ++ E G A+K A ++ S K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
C VRL + +Y+ E G L G L E++ Y + + + + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
G+ H D+KP N+ L +G K+ DFGL G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELL-QGSYG- 233
Query: 187 AAADVWSCGVILYVLIAGY-LPFD 209
AADV+S G+ + + LP
Sbjct: 234 TAADVFSLGLTILEVACNMELPHG 257
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 6e-66
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 8/218 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F++V + +TG+ AMK++++ ++K + E ++
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKG 127
+ +LH +Y+++E+ GG+L + G R+ AR Y +++ +D H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN- 185
HRD+KP+N+LLD GH++++DFG L G GTP+Y++PE+L G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 186 -----GAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
G D W+ GV Y + G PF Y
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 6e-66
Identities = 74/205 (36%), Positives = 112/205 (54%), Gaps = 1/205 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + II E +++ RHP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132
+ ++ ++E+ GGELF + +E AR Y +++ ++Y HS+ V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVW 192
+K ENL+LD GH+KI+DFGL + ++T CGTP Y+APEVL Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 193 SCGVILYVLIAGYLPFDELDLTTLY 217
GV++Y ++ G LPF D L+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-65
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 27/222 (12%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ IG G F +V A++ G++ +K +K+ ++ +RE+ + + H
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYN-NEKAEREVKALAKLDHVN 65
Query: 69 VVRLHE----------------VLASRTKIYIILEFITGGELFDKIV--HHGRLSESEAR 110
+V + + ++I +EF G L I +L + A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 111 RYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT 170
F+Q+ GVDY HSK + +RDLKP N+ L +KI DFGL + + GT
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGT 184
Query: 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y++PE +S + Y D+++ G+IL L+ E
Sbjct: 185 LRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS 225
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-65
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 8/217 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ + IG G F +V + + AMK+L++ ++K + E ++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ LH +Y+++++ GG+L + RL E AR Y +++ +D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSA-LPEQGVSLLRTTCGTPNYVAPEVL-----SH 181
HRD+KP+N+L+D GH++++DFG L E G GTP+Y++PE+L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
Y G D WS GV +Y ++ G PF L Y
Sbjct: 256 GRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 8e-65
Identities = 34/242 (14%), Positives = 66/242 (27%), Gaps = 36/242 (14%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
+ K ++ + G + V ++ E E A+KV A +++
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 64 VRHPCVVRLHEVL--------------------------ASRTKIYIILEFITG-----G 92
+ + + +++ +
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 93 ELFDKIVHHGRLSESEARRYF-QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151
D + A QLI SKG+ H P+NL + G L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFDE 210
+ + Y E L+ A + W G+ +Y + +LPF
Sbjct: 239 SALWKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295
Query: 211 LD 212
+
Sbjct: 296 VT 297
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 1e-64
Identities = 80/206 (38%), Positives = 116/206 (56%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVR 71
+ IG+G+F KV A++ A+KVL + AI+K K I E +++ K V+HP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + K+Y +L++I GGELF + E AR Y ++ + Y HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLKPEN+LLDSQGH+ ++DFGL + S T CGTP Y+APEVL + Y D
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDW 222
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W G +LY ++ G PF + +Y
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-64
Identities = 74/209 (35%), Positives = 117/209 (55%), Gaps = 5/209 (2%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRHPC 68
R +G+G + KV + TG+ AMKVL ++ I+ K K E +I++ V+HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L + K+Y+ILE+++GGELF ++ G E A Y ++ + + H KG+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN++L+ QGH+K++DFGL ++ T CGT Y+APE+L G+ A
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRA 201
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D WS G ++Y ++ G PF +
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-63
Identities = 67/206 (32%), Positives = 114/206 (55%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+ +G+G+F KV A+ +T + A+K L + ++ + E ++ L HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
+ ++ ++ ++E++ GG+L I + S A Y ++I G+ + HSKG+ +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD GH+KI+DFG+ G + T CGTP+Y+APE+L + Y + D
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDW 201
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
WS GV+LY ++ G PF D L+
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-63
Identities = 67/198 (33%), Positives = 118/198 (59%), Gaps = 2/198 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AMKV+ + + + D ++ E + + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++E++ GG+L + +L E AR Y ++ ++Y H +G+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLDS+GH+K++D+G+ + T CGTPNY+APE+L + Y G + D
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 193
Query: 192 WSCGVILYVLIAGYLPFD 209
W+ GV+++ ++AG PFD
Sbjct: 194 WALGVLMFEMMAGRSPFD 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-63
Identities = 69/206 (33%), Positives = 121/206 (58%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+G+G+F KV ++ T E A+K+L + +I+ + E ++ L + P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++Y ++E++ GG+L I GR E A Y ++ G+ + SKG+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N++LDS+GH+KI+DFG+ +T CGTP+Y+APE+++++ Y G + D
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 204
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W+ GV+LY ++AG PF+ D L+
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-63
Identities = 74/208 (35%), Positives = 120/208 (57%), Gaps = 5/208 (2%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G+G+F KV K ++ + AMKVL ++ + K E I+ V HP +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V+LH + K+Y+IL+F+ GG+LF ++ +E + + Y +L +D+ HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+RDLKPEN+LLD +GH+K++DFGLS + CGT Y+APEV++ +G+ +A
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSA 207
Query: 190 DVWSCGVILYVLIAGYLPFDELDLTTLY 217
D WS GV+++ ++ G LPF D
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-63
Identities = 73/206 (35%), Positives = 118/206 (57%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R +G+G+F KV A+ ETG+ A+KVL + I++ + E I+ L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
L + +++ ++EF+ GG+L I R E+ AR Y ++I + + H KG+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLD +GH K++DFG+ T CGTP+Y+APE+L Y G A D
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDW 207
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W+ GV+LY ++ G+ PF+ + L+
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-63
Identities = 77/206 (37%), Positives = 113/206 (54%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+ +G+GTF KV + TG AMK+L + I+ E +++ RHP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHR 131
+ ++ ++E+ GGELF + SE AR Y +++ +DY HS K V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK ENL+LD GH+KI+DFGL + + ++T CGTP Y+APEVL Y G A D
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 332
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W GV++Y ++ G LPF D L+
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-63
Identities = 66/198 (33%), Positives = 118/198 (59%), Gaps = 2/198 (1%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
R IG G++AKV + +T AM+V+ + + + D ++ E + + HP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++++ ++E++ GG+L + +L E AR Y ++ ++Y H +G+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N+LLDS+GH+K++D+G+ + T CGTPNY+APE+L + Y G + D
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 236
Query: 192 WSCGVILYVLIAGYLPFD 209
W+ GV+++ ++AG PFD
Sbjct: 237 WALGVLMFEMMAGRSPFD 254
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 6e-63
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 7/212 (3%)
Query: 4 RKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+ +G+ + R +G G F +V Q TG+ A K L++ + K K E I+
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLI 117
V +V L ++T + +++ + GG++ I + + E A Y Q++
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+++ H + + +RDLKPEN+LLD G+++ISD GL+ + G + + GTP ++APE
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+L + Y + D ++ GV LY +IA PF
Sbjct: 360 LLLGEEY-DFSVDYFALGVTLYEMIAARGPFR 390
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-61
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 6/210 (2%)
Query: 4 RKVGK--YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+ V K + R +G+G F +V Q TG+ A K L++ I K K E I+
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDG 119
+ V VV L ++ + ++L + GG+L I H G+ E+ A Y ++ G
Sbjct: 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
++ H + + +RDLKPEN+LLD GH++ISD GL+ +G + ++ GT Y+APEV+
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVV 357
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
++ Y + D W+ G +LY +IAG PF
Sbjct: 358 KNERY-TFSPDWWALGCLLYEMIAGQSPFQ 386
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 6e-61
Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 5/199 (2%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCV 69
R IG G F +V + +TG+ AMK LD+ I + E ++ LV P +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVY 129
V + + K+ IL+ + GG+L + HG SE++ R Y ++I G+++ H++ V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAA 189
+RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL ++A
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSA 372
Query: 190 DVWSCGVILYVLIAGYLPF 208
D +S G +L+ L+ G+ PF
Sbjct: 373 DWFSLGCMLFKLLRGHSPF 391
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 194 bits (493), Expect = 1e-60
Identities = 44/247 (17%), Positives = 81/247 (32%), Gaps = 38/247 (15%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL----- 63
G +G+ A + ETGES + V + Q+K E+ ++L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 64 -----------------VRHPCVVRLHEVLASRTKIYIILEFIT-----------GGELF 95
V+ P ++ V ++++ F G L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 96 DKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155
H L + Q+I + H G+ H L+P +++LD +G + ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 156 LP-EQGVSLLRTTCGTPNYVAPEVLSHKGYN----GAAADVWSCGVILYVLIAGYLPFDE 210
VS + P A +L ++ A D W+ G+ +Y + LP +
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 211 LDLTTLY 217
Sbjct: 320 DAALGGS 326
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-60
Identities = 69/206 (33%), Positives = 121/206 (58%), Gaps = 2/206 (0%)
Query: 13 RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVR 71
+G+G+F KV ++ T E A+K+L + +I+ + E ++ L + P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 72 LHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
LH + ++Y ++E++ GG+L I GR E A Y ++ G+ + SKG+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADV 191
DLK +N++LDS+GH+KI+DFG+ +T CGTP+Y+APE+++++ Y G + D
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 525
Query: 192 WSCGVILYVLIAGYLPFDELDLTTLY 217
W+ GV+LY ++AG PF+ D L+
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-60
Identities = 56/233 (24%), Positives = 97/233 (41%), Gaps = 33/233 (14%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
R + +E + +G G F V A+N + A+K + + +++ RE+ +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAK 59
Query: 64 VRHPCVVRLHEV------------LASRTKIYIILEFITGGELFDKIVHHGRLSESE--- 108
+ HP +VR + + +YI ++ L D + + E E
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 109 ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL------------ 156
F Q+ + V++ HSKG+ HRDLKP N+ +K+ DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
P + GT Y++PE + Y+ D++S G+IL+ L+ PF
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFS 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-60
Identities = 70/209 (33%), Positives = 119/209 (56%), Gaps = 11/209 (5%)
Query: 13 RTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRH-P 67
+ +G G + KV + +TG+ AMKVL ++ I+ K K + + E +++ +R P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V LH + TK+++IL++I GGELF + R +E E + Y +++ +++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS--ALPEQGVSLLRTTCGTPNYVAPEVL--SHKG 183
+ +RD+K EN+LLDS GH+ ++DFGLS + ++ CGT Y+AP+++ G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ A D WS GV++Y L+ G PF
Sbjct: 239 H-DKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-54
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G G+F +V ++ +TG A+K + + E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPR 111
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+V L+ + + I +E + GG L I G L E A Y Q ++G++Y H++ +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 129 YHRDLKPENLLLDSQG-HLKISDFGLSA-LPEQGVSLLRTTC----GTPNYVAPEVLSHK 182
H D+K +N+LL S G + DFG + L G+ T GT ++APEV+ K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELD 212
A D+WS ++ ++ G P+ +
Sbjct: 232 PC-DAKVDIWSSCCMMLHMLNGCHPWTQYF 260
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-53
Identities = 47/229 (20%), Positives = 77/229 (33%), Gaps = 27/229 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ IG G F V G A+K + + ++ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYC 123
VVR A + I E+ GG L D I + R E+E + Q+ G+ Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 124 HSKGVYHRDLKPENLLLDSQGHL-------------------KISDFGLSALPEQGVSLL 164
HS + H D+KP N+ + KI D G +S
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR----ISSP 187
Query: 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213
+ G ++A EVL + AD+++ + + D
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-52
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR 71
+G+GT+ V ++ +A+K + + + + EI++ K ++H +V+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 72 LHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEA--RRYFQQLIDGVDYCHSKGV 128
+ I I +E + GG L + G L ++E Y +Q+++G+ Y H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 129 YHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYN 185
HRD+K +N+L+++ G LKISDFG S T GT Y+APE++ +GY
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY- 202
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELD 212
G AAD+WS G + + G PF EL
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELG 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-51
Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 45/236 (19%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK------ 55
V + +YE +GEG FA V A++ T + VA+K IK + K
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKK------IKLGHRSEAKDGINRT 58
Query: 56 --REISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARR 111
REI +++ + HP ++ L + ++ I ++ +F+ + + L+ S +
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKA 116
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
Y + G++Y H + HRDLKP NLLLD G LK++DFGL+ + G+P
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGSP 165
Query: 172 N-----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG--YLP-FDELD 212
N Y APE+L + Y G D+W+ G IL L+ +LP +LD
Sbjct: 166 NRAYTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-51
Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 37/219 (16%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------R 56
+ + KYE +GEG++ V +N +TG VA+K K +D K R
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK--------KFLESDDDKMVKKIAMR 73
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQ 114
EI ++K +RH +V L EV + + Y++ EF+ + + L ++Y
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLF 131
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTP 171
Q+I+G+ +CHS + HRD+KPEN+L+ G +K+ DFG + A P +
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD--------- 182
Query: 172 NYV------APEVLSHKGYNGAAADVWSCGVILYVLIAG 204
+ V APE+L G A DVW+ G ++ + G
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-51
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 43/218 (19%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------REISI 60
KYE IGEG++ V +N +TG+ VA+K K ++ REI +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIRM 55
Query: 61 MKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLID 118
+K ++HP +V L EV + +++++ E+ D+ + + E + Q +
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQ 113
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-----NY 173
V++CH HRD+KPEN+L+ +K+ DFG + R P +
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA----------R-LLTGPSDYYDDE 162
Query: 174 V------APEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
V +PE+L Y G DVW+ G + L++G
Sbjct: 163 VATRWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSG 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-51
Identities = 78/232 (33%), Positives = 110/232 (47%), Gaps = 51/232 (21%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQIKREI 58
KYE IGEGT+ V A+N ET E VA+K + SA+ REI
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----------REI 52
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQL 116
++K ++H +VRLH+VL S K+ ++ EF + FD +G L + + QL
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQL 110
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---- 172
+ G+ +CHS+ V HRDLKP+NLL++ G LK+++FGL+ R G P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA----------R-AFGIPVRCYS 159
Query: 173 -------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAGYLPF----DELD 212
Y P+VL K Y + D+WS G I L P D D
Sbjct: 160 AEVVTLWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-50
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 9/208 (4%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ IG G+F V A G VA+K+L + ++ RE++IMK +RHP +
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNI 96
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDYCHSK 126
V + + I+ E+++ G L+ + G + + RR D G++Y H++
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 127 G--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HR+LK NLL+D + +K+ DFGLS L ++ GTP ++APEVL +
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELD 212
N +DV+S GVIL+ L P+ L+
Sbjct: 217 N-EKSDVYSFGVILWELATLQQPWGNLN 243
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-50
Identities = 67/227 (29%), Positives = 107/227 (47%), Gaps = 47/227 (20%)
Query: 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--------DRSAIIKHKMADQI 54
+ +++ +G GT+A V N TG VA+K + +AI
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI--------- 51
Query: 55 KREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGG-----ELFDKIVHHGRLSESEA 109
REIS+MK ++H +VRL++V+ + K+ ++ EF+ + L +
Sbjct: 52 -REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 110 RRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ + QL+ G+ +CH + HRDLKP+NLL++ +G LK+ DFGL+ R G
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA----------R-AFG 159
Query: 170 TPN-----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
P Y AP+VL + Y + D+WSCG IL +I G
Sbjct: 160 IPVNTFSSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITG 205
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-50
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
EV +G G F V A + VA+K ++ + K E+ + V HP +
Sbjct: 11 EVEEVVGRGAFGVVCKA--KWRAKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDYCHS- 125
V+L A + +++E+ GG L++ + L A + GV Y HS
Sbjct: 64 VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 126 --KGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
K + HRDLKP NLLL + G LKI DFG + + ++ G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---NNKGSAAWMAPEVFEGS 178
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y+ DV+S G+IL+ +I PFDE+
Sbjct: 179 NYS-EKCDVFSWGIILWEVITRRKPFDEIG 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-49
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 49/227 (21%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQI 54
+ +Y +GEGT+ +V A +T T E+VA+K + +AI
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI--------- 81
Query: 55 KREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ 114
RE+S++K ++H ++ L V+ ++++I E+ +L + + +S + +
Sbjct: 82 -REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLY 139
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDS-----QGHLKISDFGLSALPEQGVSLLRTTCG 169
QLI+GV++CHS+ HRDLKP+NLLL LKI DFGL+ R G
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAF-G 188
Query: 170 TPN-----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
P Y PE+L + Y + D+WS I ++
Sbjct: 189 IPIRQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMK 234
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-49
Identities = 71/224 (31%), Positives = 111/224 (49%), Gaps = 48/224 (21%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQI 54
+ KY+ +GEGT+ V A+++ G VA+K + +AI
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAI--------- 67
Query: 55 KREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRY 112
REIS++K + HP +V L +V+ S + ++ EF+ ++ D+ + L +S+ + Y
Sbjct: 68 -REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIY 124
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172
QL+ GV +CH + HRDLKP+NLL++S G LK++DFGL+ R G P
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA----------R-AFGIPV 173
Query: 173 -----------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
Y AP+VL K Y + D+WS G I +I G
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITG 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-49
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 44/218 (20%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL--------DRSAIIKHKMADQIKREIS 59
Y +GEGT+A V ++ T VA+K + +AI RE+S
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI----------REVS 52
Query: 60 IMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQLI 117
++K ++H +V LH+++ + + ++ E++ + D ++ + + QL+
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLL 110
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----- 172
G+ YCH + V HRDLKP+NLL++ +G LK++DFGL+ R P
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA----------RAK-SIPTKTYDN 159
Query: 173 ------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG 204
Y P++L D+W G I Y + G
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (406), Expect = 9e-49
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 48/220 (21%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL---------DRSAIIKHKMADQIKREI 58
KY IGEGT+ V AQN GE+ A+K + + I REI
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTI----------REI 51
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITG--GELFDKIVHHGRLSESEARRYFQQL 116
SI+K ++H +V+L++V+ ++ ++ ++ E + +L D G L A+ + QL
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQL 109
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---- 172
++G+ YCH + V HRDLKP+NLL++ +G LKI+DFGL+ R G P
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA----------R-AFGIPVRKYT 158
Query: 173 -------YVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
Y AP+VL K Y D+WS G I ++ G
Sbjct: 159 HEIVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNG 197
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-48
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
G +G+G F + + ETGE + MK L R + +E+ +M+ + HP V
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++ VL ++ I E+I GG L I + S+ + + + G+ Y HS +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------------TTCGTPNYV 174
HRDL N L+ ++ ++DFGL+ L + T G P ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
APE+++ + Y+ DV+S G++L +I +
Sbjct: 190 APEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYL 226
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-48
Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 4/204 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ IG+G+F +V + T + VA+K++D + I++EI+++ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPY 81
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
V + + TK++II+E++ GG D ++ G L E++ ++++ G+DY HS+
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
HRD+K N+LL G +K++DFG++ T GTP ++APEV+ Y+ +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SK 199
Query: 189 ADVWSCGVILYVLIAGYLPFDELD 212
AD+WS G+ L G P EL
Sbjct: 200 ADIWSLGITAIELARGEPPHSELH 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-48
Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 13/214 (6%)
Query: 7 GKYE-VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
G++ IG G+F V +TET VA L + K + K E ++K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 66 HPCVVRLH----EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
HP +VR + + + I ++ E +T G L + + R + +Q++ G+
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 122 YCHSKG--VYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
+ H++ + HRDLK +N+ + G +KI D GL+ L S + GTP ++APE+
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEM 201
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ Y+ + DV++ G+ + + P+ E
Sbjct: 202 YE-EKYD-ESVDVYAFGMCMLEMATSEYPYSECQ 233
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-47
Identities = 54/277 (19%), Positives = 92/277 (33%), Gaps = 71/277 (25%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKV----------------------LDRSAI 45
+E + +G G F V A+N + A+K L+ I
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 46 IKH---------------------------------KMADQIKREISIMKLVRHPCVVRL 72
+++ D +I M V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESE---ARRYFQQLIDGVDYCHSKGVY 129
+ + + +YI ++ L D + L + E F Q+ + V++ HSKG+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 130 HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT------------CGTPNYVAPE 177
HRDLKP N+ +K+ DFGL +Q GT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214
+ Y+ D++S G+IL+ L+ + E
Sbjct: 247 QIHGNNYS-HKVDIFSLGLILFELLYSFSTQMERVRI 282
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-47
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVL----DRSAIIKHKMADQIKREISIMKLVR 65
E + IG+G F V + + VA+K L + + +RE+ IM +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDY 122
HP +V+L +++EF+ G+L+ ++ + + + ++D G++Y
Sbjct: 82 HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 123 CHSKGVY--HRDLKPENLLLDSQG-----HLKISDFGLSALPEQGVSLLRTTCGTPNYVA 175
++ HRDL+ N+ L S K++DFGLS VS G ++A
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS---GLLGNFQWMA 194
Query: 176 PEVLS--HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
PE + + Y AD +S +ILY ++ G PFDE
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYS 232
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-47
Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK-------- 55
+V KYE IG+GTF +V A++ +TG+ VA+K K M + K
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--------KVLM-ENEKEGFPITAL 64
Query: 56 REISIMKLVRHPCVVRLHEVLASR--------TKIYIILEFI----TGGELFDKIVHHGR 103
REI I++L++H VV L E+ ++ IY++ +F G L +
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSN--VLVK 120
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQG 160
+ SE +R Q L++G+ Y H + HRD+K N+L+ G LK++DFGL+ +L +
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 161 VSLLRTTC-GTPNYVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
T T Y PE+L + Y G D+W G I+ +
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTR 225
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-47
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKV--LDRSAIIKHKMADQIKREISIM 61
+YE IG G + V A++ +G VA+K + + RE++++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 62 K---LVRHPCVVRLHEVLASR-----TKIYIILEFITG--GELFDKIVHHGRLSESEARR 111
+ HP VVRL +V A+ K+ ++ E + DK G L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKD 124
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
+Q + G+D+ H+ + HRDLKPEN+L+ S G +K++DFGL+ R
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----------R-IYSYQ 173
Query: 172 N----------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG 204
Y APEVL Y D+WS G I +
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRR 215
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-46
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 6/205 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E +G G V + +G +A K++ IK + +QI RE+ ++ P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG- 127
+V + S +I I +E + GG L + GR+ E + +I G+ Y K
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRD+KP N+L++S+G +K+ DFG+S + S+ + GT +Y++PE L Y+
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 209
Query: 188 AADVWSCGVILYVLIAGYLPFDELD 212
+D+WS G+ L + G P D
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPD 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-46
Identities = 62/204 (30%), Positives = 113/204 (55%), Gaps = 5/204 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ IGEG+ V A+ +G VA+K++D + K + + + E+ IM+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHF 102
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
VV +++ ++++++EF+ GG L D IV RL+E + + ++ + Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRD+K +++LL G +K+SDFG A + V ++ GTP ++APEV+S Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-AT 220
Query: 188 AADVWSCGVILYVLIAGYLPFDEL 211
D+WS G+++ ++ G P+
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSD 244
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-46
Identities = 59/204 (28%), Positives = 107/204 (52%), Gaps = 5/204 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IG+G V A + TG+ VA++ ++ + + + I EI +M+ ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V + ++++++E++ GG L D +V + E + ++ + +++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRD+K +N+LL G +K++DFG A S T GTP ++APEV++ K Y G
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195
Query: 188 AADVWSCGVILYVLIAGYLPFDEL 211
D+WS G++ +I G P+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNE 219
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-46
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMA-DQIKREISIMKLVRHPC 68
+ IG G F KV A G+ VA+K + +++E + +++HP
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++ L V + +++EF GG L ++ R+ + Q+ G++Y H + +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 129 Y---HRDLKPENLLLDSQGH--------LKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
HRDLK N+L+ + LKI+DFGL+ + + + G ++APE
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMAPE 184
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
V+ ++ +DVWS GV+L+ L+ G +PF +D
Sbjct: 185 VIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGID 218
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-46
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
E+G IG+G F +V + + E VA++++D + KRE+ + RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHEN 90
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
VV S + II G L+ + L ++ R+ Q+++ G+ Y H+KG
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS-----ALPEQGVSLLRTTCGTPNYVAPEVLSHK 182
+ H+DLK +N+ D G + I+DFGL + LR G ++APE++
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 183 GYNGA--------AADVWSCGVILYVLIAGYLPFDELD 212
+ +DV++ G I Y L A PF
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-45
Identities = 54/209 (25%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
VG+ IG G+F V + + + VA+K+L+ +A ++ K E+ +++ RH
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVN 81
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ ++ ++ I+ ++ G L+ + + + +Q G+DY H+K
Sbjct: 82 ILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQ--GVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRDLK N+ L +KI DFGL+ + G G+ ++APEV+ + N
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 186 --GAAADVWSCGVILYVLIAGYLPFDELD 212
+DV++ G++LY L+ G LP+ ++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-45
Identities = 66/231 (28%), Positives = 97/231 (41%), Gaps = 53/231 (22%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNT-ETGESVAMKV--LDR-------SAIIKHKMADQ 53
R +YE IGEG + KV A++ G VA+K + S I
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-------- 59
Query: 54 IKREISIMK---LVRHPCVVRLHEVLASR-----TKIYIILEFITG--GELFDKIVHHGR 103
RE+++++ HP VVRL +V TK+ ++ E + DK+ G
Sbjct: 60 --REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG- 116
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
+ + QL+ G+D+ HS V HRDLKP+N+L+ S G +K++DFGL+
Sbjct: 117 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA--------- 167
Query: 164 LRTTCGTPN----------YVAPEVLSHKGYNGAAADVWSCGVILYVLIAG 204
R Y APEVL Y D+WS G I +
Sbjct: 168 -R-IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRR 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-45
Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 7/205 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++V +GEG++ V A + ETG+ VA+K + ++ + + I +EISIM+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQE-IIKEISIMQQCDSP 84
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
VV+ + T ++I++E+ G + D I + + L+E E Q + G++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
HRD+K N+LL+++GH K++DFG++ ++ T GTP ++APEV+ GYN
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204
Query: 187 AAADVWSCGVILYVLIAGYLPFDEL 211
AD+WS G+ + G P+ ++
Sbjct: 205 -VADIWSLGITAIEMAEGKPPYADI 228
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-45
Identities = 41/214 (19%), Positives = 83/214 (38%), Gaps = 22/214 (10%)
Query: 10 EVGRTIGEGTFAKVKFA--QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ E ++ Q + + +KVL K D E +++ HP
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHP 67
Query: 68 CVVRLHEVLAS--RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID---GVDY 122
V+ + S +I ++ G L++ ++H G + + + +D G+ +
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 123 CHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H+ + L ++++D +IS + + P +VAPE L
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQ 181
Query: 181 HKGYNGA--AADVWSCGVILYVLIAGYLPFDELD 212
K + +AD+WS V+L+ L+ +PF +L
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-44
Identities = 63/210 (30%), Positives = 111/210 (52%), Gaps = 10/210 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E+ +G+G F KV A+N ETG A KV++ + + EI I+ HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDHP 76
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
+V+L K++I++EF GG + ++ L+E + + +Q+++ +++ HSK
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH----- 181
+ HRDLK N+L+ +G ++++DFG+SA + + + GTP ++APEV+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDEL 211
Y+ AD+WS G+ L + P EL
Sbjct: 197 TPYDY-KADIWSLGITLIEMAQIEPPHHEL 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-43
Identities = 50/219 (22%), Positives = 96/219 (43%), Gaps = 15/219 (6%)
Query: 7 GKYEVGRTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
G YE+ IG+G V A+ TGE V ++ ++ A +M ++ E+ + KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDY 122
HP +V + +++++ F+ G D ++E Q ++ +DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC-------GTPNYVA 175
H G HR +K ++L+ G + +S + R +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 176 PEVL--SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
PEVL + +GY+ A +D++S G+ L G++PF ++
Sbjct: 204 PEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMP 241
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-43
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 11/211 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHP 67
E +G GT +V + +TG +A+K + RS + +I ++ + +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK- 126
+V+ + T ++I +E + K G + E + ++ + Y K
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGYN 185
GV HRD+KP N+LLD +G +K+ DFG+S + G Y+APE +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 186 GAA----ADVWSCGVILYVLIAGYLPFDELD 212
ADVWS G+ L L G P+
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCK 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-43
Identities = 66/218 (30%), Positives = 110/218 (50%), Gaps = 17/218 (7%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
YE+ IG G A V+ A E VA+K ++ D++ +EI M HP
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCHHPN 74
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH--------HGRLSESEARRYFQQLIDGV 120
+V + + +++++++ ++GG + D I H G L ES +++++G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR-----TTCGTPNYVA 175
+Y H G HRD+K N+LL G ++I+DFG+SA G + R T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 176 PEVLS-HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
PEV+ +GY+ AD+WS G+ L G P+ +
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYP 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-43
Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRH 66
Y++ R +G G +++V A N E V +K I+K +IKREI I++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 90
Query: 67 PCVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P ++ L +++ ++ E + + ++ L++ + R Y +++ +DYCH
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQ--TLTDYDIRFYMYEILKALDYCH 147
Query: 125 SKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSLLRTTC--GTPNYVAPEVL-S 180
S G+ HRD+KP N+++D L++ D+GL+ E + + PE+L
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPF----DELD 212
++ Y+ + D+WS G +L +I PF D D
Sbjct: 205 YQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-42
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 10/209 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ R IG G+F V FA++ E VA+K + S ++ I +E+ ++ +RHP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ ++++E+ G VH L E E + G+ Y HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSH---KG 183
+ HRD+K N+LL G +K+ DFG +++ + GTP ++APEV+
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQ 229
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELD 212
Y+G DVWS G+ L P ++
Sbjct: 230 YDG-KVDVWSLGITCIELAERKPPLFNMN 257
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 46/215 (21%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
Y + IG G+F V A+ ++GE VA+K K+ + RE+ IM+ +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKL 104
Query: 65 RHPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQ 114
H +VRL S + ++L+++ ++ H+ R L + Y
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 115 QLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTC-GTPN 172
QL + Y HS G+ HRD+KP+NLLLD LK+ DFG + + G PN
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA----------KQLVRGEPN 213
Query: 173 --YV------APEV-LSHKGYNGAAADVWSCGVIL 198
Y+ APE+ Y ++ DVWS G +L
Sbjct: 214 VSYICSRYYRAPELIFGATDYT-SSIDVWSAGCVL 247
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-41
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 45/220 (20%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK--VLDRSAIIKHKMADQIKREISIMKLVR 65
Y + IG G+F V A+ E+ E VA+K + D RE+ IM++V+
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD---------KRFKNRELQIMRIVK 90
Query: 66 HPCVVRLHEVLASRT------KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQ 115
HP VV L S + ++LE++ ++ H+ + + + Y Q
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTC-GTPN- 172
L+ + Y HS G+ HRD+KP+NLLLD G LK+ DFG + + G PN
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA----------KILIAGEPNV 199
Query: 173 -YV------APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
Y+ APE+ Y D+WS G ++ L+ G
Sbjct: 200 SYICSRYYRAPELIFGATNYT-TNIDIWSTGCVMAELMQG 238
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-41
Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 19/220 (8%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G +E+ +G GT+ +V ++ +TG+ A+KV+D + ++IK+EI+++K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 66 HPCVVRLHE------VLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLI 117
H + + ++++++EF G + D K L E ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPE 177
G+ + H V HRD+K +N+LL +K+ DFG+SA ++ V T GTP ++APE
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199
Query: 178 VLSHK-----GYNGAAADVWSCGVILYVLIAGYLPFDELD 212
V++ Y+ +D+WS G+ + G P ++
Sbjct: 200 VIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMH 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-41
Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 2/204 (0%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y++ +G G + V A++T VA+K + K + + +RE+ + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V + +V Y+++E+I G L + I HG LS A + Q++DG+ + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ HRD+KP+N+L+DS LKI DFG++ AL E ++ GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EAT 189
Query: 186 GAAADVWSCGVILYVLIAGYLPFD 209
D++S G++LY ++ G PF+
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFN 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-41
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 12/212 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQI-----KREI 58
+ G Y + R +G G V A++T VA+K++ +D + +RE
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE-----TLSSDPVFRTRMQREA 85
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLID 118
++ P VV +H+ ++Y+ + I G +L + G L+ A +Q+
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-SALPEQGVSLLRTTCGTPNYVAPE 177
+D H+ G HRD+KPEN+L+ + + DFG+ SA ++ ++ L T GT Y+APE
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 178 VLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
S + AD+++ +LY + G P+
Sbjct: 206 RFSE-SHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-41
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHP 67
+ IG G + V + +G+ +A+K + + + K Q+ ++ + M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV------HHGRLSESEARRYFQQLIDGVD 121
+V+ + L +I +E ++ FDK + E + + ++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 122 YCHSKG-VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL--RTTCGTPNYVAPEV 178
+ + HRD+KP N+LLD G++K+ DFG+S Q V + G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196
Query: 179 L----SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ S +GY+ +DVWS G+ LY L G P+ + +
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWN 233
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 3 VRKVGKYEV-GRTIGEGTFAKVKFAQN--TETGESVAMK-----VLDRSAIIKHKMADQI 54
R +E G +G GT+ V A+ + + A+K + SA
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC--------- 66
Query: 55 KREISIMKLVRHPCVVRLHEVLASRT--KIYIILEF--------ITGGELFDKIVHHGRL 104
REI++++ ++HP V+ L +V S K++++ ++ I +L
Sbjct: 67 -REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL 125
Query: 105 SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS----QGHLKISDFGLS---ALP 157
+ Q++DG+ Y H+ V HRDLKP N+L+ +G +KI+D G + P
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 158 EQGVSLLRTTCGTPNYVAPEVL-SHKGYNGAAADVWSCGVILYVLIAG 204
+ ++ L T Y APE+L + Y A D+W+ G I L+
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTS 232
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-40
Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 19/216 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHP 67
E +G G + V+ ++ +G+ +A+K + + + + ++ ++ I M+ V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV-----HHGRLSESEARRYFQQLIDGVDY 122
V + L ++I +E + DK + E + ++ +++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 123 CHSKG-VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEV-- 178
HSK V HRD+KP N+L+++ G +K+ DFG+S + + G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERIN 182
Query: 179 --LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
L+ KGY+ +D+WS G+ + L P+D
Sbjct: 183 PELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWG 217
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-39
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQI-----KREISIM 61
+YE+G +G G ++V A++ VA+KVL D +RE
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-----DLARDPSFYLRFRREAQNA 66
Query: 62 KLVRHPCVVRLHEV----LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117
+ HP +V +++ + YI++E++ G L D + G ++ A
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTC--GTPNYV 174
+++ H G+ HRD+KP N+++ + +K+ DFG++ A+ + G S+ +T GT Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+PE A +DV+S G +LY ++ G PF
Sbjct: 187 SPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-39
Identities = 47/224 (20%), Positives = 94/224 (41%), Gaps = 28/224 (12%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G+G + +V + GE+VA+K+ + + + + E+ ++RH +
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64
Query: 70 VRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ S T++++I + G L+D + L R + G+ + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 126 K--------GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT----CGTPNY 173
+ + HRDLK +N+L+ G I+D GL+ + Q + L GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 174 VAPEVLSHKGYNGAA-----ADVWSCGVILYVLIAGYLPFDELD 212
+APEVL D+W+ G++L+ + + ++
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-38
Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y IGEG + V A + VA+K + S + REI I+ RH
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHE 85
Query: 68 CVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
++ +++++ + T +YI+ + + +L K++ LS + Q++ G+ Y
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTPNYV------ 174
HS V HRDLKP NLLL++ LKI DFGL A P+ + T YV
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWYR 198
Query: 175 APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
APE+ L+ KGY + D+WS G IL +++
Sbjct: 199 APEIMLNSKGYT-KSIDIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-37
Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
+++ +GEG + V A + TGE VA+K ++ + A + REI I+K +H
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKH 68
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQ-QLIDGV 120
++ + + + +YII E + +L +++ LS+ + +YF Q + V
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSD-DHIQYFIYQTLRAV 125
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN----YV-- 174
H V HRDLKP NLL++S LK+ DFGL+ + ++ + G + +V
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 175 ----APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
APEV L+ Y+ A DVWSCG IL L
Sbjct: 186 RWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLR 219
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
+YE+ IG G++ V A + VA+K + R + + + +I REI+I+ + H
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLNH 111
Query: 67 PCVVRLHEVLASRT-----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
VV++ +++ + ++Y++LE + L+E + L+ GV
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSLLRTTCGTPN------ 172
Y HS G+ HRDLKP N L++ +K+ DFGL+ PE G S L + +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 173 ------------YV------APEV-LSHKGYNGAAADVWSCGVIL 198
+V APE+ L + Y A DVWS G I
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIF 274
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-37
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
Y + +G G + V A + TG VA+K L R + ++ A + RE+ ++K +RH
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRH 83
Query: 67 PCVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
V+ L +V Y+++ F+ G +L K++ H +L E + Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT-PNYV----- 174
Y H+ G+ HRDLKP NL ++ LKI DFGL+ R YV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----------RQADSEMTGYVVTRWY 191
Query: 175 -APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
APEV L+ Y D+WS G I+ +I G
Sbjct: 192 RAPEVILNWMRYT-QTVDIWSVGCIMAEMITG 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-37
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ +G G + V A +T+TG VA+K L R A + RE+ ++K ++H
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHE 88
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
V+ L +V +Y++ + G +L + IV +L++ + Q++ G+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT-PNYV------ 174
Y HS + HRDLKP NL ++ LKI DFGL+ R T YV
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----------RHTADEMTGYVATRWYR 196
Query: 175 APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
APE+ L+ YN D+WS G I+ L+ G
Sbjct: 197 APEIMLNWMHYN-QTVDIWSVGCIMAELLTG 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 27/214 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVL----DRSAIIKHKMADQIKREISIM 61
G+YEV I G + A + G V +K L D A E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ------AMAMAERQFL 133
Query: 62 KLVRHPCVVRLHEV-----LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQL 116
V HP +V++ YI++E++ G L +L +EA Y ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL-SALPEQGVSLLRTTCGTPNYVA 175
+ + Y HS G+ + DLKPEN++L + LK+ D G S + G GTP + A
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGYLY-----GTPGFQA 245
Query: 176 PEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
PE++ + A D+++ G L L +
Sbjct: 246 PEIV--RTGPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-36
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
Y +G G + V A + +GE VA+K L R + ++ A + RE+ ++K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQH 82
Query: 67 PCVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
V+ L +V + Y+++ F+ +L KI+ + SE + + Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGL-KFSEEKIQYLVYQMLKGL 139
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT-PNYV----- 174
Y HS GV HRDLKP NL ++ LKI DFGL+ R YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----------RHADAEMTGYVVTRWY 189
Query: 175 -APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
APEV LS YN D+WS G I+ ++ G
Sbjct: 190 RAPEVILSWMHYN-QTVDIWSVGCIMAEMLTG 220
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-36
Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 30/225 (13%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ + IG+G + +V GE VA+KV + + + + EI L+RH +
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93
Query: 70 VRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ + S T++Y+I ++ G L+D + L + + G+ + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 126 K--------GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL----RTTCGTPNY 173
+ + HRDLK +N+L+ G I+D GL+ + + T GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 174 VAPEVL------SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ PEVL +H AD++S G+IL+ + + ++
Sbjct: 213 MPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVE 256
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-35
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 27/222 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ G F V A E VA+K+ K + Q + E+ + ++H
Sbjct: 25 PLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHE 78
Query: 68 CVVRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+++ + +++I F G L D + +S +E + + G+ Y
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FLKANVVSWNELCHIAETMARGLAYL 137
Query: 124 HSKGVY----------HRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTP 171
H HRD+K +N+LL + I+DFGL+ E G S T GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197
Query: 172 NYVAPEVLSHKGYNGA----AADVWSCGVILYVLIAGYLPFD 209
Y+APEVL D+++ G++L+ L + D
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-35
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMK-VLDRSAIIKHKMADQI--KREISIMKL- 63
+++V R G+GTF V+ + TG SVA+K V+ D RE+ IM+
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ----------DPRFRNRELQIMQDL 73
Query: 64 --VRHPCVVRLHEVLASRTK-------IYIILEFITGGELFDKIVHHGR----LSESEAR 110
+ HP +V+L + + + +++E++ L ++ R +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIK 132
Query: 111 RYFQQLIDGVDYCH--SKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTT 167
+ QLI + H S V HRD+KP N+L++ + G LK+ DFG + +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 168 CGTPNYVAPEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
C + Y APE+ ++ Y A D+WS G I ++ G
Sbjct: 193 C-SRYYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLG 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-35
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y + +G G V A + + + VA+K + + + REI I++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 68 CVVRLHEVLASRTK--------------IYIILEFITGGELFDKIVHHGRLSESEARRYF 113
+V++ E+L +YI+ E++ +L ++ G L E AR +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARLFM 126
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGL--SALPEQGVSLLRTTCGT 170
QL+ G+ Y HS V HRDLKP NL ++++ LKI DFGL P +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS---- 182
Query: 171 PNYV------APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
+ +P + LS Y A D+W+ G I ++ G
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTG 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 54/235 (22%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY +G+T+G G+F V + E+G+ A+K + + K RE+ IMK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVLDHV 60
Query: 68 CVVRLHEVLASRTK--------------------------------------IYIILEFI 89
+++L + + + +I+E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 90 TGGELFDKIVHHGR----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-G 144
L + R + + Y QL V + HS G+ HRD+KP+NLL++S+
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 145 HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV-LSHKGYNGAAADVWSCGVIL 198
LK+ DFG + + C + Y APE+ L Y + D+WS G +
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVF 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMKLVRH 66
Y + IG G++ V A + T ++VA+K ++R + + + +I REI+I+ ++
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--MFEDLIDCKRILREITILNRLKS 84
Query: 67 PCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
++RL++++ +YI+LE +L L+E + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGL--SALPEQGVSLLRTTCGTP-------- 171
+ H G+ HRDLKP N LL+ +K+ DFGL + E+ +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 172 ------NYV------APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
++V APE+ L + Y + D+WS G I L+
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 121
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
++ L V + +Y+++E + L +++ L Q++ G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQME-LDHERMSYLLYQMLCGIK 178
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV------A 175
+ HS G+ HRDLKP N+++ S LKI DFGL+ + TP YV A
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TP-YVVTRYYRA 231
Query: 176 PEVLSHKGYNGAAADVWSCGVILYVLIAG 204
PEV+ GY D+WS G I+ ++
Sbjct: 232 PEVILGMGYK-ENVDIWSVGCIMGEMVRH 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-35
Identities = 45/225 (20%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +IG+G F +V GE VA+K+ + + + EI ++RH +
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98
Query: 70 VRL----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ ++ + T+++++ ++ G LFD ++ ++ + G+ + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 126 K--------GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL----RTTCGTPNY 173
+ + HRDLK +N+L+ G I+D GL+ + + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 174 VAPEVL------SHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+APEVL H AD+++ G++ + + +
Sbjct: 218 MAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHE 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-35
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 84
Query: 68 CVVRLHEVLASRTK------IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
++ L V + +YI++E + L +++ L Q++ G+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGIK 141
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV------A 175
+ HS G+ HRDLKP N+++ S LKI DFGL+ + TP YV A
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TP-YVVTRYYRA 194
Query: 176 PEVLSHKGYNGAAADVWSCGVILYVLIAG 204
PEV+ GY D+WS G I+ +I G
Sbjct: 195 PEVILGMGYK-ENVDIWSVGCIMGEMIKG 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM--------ADQIKREIS 59
Y V R I G++ V ++ G VA+K + + + ++ REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 60 IMKLVRHPCVVRLHEVLASRTK-----IYIILEFITGGELFDKIVHHGRLSESEAR-RYF 113
++ HP ++ L ++ + +Y++ E + +L +++H R+ S +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQHIQYF 139
Query: 114 Q-QLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN 172
++ G+ H GV HRDL P N+LL + I DF L+ R N
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA----------REDTADAN 189
Query: 173 ---YV------APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
YV APE+ + KG+ D+WS G ++ +
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNR 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-34
Identities = 37/204 (18%), Positives = 65/204 (31%), Gaps = 30/204 (14%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+Y + G + A +T VA+ +D ++ + + + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P V R+ +V+ +R ++ E+I GG L + V S A R Q L D H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
GV P + + G + ++ +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA--------N 180
Query: 187 AAADVWSCGVILYVLIAGYLPFDE 210
D+ G LY L+ P E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-33
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 33/224 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM-ADQIKREISIMK-LVR 65
KYE+ + +G+G + V + + TGE VA+K + ++ A + REI I+ L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTELSG 67
Query: 66 HPCVVRLHEVLA--SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQ-QLIDGVDY 122
H +V L VL + +Y++ +++ +L ++ L ++Y QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEP-VHKQYVVYQLIKVIKY 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN---------- 172
HS G+ HRD+KP N+LL+++ H+K++DFGLS + + N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 173 -----YV------APEV-LSHKGYNGAAADVWSCGVILYVLIAG 204
YV APE+ L Y D+WS G IL ++ G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCG 227
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-31
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 11 VGRTIGEGTFAKVKFAQ-NTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F VK + +VA+K+L ++ + D++ E ++M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
+VR+ + +++E G L + + + + Q+ G+ Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT--P-NYVAPEVLSHKGYN 185
HRDL N+LL +Q + KISDFGLS + + P + APE +++ ++
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELD 212
+ +DVWS GV+++ G P+ +
Sbjct: 199 -SKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-31
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 10/208 (4%)
Query: 12 GRTIGEGTFAKVKFAQ-NTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+G+G+F V+ + + +G++ VA+K L + + + D RE++ M + H
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG 127
++RL+ V + ++ E G L D++ H G RY Q+ +G+ Y SK
Sbjct: 83 LIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHKGY 184
HRDL NLLL ++ +KI DFGL Q APE L + +
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDEL 211
+ A+D W GV L+ + G P+ L
Sbjct: 202 S-HASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-31
Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
+Y + R +G G F+ V A++ VAMK++ R + + EI +++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RG---DKVYTEAAEDEIKLLQRVND 74
Query: 66 ----------HPCVVRLHE--VLASRTKIYIILEF-ITGGELFD--KIVHHGRLSESEAR 110
+++L + +++++ F + G L K H + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 111 RYFQQLIDGVDYCHSK-GVYHRDLKPENLLLD------SQGHLKISDFGLSALPEQGVSL 163
+ +QL+ G+DY H + G+ H D+KPEN+L++ + +KI+D G + ++ +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT- 193
Query: 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+ T Y +PEVL + G AD+WS +++ LI G F+
Sbjct: 194 --NSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-30
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV+ + TGE VA+K L + H +K+EI I++ + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHE 83
Query: 68 CVVRLHEV--LASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCH 124
+V+ + I +I+EF+ G L + + + +++ + +Y Q+ G+DY
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSH 181
S+ HRDL N+L++S+ +KI DFGL+ E + V APE L
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 182 KGYNGAAADVWSCGVILY 199
+ A+DVWS GV L+
Sbjct: 204 SKFY-IASDVWSFGVTLH 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLVRH 66
+G IG G F +V + VA+K + D +E I+K H
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----PPDLKAKFLQEARILKQYSH 171
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHS 125
P +VRL V + IYI++E + GG+ + G L + G++Y S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG------TPNYVAPEVL 179
K HRDL N L+ + LKISDFG+S GV T APE L
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEAL 287
Query: 180 SHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
++ Y+ + +DVWS G++L+ G P+
Sbjct: 288 NYGRYS-SESDVWSFGILLWETFSLGASPY 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-30
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
+ +G+G F V+ TGE VA+K L +H + ++ REI I+K +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 68
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVD 121
+H +V+ V S + + +I+E++ G L D + H R+ + +Y Q+ G++
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEV 178
Y +K HRDL N+L++++ +KI DFGL+ + Q + + + APE
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 179 LSHKGYNGAAADVWSCGVILY 199
L+ ++ A+DVWS GV+LY
Sbjct: 189 LTESKFS-VASDVWSFGVVLY 208
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-30
Identities = 67/220 (30%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+YEV + IG+G+F +V A + + + VA+K++ R+ + + Q EI I++ +R
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152
Query: 67 ------PCVVRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLID 118
V+ + E R I + E + L++ K S R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 119 GVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
+D H + H DLKPEN+LL QG +K+ DFG S Q V T + Y AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY---TYIQSRFYRAP 268
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDL 213
EV+ Y G D+WS G IL L+ GY DE D
Sbjct: 269 EVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-30
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 12 GRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
R +GEG F KV N TGE VA+K L A +H+ K+EI I++ + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93
Query: 68 CVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+++ + +++E++ G L D + H + ++ + QQ+ +G+ Y H+
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
+ HRDL N+LLD+ +KI DFGL+ +G R + V APE L
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 183 GYNGAAADVWSCGVILY 199
+ A+DVWS GV LY
Sbjct: 213 KFY-YASDVWSFGVTLY 228
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-30
Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 35/218 (16%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ IG G + V + VA+KV + ++ ++ I + L+ H +
Sbjct: 16 KLLELIGRGRYGAVYKG--SLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNI 69
Query: 70 VRL-----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
R R + +++E+ G L + + R + G+ Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 125 S---------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR--------TT 167
+ + HRDL N+L+ + G ISDFGLS + +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 168 CGTPNYVAPEVL------SHKGYNGAAADVWSCGVILY 199
GT Y+APEVL D+++ G+I +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-30
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 11 VGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ + +G G F +V + ++ SVA+K L K E SIM HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHP 106
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
++RL V+ + I+ E++ G L + H + + + + + G+ Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHKG 183
G HRDL N+L++S K+SDFGL + E TT G + +PE ++++
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 184 YNGAAADVWSCGVILY-VLIAGYLPFDELD 212
+ +A+DVWS G++L+ V+ G P+ E+
Sbjct: 227 FT-SASDVWSYGIVLWEVMSYGERPYWEMS 255
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-30
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
+ +G+G F V+ TGE VA+K L +H + ++ REI I+K +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 99
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVD 121
+H +V+ V S + + +I+E++ G L D + H R+ + +Y Q+ G++
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEV 178
Y +K HRDL N+L++++ +KI DFGL+ + Q + + + APE
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 179 LSHKGYNGAAADVWSCGVILY 199
L+ ++ A+DVWS GV+LY
Sbjct: 220 LTESKFS-VASDVWSFGVVLY 239
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-30
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ + IG G +V + + VA+K L + E SIM
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDV--PVAIKALKAGYT--ERQRRDFLSEASIMGQF 107
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYC 123
HP ++RL V+ I+ E++ G L + H G+ + + + + G+ Y
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLS 180
G HRDL N+L+DS K+SDFGLS + E TT G + APE ++
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 181 HKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
+ ++ +A+DVWS GV+++ VL G P+ +
Sbjct: 228 FRTFS-SASDVWSFGVVMWEVLAYGERPYWNMT 259
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 11 VGRTIGEGTFAKV---KFAQNTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ IG G F +V ++ E VA+K L K E IM H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSH 105
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS 125
++RL V++ + II E++ G L + G S + + + G+ Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHK 182
HRDL N+L++S K+SDFGLS + E TT G + APE +S++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
+ +A+DVWS G++++ V+ G P+ EL
Sbjct: 226 KFT-SASDVWSFGIVMWEVMTYGERPYWEL 254
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G G + +V + +VA+K L + + +E ++MK ++HP +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNL 278
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKG 127
V+L V YII EF+T G L D + R +S Q+ ++Y K
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPN-YVAPEVLSHKGYNG 186
HR+L N L+ +K++DFGLS L P + APE L++ ++
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 397
Query: 187 AAADVWSCGVILY-VLIAGYLPFDELDL 213
+DVW+ GV+L+ + G P+ +DL
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDL 425
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-29
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 12 GRTIGEGTFAKVKFA----QNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLV 64
+G+G F V+ TG VA+K L +H DQ + REI I+K +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------QHSGPDQQRDFQREIQILKAL 81
Query: 65 RHPCVVRLHEVLASRTK--IYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVD 121
+V+ V + + +++E++ G L D + H RL S Y Q+ G++
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEV 178
Y S+ HRDL N+L++S+ H+KI+DFGL+ L + + APE
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 179 LSHKGYNGAAADVWSCGVILY 199
LS ++ +DVWS GV+LY
Sbjct: 202 LSDNIFS-RQSDVWSFGVVLY 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-28
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 15 IGEGTFAKVKFAQ-NTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G F V+ + VA+KVL + +++ RE IM + +P +VRL
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
V + +++E GG L +V + S Q+ G+ Y K HR
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGT--P-NYVAPEVLSHKGYNGAA 188
DL N+LL ++ + KISDFGLS S P + APE ++ + ++ +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 193
Query: 189 ADVWSCGVILY-VLIAGYLPFDELD 212
+DVWS GV ++ L G P+ ++
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-28
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F V GE VA+K L + K +I E +M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSK 126
V RL + + + +I + + G L D + H + + Q+ G++Y +
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGY 184
+ HRDL N+L+ + H+KI+DFGL+ L G P ++A E + H+ Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELD 212
+DVWS GV ++ ++ G P+D +
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIP 224
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+YE+ IG+G+F +V A + E VA+K++ ++ K +Q + E+ +++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109
Query: 67 P------CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLID 118
+V L R + ++ E + L+D + + +S + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 119 GVDYCHSK--GVYHRDLKPENLLLDSQGH--LKISDFGLSALPEQGVSLLRTTCGTPNYV 174
+ + + + H DLKPEN+LL + +KI DFG S Q + + Y
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY---QYIQSRFYR 225
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDL 213
+PEVL Y A D+WS G IL + G F +E+D
Sbjct: 226 SPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-28
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G+G F +V N T VA+K L + +E +MK +RH
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 323
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
+V+L+ V S IYI+ E+++ G L D + L + Q+ G+ Y
Sbjct: 324 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL+ N+L+ K++DFGL+ L E R P + APE + +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELDL 213
+DVWS G++L + G +P+ +
Sbjct: 443 -IKSDVWSFGILLTELTTKGRVPYPGMVN 470
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 13/209 (6%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G+G F +V N T VA+K L + +E +MK +RH
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEK 240
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
+V+L+ V S IYI+ E+++ G L D + L + Q+ G+ Y
Sbjct: 241 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL+ N+L+ K++DFGL+ L E R P + APE + +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 186 GAAADVWSCGVILY-VLIAGYLPFDELDL 213
+DVWS G++L + G +P+ +
Sbjct: 360 -IKSDVWSFGILLTELTTKGRVPYPGMVN 387
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-27
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 37/229 (16%)
Query: 7 GKYEVGRT-------IGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKR 56
+Y + R +GEG F +V + + +VA+K + + +K ++
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMS 62
Query: 57 EISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQ 115
E IMK + HP +V+L ++ +II+E GEL + + L Y Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 116 LIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV- 174
+ + Y S HRD+ N+L+ S +K+ DFGLS R Y
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS----------RYIEDEDYYKA 171
Query: 175 ----------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
+PE ++ + + A+DVW V ++ +L G PF L+
Sbjct: 172 SVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLE 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
E+GR IGEG F V +N +VA+K + +E M+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVREK--FLQEALTMRQF 73
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYC 123
HP +V+L V+ + ++II+E T GEL + L + Y QL + Y
Sbjct: 74 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV--------- 174
SK HRD+ N+L+ S +K+ DFGLS R + Y
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS----------RYMEDSTYYKASKGKLPIK 182
Query: 175 --APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDEL 211
APE ++ + + +A+DVW GV ++ +L+ G PF +
Sbjct: 183 WMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 15 IGEGTFAKVKFAQ-NTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G F V+ + VA+KVL + +++ RE IM + +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 73 HEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
V + +++E GG L +V + S Q+ G+ Y K HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV---APEVLSHKGYNGAA 188
+L N+LL ++ + KISDFGLS S + APE ++ + ++ +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 519
Query: 189 ADVWSCGVILY-VLIAGYLPFDELD 212
+DVWS GV ++ L G P+ ++
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMK 544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-27
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 18/217 (8%)
Query: 7 GKYEV-------GRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREI 58
GK+ + + IG G F V + VA+K + A+ + E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTIREGAMSEED----FIEEA 54
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLI 117
+M + HP +V+L+ V + I ++ EF+ G L D + G + +
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAP 176
+G+ Y V HRDL N L+ +K+SDFG++ T P + +P
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174
Query: 177 EVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
EV S Y+ + +DVWS GV+++ V G +P++
Sbjct: 175 EVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRS 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-27
Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 7 GKYEV-------GRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREI 58
G E+ + +G G F VK + + VA+K++ ++ + + +E
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFF----QEA 54
Query: 59 SIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLI 117
M + HP +V+ + V + IYI+ E+I+ G L + + HG+ L S+ +
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVC 114
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAP 176
+G+ + S HRDL N L+D +K+SDFG++ + P + AP
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174
Query: 177 EVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
EV + Y+ + +DVW+ G++++ V G +P+D
Sbjct: 175 EVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYT 210
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-27
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 12 GRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F V GE VA+K L + K +I E +M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
V RL + + + +I + + G L D + H + + Q+ G++Y +
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGY 184
+ HRDL N+L+ + H+KI+DFGL+ L G P ++A E + H+ Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELD 212
+DVWS GV ++ ++ G P+D +
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIP 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-27
Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 8/193 (4%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
+ +G G + +V + +VA+K L + ++ +E ++MK ++HP +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNL 71
Query: 70 VRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
V+L V YII EF+T G L D + + +S Q+ ++Y K
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL N L+ +K++DFGLS L P + APE L++ ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 190
Query: 187 AAADVWSCGVILY 199
+DVW+ GV+L+
Sbjct: 191 IKSDVWAFGVLLW 203
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ +TIG+G F V G VA+K + A A E S+M +RH +
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 248
Query: 70 VRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
V+L V + + +YI+ E++ G L D + GR L ++ + + ++Y
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSL-LRTTCGTPNYVAPEVLSHK 182
HRDL N+L+ K+SDFGL+ + + L ++ T APE L K
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-------APEALREK 361
Query: 183 GYNGAAADVWSCGVILY 199
++ +DVWS G++L+
Sbjct: 362 KFS-TKSDVWSFGILLW 377
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 12 GRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
GR IGEG F V +N +VA+K + ++ +E M+ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS 125
P +V+L V+ + ++II+E T GEL + L + Y QL + Y S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGY 184
K HRD+ N+L+ S +K+ DFGLS E + P ++APE ++ + +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDEL 211
+A+DVW GV ++ +L+ G PF +
Sbjct: 570 T-SASDVWMFGVCMWEILMHGVKPFQGV 596
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 12 GRTIGEGTFAKV---KFAQNTETGE-SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G F V + E+ + V +KV++ + + A + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VTDHMLAIGSLDHA 75
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSK 126
+VRL + + + ++ +++ G L D + H G L + Q+ G+ Y
Sbjct: 76 HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG-TP-NYVAPEVLSHKGY 184
G+ HR+L N+LL S ++++DFG++ L L + TP ++A E + Y
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 185 NGAAADVWSCGVILY-VLIAGYLPFDELD 212
+DVWS GV ++ ++ G P+ L
Sbjct: 195 T-HQSDVWSYGVTVWELMTFGAEPYAGLR 222
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-26
Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 22/197 (11%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ +TIG+G F V G VA+K + A A E S+M +RH +
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 76
Query: 70 VRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSK 126
V+L V + + +YI+ E++ G L D + GR L ++ + + ++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLS---ALPEQGVSL-LRTTCGTPNYVAPEVLSHK 182
HRDL N+L+ K+SDFGL+ + + L ++ T APE L K
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-------APEALREK 189
Query: 183 GYNGAAADVWSCGVILY 199
++ +DVWS G++L+
Sbjct: 190 KFS-TKSDVWSFGILLW 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-26
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
++ +G G F +V N T VA+K L + ++ E ++MK ++H
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFL----AEANLMKQLQHQR 69
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFD--KIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+VRL+ V ++ IYII E++ G L D K +L+ ++ Q+ +G+ + +
Sbjct: 70 LVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYN 185
HRDL+ N+L+ KI+DFGL+ L E R P + APE +++ +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 186 GAAADVWSCGVILY-VLIAGYLPF 208
+DVWS G++L ++ G +P+
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPY 211
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-26
Identities = 56/241 (23%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ V R +G+GTF +V Q+ + + A+KV+ R+ K K E I+K +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90
Query: 67 -----PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDG 119
+V+ H + +I E + G L++ I + + + Y +++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH-------------------------LKISDFGLS 154
++Y + H DLKPEN+LLD +K+ DFG +
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DEL 211
+ T Y APEV+ + G+ ++D+WS G +L L G L F + +
Sbjct: 210 TFKSDYHG---SIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 212 D 212
+
Sbjct: 266 E 266
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 9e-26
Identities = 50/207 (24%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 10 EVGRTIGEGTFAKVKFAQ-NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F VK+ + + VA+K++ ++ + + E +M + H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY--DVAIKMIKEGSMSEDEFI----EEAKVMMNLSHEK 80
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L+ V + I+II E++ G L + + R + + + + ++Y SK
Sbjct: 81 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL N L++ QG +K+SDFGLS P + PEVL + ++
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS- 199
Query: 187 AAADVWSCGVILY-VLIAGYLPFDELD 212
+ +D+W+ GV+++ + G +P++
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFT 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-25
Identities = 44/226 (19%), Positives = 80/226 (35%), Gaps = 36/226 (15%)
Query: 10 EVGRTIGEGTFAKV-------KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
++G+GTF K+ V +KVLD++ ++ S+M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVD 121
+ H +V + V + ++ EF+ G L + + ++ +QL +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHL--------KISDFGLSALPEQGVSLLRTTCGTPNY 173
+ + H ++ +N+LL + K+SD G+S T
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS----------ITVLPKDIL 177
Query: 174 ------VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
V PE + + A D WS G L+ + G P LD
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-24
Identities = 51/193 (26%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV 69
++ + +G G F +V A + + VA+K + ++ E ++MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL----AEANVMKTLQHDKL 245
Query: 70 VRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKG 127
V+LH V ++ IYII EF+ G L D + + + Q+ +G+ + +
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP-NYVAPEVLSHKGYNG 186
HRDL+ N+L+ + KI+DFGL+ + E R P + APE ++ +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT- 363
Query: 187 AAADVWSCGVILY 199
+DVWS G++L
Sbjct: 364 IKSDVWSFGILLM 376
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-24
Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 42/239 (17%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+YE+ T+GEG F KV + + G VA+K++ ++ + + + EI +++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69
Query: 66 -------HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQL 116
CV ++ E I I+ E + G +D I +G R+ Q+
Sbjct: 70 TTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGH-------------------LKISDFGLSALP 157
V++ HS + H DLKPEN+L + +K+ DFG +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELDL 213
++ S T T +Y APEV+ G+ DVWS G IL G+ F D +
Sbjct: 188 DEHHS---TLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-24
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
IG G F V N A+K L+R I Q E IMK H
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSH 149
Query: 67 PCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
P V+ L + L S ++L ++ G+L + I + + + + Q+ G+ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGT--PNYV---APEV 178
SK HRDL N +LD + +K++DFGL+ + ++ + G P V A E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP--VKWMALES 267
Query: 179 LSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
L + + +DVWS GV+L+ ++ G P+ +++
Sbjct: 268 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 301
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-24
Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 42/238 (17%)
Query: 7 GKYEVGRTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV- 64
+YE+ +GEGTF KV + + VA+K++ R+ K + + EI+++K +
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74
Query: 65 ------RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQL 116
+ CV + + + I E + G F+ + + R QL
Sbjct: 75 EKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGH-------------------LKISDFGLSALP 157
+ + H + H DLKPEN+L + ++++DFG +
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF---DELD 212
+ + T T +Y PEV+ G+ DVWS G IL+ G+ F + +
Sbjct: 193 HEHHT---TIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-23
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
IG G F V N A+K L+R I Q E IMK H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDFSH 85
Query: 67 PCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
P V+ L + L S ++L ++ G+L + I + + + + Q+ G+ Y
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS----------ALPEQGVSL-LRTTCGTPNY 173
SK HRDL N +LD + +K++DFGL+ + G L ++
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM------ 199
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPFDELD 212
A E L + + +DVWS GV+L+ ++ G P+ +++
Sbjct: 200 -ALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 237
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-22
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
R IG+G F V ++ + A+K L R ++ A RE +M+ + H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA--FLREGLLMRGLNH 81
Query: 67 PCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
P V+ L + L +++L ++ G+L I R + + + Q+ G++Y
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGT--PNYV---APEV 178
+ HRDL N +LD +K++DFGL+ + ++ ++ P V A E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP--VKWTALES 199
Query: 179 LSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
L + +DVWS GV+L+ +L G P+
Sbjct: 200 LQTYRFT-TKSDVWSFGVLLWELLTRGAPPY 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-22
Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 42/228 (18%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+GR +G+G F V + Q + VA+K+L I + + RE + MK H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84
Query: 67 PCVVRL------HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI--- 117
P V +L +IL F+ G+L ++ R+ E+ Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143
Query: 118 ----DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
G++Y S+ HRDL N +L + ++DFGLS R Y
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS----------RKIYSGDYY 193
Query: 174 V------------APEVLSHKGYNGAAADVWSCGVILY-VLIAGYLPF 208
A E L+ Y +DVW+ GV ++ ++ G P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPY 240
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-22
Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 49/226 (21%)
Query: 10 EVGRTIGEGTFAKVKFA-----QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
G+T+G G F KV A ++ +VA+K+L SA + + A + E+ ++ L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVLSYL 83
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGEL-----------FDKIVHHGRLSESEARRY 112
H +V L +I E+ G+L + + E
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 113 FQQLID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
+ L+ G+ + SK HRDL N+LL KI DFGL+ R
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA----------R 193
Query: 166 TTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
NYV APE + + Y +DVWS G+ L+
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-21
Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 40/217 (18%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ R +G+G+F V K E VA+K ++ +A ++ ++ + E S+MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY---FQQLI---- 117
VVRL V++ +I+E +T G+L + + ++I
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 118 ---DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
DG+ Y ++ HRDL N ++ +KI DFG++ R T Y
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT----------RDIYETDYYR 195
Query: 175 ------------APEVLSHKGYNGAAADVWSCGVILY 199
+PE L + +DVWS GV+L+
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLW 231
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-21
Identities = 55/220 (25%), Positives = 88/220 (40%), Gaps = 45/220 (20%)
Query: 12 GRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G+T+G G F KV A + VA+K+L +A K A + E+ IM L +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA--LMSELKIMSHLGQ 108
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFD-------KIVHHGRLSESEARRYFQQLID 118
H +V L + +I E+ G+L + + + + + + L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 119 -------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
G+ + SK HRD+ N+LL + KI DFGL+ R
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDS 218
Query: 172 NYV------------APEVLSHKGYNGAAADVWSCGVILY 199
NY+ APE + Y +DVWS G++L+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-21
Identities = 47/214 (21%), Positives = 75/214 (35%), Gaps = 34/214 (15%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ R +G G F +V N + VA+K L + ++ E I+
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FLMEALIISKF 131
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI------- 117
H +VR V +I+LE + GG+L + + L+
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLS-ALPE------QGVSLL--R 165
G Y HRD+ N LL G KI DFG++ + G ++L +
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
PE + + D WS GV+L+
Sbjct: 252 WM-------PPEAFMEGIFT-SKTDTWSFGVLLW 277
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 9e-21
Identities = 63/290 (21%), Positives = 100/290 (34%), Gaps = 101/290 (34%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
G+Y V R +G G F+ V + + + + VAMKV+ +SA + EI ++K VR
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSA---EHYTETALDEIRLLKSVRN 92
Query: 66 --------------------------HPCVVRLHEVLASRTKIYIILEFITGGELFDKIV 99
H C+V EVL +L++I
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMV--FEVLGHH-----LLKWI-------IKS 138
Query: 100 HHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLL------------------ 140
++ L ++ QQ++ G+DY H+K + H D+KPEN+LL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 141 -------------------------------DSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ +KI+D G + + T
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDI 254
Query: 170 TPN-YVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
Y + EVL GYN AD+WS + + L G F+
Sbjct: 255 QTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTR 303
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-21
Identities = 46/214 (21%), Positives = 75/214 (35%), Gaps = 34/214 (15%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ R +G G F +V N + VA+K L + ++ E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI------- 117
H +VR V +I++E + GG+L + + L+
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLS-ALPE------QGVSLL--R 165
G Y HRD+ N LL G KI DFG++ + G ++L +
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
PE + + D WS GV+L+
Sbjct: 211 WM-------PPEAFMEGIFT-SKTDTWSFGVLLW 236
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-20
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 37/223 (16%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ VG+ IG G F +++ +N T E VA+K+ + + Q+ E K +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RA---PQLHLEYRFYKQLGS 63
Query: 67 -PCVVRLHEVLASRTKIYIILEFITGG----ELFDKIVHHGRLSESEARRYFQQLIDGVD 121
+ +++ ++LE + G +LFD S QLI ++
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISRME 119
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLK-----ISDFGLS-----------ALPEQGVSLLR 165
Y HSK + +RD+KPEN L+ G+ I DF L+ + SL
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL-- 177
Query: 166 TTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLP 207
GT Y++ + +H G D+ + G + + G LP
Sbjct: 178 --TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-20
Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 40/220 (18%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+GE F KV E ++VA+K L A + + E + +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE--FRHEAMLRARL 69
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY---------FQQ 115
+HP VV L V+ + +I + + G+L + +V S+ +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 116 LI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE-------QGV 161
+ G++Y S V H+DL N+L+ + ++KISD GL G
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 162 SLL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
SLL R APE + + ++ +D+WS GV+L+
Sbjct: 190 SLLPIRWM-------APEAIMYGKFS-IDSDIWSYGVVLW 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-20
Identities = 57/222 (25%), Positives = 84/222 (37%), Gaps = 53/222 (23%)
Query: 12 GRTIGEGTFAKVKFAQ--NTETGESVAMKVLDRSAIIKHKMADQIK---REISIMK-LVR 65
IGEG F +V A+ A+K + A D + E+ ++ L
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDDHRDFAGELEVLCKLGH 84
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQQL 116
HP ++ L R +Y+ +E+ G L D + + + QQL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 117 ID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169
+ G+DY K HRDL N+L+ KI+DFGLS R G
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------R---G 191
Query: 170 TPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
YV A E L++ Y +DVWS GV+L+
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLW 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 1e-19
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 29/218 (13%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR- 65
K+ +GR IG G+F ++ N +T E VA+K+ + KH Q+ E I ++++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHP---QLLYESKIYRILQG 61
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCH 124
+ + ++++ + G L D R LS Q+I+ V++ H
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 125 SKGVYHRDLKPENLLLDSQGH---LKISDFGLSAL-----------PEQGVSLLRTTCGT 170
SK HRD+KP+N L+ + I DFGL+ + +L GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL----TGT 176
Query: 171 PNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLP 207
Y + V +H G D+ S G +L + G LP
Sbjct: 177 ARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-19
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 40/217 (18%)
Query: 10 EVGRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+G+ +GEG F V Q T VA+K + + + ++ E + MK H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 67 PCVVRL-----HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLI---- 117
P V+RL K +IL F+ G+L +++ RL Q L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 118 ---DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
G++Y ++ HRDL N +L + ++DFGLS + Y
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS----------KKIYSGDYYR 204
Query: 175 ------------APEVLSHKGYNGAAADVWSCGVILY 199
A E L+ + Y + +DVW+ GV ++
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMW 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-19
Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 49/224 (21%)
Query: 12 GRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
G+ +GEG F +V A VA+K+L A K + E+ +MK +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD--LISEMEMMKMI 131
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQ 114
+H ++ L +Y+I+E+ + G L + + E + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 115 QLID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167
L+ G++Y SK HRDL N+L+ +KI+DFGL+ R
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA----------RDI 241
Query: 168 CGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
Y APE L + Y +DVWS GV+L+
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-19
Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 40/219 (18%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ +GEG F KV + VA+K L + A + +RE ++ ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRY--------FQQL 116
+H +VR V + ++ E++ G+L + HG ++ A QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 117 I-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPE------QGVS 162
+ G+ Y HRDL N L+ +KI DFG+S + G +
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 163 LL--RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILY 199
+L R PE + ++ + +DVWS GV+L+
Sbjct: 221 MLPIRWM-------PPESILYRKFT-TESDVWSFGVVLW 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-19
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 49/226 (21%)
Query: 10 EVGRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+G+ +GEG F +V A + +VA+K+L A K + E+ +MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMK 95
Query: 63 -LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRY 112
+ +H ++ L +Y+I+E+ + G L + + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 113 FQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
F+ L+ G++Y S+ HRDL N+L+ +KI+DFGL+ R
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA----------R 205
Query: 166 TTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
Y APE L + Y +DVWS GV+++
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-19
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 51/223 (22%)
Query: 12 GRTIGEGTFAKV--KFAQNTETGES---VAMKVLDRSAIIKHKMADQIK--REISIMKLV 64
R +GEG F KV N + VA+K L +A + RE ++ +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-----LAARKDFQREAELLTNL 74
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQQ 115
+H +V+ + V + ++ E++ G+L I+ G+ +++ Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 116 LI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168
++ G+ Y S+ HRDL N L+ + +KI DFG+S R
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS----------RDVY 184
Query: 169 GTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
T Y PE + ++ + +DVWS GVIL+
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILW 226
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-18
Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 48/223 (21%)
Query: 12 GRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVR 65
G+ +G G F +V A T T +VA+K+L A A + E+ I+ +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIGH 89
Query: 66 HPCVVRLHEV-LASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRYFQQ 115
H VV L + +I+EF G L + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 116 LID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168
LI G+++ S+ HRDL N+LL + +KI DFGL+ R
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA----------RDIY 199
Query: 169 GTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
P+YV APE + + Y +DVWS GV+L+
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-18
Identities = 56/229 (24%), Positives = 84/229 (36%), Gaps = 54/229 (23%)
Query: 12 GRTIGEGTF-----AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+T+GEG F A + +VA+K+L +A + E +++K V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD--LLSEFNVLKQVNH 85
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGEL-----------------FDKIVHHGRLSESEA 109
P V++L+ + + +I+E+ G L E
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 110 RRYFQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162
LI G+ Y + HRDL N+L+ +KISDFGLS
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-------- 197
Query: 163 LLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R +YV A E L Y +DVWS GV+L+
Sbjct: 198 --RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-18
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 49/226 (21%)
Query: 10 EVGRTIGEGTFAKVKFA-------QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+G+ +GEG F +V A + +VA+K+L A K + E+ +MK
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD--LVSEMEMMK 141
Query: 63 -LVRHPCVVRLHEVLASRTKIYIILEFITGGELFD---------KIVHHGRLSESEARRY 112
+ +H ++ L +Y+I+E+ + G L + + E +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 113 FQQLID-------GVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
F+ L+ G++Y S+ HRDL N+L+ +KI+DFGL+ R
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA----------R 251
Query: 166 TTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
Y APE L + Y +DVWS GV+++
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-18
Identities = 57/231 (24%), Positives = 83/231 (35%), Gaps = 54/231 (23%)
Query: 10 EVGRTIGEGTF-----AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
E G+ +G G F A T VA+K+L A + A + E+ +M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA--LMSELKMMTQL 105
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGEL----------------FDKIVHHGRLSES 107
H +V L IY+I E+ G+L + E
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 108 EARRYFQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160
F+ L+ G+++ K HRDL N+L+ +KI DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 161 VSLLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R NYV APE L Y +DVWS G++L+
Sbjct: 220 ----RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-18
Identities = 46/222 (20%), Positives = 85/222 (38%), Gaps = 35/222 (15%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y+VGR IGEG+F + N + VA+K R + Q++ E KL+
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAP---QLRDEYRTYKLLAG 64
Query: 67 -PCVVRLHEVLASRTKIYIILEFITG---GELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ ++ ++++ + G +L D + S +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQS 121
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLK-----ISDFGLS-----------ALPEQGVSLLRT 166
H K + +RD+KP+N L+ + DFG+ + +L
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL--- 178
Query: 167 TCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLP 207
GT Y++ + +H G D+ + G + + G LP
Sbjct: 179 -SGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 53/231 (22%), Positives = 82/231 (35%), Gaps = 54/231 (23%)
Query: 10 EVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
E R IGEG F +V E VA+K+L A + +RE ++M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEF 107
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGEL-----------------FDKIVHHGRLSES 107
+P +V+L V A + ++ E++ G+L D S
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 108 EARRYFQQLI-------DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160
+ + G+ Y + HRDL N L+ +KI+DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 161 VSLLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R Y PE + + Y +DVW+ GV+L+
Sbjct: 222 ----RNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLW 267
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-17
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y +GR IG G+F + + GE VA+K+ KH Q+ E I K+++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHP---QLHIESKIYKMMQG 63
Query: 67 -PCVVRLHEVLASRTKIYIILEFITG---GELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
+ + A +++E + G +LF+ + S Q+I ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEY 120
Query: 123 CHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSAL-----------PEQGVSLLRTTC 168
HSK HRD+KP+N L+ + I DFGL+ + +L
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL----T 176
Query: 169 GTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLIAGYLP 207
GT Y + + +H G D+ S G +L G LP
Sbjct: 177 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-17
Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHE 74
+G G F KV + G VA+K L ++ Q + E+ ++ + H ++RL
Sbjct: 38 LGRGGFGKV-YKGRLADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94
Query: 75 VLASRTKIYIILEFITGGELFDKIVHHGRLSESEA----RRYFQQLIDGV--------DY 122
+ T+ ++ ++ G + + R +R ++ G D+
Sbjct: 95 FCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQ--RIALGSARGLAYLHDH 150
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSH 181
C K + HRD+K N+LLD + + DFGL+ L + + + T GT ++APE LS
Sbjct: 151 CDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 209
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFD 209
G + DV+ GV+L LI G FD
Sbjct: 210 -GKSSEKTDVFGYGVMLLELITGQRAFD 236
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 7e-17
Identities = 38/192 (19%), Positives = 61/192 (31%), Gaps = 48/192 (25%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVL-----DRSAIIKHKMADQIKREISIMK 62
K + IGEG F +V VA+K++ D K ++I EI I K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 63 LV---------RHPCVVRLHEV------------------------------LASRTKIY 83
+ R + L+ V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDS 142
I+LEF GG +++ S + A+ QL + + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQM-RTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 143 QGHLKISDFGLS 154
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-16
Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 41/216 (18%)
Query: 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL-- 72
IG G F KV + G VA+K + + + + EI + RHP +V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 73 ------HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQL---ID---GV 120
+L IY +++ G L + +G + + + Q+L I G+
Sbjct: 103 FCDERNEMIL-----IY---KYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-PEQGVSLLRTTC-GTPNYVAPE- 177
Y H++ + HRD+K N+LLD KI+DFG+S E + L T GT Y+ PE
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212
Query: 178 ----VLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
L+ K +DV+S GV+L+ ++
Sbjct: 213 FIKGRLTEK------SDVYSFGVVLFEVLCARSAIV 242
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-16
Identities = 44/236 (18%), Positives = 87/236 (36%), Gaps = 48/236 (20%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
++ +G+ IG G F + A T E A V+ ++++ + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAK 92
Query: 67 PCVVRLHEVLASRTKI-------------------YIILEFITGGELFDKIVHHGRLSES 107
++ + ++++E + G +L +G +S
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 108 EARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGHLKISDFGLS----------A 155
+ +++D ++Y H H D+K NLLL + + ++D+GLS
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLI---AGYLP 207
E GT + + + +HKG +DV G Y ++ G LP
Sbjct: 212 YQENPRKGHN---GTIEFTS--LDAHKGVALSRRSDVEILG---YCMLRWLCGKLP 259
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 1e-15
Identities = 60/233 (25%), Positives = 90/233 (38%), Gaps = 50/233 (21%)
Query: 4 RKVGKYEVGRTIGEGTFAKV-KFAQNTETGESVAMKVLDRSAIIK-HKMADQIKREISIM 61
+ G +GEG F V K N +VA+K L I ++ Q +EI +M
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 62 KLVRHPCVVRL--------HEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESE---- 108
+H +V L L +Y ++ G L D
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCL-----VY---VYMPNGSLLD---RLSCLDGTPPLSWH 133
Query: 109 ---------ARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-PE 158
A G+++ H HRD+K N+LLD KISDFGL+ +
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 159 QGVSLLRT-TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
+++ + GT Y+APE L G +D++S GV+L +I G DE
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDE 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-12
Identities = 40/238 (16%), Positives = 83/238 (34%), Gaps = 49/238 (20%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKHKMADQIKREISIMKLVR 65
++VG IG+G F + + + + ESV + ++ + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCI-YLADMNSSESVGSD--APCVVKVEPSDNGPLFTELKFYQRAA 91
Query: 66 HPCVVRLHEVLASRTKI-------------------YIILEFITGGELFDKIVHHGR-LS 105
P ++ + ++I++ G +L + + S
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFS 150
Query: 106 ESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGHLKISDFGLS--------- 154
+ +++D ++Y H H D+K NLLL+ + + + D+GL+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
Query: 155 -ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN-GAAADVWSCGVILYVLI---AGYLP 207
A GT + + + +H G D+ G Y +I G+LP
Sbjct: 211 KAYAADPKRCHD---GTIEFTS--IDAHNGVAPSRRGDLEILG---YCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-11
Identities = 32/238 (13%), Positives = 78/238 (32%), Gaps = 49/238 (20%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETG--------ESVAMKVLDRSAIIKHKM-------- 50
++++ + A T T + ++K+ + + ++
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 51 ADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII--------LEFITGGELFDKIVHHG 102
Q+ + + + + K + L+ D
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQ-----SALDV-SPKH 154
Query: 103 RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL--DSQGHLKISDFGLS------ 154
LSE + +L+D +++ H H ++ EN+ + + Q + ++ +G +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 155 ----ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA-AADVWSCGVILYVLIAGYLP 207
A E S G +++ + HKG + +D+ S G + + G+LP
Sbjct: 215 GKHVAYVEGSRSPHE---GDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-10
Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 23/117 (19%)
Query: 95 FDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
+ ++ L+ Y Q+ G+++ S+ HRDL N+LL + +KI DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 155 ALPEQGVSLLRTTCGTPNYV------------APEVLSHKGYNGAAADVWSCGVILY 199
R P+YV APE + + Y +DVWS GV+L+
Sbjct: 241 ----------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 36/152 (23%), Positives = 55/152 (36%), Gaps = 13/152 (8%)
Query: 10 EVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-L 63
++G+ +G G F +V A T T +VA+K+L A A + E+ I+ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHI 82
Query: 64 VRHPCVVRLH-EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
H VV L + +I+EF G L + R + + G DY
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST-YLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154
G DLK + S S F
Sbjct: 142 ---VGAIPVDLKRRLDSITSSQSSASSGFVEE 170
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 6e-05
Identities = 25/155 (16%), Positives = 56/155 (36%), Gaps = 20/155 (12%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD-QIKREISIMKLVR-- 65
+G+ +GEG + V F +E +K K+ + + ++ L
Sbjct: 92 DAIGKLMGEGKESAV-FNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 66 ----HPCVVRLHEVLASRTKIY----IILEFITGGELFDKIVHHGRLSESEARRYFQQLI 117
+ +L + + + +++E I EL+ + ++
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-------VRVENPDEVLDMIL 203
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152
+ V + +G+ H DL N+L+ + + I DF
Sbjct: 204 EEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 1e-04
Identities = 32/168 (19%), Positives = 57/168 (33%), Gaps = 26/168 (15%)
Query: 9 YEVGRTIGEGTFAKVKFAQN--TETGESVAMKV-------LDRSAIIKHKMADQIKREIS 59
+G I G A V +A ++A+K+ D+ + R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 60 IMKLVR------HPCVVRLHEVLASRTKIY------IILEFITGGELFDKIVHH--GRLS 105
+ V + R E S + Y +++EFI EL + L
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 106 ESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFG 152
E + F +++ V + + + H DL N++ + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 218 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.54 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.17 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.02 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.94 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.85 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.74 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.44 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.34 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.46 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.31 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.76 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 95.62 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.7 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 81.04 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=341.20 Aligned_cols=212 Identities=33% Similarity=0.624 Sum_probs=192.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
+.++|++++.||+|+||.||.|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++++.+.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35679999999999999999999999999999999987665555667889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC--Cc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~--~~ 162 (218)
|||||++|+|.+.+...+.+++.++..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++...... ..
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999754332 22
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
.....+|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+..+++
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 243 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIF 243 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 23455799999999999988776 9999999999999999999999988766543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=334.86 Aligned_cols=211 Identities=50% Similarity=0.951 Sum_probs=173.6
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
+++++|++.+.||+|+||.||.|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++++.+..|
T Consensus 10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 89 (275)
T 3hyh_A 10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89 (275)
T ss_dssp ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 46799999999999999999999999999999999998766555556678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+ +++|.+.+...+++++.++..++.||+.||+|||++|++|+||||+||+++.++++||+|||++....... .
T Consensus 90 ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~ 167 (275)
T 3hyh_A 90 MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-F 167 (275)
T ss_dssp EEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-c
Confidence 999999 56999999999999999999999999999999999999999999999999999999999999997654432 2
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....+|++.|+|||.+.+..+.+.++|||||||++|+|++|+.||...+..++
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~ 220 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL 220 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 33567999999999999888776899999999999999999999998776554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-56 Score=343.88 Aligned_cols=212 Identities=29% Similarity=0.598 Sum_probs=183.5
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
++.+++|++++.||+|+||.||.|.+..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++++.+.+
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 45678999999999999999999999999999999999765543 33467789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 83 YIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
|+|||||++++|.+.+...+ .+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999999996543 5789999999999999999999999999999999999999999999999999866543
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.......+|++.|+|||.+.+..++ .++|||||||++|+|++|+.||...+..++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~ 233 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNL 233 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 3333455799999999999988776 999999999999999999999998876554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=333.96 Aligned_cols=205 Identities=28% Similarity=0.492 Sum_probs=184.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
..|++.+.||+|+||.||.|.++.+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4699999999999999999999999999999999754422 2355789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|||++|+|.+++.. +.+++.++..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++............
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 99999999998865 57999999999999999999999999999999999999999999999999999765554444456
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.+|++.|+|||.+....++ .++|||||||++|+|++|+.||...+..++
T Consensus 230 ~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 278 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 278 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred cccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 6899999999999888775 999999999999999999999988776543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=331.47 Aligned_cols=208 Identities=36% Similarity=0.665 Sum_probs=178.0
Q ss_pred cceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
++|++++.||+|+||.||.|.+. .+++.||+|++......... ...+.+|+.++++++||||+++++++++.+.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999874 35788999999765433222 345778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|||||++++|.+.+...+.+++.++..++.|++.||+|||++|++|+||||+|||++.++.+||+|||++.........
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 182 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999765444444
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....+|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+..++
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~ 234 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKET 234 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHH
Confidence 4456799999999999888876 899999999999999999999998877654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=335.35 Aligned_cols=205 Identities=28% Similarity=0.492 Sum_probs=184.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.|++++.||+|+||.||.|.++.+|+.||||++...... ..+.+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999754422 2355789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|||++|+|.+++.. +.+++.++..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++............
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 99999999998864 57999999999999999999999999999999999999999999999999999765544444456
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.+|++.|+|||.+....++ .++|||||||++|+|++|+.||...+..++
T Consensus 307 ~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~ 355 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 355 (423)
T ss_dssp CEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred cccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 6799999999999888876 999999999999999999999988766543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=326.54 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=178.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
++.|++.++||+|+||.||.|.++.+|+.||||++..... ..+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999965432 23689999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCCCc--
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVS-- 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~~~-- 162 (218)
||||++++|.+++...+.+++.+++.++.|++.||.|||++||+|+||||+|||++.++ .+||+|||++........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999999999999999999999999999999999999999999999999887 699999999975433211
Q ss_pred ---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 163 ---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 163 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....+|++.|+|||.+.+..++ .++|||||||++|+|++|+.||...+..++
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 264 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCC
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHH
Confidence 11223689999999999988776 899999999999999999999998877654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=316.01 Aligned_cols=201 Identities=27% Similarity=0.526 Sum_probs=176.9
Q ss_pred cce-EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc----CCe
Q 027809 7 GKY-EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RTK 81 (218)
Q Consensus 7 ~~y-~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----~~~ 81 (218)
++| ++.+.||+|+||.||.|.+..++..||+|.+...... ....+.+.+|+.+++.++||||++++++++. .+.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 565 7888999999999999999999999999999765443 3345778999999999999999999999864 356
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEec-CCCcEEEeeccccccCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLD-SQGHLKISDFGLSALPE 158 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~-~~~~~~l~d~~~~~~~~ 158 (218)
+|+|||||++|+|.+++...+.+++..+..++.||+.||.|||+++ |+|+||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999999999999999999999999999999998 99999999999997 47999999999997544
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.. .....+|++.|+|||.+.+ .++ .++||||||+++|+|+||+.||...+
T Consensus 184 ~~--~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 184 AS--FAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TT--SBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CC--ccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 2345679999999998864 454 99999999999999999999997654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=317.20 Aligned_cols=207 Identities=26% Similarity=0.407 Sum_probs=177.4
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|.+.+.||+|+||.||+|.+. .++..||||.+.... .+..+.+.+|+.++++++||||+++++++.+.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 357999999999999999999864 357889999986543 344577899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEE
Q 027809 81 KIYIILEFITGGELFDKIVHH-------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLK 147 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~ 147 (218)
..++|||||++|+|.+++... ..+++.+++.++.|++.||.|||+++++|+||||+|||++.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 999999999999999999764 3689999999999999999999999999999999999999999999
Q ss_pred EeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 148 ISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 148 l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
|+|||++........ ......+++.|+|||.+.+..++ .++||||||+++|||+| |+.||...+..++
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 239 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999975433211 12233578899999999988776 99999999999999998 9999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=313.98 Aligned_cols=209 Identities=25% Similarity=0.417 Sum_probs=178.5
Q ss_pred cccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..+++++.+.||+|+||.||+|... .+++.||||.+.... .....+.+.+|+.++.+++||||+++++++...
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 3567899999999999999999864 356889999986443 233457789999999999999999999999998
Q ss_pred CeEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC
Q 027809 80 TKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~ 143 (218)
+..++|||||++|+|.+++... ..+++.+++.++.||+.||+|||+++++|+||||+|||++++
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999643 358999999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCC--CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 144 GHLKISDFGLSALPEQG--VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 144 ~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
+.+||+|||++...... ........+++.|+|||.+.+..++ .++||||||+++|||+| |..||...+..++
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999998754322 1222344678899999999887776 99999999999999998 8999999877654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=313.49 Aligned_cols=207 Identities=25% Similarity=0.397 Sum_probs=173.1
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..++.+.++||+|+||.||+|.+. .++..||||.+... +....+.+.+|+.++.+++||||+++++++.+.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357899999999999999999864 35789999998653 2344577899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc
Q 027809 81 KIYIILEFITGGELFDKIVHH---------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~ 145 (218)
..++|||||++|+|.+++... .++++.+++.++.|++.||.|||+++++|+||||+|||++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999998653 35899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCC--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 146 LKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 146 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
+||+|||++....... .......+++.|+|||.+.+..++ .++||||||+++|||+| |+.||...+..++
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999997543321 122334578899999999887776 99999999999999999 9999998876654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=309.91 Aligned_cols=204 Identities=24% Similarity=0.445 Sum_probs=170.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.+++++.++||+|+||+||.|.+. ..||||++..... +.+..+.+.+|+.++++++||||+++++++.. +..++|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 467889999999999999999865 3699999864432 34456789999999999999999999998865 568999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC--Cc
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~--~~ 162 (218)
||||++|+|.+.+... .++++.+++.++.|++.||.|||+++|+|+||||+|||+++++.+||+|||++...... ..
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999998654 57999999999999999999999999999999999999999999999999999754332 22
Q ss_pred ccccccccCccccccccccC--CCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 163 LLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
......|++.|+|||.+... ...+.++||||||+++|||+||+.||...+..
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~ 243 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR 243 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH
Confidence 23345789999999999643 22348999999999999999999999876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=309.01 Aligned_cols=201 Identities=27% Similarity=0.477 Sum_probs=165.0
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC---
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--- 80 (218)
|.+++|++++.||+|+||.||.|.++.+|+.||||++.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 45678999999999999999999999999999999986543 3344567889999999999999999999986433
Q ss_pred ---------eEEEEEEecCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEE
Q 027809 81 ---------KIYIILEFITGGELFDKIVHHGRL---SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKI 148 (218)
Q Consensus 81 ---------~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l 148 (218)
.+|+|||||++++|.+.+.....+ ++..++.++.|+++||+|||++||+|+||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 479999999999999999876553 45668899999999999999999999999999999999999999
Q ss_pred eeccccccCCCCCc------------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 149 SDFGLSALPEQGVS------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 149 ~d~~~~~~~~~~~~------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
+|||++........ .....+|++.|+|||.+.+..++ .++|||||||++|+|++ ||..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSS
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCC
Confidence 99999975443211 11234689999999999987776 99999999999999995 7764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=329.37 Aligned_cols=208 Identities=33% Similarity=0.538 Sum_probs=181.1
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHH---HHHHhhhhcCCCCcceEEEEEEcC
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIK---REISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
+..+++|++++.||+|+||.||.|.++.+|+.||+|++............... .++.++..++||||++++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 34688999999999999999999999999999999999765544333333333 335666777999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
+.+|+|||||+||+|.+.+...+.+++..+..++.||+.||+|||++||+|+||||+|||++.+|.+||+|||++.....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999976544
Q ss_pred CCcccccccccCcccccccccc-CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSH-KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.. ....+|++.|+|||.+.. ..++ .++|+|||||++|+|++|..||...+.
T Consensus 345 ~~--~~t~~GTp~YmAPEvl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 345 KK--PHASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp CC--CCSCCSCGGGCCHHHHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred CC--CCCccCCcCccCHHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 32 235679999999999974 4554 899999999999999999999976543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=315.06 Aligned_cols=206 Identities=30% Similarity=0.473 Sum_probs=179.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc------CC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------RT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------~~ 80 (218)
++|++++.||+|+||.||.|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999965432 33445678899999999999999999998753 36
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.+|+|||||+ ++|.+.+...+++++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999997 489999998899999999999999999999999999999999999999999999999999999754322
Q ss_pred ----CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 161 ----VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 161 ----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.......+|++.|+|||.+.+..+.+.++||||+||++|+|++|+.||...+..
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 122334578999999999887666569999999999999999999999877654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=306.09 Aligned_cols=207 Identities=26% Similarity=0.417 Sum_probs=175.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCC-----CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEc-
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLAS- 78 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~- 78 (218)
.++|++++.||+|+||.||.|.+... ++.||||.+.... .....+.+.+|+.++.+++| |||++++++|..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 46899999999999999999987653 3579999986544 23345678899999999976 899999999865
Q ss_pred CCeEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC
Q 027809 79 RTKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~ 142 (218)
.+.+++|||||++|+|.+++... ..+++.+++.++.||+.||+|||+++++|+||||+|||+++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 45689999999999999999653 34899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 143 QGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 143 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
++.+||+|||++........ ......+++.|+|||.+.+..++ .++||||||+++|||+| |..||...+..+
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999975433221 22234578899999999988776 99999999999999998 999999876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=298.40 Aligned_cols=203 Identities=28% Similarity=0.479 Sum_probs=170.9
Q ss_pred ccccccceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~ 77 (218)
+|+..++|++.+.||+|+||.||.|.++ .+++.||+|.+.... ...++.+|+.+++.+ +||||++++++++
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 4566788999999999999999999875 457889999885432 234577889999888 6999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-CcEEEeecccccc
Q 027809 78 SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLSAL 156 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-~~~~l~d~~~~~~ 156 (218)
+.+..|+||||+++++|.+.+. .+++.++..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++..
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999999998883 68999999999999999999999999999999999999876 7999999999964
Q ss_pred CCCCC----------------------------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCC
Q 027809 157 PEQGV----------------------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF 208 (218)
Q Consensus 157 ~~~~~----------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 208 (218)
..... ......+|++.|+|||.+.+....+.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 33211 11123468999999999987654458999999999999999999999
Q ss_pred CCCC
Q 027809 209 DELD 212 (218)
Q Consensus 209 ~~~~ 212 (218)
...+
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 5443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=292.92 Aligned_cols=211 Identities=35% Similarity=0.651 Sum_probs=188.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++++.||+|+||.||.|.+..+|+.+|+|++.............+.+|..+++.++||||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 46899999999999999999999999999999999976654444556778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||+++++|...+.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999987544333334
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
...++++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 213 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHH
Confidence 455688999999999877765 899999999999999999999988776543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=313.68 Aligned_cols=206 Identities=33% Similarity=0.626 Sum_probs=183.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++++.||+|+||.||.|.++.+|+.||+|.+..... ...+.+.+|+.+++.++||||++++++|++.+.+|+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999876542 2346688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC--CcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~--~~~~l~d~~~~~~~~~~~~ 162 (218)
||||++|+|.+.+.. .+.+++.++..++.||+.||.|||++|++|+||+|+|||++.+ +.+||+|||++.......
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999998864 4679999999999999999999999999999999999999754 899999999998655432
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....+|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+..++
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~ 364 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDET 364 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence 23455789999999999988775 999999999999999999999998776544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=295.84 Aligned_cols=211 Identities=35% Similarity=0.646 Sum_probs=184.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
.+++|++.+.||+|+||.||.|.+..+|+.+|+|++...........+.+..|..++..+ +||||+++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 468899999999999999999999999999999999876555555667788889999887 7999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+++++|...+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 99999999999999999899999999999999999999999999999999999999999999999999998764443334
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....++++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 232 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHH
Confidence 4455788999999999877775 899999999999999999999998876554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=290.35 Aligned_cols=211 Identities=46% Similarity=0.867 Sum_probs=189.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+++|++.+.||+|+||.||.|.+..+|+.||+|++..... +....+++.+|+.+++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 457899999999999999999999999999999999976543 3344577889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|+||+++++|.+.+...+.+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 169 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-K 169 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-G
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-c
Confidence 999999999999999988999999999999999999999999999999999999999999999999999987554432 2
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+..++
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 222 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL 222 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 33456888999999998887776899999999999999999999998776543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=291.05 Aligned_cols=198 Identities=22% Similarity=0.328 Sum_probs=161.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----eE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----KI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~----~~ 82 (218)
.+|.+.+.||+|+||.||+|.+ +|+.||||++..... .......|+..+..++||||+++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999987 578999999854331 1122345677778899999999999987543 58
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEecCCCcEEEeecccc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK--------GVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
++|||||++++|.+.+.. .++++.++++++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999875 4789999999999999999999976 8999999999999999999999999998
Q ss_pred ccCCCCCcc----cccccccCccccccccccCCC-----CCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 155 ALPEQGVSL----LRTTCGTPNYVAPEVLSHKGY-----NGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 155 ~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
......... .....+++.|+|||.+.+... .+.++||||||+++|||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 754433221 123468999999999975421 136899999999999999998776543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=291.10 Aligned_cols=214 Identities=48% Similarity=0.909 Sum_probs=190.1
Q ss_pred ccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..+.+++|++.+.||+|+||.||.|.+..+++.||+|++........+....+.+|+..++.++||||+++++++...+.
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 45788999999999999999999999999999999999976554444445678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.++|+||+ +++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999999 56899999888899999999999999999999999999999999999999999999999999987655432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
......+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+..+++
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~ 217 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF 217 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 2334568899999999987776568999999999999999999999887665543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=291.09 Aligned_cols=212 Identities=33% Similarity=0.624 Sum_probs=186.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~ 82 (218)
..+++|++.+.||+|+||.||.|.++.+|+.+|+|.+...........+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3578999999999999999999999999999999999766544444456677888888776 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++||||+++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999875443333
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....++++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 226 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 34455688999999999877665 999999999999999999999998776554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=287.92 Aligned_cols=208 Identities=32% Similarity=0.628 Sum_probs=187.1
Q ss_pred ccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
-+..+++|++.+.||+|+||.||.|.+..+++.+|+|++........+..+.+.+|..++..+ +||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 355688999999999999999999999999999999999876655556667788899999887 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++||||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998754433
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
.......++++.|+|||.+.+..+. .++|+||||+++|+|++|..||..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCC
Confidence 3334455788999999999877665 999999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=290.60 Aligned_cols=211 Identities=33% Similarity=0.632 Sum_probs=187.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
.+++|++.+.||+|+||.||.|.+..+|+.+|+|++...........+.+..|..++..+ +||+|+++++.+...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 568999999999999999999999988999999999776554445566778888888877 7999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+++++|.+.+...+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998764433333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....++++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 229 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHH
Confidence 4455688999999999877765 999999999999999999999998776554
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=292.29 Aligned_cols=206 Identities=32% Similarity=0.648 Sum_probs=182.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
.+++|++++.||+|+||.||.|.++.+++.+|+|++........+..+.+..|..++.++ +||||+++++++...+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 467899999999999999999999999999999999876655555556677888888776 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+++++|...+.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999754443344
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
....++++.|+|||.+.+..+. .++|+||||+++|+|++|..||...
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccc
Confidence 4456789999999999887775 9999999999999999999999643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=285.61 Aligned_cols=207 Identities=36% Similarity=0.729 Sum_probs=186.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.+.||+|+||.||.|.+..+|+.+|+|++...........+.+.+|..+++.++||||+++++++.+.+..++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 46899999999999999999999999999999999976554444456778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~--- 160 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--- 160 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcc---
Confidence 99999999999999988899999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~ 210 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMK 210 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHH
Confidence 245678999999999877665 89999999999999999999998776544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=281.74 Aligned_cols=208 Identities=28% Similarity=0.481 Sum_probs=181.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..++..+++|.+........+..+.+.+|+..+..++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999999999999999999999766555566678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-ccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 164 (218)
||++++++|.+++...+++++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 9999999999999988899999999999999999999999999999999999999999999999999987654322 112
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+..
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~ 218 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAV 218 (294)
T ss_dssp -----CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHH
T ss_pred CccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 234578899999999877665 8999999999999999999999877643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=287.95 Aligned_cols=209 Identities=36% Similarity=0.696 Sum_probs=188.3
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+++|++.+.||+|+||.||.|.+..+|+.+++|++...........+.+.+|..+++.++||||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 46789999999999999999999999999999999997665545455677889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+++++|.+.+...+.+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999987654432
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 196 -~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 246 (350)
T 1rdq_E 196 -WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp -CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -ccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHH
Confidence 234678899999999877765 999999999999999999999988776544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=290.17 Aligned_cols=211 Identities=38% Similarity=0.657 Sum_probs=178.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHh-hhhcCCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI-MKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~-l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..++|++.+.||+|+||.||.|.++.++..+|+|++.............+..|... ++.++||||+++++.+...+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 46789999999999999999999999999999999977655444444555566665 57789999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+++++|.+.+.....+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998754443333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....++++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~ 247 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHH
T ss_pred cccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 4456788999999999877765 899999999999999999999988776554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=285.95 Aligned_cols=208 Identities=29% Similarity=0.571 Sum_probs=184.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.+.||+|+||.||.|.+..+++.+|+|++...........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46889999999999999999999999999999999977665555566788899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+|++.+++|...+.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 171 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QI 171 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-CB
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC-ce
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997654332 23
Q ss_pred ccccccCccccccccccCC--CCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||...+.
T Consensus 172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 3456889999999997422 224899999999999999999999975443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=278.08 Aligned_cols=205 Identities=28% Similarity=0.508 Sum_probs=182.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+++.|++|.+...... ..+.+.+|+..++.++||||+++++++...+..++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 457899999999999999999999999999999998654422 24567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||+++++|.+.+... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 173 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence 99999999999988764 78999999999999999999999999999999999999999999999999987655444444
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 174 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~ 222 (297)
T 3fxz_A 174 STMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (297)
T ss_dssp CCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 455688899999999877775 8999999999999999999999876643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=284.70 Aligned_cols=211 Identities=42% Similarity=0.731 Sum_probs=182.8
Q ss_pred CccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 1 ~~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
|-...+++|++.+.||+|+||.||.|.+..+++.|++|++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 677889999999999999999999999999999999999865442 222356789999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++|+||+++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999999754322
Q ss_pred C--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 V--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. .......+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 1 1223446788999999998777655899999999999999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=290.09 Aligned_cols=210 Identities=37% Similarity=0.692 Sum_probs=185.0
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
+..++|++.+.||+|+||.||.|.+..+|+.+++|++...... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 4457899999999999999999999999999999999765543 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---CCCcEEEeeccccccCCCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~---~~~~~~l~d~~~~~~~~~~ 160 (218)
+|||++++++|.+.+.....+++.+++.++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999999999999999999999999999999999999999999999998 4678999999999766554
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
........+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~ 220 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHR 220 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence 4444455688999999999877665 89999999999999999999998776544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=292.65 Aligned_cols=210 Identities=28% Similarity=0.557 Sum_probs=182.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..+++.+|+|++.............+.+|..++..++||||+++++++.+.+..++|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 152 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence 57899999999999999999999999999999999764433333344578899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-cc
Q 027809 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-SL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 163 (218)
|||+++++|.+.+.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 999999999999987 5689999999999999999999999999999999999999999999999999986543322 22
Q ss_pred cccccccCccccccccc-----cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....++++.|+|||.+. ...+ +.++|+||||+++|+|++|..||...+..+.
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~ 289 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVET 289 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHH
Confidence 23356889999999986 2334 4899999999999999999999998776544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=294.10 Aligned_cols=212 Identities=50% Similarity=0.931 Sum_probs=189.9
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+++|++++.||+|+||.||.|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+..+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35789999999999999999999999999999999997665544455678899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|+||+++++|.+++...+.+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-F 171 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-c
Confidence 999999999999999888899999999999999999999999999999999999999999999999999997654432 2
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....++++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+..++
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 224 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL 224 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 33456889999999998777666899999999999999999999998765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=293.98 Aligned_cols=211 Identities=36% Similarity=0.659 Sum_probs=177.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+|+.||+|++.............+.+|..+++.++||||+++++++...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999976554445555677889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
||||+++++|.+.+.....+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.........
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence 99999999999999988899999999999999999999998 99999999999999999999999999998764443333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 306 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~ 357 (446)
T 4ejn_A 306 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357 (446)
T ss_dssp -CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHH
Confidence 4456688999999999877775 999999999999999999999988776543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=273.15 Aligned_cols=212 Identities=35% Similarity=0.640 Sum_probs=167.6
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
...+++|++.+.||+|++|.||.|.+..+|+.+++|.+........+..+.+.+|+..+..++||||+++++++...+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 45788999999999999999999999989999999999765544444567788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++|+|++++++|.+.+... .++++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999998775 578999999999999999999999999999999999999999999999999987654433
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~ 219 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKN 219 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-
T ss_pred CcceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHH
Confidence 333344578899999999866654 89999999999999999999998766543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=282.20 Aligned_cols=208 Identities=39% Similarity=0.699 Sum_probs=183.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++++.||+|+||.||.|.+..+|..+|+|.+........ ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4569999999999999999999999999999999976543221 1346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC----cEEEeeccccccCC
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPE 158 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~----~~~l~d~~~~~~~~ 158 (218)
++|+|++++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888999999999999999999999999999999999999998776 79999999997654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
... ......+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 171 ~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~ 225 (361)
T 2yab_A 171 DGV-EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQE 225 (361)
T ss_dssp TTC-CCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CCC-ccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 432 22345688999999999876665 89999999999999999999998876544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=290.02 Aligned_cols=211 Identities=35% Similarity=0.599 Sum_probs=182.6
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+++.+|+|++...........+.+.+|..++..++||||+++++++.+.+..++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999976544333334557789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-c
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 163 (218)
||||+++++|.+.+.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999999998865 4799999999999999999999999999999999999999999999999999975443221 2
Q ss_pred cccccccCccccccccccCCC---CCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGY---NGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....++++.|+|||.+..... .+.++|+||||+++|+|++|..||...+..++
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 234568899999999976542 24799999999999999999999998776543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=288.36 Aligned_cols=211 Identities=27% Similarity=0.556 Sum_probs=183.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+..+|+.+|+|++...........+.+.+|..++..++||||+++++++.+.+..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 35789999999999999999999999999999999976544344444567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 162 (218)
||||+++++|.+.+... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999999875 4799999999999999999999999999999999999999999999999999875543322
Q ss_pred ccccccccCcccccccccc-------CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSH-------KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....++++.|+|||.+.. ..+ +.++|+||||+++|+|++|+.||...+..++
T Consensus 219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp ECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 2223468899999999973 233 4899999999999999999999998776544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=272.56 Aligned_cols=210 Identities=37% Similarity=0.606 Sum_probs=187.4
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...++|++.+.||+|+||.||.+.+..+++.+++|++...........+.+.+|+..++.++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999997765555556677889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|+|++++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998765433333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~ 221 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLK 221 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred cccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 3345578899999999876664 8999999999999999999999876544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=278.61 Aligned_cols=210 Identities=36% Similarity=0.636 Sum_probs=172.9
Q ss_pred cccceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhh-hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..++|++.+.||+|+||.||.+.+. .+++.+++|++...... .......+.+|..+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 4578999999999999999999985 57899999998765322 2233456788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++||||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998754433
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
........+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~ 228 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKK 228 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHH
Confidence 3333345678899999999877665 89999999999999999999998876543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=273.96 Aligned_cols=206 Identities=34% Similarity=0.502 Sum_probs=176.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.+.||+|+||.||.|.+..+++.+++|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4789999999999999999999999999999999975543 333456778999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+|+++++.+.........+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 99998744444444467899999999999999999999999999999999999999999999999999976554434444
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCC-CCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPF-DELD 212 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~ 212 (218)
...+++.|+|||.+.+....+.++|+||||+++|+|++|..|| ...+
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~ 207 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC
Confidence 5567889999999987664459999999999999999887774 4433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=279.87 Aligned_cols=210 Identities=25% Similarity=0.469 Sum_probs=178.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~---- 80 (218)
..++|++.+.||+|+||.||.|.+..+++.|++|++........+....+.+|+..+..++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4678999999999999999999999999999999997765555666678899999999999999999999986543
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++||||+++++|.+++....++++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 35999999999999999998889999999999999999999999999999999999999999999999999998754432
Q ss_pred Cc---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 161 VS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 161 ~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.. ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..+
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~ 226 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVS 226 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 11 12233478899999999877665 89999999999999999999998876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=280.17 Aligned_cols=207 Identities=37% Similarity=0.742 Sum_probs=182.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..+|..+++|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999765433 33456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC---CcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~---~~~~l~d~~~~~~~~~~~~ 162 (218)
+|++++++|.+.+.....+++.+++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 9999999999999888889999999999999999999999999999999999999765 459999999987654432
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 237 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHR 237 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 22345678999999999877665 89999999999999999999998776543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=271.19 Aligned_cols=208 Identities=34% Similarity=0.667 Sum_probs=183.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.+.||+|++|.||.|.+..++..+++|++.............+.+|+..++.++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 57899999999999999999999999999999999976655555556778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+|++++++|.+.+....++++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~--~ 164 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--R 164 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--c
Confidence 99999999999999988899999999999999999999999999999999999999999999999999886544322 2
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~ 214 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQE 214 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHH
Confidence 234578899999999876664 89999999999999999999999876544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=276.86 Aligned_cols=210 Identities=37% Similarity=0.606 Sum_probs=187.7
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...++|++.+.||+|+||.||.+.+..+++.+++|++...........+.+.+|+..++.++||||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999997665555556677889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|+|++++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998765433333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~ 247 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLK 247 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 3345678899999999876664 8999999999999999999999876544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=271.22 Aligned_cols=206 Identities=27% Similarity=0.460 Sum_probs=179.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++++.||+|+||.||.|.+..+++.+++|.+... +.+..+.+.+|+..++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence 457899999999999999999999999999999988543 33445778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+|++++++|.+++.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999999999987 567999999999999999999999999999999999999999999999999999755432221
Q ss_pred c--------------ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 L--------------RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~--------------~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
. ....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 1 133577889999999877665 8999999999999999999999876554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=274.38 Aligned_cols=208 Identities=27% Similarity=0.449 Sum_probs=177.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.+.||+|++|.||.|.+..+|+.+++|++.... ......+.+.+|+..++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 689999999999999999999999999999999986543 2334456678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+|++++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 99999999999888888899999999999999999999999999999999999999999999999999976554333334
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4567889999999976544459999999999999999999999887654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=268.84 Aligned_cols=210 Identities=51% Similarity=0.951 Sum_probs=180.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+..+|+.+++|.+........+..+.+.+|+..++.++||||+++++++...+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 56899999999999999999999998999999999976654445556788899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+|++++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 167 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FL 167 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-ce
Confidence 99999999999999988899999999999999999999999999999999999999999999999999987654432 12
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+..+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 218 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 234577899999999876665689999999999999999999998766543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=274.22 Aligned_cols=208 Identities=33% Similarity=0.515 Sum_probs=175.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+. +|+.+|+|.+..... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 4688999999999999999999985 588999999865432 33344678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|||++++ +|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9999986 777776654 45999999999999999999999999999999999999999999999999999765544333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 3445678899999999765544589999999999999999999998766543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=274.94 Aligned_cols=208 Identities=38% Similarity=0.662 Sum_probs=182.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++.+.||+|+||.||.|.+..+|..+++|.+........ ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3579999999999999999999999999999999976543221 1346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC----cEEEeeccccccCC
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPE 158 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~----~~~l~d~~~~~~~~ 158 (218)
++|+|++++++|.+++.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888999999999999999999999999999999999999998877 89999999987654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.... .....+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..+
T Consensus 170 ~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~ 224 (326)
T 2y0a_A 170 FGNE-FKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQE 224 (326)
T ss_dssp TTSC-CCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred CCCc-cccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 3322 2344578899999999876665 89999999999999999999998766543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=274.57 Aligned_cols=207 Identities=31% Similarity=0.536 Sum_probs=172.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+ +|..+++|++..... ..+..+.+.+|+.++++++||||+++++++...+..++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 467899999999999999999976 578899999865543 33445678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 85 ILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
|+||+++++|.+.+..... +++.+++.++.|++.||.+||++| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999999976553 999999999999999999999999 99999999999999999999999999876554
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.........+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~ 246 (309)
T 3p86_A 192 TFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQ 246 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred cccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 43333445678899999999877665 89999999999999999999999877654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=299.35 Aligned_cols=212 Identities=33% Similarity=0.637 Sum_probs=188.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
.+++|++++.||+|+||.||.|.+..+++.||+|++...........+.+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 467899999999999999999999999999999999766554455566777888888877 6899999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+||||+++++|...+...+.+++.+++.++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++.........
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998754433333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
.....+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+++
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~ 551 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHH
Confidence 4456789999999999877775 9999999999999999999999988766543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=278.50 Aligned_cols=204 Identities=45% Similarity=0.805 Sum_probs=170.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+..+++.||+|++...... .+.+.+|+..++.++||||+++++++...+..++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 468899999999999999999999999999999999764422 2457789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc--EEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~--~~l~d~~~~~~~~~~~~ 162 (218)
|+||+++++|.+.+...+.+++.+++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999999999988889999999999999999999999999999999999999987765 9999999987433322
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+.
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 223446789999999998877765569999999999999999999987554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=289.01 Aligned_cols=207 Identities=30% Similarity=0.472 Sum_probs=184.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+|+.+|+|++.............+..|..+++.++||||+++++++......++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 46789999999999999999999999999999999976655554556778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 85 ILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
||||+++++|...+... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 99999999999988764 36999999999999999999999999999999999999999999999999999765544
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
........+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 3333345789999999999877665 99999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=275.58 Aligned_cols=207 Identities=31% Similarity=0.524 Sum_probs=164.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+|+.|++|.+.... .....+.+.+|+..++.++||||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 4678999999999999999999999999999999986544 22233567789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 85 ILEFITGGELFDKIVHH------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
|+|++++ +|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9999985 898888654 358999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 215 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE 215 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 43333344567889999999976544458999999999999999999999876643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=277.65 Aligned_cols=205 Identities=35% Similarity=0.682 Sum_probs=177.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh--hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH--KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
.++|++.+.||+|+||.||.|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3579999999999999999999999999999999865432211 13467889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc---EEEeecccccc
Q 027809 84 IILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSAL 156 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~---~~l~d~~~~~~ 156 (218)
+||||+++++|.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998777543 25899999999999999999999999999999999999976654 99999999976
Q ss_pred CCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
............+++.|+|||.+....+. .++|+||||+++|+|++|..||...
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCc
Confidence 65543333455688999999999877665 9999999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=274.35 Aligned_cols=205 Identities=30% Similarity=0.545 Sum_probs=180.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+++.+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4678999999999999999999999999999999986443 224567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC--CCcEEEeeccccccCCCCC
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~--~~~~~l~d~~~~~~~~~~~ 161 (218)
|+|++++++|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999997654 6999999999999999999999999999999999999987 7899999999997654432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~ 210 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -ccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHH
Confidence 22345578899999999866554 89999999999999999999998876544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=275.61 Aligned_cols=211 Identities=30% Similarity=0.489 Sum_probs=180.4
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.+.+++|++.+.||+|++|.||.|.+..+|+.|++|.+..... .....+.+.+|+..++.++||||+++++++...+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 5678999999999999999999999999999999999865542 333456678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|+|++++++|.+.......+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999999988888788899999999999999999999999999999999999999999999999999976554333
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 3345567889999999986644458999999999999999999999877643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=271.55 Aligned_cols=205 Identities=33% Similarity=0.544 Sum_probs=173.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.+.||+|+||.||.|.+ .+|+.+++|++..... .....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999998 5789999999865542 222346677999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
+|++++ +|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence 999986 888888654 679999999999999999999999999999999999999999999999999987544332333
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3445788999999997655445899999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=272.45 Aligned_cols=208 Identities=39% Similarity=0.703 Sum_probs=174.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhh-----------------------hhHHHHHHHHHHhh
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-----------------------HKMADQIKREISIM 61 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-----------------------~~~~~~~~~~~~~l 61 (218)
.+++|++.+.||+|+||.||.|.+..+++.||+|++....... ....+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 5789999999999999999999999999999999996554221 11235688999999
Q ss_pred hhcCCCCcceEEEEEEc--CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 027809 62 KLVRHPCVVRLHEVLAS--RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (218)
Q Consensus 62 ~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil 139 (218)
+.++||||+++++++.. .+..++|||++++++|.+.. ...++++.+++.++.|++.||.+||++|++|+||+|+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999986 56899999999999987654 3457999999999999999999999999999999999999
Q ss_pred ecCCCcEEEeeccccccCCCCCcccccccccCccccccccccCCC--CCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 140 LDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY--NGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 140 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
++.++.++|+|||++..............+++.|+|||.+..... .+.++|+||||+++|+|++|..||...+.
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999765544333345567889999999976543 24789999999999999999999987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=271.81 Aligned_cols=209 Identities=26% Similarity=0.449 Sum_probs=175.3
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+++|++.+.||+|++|.||.|.+..+++.+++|++...........+.+.+|+..+..++||||+++++++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 46789999999999999999999999999999999987665555555678899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-c
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~ 162 (218)
+++|++++++|.+++....++++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 999999999999999988899999999999999999999999999999999999999999999999999987544322 1
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred cccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 22234577899999999876664 899999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=268.49 Aligned_cols=207 Identities=37% Similarity=0.739 Sum_probs=184.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++.+.||+|++|.||.|.+..++..+++|.+...........+.+.+|+..++.++|||++++++++...+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 46899999999999999999999999999999999976554444445678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+|++++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 169 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--R 169 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--B
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--c
Confidence 99999999999999988899999999999999999999999999999999999999999999999999886544322 2
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~ 218 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHT 218 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHh
Confidence 234577899999999876665 8999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=274.57 Aligned_cols=202 Identities=36% Similarity=0.727 Sum_probs=159.1
Q ss_pred cccceEEe---eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCC
Q 027809 5 KVGKYEVG---RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~---~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~ 80 (218)
.+++|++. +.||+|+||.||.|.+..+++.+++|++.... .....+|+..++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 45678876 88999999999999999999999999986432 355678889999997 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC---cEEEeeccccccC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALP 157 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---~~~l~d~~~~~~~ 157 (218)
..++|||++++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++ .++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999988999999999999999999999999999999999999997665 8999999999765
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...........+++.|+|||.+....++ .++|+||||+++|+|++|..||...+.
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp CC----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 5544444455678899999999877775 899999999999999999999987554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=268.64 Aligned_cols=211 Identities=42% Similarity=0.731 Sum_probs=184.5
Q ss_pred CccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 1 ~~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
|-...+++|++.+.||+|++|.||.|.+..+++.+++|.+..... ....+.+.+|+..++.++|||++++++++...+
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence 667788999999999999999999999999999999999865442 234567889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++|+|++++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999999999998887778999999999999999999999999999999999999999999999999998754322
Q ss_pred C--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 V--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. .......+++.|+|||.+....+.+.++|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 1 1122345778999999998766655789999999999999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=275.98 Aligned_cols=211 Identities=25% Similarity=0.461 Sum_probs=182.8
Q ss_pred cccccceEEeeeecCc--cceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 3 VRKVGKYEVGRTIGEG--TFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g--~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
....++|++.+.||+| ++|.||.|.+..+|+.||+|.+..... ..+..+.+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 4567899999999999 999999999999999999999976543 3345677889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 81 KIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..++|+|++++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999776 679999999999999999999999999999999999999999999999999875432
Q ss_pred CCC-------cccccccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QGV-------SLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~~-------~~~~~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
... .......+++.|+|||.+.. ..+ +.++|+||||+++|+|++|..||...+..+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred cccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 211 11122356778999999986 344 489999999999999999999998866544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=288.10 Aligned_cols=206 Identities=33% Similarity=0.559 Sum_probs=183.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+|+.+|+|++.............+.+|..+++.++||||+++++++...+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999977655445556678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
||||+++++|.+.+..... +++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 9999999999998876543 99999999999999999999999999999999999999999999999999976544322
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+
T Consensus 342 -~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 342 -IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp -EECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred -ccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccc
Confidence 2345688999999999876665 89999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=264.05 Aligned_cols=209 Identities=37% Similarity=0.743 Sum_probs=183.9
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
+..++|++.+.||+|++|.||.|.+..++..+++|++..... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 456889999999999999999999999999999999976554 3334577889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc---EEEeeccccccCCCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQG 160 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~---~~l~d~~~~~~~~~~ 160 (218)
+|+|++++++|.+.+.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999999988889999999999999999999999999999999999999976655 999999998765443
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.. .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 162 ~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 214 (284)
T 3kk8_A 162 EA-WHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHR 214 (284)
T ss_dssp CB-CCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cc-ccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhH
Confidence 22 2234578899999999877665 89999999999999999999998766543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=274.15 Aligned_cols=208 Identities=28% Similarity=0.444 Sum_probs=171.8
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+++|++.+.||+|+||.||.|.+..+++.|++|.+..... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 457899999999999999999999999999999999865432 2333456778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-----CCCcEEEeeccccccCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-----SQGHLKISDFGLSALPE 158 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-----~~~~~~l~d~~~~~~~~ 158 (218)
+|+||+++ +|.+++.....+++.+++.++.|++.||.+||++|++|+||+|+||+++ .++.++|+|||++....
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999986 9999999888999999999999999999999999999999999999994 45569999999997654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 4333333455688999999998755445999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=274.05 Aligned_cols=208 Identities=26% Similarity=0.471 Sum_probs=177.9
Q ss_pred ccceEEeeeecCccceEEEEEEec-------CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~ 77 (218)
.++|++++.||+|+||.||.|.+. .++..|++|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 468999999999999999999864 245679999986543 344567789999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
..+..++|+||+++++|.+++.... .+++.+++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999997653 478999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 142 SQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.++.++|+|||++........ ......+++.|+|||.+.+..+. .++|+||||+++|+|++ |..||...+..++
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999875433221 11223356789999999877665 99999999999999999 9999998876654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=266.23 Aligned_cols=209 Identities=29% Similarity=0.535 Sum_probs=170.2
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
...+++|++.+.||+|++|.||.|.+..+|..+++|.+...........+.+.+|+..++.++||||+++++++...+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 34678999999999999999999999999999999999764444455567788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 83 YIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
++|+|++++++|.+++.. ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999988864 4568999999999999999999999999999999999999999999999999987655
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..........+++.|+|||.+....+. .++|+||||+++|+|++|..||....
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccc
Confidence 433333344578899999999876665 89999999999999999999997543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=275.14 Aligned_cols=206 Identities=27% Similarity=0.478 Sum_probs=169.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++++.||+|+||.||.|.+..+++.|++|.+..... ......+.+|+..++.++||||+++++++...+..++|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 4789999999999999999999999999999999865431 11112345788999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||++++ +|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence 999986 888877665 458999999999999999999999999999999999999999999999999987655443334
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE 207 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 44567889999999976554458999999999999999999999887654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=269.49 Aligned_cols=207 Identities=40% Similarity=0.693 Sum_probs=181.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++.+.||+|+||.||.|.+..+|..+++|.+........ ...+.+.+|+..++.++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4579999999999999999999999999999999976543221 1246788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC----cEEEeeccccccCC
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPE 158 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~----~~~l~d~~~~~~~~ 158 (218)
++|+|++++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999999888899999999999999999999999999999999999998887 79999999987654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.... .....+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..
T Consensus 171 ~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~ 224 (321)
T 2a2a_A 171 DGVE-FKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQ 224 (321)
T ss_dssp TTCC-CCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred cccc-ccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHH
Confidence 4322 2234578899999999876665 8999999999999999999999876544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=268.35 Aligned_cols=205 Identities=27% Similarity=0.499 Sum_probs=174.6
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC--eE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--KI 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--~~ 82 (218)
..++|++.+.||+|+||.||.|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34679999999999999999999999999999999875442 223466789999999999999999999987654 78
Q ss_pred EEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----cCCCcEEEeeccccc
Q 027809 83 YIILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSA 155 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~----~~~~~~~l~d~~~~~ 155 (218)
++||||+++++|.+++..... +++.+++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999999976543 8999999999999999999999999999999999999 777889999999997
Q ss_pred cCCCCCcccccccccCcccccccccc-------CCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSH-------KGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
....... .....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+
T Consensus 165 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 165 ELEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp ECCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ecCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 6544322 223457889999999862 1233489999999999999999999997544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=269.84 Aligned_cols=204 Identities=25% Similarity=0.342 Sum_probs=176.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
..++|++.+.||+|+||.||.|.+..+|+.||+|.+..... .+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34679999999999999999999999999999999865431 23577899999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc-----EEEeeccccccC
Q 027809 84 IILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSALP 157 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~-----~~l~d~~~~~~~ 157 (218)
+|||++ +++|.+++.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 8899999876 467999999999999999999999999999999999999998887 999999999754
Q ss_pred CCCCcc-------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 158 EQGVSL-------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 158 ~~~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
...... .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 332211 1344578999999999877765 99999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=267.94 Aligned_cols=202 Identities=29% Similarity=0.536 Sum_probs=177.7
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|+..+.||+|+||.||.|.+..+|+.||||++.... ....+.+.+|+..++.++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3888999999999999999999899999999986543 2234667899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
|+++++|.+.+.. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 9999999988764 579999999999999999999999999999999999999999999999999987654433333445
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 202 ~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp CSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 678899999999876665 8999999999999999999999876653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=267.08 Aligned_cols=212 Identities=31% Similarity=0.592 Sum_probs=179.8
Q ss_pred ccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE--cC
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SR 79 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~--~~ 79 (218)
+|...++|++.+.||+|++|.||.+.+..+++.+++|.+..... +....+.+.+|+..++.++||||+++++++. ..
T Consensus 1 ~p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp --CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred CCCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence 46788999999999999999999999999999999999976543 2334577889999999999999999999874 46
Q ss_pred CeEEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEecCCCcEEEee
Q 027809 80 TKIYIILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSKG-----VYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~~-----i~h~di~p~nil~~~~~~~~l~d 150 (218)
...++|+|++++++|.+++.... .+++.+++.++.|++.+|.+||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 78999999999999999987543 4899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
||.+..............+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..+
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~ 223 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKE 223 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHH
Confidence 99987654433333344578899999999876665 89999999999999999999999876543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=273.98 Aligned_cols=205 Identities=31% Similarity=0.585 Sum_probs=178.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+|+.+++|.+..... .....+.+|+.++..++||||+++++++......++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 35789999999999999999999999999999999865432 223568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC--CCcEEEeeccccccCCCCC
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~--~~~~~l~d~~~~~~~~~~~ 161 (218)
||||+++++|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999999999887554 7999999999999999999999999999999999999974 4679999999997654432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
......+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~ 256 (387)
T 1kob_A 206 -IVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDL 256 (387)
T ss_dssp -CEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred -ceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHH
Confidence 22344678899999999876665 8999999999999999999999876643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=273.62 Aligned_cols=206 Identities=33% Similarity=0.549 Sum_probs=180.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh-----hHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH-----KMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|+||.||.|.+..+++.|++|.+........ ...+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45789999999999999999999999999999999976543221 1234566789999999999999999999999
Q ss_pred CeEEEEEEecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 TKIYIILEFITGG-ELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 ~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+..++|+|++..+ +|.+.+.....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999998766 999999988899999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.... .....+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...
T Consensus 182 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 RGKL-FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCC-BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCc-eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 4322 234457889999999987777568999999999999999999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=261.22 Aligned_cols=205 Identities=41% Similarity=0.737 Sum_probs=180.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..++..+++|.+..... +..+.+.+|+..++.++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 34679999999999999999999999999999999865442 224678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---cCCCcEEEeeccccccCCCCC
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---~~~~~~~l~d~~~~~~~~~~~ 161 (218)
|+|++++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999999999999888899999999999999999999999999999999999999 788899999999987654432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+.+. + +.++|+||||+++|+|++|..||...+..+
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 214 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -chhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHH
Confidence 22344578899999998654 3 589999999999999999999998876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=270.62 Aligned_cols=209 Identities=27% Similarity=0.451 Sum_probs=176.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCc---EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+.||+|+||.||.|.+..++. .|++|.+.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 35789999999999999999999875544 59999986543 33445678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++|||++++++|.+++... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999999654 57999999999999999999999999999999999999999999999999999765443
Q ss_pred Ccc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 161 VSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 161 ~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
... .....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 263 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 221 1122345579999999876665 89999999999999999 9999988765543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=284.58 Aligned_cols=207 Identities=37% Similarity=0.706 Sum_probs=183.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..+|+.+|+|++...........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999999765544445567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---cCCCcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+|++.+++|.+.+.....+++.+++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK- 183 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence 9999999999999988899999999999999999999999999999999999999 567899999999987554432
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+.+ .+ +.++|+||||+++|+|++|..||...+..+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 234 (484)
T 3nyv_A 184 KMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYD 234 (484)
T ss_dssp SHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 2234567889999999875 44 489999999999999999999998876554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=274.06 Aligned_cols=199 Identities=38% Similarity=0.680 Sum_probs=172.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
..++|++.+.||+|+||.||.|.+..+|+.+|+|++..... ...+|+.++..+ +||||+++++++.+.+..+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 45679999999999999999999999999999999865542 123556666666 7999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC----CcEEEeeccccccCCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQ 159 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~----~~~~l~d~~~~~~~~~ 159 (218)
+||||+++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||++.++ +.++|+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999999999999988899999999999999999999999999999999999998443 3599999999976554
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.........+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...
T Consensus 173 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 173 ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCC
Confidence 43344456678999999999866565 8999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=274.00 Aligned_cols=208 Identities=30% Similarity=0.455 Sum_probs=167.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCC--
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRT-- 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~-- 80 (218)
...++|++.+.||+|+||.||.|.+..+|+.||+|++.... ........+.+|+..+..+. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34689999999999999999999999999999999985443 23444567788999999997 999999999997543
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..++|||++++ +|...+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 78999999985 88887765 57999999999999999999999999999999999999999999999999998654321
Q ss_pred ---------------------CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 161 ---------------------VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 161 ---------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 111223457889999999986444459999999999999999999999887654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=269.88 Aligned_cols=202 Identities=28% Similarity=0.489 Sum_probs=176.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.|.+..+|+.|++|.+........+..+.+.+|+..++.++||||+++++++...+..++|+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999997655445555677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||+.+ +|.+.+. ...++++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~ 208 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N 208 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----C
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----C
Confidence 99985 7777664 4567999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 166 TTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
...+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 3457889999999852 22334899999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=280.80 Aligned_cols=208 Identities=37% Similarity=0.727 Sum_probs=178.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh----------hHHHHHHHHHHhhhhcCCCCcceEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH----------KMADQIKREISIMKLVRHPCVVRLHEV 75 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~~~~~l~~l~~~~i~~~~~~ 75 (218)
.++|++++.||+|+||.||.|.+..++..+|+|++........ ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4679999999999999999999999999999999976543221 335678899999999999999999999
Q ss_pred EEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC---cEEEeecc
Q 027809 76 LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFG 152 (218)
Q Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---~~~l~d~~ 152 (218)
+......++|+||+++++|.+.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 999999999999999999999998889999999999999999999999999999999999999998776 69999999
Q ss_pred ccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
++....... ......+++.|+|||.+.. .+ +.++|+||||+++|+|++|..||...+..++
T Consensus 195 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 195 LSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255 (504)
T ss_dssp TCEECCTTS-CBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCEEcCCCC-ccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 997654432 2234568899999999864 34 4899999999999999999999998776543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=270.22 Aligned_cols=202 Identities=40% Similarity=0.735 Sum_probs=165.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..+++.|++|++.... ..+.+.+|+..+..++||||+++++++...+..++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 467999999999999999999999999999999986543 235677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---CCcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~~~~~l~d~~~~~~~~~~~~ 162 (218)
+||+++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999999999999988888999999999999999999999999999999999999975 8899999999987554321
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp -------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred ccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 22344578899999999876665 8999999999999999999999776543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=261.39 Aligned_cols=206 Identities=37% Similarity=0.719 Sum_probs=178.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
++|++.+.||+|++|.||.+.+..+++.+++|.+........ ...+.+.+|+..++.++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 679999999999999999999999999999999876543221 13567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC----cEEEeeccccccCCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQ 159 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~----~~~l~d~~~~~~~~~ 159 (218)
+|+|++++++|.+++.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999998777 899999999876543
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
... .....+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..
T Consensus 165 ~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~ 217 (283)
T 3bhy_A 165 GNE-FKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQ 217 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCc-ccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchH
Confidence 222 2234577899999999876665 8999999999999999999999876654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=270.97 Aligned_cols=205 Identities=28% Similarity=0.473 Sum_probs=180.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..++..+++|.+.... .....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 578999999999999999999999999999999987653 344457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|||+++++|.+.+.....+++..++.++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 187 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA 187 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C-
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence 99999999999999888999999999999999999999985 9999999999999999999999999988643221 12
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred cCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 234578899999999877665 99999999999999999999998766543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=271.78 Aligned_cols=200 Identities=18% Similarity=0.278 Sum_probs=166.3
Q ss_pred ccceEEeeeecCccceEEEEEE-----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc---CCCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV---RHPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l---~~~~i~~~~~~~~ 77 (218)
.++|++.+.||+|+||.||.|. +..+++.||+|.+.... ...+..+...++.+ .|+|++++++.+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3569999999999999999994 56788999999986543 12344444444444 4899999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC----------
Q 027809 78 SRTKIYIILEFITGGELFDKIVH-----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---------- 142 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---------- 142 (218)
..+..++||||+++++|.+++.. ...+++.+++.++.|++.||.|||++|++|+||+|+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999999974 456999999999999999999999999999999999999988
Q ss_pred -CCcEEEeeccccccCC--CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 143 -QGHLKISDFGLSALPE--QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 143 -~~~~~l~d~~~~~~~~--~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
++.++|+|||++.... ..........+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCC
Confidence 8999999999996432 112223345688999999999887765 99999999999999999999996543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=263.32 Aligned_cols=204 Identities=39% Similarity=0.760 Sum_probs=178.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.+.+..+|+.+++|.+...... ..+.+.+|+..++.++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 46799999999999999999999999999999998754321 235678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---cCCCcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+|++++++|.+.+...+.+++.+++.++.|++.+|.+||++|++|+||+|+||++ +.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999999999999888899999999999999999999999999999999999999 77889999999998754432
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+..+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~ 214 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESK 214 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 22334578899999999876665 89999999999999999999998766543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=266.91 Aligned_cols=203 Identities=26% Similarity=0.433 Sum_probs=171.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC---
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--- 80 (218)
+.+++|++.+.||+|+||.||.|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45789999999999999999999999999999999997544 3334577899999999999999999999875432
Q ss_pred ------------------------------------------------------eEEEEEEecCCCChHHHHHhcCC---
Q 027809 81 ------------------------------------------------------KIYIILEFITGGELFDKIVHHGR--- 103 (218)
Q Consensus 81 ------------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~--- 103 (218)
..++|||++++++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987654
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC------------cccccccccC
Q 027809 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV------------SLLRTTCGTP 171 (218)
Q Consensus 104 ~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~------------~~~~~~~~~~ 171 (218)
.++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... .......+++
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 4566799999999999999999999999999999999999999999999987654431 1122345788
Q ss_pred ccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 172 ~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
.|+|||.+.+..+. .++|+||||+++|+|++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChh
Confidence 99999999877665 99999999999999999987763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=263.08 Aligned_cols=205 Identities=30% Similarity=0.548 Sum_probs=180.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.|.+..+++.+++|.+..... ....+.+.+|+..++.++|||++++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4569999999999999999999999999999999875542 23457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+|++++++|.+++.. .++++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 999999999988764 5799999999999999999999999999999999999999999999999999876554333333
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~ 225 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPM 225 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHH
Confidence 45577899999999876665 8999999999999999999999876554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=279.69 Aligned_cols=206 Identities=38% Similarity=0.698 Sum_probs=179.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 46799999999999999999999999999999998654432 22356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---CCCcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~---~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+|++.+++|.+.+.....+++.+++.++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++.......
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 99999999999998888999999999999999999999999999999999999995 45679999999987554432
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+.+. + +.++|+||||+++|+|++|..||...+..+
T Consensus 179 ~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 229 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (486)
T ss_dssp ---CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 22345688899999999753 4 489999999999999999999998876544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=261.22 Aligned_cols=205 Identities=33% Similarity=0.635 Sum_probs=173.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.+.+..++..+++|.+.... .....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 467999999999999999999999999999999987654 223357788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---cCCCcEEEeeccccccCC
Q 027809 86 LEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSALPE 158 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---~~~~~~~l~d~~~~~~~~ 158 (218)
+|++++++|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998888543 679999999999999999999999999999999999999 456789999999997654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.... .....+++.|+|||.+.. .+ +.++|+||||+++|+|++|..||...+..+
T Consensus 179 ~~~~-~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~ 232 (285)
T 3is5_A 179 SDEH-STNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred Cccc-CcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHH
Confidence 4322 234457889999999863 34 489999999999999999999998876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=279.57 Aligned_cols=206 Identities=36% Similarity=0.702 Sum_probs=175.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++++.||+|+||.||.|.+..++..+++|++........ ....+.+|+.+++.++||||+++++++...+..++|+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 469999999999999999999999999999999976543222 2466889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC---CcEEEeeccccccCCCCCcc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~---~~~~l~d~~~~~~~~~~~~~ 163 (218)
||+++++|.+.+....++++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~ 194 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-K 194 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-C
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-c
Confidence 999999999999888899999999999999999999999999999999999999764 459999999987654432 2
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....+++.|+|||.+.. .+ +.++|+||||+++|+|++|..||...+..++
T Consensus 195 ~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 245 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 234568899999999863 44 4899999999999999999999998776543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=261.25 Aligned_cols=207 Identities=29% Similarity=0.462 Sum_probs=168.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhh--hhHHHHHHHHHHhh---hhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIM---KLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~~~l---~~l~~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|+||.||.|.+..+++.||+|.+....... ........+|+..+ ..++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3578999999999999999999999999999999986433111 11112333444444 445699999999998765
Q ss_pred C-----eEEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecc
Q 027809 80 T-----KIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (218)
Q Consensus 80 ~-----~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~ 152 (218)
. ..++++|++++ +|.+++..... +++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 4 58999999985 99998877654 8999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
++........ .....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 166 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 166 LARIYSYQMA-LTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp CTTTSTTCCC-SGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred cccccCCCcc-cCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9976544322 2345678899999999877765 8999999999999999999999876654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=266.05 Aligned_cols=208 Identities=28% Similarity=0.415 Sum_probs=178.4
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|+||.||.|.+. .++..+++|.+.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 468999999999999999999873 345789999986543 3444677889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGR------------------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPE 136 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~------------------------~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~ 136 (218)
..++|+|++++++|.+++..... +++.+++.++.|++.||.+||++|++|+||+|+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 99999999999999999976543 889999999999999999999999999999999
Q ss_pred CeEecCCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 137 NLLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 137 nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
||+++.++.++|+|||++......... .....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+.
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999998754432221 1223356789999999876665 89999999999999999 9999998877
Q ss_pred ccc
Q 027809 214 TTL 216 (218)
Q Consensus 214 ~~~ 216 (218)
.++
T Consensus 259 ~~~ 261 (314)
T 2ivs_A 259 ERL 261 (314)
T ss_dssp GGH
T ss_pred HHH
Confidence 654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=277.65 Aligned_cols=203 Identities=30% Similarity=0.486 Sum_probs=171.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++++.||+|+||.||.|.+..+++.||+|++.... ......+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 4688999999999999999999999999999999997653 2344467788999999999999999999998643
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++||||+++ .|.+.+. ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 467999999987 5655554 358999999999999999999999999999999999999999999999999997655
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... ......+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+.
T Consensus 216 ~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 216 TSF-MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp -CC-CC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCc-ccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 432 22345678899999999987776 899999999999999999999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=270.42 Aligned_cols=209 Identities=27% Similarity=0.402 Sum_probs=178.1
Q ss_pred cccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|+||.||.|.+.. ++..|++|.+.... ..+..+.+.+|+..++.++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 35789999999999999999999873 45889999986543 334457788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHH------------------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKP 135 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p 135 (218)
+..++|+||+++++|.+++... ..+++.+++.++.|++.+|.+||++|++|+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999999763 5689999999999999999999999999999999
Q ss_pred CCeEecCCCcEEEeeccccccCCCCC--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCC
Q 027809 136 ENLLLDSQGHLKISDFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELD 212 (218)
Q Consensus 136 ~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 212 (218)
+||+++.++.++|+|||++....... .......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 99999999999999999986433221 112233456789999999876665 99999999999999999 999998876
Q ss_pred cccc
Q 027809 213 LTTL 216 (218)
Q Consensus 213 ~~~~ 216 (218)
..++
T Consensus 282 ~~~~ 285 (343)
T 1luf_A 282 HEEV 285 (343)
T ss_dssp HHHH
T ss_pred hHHH
Confidence 6543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=269.41 Aligned_cols=209 Identities=29% Similarity=0.443 Sum_probs=174.8
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----- 78 (218)
..+++|++.+.||+|+||.||.|.+..+|+.|++|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 3678999999999999999999999999999999998654422 2223556789999999999999999999876
Q ss_pred ---CCeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccc
Q 027809 79 ---RTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 79 ---~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
.+..++|+|++++ +|...+.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999987 66666654 367999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC----CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 155 ALPEQG----VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 155 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...... ........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 235 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 754321 111223456889999999976554458999999999999999999999887643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=258.84 Aligned_cols=210 Identities=32% Similarity=0.594 Sum_probs=180.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh------hhhhHHHHHHHHHHhhhhcC-CCCcceEEEEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI------IKHKMADQIKREISIMKLVR-HPCVVRLHEVL 76 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~ 76 (218)
...++|++.+.||+|++|.||.|.+..+|+.|++|++..... ......+.+.+|+..++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 356899999999999999999999999999999999865431 12233466788999999995 99999999999
Q ss_pred EcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccccc
Q 027809 77 ASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (218)
Q Consensus 77 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~ 156 (218)
...+..++|+|++++++|.+++.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccCcccccccccc-----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..... ......+++.|+|||.+.. ....+.++|+||||+++++|++|..||...+..
T Consensus 174 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 235 (298)
T 1phk_A 174 LDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235 (298)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH
Confidence 54332 2233457789999999852 222348999999999999999999999876543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=270.95 Aligned_cols=207 Identities=27% Similarity=0.439 Sum_probs=175.1
Q ss_pred cccceEEeeeecCccceEEEEEE-----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS 78 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~ 78 (218)
..++|++.+.||+|+||.||.|. ...+++.|++|.+.... .....+.+.+|+.++..+ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45789999999999999999998 45567899999986543 333456788999999999 78999999999876
Q ss_pred CC-eEEEEEEecCCCChHHHHHhcCC------------------------------------------------------
Q 027809 79 RT-KIYIILEFITGGELFDKIVHHGR------------------------------------------------------ 103 (218)
Q Consensus 79 ~~-~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------ 103 (218)
.+ ..++|+||+++++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 54 48999999999999999976533
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--ccccccc
Q 027809 104 ------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCG 169 (218)
Q Consensus 104 ------------~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 169 (218)
+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 89999999999999999999999999999999999999999999999999975433221 2223346
Q ss_pred cCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 170 ~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..
T Consensus 258 t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp CGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 7789999999877665 99999999999999998 99999887643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=275.15 Aligned_cols=207 Identities=29% Similarity=0.485 Sum_probs=177.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..++..||+|.+.... ..+..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999899999999986432 333445688999999999999999999999988899999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||++++++|.+++...+ .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 99999999999987654 69999999999999999999999999999999999999999999999999987543321111
Q ss_pred c--cccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 165 R--TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 165 ~--~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
. ...+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~ 323 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQ 323 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 11235679999999866654 89999999999999998 999999876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=277.49 Aligned_cols=204 Identities=17% Similarity=0.233 Sum_probs=166.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHH---HhhhhcCCCCcceEE-------EE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREI---SIMKLVRHPCVVRLH-------EV 75 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~---~~l~~l~~~~i~~~~-------~~ 75 (218)
.++|++.+.||+|+||.||.|.+..+|+.||||++...........+.+.+|+ ..+..++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999999889999999999765444445567788888 566666899999988 77
Q ss_pred EEcCC-----------------eEEEEEEecCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceec
Q 027809 76 LASRT-----------------KIYIILEFITGGELFDKIVHHGRLSE-------SEARRYFQQLIDGVDYCHSKGVYHR 131 (218)
Q Consensus 76 ~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~~~~~i~~~l~~Lh~~~i~h~ 131 (218)
++..+ ..+++||+++ ++|.+++.....+++ ..++.++.|++.||.|||++|++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 76553 2889999995 699999987665555 8888999999999999999999999
Q ss_pred cCCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccccccccccC-----------CCCCcchhhhhHhHHHHH
Q 027809 132 DLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK-----------GYNGAAADVWSCGVILYV 200 (218)
Q Consensus 132 di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-----------~~~~~~~Di~slG~~l~~ 200 (218)
||+|+||+++.++.++|+|||++..... ......+ +.|+|||.+... .++ .++|+||||+++|+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHHH
Confidence 9999999999999999999999875433 1223446 899999999866 554 99999999999999
Q ss_pred HhhcCCCCCCCCccc
Q 027809 201 LIAGYLPFDELDLTT 215 (218)
Q Consensus 201 l~~g~~pf~~~~~~~ 215 (218)
|++|..||...+..+
T Consensus 306 lltg~~Pf~~~~~~~ 320 (377)
T 3byv_A 306 IWCADLPITKDAALG 320 (377)
T ss_dssp HHHSSCCC------C
T ss_pred HHHCCCCCccccccc
Confidence 999999998766544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=269.75 Aligned_cols=208 Identities=27% Similarity=0.467 Sum_probs=178.4
Q ss_pred ccceEEeeeecCccceEEEEEEecC-------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~ 77 (218)
.++|++.+.||+|+||.||.|.+.. ++..+++|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 4789999999999999999999753 33579999986543 344567788999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
..+..++|+|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 9999999999999999999997754 489999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 142 SQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.++.++|+|||++........ ......+++.|+|||.+.+..++ .++|+||||+++++|++ |..||...+..++
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999975543221 12223456789999999876665 99999999999999999 9999998776543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=267.03 Aligned_cols=208 Identities=36% Similarity=0.661 Sum_probs=179.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh-----hhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-----IKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|++|.||.|.+..+|+.|+||++..... ...+..+.+.+|...+..+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3679999999999999999999998999999999865431 1223356678899999998 799999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
+..++||||+++++|.+.+.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999998875544
Q ss_pred CCcccccccccCccccccccccC-----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHK-----GYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.. ......+++.|+|||.+... ...+.++|+||||+++|+|++|..||...+..
T Consensus 253 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 253 GE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred Cc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 32 22345678899999998632 12248999999999999999999999876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=273.54 Aligned_cols=204 Identities=27% Similarity=0.430 Sum_probs=171.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++.+.||+|+||.||.|.+..+++.||||++.... ......+++.+|+.+++.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4578999999999999999999999999999999996543 3344567788999999999999999999998765
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...++|+|++++ +|.+.+.....+++.+++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 579999999975 9999998888899999999999999999999999999999999999999999999999999976543
Q ss_pred CCc----------------------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 160 GVS----------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 160 ~~~----------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
... ......+++.|+|||.+......+.++|+|||||++|+|++|..||..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 211 123456788999999875444345999999999999999986555543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=271.65 Aligned_cols=211 Identities=28% Similarity=0.433 Sum_probs=172.1
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhh--hhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
....++|++.+.||+|+||.||.|.+..+|+.|++|.+....... ....+.+.+|+..++.++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 346789999999999999999999999999999999986543221 112245778999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|+|++++ +|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999987 888777654 4689999999999999999999999999999999999999999999999999976554
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.........+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~ 219 (346)
T 1ua2_A 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 219 (346)
T ss_dssp CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 4333344567889999999976554458999999999999999999999876643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=265.94 Aligned_cols=200 Identities=28% Similarity=0.491 Sum_probs=174.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-----CCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-----HPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-----~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|+||.||.|.+..+++.||+|++.... ...+....|..+++.++ ||||+++++++...+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 578999999999999999999999999999999986433 22345667788888876 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC----------------
Q 027809 81 KIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---------------- 142 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---------------- 142 (218)
..++|+|++ +++|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999999 779999997754 5899999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 143 ---------QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 143 ---------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
++.++|+|||++....... ....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 7889999999997544322 234578899999999877765 999999999999999999999987664
Q ss_pred c
Q 027809 214 T 214 (218)
Q Consensus 214 ~ 214 (218)
.
T Consensus 265 ~ 265 (360)
T 3llt_A 265 M 265 (360)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=258.78 Aligned_cols=206 Identities=25% Similarity=0.436 Sum_probs=176.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+. ++..+++|++...... .+.+.+|+..+++++||||+++++++...+..++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 3578999999999999999999986 5778999998654422 3568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 162 (218)
|+|++++++|.+++... ..+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999998654 4589999999999999999999999999999999999999999999999999875543211
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~ 216 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 216 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred cccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 12223345679999999877665 89999999999999999 9999998776543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=260.34 Aligned_cols=203 Identities=32% Similarity=0.555 Sum_probs=173.6
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+..+|..|++|.+.... ..+.+.+|+..+..++||||+++++++...+..++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999986543 23567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+|++++++|.+++. ....+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 999999999999886 4567999999999999999999999999999999999999999999999999998765443333
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~ 230 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHP 230 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence 3344577899999999876665 899999999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=276.48 Aligned_cols=205 Identities=29% Similarity=0.420 Sum_probs=161.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-----cCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-----SRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~-----~~~ 80 (218)
.++|++++.||+|+||.||.|.+..+++.||+|++.... ......+++.+|+.+++.++||||+++++++. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999986543 23444677889999999999999999999984 335
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..|+|+|+++ ++|.+.+.....+++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7999999986 489999988888999999999999999999999999999999999999999999999999999765422
Q ss_pred Cc---------------------------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh----------
Q 027809 161 VS---------------------------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA---------- 203 (218)
Q Consensus 161 ~~---------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~---------- 203 (218)
.. ......+++.|+|||.+......+.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 11 12234568889999987544433599999999999999999
Q ss_pred -cCCCCCCCC
Q 027809 204 -GYLPFDELD 212 (218)
Q Consensus 204 -g~~pf~~~~ 212 (218)
|.+||...+
T Consensus 290 ~~~p~f~g~~ 299 (458)
T 3rp9_A 290 DRGPLFPGSS 299 (458)
T ss_dssp GCCCSCC---
T ss_pred cccccCCCCc
Confidence 677776544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=257.71 Aligned_cols=205 Identities=26% Similarity=0.455 Sum_probs=176.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+. ++..+++|.+...... .+.+.+|+..+..++||||+++++++...+..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 4678999999999999999999876 5678999998654422 3557899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+|++++++|.+.+.... .+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999999997754 5999999999999999999999999999999999999999999999999998755443221
Q ss_pred -cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence 1223345679999999876665 89999999999999999 999998776543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=255.31 Aligned_cols=201 Identities=26% Similarity=0.488 Sum_probs=175.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc----CCeE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RTKI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----~~~~ 82 (218)
..|++.+.||+|+||.||.|.+..++..+++|.+...... ....+.+.+|+..++.++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 4489999999999999999999999999999998765443 3345778899999999999999999998864 4568
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEec-CCCcEEEeeccccccCCC
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLD-SQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~-~~~~~~l~d~~~~~~~~~ 159 (218)
++|+|++++++|.+++.....+++..++.++.|++.+|.+||+.+ ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 999999999999999998889999999999999999999999999 99999999999997 789999999999875444
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.. .....+++.|+|||.+.+ .+ +.++|+||||+++|+|++|..||....
T Consensus 185 ~~--~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 185 SF--AKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp TS--BEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cc--cccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 32 223457889999998864 34 489999999999999999999998744
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=270.83 Aligned_cols=208 Identities=23% Similarity=0.349 Sum_probs=174.1
Q ss_pred ccceEEeeeecCccceEEEEEEe-----cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|+||.||.|.+ ..++..|++|.+.... .......+.+|+.++..++||||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46799999999999999999994 4567789999986433 3334456888999999999999999999999988
Q ss_pred eEEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC---cEEEee
Q 027809 81 KIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISD 150 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---~~~l~d 150 (218)
..++|||++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999997653 489999999999999999999999999999999999998554 599999
Q ss_pred ccccccCCCC--CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 151 FGLSALPEQG--VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
||++...... ........+++.|+|||.+.+..+. .++|+||||+++|+|++ |..||...+..++
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~ 295 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9998643211 1112233457789999999877765 89999999999999998 9999998776543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=269.10 Aligned_cols=211 Identities=33% Similarity=0.571 Sum_probs=174.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh--hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII--KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
...++|++.+.||+|+||.||.|.+..++..+++|++...... +....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3457899999999999999999999999999999998755432 23446778999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 027809 82 IYIILEFITGGELFDKIVHH----------------------------------------GRLSESEARRYFQQLIDGVD 121 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~----------------------------------------~~~~~~~~~~~~~~i~~~l~ 121 (218)
.++|+||+++++|.+.+... ..+++..++.++.|++.+|.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999887421 12367889999999999999
Q ss_pred HHHhCCceeccCCCCCeEecCCC--cEEEeeccccccCCCCC----cccccccccCccccccccccC-CCCCcchhhhhH
Q 027809 122 YCHSKGVYHRDLKPENLLLDSQG--HLKISDFGLSALPEQGV----SLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSC 194 (218)
Q Consensus 122 ~Lh~~~i~h~di~p~nil~~~~~--~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~sl 194 (218)
+||++|++|+||+|+||+++.++ .++|+|||++....... .......+++.|+|||.+... ...+.++|+|||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 89999999987432211 112344578899999999642 333589999999
Q ss_pred hHHHHHHhhcCCCCCCCCcc
Q 027809 195 GVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 195 G~~l~~l~~g~~pf~~~~~~ 214 (218)
|+++|+|++|..||...+..
T Consensus 263 G~il~el~~g~~pf~~~~~~ 282 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDA 282 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHH
T ss_pred HHHHHHHHHCCCCCCCCChH
Confidence 99999999999999876654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=269.05 Aligned_cols=203 Identities=32% Similarity=0.500 Sum_probs=169.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++.+.||+|+||.||.|.+..+|+.||+|++.... ......+++.+|+..++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3578999999999999999999999999999999985543 2344567788999999999999999999998755
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++|+|++ +++|.+.+.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3469999999 6699888876 579999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.. .....+++.|+|||.+.+....+.++|+||||+++++|++|..||...+.
T Consensus 180 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 180 SE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp SS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 22345678999999998744445999999999999999999999987664
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=259.93 Aligned_cols=207 Identities=27% Similarity=0.434 Sum_probs=180.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+..++..+++|.+.... ...+.+.+|+..++.++||||+++++++...+..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 4578999999999999999999999999999999986543 234678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
|+|++++++|.+.+... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999999764 3589999999999999999999999999999999999999999999999999976554322
Q ss_pred -ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 -LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 -~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~ 221 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 221 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 22233356689999999877665 99999999999999999 9999998776554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=272.03 Aligned_cols=207 Identities=26% Similarity=0.452 Sum_probs=167.1
Q ss_pred ccceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++.+.||+|+||.||.|.+. .++..|++|.+.... .....+.+.+|+.++.+++||||+++++++...+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 457999999999999999999876 456789999986543 334456788999999999999999999999998999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++|+||+++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999999997654 69999999999999999999999999999999999999999999999999987654322
Q ss_pred ccc---ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 162 SLL---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... ....+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~ 258 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQD 258 (373)
T ss_dssp ------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHH
T ss_pred ccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 111 112235679999999877765 89999999999999998 999998776544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=257.90 Aligned_cols=202 Identities=23% Similarity=0.353 Sum_probs=174.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~ 83 (218)
..++|++.+.||+|++|.||.|.+..+++.|++|++..... .+.+.+|+..++.+ +|++++++++++......+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 35679999999999999999999999999999999865432 23466788888888 7899999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc-----EEEeeccccccC
Q 027809 84 IILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH-----LKISDFGLSALP 157 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~-----~~l~d~~~~~~~ 157 (218)
+|+|++ +++|.+++.... ++++.+++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 889999998754 5999999999999999999999999999999999999987765 999999999755
Q ss_pred CCCCc-------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..... ......+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 44321 12334578899999999877665 999999999999999999999988653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=264.89 Aligned_cols=210 Identities=26% Similarity=0.430 Sum_probs=162.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCc---EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+.||+|+||.||.|.+..++. .+++|.+...... ....+.+.+|+..++.++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 45789999999999999999999887665 7999998654332 3345778899999999999999999999976655
Q ss_pred E------EEEEEecCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEe
Q 027809 82 I------YIILEFITGGELFDKIVHHG------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKIS 149 (218)
Q Consensus 82 ~------~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~ 149 (218)
. ++|+|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 4 99999999999999886543 58999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 150 DFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 150 d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
|||++........ ......+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..++
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 248 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence 9999875443221 11223345689999999877665 99999999999999999 9999998776554
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=265.59 Aligned_cols=207 Identities=25% Similarity=0.378 Sum_probs=177.4
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...++|++.+.||+|+||.||.|.+. ++..|++|.+.... ....+.+.+|+..++.++||||+++++++...+..+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 35688999999999999999999964 68899999876543 233567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 84 IILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
+|+|++++++|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999998886543 589999999999999999999999999999999999999999999999999875433
Q ss_pred CC--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 160 GV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 160 ~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.. .......+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||....+.+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~ 248 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPRE 248 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHH
Confidence 21 112233468899999999876665 89999999999999999999998766543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=266.53 Aligned_cols=203 Identities=31% Similarity=0.492 Sum_probs=168.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~---- 80 (218)
..++|++.+.||+|+||.||.|.+..+++.||+|++..... .....+.+.+|+..++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 46899999999999999999999999999999999875432 3344567889999999999999999999997554
Q ss_pred --eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 81 --KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 81 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..++|||++++ +|.+.+. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999986 7777775 468999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.
T Consensus 179 ~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 179 TSF-MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp ------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc-ccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 432 22234578899999999877665 899999999999999999999987764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=259.74 Aligned_cols=200 Identities=26% Similarity=0.380 Sum_probs=164.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.++||+|+||.||.|.+..+|+.||||++...........+.+.+........+||||+++++++...+..++|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999986544333333344444444444559999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|++. ++|.+.+... ..+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 137 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 214 (311)
T 3p1a_A 137 ELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AGE 214 (311)
T ss_dssp ECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred eccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CCc
Confidence 9995 4887777654 469999999999999999999999999999999999999999999999999987554332 223
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
...+++.|+|||.+.+ .+ +.++|+||||+++++|++|..|+..
T Consensus 215 ~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred ccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3457889999999875 44 4899999999999999999666543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=261.94 Aligned_cols=206 Identities=33% Similarity=0.585 Sum_probs=172.1
Q ss_pred ccccceEEe-eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCe
Q 027809 4 RKVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (218)
Q Consensus 4 ~~~~~y~~~-~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~ 81 (218)
+..++|++. +.||+|+||.||.|.+..+++.|++|++.... ....+.+.+|+..+.++ +||||+++++++...+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 445679985 78999999999999999999999999986543 22346677889888885 79999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc---EEEeeccccccCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPE 158 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~---~~l~d~~~~~~~~ 158 (218)
.++|||++++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999999999998889999999999999999999999999999999999999988776 9999999986543
Q ss_pred CCC-------cccccccccCcccccccccc-----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGV-------SLLRTTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~-------~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... .......+++.|+|||.+.. ..+ +.++|+||||+++|+|++|..||...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCccccc
Confidence 211 11123347889999999864 223 4899999999999999999999987653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=266.29 Aligned_cols=201 Identities=32% Similarity=0.597 Sum_probs=169.2
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
...+.||+|+||.||.|.+..+|..|++|++..... ...+.+.+|+.++..++||||+++++++...+..++||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 336789999999999999999999999999876542 23467889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe--cCCCcEEEeeccccccCCCCCccccc
Q 027809 90 TGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL--DSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 90 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~--~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
++++|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++........ ...
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-~~~ 247 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKV 247 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-CCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-ccc
Confidence 999998888654 469999999999999999999999999999999999999 5678899999999876544322 223
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
..+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 248 ~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~ 295 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4578899999999766554 89999999999999999999998776543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=258.40 Aligned_cols=205 Identities=24% Similarity=0.449 Sum_probs=173.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.+.+. ++..+++|.+...... .+.+.+|+..+..++||||+++++++...+..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 3568999999999999999999876 6778999998654322 2567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-
Q 027809 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 162 (218)
|+|++++++|.+++.. ...+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999999999976 56799999999999999999999999999999999999999999999999999875543211
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~ 229 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence 11222345679999999877665 89999999999999998 999999876543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=265.99 Aligned_cols=206 Identities=26% Similarity=0.426 Sum_probs=173.4
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|+||.||.|.+. .++..|++|.+.... .....+.+.+|+..+..+ +||||+++++++...
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 468999999999999999999973 356789999986543 233346788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHG-----------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPE 136 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~ 136 (218)
+..++|||++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999997653 3789999999999999999999999999999999
Q ss_pred CeEecCCCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 137 NLLLDSQGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 137 nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
||+++.++.++|+|||++........ ......+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+.
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999975443222 12223456789999999876665 99999999999999998 9999988765
Q ss_pred c
Q 027809 214 T 214 (218)
Q Consensus 214 ~ 214 (218)
.
T Consensus 281 ~ 281 (344)
T 1rjb_A 281 D 281 (344)
T ss_dssp S
T ss_pred H
Confidence 4
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=261.87 Aligned_cols=206 Identities=26% Similarity=0.420 Sum_probs=177.0
Q ss_pred ccceEEeeeecCccceEEEEEEe-----cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|+||.||.|.+ ..++..|++|.+.... .....+.+.+|+..+..+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 46899999999999999999985 3567899999986543 233457788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 80 TKIYIILEFITGGELFDKIVHHG------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
+..++|+|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc
Confidence 99999999999999999997654 489999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 142 SQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
.++.++|+|||++......... .....+++.|+|||.+.+..+. .++|+||||+++|+|++ |..||...+..
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9999999999998765543221 1223356689999999876665 99999999999999998 99999887643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=265.19 Aligned_cols=208 Identities=27% Similarity=0.456 Sum_probs=177.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR---- 79 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~---- 79 (218)
...++|++.+.||+|+||.||.|.+..++..|++|++.... .....+.+.+|+.++..++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 34468999999999999999999999999999999986433 334457788999999999999999999998654
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++|+|++++ +|.+.+.. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 468999999986 88888765 479999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
..... .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 32211 2234678899999987655544589999999999999999999998876544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=258.92 Aligned_cols=209 Identities=28% Similarity=0.451 Sum_probs=166.6
Q ss_pred ccccceEEeeeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
...++|++.+.||+|+||.||.|.+..+ +..+++|...... .....+.+.+|+..++.++||||+++++++. .+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence 3467899999999999999999998653 4568999875433 3444577889999999999999999999985 45
Q ss_pred eEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|+|++++++|.+++.... .+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 6899999999999999997654 689999999999999999999999999999999999999999999999999876543
Q ss_pred CCc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 160 GVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 160 ~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
... ......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~ 226 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ccccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHH
Confidence 221 11223345689999999876665 89999999999999996 9999998766543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=264.66 Aligned_cols=207 Identities=27% Similarity=0.421 Sum_probs=174.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEE--EEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESV--AMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~--~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+.||+|+||.||.|.+..++..+ ++|.+.... .....+.+.+|+..+..+ +||||+++++++...+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 4589999999999999999999998888765 888886433 333456688999999999 89999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc
Q 027809 82 IYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~ 145 (218)
.++|+|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 999999999999999997654 6899999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 146 LKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 146 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
++|+|||++........ .....+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 181 ~kL~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp EEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEEcccCcCcccccccc-ccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 99999999864332211 1223356789999999766554 89999999999999998 999998876554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=255.32 Aligned_cols=206 Identities=23% Similarity=0.284 Sum_probs=175.7
Q ss_pred CccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 1 ~~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
|-.+..++|++.+.||+|++|.||.|.+..+++.+++|.+........ ....+.+++..+..+ +||||+++++++...
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 344567889999999999999999999999999999999876543332 345677888888888 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC------------
Q 027809 80 TKIYIILEFITGGELFDKIVHH----GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ------------ 143 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~------------ 143 (218)
+..++|+|++++++|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------
T ss_pred CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 9999999999999999999765 679999999999999999999999999999999999999844
Q ss_pred -------CcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 144 -------GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 144 -------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..++|+|||.+....... ...+++.|+|||.+......+.++|+||||+++++|++|..|+...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999987654432 2347789999999986644457999999999999999999887544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=264.02 Aligned_cols=208 Identities=26% Similarity=0.476 Sum_probs=176.0
Q ss_pred ccceEEeeeecCccceEEEEEEec-------CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-------ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~ 77 (218)
.++|++.+.||+|+||.||.|.+. .++..|++|.+.... .....+.+.+|+..++.+ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 478999999999999999999875 356789999986543 344467788999999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
..+..++|+|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 191 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEc
Confidence 9999999999999999999997654 389999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 142 SQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.++.++|+|||++......... .....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..++
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 9999999999998755432211 1222345689999999766654 89999999999999999 9999988766543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=266.65 Aligned_cols=200 Identities=37% Similarity=0.652 Sum_probs=164.4
Q ss_pred cccceEEe-eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhh-hhcCCCCcceEEEEEEc----
Q 027809 5 KVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVRLHEVLAS---- 78 (218)
Q Consensus 5 ~~~~y~~~-~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~~i~~~~~~~~~---- 78 (218)
.+++|.+. +.||+|+||.||.+.+..+|+.||+|++... ..+.+|+..+ +..+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 46778887 7899999999999999999999999998542 2344556555 45589999999999865
Q ss_pred CCeEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---CCcEEEeeccc
Q 027809 79 RTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGL 153 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~~~~~l~d~~~ 153 (218)
....++||||+++++|.+.+.... .+++.+++.++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567999999999999999997653 5999999999999999999999999999999999999987 78899999999
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+....... ......+++.|+|||.+....++ .++|+||||+++|+|++|..||...+..
T Consensus 211 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 211 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp CEECC------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred ccccCCCC-ccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 87544322 22345678899999999877775 8999999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=259.78 Aligned_cols=202 Identities=30% Similarity=0.507 Sum_probs=169.4
Q ss_pred ccceEEeeeecCccceEEEEEE----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--C
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--R 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~ 79 (218)
.++|++.+.||+|+||.||.|. +..+++.|++|.+.... .+..+.+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4689999999999999999998 56688999999986543 3445678899999999999999999999854 3
Q ss_pred CeEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++|+|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 56899999999999999997754 59999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 159 QGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 159 ~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
..... .....++..|+|||.+.+..++ .++|+||||+++|+|++|..||...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCC
Confidence 33211 1222345679999999877765 9999999999999999999998653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=261.30 Aligned_cols=207 Identities=30% Similarity=0.505 Sum_probs=172.6
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+..++..+++|.+.... ....+.+.+|+..+..++||||+++++++...+..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4578999999999999999999999999999999986543 2335678889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 85 ILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|+|++++++|.+++.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999999988865 467999999999999999999999999999999999999999999999999987533222112
Q ss_pred cccccccCccccccccc----cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 164 LRTTCGTPNYVAPEVLS----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.....+++.|+|||.+. .....+.++|+||||+++|+|++|..||...+..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 228 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 22345678999999984 2233348999999999999999999999887654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=263.32 Aligned_cols=208 Identities=27% Similarity=0.451 Sum_probs=168.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcE----EEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~----~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..++|++.+.||+|+||.||.|.+..++.. +++|.+.... .....+.+.+|+..++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 457899999999999999999998877665 4777664332 3334567889999999999999999999998755
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+++++++.+++|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 78899999999999998774 5799999999999999999999999999999999999999999999999999875443
Q ss_pred CCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 160 GVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 160 ~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.... .....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 228 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred CcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHH
Confidence 2221 1223346689999999877765 99999999999999999 9999998776543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=260.25 Aligned_cols=207 Identities=27% Similarity=0.478 Sum_probs=170.0
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS---- 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~---- 78 (218)
...++|++.+.||+|++|.||.|.+..+|+.|++|++..... ..+.+.+|+..++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 456889999999999999999999999999999999865432 235677888899988 79999999999875
Q ss_pred --CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccc
Q 027809 79 --RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 79 --~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
.+..++|+|++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 46899999999999999999764 57899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCcccccccccc----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 155 ALPEQGVSLLRTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..............+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 765443333334457889999999862 222348999999999999999999999876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=271.85 Aligned_cols=206 Identities=41% Similarity=0.767 Sum_probs=167.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh-----hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|+||.||.|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 47899999999999999999999999999999999765432 11222347889999999999999999999865 4
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC---cEEEeeccccccC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG---HLKISDFGLSALP 157 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~---~~~l~d~~~~~~~ 157 (218)
..++|||++++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999888888999999999999999999999999999999999999996544 5999999999865
Q ss_pred CCCCcccccccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
... .......+++.|+|||.+.. ....+.++|+||||+++|+|++|..||.....
T Consensus 293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 293 GET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp C------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred CCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 543 22234567889999999863 22224799999999999999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=255.25 Aligned_cols=205 Identities=26% Similarity=0.459 Sum_probs=172.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhH----HHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM----ADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~----~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..++|++.+.||+|+||.||.|.+..+++.+++|.+.......... .+.+.+|+..++.++||||+++++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3578999999999999999999999999999999986544322221 267889999999999999999999987665
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecCCCc-----EEEeecc
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGH-----LKISDFG 152 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~~~~-----~~l~d~~ 152 (218)
++|+|++++++|.+.+... .++++..++.++.|++.+|.+||++| ++|+||+|+||+++.++. ++|+|||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 6999999999998877554 47999999999999999999999999 999999999999988776 9999999
Q ss_pred ccccCCCCCcccccccccCccccccccccC-CCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
++...... .....+++.|+|||.+... ...+.++|+||||+++|+|++|..||...+..
T Consensus 175 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 175 LSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp TCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred cccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 98754432 2234578899999998432 22258999999999999999999999876644
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=263.08 Aligned_cols=208 Identities=30% Similarity=0.557 Sum_probs=158.6
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+..+++.|++|.+.... .....+.+.+|+..+..++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh--cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 3578999999999999999999998889999999885443 22335667899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecccccc
Q 027809 85 ILEFITGGELFDKIVH--------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL 156 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~ 156 (218)
|+|++++++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999998864 45689999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCc-----ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 157 PEQGVS-----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 157 ~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...... ......+++.|+|||.+......+.++|+||||+++|+|++|..||...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 233 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh
Confidence 433211 1123357789999999875333348999999999999999999999876554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=266.74 Aligned_cols=208 Identities=33% Similarity=0.619 Sum_probs=174.4
Q ss_pred cccceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhh-hhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~-~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.+++|++.+.||+|+||.||.+.+. .+++.|++|++...... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3579999999999999999999984 47899999998643321 112234456778888888 699999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
+..++||||+++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875433
Q ss_pred C-CcccccccccCccccccccccC-CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 160 G-VSLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 160 ~-~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
. ........+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||...+
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 2 1222334578999999999753 223589999999999999999999997544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=264.73 Aligned_cols=207 Identities=25% Similarity=0.449 Sum_probs=171.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcE----EEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~----~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..++|++.+.||+|+||.||.|.+..++.. +++|.+.... .......+.+++..+..++||||+++++++.. +
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-S
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence 356899999999999999999999877765 7777764332 22223456688889999999999999999864 5
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|+|++.+++|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 689999999999999988764 5799999999999999999999999999999999999999999999999999976543
Q ss_pred CCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 160 GVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 160 ~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... ......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred ccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 322 12233456789999999877665 99999999999999999 999999876544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=266.96 Aligned_cols=204 Identities=18% Similarity=0.236 Sum_probs=166.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCC-----CcEEEEEEEecchhhhhhHH--------HHHHHHHHhhhhcCCCCcceE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTET-----GESVAMKVLDRSAIIKHKMA--------DQIKREISIMKLVRHPCVVRL 72 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~--------~~~~~~~~~l~~l~~~~i~~~ 72 (218)
.++|++.+.||+|+||.||.|.+..+ ++.|++|++........... ....+++..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 35899999999999999999998764 57899999865542111111 123345566778899999999
Q ss_pred EEEEEcC----CeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec--CCCc
Q 027809 73 HEVLASR----TKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGH 145 (218)
Q Consensus 73 ~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~--~~~~ 145 (218)
++++... ...++|||++ +++|.+++... ..+++.+++.++.|++.||.|||++|++|+||+|+||+++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998653 5689999999 88999999776 6799999999999999999999999999999999999998 8899
Q ss_pred EEEeeccccccCCCCCcc-------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 146 LKISDFGLSALPEQGVSL-------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 146 ~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
++|+|||++......... .....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCcccc
Confidence 999999999654332111 1223478899999999877765 9999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=255.44 Aligned_cols=206 Identities=28% Similarity=0.499 Sum_probs=165.8
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhh-hhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-HKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
-...++|++.+.||+|++|.||.|.+. +..+++|.+....... ....+.+.+|...++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 446789999999999999999999975 7889999986543222 2335678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCeEecC--------CCcEEEee
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG---VYHRDLKPENLLLDS--------QGHLKISD 150 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~---i~h~di~p~nil~~~--------~~~~~l~d 150 (218)
.++|+|++++++|.+.+. ..++++.+++.++.|++.+|.+||++| ++|+||+|+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999988875 458999999999999999999999999 899999999999986 67899999
Q ss_pred ccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
||++........ ....+++.|+|||.+.+..++ .++|+||||+++++|++|..||...+..
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (271)
T 3dtc_A 160 FGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGL 220 (271)
T ss_dssp CCC---------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred CCcccccccccc--cCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999875444322 234578899999999877665 9999999999999999999999886643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=267.85 Aligned_cols=202 Identities=27% Similarity=0.429 Sum_probs=168.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----- 78 (218)
...++|++++.||+|+||.||.|.+..+|+.||+|++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 346789999999999999999999999999999999865432 22368899999999999999999843
Q ss_pred ---------------------------------CCeEEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 027809 79 ---------------------------------RTKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVD 121 (218)
Q Consensus 79 ---------------------------------~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~ 121 (218)
....++||||+++ +|.+.+. ....+++..++.++.|++.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3358899999986 7666654 3567999999999999999999
Q ss_pred HHHhCCceeccCCCCCeEec-CCCcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHH
Q 027809 122 YCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYV 200 (218)
Q Consensus 122 ~Lh~~~i~h~di~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~ 200 (218)
+||++|++|+||+|+||+++ .++.++|+|||++........ .....+++.|+|||.+.+....+.++|+||+|+++|+
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 99999999999999999997 688999999999975544322 2244568899999998765544599999999999999
Q ss_pred HhhcCCCCCCCCcc
Q 027809 201 LIAGYLPFDELDLT 214 (218)
Q Consensus 201 l~~g~~pf~~~~~~ 214 (218)
|++|+.||...+..
T Consensus 235 ll~g~~pf~~~~~~ 248 (383)
T 3eb0_A 235 LILGKPLFSGETSI 248 (383)
T ss_dssp HHHSSCSSCCSSHH
T ss_pred HHhCCCCCCCCChH
Confidence 99999999986643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=271.58 Aligned_cols=204 Identities=27% Similarity=0.498 Sum_probs=173.2
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC--eEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--KIY 83 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--~~~ 83 (218)
.++|++.+.||+|+||.||.|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 4679999999999999999999999999999999865442 223466778999999999999999999998654 789
Q ss_pred EEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----cCCCcEEEeecccccc
Q 027809 84 IILEFITGGELFDKIVHHGR---LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLKISDFGLSAL 156 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~----~~~~~~~l~d~~~~~~ 156 (218)
+||||+++++|.+++..... +++.+++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999999876543 9999999999999999999999999999999999999 7777899999999976
Q ss_pred CCCCCcccccccccCccccccccccC-------CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHK-------GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
...... .....+++.|+|||.+... ...+.++|+||||+++|+|++|..||...+
T Consensus 166 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 166 LEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp CCCGGG-SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred ccCCCc-cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 544322 2234578899999998642 112378999999999999999999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=260.32 Aligned_cols=206 Identities=41% Similarity=0.767 Sum_probs=171.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh-----hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|+||.||.|.+..+++.|++|.+...... .......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999999999999999998654321 1122345788999999999999999999987665
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc---EEEeeccccccC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALP 157 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~---~~l~d~~~~~~~ 157 (218)
.++|+|++++++|.+.+.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988889999999999999999999999999999999999999987664 999999998765
Q ss_pred CCCCcccccccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.... ......+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...+.
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 168 GETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 4321 1223457889999999742 22334899999999999999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=266.87 Aligned_cols=203 Identities=29% Similarity=0.483 Sum_probs=158.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----- 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----- 79 (218)
..++|++.+.||+|+||.||.|.+..+|+.||+|++.... ......+.+.+|+..++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3478999999999999999999999999999999986543 2334456788999999999999999999998643
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++++|++ +++|.+.+.. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 5688887765 579999999999999999999999999999999999999999999999999987644
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.. .....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...+.
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 184 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32 22345788999999998644445899999999999999999999988764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=259.54 Aligned_cols=200 Identities=30% Similarity=0.469 Sum_probs=169.3
Q ss_pred cceEEeeeecCccceEEEEEE----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--C
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--T 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~ 80 (218)
.+|++.+.||+|+||.||.|. +..+++.|++|.+.... .....+.+.+|+..++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 459999999999999999998 56688999999986543 333457788999999999999999999999766 6
Q ss_pred eEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|+|++++++|.+++.. ...+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 68999999999999999954 45799999999999999999999999999999999999999999999999999876544
Q ss_pred CCc---ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 160 GVS---LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 160 ~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
... ......++..|+|||.+.+..+. .++|+||||+++|+|++|..|+.
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCc
Confidence 322 12233456679999999876665 89999999999999999998864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=254.96 Aligned_cols=206 Identities=23% Similarity=0.381 Sum_probs=162.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...++|++.+.||+|+||.||.|.+..+|+.+++|.+..... .....+.+.++...++.++|||++++++++...+..+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 356899999999999999999999999999999999865432 2333445556666688889999999999999999999
Q ss_pred EEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 84 IILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+|+|++++ +|.+.+.. ...+++..++.++.|++.+|.+||++ |++|+||+|+||+++.++.++|+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999986 77666543 56799999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccccCccccccccc---cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.... .....+++.|+|||.+. .....+.++|+||||+++|+|++|..||....
T Consensus 162 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 162 DDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred cccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 4322 22345788999999973 22233589999999999999999999998643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=260.83 Aligned_cols=207 Identities=25% Similarity=0.355 Sum_probs=176.0
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++.+.||+|+||.||.|.+. .++..+++|.+.... .......+.+|+..++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 478999999999999999999876 356789999986543 3334566889999999999999999999999989
Q ss_pred eEEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEee
Q 027809 81 KIYIILEFITGGELFDKIVHH----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d 150 (218)
..++|+|++++++|.+++... .++++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECc
Confidence 999999999999999988653 3568999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 151 FGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 151 ~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
||++........ ......+++.|+|||.+.+..+. .++|+||||+++|+|++ |..||...+..+
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~ 248 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence 999875433221 11222346789999999876665 89999999999999999 999998876544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=261.04 Aligned_cols=202 Identities=26% Similarity=0.292 Sum_probs=168.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~---- 80 (218)
..++|++.+.||+|+||.||.|.+. ++.||+|++.... ........|+..+..++||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 4578999999999999999999875 6899999986433 22234556888999999999999999987633
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCCeEecCCCcEEEee
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK----------GVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~----------~i~h~di~p~nil~~~~~~~~l~d 150 (218)
..++|+||+++++|.+++.. ..+++.+++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 47999999999999999866 4699999999999999999999999 999999999999999999999999
Q ss_pred ccccccCCCCCc--ccccccccCccccccccccCCCC----CcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 151 FGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYN----GAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 151 ~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~----~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
||++........ ......+++.|+|||.+.+.... +.++|+||||+++|+|++|..||.....
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 999965443222 12234578899999999763222 3578999999999999999999986543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=261.09 Aligned_cols=207 Identities=27% Similarity=0.398 Sum_probs=169.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC----cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
.++|++.+.||+|+||.||.|.+..++ ..|++|.+.... .......+.+|+..+..++||||+++++++...+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 467999999999999999999876543 459999986543 33345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++|+|++++++|.+++... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999999998765 57999999999999999999999999999999999999999999999999998765432
Q ss_pred Ccc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 161 VSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 161 ~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... .....+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~ 258 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHE 258 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 211 1122245679999999876665 89999999999999998 999998776543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=260.59 Aligned_cols=203 Identities=27% Similarity=0.487 Sum_probs=169.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC--CCcceEEEEEEcCCeE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASRTKI 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~--~~i~~~~~~~~~~~~~ 82 (218)
..++|++.+.||+|+||.||.+.+. ++..+|+|.+..... .....+.+.+|+..+..++| +||+++++++...+..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3467999999999999999999874 688999999875543 33445778899999999986 9999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++|||+ .+++|.+++.....+++.+++.++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||++........
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 999995 5679999999988999999999999999999999999999999999999996 67899999999976543322
Q ss_pred --ccccccccCcccccccccc----------CCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 163 --LLRTTCGTPNYVAPEVLSH----------KGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 163 --~~~~~~~~~~~~~Pe~~~~----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
......+++.|+|||.+.. ....+.++|+||||+++|+|++|..||...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 1224467899999999864 122348999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=269.24 Aligned_cols=201 Identities=28% Similarity=0.534 Sum_probs=172.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-eEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT-KIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~-~~~ 83 (218)
..++|++.+.||+|+||.||.+.+. +..||||.+.... ..+.+.+|+.++++++||||+++++++.... ..+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 4578999999999999999999875 6799999986543 2466889999999999999999999986554 799
Q ss_pred EEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 84 IILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+|+|++++++|.+++..... +++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999999999987654 7999999999999999999999999999999999999999999999999987443321
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 344 ---~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~ 395 (450)
T 1k9a_A 344 ---DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred ---cCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 123456789999999877665 99999999999999998 9999998776543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=258.32 Aligned_cols=211 Identities=34% Similarity=0.639 Sum_probs=173.4
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhh-hhHHHHHHHHHHhhhhcCCCCcceEEEEE--EcCC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK-HKMADQIKREISIMKLVRHPCVVRLHEVL--ASRT 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~~~~~l~~l~~~~i~~~~~~~--~~~~ 80 (218)
+.+++|++.+.||+|+||.||.+.+..++..+++|++....... ....+.+.+|+..++.++||||+++++++ ...+
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 46789999999999999999999999999999999987654322 23456788999999999999999999998 4456
Q ss_pred eEEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 81 KIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..++|+|+++++ |.+.+.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 799999999875 6666655 3568999999999999999999999999999999999999999999999999987544
Q ss_pred CC--CcccccccccCccccccccccCCC-CCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QG--VSLLRTTCGTPNYVAPEVLSHKGY-NGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~--~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.. ........+++.|+|||.+.+... .+.++|+||||+++|+|++|..||...+..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 220 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Confidence 22 122223457889999999975432 2479999999999999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=256.59 Aligned_cols=202 Identities=22% Similarity=0.317 Sum_probs=172.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCC-------cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETG-------ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA 77 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~-------~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~ 77 (218)
..++|++.+.||+|+||.||.|.+..++ ..+++|.+.... ....+.+.+|+..++.++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4678999999999999999999988766 469999885433 334567889999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc--------EEE
Q 027809 78 SRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--------LKI 148 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~--------~~l 148 (218)
..+..++|+|++++++|.+++..... +++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 98899999999999999999977654 999999999999999999999999999999999999988887 999
Q ss_pred eeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 149 SDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 149 ~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
+|||++...... ....+++.|+|||.+.+....+.++|+||||+++|+|++ +..||...+.
T Consensus 163 ~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 163 SDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 999998654332 123467789999999873444599999999999999999 5666665543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=253.50 Aligned_cols=203 Identities=19% Similarity=0.322 Sum_probs=174.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC--CeE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR--TKI 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~--~~~ 82 (218)
.+++|++.+.||+|++|.||.|.+. +..+++|++..... +....+.+.+|+..++.++||||+++++++... +..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 5689999999999999999999985 78899999876542 334456788999999999999999999999876 788
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 83 YIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
++|+|++++++|.+++.... .+++.+++.++.|++.||.+||+++ ++|+||+|+||+++.++.++++|+++.....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999998765 4899999999999999999999999 9999999999999999999999888765432
Q ss_pred CCCcccccccccCccccccccccCCCCC--cchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNG--AAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~--~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.. ...+++.|+|||.+.+..... .++|+||||+++|+|++|..||...+..+
T Consensus 165 ~~-----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 218 (271)
T 3kmu_A 165 SP-----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME 218 (271)
T ss_dssp CT-----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH
T ss_pred cc-----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH
Confidence 21 334678999999998654442 37999999999999999999998776543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=254.40 Aligned_cols=206 Identities=39% Similarity=0.706 Sum_probs=178.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.|.+..+++.+++|++...... ....+.+.+|+..++.++||||+++++++...+..++|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 46899999999999999999999989999999998654432 23356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC---CcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~---~~~~l~d~~~~~~~~~~~~ 162 (218)
+|++++++|.+.+.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 9999999999999888899999999999999999999999999999999999999654 4699999999875543322
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.....+++.|+|||.+.+. + +.++|+||||+++++|++|..||...+..+
T Consensus 180 -~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (287)
T 2wei_A 180 -MKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYD 229 (287)
T ss_dssp -CSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -cccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 2233467789999998754 4 489999999999999999999998766543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=253.03 Aligned_cols=205 Identities=25% Similarity=0.436 Sum_probs=176.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.+.+. ++..+++|.+...... .+.+.+|+..++.++|||++++++++...+..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence 4578999999999999999999986 5778999998754422 2567899999999999999999999999899999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-c
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~ 162 (218)
|+|++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999999998765 468999999999999999999999999999999999999999999999999987554321 1
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 213 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence 11223345689999999876665 89999999999999999 999998876544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=260.66 Aligned_cols=208 Identities=27% Similarity=0.451 Sum_probs=169.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEE----EEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESV----AMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~----~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..++|++.+.||+|+||.||.|.+..+++.+ ++|.+.... .....+.+.+|+..++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4578999999999999999999998777654 666664332 2334577889999999999999999999998765
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.+++++++.+++|.+.+... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 78899999999999998764 5699999999999999999999999999999999999999999999999999976543
Q ss_pred CCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 160 GVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 160 ~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.... .....+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 228 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 2221 1223345689999999877775 99999999999999999 9999998776553
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=261.01 Aligned_cols=206 Identities=26% Similarity=0.436 Sum_probs=175.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCc-----EEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE-----SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|+||.||.|.+..++. .+++|.+.... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 4679999999999999999999876554 79999986543 333456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc
Q 027809 80 TKIYIILEFITGGELFDKIVHH--------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH 145 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~ 145 (218)
+..++|+|++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 9999999999999999988653 35799999999999999999999999999999999999999999
Q ss_pred EEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 146 LKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 146 ~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
++|+|||++........ ......+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||......
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999975433221 11223356689999999876665 99999999999999998 99999876543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=266.04 Aligned_cols=205 Identities=26% Similarity=0.534 Sum_probs=177.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhH--------------HHHHHHHHHhhhhcCCCCcc
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM--------------ADQIKREISIMKLVRHPCVV 70 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~--------------~~~~~~~~~~l~~l~~~~i~ 70 (218)
..++|++.+.||+|++|.||.|.+ +|+.|++|.+.......... .+.+.+|+..+..++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 468999999999999999999998 88999999997554332211 26788999999999999999
Q ss_pred eEEEEEEcCCeEEEEEEecCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEec
Q 027809 71 RLHEVLASRTKIYIILEFITGGELFDK------IVH--HGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLD 141 (218)
Q Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~ 141 (218)
++++++...+..++|+|++++++|.++ +.. ...+++..++.++.|++.||.+||+ +|++|+||+|+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999887 555 5679999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcccccccccCccccccccccC-CCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 142 SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHK-GYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.++.++|+|||.+...... ......+++.|+|||.+.+. .+.+.++|+||||+++|+|++|..||...+.
T Consensus 187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999998765443 22344578899999999876 4433399999999999999999999987665
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=274.69 Aligned_cols=206 Identities=26% Similarity=0.436 Sum_probs=179.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
..+|++.+.||+|+||.||.|.+..++..|++|.+..... ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 4579999999999999999999998899999999865432 246788999999999999999999999998999999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 162 (218)
||++++++|.+++... ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999999764 4589999999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~ 428 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 428 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 11223345689999999876665 89999999999999999 9999998876654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=262.87 Aligned_cols=202 Identities=26% Similarity=0.471 Sum_probs=170.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC--CCCcceEEEEEEcCCeEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--HPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~--~~~i~~~~~~~~~~~~~~l 84 (218)
.+|++.+.||+|+||.||.+.+.. +..||+|++..... ..+..+.+.+|+.++..++ ||||+++++++...+..++
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 459999999999999999999865 88999999876543 3344677889999999996 4999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-- 162 (218)
||| +.+++|.+++.....+++.+++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 55679999999888999999999999999999999999999999999999994 68999999999976543221
Q ss_pred ccccccccCccccccccccC----------CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 163 LLRTTCGTPNYVAPEVLSHK----------GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
......+++.|+|||.+... ...+.++||||||+++|+|++|..||....
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 12344688999999998642 223489999999999999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=256.36 Aligned_cols=197 Identities=27% Similarity=0.524 Sum_probs=171.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEc--CCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLAS--RTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~--~~~ 81 (218)
..++|++.+.||+|+||.||.|.+..+++.+++|++.... .+.+.+|+.+++.++ ||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 4578999999999999999999999999999999986433 356789999999997 9999999999987 667
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~ 160 (218)
.++|+|++++++|.+.+. .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 899999999999988764 489999999999999999999999999999999999998776 8999999999755443
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.. .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...
T Consensus 185 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~ 234 (330)
T 3nsz_A 185 QE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234 (330)
T ss_dssp CC-CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred Cc-cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 22 234457788999999987454459999999999999999999999543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=256.44 Aligned_cols=208 Identities=24% Similarity=0.393 Sum_probs=173.9
Q ss_pred cccceEEee-eecCccceEEEEEEe--cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGR-TIGEGTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~-~l~~g~~g~vy~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+ .||+|+||.||.|.+ ..+++.+++|.+.... ......+.+.+|+..++.++||||+++++++ ..+.
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 356899998 999999999999954 4567899999986543 2333457788999999999999999999999 4567
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.++|+|++++++|.+++.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999999999999988889999999999999999999999999999999999999999999999999987554332
Q ss_pred ccc---ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 162 SLL---RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~---~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... ....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 228 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred CcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 211 112245689999999766654 89999999999999999 999999876544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=265.57 Aligned_cols=202 Identities=18% Similarity=0.211 Sum_probs=158.1
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc--CCCCcceEE-------EEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV--RHPCVVRLH-------EVLA 77 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l--~~~~i~~~~-------~~~~ 77 (218)
.+|++.+.||+|+||.||.|.+..+|+.||+|++...........+.+.+|+..++.+ +|||+++++ +.+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999876654555566777775444444 699988855 5554
Q ss_pred cC-----------------CeEEEEEEecCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceeccC
Q 027809 78 SR-----------------TKIYIILEFITGGELFDKIVHH-GRLSESEA------RRYFQQLIDGVDYCHSKGVYHRDL 133 (218)
Q Consensus 78 ~~-----------------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~------~~~~~~i~~~l~~Lh~~~i~h~di 133 (218)
.. ...++||||++ ++|.+++... ..+++..+ +.++.|++.||.|||++|++|+||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 32 34899999999 6999999764 34556666 788899999999999999999999
Q ss_pred CCCCeEecCCCcEEEeeccccccCCCCCcccccccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 134 KPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 134 ~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
+|+||+++.++.++|+|||++........ ...+++.|+|||.+.+ ..+ +.++|+||||+++|+|++|..||...
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTRGP---ASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCEEE---GGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCCcc---CccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999986543221 3345589999999976 445 49999999999999999999999887
Q ss_pred Cc
Q 027809 212 DL 213 (218)
Q Consensus 212 ~~ 213 (218)
++
T Consensus 297 ~~ 298 (371)
T 3q60_A 297 TP 298 (371)
T ss_dssp CT
T ss_pred Cc
Confidence 44
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=251.81 Aligned_cols=206 Identities=26% Similarity=0.373 Sum_probs=172.8
Q ss_pred CccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEE-EcC
Q 027809 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL-ASR 79 (218)
Q Consensus 1 ~~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~-~~~ 79 (218)
|-.+..++|++.+.||+|++|.||.|.+..+++.|++|++..... .+.+.+|...++.++|+++++.+..+ ...
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 345667899999999999999999999999999999999865432 13577889999999987766665554 667
Q ss_pred CeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---cCCCcEEEeeccccc
Q 027809 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSA 155 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---~~~~~~~l~d~~~~~ 155 (218)
+..++|+|++ +++|.+++.. ...+++.+++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 7889999999 7899999874 4579999999999999999999999999999999999999 488899999999987
Q ss_pred cCCCCCc-------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....... ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 6544322 12334578899999999877665 999999999999999999999987554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=264.88 Aligned_cols=200 Identities=31% Similarity=0.483 Sum_probs=171.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc------CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV------RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l------~~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|+||.||.|.+..+++.||+|++..... ..+.+.+|+.+++.+ +|+|++++++.+...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 4679999999999999999999999999999999865432 234455566666555 577999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc--EEEeeccccc
Q 027809 80 TKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH--LKISDFGLSA 155 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~--~~l~d~~~~~ 155 (218)
+..++|+|++++ +|.+.+.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.
T Consensus 172 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 999999999975 8888887654 4899999999999999999999999999999999999999887 9999999987
Q ss_pred cCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...... ....+++.|+|||.+.+..+. .++||||||+++|+|++|..||...+..
T Consensus 251 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 251 YEHQRV---YTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp ETTCCC---CSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ecCCcc---cccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 544322 234578899999999877775 9999999999999999999999887654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=261.64 Aligned_cols=203 Identities=19% Similarity=0.243 Sum_probs=165.0
Q ss_pred ccceEEeeeecCccceEEEEEEecC---CCcEEEEEEEecchhhhhh--------HHHHHHHHHHhhhhcCCCCcceEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHK--------MADQIKREISIMKLVRHPCVVRLHE 74 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~--------~~~~~~~~~~~l~~l~~~~i~~~~~ 74 (218)
.++|++.+.||+|+||.||.|.+.. ++..+++|........... ....+.+++..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3679999999999999999999987 7788999998754321111 1123556778888999999999999
Q ss_pred EEEc----CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC--cEEE
Q 027809 75 VLAS----RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG--HLKI 148 (218)
Q Consensus 75 ~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~--~~~l 148 (218)
++.. ....++|||++ +++|.+++.....+++.+++.++.|++.||.+||++|++|+||+|+||+++.++ .++|
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9877 77899999999 889999998878999999999999999999999999999999999999998877 9999
Q ss_pred eeccccccCCCCC-------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 149 SDFGLSALPEQGV-------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 149 ~d~~~~~~~~~~~-------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
+|||++....... .......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||..
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccc
Confidence 9999996543211 111334578899999999876665 999999999999999999999965
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=256.39 Aligned_cols=206 Identities=28% Similarity=0.459 Sum_probs=171.1
Q ss_pred ccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE----
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA---- 77 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~---- 77 (218)
+....++|++.+.||+|++|.||.+.+..+|+.|++|.+.... ....+.+.+|+..++.++||||+++++++.
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 3445678999999999999999999999999999999885532 334567889999999999999999999986
Q ss_pred cCCeEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 78 SRTKIYIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
.....++|+|++++++|.+.+.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 34578999999999999988876 46799999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcc---------cccccccCccccccccccCCC--CCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 154 SALPEQGVSL---------LRTTCGTPNYVAPEVLSHKGY--NGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 154 ~~~~~~~~~~---------~~~~~~~~~~~~Pe~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
+......... .....+++.|+|||.+..... .+.++|+||||+++|+|++|..||..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 7654321111 012235788999999865432 24899999999999999999999954
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=256.53 Aligned_cols=210 Identities=24% Similarity=0.403 Sum_probs=167.3
Q ss_pred cccceEEeeeecCccceEEEEEEecC---CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTE---TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~- 80 (218)
..++|++.+.||+|+||.||.|.+.. ++..+++|.+..... .....+.+.+|+..++.++||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 45789999999999999999998765 445899999865432 3334567889999999999999999999987644
Q ss_pred ----eEEEEEEecCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEee
Q 027809 81 ----KIYIILEFITGGELFDKIVH------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 81 ----~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d 150 (218)
..++|+|++++++|.+++.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECS
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEee
Confidence 35999999999999999843 35689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCC--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 151 FGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
||++....... .......+++.|+|||.+.+..+. .++|+||||+++|+|++ |..||...+..++
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 99987544321 111223356689999999877665 89999999999999999 9999998776553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=263.11 Aligned_cols=203 Identities=30% Similarity=0.478 Sum_probs=171.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE--
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI-- 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~-- 82 (218)
..++|++.+.||+|+||.||.|.+..+|+.||+|++.... ......+.+.+|+..++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 3478999999999999999999999999999999986543 2334457788999999999999999999999866544
Q ss_pred ----EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 83 ----YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 83 ----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
++|+|++.+ +|.+.+. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 119 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 119 FYDFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCCCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ceeEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 999999985 7877663 459999999999999999999999999999999999999999999999999987554
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
... ....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 196 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 248 (371)
T 4exu_A 196 AEM---TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 248 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCc---CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 322 23456889999999987444458999999999999999999999887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=259.65 Aligned_cols=208 Identities=35% Similarity=0.611 Sum_probs=175.2
Q ss_pred cccceEEe-eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeE
Q 027809 5 KVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (218)
Q Consensus 5 ~~~~y~~~-~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~ 82 (218)
..++|.+. +.||+|+||.||.|.+..+++.+|+|++...... ......+.+|+..+..+. ||||+++++++...+..
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 34668887 8999999999999999999999999998765432 233466788899998885 59999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---CCcEEEeeccccccC
Q 027809 83 YIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLSALP 157 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~~~~~l~d~~~~~~~ 157 (218)
++|+|++++++|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999998888543 57999999999999999999999999999999999999987 789999999999765
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
..... .....+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..+
T Consensus 185 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~ 240 (327)
T 3lm5_A 185 GHACE-LREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQE 240 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCccc-cccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence 44322 2234578899999999877665 89999999999999999999998776543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=258.42 Aligned_cols=206 Identities=27% Similarity=0.440 Sum_probs=174.3
Q ss_pred ccceEEeeeecCccceEEEEEEe-----cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQN-----TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~-----~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.++|++.+.||+|+||.||.|.+ ..+++.|++|.+.... .....+.+.+|+..+..+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 46899999999999999999985 3466899999986543 333456788999999999 689999999998764
Q ss_pred C-eEEEEEEecCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC
Q 027809 80 T-KIYIILEFITGGELFDKIVHHGR----------------LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS 142 (218)
Q Consensus 80 ~-~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~ 142 (218)
+ ..++|+|++++++|.+++..... +++.+++.++.|++.||.+||++|++|+||+|+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4 58999999999999999977554 889999999999999999999999999999999999999
Q ss_pred CCcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 143 QGHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 143 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
++.++|+|||++........ ......+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99999999999875443222 12233456789999999877665 99999999999999998 99999876643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=253.14 Aligned_cols=210 Identities=24% Similarity=0.387 Sum_probs=172.9
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCc---EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
+...-+|++.+.||+|+||.||.|.+..++. .+++|.+.... .....+.+.+|+..++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 3444568889999999999999998765444 79999886533 344567788999999999999999999999765
Q ss_pred CeE-EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 80 TKI-YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 80 ~~~-~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
+.. ++++|++.+++|.+.+.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 554 999999999999999876 456899999999999999999999999999999999999999999999999998754
Q ss_pred CCCC----cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 158 EQGV----SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 158 ~~~~----~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.... .......+++.|+|||.+.+..++ .++|+||||+++|+|++ |.+||...+..+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~ 236 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence 3321 112223456789999999877665 89999999999999999 666676665543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=252.97 Aligned_cols=208 Identities=27% Similarity=0.442 Sum_probs=174.3
Q ss_pred ccccceEEee-eecCccceEEEEEEec--CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 4 RKVGKYEVGR-TIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 4 ~~~~~y~~~~-~l~~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
-..++|.+.+ .||+|+||.||.|.+. .++..+++|.+.... .....+.+.+|+..++.++||||+++++++. .+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence 3457788887 9999999999999854 467789999987643 3445677889999999999999999999995 45
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|+|++++++|.+++... ..+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 689999999999999988654 4699999999999999999999999999999999999999999999999999876543
Q ss_pred CCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 160 GVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 160 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.... .....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 221 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred CcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 2221 1122346789999999766655 89999999999999998 999998876544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=263.37 Aligned_cols=201 Identities=26% Similarity=0.391 Sum_probs=171.6
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+. ++..|++|.+...... .....+.+|+..+..++||||+++++++...+..++
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 3568999999999999999999854 6889999998654422 122357899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 85 ILEFITGGELFDKIVHHG----RLSESEARRYFQQLIDGVDYCHSK---GVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~Lh~~---~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
|+|++++++|.+.+.... ++++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999999999997653 389999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 158 EQGVS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 158 ~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
..... ......+++.|+|||.+....++ .++|+||||+++|+|++|..||.
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CcccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCccc
Confidence 43322 22233478899999999776664 89999999999999999999995
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=258.42 Aligned_cols=206 Identities=32% Similarity=0.486 Sum_probs=173.4
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR---- 79 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~---- 79 (218)
...++|++.+.||+|+||.||.|.+..+|+.|++|.+.... .......+.+|+..++.++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34578999999999999999999999999999999985433 334456778999999999999999999987653
Q ss_pred -CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 -TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++|+|++++ +|.+.+.. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 86 ~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 679999999985 88888765 579999999999999999999999999999999999999999999999999987554
Q ss_pred CCCcc----------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 159 QGVSL----------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 159 ~~~~~----------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
..... .....+++.|+|||.+......+.++|+||||+++|+|++|..||...+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 32111 11234678899999987544445899999999999999999999987663
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=252.76 Aligned_cols=196 Identities=28% Similarity=0.415 Sum_probs=170.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc------
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------ 78 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------ 78 (218)
..++|++.+.||+|++|.||.|.+..+++.+++|.+.... +.+.+|+..++.++|||++++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 3467999999999999999999999899999999986543 245678999999999999999998754
Q ss_pred ----------CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcE
Q 027809 79 ----------RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHL 146 (218)
Q Consensus 79 ----------~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~ 146 (218)
....++|+|++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence 44589999999999999999654 579999999999999999999999999999999999999999999
Q ss_pred EEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 147 KISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 147 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
+|+|||++........ .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||.
T Consensus 162 kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHH
T ss_pred EECcchhheecccccc-ccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcch
Confidence 9999999876544322 2234578899999999876665 89999999999999999998874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=251.57 Aligned_cols=207 Identities=26% Similarity=0.384 Sum_probs=171.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+.||+|++|.||.|.+..+ +..+++|.+.... .....+.+.+|+..++.++|||++++++++... .
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence 457899999999999999999986543 3469999886543 333457788999999999999999999998754 4
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++|+|++++++|.+.+... ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 68999999999999999765 45999999999999999999999999999999999999999999999999998765432
Q ss_pred Cc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 161 VS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 161 ~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.. ......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~ 222 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKD 222 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred cccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence 21 11223346689999999876665 89999999999999998 999998665543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=254.64 Aligned_cols=205 Identities=29% Similarity=0.451 Sum_probs=167.2
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-------
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA------- 77 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~------- 77 (218)
..++|++.+.||+|++|.||.|.+..+++.|++|.+.... ....+.+.+|+..++.++|||++++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 4578999999999999999999999999999999986543 344567889999999999999999999873
Q ss_pred -------cCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-CCCcEEEe
Q 027809 78 -------SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKIS 149 (218)
Q Consensus 78 -------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-~~~~~~l~ 149 (218)
.....++|+|++++ +|.+.+.. +++++..++.++.|++.||.+||++|++|+||+|+||+++ .++.++|+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 34678999999985 99888764 5789999999999999999999999999999999999997 56799999
Q ss_pred eccccccCCCCC---cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 150 DFGLSALPEQGV---SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 150 d~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
|||++....... .......+++.|+|||.+......+.++|+||||+++|+|++|..||...+..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999987654321 11223345778999999876444458999999999999999999999887643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=251.00 Aligned_cols=206 Identities=25% Similarity=0.365 Sum_probs=167.9
Q ss_pred ccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEE-EcCC
Q 027809 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL-ASRT 80 (218)
Q Consensus 2 ~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~-~~~~ 80 (218)
-.+..++|++.+.||+|++|.||.|.+..+++.|++|+....... +.+.+|..+++.++|++++..+..+ ...+
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp -------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 345668899999999999999999999999999999986554321 3467888899999887766666554 6778
Q ss_pred eEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---cCCCcEEEeecccccc
Q 027809 81 KIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSAL 156 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---~~~~~~~l~d~~~~~~ 156 (218)
..++|+|++ +++|.+.+.. ..++++.+++.++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||++..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 899999999 7899998875 4579999999999999999999999999999999999999 7889999999999975
Q ss_pred CCCCCc-------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 157 PEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 157 ~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...... ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 543321 12234578899999999877765 9999999999999999999999876544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=253.53 Aligned_cols=210 Identities=25% Similarity=0.333 Sum_probs=171.8
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCC---cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEE-Ec
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVL-AS 78 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~-~~ 78 (218)
.....+|++.+.||+|+||.||.|.+..++ ..+++|.+.... .....+.+.+|+..+++++||||+++++++ ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 345567999999999999999999865433 358888876533 344457788999999999999999999986 45
Q ss_pred CCeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccC
Q 027809 79 RTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~ 157 (218)
.+..++|+|++++++|.+++... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 56789999999999999999763 46899999999999999999999999999999999999999999999999999755
Q ss_pred CCCCc----ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 158 EQGVS----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 158 ~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
..... ......+++.|+|||.+.+..++ .++|+||||+++|+|++ |.+||...+..+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 240 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTT
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 43221 11223355689999999877665 89999999999999999 778887766543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=259.39 Aligned_cols=208 Identities=23% Similarity=0.340 Sum_probs=170.0
Q ss_pred cccceEEeeeecCccceEEEEEE-----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|+||.||.|. +..++..|++|.+.... .......+.+|+..++.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 34789999999999999999998 45677899999986433 333456788999999999999999999999998
Q ss_pred CeEEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---CCcEEEe
Q 027809 80 TKIYIILEFITGGELFDKIVHHG-------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKIS 149 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~~~~~l~ 149 (218)
+..++|+|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++. +..++|+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 89999999999999999998753 4889999999999999999999999999999999999984 4569999
Q ss_pred eccccccCCCCC--cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 150 DFGLSALPEQGV--SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 150 d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
|||++....... .......+++.|+|||.+....+. .++|+||||+++|+|++ |..||...+..+
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 253 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence 999986432221 111233456789999999876665 99999999999999998 999998876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=261.65 Aligned_cols=200 Identities=31% Similarity=0.501 Sum_probs=169.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC--------CCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--------HPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~--------~~~i~~~~~~~~ 77 (218)
.++|++.+.||+|+||.||.|.+..+++.||+|++.... ...+.+.+|+.+++.++ |+|++++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 478999999999999999999999999999999986432 23456778888888875 788999999987
Q ss_pred ----cCCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCC------
Q 027809 78 ----SRTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQG------ 144 (218)
Q Consensus 78 ----~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~------ 144 (218)
.....++|||++.+ +|.+.+... ..+++.+++.++.||+.||.+||++ |++|+||+|+||+++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 55689999999955 665555543 4699999999999999999999998 999999999999998775
Q ss_pred -------------------------------------------cEEEeeccccccCCCCCcccccccccCcccccccccc
Q 027809 145 -------------------------------------------HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181 (218)
Q Consensus 145 -------------------------------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 181 (218)
.++|+|||++....... ....+++.|+|||.+.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---CSCCSCGGGCCHHHHHT
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---ccCCCCCcccCChhhcC
Confidence 79999999997654432 23457889999999987
Q ss_pred CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 182 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..+. .++||||||+++|+|++|..||...+..
T Consensus 268 ~~~~-~~~DiwslG~il~elltg~~pf~~~~~~ 299 (397)
T 1wak_A 268 SGYN-TPADIWSTACMAFELATGDYLFEPHSGE 299 (397)
T ss_dssp SCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred CCCC-cHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence 7765 8999999999999999999999876644
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=253.33 Aligned_cols=202 Identities=27% Similarity=0.505 Sum_probs=160.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.+.+.. .+++|++..... .....+.+.+|+..+++++|||+++++++. ..+..++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 4689999999999999999998653 599999865442 344457788999999999999999999965 45668999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC--Cc
Q 027809 86 LEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--VS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~--~~ 162 (218)
+|++++++|.+.+.. ...+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999999998854 456899999999999999999999999999999999999999999999999998754321 12
Q ss_pred ccccccccCccccccccc---cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 163 LLRTTCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......+++.|+|||.+. ...+ +.++|+||||+++|+|++|..||...+.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp ------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccch
Confidence 223345788999999986 3333 4799999999999999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=259.14 Aligned_cols=205 Identities=34% Similarity=0.580 Sum_probs=176.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---hHHHHHHHHHHhhhhcC--CCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVR--HPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~~~l~~l~--~~~i~~~~~~~~~~ 79 (218)
..++|++.+.||+|+||.||.|.+..+++.|++|.+........ ...+.+.+|+..++.++ |+|++++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 45789999999999999999999999999999999976543221 11234557788888886 59999999999999
Q ss_pred CeEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-CCCcEEEeeccccccC
Q 027809 80 TKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALP 157 (218)
Q Consensus 80 ~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-~~~~~~l~d~~~~~~~ 157 (218)
+..++|+|++.+ ++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++ +++.++|+|||++...
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999999986 79999999888999999999999999999999999999999999999998 7899999999998765
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.... .....+++.|+|||.+....+.+.++|+||||+++|+|++|..||...
T Consensus 201 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 201 KDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp CSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 4422 223457889999999987766558899999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=254.61 Aligned_cols=200 Identities=30% Similarity=0.514 Sum_probs=171.2
Q ss_pred ccceEEeeeecCccceEEEEEEe-cCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCC------CcceEEEEEEc
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQN-TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP------CVVRLHEVLAS 78 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~------~i~~~~~~~~~ 78 (218)
.++|++.+.||+|+||.||.|.+ ..++..|++|++.... ...+.+.+|+..++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999998 4578899999986432 2345667778888777654 59999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC--------------
Q 027809 79 RTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-------------- 142 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-------------- 142 (218)
.+..++|+|++ +++|.+.+.... ++++.+++.++.|++.||.+||++|++|+||+|+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 679999887765 6889999999999999999999999999999999999987
Q ss_pred -----CCcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 143 -----QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 143 -----~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
++.++|+|||++....... ....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC---CSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccCCCceEeeCcccccCcccc---ccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 6689999999987644322 234578899999999877765 9999999999999999999999887654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=256.66 Aligned_cols=203 Identities=30% Similarity=0.463 Sum_probs=173.5
Q ss_pred ccceEEeeeecCccceEEEEEE----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE--cC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~--~~ 79 (218)
.++|++.+.||+|+||.||.+. +..++..|++|.+.... ....+.+.+|+.+++.++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 4689999999999999999998 56788999999986543 333567889999999999999999999886 55
Q ss_pred CeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
...++|+|++++++|.+++.. ...+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 679999999999999999976 4569999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 159 QGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 159 ~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..... .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 33221 1223356679999999876664 89999999999999999999986543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=260.12 Aligned_cols=205 Identities=24% Similarity=0.411 Sum_probs=160.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC---
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT--- 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~--- 80 (218)
..+++|++.+.||+|+||.||.|.+..+|..||+|.+...... .....+++..+..++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4678999999999999999999999999999999988654322 234556777788889999999999986433
Q ss_pred ----eEEEEEEecCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEecC-CCcEEEe
Q 027809 81 ----KIYIILEFITGGELFDKI----VHHGRLSESEARRYFQQLIDGVDYCH--SKGVYHRDLKPENLLLDS-QGHLKIS 149 (218)
Q Consensus 81 ----~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~~~~~i~~~l~~Lh--~~~i~h~di~p~nil~~~-~~~~~l~ 149 (218)
..++||||+++ +|...+ .....+++..++.++.|++.++.+|| ++|++|+||+|+||+++. ++.++|+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 38899999987 544433 34567899999999999999999999 999999999999999986 8999999
Q ss_pred eccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 150 DFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 150 d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
|||++........ .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 175 Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 175 DFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp CCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 9999976554322 223456889999999976554459999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=254.02 Aligned_cols=200 Identities=24% Similarity=0.412 Sum_probs=163.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhh--cCCCCcceEEEEEEc---
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLAS--- 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~--l~~~~i~~~~~~~~~--- 78 (218)
...++|++.+.||+|+||.||.|.+ +++.||+|++.... ......+.+.+.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 4567899999999999999999987 58899999985432 2333444555544 799999999998643
Q ss_pred -CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEecCCCcEEEe
Q 027809 79 -RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH--------SKGVYHRDLKPENLLLDSQGHLKIS 149 (218)
Q Consensus 79 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~i~h~di~p~nil~~~~~~~~l~ 149 (218)
....++|+|++++++|.+++.. ..+++..++.++.|++.||.+|| +++++|+||+|+||+++.++.++|+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3568999999999999999854 57999999999999999999999 9999999999999999999999999
Q ss_pred eccccccCCCCCcc----cccccccCccccccccccCCCC-----CcchhhhhHhHHHHHHhhc----------CCCCCC
Q 027809 150 DFGLSALPEQGVSL----LRTTCGTPNYVAPEVLSHKGYN-----GAAADVWSCGVILYVLIAG----------YLPFDE 210 (218)
Q Consensus 150 d~~~~~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~pf~~ 210 (218)
|||++......... .....+++.|+|||.+...... +.++|+||||+++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99998654332221 1223578899999999765322 2689999999999999999 888866
Q ss_pred CC
Q 027809 211 LD 212 (218)
Q Consensus 211 ~~ 212 (218)
..
T Consensus 236 ~~ 237 (301)
T 3q4u_A 236 VV 237 (301)
T ss_dssp TS
T ss_pred cC
Confidence 43
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=267.81 Aligned_cols=205 Identities=25% Similarity=0.473 Sum_probs=174.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+. ++..||||.+.... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3467999999999999999999986 46789999986543 22567889999999999999999999986 556899
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 85 ILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
|||++++++|.+++... ..+++.+++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999999754 3689999999999999999999999999999999999999999999999999976443211
Q ss_pred -ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 -LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 -~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~ 394 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEV 394 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 11222345689999999876665 99999999999999999 9999998776543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=254.55 Aligned_cols=203 Identities=31% Similarity=0.468 Sum_probs=154.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEE--------
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLA-------- 77 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~-------- 77 (218)
.+|++.+.||+|+||.||.|.+..+++.|++|.+.... ....+.+.+|+..+..+. ||||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 47999999999999999999999999999999885443 333466788999999996 999999999983
Q ss_pred cCCeEEEEEEecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEecCCCcEEEeecc
Q 027809 78 SRTKIYIILEFITGGELFDKIVH---HGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLDSQGHLKISDFG 152 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~~~~~~~l~d~~ 152 (218)
.....++++|++++ +|.+.+.. ..++++.+++.++.|++.+|.+||++| ++|+||+|+||+++.++.++|+|||
T Consensus 105 ~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 105 GQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 34468999999974 88887754 457999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCcc------------cccccccCccccccccc---cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 153 LSALPEQGVSL------------LRTTCGTPNYVAPEVLS---HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 153 ~~~~~~~~~~~------------~~~~~~~~~~~~Pe~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
++......... .....+++.|+|||.+. +..+ +.++|+||||+++|+|++|..||...+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 99765442211 11234678899999983 3333 48999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=251.11 Aligned_cols=203 Identities=26% Similarity=0.453 Sum_probs=172.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|++|.||.|.+. ++..+++|.+..... ..+.+.+|+..++.++|||++++++++.. +..++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 478999999999999999999975 567899999865432 24568899999999999999999999864 458999
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc
Q 027809 86 LEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
+|++++++|.+++.... .+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999999987543 7999999999999999999999999999999999999999999999999998765443221
Q ss_pred -cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 164 -LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 164 -~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.....+++.|+|||.+....++ .++|+||||+++++|++ |..||...+..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~ 218 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred cccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHH
Confidence 2223346689999999766554 89999999999999999 999998876544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=259.63 Aligned_cols=207 Identities=23% Similarity=0.392 Sum_probs=166.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh--------hhhhHHHHHHHHHHhhhhcCCCCcceEEEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI--------IKHKMADQIKREISIMKLVRHPCVVRLHEVL 76 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~ 76 (218)
..++|++.+.||+|+||.||.|.+.. |..|++|.+..... ......+.+.+|+..++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45889999999999999999999864 89999999854322 2233457789999999999999999999998
Q ss_pred E-----cCCeEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEee
Q 027809 77 A-----SRTKIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 77 ~-----~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d 150 (218)
. .....++|+|++++ +|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 4 33468999999985 777766544 4689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 151 FGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
||++........ .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..
T Consensus 178 fg~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 178 FNLAREDTADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCcccccccccc-cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999875443222 223456778999999986444459999999999999999999999886643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=251.89 Aligned_cols=200 Identities=29% Similarity=0.536 Sum_probs=165.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-CCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~-~~~~~ 83 (218)
..++|++.+.||+|++|.||.+.+. |..+++|.+.... ..+.+.+|+..++.++|||++++++++.. .+..+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 4688999999999999999999874 7899999986433 34668899999999999999999998754 45789
Q ss_pred EEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 84 IILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+|+|++++++|.+++..... +++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999999999976543 8999999999999999999999999999999999999999999999999987544322
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
. ...+++.|+|||.+.+..++ .++|+||||+++|+|++ |..||...+..+
T Consensus 172 ~---~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 172 D---TGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred c---CCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 1 23456789999999876665 89999999999999998 999998876554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=254.72 Aligned_cols=209 Identities=28% Similarity=0.459 Sum_probs=165.7
Q ss_pred cccceEEeeeecCccceEEEEEEecC-CCc--EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTE-TGE--SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~-~~~--~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+.||+|++|.||.|.+.. ++. .|++|.+........+..+.+.+|+..++.++||||+++++++....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 45689999999999999999998643 333 68999887655445556678899999999999999999999998755
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++|+|++++++|.+.+... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 88999999999999988764 56999999999999999999999999999999999999999999999999998765433
Q ss_pred Ccc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 161 VSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 161 ~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
... .....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 232 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHH
Confidence 221 1223345679999999866654 89999999999999999 999998876544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=265.25 Aligned_cols=199 Identities=30% Similarity=0.436 Sum_probs=164.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc------C
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------R 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------~ 79 (218)
..+|++.+.||+|+||.||.|.+..+|+.||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 347999999999999999999999999999999986543 123368899999999999999998743 2
Q ss_pred CeEEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-CcEEEeecccc
Q 027809 80 TKIYIILEFITGGELFDKIV----HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-GHLKISDFGLS 154 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-~~~~l~d~~~~ 154 (218)
...++|+||+++ +|.+.+. ....+++..++.++.|++.||.|||++|++|+||+|+|||++.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 247799999986 6655553 34679999999999999999999999999999999999999855 57899999999
Q ss_pred ccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
........ .....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...+.
T Consensus 205 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 205 KQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262 (420)
T ss_dssp EECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 75443322 22345788999999997654345899999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=256.57 Aligned_cols=201 Identities=30% Similarity=0.482 Sum_probs=169.4
Q ss_pred cce-EEeeeecCccceEEEEEE----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--C
Q 027809 7 GKY-EVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--R 79 (218)
Q Consensus 7 ~~y-~~~~~l~~g~~g~vy~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~ 79 (218)
++| ++++.||+|+||.||.+. +..+++.|++|++.... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 445 999999999999997765 34578899999987543 33445778899999999999999999999986 4
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...++|+|++++++|.+++... .+++.+++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 6789999999999999988654 599999999999999999999999999999999999999999999999999976554
Q ss_pred CCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 160 GVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 160 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.... .....+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCccccc
Confidence 3221 2223456679999999876665 8999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=253.16 Aligned_cols=202 Identities=28% Similarity=0.457 Sum_probs=168.9
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
+|.....||+|++|.||.|.+..++..|++|.+.... ....+.+.+|+..++.++||||+++++++...+..++|+|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3444458999999999999999999999999986543 2335678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeeccccccCCCCCcc
Q 027809 88 FITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~ 163 (218)
++++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||.+.........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999999987652 4678999999999999999999999999999999999987 899999999998765443333
Q ss_pred cccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 164 LRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.....+++.|+|||.+.... ..+.++|+||||+++|+|++|..||...+
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 33445788999999997532 12489999999999999999999997543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=259.14 Aligned_cols=201 Identities=30% Similarity=0.490 Sum_probs=169.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe----
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK---- 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~---- 81 (218)
.++|++.+.||+|+||.||.|.+..+|+.|++|.+.... ......+.+.+|+..++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999986543 233445678899999999999999999999976543
Q ss_pred --EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 82 --IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 82 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.++|+|++++ +|.+.+. ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 5999999985 8876653 3589999999999999999999999999999999999999999999999999875443
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.
T Consensus 179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 12345678999999997644445899999999999999999999987764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=260.21 Aligned_cols=197 Identities=14% Similarity=0.218 Sum_probs=167.2
Q ss_pred ccceEEeeeecCccceEEEEEEecC--------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcce------
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE--------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVR------ 71 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~------ 71 (218)
.++|++.+.||+|+||.||.|.+.. +++.+|+|.+... +.+.+|+..++.++|||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999999987 4789999998643 34668888888889988877
Q ss_pred ---------EEEEEEc-CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 027809 72 ---------LHEVLAS-RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLL 139 (218)
Q Consensus 72 ---------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil 139 (218)
+++++.. .+..++|||++ +++|.+++... ..+++.+++.++.|++.||.+||++|++|+||+|+||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 77899999999 88999999876 78999999999999999999999999999999999999
Q ss_pred ecCCC--cEEEeeccccccCCCCCc-------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 140 LDSQG--HLKISDFGLSALPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 140 ~~~~~--~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
++.++ .++|+|||++........ ......+++.|+|||.+.+..++ .++|+||||+++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 899999999975443211 11223578899999999876665 899999999999999999999987
Q ss_pred CC
Q 027809 211 LD 212 (218)
Q Consensus 211 ~~ 212 (218)
.+
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 64
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=252.83 Aligned_cols=207 Identities=31% Similarity=0.485 Sum_probs=169.5
Q ss_pred cccccceEEeeeecCccceEEEEEEec-CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhh---hcCCCCcceEEEEEE-
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNT-ETGESVAMKVLDRSAIIKHKMADQIKREISIMK---LVRHPCVVRLHEVLA- 77 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~---~l~~~~i~~~~~~~~- 77 (218)
.+..++|++.+.||+|+||.||.|.+. .+|+.|++|.+........ ....+.+|+..++ .++||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 345688999999999999999999985 6788999999865432211 1122334454444 448999999999987
Q ss_pred ----cCCeEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeec
Q 027809 78 ----SRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 78 ----~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
.....++|+|++++ +|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 55679999999985 9999887653 4899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
|++....... ......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||...+.
T Consensus 165 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 165 GLARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CSCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCC-CccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9987654322 22234578899999999876665 899999999999999999999987654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=262.37 Aligned_cols=200 Identities=30% Similarity=0.438 Sum_probs=163.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~---- 80 (218)
..++|++.+.||+|+||.||.|.+..++. +++|++..... ...+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 35679999999999999999999876655 88887755432 1236888999999999999999985433
Q ss_pred --eEEEEEEecCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-CCCcEEEeecccc
Q 027809 81 --KIYIILEFITGGELFDKI---VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLS 154 (218)
Q Consensus 81 --~~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-~~~~~~l~d~~~~ 154 (218)
..++|+||++++.+.... .....+++..++.++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++
T Consensus 110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 388999999874333222 2356799999999999999999999999999999999999998 7999999999999
Q ss_pred ccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
......... ....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...+.
T Consensus 190 ~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 190 KILIAGEPN-VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp EECCTTCCC-CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCCCCC-cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 765443222 2345688999999997654445899999999999999999999988764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=251.97 Aligned_cols=203 Identities=28% Similarity=0.422 Sum_probs=171.5
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchh-hhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
|..++.||+|++|.||.|.+ ++..+++|.+..... ...+..+.+.+|+..++.++||||+++++++...+..++|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 34458999999999999986 578999999865432 233456778899999999999999999999999899999999
Q ss_pred ecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc--
Q 027809 88 FITGGELFDKIVH---HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-- 162 (218)
Q Consensus 88 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-- 162 (218)
++++++|.+.+.. ..++++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999998864 34689999999999999999999999999999999999999999999999999875443221
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+.+. + +.++|+||||+++|+|++|..||...+..+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 12233578899999998653 3 489999999999999999999998766543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=259.99 Aligned_cols=207 Identities=25% Similarity=0.337 Sum_probs=164.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC---cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-cCCe
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-SRTK 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~-~~~~ 81 (218)
..+|++.+.||+|+||.||.|.+..++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++++. ..+.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 346899999999999999999876432 457888875432 3344677889999999999999999999864 4567
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++|+||+++++|.+++... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 89999999999999999765 35889999999999999999999999999999999999999999999999998754332
Q ss_pred Cc----ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 161 VS----LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 161 ~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.. ......+++.|+|||.+.+..++ .++|+||||+++|+|++ |.+||...+..+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~ 304 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence 11 11223355689999999877665 99999999999999999 889998776544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=248.81 Aligned_cols=197 Identities=30% Similarity=0.536 Sum_probs=164.5
Q ss_pred cccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc----
Q 027809 3 VRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS---- 78 (218)
Q Consensus 3 ~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~---- 78 (218)
.+..++|++.+.||+|+||.||.|.+..+++.+++|.+... ....+.+.+|+..++.++|||++++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (303)
T 1zy4_A 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNF 77 (303)
T ss_dssp BHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCC
T ss_pred CcccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcch
Confidence 35668899999999999999999999999999999998543 2335678899999999999999999998754
Q ss_pred ---------CCeEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEE
Q 027809 79 ---------RTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKI 148 (218)
Q Consensus 79 ---------~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l 148 (218)
.+..++|+|++++++|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 78 VKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp CC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 457899999999999999997543 5788999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCC--------------cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh
Q 027809 149 SDFGLSALPEQGV--------------SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA 203 (218)
Q Consensus 149 ~d~~~~~~~~~~~--------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~ 203 (218)
+|||++....... .......+++.|+|||.+.+....+.++|+||||+++|+|++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999987543221 112234467899999999865444589999999999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=251.89 Aligned_cols=204 Identities=23% Similarity=0.423 Sum_probs=152.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|+||.||.|.+..+|+.|++|.+..... .....+.+.++...++.++||||+++++++...+..++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 35789999999999999999999999999999999975432 22222333344447778899999999999999999999
Q ss_pred EEEecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 85 ILEFITGGELFDKIVH-----HGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
|+|++++ +|.+.+.. ...+++..++.++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||++....
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9999986 77777753 56789999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcccccccccCccccccccc----cCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLS----HKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
.... .....+++.|+|||.+. ...+ +.++|+||||+++|+|++|..||...+
T Consensus 178 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 178 DSIA-KTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -----------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred cccc-cccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 4322 12335778999999984 3334 489999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=257.26 Aligned_cols=204 Identities=33% Similarity=0.595 Sum_probs=167.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---hHHHHHHHHHHhhhhc----CCCCcceEEEEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLV----RHPCVVRLHEVLA 77 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~~~l~~l----~~~~i~~~~~~~~ 77 (218)
..++|++.+.||+|+||.||.|.+..+++.|++|.+........ .....+.+|+..+..+ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 35789999999999999999999999999999999865543221 1123355678888887 8999999999999
Q ss_pred cCCeEEEEEEe-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec-CCCcEEEeeccccc
Q 027809 78 SRTKIYIILEF-ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSA 155 (218)
Q Consensus 78 ~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~-~~~~~~l~d~~~~~ 155 (218)
..+..++|+|+ +.+++|.+++.....+++.+++.++.|++.+|.+||++|++|+||+|+||+++ .++.++|+|||++.
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~ 188 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence 88899999999 78889999999888999999999999999999999999999999999999998 88999999999987
Q ss_pred cCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 156 LPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
...... .....+++.|+|||.+....+.+.++|+||||+++|+|++|..||..
T Consensus 189 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 189 LLHDEP--YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCSSC--BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hcccCc--ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 654432 22345788999999998766655689999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=250.26 Aligned_cols=196 Identities=32% Similarity=0.530 Sum_probs=163.2
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...++|++.+.||+|+||.||.+.+. ++.+++|.+.... ..+.+.+|+..++.++||||+++++++.+ ..+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999875 6789999885432 34668899999999999999999998764 378
Q ss_pred EEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCCeEecCCCc-EEEeecccccc
Q 027809 84 IILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHS---KGVYHRDLKPENLLLDSQGH-LKISDFGLSAL 156 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~---~~i~h~di~p~nil~~~~~~-~~l~d~~~~~~ 156 (218)
+|+||+++++|.+.+.... .++...++.++.|++++|.+||+ +|++|+||+|+||+++.++. ++|+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997665 36899999999999999999999 89999999999999988886 79999999875
Q ss_pred CCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..... ....+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+
T Consensus 156 ~~~~~---~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 156 IQTHM---TNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccccc---ccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 44322 233478899999999876665 89999999999999999999998654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=265.10 Aligned_cols=203 Identities=26% Similarity=0.410 Sum_probs=168.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+.. +..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 4679999999999999999999874 46799999865432 23568899999999999999999999876 668999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 162 (218)
||++++++|.+++... ..+++.+++.++.|++.||.+||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999999643 5689999999999999999999999999999999999999999999999999975543211
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 389 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNRE 389 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred cccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 11223345689999999876665 99999999999999999 999999876554
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=261.84 Aligned_cols=206 Identities=25% Similarity=0.390 Sum_probs=174.4
Q ss_pred CccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcC
Q 027809 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASR 79 (218)
Q Consensus 1 ~~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~ 79 (218)
|-++..++|++.+.||+|+||.||.|.+..+++.||||++...... ..+..|..+++.++| +++..+..++...
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 5567789999999999999999999999999999999987654321 346688888999987 5666666666778
Q ss_pred CeEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe---cCCCcEEEeeccccc
Q 027809 80 TKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---DSQGHLKISDFGLSA 155 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---~~~~~~~l~d~~~~~ 155 (218)
+..++|||++ +++|.+++.. ...+++.+++.++.||+.+|.|||++|++|+||+|+|||+ +.++.++|+|||++.
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 8899999999 7799999875 4579999999999999999999999999999999999999 588999999999997
Q ss_pred cCCCCCcc-------cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 156 LPEQGVSL-------LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 156 ~~~~~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
........ .....+++.|+|||.+.+..+. .++||||||+++|+|++|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 55432211 1244578899999999877765 999999999999999999999998665
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=253.81 Aligned_cols=200 Identities=35% Similarity=0.600 Sum_probs=147.5
Q ss_pred cccceEEee-eecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc----C
Q 027809 5 KVGKYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----R 79 (218)
Q Consensus 5 ~~~~y~~~~-~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----~ 79 (218)
..++|++.+ .||+|+||.||.|.+..+|+.||+|++.... ....+....++.++|||++++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 457899965 6999999999999999999999999986533 122233344566799999999999875 4
Q ss_pred CeEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---CCcEEEeecccc
Q 027809 80 TKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGLS 154 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~~~~~l~d~~~~ 154 (218)
...++|+||+++++|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56899999999999999998764 6999999999999999999999999999999999999976 455999999998
Q ss_pred ccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 155 ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...... ......+++.|+|||.+....+. .++|+||||+++|+|++|..||...+..
T Consensus 179 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 179 KETTQN--ALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp EEC------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eecccc--ccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 754432 22244568899999999766554 8999999999999999999999766543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=271.69 Aligned_cols=206 Identities=26% Similarity=0.449 Sum_probs=169.6
Q ss_pred cceEEee-eecCccceEEEEEEec--CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 7 GKYEVGR-TIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 7 ~~y~~~~-~l~~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
+++.+.+ .||+|+||.||.|.+. +++..||||.+.... .....+.+.+|+.+++.++||||+++++++.. +..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 3455555 8999999999999876 345679999986543 23345778899999999999999999999976 5689
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 84 IILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+||||+++++|.+++... ..+++.+++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999988654 4699999999999999999999999999999999999999999999999999976543221
Q ss_pred c---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 L---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
. .....+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..++
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 548 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 1 1122345789999999877665 89999999999999998 9999998776553
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=271.98 Aligned_cols=202 Identities=24% Similarity=0.417 Sum_probs=169.1
Q ss_pred eeeecCccceEEEEEEec--CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEec
Q 027809 12 GRTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
.+.||+|+||.||.|.+. .+++.||||++.... ......+.+.+|+.+++.++||||++++++++.. ..++||||+
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEcc
Confidence 358999999999999654 556889999986543 2334457789999999999999999999999754 588999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc---cccc
Q 027809 90 TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS---LLRT 166 (218)
Q Consensus 90 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 166 (218)
++++|.+++.....+++.+++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9999999999888999999999999999999999999999999999999999999999999999875443221 1122
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
..+++.|+|||.+....++ .++||||||+++|+|++ |..||...+..++
T Consensus 532 ~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 581 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581 (635)
T ss_dssp ---CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred CCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2345689999999877775 99999999999999998 9999998776543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=249.44 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=161.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC----Ce
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR----TK 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~----~~ 81 (218)
.++|++.+.||+|+||.||.|.+. ++.||+|++.... ........++.....++||||+++++++... ..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 468999999999999999999875 7899999985433 1111223334444455999999999998876 78
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEecCCCcEEEeeccc
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK--------GVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~--------~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
.++|+||+++++|.+++.. ..+++.+++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999999999999865 4799999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCcc----cccccccCccccccccccCCCCCc-----chhhhhHhHHHHHHhhc----------CCCCCCCC
Q 027809 154 SALPEQGVSL----LRTTCGTPNYVAPEVLSHKGYNGA-----AADVWSCGVILYVLIAG----------YLPFDELD 212 (218)
Q Consensus 154 ~~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~-----~~Di~slG~~l~~l~~g----------~~pf~~~~ 212 (218)
+......... .....+++.|+|||.+........ ++|+||||+++|+|++| ..||....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 8654332221 123457889999999976655422 48999999999999999 77776543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=254.11 Aligned_cols=202 Identities=28% Similarity=0.454 Sum_probs=170.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CC-----CcceEEEEEEc
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HP-----CVVRLHEVLAS 78 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~-----~i~~~~~~~~~ 78 (218)
..++|++.+.||+|+||.||.|.+..+++.||+|++.... .....+..|...++.++ |+ +++++.+.+..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 4678999999999999999999999999999999986543 22345566777777664 34 59999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEec--CCCcEEEeecc
Q 027809 79 RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCH--SKGVYHRDLKPENLLLD--SQGHLKISDFG 152 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh--~~~i~h~di~p~nil~~--~~~~~~l~d~~ 152 (218)
.+..++|+|++++ +|.+.+... ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++ .++.++|+|||
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 9999999999975 998888765 46899999999999999999999 57999999999999995 46789999999
Q ss_pred ccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 153 LSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
++....... ....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..+
T Consensus 207 ~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 207 SSCQLGQRI---YQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp TCEETTCCC---CSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred Cceeccccc---ccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 997654322 234577899999999877765 99999999999999999999999876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=251.52 Aligned_cols=200 Identities=26% Similarity=0.474 Sum_probs=168.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC-cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC------cceEEEEEEc
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC------VVRLHEVLAS 78 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~-~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~------i~~~~~~~~~ 78 (218)
.++|++.+.||+|+||.||.|.+..++ ..|++|++.... ...+.+.+|+..++.++|++ ++.+.+++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 478999999999999999999998776 689999986432 23455677888888776544 8999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----------------
Q 027809 79 RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL---------------- 140 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~---------------- 140 (218)
.+..++|+|++.+ ++.+.+... .++++.+++.++.|++.||.+||++|++|+||+|+||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 9999999999955 666666554 368999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 141 ---DSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 141 ---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+.++.++|+|||++....... ....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+..
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC---CSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccCCCcEEEeecCccccccccc---cCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 567899999999987644332 234578899999999877765 8999999999999999999999887644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=252.29 Aligned_cols=201 Identities=30% Similarity=0.500 Sum_probs=170.5
Q ss_pred ccceEEeeeecCccceEEEEEE----ecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC-
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQ----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT- 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~- 80 (218)
.++|++.+.||+|++|.||.+. +..+++.|++|.+... ..+..+.+.+|+..++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 4569999999999999999998 4567899999998653 2344567889999999999999999999986543
Q ss_pred -eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 81 -KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 81 -~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..++|+|++++++|.+++... ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 689999999999999999775 458999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 159 QGVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 159 ~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
..... .....++..|+|||.+.+..++ .++|+||||+++++|++|..||..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCC
Confidence 43221 1122345679999999876654 899999999999999999998864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=259.91 Aligned_cols=202 Identities=28% Similarity=0.499 Sum_probs=156.1
Q ss_pred ccceEE-eeeecCccceEEEEEEec--CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE--cCC
Q 027809 6 VGKYEV-GRTIGEGTFAKVKFAQNT--ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA--SRT 80 (218)
Q Consensus 6 ~~~y~~-~~~l~~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~--~~~ 80 (218)
.+.|++ +++||+|+||.||.|.+. .++..+|+|.+..... ...+.+|+.+++.++||||+++++++. ...
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 345777 558999999999999965 5688999999864432 245678999999999999999999984 467
Q ss_pred eEEEEEEecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEe----cCCCcEE
Q 027809 81 KIYIILEFITGGELFDKIVHH---------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLL----DSQGHLK 147 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~----~~~~~~~ 147 (218)
..++|+||+.+ +|.+.+... ..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 89999999986 777776532 248999999999999999999999999999999999999 6778999
Q ss_pred EeeccccccCCCCC---cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 148 ISDFGLSALPEQGV---SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 148 l~d~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
|+|||++....... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+.
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999997654321 1122345788999999998755445999999999999999999999976543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=243.95 Aligned_cols=180 Identities=20% Similarity=0.269 Sum_probs=158.9
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..+++.|++|++........+..+.+.+|+..+..++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 37899999999999999999999999999999999766554555667888999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|||+++++|.+++..+ ....++.+++.|++.+|.+||++|++|+||+|+||+++.++.++|++.+
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 9999999999998543 4667899999999999999999999999999999999999999997432
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
|++| .+.++|+||||+++|+|++|+.||...+..+
T Consensus 175 -------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 175 -------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp -------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred -------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 2222 2489999999999999999999999876543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=246.70 Aligned_cols=206 Identities=27% Similarity=0.437 Sum_probs=157.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+++|++.+.||+|+||.||.|.+..+|+.|++|.+..... .....+.+.++...++.++||||+++++++...+..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 357899999999999999999999999999999999976542 2233344556666778889999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 84 IILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+|+|++ ++.+...... ...+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999999 4455555443 46799999999999999999999985 99999999999999999999999999986544322
Q ss_pred cccccccccCcccccccccc----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 162 SLLRTTCGTPNYVAPEVLSH----KGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
. .....+++.|+|||.+.. ....+.++|+||||+++|+|++|..||....
T Consensus 180 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (318)
T 2dyl_A 180 A-KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred c-ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC
Confidence 1 223457889999999952 2223489999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=246.45 Aligned_cols=204 Identities=26% Similarity=0.462 Sum_probs=168.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC--CCCcceEEEEEEcCCeE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--HPCVVRLHEVLASRTKI 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~--~~~i~~~~~~~~~~~~~ 82 (218)
..++|++.+.||+|+||.||.+.+. +++.+++|.+..... .....+.+.+|+..+..++ |+|++++++++...+..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 4567999999999999999999985 588999999865443 3344577889999999997 59999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
++++| +.+++|.+++.....+++.+++.++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||++........
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC------
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc
Confidence 99999 55679999999888999999999999999999999999999999999999995 58999999999876543222
Q ss_pred c--cccccccCccccccccccC----------CCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 163 L--LRTTCGTPNYVAPEVLSHK----------GYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 163 ~--~~~~~~~~~~~~Pe~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
. .....+++.|+|||.+... ...+.++|+||||+++|+|++|..||....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 1 2234578899999998652 233589999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=266.71 Aligned_cols=204 Identities=25% Similarity=0.411 Sum_probs=173.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+.. +..|+||++..... ..+.+.+|+.+++.++|+||+++++++.. +..++|
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 4679999999999999999999874 46799999865432 23568899999999999999999999876 668999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 162 (218)
|||+++++|.+++... ..+++.+++.++.|++.+|.|||+++++|+||+|+|||++.++.++|+|||++........
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999999643 5689999999999999999999999999999999999999999999999999976543211
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
......++..|+|||.+....++ .++||||||+++|+|++ |..||...+..++
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~ 473 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREV 473 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH
T ss_pred cccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 11122345689999999876665 99999999999999999 9999998765443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=268.26 Aligned_cols=207 Identities=28% Similarity=0.457 Sum_probs=172.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCC---CcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTET---GESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~---~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
..++|++.+.||+|+||.||.|.+..+ +..+++|.+.... .....+.+.+|+..++.++||||+++++++.+ +.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 357899999999999999999998643 4578999875433 34445778899999999999999999999854 56
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 899999999999999997654 6899999999999999999999999999999999999999999999999999765433
Q ss_pred Cc-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 161 VS-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 161 ~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.. ......+++.|+|||.+....++ .++|+||||+++|+|++ |..||...+..+
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 600 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNND 600 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 21 11223345689999999877665 89999999999999997 999998876544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=252.94 Aligned_cols=199 Identities=26% Similarity=0.499 Sum_probs=165.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-----------CCCcceEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-----------HPCVVRLH 73 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-----------~~~i~~~~ 73 (218)
..++|++.+.||+|+||.||.|.+..+++.||+|++..... ..+.+.+|+..++.++ |+||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 35789999999999999999999999999999999865432 2345667777777665 78999999
Q ss_pred EEEEcCC----eEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEec-----
Q 027809 74 EVLASRT----KIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLD----- 141 (218)
Q Consensus 74 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~-~i~h~di~p~nil~~----- 141 (218)
+++...+ ..++++|++ +++|.+.+... ..+++..++.++.|++.||.+||++ |++|+||+|+||+++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987543 789999999 77999988763 4599999999999999999999998 999999999999994
Q ss_pred -CCCcEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 142 -SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 142 -~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
..+.++|+|||++....... ....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCCC---CCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 34479999999987654432 234578899999999877665 99999999999999999999998765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=247.18 Aligned_cols=199 Identities=24% Similarity=0.394 Sum_probs=166.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhh--cCCCCcceEEEEEEcCC---
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL--VRHPCVVRLHEVLASRT--- 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~--l~~~~i~~~~~~~~~~~--- 80 (218)
.++|++.+.||+|+||.||.|.+ +|+.|++|.+.... ...+..|..++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 36799999999999999999987 47899999985432 2445566777766 78999999999998765
Q ss_pred -eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEecCCCcEEEeec
Q 027809 81 -KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH--------SKGVYHRDLKPENLLLDSQGHLKISDF 151 (218)
Q Consensus 81 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh--------~~~i~h~di~p~nil~~~~~~~~l~d~ 151 (218)
..++|+|++++++|.+++.. .++++.+++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 79999999999999999865 47899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCcc----cccccccCccccccccccCCCC-----CcchhhhhHhHHHHHHhhc----------CCCCCCCC
Q 027809 152 GLSALPEQGVSL----LRTTCGTPNYVAPEVLSHKGYN-----GAAADVWSCGVILYVLIAG----------YLPFDELD 212 (218)
Q Consensus 152 ~~~~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~pf~~~~ 212 (218)
|++......... .....+++.|+|||.+...... +.++|+||||+++|+|++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998754433221 2233578899999999754322 2589999999999999999 88997764
Q ss_pred c
Q 027809 213 L 213 (218)
Q Consensus 213 ~ 213 (218)
+
T Consensus 272 ~ 272 (342)
T 1b6c_B 272 P 272 (342)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=250.54 Aligned_cols=200 Identities=23% Similarity=0.325 Sum_probs=158.9
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-----c
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-----S 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~-----~ 78 (218)
..+++|++.+.||+|+||.||.|.+ +++.||+|++...... ......++..+..++||||+++++.+. .
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 3578999999999999999999976 5789999998644311 112234455566789999999998653 2
Q ss_pred CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCeEecCCCcEEEe
Q 027809 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK---------GVYHRDLKPENLLLDSQGHLKIS 149 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~---------~i~h~di~p~nil~~~~~~~~l~ 149 (218)
....++||||+++++|.+++... ..++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 33678999999999999998654 558999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCC--------cccccccccCccccccccccCC------CCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 150 DFGLSALPEQGV--------SLLRTTCGTPNYVAPEVLSHKG------YNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 150 d~~~~~~~~~~~--------~~~~~~~~~~~~~~Pe~~~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
|||++....... .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||-.
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999997543321 1112335788999999997521 113689999999999999999766643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=271.01 Aligned_cols=195 Identities=27% Similarity=0.436 Sum_probs=166.5
Q ss_pred ccceEEeeeecCccceEEEEEEecC-CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCe---
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTK--- 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~--- 81 (218)
.++|++.+.||+|+||.||.+.+.. +|+.|+||.+.... ..+....+.+|...+..++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 3789999999999999999999976 78999999886432 33445678899999999999999999999986554
Q ss_pred --EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 82 --IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 82 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.|+||||+++++|.+.+.. .+++.+++.++.|++.+|.|||++|++|+||+|+||+++.+ .++|+|||++.....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 7999999999999887654 79999999999999999999999999999999999999875 999999999875543
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
. ....+++.|+|||.+.... +.++||||||+++++|++|..||...
T Consensus 234 ~----~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 234 F----GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp C----SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred C----CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccc
Confidence 3 2345788999999987543 58999999999999999999998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=268.88 Aligned_cols=204 Identities=32% Similarity=0.508 Sum_probs=172.8
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----- 78 (218)
..+++|++.+.||+|+||.||.|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 46789999999999999999999999999999999886543 34445778899999999999999999998754
Q ss_pred -CCeEEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCc---EEEeec
Q 027809 79 -RTKIYIILEFITGGELFDKIVHHG---RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGH---LKISDF 151 (218)
Q Consensus 79 -~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~---~~l~d~ 151 (218)
.+..++|+||+++++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+||
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 667899999999999999997654 5899999999999999999999999999999999999987665 999999
Q ss_pred cccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 152 GLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
|++........ .....+++.|+|||.+.+..++ .++|+||||+++|+|++|..||...
T Consensus 169 G~a~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 169 GYAKELDQGEL-CTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCBTTSCCC-CCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccc-cccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcc
Confidence 99986554322 2344678899999999877665 8999999999999999999999653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=250.98 Aligned_cols=206 Identities=28% Similarity=0.432 Sum_probs=168.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++.+.||+|++|.||.|.+.+ .+++|.+..... +....+.+.+|+..++.++||||+++++++...+..++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 45889999999999999999998753 489998865432 22223456788999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC---
Q 027809 85 ILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG--- 160 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~--- 160 (218)
++|++++++|.+++.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999999987654 689999999999999999999999999999999999997 789999999987654321
Q ss_pred --CcccccccccCccccccccccC--------CCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 161 --VSLLRTTCGTPNYVAPEVLSHK--------GYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 161 --~~~~~~~~~~~~~~~Pe~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
........+++.|+|||.+... ...+.++|+||||+++|+|++|..||...+..+
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 250 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1112233467889999999742 222589999999999999999999998876543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=250.09 Aligned_cols=198 Identities=29% Similarity=0.415 Sum_probs=154.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 85 (218)
+.|.+.+.||+|+||+||.+. ..+|+.||||.+.... .+.+.+|+..+..+ +||||+++++++...+..++|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 346778999999999998654 4578999999886533 24566788888876 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC-------------Cc
Q 027809 86 LEFITGGELFDKIVHHGRL-------SESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ-------------GH 145 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~-------------~~ 145 (218)
+|++++ +|.+.+...... ++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.
T Consensus 88 ~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 999975 999999765432 233467899999999999999999999999999999654 48
Q ss_pred EEEeeccccccCCCCCcc----cccccccCccccccccccC------CCCCcchhhhhHhHHHHHHhh-cCCCCCCCC
Q 027809 146 LKISDFGLSALPEQGVSL----LRTTCGTPNYVAPEVLSHK------GYNGAAADVWSCGVILYVLIA-GYLPFDELD 212 (218)
Q Consensus 146 ~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 212 (218)
++|+|||++......... .....+++.|+|||.+.+. ...+.++|+||||+++|+|++ |..||....
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999999765443221 2234678899999999651 233589999999999999999 999997653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=248.64 Aligned_cols=198 Identities=27% Similarity=0.397 Sum_probs=156.7
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+|++.+.||+|+||.|+. ....+++.||||.+..... ....+|+.+++.+ +||||+++++++.+....++|+
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 599999999999999753 3345788999999865332 2245788888888 7999999999999999999999
Q ss_pred EecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---C--CcEEEeeccccccCCCC
Q 027809 87 EFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---Q--GHLKISDFGLSALPEQG 160 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~--~~~~l~d~~~~~~~~~~ 160 (218)
|++++ +|.+.+.... ..++.+++.++.|++.||.|||++|++|+||+|+||+++. + ..++|+|||++......
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99975 9988887654 4566678899999999999999999999999999999953 2 35889999998765432
Q ss_pred C---cccccccccCccccccccccC--CCCCcchhhhhHhHHHHHHhh-cCCCCCCCCc
Q 027809 161 V---SLLRTTCGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIA-GYLPFDELDL 213 (218)
Q Consensus 161 ~---~~~~~~~~~~~~~~Pe~~~~~--~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 213 (218)
. .......+++.|+|||.+... ...+.++|+||||+++|+|++ |..||.....
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 2 122334578999999999742 222479999999999999999 9999976543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=231.48 Aligned_cols=178 Identities=35% Similarity=0.638 Sum_probs=151.4
Q ss_pred cccceEEe-eeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhh-hhcCCCCcceEEEEEEc----
Q 027809 5 KVGKYEVG-RTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVRLHEVLAS---- 78 (218)
Q Consensus 5 ~~~~y~~~-~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~~i~~~~~~~~~---- 78 (218)
.+++|.+. +.||+|++|.||.+.+..+++.||+|.+... ....+|+..+ +..+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 56789888 7899999999999999999999999998643 2344566665 56689999999999876
Q ss_pred CCeEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---CCcEEEeeccc
Q 027809 79 RTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGL 153 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~~~~~l~d~~~ 153 (218)
....++|+|++++++|.+.+.... .+++.+++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 678999999999999999998764 6999999999999999999999999999999999999987 78899999998
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
+..... ..+ +.++|+||||+++|+|++|..||...+.
T Consensus 167 a~~~~~----------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 167 AKETTG----------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp CEECTT----------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred cccccc----------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 753221 122 3789999999999999999999976654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=248.37 Aligned_cols=204 Identities=19% Similarity=0.213 Sum_probs=156.6
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCc---------ce-----
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCV---------VR----- 71 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i---------~~----- 71 (218)
..|+..+.||+|+||.||.|.+..+|+.||||++...........+.+.+|+..+..++| ++. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358999999999999999999999999999999875444444446778899999998876 211 11
Q ss_pred -------EEEEEEc-----CCeEEEEEEecCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 027809 72 -------LHEVLAS-----RTKIYIILEFITGGELFDKIVH-------HGRLSESEARRYFQQLIDGVDYCHSKGVYHRD 132 (218)
Q Consensus 72 -------~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~d 132 (218)
+...+.. ....+++++.+. ++|.+++.. ...+++..++.++.|++.||.|||++|++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 224677777765 588887741 23477889999999999999999999999999
Q ss_pred CCCCCeEecCCCcEEEeeccccccCCCCCcccccccccCccccccccc----------cCCCCCcchhhhhHhHHHHHHh
Q 027809 133 LKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS----------HKGYNGAAADVWSCGVILYVLI 202 (218)
Q Consensus 133 i~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~----------~~~~~~~~~Di~slG~~l~~l~ 202 (218)
|||+||+++.++.+||+|||++...... .....+ +.|+|||.+. ...+ +.++|+||||+++|+|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHH
Confidence 9999999999999999999998755443 233456 8999999993 3333 47999999999999999
Q ss_pred hcCCCCCCCCcccc
Q 027809 203 AGYLPFDELDLTTL 216 (218)
Q Consensus 203 ~g~~pf~~~~~~~~ 216 (218)
+|+.||...+..+.
T Consensus 312 tg~~Pf~~~~~~~~ 325 (413)
T 3dzo_A 312 CADLPNTDDAALGG 325 (413)
T ss_dssp HSSCCCCTTGGGSC
T ss_pred HCCCCCCCcchhhh
Confidence 99999988766543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=251.09 Aligned_cols=195 Identities=24% Similarity=0.300 Sum_probs=160.1
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh-----hhhHHHHHHHHHHhhhhcC---------CCCcce
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVR---------HPCVVR 71 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~~~~~l~~l~---------~~~i~~ 71 (218)
.++|++.+.||+|+||.||.|.+ +|+.||+|.+...... .....+.+.+|+.+++.++ |||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 6799999999765321 2223456777777777775 888888
Q ss_pred EEEEEE------------------------------cCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 027809 72 LHEVLA------------------------------SRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121 (218)
Q Consensus 72 ~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~ 121 (218)
+.+.+. ..+..++||||++++++.+.+.. ..+++.+++.++.|++.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 877642 26789999999998866555543 57899999999999999999
Q ss_pred HHH-hCCceeccCCCCCeEecCCC--------------------cEEEeeccccccCCCCCcccccccccCccccccccc
Q 027809 122 YCH-SKGVYHRDLKPENLLLDSQG--------------------HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180 (218)
Q Consensus 122 ~Lh-~~~i~h~di~p~nil~~~~~--------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 180 (218)
||| ++|++|+||||+|||++.++ .+||+|||++...... ...+++.|+|||.+.
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhc
Confidence 999 99999999999999999887 8999999999765432 346788999999998
Q ss_pred cCCCCCcchhhhhHhHH-HHHHhhcCCCCCC
Q 027809 181 HKGYNGAAADVWSCGVI-LYVLIAGYLPFDE 210 (218)
Q Consensus 181 ~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~ 210 (218)
+.. +.++|||||+.+ .+++++|..||..
T Consensus 251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCS--SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred CCC--ccceehhhhhCCCCcccccccCCCcc
Confidence 655 589999998766 7778999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=237.74 Aligned_cols=188 Identities=15% Similarity=0.139 Sum_probs=133.3
Q ss_pred ecCccceEEEEEEecCCCcEEEEEEEecchh-------hhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCCeEEEEE
Q 027809 15 IGEGTFAKVKFAQNTETGESVAMKVLDRSAI-------IKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 15 l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
...|+.|....+...-.|+.+++|.+..... ......+.+.+|+.+++++ +|+|++++++++++++..|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 3445555444444444578899999965421 1233456689999999999 6899999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
||++|++|.+.+...+++++.+ ++.||+.||.|+|++||+|+||||+|||++++|++||+|||++............
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~~---I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t 398 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDREK---ILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTN 398 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHHH---HHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHH
T ss_pred ecCCCCcHHHHHHhCCCCCHHH---HHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccC
Confidence 9999999999999988888764 6789999999999999999999999999999999999999999765554444445
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCC
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLP 207 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 207 (218)
.++++.|+|||.+.+.. ..++|+||+|+.++++.++..|
T Consensus 399 ~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 399 LVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ceechhhccHHHhCCCC--CCcccccccccchhhhccccch
Confidence 67899999999997543 3689999999988877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-29 Score=205.95 Aligned_cols=187 Identities=20% Similarity=0.206 Sum_probs=141.8
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh-----hhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----KHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
...+.||+|+||.||++.. .+..+++|........ .....+++.+|+.++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4467899999999999943 5678899887543322 22234568999999999999999954444445556799
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~- 163 (218)
||||+++++|.+++.. +..++.|++++|.+||++|++|+||||+||+++. .++|+|||++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999988865 6789999999999999999999999999999988 9999999999866543221
Q ss_pred ------cccccccCcccccccccc--CCCCCcchhhhhHhHHHHHHhhcCCCCC
Q 027809 164 ------LRTTCGTPNYVAPEVLSH--KGYNGAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 164 ------~~~~~~~~~~~~Pe~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
.....+++.|+|||.+.. ..+. ...|+||..+-..+-+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence 124457899999999975 4443 67799999988888888877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=165.20 Aligned_cols=135 Identities=19% Similarity=0.258 Sum_probs=107.4
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---------------hHHHHHHHHHHhhhhcCCCCcceE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---------------KMADQIKREISIMKLVRHPCVVRL 72 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---------------~~~~~~~~~~~~l~~l~~~~i~~~ 72 (218)
.|++++.||+|++|.||.|.+ .+|..+|+|.+........ .....+.+|+.+++.++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 345559999999999999999 7899999999854321111 234568899999999984 555
Q ss_pred EEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeecc
Q 027809 73 HEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFG 152 (218)
Q Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~ 152 (218)
.+++.. +..++||||+++++|.+ + ...+...++.|++.++.+||++|++|+||+|+||+++ ++.++|+|||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 554443 44699999999999977 3 1234557999999999999999999999999999999 9999999999
Q ss_pred ccc
Q 027809 153 LSA 155 (218)
Q Consensus 153 ~~~ 155 (218)
++.
T Consensus 238 ~a~ 240 (282)
T 1zar_A 238 QSV 240 (282)
T ss_dssp TCE
T ss_pred CCe
Confidence 886
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-22 Score=149.09 Aligned_cols=140 Identities=20% Similarity=0.250 Sum_probs=108.2
Q ss_pred eEEeeeecCccceEEEEEEecCCCcE--EEEEEEecchhh---------------------hhhHHHHHHHHHHhhhhcC
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGES--VAMKVLDRSAII---------------------KHKMADQIKREISIMKLVR 65 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~--~~ik~~~~~~~~---------------------~~~~~~~~~~~~~~l~~l~ 65 (218)
|++.+.||+|++|.||.|.+..+|.. +|||++...... .......+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778888 999987543211 0111235788899999988
Q ss_pred CCC--cceEEEEEEcCCeEEEEEEecCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCC
Q 027809 66 HPC--VVRLHEVLASRTKIYIILEFITG-G----ELFDKIVHHGRLSESEARRYFQQLIDGVDYCH-SKGVYHRDLKPEN 137 (218)
Q Consensus 66 ~~~--i~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh-~~~i~h~di~p~n 137 (218)
|++ ++.+++. ...++||||+.+ + +|.+.... .++..+..++.|++.++.+|| ++|++|+||+|.|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 765 3444543 245899999942 2 66655432 245678899999999999999 9999999999999
Q ss_pred eEecCCCcEEEeeccccccC
Q 027809 138 LLLDSQGHLKISDFGLSALP 157 (218)
Q Consensus 138 il~~~~~~~~l~d~~~~~~~ 157 (218)
|+++. .++|+|||++...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99987 9999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.2e-19 Score=137.56 Aligned_cols=139 Identities=17% Similarity=0.196 Sum_probs=99.8
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh-----------------hh--hHHHHHHHHHHhhhhcCCCC
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII-----------------KH--KMADQIKREISIMKLVRHPC 68 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----------------~~--~~~~~~~~~~~~l~~l~~~~ 68 (218)
-|++++.||.|++|.||.|.+. +|+.||||++...... +. ........|...+..+.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4899999999999999999975 6899999987432110 00 00112234566666665443
Q ss_pred c--ceEEEEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC--
Q 027809 69 V--VRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-- 144 (218)
Q Consensus 69 i--~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-- 144 (218)
+ +..++.. . .++|||++++.+|.+.. .......++.|++.++.+||++|++|+||+|.|||+++++
T Consensus 175 v~vp~p~~~~--~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQS--R--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEEE--T--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeecc--C--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 3 3333332 2 26999999998885432 1223457789999999999999999999999999998776
Q ss_pred --------cEEEeeccccccC
Q 027809 145 --------HLKISDFGLSALP 157 (218)
Q Consensus 145 --------~~~l~d~~~~~~~ 157 (218)
.+.++||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-13 Score=102.92 Aligned_cols=145 Identities=16% Similarity=0.140 Sum_probs=111.8
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~ 82 (218)
+.++.|++...++.++.+.||.+... +..+++|......... ...+.+|...++.+. +..++++++++...+..
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 45678999999999999999998743 5789999886432111 234677888888774 56788899999888899
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS------------------------------------- 125 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~------------------------------------- 125 (218)
|+|||+++|.+|.+... +......++.++++++..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999988876421 223345778899999999998
Q ss_pred ----------------------CCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 126 ----------------------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 126 ----------------------~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..++|||++|.||++++++.+.++||+.+....
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd 215 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCC
Confidence 448999999999999876666799999776443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.43 E-value=6.4e-13 Score=99.03 Aligned_cols=139 Identities=14% Similarity=0.167 Sum_probs=98.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC--cceEEEEEEcCCeE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEVLASRTKI 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~--i~~~~~~~~~~~~~ 82 (218)
.+..+.+....+.|..+.+|.+.. .+|..+++|...... ...+..|...++.+.+.+ +++++.+....+..
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 345677654444566689999864 456789999875431 134566777777775433 56688888887889
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG----------------------------------- 127 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~----------------------------------- 127 (218)
++|||+++|.+|. . ...+ ...++.+++.++..||...
T Consensus 91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999998873 1 1112 2255667777777777543
Q ss_pred -----------------------ceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 128 -----------------------VYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 128 -----------------------i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
++|||++|.||++++++.+.++||+.+....
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 9999999999999877667799999876543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.3e-11 Score=95.00 Aligned_cols=144 Identities=19% Similarity=0.313 Sum_probs=105.0
Q ss_pred EEeeeecCccceEEEEEEecCCCcEEEEEEEe--cchhhhhhHHHHHHHHHHhhhhcCC--CCcceEEEEEEcC---CeE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLD--RSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASR---TKI 82 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~--~~~~~~~~~~~~~~~~~~~l~~l~~--~~i~~~~~~~~~~---~~~ 82 (218)
..++.++.|.++.+|.+... +..+++|... .... ......+.+|...++.+.. ..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34778899999999998754 4578888765 2221 1123456778888888864 4578888888765 458
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS------------------------------------- 125 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~------------------------------------- 125 (218)
|+|||+++|.++.+. .-..++..+...++.+++.+|..||.
T Consensus 117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999999999777431 12346788888999999999999997
Q ss_pred ---------------------CCceeccCCCCCeEecCCCc--EEEeeccccccCCC
Q 027809 126 ---------------------KGVYHRDLKPENLLLDSQGH--LKISDFGLSALPEQ 159 (218)
Q Consensus 126 ---------------------~~i~h~di~p~nil~~~~~~--~~l~d~~~~~~~~~ 159 (218)
..++|||++|.||+++.++. +.++||+.+.....
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~p 251 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGHP 251 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEECH
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCCH
Confidence 35899999999999987753 68999998875443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3e-11 Score=92.22 Aligned_cols=185 Identities=18% Similarity=0.208 Sum_probs=119.4
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCC--cceEEEEEEcCC---eEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPC--VVRLHEVLASRT---KIYII 85 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv 85 (218)
++.++.|....+|.+. ..+++|..... .....+..|...++.+. +.. +++++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568889999888763 45888875432 23466778888887773 322 445555543332 45889
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS---------------------------------------- 125 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---------------------------------------- 125 (218)
|++++|.++..... ..++..+...++.+++..+..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865333 356777778888888888888885
Q ss_pred ------------------CCceeccCCCCCeEecC--CCcEEEeeccccccCCCCCcccccccccCccccccccc----c
Q 027809 126 ------------------KGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS----H 181 (218)
Q Consensus 126 ------------------~~i~h~di~p~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~----~ 181 (218)
..++|||++|.||++++ ++.+.++||+.+................ .-..|+... .
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHH
Confidence 13699999999999987 5568899999876544322211111000 001122111 0
Q ss_pred CCCC---------CcchhhhhHhHHHHHHhhcCCCCC
Q 027809 182 KGYN---------GAAADVWSCGVILYVLIAGYLPFD 209 (218)
Q Consensus 182 ~~~~---------~~~~Di~slG~~l~~l~~g~~pf~ 209 (218)
-... ....+.|+++.+++.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0000 123689999999999999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=3.8e-08 Score=73.60 Aligned_cols=136 Identities=14% Similarity=0.179 Sum_probs=95.1
Q ss_pred eecCccce-EEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcCCeEEEEEEecCC
Q 027809 14 TIGEGTFA-KVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIYIILEFITG 91 (218)
Q Consensus 14 ~l~~g~~g-~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~ 91 (218)
.+..|..+ .+|......++..+++|.-.... ...+..|...++.+.. --+++++.++++.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 44445554 58888777777889999865432 3456677877777742 2367788998888999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 027809 92 GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS---------------------------------------------- 125 (218)
Q Consensus 92 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~---------------------------------------------- 125 (218)
.++.+..... ......++.+++..+..||.
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8876654321 12233445555555555553
Q ss_pred ------------CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 ------------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ------------~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|||+++.||++++++.+-|+||+.+.....
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gdp 226 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADR 226 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEET
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCCH
Confidence 1278999999999998877778999998775444
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=1.3e-07 Score=72.21 Aligned_cols=139 Identities=19% Similarity=0.234 Sum_probs=93.1
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCC---CcceEEEEEE-cCCeEEEEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP---CVVRLHEVLA-SRTKIYIILE 87 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e 87 (218)
++.++.|....+|.. +..+++|+-.. ......+..|...++.+.+. .+++++.+.. ..+..+++|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456777888888887 45688887422 22346788899999888642 3566677664 4556789999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK----------------------------------------- 126 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~----------------------------------------- 126 (218)
+++|.++..... ..++..+...++.++...+..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988865321 1234444444445554444444431
Q ss_pred -------------------CceeccCCCCCeEecC---CCc-EEEeeccccccCCCCCc
Q 027809 127 -------------------GVYHRDLKPENLLLDS---QGH-LKISDFGLSALPEQGVS 162 (218)
Q Consensus 127 -------------------~i~h~di~p~nil~~~---~~~-~~l~d~~~~~~~~~~~~ 162 (218)
.++|+|++|.|++++. ++. +.++||+.+....+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~~D 230 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPDYD 230 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGGGG
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHHHH
Confidence 3599999999999987 355 58999998876555433
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=2.1e-06 Score=67.81 Aligned_cols=80 Identities=18% Similarity=0.137 Sum_probs=47.2
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchh-hhh---hHHHHHHHHHHhhhhcCC--C-CcceEEEEEEcCCeEE
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IKH---KMADQIKREISIMKLVRH--P-CVVRLHEVLASRTKIY 83 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~---~~~~~~~~~~~~l~~l~~--~-~i~~~~~~~~~~~~~~ 83 (218)
..+.+|.|..+.+|.+....++..+++|....... ... ....+...|...++.+.. + .+++++.+. .+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence 36789999999999997665678899997643211 000 112344566666666532 3 344555542 34457
Q ss_pred EEEEecCCC
Q 027809 84 IILEFITGG 92 (218)
Q Consensus 84 lv~e~~~~~ 92 (218)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.6e-06 Score=67.39 Aligned_cols=82 Identities=10% Similarity=0.240 Sum_probs=51.0
Q ss_pred EEeeee-cCccceEEEEEEec--C----CCcEEEEEEEecch---hhhhhHHHHHHHHHHhhhhcC---CCCcceEEEEE
Q 027809 10 EVGRTI-GEGTFAKVKFAQNT--E----TGESVAMKVLDRSA---IIKHKMADQIKREISIMKLVR---HPCVVRLHEVL 76 (218)
Q Consensus 10 ~~~~~l-~~g~~g~vy~~~~~--~----~~~~~~ik~~~~~~---~~~~~~~~~~~~~~~~l~~l~---~~~i~~~~~~~ 76 (218)
...+.| +.|....+|.+... . ++..+++|...... ... ...+..|...++.+. .-.+++++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 445777 78888899987643 1 15678888764432 101 123445566665553 23467778877
Q ss_pred EcC---CeEEEEEEecCCCCh
Q 027809 77 ASR---TKIYIILEFITGGEL 94 (218)
Q Consensus 77 ~~~---~~~~lv~e~~~~~~L 94 (218)
.+. +..|+|||+++|.++
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCC
T ss_pred cCCCccCCceEEEEecCCCCh
Confidence 654 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=1.7e-05 Score=60.97 Aligned_cols=34 Identities=18% Similarity=0.275 Sum_probs=29.5
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|||+++.||+++.++.+.++||+.+.....
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~~ 255 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDLP 255 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEECCT
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccCCh
Confidence 5799999999999998888999999998765544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.22 E-value=2.9e-05 Score=59.18 Aligned_cols=76 Identities=14% Similarity=0.193 Sum_probs=57.5
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC---CCCcceEEEEEEcCCeEEEEEE
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR---HPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e 87 (218)
-.+.++.|....+|.+.. ++..+++|...... ...+..|...++.+. ...+++++.+....+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 467789999999999875 46688899865431 345667777777663 3567888888887888999999
Q ss_pred ecCCCCh
Q 027809 88 FITGGEL 94 (218)
Q Consensus 88 ~~~~~~L 94 (218)
++++.++
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.08 E-value=3e-05 Score=61.67 Aligned_cols=79 Identities=10% Similarity=0.061 Sum_probs=46.0
Q ss_pred hCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccc-ccCccccccccccCCC--CCcchhhhhHhHHHHHH
Q 027809 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC-GTPNYVAPEVLSHKGY--NGAAADVWSCGVILYVL 201 (218)
Q Consensus 125 ~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~-~~~~~~~Pe~~~~~~~--~~~~~Di~slG~~l~~l 201 (218)
...++|||++|.||+++.++ +.++||+.+....+......... ....|++|+....... ...+..+.++...+++.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45699999999999998776 99999998876554433221110 0123455554431111 11234444666666655
Q ss_pred hhc
Q 027809 202 IAG 204 (218)
Q Consensus 202 ~~g 204 (218)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.87 E-value=4e-05 Score=58.08 Aligned_cols=139 Identities=14% Similarity=0.109 Sum_probs=74.1
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc-ceEEEEEEcCCeEEEEEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILE 87 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e 87 (218)
+.-.+.++.|....+|.+ ..+++|+...... .. .....|...++.+...++ ++++.... +.-++++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE---EY-INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-------C-CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCcc---ce-eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEe
Confidence 333788888999999988 4588888754321 10 112345555554432222 55665533 33468999
Q ss_pred ec-CCCChHHHHH---------------h-c---CCC----C-HHHHHHHHHH--------------HHHHHH----HHH
Q 027809 88 FI-TGGELFDKIV---------------H-H---GRL----S-ESEARRYFQQ--------------LIDGVD----YCH 124 (218)
Q Consensus 88 ~~-~~~~L~~~~~---------------~-~---~~~----~-~~~~~~~~~~--------------i~~~l~----~Lh 124 (218)
++ ++.++..... . + ..+ + ...+..+... +...+. .+.
T Consensus 88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~ 167 (301)
T 3dxq_A 88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA 167 (301)
T ss_dssp CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence 99 6655532100 0 0 001 1 1111111111 111111 111
Q ss_pred ----hCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 125 ----SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 125 ----~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
...++|||+.|.||+ ..++.+.++||..+......
T Consensus 168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~~~ 206 (301)
T 3dxq_A 168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMNDPL 206 (301)
T ss_dssp SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEECTH
T ss_pred hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCCCHH
Confidence 123899999999999 56677899999988765543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.001 Score=49.87 Aligned_cols=79 Identities=10% Similarity=0.021 Sum_probs=52.5
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC---CCcceEEEEEEcCCeEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH---PCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~---~~i~~~~~~~~~~~~~~l 84 (218)
+..-++.+|.|..+.+|.+... +|+.+++|......... ...+..|...++.+.. --+++++... ..++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 4667888999999999999854 78899999764432111 2335677777777642 2345555542 2368
Q ss_pred EEEecCCCCh
Q 027809 85 ILEFITGGEL 94 (218)
Q Consensus 85 v~e~~~~~~L 94 (218)
++|++++...
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999886543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00025 Score=56.51 Aligned_cols=74 Identities=15% Similarity=0.165 Sum_probs=46.5
Q ss_pred EeeeecCccceEEEEEEecC-------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc-ceEEEEEEcCCeE
Q 027809 11 VGRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKI 82 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i-~~~~~~~~~~~~~ 82 (218)
-++.++.|....+|.+.... ++..+++|+..... . ...+..|...++.+...++ +++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678878889999987642 25789999874321 1 1233356666766643333 566766542
Q ss_pred EEEEEecCCCC
Q 027809 83 YIILEFITGGE 93 (218)
Q Consensus 83 ~lv~e~~~~~~ 93 (218)
.+|+++++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28899988633
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00082 Score=51.16 Aligned_cols=143 Identities=13% Similarity=0.126 Sum_probs=74.4
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC--cceEEEE------EEcCC
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC--VVRLHEV------LASRT 80 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~--i~~~~~~------~~~~~ 80 (218)
..-.+.++.|....+|.+... +| .+++|...... +. ..+..+...++.+.... +++++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 344667777888889988754 33 68889876521 11 22333444444332111 2222211 12345
Q ss_pred eEEEEEEecCCCChHH---------------HHHhcCCC--------C---HHHHHH------------HHHHHHHHHHH
Q 027809 81 KIYIILEFITGGELFD---------------KIVHHGRL--------S---ESEARR------------YFQQLIDGVDY 122 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~---------------~~~~~~~~--------~---~~~~~~------------~~~~i~~~l~~ 122 (218)
..++++++++|.++.. +......+ . +...+. +...+...+..
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 6789999998754310 00100011 1 111000 00113344455
Q ss_pred HHh-------CCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 123 CHS-------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 123 Lh~-------~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
+.+ .+++|||+++.||+++.++.+.++||+.+....
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g~ 219 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDL 219 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccCch
Confidence 542 369999999999999877666899998876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00051 Score=53.80 Aligned_cols=140 Identities=18% Similarity=0.201 Sum_probs=80.1
Q ss_pred eeeecCccceEEEEEEecC-------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcCCeEE
Q 027809 12 GRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIY 83 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~~~~~ 83 (218)
++.+..|-...+|.+.... ++..+++|+..... .....+.+|...++.+.. .--++++..+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 4566667777888887642 35789999853311 123445577777776642 223667766643 2
Q ss_pred EEEEecCCCChHH----------HH----Hh-c-------CCCC--HHHHHHHHHHHHH-------------------HH
Q 027809 84 IILEFITGGELFD----------KI----VH-H-------GRLS--ESEARRYFQQLID-------------------GV 120 (218)
Q Consensus 84 lv~e~~~~~~L~~----------~~----~~-~-------~~~~--~~~~~~~~~~i~~-------------------~l 120 (218)
+|+|+++|.+|.. .+ .. + .+.. +.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998754421 11 00 0 1112 3455555544322 12
Q ss_pred HHH----Hh----CCceeccCCCCCeEecCC----CcEEEeeccccccCCC
Q 027809 121 DYC----HS----KGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQ 159 (218)
Q Consensus 121 ~~L----h~----~~i~h~di~p~nil~~~~----~~~~l~d~~~~~~~~~ 159 (218)
..| .. ..++|+|+.+.||+++.+ +.+.++||..+.....
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~~ 257 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNYR 257 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEEH
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCCh
Confidence 333 22 249999999999999876 7899999998875443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00096 Score=51.11 Aligned_cols=37 Identities=24% Similarity=0.346 Sum_probs=30.1
Q ss_pred CCceeccCCCCCeEecCC----CcEEEeeccccccCCCCCc
Q 027809 126 KGVYHRDLKPENLLLDSQ----GHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~----~~~~l~d~~~~~~~~~~~~ 162 (218)
..++|||+++.||+++.+ +.+.++||+.+........
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~~D 223 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRAYD 223 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTTHH
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCHHH
Confidence 469999999999999874 6799999998876555433
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0053 Score=47.22 Aligned_cols=34 Identities=21% Similarity=0.353 Sum_probs=28.8
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|||+++.|+++++++.+.++||+.+.....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 3599999999999998888899999987765443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0025 Score=45.61 Aligned_cols=97 Identities=15% Similarity=0.124 Sum_probs=63.9
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccccc
Q 027809 92 GELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCG 169 (218)
Q Consensus 92 ~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 169 (218)
.+|.+.+... .+++++++|.++.|.+.+|...-. +.-...-+.|..|++..+|.+...+ +.+. ..
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG 99 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence 3788888654 589999999999999999887732 2222345667899999999988864 1110 01
Q ss_pred cCccccccccccCCCCCcchhhhhHhHHHHHHhh
Q 027809 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA 203 (218)
Q Consensus 170 ~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~ 203 (218)
...+.+||... ...+.+.-|||||+++|.-+-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 12456787763 223478999999999997663
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0053 Score=46.75 Aligned_cols=32 Identities=16% Similarity=0.040 Sum_probs=26.4
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|||+++.||+++ + .+.++||+.+.....
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~ 226 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPA 226 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCEECT
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcH
Confidence 3489999999999998 4 899999987765443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0012 Score=51.47 Aligned_cols=75 Identities=13% Similarity=0.075 Sum_probs=41.3
Q ss_pred EeeeecCccceEEEEEEecC--------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC-cceEEEEEEcCCe
Q 027809 11 VGRTIGEGTFAKVKFAQNTE--------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASRTK 81 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~--------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~-i~~~~~~~~~~~~ 81 (218)
..+.++.|....+|.+.... .+..+++|+...... . ......|...++.+...+ .++++..+ .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35677778888899887643 136788898654221 1 111245555555554323 45666554 22
Q ss_pred EEEEEEecCCCC
Q 027809 82 IYIILEFITGGE 93 (218)
Q Consensus 82 ~~lv~e~~~~~~ 93 (218)
++|+++++|.+
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0046 Score=49.66 Aligned_cols=76 Identities=13% Similarity=0.148 Sum_probs=46.0
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc-ceEEEEEEcCCeEEEEEEec
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV-VRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~ 89 (218)
-++.|+.|-...+|.+.....+..+++|+..... ... -+...|...++.+...++ ++++..+. +. .|+||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEI-INREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence 3567887888899998875445789999874321 111 112466777777754444 56677663 22 499999
Q ss_pred CCCCh
Q 027809 90 TGGEL 94 (218)
Q Consensus 90 ~~~~L 94 (218)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.012 Score=46.77 Aligned_cols=32 Identities=31% Similarity=0.497 Sum_probs=27.5
Q ss_pred CceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 127 ~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
.++|+|+.+.|++ +.++.+.++||..+.....
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~~~ 294 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAINFA 294 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEEEH
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCcCCh
Confidence 4899999999999 7888999999998875543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.76 E-value=0.067 Score=42.08 Aligned_cols=33 Identities=30% Similarity=0.486 Sum_probs=27.4
Q ss_pred ceeccCCCCCeEe------cCCCcEEEeeccccccCCCC
Q 027809 128 VYHRDLKPENLLL------DSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 128 i~h~di~p~nil~------~~~~~~~l~d~~~~~~~~~~ 160 (218)
++|+|+.+.||++ +++..+.++||..+......
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~~~ 284 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRG 284 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEEHH
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCCch
Confidence 6799999999999 45677999999998865543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.095 Score=37.46 Aligned_cols=83 Identities=14% Similarity=0.187 Sum_probs=60.7
Q ss_pred CCCCcceEEEEEEcCCeEEEEEEecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCCeEecC
Q 027809 65 RHPCVVRLHEVLASRTKIYIILEFITGG-ELFDKIVHHGRLSESEARRYFQQLIDGVD-YCHSKGVYHRDLKPENLLLDS 142 (218)
Q Consensus 65 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~~l~-~Lh~~~i~h~di~p~nil~~~ 142 (218)
.+|++ -..+-...+.+.+.++--++. +.. .+ ..++..+.++++.+++.... ++++ -++--++|+|++++.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i---~~~~~~eKlrll~nl~~L~~~~~~~--r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI---RKTTLLSRIRAAIHLVSKVKHHSAR--RLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH---HTSCHHHHHHHHHHHHHHHSSCCSS--SEECCCCGGGEEECT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH---HhcCHHHHHHHHHHHHHHHHHhhhC--ceeEEEeCceEEEeC
Confidence 57888 444446667777777665333 333 33 36789999999999998777 5443 466789999999999
Q ss_pred CCcEEEeeccccc
Q 027809 143 QGHLKISDFGLSA 155 (218)
Q Consensus 143 ~~~~~l~d~~~~~ 155 (218)
++.+++.-.|+..
T Consensus 120 ~~~p~i~hRGi~~ 132 (219)
T 4ano_A 120 ALEPFFLHVGVKE 132 (219)
T ss_dssp TCCEEESCCEETT
T ss_pred CCcEEEEEcCCcc
Confidence 9999999887643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.70 E-value=0.063 Score=38.26 Aligned_cols=84 Identities=17% Similarity=0.246 Sum_probs=60.8
Q ss_pred CCCCcceEEEEEEcCCeEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC
Q 027809 65 RHPCVVRLHEVLASRTKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (218)
Q Consensus 65 ~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~ 143 (218)
.+|++++. .+-+..+.+.+.++.-+. .++.. -...+....++++.+++....++++ -+|--++|+|++++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcCC
Confidence 57888877 566666666666655432 23322 2357899999999999998855543 3677899999999999
Q ss_pred CcEEEeeccccc
Q 027809 144 GHLKISDFGLSA 155 (218)
Q Consensus 144 ~~~~l~d~~~~~ 155 (218)
+.+++.-.|+..
T Consensus 116 ~~p~i~~RGik~ 127 (215)
T 4ann_A 116 GLPIAKTRGLQN 127 (215)
T ss_dssp SCEEESCCEETT
T ss_pred CCEEEEEccCcc
Confidence 999999877643
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=81.04 E-value=13 Score=28.36 Aligned_cols=140 Identities=13% Similarity=0.124 Sum_probs=75.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEE-----------
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEV----------- 75 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~----------- 75 (218)
.+++.++....|..|..+... ++..++||.. . ....+.+-.++...-.++-|...-+...
T Consensus 69 ~~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s--~----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L 139 (342)
T 1cja_A 69 QQFKGIERSEKGTEGLFFVET---ESGVFIVKRS--T----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECL 139 (342)
T ss_dssp GGEEEEEECCSTTSCEEEEEE---SSCEEEEECC--T----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHH
T ss_pred cCeeEEEeccCCCCCeEEEEe---CCCEEEEeCc--H----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHH
Confidence 347777888878766665555 4678899943 1 1133445555555445555553322211
Q ss_pred ------E-----EcCCeEEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHH--HHHHHHHHhCC--c--e-eccCCC
Q 027809 76 ------L-----ASRTKIYIILEFITGGELFDKIVH--HGRLSESEARRYFQQL--IDGVDYCHSKG--V--Y-HRDLKP 135 (218)
Q Consensus 76 ------~-----~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i--~~~l~~Lh~~~--i--~-h~di~p 135 (218)
. ...+..+++|+|.+|..|...-.. ...+.. +.+.++ +-++..+..++ . . .+.-++
T Consensus 140 ~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~----~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~ 215 (342)
T 1cja_A 140 AAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTK----STMQQLGSLMALDVIVNNSDRLPIAWTNEGNL 215 (342)
T ss_dssp HHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCH----HHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCG
T ss_pred HHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCH----HHHHhhchhheehhhhcCCccCcccccCCCCh
Confidence 0 012257799999987665321100 001222 223333 22344555443 1 1 123588
Q ss_pred CCeEecCCC-cEEEeeccccccCCC
Q 027809 136 ENLLLDSQG-HLKISDFGLSALPEQ 159 (218)
Q Consensus 136 ~nil~~~~~-~~~l~d~~~~~~~~~ 159 (218)
.||++++++ .+.++|-++++....
T Consensus 216 ~NIL~~~~n~~~~~IDhn~af~~~s 240 (342)
T 1cja_A 216 DNIMLSERGATVVPIDSKIIPLDAS 240 (342)
T ss_dssp GGEEEESBTTCEEECSCCCCCCCSS
T ss_pred hheEEeCCCCeEEEEcCCccccCCc
Confidence 999997654 488999988876543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 218 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-75 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-72 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-71 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-67 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-66 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-64 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-64 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-63 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-63 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-62 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-61 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-58 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-57 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-57 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-55 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-54 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-54 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-48 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-42 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 5e-75
Identities = 74/210 (35%), Positives = 118/210 (56%), Gaps = 3/210 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E+GR +G+G F V A+ ++ +A+KVL ++ + K + Q++RE+ I +RHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++RL+ T++Y+ILE+ G ++ ++ + E Y +L + + YCHSK
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRD+KPENLLL S G LKI+DFG S S T CGT +Y+ PE++ + +
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMH-DE 183
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLY 217
D+WS GV+ Y + G PF+ Y
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETY 213
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 3e-73
Identities = 86/207 (41%), Positives = 130/207 (62%), Gaps = 4/207 (1%)
Query: 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
V +++ +T+GEG + +V+ A N T E+VA+K++D + + IK+EI I K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
H VV+ + Y+ LE+ +GGELFD+I + E +A+R+F QL+ GV Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSAL--PEQGVSLLRTTCGTPNYVAPEVLSHKG 183
G+ HRD+KPENLLLD + +LKISDFGL+ + LL CGT YVAPE+L +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDE 210
++ DVWSCG++L ++AG LP+D+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQ 208
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 6e-72
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 6/210 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+E +G G V + +G +A K++ IK + +QI RE+ ++ P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK- 126
+V + S +I I +E + GG L + GR+ E + +I G+ Y K
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
+ HRD+KP N+L++S+G +K+ DFG+S ++ + GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPERLQGTHY-S 181
Query: 187 AAADVWSCGVILYVLIAGYLPFDELDLTTL 216
+D+WS G+ L + G P D L
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 6e-71
Identities = 70/216 (32%), Positives = 116/216 (53%), Gaps = 3/216 (1%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKL 63
++ ++ G+ +GEG+F+ V A+ T A+K+L++ IIK + RE +M
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 64 VRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
+ HP V+L+ K+Y L + GEL I G E+ R Y +++ ++Y
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGTPNYVAPEVLSH 181
H KG+ HRDLKPEN+LL+ H++I+DFG + + R GT YV+PE+L+
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
K ++D+W+ G I+Y L+AG PF + ++
Sbjct: 185 KSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (547), Expect = 2e-70
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 6/207 (2%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ R IG G+F V FA++ E VA+K + S ++ I +E+ ++ +RHP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ ++++E+ G VH L E E + G+ Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL--SHKGYN 185
+ HRD+K N+LL G +K+ DFG +++ + GTP ++APEV+ +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 191
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELD 212
DVWS G+ L P ++
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMN 218
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 8e-70
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 8/214 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+E+ +G+G F KV AQN ET A KV+D + + EI I+ HP
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPN 70
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSKG 127
+V+L + ++I++EF GG + ++ R L+ES+ + +Q +D ++Y H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL----SHKG 183
+ HRDLK N+L G +K++DFG+SA + + + GTP ++APEV+ S
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
ADVWS G+ L + P EL+ +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-68
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 5/206 (2%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
KY IG+G V A + TG+ VA++ ++ + + I EI +M+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKN 76
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P +V + ++++++E++ GG L D +V + E + ++ + +++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRD+K +N+LL G +K++DFG A S T GTP ++APEV++ K Y G
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-G 194
Query: 187 AAADVWSCGVILYVLIAGYLPFDELD 212
D+WS G++ +I G P+ +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 209 bits (533), Expect = 1e-67
Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 8/213 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y++ +G G F V TG + A K + + +++EI M ++RHP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 83
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSK 126
+V LH+ ++ +I EF++GGELF+K+ H ++SE EA Y +Q+ G+ + H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 127 GVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
H DLKPEN++ ++ LK+ DFGL+A + S ++ T GT + APEV K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTTGTAEFAAPEVAEGKPV 202
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
G D+WS GV+ Y+L++G PF +
Sbjct: 203 -GYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 209 bits (532), Expect = 2e-67
Identities = 65/214 (30%), Positives = 111/214 (51%), Gaps = 8/214 (3%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y++ +G G F V TG K ++ + +K EISIM + H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISIMNQLHH 85
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHS 125
P ++ LH+ + ++ +ILEF++GGELFD+I ++SE+E Y +Q +G+ + H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 126 KGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
+ H D+KPEN++ +++ +KI DFGL+ +++ T T + APE++ +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP 204
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
G D+W+ GV+ YVL++G PF D
Sbjct: 205 V-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-67
Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
YEV TIG G++ + + + G+ + K LD ++ + + + E+++++ ++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 68 CVVRLHEVLASRT--KIYIILEFITGGELFDKIVHHGR----LSESEARRYFQQLIDGVD 121
+VR ++ + RT +YI++E+ GG+L I + L E R QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 122 YCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAP 176
CH + V HRDLKP N+ LD + ++K+ DFGL+ + S + GTP Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 177 EVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
E ++ Y +D+WS G +LY L A PF L
Sbjct: 184 EQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELA 223
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-67
Identities = 67/210 (31%), Positives = 116/210 (55%), Gaps = 2/210 (0%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHP 67
+ + + +G+G+F KV A+ +T + A+K L + ++ + E ++ L HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ + ++ ++ ++E++ GG+L I + S A Y ++I G+ + HSKG
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ +RDLK +N+LLD GH+KI+DFG+ G + T CGTP+Y+APE+L + Y
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NH 182
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ D WS GV+LY ++ G PF D L+
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (524), Expect = 8e-67
Identities = 87/213 (40%), Positives = 131/213 (61%), Gaps = 7/213 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y+ +G G F++V A++ T + VA+K + + A+ + ++ EI+++ ++HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHP 67
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V L ++ S +Y+I++ ++GGELFD+IV G +E +A R Q++D V Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 128 VYHRDLKPENLLL---DSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ HRDLKPENLL D + ISDFGLS + + G S+L T CGTP YVAPEVL+ K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY 186
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
A D WS GVI Y+L+ GY PF + + L+
Sbjct: 187 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 203 bits (518), Expect = 2e-66
Identities = 68/222 (30%), Positives = 116/222 (52%), Gaps = 13/222 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH------KMADQIKREISIM 61
YE +G G + V+ + T + A+K++D + ++ + +E+ I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 62 KLVR-HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
+ V HP +++L + + T +++ + + GELFD + LSE E R+ + L++ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
H + HRDLKPEN+LLD ++K++DFG S + G LR CGTP+Y+APE++
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 182
Query: 181 -----HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ G D+WS GVI+Y L+AG PF +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-64
Identities = 55/211 (26%), Positives = 105/211 (49%), Gaps = 10/211 (4%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
G+ VG+ IG G+F V + VA+K+L+ +A ++ K E+ +++ RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHS 125
++ ++ ++ I+ ++ G L+ + + + + +Q G+DY H+
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSAL--PEQGVSLLRTTCGTPNYVAPEVLSHKG 183
K + HRDLK N+ L +KI DFGL+ + G G+ ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 184 YN--GAAADVWSCGVILYVLIAGYLPFDELD 212
N +DV++ G++LY L+ G LP+ ++
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 8e-64
Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 13/212 (6%)
Query: 7 GKY-EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
G++ + IG G+F V +TET VA L + K + + K E ++K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 66 HPCVVRLHEVLASRTK----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
HP +VR ++ S K I ++ E +T G L + + R + +Q++ G+
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 122 YCHSKG--VYHRDLKPENLLLDSQ-GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
+ H++ + HRDLK +N+ + G +KI D GL+ L S + GTP ++APE+
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEM 184
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
K + DV++ G+ + + P+ E
Sbjct: 185 YEEKY--DESVDVYAFGMCMLEMATSEYPYSE 214
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-64
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 9/213 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY + +G G F V T + ++ K + +K +K+EISI+ + RH
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK----VKGTDQVLVKKEISILNIARHR 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSK 126
++ LHE S ++ +I EFI+G ++F++I L+E E Y Q+ + + + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 127 GVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
+ H D++PEN++ ++ +KI +FG + + G R P Y APEV H
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180
Query: 185 NGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
A D+WS G ++YVL++G PF +
Sbjct: 181 -STATDMWSLGTLVYVLLSGINPFLAETNQQII 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 199 bits (506), Expect = 2e-63
Identities = 69/212 (32%), Positives = 112/212 (52%), Gaps = 5/212 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR--- 65
+ V R IG G F +V + +TG+ AMK LD+ I + E ++ LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
P +V + + K+ IL+ + GG+L + HG SE++ R Y ++I G+++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYN 185
+ V +RDLKP N+LLD GH++ISD GL+ + + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAY 183
Query: 186 GAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
++AD +S G +L+ L+ G+ PF + +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-63
Identities = 74/210 (35%), Positives = 114/210 (54%), Gaps = 1/210 (0%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ + +G+GTF KV + TG AMK+L + II E +++ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+ L + ++ ++E+ GGELF + +E AR Y +++ ++Y HS+
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V +RD+K ENL+LD GH+KI+DFGL + ++T CGTP Y+APEVL Y G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLY 217
A D W GV++Y ++ G LPF D L+
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 196 bits (498), Expect = 7e-63
Identities = 74/210 (35%), Positives = 124/210 (59%), Gaps = 4/210 (1%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+++ RT+G G+F +V ++ G AMKVL + +++ K + E ++ +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGV 128
++R+ +I++I+++I GGELF + R A+ Y ++ ++Y HSK +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 129 YHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
+RDLKPEN+LLD GH+KI+DFG + + + T CGTP+Y+APEV+S K Y +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPY-NKS 181
Query: 189 ADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
D WS G+++Y ++AGY PF + + Y
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (490), Expect = 3e-62
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 8/218 (3%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+YE+G +G G ++V A++ VA+KVL + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 67 PCVVRLHEVLASRTK----IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
P +V +++ + T YI++E++ G L D + G ++ A +++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL---PEQGVSLLRTTCGTPNYVAPEVL 179
H G+ HRD+KP N+++ + +K+ DFG++ V+ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
A +DV+S G +LY ++ G PF ++
Sbjct: 187 RGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-61
Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 9/210 (4%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKM---ADQIKREISIMKL 63
+Y+VG +G G F V VA+K +++ I ++ E+ ++K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 64 VR--HPCVVRLHEVLASRTKIYIILEFITGG-ELFDKIVHHGRLSESEARRYFQQLIDGV 120
V V+RL + +ILE +LFD I G L E AR +F Q+++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 121 DYCHSKGVYHRDLKPENLLLD-SQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVL 179
+CH+ GV HRD+K EN+L+D ++G LK+ DFG AL + ++ GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWI 181
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
+ Y+G +A VWS G++LY ++ G +PF+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 1e-60
Identities = 76/210 (36%), Positives = 126/210 (60%), Gaps = 4/210 (1%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+++ +T+G G+F +V ++ E+G AMK+LD+ ++K K + E I++ V P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L + +Y+++E++ GGE+F + GR SE AR Y Q++ +Y HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ +RDLKPENLL+D QG+++++DFG + ++ T CGTP +APE++ KGYN
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKGYN-K 217
Query: 188 AADVWSCGVILYVLIAGYLPFDELDLTTLY 217
A D W+ GV++Y + AGY PF +Y
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-60
Identities = 80/209 (38%), Positives = 124/209 (59%), Gaps = 9/209 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK---MADQIKREISIMKLV 64
Y+ G +G G FA VK + TG A K + + + + I+RE+SI+K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
+HP V+ LHEV ++T + +ILE + GGELFD + L+E EA + +Q+++GV Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 125 SKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
S + H DLKPEN++L + +KI DFGL+ + G + + GTP +VAPE+++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 189
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFD 209
++ G AD+WS GVI Y+L++G PF
Sbjct: 190 YEPL-GLEADMWSIGVITYILLSGASPFL 217
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-59
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 21/218 (9%)
Query: 6 VGKYEV-GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KL 63
+ Y+V + +G G KV N T E A+K+L + + +RE+ + +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRA 61
Query: 64 VRHPCVVRLHEVL----ASRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLI 117
+ P +VR+ +V A R + I++E + GGELF +I G +E EA + +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121
Query: 118 DGVDYCHSKGVYHRDLKPENLLLDSQ---GHLKISDFGLSALPEQGVSLLRTTCGTPNYV 174
+ + Y HS + HRD+KPENLL S+ LK++DFG + + L T C TP YV
Sbjct: 122 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYV 180
Query: 175 APEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
APEVL + Y + D+WS GVI+Y+L+ GY PF
Sbjct: 181 APEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNH 217
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-58
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 2/202 (0%)
Query: 10 EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK--MADQIKREISIMKLVRHP 67
E +GEG FA V A++ T + VA+K + + K + REI +++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
++ L + ++ I ++ +F+ + L+ S + Y + G++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
+ HRDLKP NLLLD G LK++DFGL+ T Y APE+L G
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 188 AADVWSCGVILYVLIAGYLPFD 209
D+W+ G IL L+
Sbjct: 181 GVDMWAVGCILAELLLRVPFLP 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-58
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 10/209 (4%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y IGEG + V A + VA+K + + REI I+ RH
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 67 PCVVRLHEVLASRT----KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
++ +++++ + T K ++ + G +L+ ++ LS + Q++ G+ Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKY 124
Query: 123 CHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL---PEQGVSLLRTTCGTPNYVAPEVL 179
HS V HRDLKP NLLL++ LKI DFGL+ + L T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 180 SHKGYNGAAADVWSCGVILYVLIAGYLPF 208
+ + D+WS G IL +++ F
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIF 213
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 1e-57
Identities = 68/203 (33%), Positives = 106/203 (52%), Gaps = 2/203 (0%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ IGEGT+ V A+N TGE VA+K + R + REIS++K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHP 61
Query: 68 CVVRLHEVLASRTKIYIILEFI-TGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
+V+L +V+ + K+Y++ EF+ + F + + Y QL+ G+ +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRDLKP+NLL++++G +K++DFGL+ V T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 187 AAADVWSCGVILYVLIAGYLPFD 209
A D+WS G I ++ F
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-57
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 13/220 (5%)
Query: 2 VVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM 61
+V KYE IG+GTF +V A++ +TG+ VA+K + K REI I+
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKIL 63
Query: 62 KLVRHPCVVRLHEVLASRT--------KIYIILEFITGGELFDKIVHHGRLSESEARRYF 113
+L++H VV L E+ ++ IY++ +F + + SE +R
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS----LLRTTCG 169
Q L++G+ Y H + HRD+K N+L+ G LK++DFGL+ +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFD 209
T Y PE+L + G D+W G I+ +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 9e-57
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ ++ +TIG+G F V G VA+K + A E S+M +RH
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-----NDATAQAFLAEASVMTQLRHS 60
Query: 68 CVVRLHEVLA-SRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCH 124
+V+L V+ + +YI+ E++ G L D + GR L ++ + + ++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGY 184
HRDL N+L+ K+SDFGL+ ++ S T + APE L K +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 177
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+ +DVWS G++L+ + + G +P+ + L +
Sbjct: 178 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 178 bits (452), Expect = 2e-56
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 2/202 (0%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KY IGEGT+ V AQN GE+ A+K + + REISI+K ++H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHS 60
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L++V+ ++ ++ ++ E + V G L A+ + QL++G+ YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRDLKP+NLL++ +G LKI+DFGL+ V T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 188 AADVWSCGVILYVLIAGYLPFD 209
D+WS G I ++ G F
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFP 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-56
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
Y + +G G + V A + TG VA+K L R A + RE+ ++K +RH
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHE 77
Query: 68 CVVRLHEV------LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVD 121
V+ L +V L T Y+++ F+ G K++ H +L E + Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 122 YCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSH 181
Y H+ G+ HRDLKP NL ++ LKI DFGL+ + S + T Y APEV+ +
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVILN 192
Query: 182 KGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
D+WS G I+ +I G F D
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-55
Identities = 50/211 (23%), Positives = 97/211 (45%), Gaps = 9/211 (4%)
Query: 13 RTIGEGTFAKVKFA--QNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVV 70
+ +G G F VK Q + ++VA+K+L A + D++ E ++M+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 71 RLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYH 130
R+ + +++E G L + + + + Q+ G+ Y H
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 131 RDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSHKGYNGA 187
RDL N+LL +Q + KISDFGLS + + + APE +++ + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 189
Query: 188 AADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+DVWS GV+++ + G P+ + + +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-55
Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 1/201 (0%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
KYE IGEGT+ V A+N ET E VA+K + + REI ++K ++H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHK 61
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+VRLH+VL S K+ ++ EF +G L + + QL+ G+ +CHS+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGA 187
V HRDLKP+NLL++ G LK+++FGL+ V T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 188 AADVWSCGVILYVLIAGYLPF 208
+ D+WS G I L P
Sbjct: 182 SIDMWSAGCIFAELANAGRPL 202
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-54
Identities = 50/212 (23%), Positives = 103/212 (48%), Gaps = 9/212 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ +G G F VK+ + VA+K++ ++ + D+ E +M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L+ V + I+II E++ G L + + R + + + + ++Y SK
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
HRDL N L++ QG +K+SDFGLS + + + + + PEVL + ++
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS- 179
Query: 187 AAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+ +D+W+ GV+++ + + G +P++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 211
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 173 bits (439), Expect = 3e-54
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 9/214 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G G + +V + +VA+K L + ++ +E ++MK ++HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHP 73
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHS 125
+V+L V YII EF+T G L D + R +S Q+ ++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT-TCGTPNYVAPEVLSHKGY 184
K HRDL N L+ +K++DFGLS L + APE L++ +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 185 NGAAADVWSCGVILYVLI-AGYLPFDELDLTTLY 217
+DVW+ GV+L+ + G P+ +DL+ +Y
Sbjct: 194 -SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-54
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 10/217 (4%)
Query: 9 YEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
+ +G+G+F V+ + + SVA+K L + + + D RE++ M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCH 124
H ++RL+ V+ + + ++ E G L D++ H G RY Q+ +G+ Y
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT---CGTPNYVAPEVLSH 181
SK HRDL NLLL ++ +KI DFGL Q + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 182 KGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+ + A+D W GV L+ + G P+ L+ + +
Sbjct: 189 RTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 174 bits (441), Expect = 4e-54
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRH 66
Y++ R +G G +++V A N E V +K I+K +IKREI I++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 89
Query: 67 PCVVRLHEVLASRTK--IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCH 124
P ++ L +++ ++ E + + + L++ + R Y +++ +DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQ---LYQTLTDYDIRFYMYEILKALDYCH 146
Query: 125 SKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
S G+ HRD+KP N+++D + L++ D+GL+ G + + PE+L
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQ 205
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDE 210
+ D+WS G +L +I PF
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 9e-54
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 13/219 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLVR 65
++ + IG G F +V G+ VA+K L K E SIM
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFD 85
Query: 66 HPCVVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCH 124
HP V+ L V+ T + II EF+ G L + G+ + + + + G+ Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-----CGTPNYVAPEVL 179
HRDL N+L++S K+SDFGLS E S T + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 180 SHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
++ + A+DVWS G++++ +++ G P+ ++ +
Sbjct: 206 QYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-53
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 8/214 (3%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+Y+ +G G + V A +T+TG VA+K L R A + RE+ ++K ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 77
Query: 68 CVVRLHEVLASRTKI----YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYC 123
V+ L +V + + L G + IV +L++ + Q++ G+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKG 183
HS + HRDLKP NL ++ LKI DFGL+ + ++ T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIMLNWM 194
Query: 184 YNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
+ D+WS G I+ L+ G F D
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 228
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-53
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
Y + IG G+F V A+ ++GE VA+K + + K RE+ IM+ + H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74
Query: 69 VVRLHEVLAS------RTKIYIILEFITGG---ELFDKIVHHGRLSESEARRYFQQLIDG 119
+VRL S + ++L+++ L + Y QL
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEV 178
+ Y HS G+ HRD+KP+NLLLD LK+ DFG + +G + + Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPEL 193
Query: 179 LSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212
+ ++ DVWS G +L L+ G F
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-52
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 11/210 (5%)
Query: 15 IGEGTFAKVKFAQN--TETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRL 72
+G G F V+ + VA+KVL + + +++ RE IM + +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 73 HEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHR 131
V + +++E GG L +V + S Q+ G+ Y K HR
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 132 DLKPENLLLDSQGHLKISDFGLSAL---PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAA 188
DL N+LL ++ + KISDFGLS + + + APE ++ + ++ +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192
Query: 189 ADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+DVWS GV ++ ++ G P+ ++ +
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-52
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 11/214 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
++ +G G F +V VA+K L + ++ D E ++MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG--RLSESEARRYFQQLIDGVDYCHS 125
+VRL+ V+ ++ IYII E++ G L D + +L+ ++ Q+ +G+ +
Sbjct: 69 RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGY 184
+ HRDL+ N+L+ KI+DFGL+ L E R + APE +++ G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GT 186
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+DVWS G++L ++ G +P+ + +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (423), Expect = 8e-52
Identities = 43/224 (19%), Positives = 83/224 (37%), Gaps = 19/224 (8%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
Y+VGR IGEG+F + N + VA+K + A Q++ E KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAG 59
Query: 67 -PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS 125
+ ++ ++++ + + + S +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 126 KGVYHRDLKPENLLLDSQ-----GHLKISDFGLSALPEQGVS-------LLRTTCGTPNY 173
K + +RD+KP+N L+ + + DFG+ V+ + GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
++ + D+ + G + + G LP+ L T
Sbjct: 180 MSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 9e-52
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 11/214 (5%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHP 67
+ +G+G F +V T VA+K L + + +E +MK +RH
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR--LSESEARRYFQQLIDGVDYCHS 125
+V+L+ V+ S IYI+ E+++ G L D + L + Q+ G+ Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHKGY 184
HRDL+ N+L+ K++DFGL+ L E R + APE + +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+DVWS G++L L G +P+ + +
Sbjct: 192 T-IKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-51
Identities = 54/242 (22%), Positives = 96/242 (39%), Gaps = 35/242 (14%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES-----VAMKVLDRSAIIKHKMADQIKREISIM- 61
E G+ +G G F KV A ++ VA+K+L A + + E+ +M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHH-------------------- 101
+L H +V L IY+I E+ G+L + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 102 ---GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSAL-- 156
L+ + + Q+ G+++ K HRDL N+L+ +KI DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 157 PEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215
+ + ++APE L Y +DVWS G++L+ + + G P+ + +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 216 LY 217
+
Sbjct: 275 NF 276
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-51
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 8/204 (3%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
+ IG G F V + VA+K + A+ + + E +M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 69 VVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYCHSKG 127
+V+L+ V + I ++ EF+ G L D G + + +G+ Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 128 VYHRDLKPENLLLDSQGHLKISDFGL-SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNG 186
V HRDL N L+ +K+SDFG+ + + + T + +PEV S Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-S 180
Query: 187 AAADVWSCGVILYVLIAGYLPFDE 210
+ +DVWS GV+++ + + E
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYE 204
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-51
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 6/215 (2%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDR--SAIIKHKMADQIKREISIMKLVRH 66
++ + +G G F V GE V + V + K +I E +M V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 67 PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSK 126
P V RL + + T I G L H + + Q+ G++Y +
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC--GTPNYVAPEVLSHKGY 184
+ HRDL N+L+ + H+KI+DFGL+ L ++A E + H+ Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 185 NGAAADVWSCGVILYVLIA-GYLPFDELDLTTLYS 218
+DVWS GV ++ L+ G P+D + + + S
Sbjct: 191 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 224
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-51
Identities = 73/215 (33%), Positives = 120/215 (55%), Gaps = 9/215 (4%)
Query: 4 RKVG--KYEVGRTIGEGTFAKVKFAQ---NTETGESVAMKVLDRSAII-KHKMADQIKRE 57
KVG +E+ + +G G + KV + +TG+ AMKVL ++ I+ K K + + E
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 58 ISIMKLVRH-PCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQL 116
+++ +R P +V LH + TK+++IL++I GGELF + R +E E + Y ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 117 IDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLS-ALPEQGVSLLRTTCGTPNYVA 175
+ +++ H G+ +RD+K EN+LLDS GH+ ++DFGLS CGT Y+A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 176 PEVLSHKGYN-GAAADVWSCGVILYVLIAGYLPFD 209
P+++ A D WS GV++Y L+ G PF
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (420), Expect = 2e-51
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 17/228 (7%)
Query: 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISI 60
M +R +Y +GR IG G+F + + GE VA+K+ Q+ E I
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKI 55
Query: 61 MKLVRHP-CVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDG 119
K+++ + + A +++E + + S Q+I
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115
Query: 120 VDYCHSKGVYHRDLKPENLLLDSQGH---LKISDFGLSALPEQGVSL-------LRTTCG 169
++Y HSK HRD+KP+N L+ + I DFGL+ + + G
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 170 TPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
T Y + + D+ S G +L G LP+ L T
Sbjct: 176 TARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-51
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 13/224 (5%)
Query: 4 RKVGKYEVGRTIGEGTFAKVKFAQNTET-GESVAMKVLDRSAIIKHKMADQIKREISIMK 62
R +YE IGEG + KV A++ + G VA+K + R + M RE+++++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLR 62
Query: 63 L---VRHPCVVRLHEVLAS-----RTKIYIILEFITGGEL-FDKIVHHGRLSESEARRYF 113
HP VVRL +V TK+ ++ E + + V + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
QL+ G+D+ HS V HRDLKP+N+L+ S G +K++DFGL+ + ++ L + T Y
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWY 181
Query: 174 VAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
APEVL Y D+WS G I + F
Sbjct: 182 RAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-51
Identities = 55/227 (24%), Positives = 90/227 (39%), Gaps = 20/227 (8%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHP 67
+ IGEG F +V A+ + G + + E+ ++ KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 68 CVVRLHEVLASRTKIYIILEFITGGELFDKIVHH----------------GRLSESEARR 111
++ L R +Y+ +E+ G L D + LS +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 112 YFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTP 171
+ + G+DY K HRDL N+L+ KI+DFGLS E V
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPV 190
Query: 172 NYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
++A E L++ +DVWS GV+L+ +++ G P+ + LY
Sbjct: 191 RWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-50
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 10/216 (4%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES---VAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ E+GR IGEG F V VA+K + ++ +E M+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFD-KIVHHGRLSESEARRYFQQLIDGVDYC 123
HP +V+L V+ + ++II+E T GEL V L + Y QL + Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT-CGTPNYVAPEVLSHK 182
SK HRD+ N+L+ S +K+ DFGLS E + ++APE ++ +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 183 GYNGAAADVWSCGVILY-VLIAGYLPFDELDLTTLY 217
+ A+DVW GV ++ +L+ G PF + +
Sbjct: 185 RFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-49
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 11/209 (5%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGES----VAMKVLDRSAIIKHKMADQIKREISIMKLV 64
+ IG G F +V + VA+K L K ++ E IM
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQF 66
Query: 65 RHPCVVRLHEVLASRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYC 123
H ++RL V++ + II E++ G L + G S + + + G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 124 HSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC---GTPNYVAPEVLS 180
+ HRDL N+L++S K+SDFGLS + E TT + APE +S
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFD 209
++ + A+DVWS G++++ ++
Sbjct: 187 YRKFTS-ASDVWSFGIVMWEVMTYGERPY 214
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 4e-49
Identities = 56/242 (23%), Positives = 94/242 (38%), Gaps = 35/242 (14%)
Query: 8 KYEVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
E R IGEG F +V E VA+K+L A M +RE ++M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR------------------- 103
+P +V+L V A + ++ E++ G+L + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 104 -----LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158
LS +E +Q+ G+ Y + HRDL N L+ +KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 159 QGVSLLRTT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYL-PFDELDLTT 215
++ PE + + Y +DVW+ GV+L+ + + L P+ +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 216 LY 217
+
Sbjct: 251 VI 252
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-48
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 29/229 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIM- 61
+ G+T+G G F KV A ++ +VA+K+L SA + + + + E+ ++
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 62 KLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG------------------R 103
L H +V L +I E+ G+L + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
L + + Q+ G+ + SK HRDL N+LL KI DFGL+ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 164 LRTT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
+ ++APE + +DVWS G+ L+ L +
Sbjct: 202 VVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-47
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 12/217 (5%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+Y+ + IG G V A + +VA+K L R A + RE+ +MK V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNH 75
Query: 67 PCVVRLHEV------LASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGV 120
++ L V L +Y+++E + V L Q++ G+
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGI 132
Query: 121 DYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLS 180
+ HS G+ HRDLKP N+++ S LKI DFGL+ ++ T Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVIL 191
Query: 181 HKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217
GY D+WS G I+ ++ + F D +
Sbjct: 192 GMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-46
Identities = 44/225 (19%), Positives = 90/225 (40%), Gaps = 28/225 (12%)
Query: 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH 66
+ +IG+G F +V GE VA+K+ + + + + EI ++RH
Sbjct: 3 RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 67 PCVVRLHEVL----ASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDY 122
++ + T+++++ ++ G LFD + + ++ + G+ +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 123 CHS--------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT----CGT 170
H + HRDLK +N+L+ G I+D GL+ + + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 171 PNYVAPEVLS-----HKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
Y+APEVL + AD+++ G++ + +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-45
Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 30/237 (12%)
Query: 8 KYEVGRTIGEGTFAKVKFAQNTETGES-------VAMKVLDRSAIIKHKMADQIKREISI 60
+ +G+ +GEG F +V A+ + VA+K+L A K + E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 61 MK-LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHG----------------R 103
MK + +H ++ L +Y+I+E+ + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 104 LSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL 163
LS + Q+ G++Y SK HRDL N+L+ +KI+DFGL+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 164 LRT--TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217
+T ++APE L + Y +DVWS GV+L+ + G P+ + + L+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-44
Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 21/228 (9%)
Query: 8 KYEVGRTIGEGTFAKV-----KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
K + R +G+G+F V K E VA+K ++ +A ++ + + E S+MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 63 LVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGR----------LSESEARRY 112
VVRL V++ +I+E +T G+L + S S+ +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 113 FQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT--CGT 170
++ DG+ Y ++ HRDL N ++ +KI DFG++ + +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 171 PNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLY 217
+++PE L + +DVWS GV+L+ + P+ L +
Sbjct: 199 VRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 4e-44
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 12/208 (5%)
Query: 12 GRTIGEGTFAKV---KFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC 68
IG G F V N A+K L+R I Q E IMK HP
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 69 VVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR-LSESEARRYFQQLIDGVDYCHSK 126
V+ L + L S ++L ++ G+L + I + + + + Q+ G+ + SK
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 127 GVYHRDLKPENLLLDSQGHLKISDFGLSAL----PEQGVSLLRTTCGTPNYVAPEVLSHK 182
HRDL N +LD + +K++DFGL+ V ++A E L
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208
Query: 183 GYNGAAADVWSCGVILYVLIAGYLPFDE 210
+DVWS GV+L+ L+ P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYP 236
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-42
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 26/227 (11%)
Query: 8 KYEVGRTIGEGTFAKVKFAQ-----NTETGESVAMKVLDRSAIIKHKMADQIKREISIMK 62
+ ++G+ +G G F +V A T T +VA+K+L A + ++
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIH 72
Query: 63 LVRHPCVVRLHEV-LASRTKIYIILEFITGGELFDKIVHHGR----------------LS 105
+ H VV L + +I+EF G L + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 106 ESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165
Y Q+ G+++ S+ HRDL N+LL + +KI DFGL+ + +R
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 166 TT--CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210
++APE + + Y +DVWS GV+L+ + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYP 238
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 133 bits (335), Expect = 3e-38
Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 31/237 (13%)
Query: 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV 64
K +Y + R +G G F+ V A++ VAMK++ + + + EI +++ V
Sbjct: 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRV 66
Query: 65 RHPCVVRL-------------HEVLASRTKIYIILEFITGG---ELFDKIVHHGRLSESE 108
+ H +++++ F G K H +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 109 ARRYFQQLIDGVDYCHSK-GVYHRDLKPENLLLDSQG------HLKISDFGLSALPEQGV 161
++ +QL+ G+DY H + G+ H D+KPEN+L++ +KI+D G + ++
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLYS 218
+ T Y +PEVL + G AD+WS +++ LI G F+ + +
Sbjct: 187 ---TNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 2e-21
Identities = 33/217 (15%), Positives = 66/217 (30%), Gaps = 52/217 (23%)
Query: 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMAD---------------Q 53
+G+ +GEG + V + E +K K+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 54 IKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYF 113
+ E ++ ++ V +++ +++E I R+
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 114 QQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTCGTPNY 173
+++ V + +G+ H DL N+L+ +G + I DF S G
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS-----------VEVGEEG- 156
Query: 174 VAPEVLSHKGYN---------GAAADVWSCGVILYVL 201
E+L N D+ S I +L
Sbjct: 157 -WREILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 218 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.82 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=324.27 Aligned_cols=208 Identities=35% Similarity=0.670 Sum_probs=189.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++++.||+|+||.||.|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 67899999999999999999999999999999999776655555667788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||||++++|.+.+....++++.+++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....... ..
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--~~ 162 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RT 162 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--CE
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--cc
Confidence 9999999999999998999999999999999999999999999999999999999999999999999997654432 23
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
...+++.|+|||.+.+..++ .++||||||+++|+|++|+.||...+..++
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 212 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQET 212 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred ccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHH
Confidence 45688999999999987775 999999999999999999999998876654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=323.35 Aligned_cols=208 Identities=41% Similarity=0.729 Sum_probs=182.0
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
..+++|++++.||+|+||.||.|.++.+|+.||+|++..... .+..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 357899999999999999999999999999999999976542 223456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC--
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-- 161 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-- 161 (218)
+||||+++++|.+.+.....+++.+++.++.||+.||.|||++|++|+||||+||++++++++||+|||++.......
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999999999888899999999999999999999999999999999999999999999999999997543321
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.......|++.|+|||.+.+..+.+.++||||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 2233456899999999998877766789999999999999999999976543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=326.48 Aligned_cols=212 Identities=34% Similarity=0.656 Sum_probs=194.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++++.||+|+||.||.|.++.+|+.||+|++...........+.+.+|..+++.++||||+++++++.+.+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 57899999999999999999999999999999999987665555566788899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||+++++|.+.+.....+++..++.++.|++.||+|||++|++|+||||+||+++.+|.+||+|||++..........
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998655544444
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
...+|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+..+++
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 214 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHH
Confidence 556789999999999988886 8999999999999999999999998876653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=320.95 Aligned_cols=210 Identities=33% Similarity=0.617 Sum_probs=186.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
-++|++++.||+|+||.||.|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999776655555667889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC--cc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV--SL 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 163 (218)
|||+++++|.+.+...+.+++.+++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++....... ..
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~ 166 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997554321 12
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....|++.|+|||.+.+..++ .++|||||||++|+|++|+.||...+..++
T Consensus 167 ~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 218 (288)
T d1uu3a_ 167 ANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218 (288)
T ss_dssp ---CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence 2334688999999999887775 899999999999999999999998776554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=317.22 Aligned_cols=203 Identities=28% Similarity=0.518 Sum_probs=181.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 479999999999999999999999999999999865432 22466889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRT 166 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 166 (218)
|||++++|.+++.. +.+++.+++.++.||+.||.|||++|++|+||||+||+++.++++||+|||++............
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 99999999887654 57999999999999999999999999999999999999999999999999999765544444455
Q ss_pred ccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 167 TCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 167 ~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..+++.|+|||.+.+..++ .++||||||+++|+|++|+.||...+..
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~ 222 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPL 222 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred cccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHH
Confidence 6789999999999887775 8999999999999999999999877654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-52 Score=320.03 Aligned_cols=207 Identities=36% Similarity=0.727 Sum_probs=189.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++++.||+|+||.||.|.++.+|+.||+|++........+..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 67899999999999999999999999999999999776655556678889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
|||+++++|...+.....+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++....... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~---~ 159 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---Y 159 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997655432 2
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
...|++.|+|||.+.+..++ .++|+||||+++|+|++|+.||...+..++
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 209 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred cccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHH
Confidence 45688999999999877776 899999999999999999999998876654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=314.43 Aligned_cols=210 Identities=31% Similarity=0.602 Sum_probs=172.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc--CCeE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS--RTKI 82 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~--~~~~ 82 (218)
+.++|++.+.||+|+||.||+|.++.+|+.||+|.+...... +...+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 457899999999999999999999999999999999765443 3445778899999999999999999999854 4568
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEecCCCcEEEeeccc
Q 027809 83 YIILEFITGGELFDKIVH----HGRLSESEARRYFQQLIDGVDYCHSKG-----VYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~Lh~~~-----i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
|+|||||++++|.+++.. ...+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998854 357999999999999999999999876 99999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
+..............+++.|+|||.+.+..++ .++||||||+++|+|++|+.||...+..++
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~ 222 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKEL 222 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eeecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHH
Confidence 97655544444456788999999999877775 999999999999999999999998876654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=320.58 Aligned_cols=206 Identities=28% Similarity=0.468 Sum_probs=183.3
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
...++|++++.||+|+||+||.|.+..+|+.||+|++.... .....+.+.+|+.++++++||||++++++|.+.+..+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35678999999999999999999999999999999987543 3344567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 162 (218)
+||||+++++|.+.+.+.+.+++..++.++.|++.||.|||+ +||+|+||||+|||+++++++||+|||++....+.
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999998999999999999999999999997 59999999999999999999999999998754332
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
......|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+..
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 22345789999999999988776 9999999999999999999999876543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=316.17 Aligned_cols=211 Identities=32% Similarity=0.617 Sum_probs=187.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhh-hhcCCCCcceEEEEEEcCCeEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIM-KLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l-~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
+++|++++.||+|+||+||+|.+..+|+.||||++........+..+.+..|...+ +.++||||+++++++.+.+..|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 47899999999999999999999999999999999766554444455555666555 47899999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||||+++|+|.+++.....+++.+++.++.||+.||+|||++|++|+||+|+|||++++++++|+|||++..........
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998655544444
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTLY 217 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 217 (218)
....+++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+..+++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHH
Confidence 456788999999999988876 8999999999999999999999988876643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-52 Score=315.93 Aligned_cols=204 Identities=27% Similarity=0.464 Sum_probs=183.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEE
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILE 87 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 87 (218)
.|+.++.||+|+||.||.|.+..+|+.||||++........+..+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999977665566666788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccccc
Q 027809 88 FITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTT 167 (218)
Q Consensus 88 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 167 (218)
||.+++|...+....++++.+++.++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++...... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSF 171 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----Ccc
Confidence 9999999888888889999999999999999999999999999999999999999999999999999765442 245
Q ss_pred cccCccccccccccC--CCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 168 CGTPNYVAPEVLSHK--GYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.|++.|+|||.+.+. ...+.++||||||+++|+|++|..||...+..+
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 688999999998643 222489999999999999999999998876544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=315.10 Aligned_cols=206 Identities=32% Similarity=0.534 Sum_probs=180.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
+.|++++.||+|+||.||.|.+..+|..||+|++.... .+..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999986543 233466789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
||+++++|.+++.. ..++++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...........
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999999998765 45799999999999999999999999999999999999999999999999999865443323333
Q ss_pred cccccCcccccccccc-----CCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 166 TTCGTPNYVAPEVLSH-----KGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
...+++.|+|||.+.. ..+ +.++||||||+++|+|++|+.||...++.++
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~ 223 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRV 223 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred ccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH
Confidence 4568899999999852 233 4899999999999999999999998877654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-51 Score=319.75 Aligned_cols=208 Identities=36% Similarity=0.701 Sum_probs=189.5
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++++.||+|+||.||.|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++......++
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 46899999999999999999999999999999999976665555566788899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 85 ILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
|+|++.+++|...+...+.+++.+++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--- 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---
Confidence 99999999999999998999999999999999999999999999999999999999999999999999997654432
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
....+++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+..++
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~ 246 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQI 246 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHH
Confidence 245688999999999887776 999999999999999999999998776544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=314.69 Aligned_cols=206 Identities=41% Similarity=0.785 Sum_probs=167.9
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++.+.||+|+||.||.|.++.+|+.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45999999999999999999999999999999997655332 2356778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---CCCcEEEeeccccccCCCCCcc
Q 027809 87 EFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSALPEQGVSL 163 (218)
Q Consensus 87 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~---~~~~~~l~d~~~~~~~~~~~~~ 163 (218)
|||++++|.+.+...+.+++.++..++.||+.||.|||++|++|+||+|+||++. +++.+||+|||++....... .
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-~ 165 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-V 165 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-e
Confidence 9999999999999988999999999999999999999999999999999999994 57899999999997654432 2
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.....|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..++
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp -------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 3345689999999999887775 899999999999999999999988765543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=302.03 Aligned_cols=202 Identities=27% Similarity=0.515 Sum_probs=176.6
Q ss_pred ccce-EEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc----CC
Q 027809 6 VGKY-EVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----RT 80 (218)
Q Consensus 6 ~~~y-~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----~~ 80 (218)
-++| ++.+.||+|+||+||+|.+..++..||+|.+...... ....+.+.+|+.++++++||||++++++++. ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 4566 7888999999999999999999999999998765443 3345778899999999999999999999864 45
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEec-CCCcEEEeeccccccC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKG--VYHRDLKPENLLLD-SQGHLKISDFGLSALP 157 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~--i~h~di~p~nil~~-~~~~~~l~d~~~~~~~ 157 (218)
.+++||||+++++|.+++.....+++.+++.++.||++||+|||+++ ++|+||||+|||++ +++.+||+|||++...
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 68999999999999999999899999999999999999999999998 99999999999996 5789999999999764
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
... ......|++.|+|||.+.+ .+ +.++||||||+++|+|++|+.||...+
T Consensus 166 ~~~--~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 166 RAS--FAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp CTT--SBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cCC--ccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 432 2235578999999999864 45 499999999999999999999998654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.1e-51 Score=316.26 Aligned_cols=209 Identities=32% Similarity=0.523 Sum_probs=180.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHH---HHHHHhhhhcCCCCcceEEEEEEcCCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQI---KREISIMKLVRHPCVVRLHEVLASRTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~~i~~~~~~~~~~~~ 81 (218)
.+++|++.+.||+|+||.||.|.+..+|+.||+|++........+....+ ..++.+++.++||||+++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46899999999999999999999999999999999976554433333333 344667777889999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.|+||||+++++|.+.+.....+++.+++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997554432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.....|++.|+|||.+......+.++|+|||||++|+|++|+.||...+..+
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2345689999999999754433589999999999999999999998766543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=306.49 Aligned_cols=208 Identities=38% Similarity=0.660 Sum_probs=183.2
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhh---hHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKH---KMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
++|++++.||+|+||.||.|.++.+|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 569999999999999999999999999999999975443221 23567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC----cEEEeeccccccCCC
Q 027809 84 IILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG----HLKISDFGLSALPEQ 159 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~----~~~l~d~~~~~~~~~ 159 (218)
+|||||++++|.+++...+.+++.+++.++.|++.||.|||+++++|+||+|+||+++.++ .+|++|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999999988999999999999999999999999999999999999998766 599999999876544
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
.. ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+.
T Consensus 170 ~~-~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 224 (293)
T d1jksa_ 170 GN-EFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQET 224 (293)
T ss_dssp SC-BCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred Cc-cccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHH
Confidence 32 22345678899999999877665 999999999999999999999998776543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-50 Score=313.67 Aligned_cols=207 Identities=33% Similarity=0.618 Sum_probs=182.3
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
.+++|++++.||+|+||.||.|.+..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999865442 234678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC--CCcEEEeeccccccCCCCC
Q 027809 85 ILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS--QGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 85 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~--~~~~~l~d~~~~~~~~~~~ 161 (218)
|||||++++|.+.+. ..+++++.+++.++.||+.||.|||++|++|+||||+||+++. ++.+||+|||++.......
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999999885 4567999999999999999999999999999999999999954 5789999999987654432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..++
T Consensus 181 -~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 233 (350)
T d1koaa2 181 -SVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDET 233 (350)
T ss_dssp -CEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -ccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence 23345688999999999887775 899999999999999999999998776554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-50 Score=312.38 Aligned_cols=206 Identities=31% Similarity=0.582 Sum_probs=181.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++++.||+|+||.||.|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56799999999999999999999999999999998765422 245678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec--CCCcEEEeeccccccCCCCCc
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD--SQGHLKISDFGLSALPEQGVS 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~--~~~~~~l~d~~~~~~~~~~~~ 162 (218)
||||++++|.+.+... .++++.+++.++.||+.||.|||++|++|+||||+|||++ .++.++|+|||++.......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999998877654 4699999999999999999999999999999999999997 57899999999997655432
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
......+++.|+|||.+.+..++ .++|||||||++|+|++|..||...+..++
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 236 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred ceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 23345678899999999887775 999999999999999999999998776543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-50 Score=303.69 Aligned_cols=209 Identities=25% Similarity=0.473 Sum_probs=178.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----e
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----K 81 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~----~ 81 (218)
.++|++.+.||+|+||.||.|.+..+|+.||+|++......+.+..+.+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 456999999999999999999999999999999997766656666778999999999999999999999987533 4
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.|+||||+++++|.+.+...+++++.+++.++.||+.||++||++|++|+||||+||+++.++..+++|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999876433221
Q ss_pred ---cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 162 ---SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 162 ---~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
.......+++.|+|||.+.+..++ .++||||||+++|+|++|+.||...++.+
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp -------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHH
Confidence 223344688999999999877775 89999999999999999999999877654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-49 Score=299.05 Aligned_cols=210 Identities=32% Similarity=0.600 Sum_probs=183.7
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh------hhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEc
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII------KHKMADQIKREISIMKLVR-HPCVVRLHEVLAS 78 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~ 78 (218)
.++|++.+.||+|+||+||+|.+..+|+.+|+|++...... ..+..+++.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57899999999999999999999999999999999764432 1223456788999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 79 RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
++..|+||||+++++|.+.+..++++++.++..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccccCccccccccccC-----CCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHK-----GYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
... ......+++.|+|||.+.+. ...+.++|+||+|+++|+|++|+.||...+..++
T Consensus 162 ~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 162 PGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223 (277)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence 432 22345678899999998632 2225799999999999999999999998876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=304.13 Aligned_cols=207 Identities=30% Similarity=0.544 Sum_probs=182.3
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~ 83 (218)
+.+++|++++.||+|+||+||.|.++.+|+.+|+|++...... ...+.+|+.+++.++||||+++++++++.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3578999999999999999999999999999999999765422 245778999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC--CcEEEeeccccccCCCC
Q 027809 84 IILEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ--GHLKISDFGLSALPEQG 160 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~--~~~~l~d~~~~~~~~~~ 160 (218)
+|||||++++|.+.+...+ ++++.+++.++.||+.||+|||++|++|+||+|+||+++.+ ..++++|||++......
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999997665 79999999999999999999999999999999999999754 47999999998765443
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
. ......+++.|+|||...+..+. .++|+||||+++|+|++|..||...+..++
T Consensus 158 ~-~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~ 211 (321)
T d1tkia_ 158 D-NFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQI 211 (321)
T ss_dssp C-EEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred C-cccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2 23345678899999999877775 899999999999999999999998876544
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=302.40 Aligned_cols=208 Identities=27% Similarity=0.443 Sum_probs=168.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCc---EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGE---SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~---~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++.+.||+|+||.||+|.++.+++ .|+||.+.... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 4689999999999999999999876654 57888775433 344456789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++|||||++++|.+++... +.+++.+++.++.|++.||.|||+++++|+||+|+|||++.++.+||+|||++.......
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999988764 468999999999999999999999999999999999999999999999999997544322
Q ss_pred cc-----cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 162 SL-----LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 162 ~~-----~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.. .....+++.|+|||.+.+..++ .++||||||+++|||+| |..||...+..++
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~ 242 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHH
Confidence 11 1123357789999999877765 89999999999999998 8999998876654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=300.13 Aligned_cols=206 Identities=26% Similarity=0.423 Sum_probs=177.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.+..+|..||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 4689999999999999999999999999999999865432 246688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-c
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~ 162 (218)
|||+++|+|.+.+... ..+++..++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++....... .
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999998654 568999999999999999999999999999999999999999999999999998654432 2
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcC-CCCCCCCcccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGY-LPFDELDLTTL 216 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~ 216 (218)
......+++.|+|||.+.+..++ .++||||||+++|+|++|. +||...+..++
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~ 225 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 225 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHH
Confidence 22333467889999999887775 9999999999999999955 55666555443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=299.12 Aligned_cols=207 Identities=32% Similarity=0.500 Sum_probs=177.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++++.||+|+||.||.|.+..+|+.||+|++..... .+...+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4789999999999999999999999999999999965432 233356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccc
Q 027809 86 LEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLL 164 (218)
Q Consensus 86 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 164 (218)
||++.++.+..... ....+++.+++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+..........
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99998754443333 34569999999999999999999999999999999999999999999999999997655544444
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
....+++.|+|||.+....+.+.++|+||||+++|+|++|+.||...+.
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 5567889999999988777767999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=301.67 Aligned_cols=204 Identities=27% Similarity=0.398 Sum_probs=173.5
Q ss_pred EeeeecCccceEEEEEEecCCCcEEEEEEEecchhhh--hhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEe
Q 027809 11 VGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIK--HKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEF 88 (218)
Q Consensus 11 ~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 88 (218)
.+++||+|+||+||.|.+..+|+.||||++....... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999986543221 12235678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCccccccc
Q 027809 89 ITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLRTTC 168 (218)
Q Consensus 89 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 168 (218)
+.++++.........+++.++..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++..............
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 99987777766677899999999999999999999999999999999999999999999999999976555444444556
Q ss_pred ccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 169 GTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 169 ~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+++.|+|||.+......+.++|||||||++|+|++|..||...+..
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 207 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH
Confidence 8899999999876555458999999999999999999999876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=292.58 Aligned_cols=205 Identities=25% Similarity=0.437 Sum_probs=168.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
-++|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+..+++++||||+++++++...+..++|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 358999999999999999999976 5678999998654322 35688999999999999999999999988999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-c
Q 027809 86 LEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS-L 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 163 (218)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++........ .
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999999987654 5688999999999999999999999999999999999999999999999999976544322 2
Q ss_pred cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 164 LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 164 ~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.....+++.|+|||.+....++ .++||||||+++|||+| |.+||...+..++
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~ 211 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 211 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHH
Confidence 2334578899999999877775 99999999999999999 6778877766544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=296.87 Aligned_cols=205 Identities=26% Similarity=0.472 Sum_probs=170.1
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~l 84 (218)
..++|++++.||+|+||.||.|..+ ..||||++..... +.+..+.+.+|+.++.+++||||+++++++.. +..++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 3578999999999999999999764 3699999865433 33456788999999999999999999998754 56899
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC--
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-- 161 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-- 161 (218)
||||+++++|.+++... .++++.+++.++.|+++||+|||+++++|+||||+|||++.++.+||+|||++.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999998654 569999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccCccccccccccCC--CCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKG--YNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.......+++.|+|||.+.... ..+.++||||||+++|||+||+.||...+..
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~ 215 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH
Confidence 2223345788999999986432 2358999999999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=300.12 Aligned_cols=206 Identities=26% Similarity=0.435 Sum_probs=173.4
Q ss_pred cceEEeeeecCccceEEEEEEecCCCc-----EEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGE-----SVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~-----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
++|++++.||+|+||.||.|.+...++ .|++|.+.... .......+.+|+.++.++ +||||+++++++...+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999875543 68999885543 233346678899999888 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-----------------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPEN 137 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~n 137 (218)
..++|||||++|+|.+++... ..+++.+++.++.|++.||.|||+++++|+||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999999999998654 248999999999999999999999999999999999
Q ss_pred eEecCCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcc
Q 027809 138 LLLDSQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLT 214 (218)
Q Consensus 138 il~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 214 (218)
|+++.++.+||+|||++......... .....+++.|+|||.+.+..++ .++||||||+++|||++ |..||...+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999755443222 2234468899999999877775 99999999999999997 99999987665
Q ss_pred c
Q 027809 215 T 215 (218)
Q Consensus 215 ~ 215 (218)
+
T Consensus 274 ~ 274 (325)
T d1rjba_ 274 A 274 (325)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=293.38 Aligned_cols=207 Identities=27% Similarity=0.443 Sum_probs=174.8
Q ss_pred ccceEEeee-ecCccceEEEEEEecC--CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRT-IGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~-l~~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|.+.+. ||+|+||.||.|.++. ++..||||.+.... .....+.+.+|+.++++++||||+++++++..+ ..
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 367888885 9999999999998753 44579999986543 344467788999999999999999999998764 57
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999999998755 4579999999999999999999999999999999999999999999999999997654322
Q ss_pred cc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 162 SL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 162 ~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.. .....+++.|+|||.+....++ .++||||||+++|||+| |+.||...+..++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~ 221 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEV 221 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH
T ss_pred cccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHH
Confidence 21 1223467899999999877665 99999999999999998 9999998876654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-48 Score=294.84 Aligned_cols=207 Identities=33% Similarity=0.517 Sum_probs=178.8
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++.+.||+|+||+||+|.++ +|+.||||++..... .....+.+.+|+.++++++||||+++++.+.+.+..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999985 789999999966543 333457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
+|++.++.+.......+.+++.+++.++.|++.||++||+++++|+||||+||+++.++.+|++|||.+...........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 99999877777777788899999999999999999999999999999999999999999999999999976554433334
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
...+++.|+|||.+.+..+.+.++|+||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~ 207 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH
Confidence 4557889999999987776679999999999999999999999876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=289.33 Aligned_cols=204 Identities=25% Similarity=0.458 Sum_probs=178.3
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIIL 86 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 86 (218)
++|++++.||+|+||+||+|..+ ++..||||++...... .+.+.+|+..+.+++||||+++++++...+..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 68999999999999999999985 6788999998765432 356889999999999999999999999989999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC-Cccc
Q 027809 87 EFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG-VSLL 164 (218)
Q Consensus 87 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~-~~~~ 164 (218)
||+++++|...+.. ...+++..+++++.|+++||.|||++|++|+||+|+||+++.++.+||+|||++...... ....
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 99999999888654 457899999999999999999999999999999999999999999999999999754432 2222
Q ss_pred ccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 165 RTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 165 ~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
....+++.|+|||.+.+..++ .++||||||+++|||+| |+.||...+..++
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred cccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHH
Confidence 234577899999999987776 89999999999999998 8999999887654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=294.39 Aligned_cols=205 Identities=34% Similarity=0.572 Sum_probs=176.4
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhh---HHHHHHHHHHhhhhcC--CCCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHK---MADQIKREISIMKLVR--HPCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~~~~~~l~~l~--~~~i~~~~~~~~~~ 79 (218)
..++|++++.||+|+||.||.|.+..+|+.||||++......... ...++.+|+.++++++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 357899999999999999999999999999999999754432211 1233567888888886 89999999999999
Q ss_pred CeEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-CCcEEEeeccccccC
Q 027809 80 TKIYIILEFITG-GELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-QGHLKISDFGLSALP 157 (218)
Q Consensus 80 ~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-~~~~~l~d~~~~~~~ 157 (218)
+..++|+|++.+ +++.+.+.....+++.+++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 999999999976 578888888889999999999999999999999999999999999999985 579999999999765
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
... ......|++.|+|||.+.+..+.+.++||||||+++|+|++|+.||...
T Consensus 162 ~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 162 KDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 443 2234568899999999987776667899999999999999999999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=293.13 Aligned_cols=201 Identities=24% Similarity=0.416 Sum_probs=169.3
Q ss_pred eeecCccceEEEEEEecC--CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEEEEecC
Q 027809 13 RTIGEGTFAKVKFAQNTE--TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYIILEFIT 90 (218)
Q Consensus 13 ~~l~~g~~g~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 90 (218)
+.||+|+||.||+|.++. +++.||||++.... .+.+..+.+.+|+.++++++||||++++++++.+ ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 479999999999998653 45789999986543 2344457789999999999999999999999764 5789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc---cccc
Q 027809 91 GGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL---LRTT 167 (218)
Q Consensus 91 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~ 167 (218)
+++|.+++....++++.+++.++.||+.||.|||+++++|+||+|+||+++.++.++++|||++......... ....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999999899999999999999999999999999999999999999999999999999999754432221 2233
Q ss_pred cccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 168 CGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 168 ~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.+++.|+|||.+....++ .++||||||+++|||++ |+.||...+..++
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~ 219 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHH
Confidence 467899999999877665 89999999999999998 9999998876654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=294.28 Aligned_cols=200 Identities=37% Similarity=0.626 Sum_probs=171.3
Q ss_pred cccceEEee-eecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhh-hcCCCCcceEEEEEEc----
Q 027809 5 KVGKYEVGR-TIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMK-LVRHPCVVRLHEVLAS---- 78 (218)
Q Consensus 5 ~~~~y~~~~-~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~-~l~~~~i~~~~~~~~~---- 78 (218)
.+++|++.+ .||+|+||.||.|.+..+++.||||++... ..+.+|+.++. ..+||||+++++++++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 368999875 599999999999999999999999998543 34556777754 4589999999999865
Q ss_pred CCeEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC---CCcEEEeeccc
Q 027809 79 RTKIYIILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS---QGHLKISDFGL 153 (218)
Q Consensus 79 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~---~~~~~l~d~~~ 153 (218)
...+|+|||||++|+|.+++... ..+++.+++.++.|++.||.|||++|++|+||+|+||+++. ++.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 46799999999999999999764 36899999999999999999999999999999999999975 45799999999
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+....... ......+++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+..
T Consensus 161 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 161 AKETTSHN-SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp CEECCCCC-CCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred eeeccCCC-ccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 97654432 23355689999999999887776 8999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=288.60 Aligned_cols=203 Identities=26% Similarity=0.445 Sum_probs=171.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++++.||+|+||.||+|.++ ++..||||++..... ..+.+.+|+.++.+++||||+++++++.+ +..++|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 468999999999999999999976 567899999865432 23568899999999999999999998765 457899
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCc-
Q 027809 86 LEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVS- 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 162 (218)
|||+++|+|.+.+... .++++.+++.++.||++||.|||+++++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999998876443 3699999999999999999999999999999999999999999999999999976554322
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
......+++.|+|||.+....++ .++||||||+++|||+| |.+||...+..+
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred cccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHH
Confidence 22334577899999999876665 99999999999999999 566666665543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=286.19 Aligned_cols=206 Identities=26% Similarity=0.386 Sum_probs=167.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCC----cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETG----ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
..|++.++||+|+||.||+|.++.++ ..||||.+.... ..+....+.+|+.++++++||||+++++++...+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 56999999999999999999987554 469999986543 333456688999999999999999999999998999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++|+|++.++++.+.+... ..+++.+++.++.|++.|++|||+++++|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999999998877655 579999999999999999999999999999999999999999999999999997644322
Q ss_pred cc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhc-CCCCCCCCccc
Q 027809 162 SL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTT 215 (218)
Q Consensus 162 ~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~ 215 (218)
.. .....+++.|+|||.+.+..++ .++||||||+++|||++| .+||...+..+
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~ 221 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHE 221 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHH
Confidence 21 2233467899999999877775 899999999999999995 55565555443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=284.67 Aligned_cols=208 Identities=28% Similarity=0.447 Sum_probs=166.5
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC---cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.++|++++.||+|+||.||.|.+..++ ..|++|.+.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeE
Confidence 368999999999999999999886543 457888764433 44445778999999999999999999999864 568
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVH-HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
++||||+++++|.+++.. ..++++.+++.++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999887655 4578999999999999999999999999999999999999999999999999997644322
Q ss_pred c-ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 162 S-LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 162 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
. ......+++.|+|||.+....++ .++||||||+++|||++ |.+||...+..+++
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~ 219 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHH
Confidence 2 22334467899999999877775 89999999999999998 99999998877653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=287.41 Aligned_cols=207 Identities=27% Similarity=0.444 Sum_probs=170.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCc----EEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGE----SVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~ 82 (218)
.+|++++.||+|+||.||+|.+..+|+ +||+|.+.... +.+..+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 679999999999999999999887765 57888775433 334467789999999999999999999999875 46
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 83 YIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+++++++.+++|.+.+... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7788888888988877654 579999999999999999999999999999999999999999999999999997654322
Q ss_pred cc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 162 SL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 162 ~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
.. .....+++.|+|||.+.+..++ .++||||||+++|||+| |..||...+..+++
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~ 223 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 22 2233468899999999887775 99999999999999998 89999998877653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=284.48 Aligned_cols=211 Identities=28% Similarity=0.449 Sum_probs=167.5
Q ss_pred ccccceEEeeeecCccceEEEEEEecCC-C--cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTET-G--ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~-~--~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
..-++|++.+.||+|+||.||+|....+ + ..||||.+........+..+.+.+|+.++++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3457799999999999999999986533 2 3689999876665566667889999999999999999999999976 4
Q ss_pred eEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|+||++++++.+.+... +++++..++.++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 678999999999998776554 5799999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCcccc
Q 027809 160 GVSL---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTL 216 (218)
Q Consensus 160 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 216 (218)
.... .....++..|+|||.+.+..++ .++||||||+++|||++ |..||...+..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~ 223 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHH
Confidence 3221 1223356789999999877665 89999999999999998 8999998876654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=281.42 Aligned_cols=204 Identities=34% Similarity=0.499 Sum_probs=182.0
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
+++|++++.||+|+||+||.|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999966543 344567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcccc
Q 027809 86 LEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSLLR 165 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 165 (218)
++++.+++|...+...+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++|||.+...........
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 99999999988888888999999999999999999999999999999999999999999999999999986655443334
Q ss_pred cccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCC
Q 027809 166 TTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDE 210 (218)
Q Consensus 166 ~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 210 (218)
...+++.|.|||.+......+.++||||||+++|+|++|..||-.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 445677899999988766656999999999999999999999643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=282.40 Aligned_cols=203 Identities=25% Similarity=0.400 Sum_probs=166.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCCeEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRTKIYII 85 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~~~~lv 85 (218)
.++|++.+.||+|+||.||.|.++. +..||||++...... .+.+.+|+.++.+++||||+++++++.+ +..++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 5789999999999999999999864 467999998654422 3568899999999999999999999855 557899
Q ss_pred EEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC-c
Q 027809 86 LEFITGGELFDKIVH--HGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV-S 162 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~-~ 162 (218)
|||+++|+|...+.. ...+++.+++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++....... .
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999999888754 3569999999999999999999999999999999999999999999999999997554322 2
Q ss_pred ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhc-CCCCCCCCccc
Q 027809 163 LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTT 215 (218)
Q Consensus 163 ~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~ 215 (218)
......+++.|+|||.+....++ .++||||||+++|||++| .+|+...+..+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~ 222 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNRE 222 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred eeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 22334578899999999877775 999999999999999995 55566555443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=285.15 Aligned_cols=210 Identities=27% Similarity=0.413 Sum_probs=175.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcE--EEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcCC
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGES--VAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASRT 80 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~--~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~~ 80 (218)
..+++|++.+.||+|+||.||+|.++.+|.. |+||.+.... ..+..+.+.+|+.++..+ +||||+++++++...+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 3567999999999999999999999888764 5667664332 333456788999999998 7999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC
Q 027809 81 KIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG 144 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~ 144 (218)
..++||||+++|+|.+++... ..+++.+++.++.||+.|+.|||+++++|+||+|+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998643 4689999999999999999999999999999999999999999
Q ss_pred cEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhc-CCCCCCCCccccc
Q 027809 145 HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLY 217 (218)
Q Consensus 145 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~ 217 (218)
.+||+|||++........ .....++..|+|||.+....++ .++||||||+++|+|++| .+||...+..+++
T Consensus 165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred ceEEcccccccccccccc-ccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999875443222 1234477899999999877775 899999999999999995 5689888876653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-46 Score=283.46 Aligned_cols=208 Identities=26% Similarity=0.394 Sum_probs=176.7
Q ss_pred ccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++++.||+|+||.||+|.+.. ++..||||++.... ..+..+++.+|+.++++++|||++++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 4679999999999999999998753 45789999986543 3344577899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHG------------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPE 136 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~ 136 (218)
..++++|++++++|.+++.... .+++.+++.++.|++.||+|||+++++|+||+|+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999886432 3789999999999999999999999999999999
Q ss_pred CeEecCCCcEEEeeccccccCCCC--CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhc-CCCCCCCCc
Q 027809 137 NLLLDSQGHLKISDFGLSALPEQG--VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDL 213 (218)
Q Consensus 137 nil~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~ 213 (218)
||+++.++.+||+|||++...... ........+++.|+|||.+....++ .++||||||+++|||++| ..||...+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999998643322 1222234567899999999987776 999999999999999998 478998887
Q ss_pred ccc
Q 027809 214 TTL 216 (218)
Q Consensus 214 ~~~ 216 (218)
.++
T Consensus 249 ~e~ 251 (301)
T d1lufa_ 249 EEV 251 (301)
T ss_dssp HHH
T ss_pred HHH
Confidence 665
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=285.93 Aligned_cols=206 Identities=28% Similarity=0.456 Sum_probs=170.9
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~---- 80 (218)
...+|++++.||+|+||+||.|.+..+|+.||||++.... .....+.+.+|+.++++++|||++++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 3468999999999999999999999999999999986543 3445677889999999999999999999986543
Q ss_pred eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCC
Q 027809 81 KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQG 160 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~ 160 (218)
..+++++++.+++|.+++.. ..+++..++.++.|++.||+|||++|++|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 23444455668899998865 47999999999999999999999999999999999999999999999999998754332
Q ss_pred C---cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 V---SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. .......+++.|+|||.+......+.++|+||+|+++|+|++|..||...+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 1 1233455788999999987665556899999999999999999999987664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=284.02 Aligned_cols=210 Identities=29% Similarity=0.399 Sum_probs=174.3
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-----
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS----- 78 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~----- 78 (218)
..+++|++++.||+|+||+||.|.+..+|+.||||++...... +...+++.+|+.+++.++|||++++++++..
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 3579999999999999999999999999999999998655432 3334667899999999999999999998754
Q ss_pred ---CCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccc
Q 027809 79 ---RTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSA 155 (218)
Q Consensus 79 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~ 155 (218)
.+..++++|++.++.+.........+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++++|||++.
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999887776666666789999999999999999999999999999999999999999999999999986
Q ss_pred cCCCC----CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 156 LPEQG----VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 156 ~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
..... ........+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+..
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~ 228 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH
Confidence 44321 112223457889999999986654458999999999999999999999876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=286.68 Aligned_cols=204 Identities=31% Similarity=0.493 Sum_probs=171.0
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT---- 80 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~---- 80 (218)
.-++|++++.||+|+||+||.|.+..+|+.||||++.... .+....+.+.+|+.++++++|||+++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 3478999999999999999999999999999999986543 34455677889999999999999999999997544
Q ss_pred --eEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 81 --KIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 81 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
.+++||||+ +.+|.... ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++++|||++....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 44666555 45689999999999999999999999999999999999999999999999999997655
Q ss_pred CCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 159 QGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 159 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
... ....+++.|+|||.+.+..+.+.++|+||+|+++|+|++|..||...+..
T Consensus 173 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~ 225 (346)
T d1cm8a_ 173 SEM---TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225 (346)
T ss_dssp SSC---CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred Ccc---ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH
Confidence 432 24567889999999987666669999999999999999999999887643
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=277.66 Aligned_cols=202 Identities=27% Similarity=0.510 Sum_probs=167.8
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE-cCCeEE
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA-SRTKIY 83 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~-~~~~~~ 83 (218)
..++|++++.||+|+||.||+|.++ |..||||.+..+. ..+.+.+|+..+++++||||+++++++. ..+.++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 4678999999999999999999984 6789999985433 3466889999999999999999999885 456689
Q ss_pred EEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 84 IILEFITGGELFDKIVHH--GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 84 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
+|+||+++++|.+++... ..+++..++.++.|++.|+.|||+++++|+||+|+||+++.++.++++|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 999999999999998654 358999999999999999999999999999999999999999999999999987544322
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
....+++.|+|||.+.+..++ .++||||||+++|||+| |..||...+..+++
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~ 210 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred ---ccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 233467799999999877665 99999999999999998 89999988876653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=281.99 Aligned_cols=208 Identities=30% Similarity=0.440 Sum_probs=168.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCC-CcEEEEEEEecchhhhhhHHHHHHHHHHhh---hhcCCCCcceEEEEEE--
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTET-GESVAMKVLDRSAIIKHKMADQIKREISIM---KLVRHPCVVRLHEVLA-- 77 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l---~~l~~~~i~~~~~~~~-- 77 (218)
+..++|++++.||+|+||+||.|.+.++ ++.||||++......... ...+.+|+..+ ...+||||++++++|.
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC-BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH-HHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 3467899999999999999999998765 567899998654322211 12233445544 4458999999999985
Q ss_pred ---cCCeEEEEEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 78 ---SRTKIYIILEFITGGELFDKIV-HHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 78 ---~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
.....++++|+++++.+..... ....+++..++.++.|++.||+|||+++++|+||||+|||++.++.++|+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 2357899999999876654433 345689999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 154 SALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
+...... .......+++.|+|||.+.+..++ .++|||||||++|+|++|+.||...+..
T Consensus 163 ~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~ 221 (305)
T d1blxa_ 163 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDV 221 (305)
T ss_dssp CCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hhhhccc-ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHH
Confidence 8755433 223456689999999999887776 9999999999999999999999877654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-46 Score=284.22 Aligned_cols=212 Identities=33% Similarity=0.608 Sum_probs=180.5
Q ss_pred cccceEEeeeecCccceEEEEEEec---CCCcEEEEEEEecchhh-hhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcC
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNT---ETGESVAMKVLDRSAII-KHKMADQIKREISIMKLVRH-PCVVRLHEVLASR 79 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~---~~~~~~~ik~~~~~~~~-~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~ 79 (218)
.+++|++++.||+|+||.||+|.+. .+|+.||+|.+...... +....+.+.+|+.+++.++| |||+++++++++.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 3578999999999999999999874 46889999998654322 22234567789999999977 8999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...++++|++.+++|.+.+...+.+++..++.++.|++.|++|+|+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999875433
Q ss_pred C-CcccccccccCccccccccccCC-CCCcchhhhhHhHHHHHHhhcCCCCCCCCcccc
Q 027809 160 G-VSLLRTTCGTPNYVAPEVLSHKG-YNGAAADVWSCGVILYVLIAGYLPFDELDLTTL 216 (218)
Q Consensus 160 ~-~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 216 (218)
. ........+++.|++||.+.... ..+.++|||||||++|+|++|..||...+..+.
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~ 240 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS 240 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2 22233456788999999997543 335799999999999999999999988766543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=280.19 Aligned_cols=209 Identities=27% Similarity=0.480 Sum_probs=172.4
Q ss_pred ccceEEeeeecCccceEEEEEEecCCC-------cEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETG-------ESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLA 77 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~-------~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~ 77 (218)
.++|++++.||+|+||.||.|.....+ ..||||++.... ..+....+.+|...+.++ +||||+++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 478999999999999999999876443 478999986544 333456677888888777 7999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 78 SRTKIYIILEFITGGELFDKIVHHG----------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 78 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
+++..++||||+++|+|.+++.... .+++.+++.++.||+.||+|||+++++|+||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999996543 489999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccccc
Q 027809 142 SQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTTLY 217 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 217 (218)
.++.+||+|||++......... .....+++.|+|||.+.+..++ .++||||||+++|+|++ |..||...+..+++
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999998765443221 2234567899999999887776 99999999999999998 89999988876553
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=284.97 Aligned_cols=199 Identities=30% Similarity=0.408 Sum_probs=166.0
Q ss_pred ceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc------CCe
Q 027809 8 KYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS------RTK 81 (218)
Q Consensus 8 ~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~------~~~ 81 (218)
+|+..++||+|+||+||.|.+..+|+.||||++..... ...+|+.++++++||||++++++|.. ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 69999999999999999999999999999999866442 23368899999999999999999843 335
Q ss_pred EEEEEEecCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccC
Q 027809 82 IYIILEFITGGELFDK---IVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALP 157 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~ 157 (218)
+++||||++++.+... ......+++.+++.++.|++.||+|||++||+|+||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999987543332 23455799999999999999999999999999999999999998765 8999999998755
Q ss_pred CCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 158 EQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.... ......+++.|+|||.+......+.++||||+||++|+|++|..||...+..
T Consensus 174 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~ 229 (350)
T d1q5ka_ 174 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV 229 (350)
T ss_dssp CTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred cCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH
Confidence 4332 2234567889999999876554459999999999999999999999877643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-45 Score=277.11 Aligned_cols=206 Identities=26% Similarity=0.412 Sum_probs=161.7
Q ss_pred cceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEc-C
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLAS-R 79 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~-~ 79 (218)
++|++++.||+|+||.||+|.+.. +++.||+|.+.... .....+.+.++...+.++ +|+|++.+++++.. .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 689999999999999999999764 34679999986443 223345566777777666 68999999998764 4
Q ss_pred CeEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCC
Q 027809 80 TKIYIILEFITGGELFDKIVHH----------------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQ 143 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~ 143 (218)
+..++|||||++++|.+++... ..+++.+++.++.|++.||.|||+++++|+||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999999998653 248899999999999999999999999999999999999999
Q ss_pred CcEEEeeccccccCCCCCc--ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhc-CCCCCCCCccc
Q 027809 144 GHLKISDFGLSALPEQGVS--LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTT 215 (218)
Q Consensus 144 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~ 215 (218)
+.+||+|||++........ ......+++.|+|||.+.+..++ .++||||||+++|||++| ..||...+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999975443222 22234578899999999877765 999999999999999986 67898776543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-44 Score=272.08 Aligned_cols=202 Identities=22% Similarity=0.330 Sum_probs=171.6
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC-CCcceEEEEEEcCCeEEE
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH-PCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~-~~i~~~~~~~~~~~~~~l 84 (218)
-++|++++.||+|+||.||.|.+..+|+.||+|++..... ...+.+|++.+..++| +|++.+++++......++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999998855431 1345677888888876 899999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecC-----CCcEEEeeccccccCC
Q 027809 85 ILEFITGGELFDKIVHH-GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDS-----QGHLKISDFGLSALPE 158 (218)
Q Consensus 85 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~-----~~~~~l~d~~~~~~~~ 158 (218)
|||++. ++|.+.+... ..++..++..++.|++.+|++||++|++|+||||+||+++. ++.++|+|||++....
T Consensus 79 vme~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 999994 6888888665 46999999999999999999999999999999999999964 5789999999997644
Q ss_pred CCCc-------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCcc
Q 027809 159 QGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLT 214 (218)
Q Consensus 159 ~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 214 (218)
.... ......|++.|+|||.+.+..++ .++|+||||+++|+|++|..||+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 3211 12234588999999999887775 9999999999999999999999876544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-44 Score=272.68 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=169.4
Q ss_pred CccccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCC-cceEEEEEEcC
Q 027809 1 MVVRKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPC-VVRLHEVLASR 79 (218)
Q Consensus 1 ~~~~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~-i~~~~~~~~~~ 79 (218)
|=.+.-++|++++.||+|+||.||.|.+..+|+.||||++...... +.+..|.++++.++|++ ++.+..++...
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 4456667899999999999999999999999999999988654321 34678899999998765 55556666788
Q ss_pred CeEEEEEEecCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec---CCCcEEEeeccccc
Q 027809 80 TKIYIILEFITGGELFDKI-VHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD---SQGHLKISDFGLSA 155 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~---~~~~~~l~d~~~~~ 155 (218)
+..++|||++++ ++...+ .....+++.+++.++.|++.||++||++|++|+||||+||+++ .+..++++|||++.
T Consensus 76 ~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 76 DYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred CEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 899999999966 554444 4456899999999999999999999999999999999999985 35579999999997
Q ss_pred cCCCCCc-------ccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCccc
Q 027809 156 LPEQGVS-------LLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDLTT 215 (218)
Q Consensus 156 ~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 215 (218)
....... ......+++.|+|||.+.+..++ .++||||||+++|+|++|..||...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 6543221 12234588999999999887775 99999999999999999999998876654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-44 Score=276.39 Aligned_cols=199 Identities=27% Similarity=0.506 Sum_probs=170.7
Q ss_pred cccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEc--CCe
Q 027809 5 KVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLAS--RTK 81 (218)
Q Consensus 5 ~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~--~~~ 81 (218)
..++|++++.||+|+||+||.|.+..+|+.||+|++.... .+++.+|+.++++++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999986433 356788999999995 9999999999974 456
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCC-cEEEeeccccccCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQG-HLKISDFGLSALPEQG 160 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~-~~~l~d~~~~~~~~~~ 160 (218)
.++||||+++++|... ...+++.++..++.||+.||.|||++|++|+||||+|||++.++ .++|+|||++......
T Consensus 107 ~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999999998654 35799999999999999999999999999999999999998655 6999999999755443
Q ss_pred CcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 161 VSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 161 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
. ......+++.|+|||.+.+....+.++|+||+|+++++|++|..||...+.
T Consensus 184 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 184 Q-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp C-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred C-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 2 223455788999999988765546999999999999999999999986553
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=275.98 Aligned_cols=209 Identities=24% Similarity=0.343 Sum_probs=178.2
Q ss_pred ccceEEeeeecCccceEEEEEEecC-----CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTE-----TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT 80 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~ 80 (218)
.++|++++.||+|+||.||.|.+.. ++..||||++.... ..+....+.+|+.++++++||||+++++++...+
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 4789999999999999999998753 35689999986543 3344567889999999999999999999999889
Q ss_pred eEEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEee
Q 027809 81 KIYIILEFITGGELFDKIVHH----------GRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISD 150 (218)
Q Consensus 81 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d 150 (218)
..++|+|++++|+|.+++... ..+++.++..++.|+++||.|||+++++|+||+|+|||++.++.+||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 999999999999999888543 2468999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhc-CCCCCCCCccccc
Q 027809 151 FGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAG-YLPFDELDLTTLY 217 (218)
Q Consensus 151 ~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~ 217 (218)
||++......... .....+++.|+|||.+.+..+. .++|+||||+++|||++| ..||+..+..+++
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9998755433221 2233568899999999877775 899999999999999997 6899988776543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=275.30 Aligned_cols=207 Identities=26% Similarity=0.415 Sum_probs=176.6
Q ss_pred ccceEEeeeecCccceEEEEEEec-----CCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhc-CCCCcceEEEEEEcC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNT-----ETGESVAMKVLDRSAIIKHKMADQIKREISIMKLV-RHPCVVRLHEVLASR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l-~~~~i~~~~~~~~~~ 79 (218)
.++|++++.||+|+||.||.|.+. .+++.||||.+.... .......+.+|+.++..+ +||||+++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 378999999999999999999863 456789999986544 333456788999999998 699999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEec
Q 027809 80 TKIYIILEFITGGELFDKIVHHG------------------RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLD 141 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~ 141 (218)
+..+++||||++++|.+++.... .+++..+..++.||+.|+.+||+++++|+||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999986543 589999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccccccCCCCCcc--cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhh-cCCCCCCCCccc
Q 027809 142 SQGHLKISDFGLSALPEQGVSL--LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIA-GYLPFDELDLTT 215 (218)
Q Consensus 142 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 215 (218)
.++.++++|||.+......... .....+++.|+|||.+....++ .++||||||+++|+|+| |.+||...+..+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999865543222 2234578899999999877765 99999999999999998 777787776644
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=278.85 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=170.0
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcC-----Ce
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASR-----TK 81 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~-----~~ 81 (218)
++|++++.||+|+||+||.|.+..+|+.||||++..... +....+++.+|+.++++++|||++++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 579999999999999999999999999999999865432 334456788999999999999999999998532 23
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCC
Q 027809 82 IYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGV 161 (218)
Q Consensus 82 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~ 161 (218)
.+++++++.+++|.+++.. .++++.+++.++.||+.||.|||++|++|+||||+||+++.++.++++|||++......
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~- 174 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 174 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc-
Confidence 4566677778899988754 57999999999999999999999999999999999999999999999999998755432
Q ss_pred cccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 162 SLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 162 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.....+++.|+|||...+..+.+.++|+||||+++|+|++|..||...+.
T Consensus 175 --~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp --GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred --cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 22445778999999988776666999999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=269.19 Aligned_cols=199 Identities=25% Similarity=0.315 Sum_probs=165.2
Q ss_pred EEeeeecCccceEEEEEEecCCC---cEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEc-CCeEEEE
Q 027809 10 EVGRTIGEGTFAKVKFAQNTETG---ESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLAS-RTKIYII 85 (218)
Q Consensus 10 ~~~~~l~~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 85 (218)
...++||+|+||+||+|.+..++ ..||||.+.... +....+++.+|+..+.+++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34678999999999999986543 368999886433 44556789999999999999999999999764 5689999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCCCCcc-
Q 027809 86 LEFITGGELFDKIVHHG-RLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQGVSL- 163 (218)
Q Consensus 86 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~~~~~- 163 (218)
||||++++|.+++.... .+++..++.++.|++.||.|||+++++|+||+|+|||+++++.+||+|||++.........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999999887544 5778899999999999999999999999999999999999999999999999765432211
Q ss_pred ---cccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCC
Q 027809 164 ---LRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDEL 211 (218)
Q Consensus 164 ---~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 211 (218)
.....+++.|+|||.+....++ .++||||||+++|||++|..||...
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~ 237 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPD 237 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred ceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCC
Confidence 2223467899999999877765 9999999999999999977776543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=275.72 Aligned_cols=202 Identities=29% Similarity=0.474 Sum_probs=165.3
Q ss_pred ccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEE------cC
Q 027809 6 VGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLA------SR 79 (218)
Q Consensus 6 ~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~------~~ 79 (218)
.++|++++.||+|+||+||.|.+..+|..||||++..... +.....++.+|+.++++++||||++++++|. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999976543 3444567889999999999999999999985 34
Q ss_pred CeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 80 TKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 80 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
...|+||||+.++.+ +.. ...+++..++.++.|++.||.+||++|++|+||||+||+++.++.++++|||++.....
T Consensus 95 ~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 689999999987544 433 35789999999999999999999999999999999999999999999999998775544
Q ss_pred CCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 160 GVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 160 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.. ......+++.|+|||.+.+..++ .++||||+||++++|++|..||...+.
T Consensus 172 ~~-~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 172 SF-MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc-ccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCH
Confidence 32 22344578899999999887665 899999999999999999999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=265.60 Aligned_cols=199 Identities=22% Similarity=0.331 Sum_probs=161.8
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCcceEEEEEEcCC----eE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCVVRLHEVLASRT----KI 82 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i~~~~~~~~~~~----~~ 82 (218)
.+|.+.+.||+|+||.||+|.. +|..||||.+..... .......++..+.+++||||+++++++...+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4689999999999999999986 578999999854331 1122335666777889999999999986543 68
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCCeEecCCCcEEEeecccc
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS--------KGVYHRDLKPENLLLDSQGHLKISDFGLS 154 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~--------~~i~h~di~p~nil~~~~~~~~l~d~~~~ 154 (218)
++||||+++++|.+++... ++++.+++.++.|++.++.++|. +|++|+||+|+||+++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999764 78999999999999999999996 58999999999999999999999999998
Q ss_pred ccCCCCCc----ccccccccCccccccccccCCC-----CCcchhhhhHhHHHHHHhhcCCCCCCCC
Q 027809 155 ALPEQGVS----LLRTTCGTPNYVAPEVLSHKGY-----NGAAADVWSCGVILYVLIAGYLPFDELD 212 (218)
Q Consensus 155 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~ 212 (218)
........ ......+++.|+|||.+.+... .+.++||||||+++|||++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 75543222 1223457899999999875432 1368999999999999999998886544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-37 Score=237.48 Aligned_cols=199 Identities=26% Similarity=0.473 Sum_probs=154.7
Q ss_pred cceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-----------CCCcceEEEE
Q 027809 7 GKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-----------HPCVVRLHEV 75 (218)
Q Consensus 7 ~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-----------~~~i~~~~~~ 75 (218)
+||++++.||+|+||+||.|.+..+|+.||||++...... .+...+|+.+++.++ |+|+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 4699999999999999999999999999999999765422 234456666665553 5889999988
Q ss_pred EEc--CCeEEEEEEecCCCCh-HHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEecCCC-----
Q 027809 76 LAS--RTKIYIILEFITGGEL-FDKI--VHHGRLSESEARRYFQQLIDGVDYCHS-KGVYHRDLKPENLLLDSQG----- 144 (218)
Q Consensus 76 ~~~--~~~~~lv~e~~~~~~L-~~~~--~~~~~~~~~~~~~~~~~i~~~l~~Lh~-~~i~h~di~p~nil~~~~~----- 144 (218)
+.. ....+.+++++..... .... .....+++..+..++.|++.|+.+||+ .|++|+||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 753 4456666666554332 2222 333568999999999999999999997 8999999999999997655
Q ss_pred -cEEEeeccccccCCCCCcccccccccCccccccccccCCCCCcchhhhhHhHHHHHHhhcCCCCCCCCc
Q 027809 145 -HLKISDFGLSALPEQGVSLLRTTCGTPNYVAPEVLSHKGYNGAAADVWSCGVILYVLIAGYLPFDELDL 213 (218)
Q Consensus 145 -~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 213 (218)
.++++|||.+....... ....+++.|+|||.+....++ .++|+||+|+++++|++|+.||...+.
T Consensus 169 ~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY---TNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ceeeEeeccccccccccc---ccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCcc
Confidence 39999999987544322 245678899999999987775 899999999999999999999986543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.4e-26 Score=161.21 Aligned_cols=137 Identities=18% Similarity=0.232 Sum_probs=106.8
Q ss_pred eEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhh---------------hhhHHHHHHHHHHhhhhcCCCCcceEE
Q 027809 9 YEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAII---------------KHKMADQIKREISIMKLVRHPCVVRLH 73 (218)
Q Consensus 9 y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~---------------~~~~~~~~~~~~~~l~~l~~~~i~~~~ 73 (218)
+.++++||+|+||.||.|.+. +|+.||||++...... ..........+...+.++.+.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999875 6899999987432110 111223345678888899999999888
Q ss_pred EEEEcCCeEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEecCCCcEEEeeccc
Q 027809 74 EVLASRTKIYIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHSKGVYHRDLKPENLLLDSQGHLKISDFGL 153 (218)
Q Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~~~i~h~di~p~nil~~~~~~~~l~d~~~ 153 (218)
+... .+++||++++..+. .++......++.|++.++.+||++|++|+||||+||+++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7642 26899999886543 24556677899999999999999999999999999999865 488999998
Q ss_pred cccCC
Q 027809 154 SALPE 158 (218)
Q Consensus 154 ~~~~~ 158 (218)
+....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 86543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.82 E-value=3.6e-08 Score=71.52 Aligned_cols=146 Identities=15% Similarity=0.132 Sum_probs=93.1
Q ss_pred ccccceEEeeeecCccceEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeE
Q 027809 4 RKVGKYEVGRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKI 82 (218)
Q Consensus 4 ~~~~~y~~~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~ 82 (218)
+.++.|+..+..+.++.+.+|.+. .++..+++|......... ...+..|...+..+. +--+++++.+.+..+..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 456788888876655567889775 355678888775443222 223455666666553 32357788888888899
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 027809 83 YIILEFITGGELFDKIVHHGRLSESEARRYFQQLIDGVDYCHS------------------------------------- 125 (218)
Q Consensus 83 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~Lh~------------------------------------- 125 (218)
++||++.+|.++.+..... .....++.++++.+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999999987765432211 1111223333333333332
Q ss_pred ----------------------CCceeccCCCCCeEecCCCcEEEeeccccccCCC
Q 027809 126 ----------------------KGVYHRDLKPENLLLDSQGHLKISDFGLSALPEQ 159 (218)
Q Consensus 126 ----------------------~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~~ 159 (218)
..++|||++|.||++++++..-++||+.+.....
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~~ 216 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADK 216 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEEH
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCCH
Confidence 1278999999999998776677999998765443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.40 E-value=1.2e-06 Score=67.16 Aligned_cols=81 Identities=17% Similarity=0.133 Sum_probs=46.8
Q ss_pred eeeecCccceEEEEEEecCCCcEEEEEEEecchh-hh---hhHHHHHHHHHHhhhhcC-C--CCcceEEEEEEcCCeEEE
Q 027809 12 GRTIGEGTFAKVKFAQNTETGESVAMKVLDRSAI-IK---HKMADQIKREISIMKLVR-H--PCVVRLHEVLASRTKIYI 84 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~---~~~~~~~~~~~~~l~~l~-~--~~i~~~~~~~~~~~~~~l 84 (218)
.+.+|.|....||.+.+..+++.+++|.-..... .. +....+...|...+..+. + ..+++++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 5578999999999998877788899986532110 00 111234445565555542 2 3456666553 334578
Q ss_pred EEEecCCCCh
Q 027809 85 ILEFITGGEL 94 (218)
Q Consensus 85 v~e~~~~~~L 94 (218)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.38 E-value=7e-07 Score=64.20 Aligned_cols=75 Identities=13% Similarity=0.136 Sum_probs=48.8
Q ss_pred eeecCccc-eEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCC--CCcceEEEEEEcCCeEEEEEEec
Q 027809 13 RTIGEGTF-AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRH--PCVVRLHEVLASRTKIYIILEFI 89 (218)
Q Consensus 13 ~~l~~g~~-g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~ 89 (218)
+.+..|.. ..+|..... ++..+++|....... ..+..|...++.+.. --+++++....+.+..++|++++
T Consensus 16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred EEcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 34555554 567877753 566788887644331 234455555555532 23677888888888999999999
Q ss_pred CCCCh
Q 027809 90 TGGEL 94 (218)
Q Consensus 90 ~~~~L 94 (218)
+|.++
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 87554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.33 E-value=0.0009 Score=50.79 Aligned_cols=74 Identities=16% Similarity=0.168 Sum_probs=46.4
Q ss_pred eeeecCccceEEEEEEecC-------CCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcC-CCCcceEEEEEEcCCeEE
Q 027809 12 GRTIGEGTFAKVKFAQNTE-------TGESVAMKVLDRSAIIKHKMADQIKREISIMKLVR-HPCVVRLHEVLASRTKIY 83 (218)
Q Consensus 12 ~~~l~~g~~g~vy~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~-~~~i~~~~~~~~~~~~~~ 83 (218)
++.|+.|-.-.+|.+.... ..+.+++++..... . .-...+|..+++.+. +.--++++.++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 5677778888899887543 24568888765321 1 123446666666664 3334577777643 5
Q ss_pred EEEEecCCCCh
Q 027809 84 IILEFITGGEL 94 (218)
Q Consensus 84 lv~e~~~~~~L 94 (218)
.|+|++++.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78899887443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.16 E-value=0.0037 Score=45.60 Aligned_cols=33 Identities=24% Similarity=0.294 Sum_probs=28.4
Q ss_pred CCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 126 KGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 126 ~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
.|++|||+.+.|++++.+...-++||+.++...
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~~ 215 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACNDL 215 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred cccccCCcchhhhhcccccceeEecccccccch
Confidence 469999999999999988778899999887443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.003 Score=46.49 Aligned_cols=131 Identities=16% Similarity=0.132 Sum_probs=71.5
Q ss_pred eEEEEEEecCCCcEEEEEEEecchhhhhhHHHHHHHHHHhhhhcCCCCc---ceE----EEEEEcCCeEEEEEEecCCCC
Q 027809 21 AKVKFAQNTETGESVAMKVLDRSAIIKHKMADQIKREISIMKLVRHPCV---VRL----HEVLASRTKIYIILEFITGGE 93 (218)
Q Consensus 21 g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~i---~~~----~~~~~~~~~~~lv~e~~~~~~ 93 (218)
..||.+.. .+|..+++|+..... .+ .+.+.+|...+..+....+ .++ -..+...+..+.++++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~-~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER-WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT-SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC-CC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 57888875 478889999975432 22 2345556655555532111 111 122355677889999988633
Q ss_pred h-----HHHH------Hh------c------CC-------------------CC---HHHHHHHHHHHHHHHHHHH----
Q 027809 94 L-----FDKI------VH------H------GR-------------------LS---ESEARRYFQQLIDGVDYCH---- 124 (218)
Q Consensus 94 L-----~~~~------~~------~------~~-------------------~~---~~~~~~~~~~i~~~l~~Lh---- 124 (218)
+ .... .. . .. ++ .......+.++...+...-
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 2 1111 00 0 00 11 1112233333333333321
Q ss_pred hCCceeccCCCCCeEecCCCcEEEeeccccccCC
Q 027809 125 SKGVYHRDLKPENLLLDSQGHLKISDFGLSALPE 158 (218)
Q Consensus 125 ~~~i~h~di~p~nil~~~~~~~~l~d~~~~~~~~ 158 (218)
..+++|||++|.|+++++ + ..++||+-++...
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~g~ 222 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARNGP 222 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCCEEC
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhcccCc
Confidence 135899999999999964 3 4589999877543
|